pmid,year,mesh,meshTreeNumber
16395289,2006-01-04T00:00:00,Adult,M01.060.116
16395289,2006-01-04T00:00:00,Aged,M01.060.116.100
16395289,2006-01-04T00:00:00,Brain Ischemia,C10.228.140.300.150
16395289,2006-01-04T00:00:00,Brain Ischemia,C14.907.253.092
16395289,2006-01-04T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16395289,2006-01-04T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16395289,2006-01-04T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16395289,2006-01-04T00:00:00,Gene Expression Profiling,E05.393.332
16395289,2006-01-04T00:00:00,Gene Expression Regulation,G05.355.315
16395289,2006-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16395289,2006-01-04T00:00:00,Inflammation,C23.550.470
16395289,2006-01-04T00:00:00,Middle Aged,M01.060.116.630
16395289,2006-01-04T00:00:00,Monocytes,A11.118.637.555.652
16395289,2006-01-04T00:00:00,Monocytes,A11.148.580
16395289,2006-01-04T00:00:00,Monocytes,A11.627.624
16395289,2006-01-04T00:00:00,Monocytes,A11.733.547
16395289,2006-01-04T00:00:00,Monocytes,A15.145.229.637.555.652
16395289,2006-01-04T00:00:00,Monocytes,A15.378.316.580
16395289,2006-01-04T00:00:00,Monocytes,A15.382.490.555.652
16395289,2006-01-04T00:00:00,Monocytes,A15.382.680.547
16395289,2006-01-04T00:00:00,Monocytes,A15.382.812.547
16395289,2006-01-04T00:00:00,Neutrophils,A11.118.637.415.583
16395289,2006-01-04T00:00:00,Neutrophils,A11.627.340.583
16395289,2006-01-04T00:00:00,Neutrophils,A11.733.689
16395289,2006-01-04T00:00:00,Neutrophils,A15.145.229.637.415.583
16395289,2006-01-04T00:00:00,Neutrophils,A15.382.490.315.583
16395289,2006-01-04T00:00:00,Neutrophils,A15.382.680.689
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16395289,2006-01-04T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16395289,2006-01-04T00:00:00,Peptides,D12.644
16395289,2006-01-04T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
16395289,2006-01-04T00:00:00,Stroke,C10.228.140.300.775
16395289,2006-01-04T00:00:00,Stroke,C14.907.253.855
16395289,2006-01-04T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16395289,2006-01-04T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16395289,2006-01-04T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16395289,2006-01-04T00:00:00,Tissue Plasminogen Activator,D23.119.970
16399687,2006-01-04T00:00:00,Animals,B01.050
16399687,2006-01-04T00:00:00,Dopamine,D02.092.211.215.311.342
16399687,2006-01-04T00:00:00,Dopamine,D02.092.311.342
16399687,2006-01-04T00:00:00,Neurons,A08.663
16399687,2006-01-04T00:00:00,Neurons,A11.671
16399687,2006-01-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16399687,2006-01-04T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16399687,2006-01-04T00:00:00,Sleep,F02.830.855
16399687,2006-01-04T00:00:00,Sleep,G11.561.600.815
16399687,2006-01-04T00:00:00,Wakefulness,F02.830.104.821
16399687,2006-01-04T00:00:00,Wakefulness,G11.561.600.042.738
16461051,2006-01-04T00:00:00,Adult,M01.060.116
16461051,2006-01-04T00:00:00,Atrial Fibrillation,C14.280.067.198
16461051,2006-01-04T00:00:00,Atrial Fibrillation,C23.550.073.198
16461051,2006-01-04T00:00:00,Collagen,D05.750.078.280
16461051,2006-01-04T00:00:00,Collagen,D12.776.860.300.250
16461051,2006-01-04T00:00:00,Heart Atria,A07.541.358
16461051,2006-01-04T00:00:00,Heart Failure,C14.280.434
16461051,2006-01-04T00:00:00,Heart Ventricles,A07.541.560
16461051,2006-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16461051,2006-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16461051,2006-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16461051,2006-01-04T00:00:00,Middle Aged,M01.060.116.630
16461051,2006-01-04T00:00:00,Myocardium,A02.633.580
16461051,2006-01-04T00:00:00,Myocardium,A07.541.704
16461051,2006-01-04T00:00:00,Myocardium,A10.690.552.750
16461051,2006-01-04T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
16461051,2006-01-04T00:00:00,Ventricular Remodeling,C23.300.985
16461051,2006-01-04T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16500415,2006-01-04T00:00:00,Adult,M01.060.116
16500415,2006-01-04T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16500415,2006-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16500415,2006-01-04T00:00:00,Laparoscopy,E01.370.388.250.520
16500415,2006-01-04T00:00:00,Laparoscopy,E04.800.250.520
16407281,2006-01-05T00:00:00,Adult,M01.060.116
16407281,2006-01-05T00:00:00,Amino Acid Sequence,G02.111.570.060
16407281,2006-01-05T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16407281,2006-01-05T00:00:00,Animals,B01.050
16407281,2006-01-05T00:00:00,Epithelial Cells,A11.436
16407281,2006-01-05T00:00:00,Gene Expression,G05.355.310
16407281,2006-01-05T00:00:00,Hemoglobins,D12.776.124.400
16407281,2006-01-05T00:00:00,Hemoglobins,D12.776.422.316.762
16407281,2006-01-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16407281,2006-01-05T00:00:00,Molecular Sequence Data,L01.453.245.667
16407281,2006-01-05T00:00:00,Pulmonary Alveoli,A04.411.715
16407281,2006-01-05T00:00:00,"RNA, Messenger",D13.444.735.544
16407281,2006-01-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16399872,2006-01-06T00:00:00,Animals,B01.050
16399872,2006-01-06T00:00:00,Apoptosis,G04.299.139.160
16399872,2006-01-06T00:00:00,Calcium,D01.268.552.100
16399872,2006-01-06T00:00:00,Calcium,D01.552.539.288
16399872,2006-01-06T00:00:00,Calcium,D23.119.100
16399872,2006-01-06T00:00:00,Calcium Signaling,G02.111.087.800.800.100
16399872,2006-01-06T00:00:00,Calcium Signaling,G02.149.115.800.800.100
16399872,2006-01-06T00:00:00,Calcium Signaling,G03.495.166.500.100
16399872,2006-01-06T00:00:00,Calcium Signaling,G04.299.880.800.100
16399872,2006-01-06T00:00:00,Ion Channels,D12.776.157.530.400
16399872,2006-01-06T00:00:00,Ion Channels,D12.776.543.550.425
16399872,2006-01-06T00:00:00,Ion Channels,D12.776.543.585.400
16399872,2006-01-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16399872,2006-01-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16399872,2006-01-06T00:00:00,Reactive Oxygen Species,D01.339.431
16399872,2006-01-06T00:00:00,Reactive Oxygen Species,D01.650.775
16399872,2006-01-06T00:00:00,Reperfusion Injury,C14.907.725
16399872,2006-01-06T00:00:00,Reperfusion Injury,C23.550.767.877
16399955,2006-01-06T00:00:00,Animals,B01.050
16399955,2006-01-06T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
16399955,2006-01-06T00:00:00,Glutathione,D12.644.456.448
16399955,2006-01-06T00:00:00,Hyperoxia,C23.888.852.567
16399955,2006-01-06T00:00:00,Lung,A04.411
16399955,2006-01-06T00:00:00,Lung Diseases,C08.381
16399955,2006-01-06T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16399955,2006-01-06T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16399955,2006-01-06T00:00:00,Oxidative Stress,G03.495.710
16399955,2006-01-06T00:00:00,Oxidative Stress,G07.700.830.750
16399955,2006-01-06T00:00:00,Oxygen,D01.268.185.550
16399955,2006-01-06T00:00:00,Oxygen,D01.362.670
16399955,2006-01-06T00:00:00,Peroxidases,D08.811.682.732
16399955,2006-01-06T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
16399955,2006-01-06T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
16399955,2006-01-06T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
16399955,2006-01-06T00:00:00,Peroxiredoxins,D08.811.682.732.850
16406215,2006-01-06T00:00:00,Adult,M01.060.116
16406215,2006-01-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16406215,2006-01-06T00:00:00,Personality,F01.752
16406215,2006-01-06T00:00:00,Personality Inventory,F04.711.647.513
16406215,2006-01-06T00:00:00,Questionnaires,E05.318.308.750
16406215,2006-01-06T00:00:00,Questionnaires,L01.280.800
16406215,2006-01-06T00:00:00,Questionnaires,N05.715.360.300.695
16406215,2006-01-06T00:00:00,Questionnaires,N06.850.520.308.750
16401625,2006-01-09T00:00:00,Adenoviridae,B04.280.030
16401625,2006-01-09T00:00:00,Adenoviridae,B04.909.204.097
16401625,2006-01-09T00:00:00,Animals,B01.050
16401625,2006-01-09T00:00:00,Apoptosis,G04.299.139.160
16401625,2006-01-09T00:00:00,Gene Transfer Techniques,E05.393.350
16401625,2006-01-09T00:00:00,Gentamicins,D09.408.051.374
16401625,2006-01-09T00:00:00,Kidney,A05.810.453
16401625,2006-01-09T00:00:00,Kinins,D12.644.276.812
16401625,2006-01-09T00:00:00,Kinins,D12.776.467.812
16401625,2006-01-09T00:00:00,Kinins,D23.469.050.375
16401625,2006-01-09T00:00:00,Kinins,D23.529.812
16401625,2006-01-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16401625,2006-01-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16401625,2006-01-09T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
16401625,2006-01-09T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
16401625,2006-01-09T00:00:00,Tissue Kallikreins,D23.101.840.870
16388594,2006-01-10T00:00:00,Animals,B01.050
16388594,2006-01-10T00:00:00,Binding Sites,G02.111.570.120
16388594,2006-01-10T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
16388594,2006-01-10T00:00:00,Gene Expression Regulation,G05.355.315
16388594,2006-01-10T00:00:00,Genetic Vectors,G05.360.337
16388594,2006-01-10T00:00:00,Mitosis,G04.299.134.220.220.781
16388594,2006-01-10T00:00:00,Mitosis,G05.355.105.220.781
16388594,2006-01-10T00:00:00,Mutation,G05.365.590
16388594,2006-01-10T00:00:00,Tubulin,D05.750.078.734.800
16388594,2006-01-10T00:00:00,Tubulin,D12.776.220.600.800
16388594,2006-01-10T00:00:00,Tubulin,D12.776.641.920
16874071,2006-01-10T00:00:00,Amines,D02.092
16874071,2006-01-10T00:00:00,Animals,B01.050
16874071,2006-01-10T00:00:00,Autophagy,G04.299.139.399
16874071,2006-01-10T00:00:00,Autophagy,G04.299.482.350.091
16874071,2006-01-10T00:00:00,Fluorescent Dyes,D27.720.233.348
16874071,2006-01-10T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16874071,2006-01-10T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16874071,2006-01-10T00:00:00,Hepatocytes,A11.436.348
16874071,2006-01-10T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
16874071,2006-01-10T00:00:00,"Microscopy, Confocal",E05.595.395
16874071,2006-01-10T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
16874071,2006-01-10T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
16874071,2006-01-10T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
16874071,2006-01-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16410474,2006-01-12T00:00:00,Brain,A08.186.211
16410474,2006-01-12T00:00:00,Brain Ischemia,C10.228.140.300.150
16410474,2006-01-12T00:00:00,Brain Ischemia,C14.907.253.092
16410474,2006-01-12T00:00:00,Cerebrovascular Disorders,C10.228.140.300
16410474,2006-01-12T00:00:00,Cerebrovascular Disorders,C14.907.253
16410474,2006-01-12T00:00:00,Cost-Benefit Analysis,N03.219.151.125
16410474,2006-01-12T00:00:00,Health Policy,I01.880.604.825.608.400
16410474,2006-01-12T00:00:00,Health Policy,N03.706.825.608.428
16410474,2006-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16410474,2006-01-12T00:00:00,Ischemia,C23.550.513
16410474,2006-01-12T00:00:00,Stroke,C10.228.140.300.775
16410474,2006-01-12T00:00:00,Stroke,C14.907.253.855
16410474,2006-01-12T00:00:00,Treatment Outcome,E01.789.800
16410474,2006-01-12T00:00:00,Treatment Outcome,N04.761.559.590.800
16410474,2006-01-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16410615,2006-01-12T00:00:00,"Gene Expression Regulation, Viral",G05.355.315.385
16410615,2006-01-12T00:00:00,Hepatitis B virus,B04.280.375.650.425
16410615,2006-01-12T00:00:00,Hepatitis B virus,B04.450.390.650.425
16410615,2006-01-12T00:00:00,Hepatitis B virus,B04.909.204.340.650.425
16410615,2006-01-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16410615,2006-01-12T00:00:00,"RNA, Viral",D13.444.735.828
16410615,2006-01-12T00:00:00,RNA-Binding Proteins,D12.776.157.725
16410615,2006-01-12T00:00:00,RNA-Binding Proteins,D12.776.664.962
16201965,2006-01-15T00:00:00,Ceramides,D02.065.313
16201965,2006-01-15T00:00:00,Ceramides,D09.400.410.420.525.200
16201965,2006-01-15T00:00:00,Ceramides,D10.390.470.675.200
16201965,2006-01-15T00:00:00,Ceramides,D10.570.877.360.612.200
16201965,2006-01-15T00:00:00,Gene Expression Regulation,G05.355.315
16201965,2006-01-15T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
16201965,2006-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16201965,2006-01-15T00:00:00,Oxidative Stress,G03.495.710
16201965,2006-01-15T00:00:00,Oxidative Stress,G07.700.830.750
16201965,2006-01-15T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
16201965,2006-01-15T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
16201965,2006-01-15T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
16201965,2006-01-15T00:00:00,Reactive Oxygen Species,D01.339.431
16201965,2006-01-15T00:00:00,Reactive Oxygen Species,D01.650.775
16201965,2006-01-15T00:00:00,Sphingosine,D02.033.100.700
16201965,2006-01-15T00:00:00,Sphingosine,D02.033.455.843
16201965,2006-01-15T00:00:00,Sphingosine,D02.092.063.700
16201965,2006-01-15T00:00:00,Substrate Specificity,G02.111.835
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16201965,2006-01-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16393984,2006-01-15T00:00:00,Autoantigens,D23.050.422
16393984,2006-01-15T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
16393984,2006-01-15T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
16393984,2006-01-15T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
16393984,2006-01-15T00:00:00,Cell Proliferation,G04.299.233.750
16393984,2006-01-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16393984,2006-01-15T00:00:00,Dendritic Cells,A11.066.270
16393984,2006-01-15T00:00:00,Dendritic Cells,A11.436.270
16393984,2006-01-15T00:00:00,Dendritic Cells,A15.382.066.270
16393984,2006-01-15T00:00:00,Dendritic Cells,A15.382.812.260
16393984,2006-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16393984,2006-01-15T00:00:00,Lymphocyte Activation,E01.450.495.482
16393984,2006-01-15T00:00:00,Lymphocyte Activation,E05.478.594.530
16393984,2006-01-15T00:00:00,Lymphocyte Activation,G12.425.747
16393984,2006-01-15T00:00:00,Lymphocyte Activation,G12.450.050.400.545
16393984,2006-01-15T00:00:00,Melanoma,C04.557.465.625.650.510
16393984,2006-01-15T00:00:00,Melanoma,C04.557.580.625.650.510
16393984,2006-01-15T00:00:00,Melanoma,C04.557.665.510
16393984,2006-01-15T00:00:00,Neoplasm Proteins,D12.776.624
16393984,2006-01-15T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
16393984,2006-01-15T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
16393984,2006-01-15T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
16423990,2006-01-15T00:00:00,Animals,B01.050
16423990,2006-01-15T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
16423990,2006-01-15T00:00:00,Doxorubicin,D04.615.562.050.200.175
16423990,2006-01-15T00:00:00,Doxorubicin,D09.408.051.059.200.175
16423990,2006-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16423990,2006-01-15T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
16423990,2006-01-15T00:00:00,"Mammary Neoplasms, Animal",C22.520
16423990,2006-01-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16423990,2006-01-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16423990,2006-01-15T00:00:00,Polyethylene Glycols,D02.033.455.250.700
16423990,2006-01-15T00:00:00,Polyethylene Glycols,D05.750.741
16423990,2006-01-15T00:00:00,Polyethylene Glycols,D25.720.741
16423990,2006-01-15T00:00:00,Polyethylene Glycols,J01.637.051.720.741
16423990,2006-01-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16424029,2006-01-15T00:00:00,Antineoplastic Agents,D27.505.954.248
16424029,2006-01-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
16424029,2006-01-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
16424029,2006-01-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
16424029,2006-01-15T00:00:00,Disease Progression,C23.550.291.656
16424029,2006-01-15T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
16424029,2006-01-15T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
16424029,2006-01-15T00:00:00,Homeodomain Proteins,D12.776.260.400
16424029,2006-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16424029,2006-01-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
16424029,2006-01-15T00:00:00,Lung Neoplasms,C08.381.540
16424029,2006-01-15T00:00:00,Lung Neoplasms,C08.785.520
16424029,2006-01-15T00:00:00,Quinazolines,D03.438.786
16424029,2006-01-15T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
16424029,2006-01-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
16424029,2006-01-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
16424029,2006-01-15T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
16424029,2006-01-15T00:00:00,Transcription Factors,D12.776.930
16424029,2006-01-15T00:00:00,"Tumor Markers, Biological",D23.101.840
16468387,2006-01-15T00:00:00,Plutonium,D01.268.033.700
16468387,2006-01-15T00:00:00,Plutonium,D01.268.271.100.700
16468387,2006-01-15T00:00:00,Plutonium,D01.268.556.700
16468387,2006-01-15T00:00:00,Plutonium,D01.552.020.734
16468387,2006-01-15T00:00:00,Plutonium,D01.552.544.700
16468387,2006-01-15T00:00:00,South Carolina,Z01.107.567.875.075.662
16468387,2006-01-15T00:00:00,South Carolina,Z01.107.567.875.750.700
16468387,2006-01-15T00:00:00,"Water Pollutants, Radioactive",D20.693.903
16468387,2006-01-15T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
16401067,2006-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16401067,2006-01-17T00:00:00,Peroxidases,D08.811.682.732
16401067,2006-01-17T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
16401067,2006-01-17T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
16401067,2006-01-17T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
16401067,2006-01-17T00:00:00,Peroxiredoxins,D08.811.682.732.850
16418273,2006-01-17T00:00:00,Cell Cycle Proteins,D12.776.167
16418273,2006-01-17T00:00:00,Chromatin Immunoprecipitation,E05.393.170
16418273,2006-01-17T00:00:00,Chromatin Immunoprecipitation,E05.478.605.160
16418273,2006-01-17T00:00:00,DNA Helicases,D08.811.277.040.025.159
16418273,2006-01-17T00:00:00,DNA Helicases,D08.811.399.340
16418273,2006-01-17T00:00:00,DNA Replication,G02.111.087.222
16418273,2006-01-17T00:00:00,DNA Replication,G02.149.115.222
16418273,2006-01-17T00:00:00,DNA Replication,G05.355.200
16418273,2006-01-17T00:00:00,DNA-Binding Proteins,D12.776.260
16418273,2006-01-17T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
16418273,2006-01-17T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
16418273,2006-01-17T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
16418273,2006-01-17T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
16418273,2006-01-17T00:00:00,"Models, Genetic",E05.599.395.397
16418273,2006-01-17T00:00:00,Plasmids,G05.360.600
16418273,2006-01-17T00:00:00,Protein Interaction Mapping,E05.601.690
16418273,2006-01-17T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
16418273,2006-01-17T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
16418273,2006-01-17T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
16418273,2006-01-17T00:00:00,"Transcription, Genetic",G02.111.087.847
16418273,2006-01-17T00:00:00,"Transcription, Genetic",G02.149.115.847
16418273,2006-01-17T00:00:00,"Transcription, Genetic",G05.355.310.700
16418449,2006-01-17T00:00:00,Diastole,G09.330.190.541.295
16418449,2006-01-17T00:00:00,Diastole,G11.427.590.540.554.250
16418449,2006-01-17T00:00:00,Diastole,G11.427.590.540.570.295
16418449,2006-01-17T00:00:00,Heart Failure,C14.280.434
16418449,2006-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16418449,2006-01-17T00:00:00,Myocardial Contraction,G09.330.190.541
16418449,2006-01-17T00:00:00,Myocardial Contraction,G11.427.590.540.570
16418449,2006-01-17T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16413134,2006-01-18T00:00:00,"Adaptation, Psychological",F01.058
16413134,2006-01-18T00:00:00,Adolescent,M01.060.057
16413134,2006-01-18T00:00:00,Adult,M01.060.116
16413134,2006-01-18T00:00:00,Age Factors,N05.715.350.075
16413134,2006-01-18T00:00:00,Age Factors,N06.850.490.250
16413134,2006-01-18T00:00:00,Alcoholism,C21.739.100.250
16413134,2006-01-18T00:00:00,Alcoholism,F03.900.100.350
16413134,2006-01-18T00:00:00,Child Abuse,I01.198.240.856.350.250
16413134,2006-01-18T00:00:00,Child Abuse,I01.880.735.900.350.250
16413134,2006-01-18T00:00:00,Child Abuse,I01.880.787.293.292
16413134,2006-01-18T00:00:00,Circadian Rhythm,G07.180.562.190
16413134,2006-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16413134,2006-01-18T00:00:00,Hydrocortisone,D04.808.745.745.654.600
16413134,2006-01-18T00:00:00,Hydrocortisone,D06.472.040.585.353.476
16413134,2006-01-18T00:00:00,Hydrocortisone,D06.472.040.585.478.392
16413134,2006-01-18T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
16413134,2006-01-18T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
16413134,2006-01-18T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
16413134,2006-01-18T00:00:00,Middle Aged,M01.060.116.630
16413134,2006-01-18T00:00:00,Pituitary-Adrenal System,A06.407.691
16413134,2006-01-18T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16413134,2006-01-18T00:00:00,"Stress, Physiological",G07.700.830
16413140,2006-01-18T00:00:00,Animals,B01.050
16413140,2006-01-18T00:00:00,Central Nervous System Stimulants,D27.505.696.282
16413140,2006-01-18T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
16413140,2006-01-18T00:00:00,Columbidae,B01.050.150.900.248.165.150
16413140,2006-01-18T00:00:00,Dextroamphetamine,D02.092.471.683.152.110.200
16413140,2006-01-18T00:00:00,Discrimination Learning,F02.463.425.280
16413140,2006-01-18T00:00:00,Drug Tolerance,G07.690.812.260
16413140,2006-01-18T00:00:00,Drug Tolerance,G07.700.680.260
16413140,2006-01-18T00:00:00,Reaction Time,F02.830.650
16413140,2006-01-18T00:00:00,Reaction Time,F04.669.817
16413140,2006-01-18T00:00:00,Reaction Time,G11.561.677
16413147,2006-01-18T00:00:00,Adult,M01.060.116
16413147,2006-01-18T00:00:00,Age of Onset,N05.715.350.075.100
16413147,2006-01-18T00:00:00,Age of Onset,N06.850.490.250.100
16413147,2006-01-18T00:00:00,Alcoholism,C21.739.100.250
16413147,2006-01-18T00:00:00,Alcoholism,F03.900.100.350
16413147,2006-01-18T00:00:00,Cocaine-Related Disorders,C21.739.300
16413147,2006-01-18T00:00:00,Cocaine-Related Disorders,F03.900.300
16413147,2006-01-18T00:00:00,Demography,I01.240
16413147,2006-01-18T00:00:00,Demography,N01.224
16413147,2006-01-18T00:00:00,Demography,N06.850.505.400
16413147,2006-01-18T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
16413147,2006-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16413147,2006-01-18T00:00:00,Mental Disorders,F03
16413147,2006-01-18T00:00:00,Phenotype,G05.695
16413147,2006-01-18T00:00:00,Prevalence,E05.318.308.985.525.750
16413147,2006-01-18T00:00:00,Prevalence,L01.280.975.525.750
16413147,2006-01-18T00:00:00,Prevalence,N01.224.935.597.750
16413147,2006-01-18T00:00:00,Prevalence,N06.850.505.400.975.525.750
16413147,2006-01-18T00:00:00,Prevalence,N06.850.520.308.985.525.750
16413147,2006-01-18T00:00:00,Risk Factors,E05.318.740.600.800.725
16413147,2006-01-18T00:00:00,Risk Factors,N05.715.350.200.700
16413147,2006-01-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16413147,2006-01-18T00:00:00,Risk Factors,N06.850.490.625.750
16413147,2006-01-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16458146,2006-01-18T00:00:00,Adult,M01.060.116
16458146,2006-01-18T00:00:00,Heart Failure,C14.280.434
16458146,2006-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16458146,2006-01-18T00:00:00,Middle Aged,M01.060.116.630
16458146,2006-01-18T00:00:00,Obesity,C18.654.726.500
16458146,2006-01-18T00:00:00,Obesity,C23.888.144.699.500
16458146,2006-01-18T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16458146,2006-01-18T00:00:00,Obesity,G07.100.100.160.120.699.500
16458146,2006-01-18T00:00:00,Risk Factors,E05.318.740.600.800.725
16458146,2006-01-18T00:00:00,Risk Factors,N05.715.350.200.700
16458146,2006-01-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16458146,2006-01-18T00:00:00,Risk Factors,N06.850.490.625.750
16458146,2006-01-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16458146,2006-01-18T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
16458146,2006-01-18T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
16458146,2006-01-18T00:00:00,Stroke Volume,E01.370.370.380.150.700
16458146,2006-01-18T00:00:00,Stroke Volume,G09.330.380.124.882
16458146,2006-01-18T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
16571445,2006-01-18T00:00:00,Accidental Falls,N06.850.135.122
16571445,2006-01-18T00:00:00,Adult,M01.060.116
16571445,2006-01-18T00:00:00,"Diagnosis, Differential",E01.171
16571445,2006-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16571445,2006-01-18T00:00:00,Kidney Pelvis,A05.810.453.537
16571445,2006-01-18T00:00:00,Stents,E07.695.750
16571445,2006-01-18T00:00:00,Ureter,A05.810.776
16571445,2006-01-18T00:00:00,"Wounds, Nonpenetrating",C21.866.974
16426590,2006-01-19T00:00:00,Animals,B01.050
16426590,2006-01-19T00:00:00,Cell Membrane,A11.284.149
16426590,2006-01-19T00:00:00,Cytokines,D12.644.276.374
16426590,2006-01-19T00:00:00,Cytokines,D12.776.467.374
16426590,2006-01-19T00:00:00,Cytokines,D23.529.374
16426590,2006-01-19T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
16426590,2006-01-19T00:00:00,Gene Expression Regulation,G05.355.315
16426590,2006-01-19T00:00:00,Heart Failure,C14.280.434
16426590,2006-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16426590,2006-01-19T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16426590,2006-01-19T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16426590,2006-01-19T00:00:00,Myocardium,A02.633.580
16426590,2006-01-19T00:00:00,Myocardium,A07.541.704
16426590,2006-01-19T00:00:00,Myocardium,A10.690.552.750
16426590,2006-01-19T00:00:00,Renin-Angiotensin System,G03.495.805
16426590,2006-01-19T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
16426590,2006-01-19T00:00:00,Signal Transduction,G02.111.087.800
16426590,2006-01-19T00:00:00,Signal Transduction,G02.149.115.800
16426590,2006-01-19T00:00:00,Signal Transduction,G04.299.880
16427036,2006-01-19T00:00:00,Animals,B01.050
16427036,2006-01-19T00:00:00,Cardiovascular Diseases,C14
16427036,2006-01-19T00:00:00,"Endothelium, Vascular",A07.231.330
16427036,2006-01-19T00:00:00,"Endothelium, Vascular",A10.272.491.355
16427036,2006-01-19T00:00:00,Extracellular Matrix,A11.284.295.310
16427036,2006-01-19T00:00:00,Gene Expression Regulation,G05.355.315
16427036,2006-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16427036,2006-01-19T00:00:00,Inflammation,C23.550.470
16427036,2006-01-19T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16427036,2006-01-19T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16427036,2006-01-19T00:00:00,"Models, Animal",E05.598
16427036,2006-01-19T00:00:00,Ventricular Remodeling,C23.300.985
16427036,2006-01-19T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16427280,2006-01-19T00:00:00,Child,M01.060.406
16427280,2006-01-19T00:00:00,"Child, Preschool",M01.060.406.448
16427280,2006-01-19T00:00:00,Fibroblasts,A11.329.228
16427280,2006-01-19T00:00:00,Fibroblasts,A11.872.228
16427280,2006-01-19T00:00:00,Genetic Testing,E01.370.427
16427280,2006-01-19T00:00:00,Genetic Testing,E05.393.435
16427280,2006-01-19T00:00:00,Genetic Testing,N02.421.143.827.233.221
16427280,2006-01-19T00:00:00,Genetic Testing,N02.421.308.430
16427280,2006-01-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16427280,2006-01-19T00:00:00,Infant,M01.060.703
16427280,2006-01-19T00:00:00,Lymphocytes,A11.118.637.555.567
16427280,2006-01-19T00:00:00,Lymphocytes,A15.145.229.637.555.567
16427280,2006-01-19T00:00:00,Lymphocytes,A15.382.490.555.567
16427280,2006-01-19T00:00:00,Mutation,G05.365.590
16428897,2006-01-20T00:00:00,Endoscopy,E01.370.388.250
16428897,2006-01-20T00:00:00,Endoscopy,E04.800.250
16428897,2006-01-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16428897,2006-01-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16428897,2006-01-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16428897,2006-01-20T00:00:00,Middle Aged,M01.060.116.630
16428897,2006-01-20T00:00:00,Treatment Outcome,E01.789.800
16428897,2006-01-20T00:00:00,Treatment Outcome,N04.761.559.590.800
16428897,2006-01-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16432652,2006-01-21T00:00:00,Animals,B01.050
16432652,2006-01-21T00:00:00,Endoscopy,E01.370.388.250
16432652,2006-01-21T00:00:00,Endoscopy,E04.800.250
16432652,2006-01-21T00:00:00,"Models, Animal",E05.598
16432652,2006-01-21T00:00:00,Splenectomy,E04.726
16432652,2006-01-21T00:00:00,Swine,B01.050.150.900.649.077.880
16411681,2006-01-23T00:00:00,Antioxidants,D27.505.519.217
16411681,2006-01-23T00:00:00,Antioxidants,D27.505.696.706.125
16411681,2006-01-23T00:00:00,Antioxidants,D27.720.799.047
16411681,2006-01-23T00:00:00,Copper,D01.268.556.195
16411681,2006-01-23T00:00:00,Copper,D01.268.956.170
16411681,2006-01-23T00:00:00,Copper,D01.552.544.195
16411681,2006-01-23T00:00:00,Cystine,D01.248.497.158.874.390.369
16411681,2006-01-23T00:00:00,Cystine,D01.875.350.850.150.369
16411681,2006-01-23T00:00:00,Cystine,D02.886.030.230.369
16411681,2006-01-23T00:00:00,Cystine,D02.886.520.150.087
16411681,2006-01-23T00:00:00,Cystine,D12.125.095.369
16411681,2006-01-23T00:00:00,Cystine,D12.125.119.369
16411681,2006-01-23T00:00:00,Cystine,D12.125.166.230.369
16411681,2006-01-23T00:00:00,DNA,D13.444.308
16411681,2006-01-23T00:00:00,DNA Damage,C21.111
16411681,2006-01-23T00:00:00,DNA Damage,G05.355.180
16411681,2006-01-23T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16411681,2006-01-23T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16411681,2006-01-23T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16411681,2006-01-23T00:00:00,Molecular Structure,G02.111.570
16411681,2006-01-23T00:00:00,Molecular Structure,G02.575
16411681,2006-01-23T00:00:00,Molecular Structure,G02.842.575
16411681,2006-01-23T00:00:00,Organoselenium Compounds,D02.712
16411681,2006-01-23T00:00:00,Selenium,D01.268.185.850
16411681,2006-01-23T00:00:00,Selenium,D01.578.700
16431135,2006-01-23T00:00:00,Adult,M01.060.116
16431135,2006-01-23T00:00:00,Blood Glucose,D09.546.359.448.500
16431135,2006-01-23T00:00:00,Blood Pressure,E01.370.600.875.249
16431135,2006-01-23T00:00:00,Blood Pressure,G09.330.380.076
16431135,2006-01-23T00:00:00,Body Mass Index,E01.370.600.115.100.125
16431135,2006-01-23T00:00:00,Body Mass Index,E05.041.124.125
16431135,2006-01-23T00:00:00,Body Mass Index,G07.100.100.125
16431135,2006-01-23T00:00:00,Body Mass Index,N06.850.505.200.100.175
16431135,2006-01-23T00:00:00,Cholesterol,D04.808.247.222.284
16431135,2006-01-23T00:00:00,Cholesterol,D04.808.247.808.197
16431135,2006-01-23T00:00:00,Cholesterol,D10.570.938.208
16431135,2006-01-23T00:00:00,Cholesterol,D10.851.208
16431135,2006-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16431135,2006-01-23T00:00:00,Hypertension,C14.907.489
16431135,2006-01-23T00:00:00,Insulin,D06.472.699.587.740.625
16431135,2006-01-23T00:00:00,Insulin,D12.644.548.586.740.625
16431135,2006-01-23T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
16431135,2006-01-23T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
16431135,2006-01-23T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
16431135,2006-01-23T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
16431135,2006-01-23T00:00:00,Middle Aged,M01.060.116.630
16431135,2006-01-23T00:00:00,"Models, Statistical",E05.318.740.500
16431135,2006-01-23T00:00:00,"Models, Statistical",E05.599.835
16431135,2006-01-23T00:00:00,"Models, Statistical",N05.715.360.750.530
16431135,2006-01-23T00:00:00,"Models, Statistical",N06.850.520.830.500
16431135,2006-01-23T00:00:00,Risk Factors,E05.318.740.600.800.725
16431135,2006-01-23T00:00:00,Risk Factors,N05.715.350.200.700
16431135,2006-01-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16431135,2006-01-23T00:00:00,Risk Factors,N06.850.490.625.750
16431135,2006-01-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16432045,2006-01-23T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16432045,2006-01-23T00:00:00,Blood Pressure,E01.370.600.875.249
16432045,2006-01-23T00:00:00,Blood Pressure,G09.330.380.076
16432045,2006-01-23T00:00:00,Diastole,G09.330.190.541.295
16432045,2006-01-23T00:00:00,Diastole,G11.427.590.540.554.250
16432045,2006-01-23T00:00:00,Diastole,G11.427.590.540.570.295
16432045,2006-01-23T00:00:00,Goals,F01.658.500
16432045,2006-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16432045,2006-01-23T00:00:00,Hypertension,C14.907.489
16432045,2006-01-23T00:00:00,Middle Aged,M01.060.116.630
16432045,2006-01-23T00:00:00,"Models, Statistical",E05.318.740.500
16432045,2006-01-23T00:00:00,"Models, Statistical",E05.599.835
16432045,2006-01-23T00:00:00,"Models, Statistical",N05.715.360.750.530
16432045,2006-01-23T00:00:00,"Models, Statistical",N06.850.520.830.500
16432045,2006-01-23T00:00:00,Quality of Health Care,N04.761
16432045,2006-01-23T00:00:00,Quality of Health Care,N05.715
16432056,2006-01-23T00:00:00,Aged,M01.060.116.100
16432056,2006-01-23T00:00:00,Anticoagulants,D27.505.954.502.119
16432056,2006-01-23T00:00:00,Brain Ischemia,C10.228.140.300.150
16432056,2006-01-23T00:00:00,Brain Ischemia,C14.907.253.092
16432056,2006-01-23T00:00:00,"Constriction, Pathologic",C23.300.287
16432056,2006-01-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16432056,2006-01-23T00:00:00,Middle Aged,M01.060.116.630
16432056,2006-01-23T00:00:00,Risk Factors,E05.318.740.600.800.725
16432056,2006-01-23T00:00:00,Risk Factors,N05.715.350.200.700
16432056,2006-01-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16432056,2006-01-23T00:00:00,Risk Factors,N06.850.490.625.750
16432056,2006-01-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16432056,2006-01-23T00:00:00,Stroke,C10.228.140.300.775
16432056,2006-01-23T00:00:00,Stroke,C14.907.253.855
16432056,2006-01-23T00:00:00,Warfarin,D03.438.150.446.520.914
16432056,2006-01-23T00:00:00,Warfarin,D03.830.219.446.520.914
16434574,2006-01-24T00:00:00,Animals,B01.050
16434574,2006-01-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
16434574,2006-01-24T00:00:00,Fluorescent Dyes,D27.720.233.348
16434574,2006-01-24T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16434574,2006-01-24T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16434574,2006-01-24T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16434574,2006-01-24T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16434574,2006-01-24T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16434574,2006-01-24T00:00:00,Indican,D03.438.473.393
16434574,2006-01-24T00:00:00,Mesangial Cells,A05.810.453.324.359.620
16434574,2006-01-24T00:00:00,Mesangial Cells,A05.810.453.736.520.620
16434574,2006-01-24T00:00:00,Mesangial Cells,A11.329.228.950
16434574,2006-01-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16434574,2006-01-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16434574,2006-01-24T00:00:00,Reactive Oxygen Species,D01.339.431
16434574,2006-01-24T00:00:00,Reactive Oxygen Species,D01.650.775
16434574,2006-01-24T00:00:00,Superoxide Dismutase,D08.811.682.881
16434574,2006-01-24T00:00:00,Superoxides,D01.248.497.158.685.750.850
16434574,2006-01-24T00:00:00,Superoxides,D01.339.431.374.850
16434574,2006-01-24T00:00:00,Superoxides,D01.339.431.750
16434574,2006-01-24T00:00:00,Superoxides,D01.650.550.750.800
16434617,2006-01-24T00:00:00,DNA,D13.444.308
16434617,2006-01-24T00:00:00,Enzyme Inhibitors,D27.505.519.389
16434617,2006-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16434617,2006-01-24T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16434617,2006-01-24T00:00:00,Mitochondria,A11.284.835.626
16434617,2006-01-24T00:00:00,Molecular Weight,G02.842.580
16319536,2006-01-25T00:00:00,Animals,B01.050
16319536,2006-01-25T00:00:00,Cell Aging,G04.299.119
16319536,2006-01-25T00:00:00,Hematopoietic Stem Cells,A11.148.378
16319536,2006-01-25T00:00:00,Hematopoietic Stem Cells,A11.872.378
16319536,2006-01-25T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
16319536,2006-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16319536,2006-01-25T00:00:00,Signal Transduction,G02.111.087.800
16319536,2006-01-25T00:00:00,Signal Transduction,G02.149.115.800
16319536,2006-01-25T00:00:00,Signal Transduction,G04.299.880
16436587,2006-01-25T00:00:00,Animals,B01.050
16436587,2006-01-25T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
16436587,2006-01-25T00:00:00,GTP-Binding Proteins,D12.776.157.325
16436587,2006-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16436587,2006-01-25T00:00:00,Signal Transduction,G02.111.087.800
16436587,2006-01-25T00:00:00,Signal Transduction,G02.149.115.800
16436587,2006-01-25T00:00:00,Signal Transduction,G04.299.880
16436789,2006-01-25T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16436789,2006-01-25T00:00:00,Atherosclerosis,C14.907.137.126.307
16436789,2006-01-25T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
16436789,2006-01-25T00:00:00,Carotid Stenosis,C14.907.137.230
16436789,2006-01-25T00:00:00,Carotid Stenosis,C14.907.253.123.360
16436789,2006-01-25T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
16436789,2006-01-25T00:00:00,"Emergency Service, Hospital",N02.421.297.195
16436789,2006-01-25T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
16436789,2006-01-25T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16436789,2006-01-25T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16436789,2006-01-25T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16436789,2006-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16436789,2006-01-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16436789,2006-01-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16436789,2006-01-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16436789,2006-01-25T00:00:00,Hypertension,C14.907.489
16436789,2006-01-25T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
16436789,2006-01-25T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
16436789,2006-01-25T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
16436789,2006-01-25T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
16436789,2006-01-25T00:00:00,Practice Guidelines as Topic,N05.700.350.650
16436789,2006-01-25T00:00:00,Risk Factors,E05.318.740.600.800.725
16436789,2006-01-25T00:00:00,Risk Factors,N05.715.350.200.700
16436789,2006-01-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16436789,2006-01-25T00:00:00,Risk Factors,N06.850.490.625.750
16436789,2006-01-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16436789,2006-01-25T00:00:00,Stroke,C10.228.140.300.775
16436789,2006-01-25T00:00:00,Stroke,C14.907.253.855
16436789,2006-01-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16436789,2006-01-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16436789,2006-01-25T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16436789,2006-01-25T00:00:00,Tissue Plasminogen Activator,D23.119.970
16436789,2006-01-25T00:00:00,Triage,N02.421.297.900
17699223,2006-01-25T00:00:00,Adult,M01.060.116
17699223,2006-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17699223,2006-01-25T00:00:00,Hypercalcemia,C18.452.174.451
17699223,2006-01-25T00:00:00,Hypercalcemia,C18.452.950.340
17699223,2006-01-25T00:00:00,Kidney Transplantation,E02.870.500
17699223,2006-01-25T00:00:00,Kidney Transplantation,E04.936.450.485
17699223,2006-01-25T00:00:00,Kidney Transplantation,E04.950.774.400
17699223,2006-01-25T00:00:00,Middle Aged,M01.060.116.630
16439618,2006-01-26T00:00:00,Adenosine Triphosphatases,D08.811.277.040.025
16439618,2006-01-26T00:00:00,Animals,B01.050
16439618,2006-01-26T00:00:00,Cannabinoids,D02.455.849.090
16439618,2006-01-26T00:00:00,Cell Line,A11.251.210
16439618,2006-01-26T00:00:00,Endothelial Cells,A11.436.275
16439618,2006-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
16439618,2006-01-26T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
16439618,2006-01-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16439618,2006-01-26T00:00:00,Verapamil,D02.092.471.683.953
16443385,2006-01-27T00:00:00,Adolescent,M01.060.057
16443385,2006-01-27T00:00:00,Adult,M01.060.116
16443385,2006-01-27T00:00:00,African Americans,M01.686.508.100.100
16443385,2006-01-27T00:00:00,African Americans,M01.686.754.100
16443385,2006-01-27T00:00:00,Aged,M01.060.116.100
16443385,2006-01-27T00:00:00,Child,M01.060.406
16443385,2006-01-27T00:00:00,"Child, Preschool",M01.060.406.448
16443385,2006-01-27T00:00:00,European Continental Ancestry Group,M01.686.508.400
16443385,2006-01-27T00:00:00,Geographic Information Systems,L01.470.750.750.462
16443385,2006-01-27T00:00:00,Geographic Information Systems,L01.700.508.300.314
16443385,2006-01-27T00:00:00,Health Services Accessibility,N04.590.374.350
16443385,2006-01-27T00:00:00,Health Services Accessibility,N05.300.430
16443385,2006-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16443385,2006-01-27T00:00:00,Incidence,E05.318.308.985.525.375
16443385,2006-01-27T00:00:00,Incidence,L01.280.975.525.375
16443385,2006-01-27T00:00:00,Incidence,N01.224.935.597.500
16443385,2006-01-27T00:00:00,Incidence,N06.850.505.400.975.525.375
16443385,2006-01-27T00:00:00,Incidence,N06.850.520.308.985.525.375
16443385,2006-01-27T00:00:00,Infant,M01.060.703
16443385,2006-01-27T00:00:00,"Infant, Newborn",M01.060.703.520
16443385,2006-01-27T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
16443385,2006-01-27T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
16443385,2006-01-27T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
16443385,2006-01-27T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
16443385,2006-01-27T00:00:00,Middle Aged,M01.060.116.630
16443385,2006-01-27T00:00:00,Risk Factors,E05.318.740.600.800.725
16443385,2006-01-27T00:00:00,Risk Factors,N05.715.350.200.700
16443385,2006-01-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16443385,2006-01-27T00:00:00,Risk Factors,N06.850.490.625.750
16443385,2006-01-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16443385,2006-01-27T00:00:00,South Carolina,Z01.107.567.875.075.662
16443385,2006-01-27T00:00:00,South Carolina,Z01.107.567.875.750.700
16446540,2006-01-27T00:00:00,Aged,M01.060.116.100
16446540,2006-01-27T00:00:00,Brain Ischemia,C10.228.140.300.150
16446540,2006-01-27T00:00:00,Brain Ischemia,C14.907.253.092
16446540,2006-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16446540,2006-01-27T00:00:00,Middle Aged,M01.060.116.630
16446540,2006-01-27T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16446540,2006-01-27T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16446540,2006-01-27T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16446540,2006-01-27T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16446540,2006-01-27T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16446540,2006-01-27T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16446540,2006-01-27T00:00:00,Smoking,F01.145.466.753
16446540,2006-01-27T00:00:00,Stroke,C10.228.140.300.775
16446540,2006-01-27T00:00:00,Stroke,C14.907.253.855
16446540,2006-01-27T00:00:00,Treatment Outcome,E01.789.800
16446540,2006-01-27T00:00:00,Treatment Outcome,N04.761.559.590.800
16446540,2006-01-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16645883,2006-01-28T00:00:00,Blood Platelets,A11.118.188
16645883,2006-01-28T00:00:00,Blood Platelets,A15.145.229.188
16645883,2006-01-28T00:00:00,Cancer Vaccines,D20.215.894.200
16645883,2006-01-28T00:00:00,Clinical Trials as Topic,E05.318.760.535
16645883,2006-01-28T00:00:00,Clinical Trials as Topic,E05.337.250
16645883,2006-01-28T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16645883,2006-01-28T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16645883,2006-01-28T00:00:00,Diphtheria Toxin,D08.811.913.400.725.115.220
16645883,2006-01-28T00:00:00,Diphtheria Toxin,D23.946.123.305
16645883,2006-01-28T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
16645883,2006-01-28T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
16645883,2006-01-28T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
16645883,2006-01-28T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
16645883,2006-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16645883,2006-01-28T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16645883,2006-01-28T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16645883,2006-01-28T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16645883,2006-01-28T00:00:00,Immunotoxins,D12.776.124.486.485.114.580.450
16645883,2006-01-28T00:00:00,Immunotoxins,D12.776.124.790.651.114.580.450
16645883,2006-01-28T00:00:00,Immunotoxins,D12.776.377.715.548.114.580.450
16645883,2006-01-28T00:00:00,Immunotoxins,D27.888.569.271
16645883,2006-01-28T00:00:00,Interleukin-2,D12.644.276.374.465.502
16645883,2006-01-28T00:00:00,Interleukin-2,D12.644.276.374.480.372
16645883,2006-01-28T00:00:00,Interleukin-2,D12.776.467.374.465.502
16645883,2006-01-28T00:00:00,Interleukin-2,D12.776.467.374.480.372
16645883,2006-01-28T00:00:00,Interleukin-2,D23.529.374.465.502
16645883,2006-01-28T00:00:00,Interleukin-2,D23.529.374.480.372
16645883,2006-01-28T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16645883,2006-01-28T00:00:00,Recombinant Proteins,D12.776.828
16447063,2006-01-31T00:00:00,Animals,B01.050
16447063,2006-01-31T00:00:00,"Behavior, Animal",F01.145.113
16447063,2006-01-31T00:00:00,Enzyme Inhibitors,D27.505.519.389
16447063,2006-01-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16447063,2006-01-31T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16447063,2006-01-31T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
16447063,2006-01-31T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
16447063,2006-01-31T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
16516816,2006-01-31T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
16516816,2006-01-31T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
16516816,2006-01-31T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
16516816,2006-01-31T00:00:00,Antigen-Antibody Complex,D23.050.101
16516816,2006-01-31T00:00:00,Atherosclerosis,C14.907.137.126.307
16516816,2006-01-31T00:00:00,Cell Survival,G04.299.316
16516816,2006-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16516816,2006-01-31T00:00:00,Inflammation,C23.550.470
16516816,2006-01-31T00:00:00,"Lipoproteins, LDL",D10.532.515
16516816,2006-01-31T00:00:00,"Lipoproteins, LDL",D12.776.521.550
16516816,2006-01-31T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
16516816,2006-01-31T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
16516816,2006-01-31T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
16516816,2006-01-31T00:00:00,"Receptors, IgG",D23.101.100.110.695
16516816,2006-01-31T00:00:00,Signal Transduction,G02.111.087.800
16516816,2006-01-31T00:00:00,Signal Transduction,G02.149.115.800
16516816,2006-01-31T00:00:00,Signal Transduction,G04.299.880
15937868,2006-02-01T00:00:00,Adult,M01.060.116
15937868,2006-02-01T00:00:00,African Americans,M01.686.508.100.100
15937868,2006-02-01T00:00:00,African Americans,M01.686.754.100
15937868,2006-02-01T00:00:00,Breast Neoplasms,C04.588.180
15937868,2006-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
15937868,2006-02-01T00:00:00,Demography,I01.240
15937868,2006-02-01T00:00:00,Demography,N01.224
15937868,2006-02-01T00:00:00,Demography,N06.850.505.400
15937868,2006-02-01T00:00:00,Disease-Free Survival,E01.789.200
15937868,2006-02-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
15937868,2006-02-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
15937868,2006-02-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
15937868,2006-02-01T00:00:00,Energy Intake,G07.610.240.340
15937868,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
15937868,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
15937868,2006-02-01T00:00:00,Motor Activity,F01.145.632
15937868,2006-02-01T00:00:00,Motor Activity,G11.427.590.530.698
15937868,2006-02-01T00:00:00,Obesity,C18.654.726.500
15937868,2006-02-01T00:00:00,Obesity,C23.888.144.699.500
15937868,2006-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
15937868,2006-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
15937868,2006-02-01T00:00:00,Questionnaires,E05.318.308.750
15937868,2006-02-01T00:00:00,Questionnaires,L01.280.800
15937868,2006-02-01T00:00:00,Questionnaires,N05.715.360.300.695
15937868,2006-02-01T00:00:00,Questionnaires,N06.850.520.308.750
15937868,2006-02-01T00:00:00,Weight Loss,C23.888.144.243.963
15937868,2006-02-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16201964,2006-02-01T00:00:00,Gene Deletion,G05.355.600.800.320
16201964,2006-02-01T00:00:00,Gene Deletion,G05.365.590.762.320
16201964,2006-02-01T00:00:00,"Gene Expression Regulation, Fungal",G05.355.315.330
16201964,2006-02-01T00:00:00,Hot Temperature,G01.906.595.543
16201964,2006-02-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
16201964,2006-02-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
16201964,2006-02-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
16201964,2006-02-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
16201964,2006-02-01T00:00:00,Reproduction,G08.686.785.760
16201964,2006-02-01T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
16201964,2006-02-01T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
16201964,2006-02-01T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
16201964,2006-02-01T00:00:00,Sphingolipids,D10.570.877
16201964,2006-02-01T00:00:00,Sphingolipids,D10.808
16270301,2006-02-01T00:00:00,Animals,B01.050
16270301,2006-02-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16270301,2006-02-01T00:00:00,Cocaine,D02.145.074.722.388
16270301,2006-02-01T00:00:00,Cocaine,D03.132.889.354
16270301,2006-02-01T00:00:00,Cocaine,D03.605.869.388
16270301,2006-02-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
16270301,2006-02-01T00:00:00,Cocaine-Related Disorders,C21.739.300
16270301,2006-02-01T00:00:00,Cocaine-Related Disorders,F03.900.300
16270301,2006-02-01T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
16270301,2006-02-01T00:00:00,Dopamine,D02.092.211.215.311.342
16270301,2006-02-01T00:00:00,Dopamine,D02.092.311.342
16270301,2006-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
16270301,2006-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
16270301,2006-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
16270301,2006-02-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
16270301,2006-02-01T00:00:00,Motor Activity,F01.145.632
16270301,2006-02-01T00:00:00,Motor Activity,G11.427.590.530.698
16270301,2006-02-01T00:00:00,Sex Factors,N05.715.350.675
16270301,2006-02-01T00:00:00,Sex Factors,N06.850.490.875
16382087,2006-02-01T00:00:00,Adolescent,M01.060.057
16382087,2006-02-01T00:00:00,Child,M01.060.406
16382087,2006-02-01T00:00:00,Demography,I01.240
16382087,2006-02-01T00:00:00,Demography,N01.224
16382087,2006-02-01T00:00:00,Demography,N06.850.505.400
16382087,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16382087,2006-02-01T00:00:00,Questionnaires,E05.318.308.750
16382087,2006-02-01T00:00:00,Questionnaires,L01.280.800
16382087,2006-02-01T00:00:00,Questionnaires,N05.715.360.300.695
16382087,2006-02-01T00:00:00,Questionnaires,N06.850.520.308.750
16382087,2006-02-01T00:00:00,Social Environment,I01.880.656
16382093,2006-02-01T00:00:00,Child,M01.060.406
16382093,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16382093,2006-02-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
16385577,2006-02-01T00:00:00,Amides,D02.065
16385577,2006-02-01T00:00:00,Animals,B01.050
16385577,2006-02-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16385577,2006-02-01T00:00:00,Apoptosis,G04.299.139.160
16385577,2006-02-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16385577,2006-02-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16385577,2006-02-01T00:00:00,Caspases,D12.644.360.075.405
16385577,2006-02-01T00:00:00,Caspases,D12.776.476.075.405
16385577,2006-02-01T00:00:00,Cell Survival,G04.299.316
16385577,2006-02-01T00:00:00,Drug Interactions,G07.690.812.240
16385577,2006-02-01T00:00:00,Drug Interactions,G07.700.680.240
16385577,2006-02-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16385577,2006-02-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16385577,2006-02-01T00:00:00,Flow Cytometry,E05.200.500.386.350
16385577,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16385577,2006-02-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
16385577,2006-02-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
16385577,2006-02-01T00:00:00,Lovastatin,D02.455.426.559.847.638.400
16385577,2006-02-01T00:00:00,Lovastatin,D04.615.638.400
16385577,2006-02-01T00:00:00,Mevalonic Acid,D02.241.511.579
16385577,2006-02-01T00:00:00,Neoplasms,C04
16385577,2006-02-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16385577,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16385577,2006-02-01T00:00:00,Signal Transduction,G02.111.087.800
16385577,2006-02-01T00:00:00,Signal Transduction,G02.149.115.800
16385577,2006-02-01T00:00:00,Signal Transduction,G04.299.880
16385598,2006-02-01T00:00:00,Electrophoresis,E05.196.401
16385598,2006-02-01T00:00:00,Electrophoresis,E05.301.300
16385598,2006-02-01T00:00:00,Electrophoresis,G02.149.767.570
16385598,2006-02-01T00:00:00,Electrophoresis,G02.842.750.570
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,G17.800
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16385598,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16389063,2006-02-01T00:00:00,Adult,M01.060.116
16389063,2006-02-01T00:00:00,Aged,M01.060.116.100
16389063,2006-02-01T00:00:00,Anxiety Disorders,F03.080
16389063,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16389063,2006-02-01T00:00:00,Interpersonal Relations,F01.829.401
16389063,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16389063,2006-02-01T00:00:00,Phobic Disorders,F03.080.725
16389063,2006-02-01T00:00:00,Prevalence,E05.318.308.985.525.750
16389063,2006-02-01T00:00:00,Prevalence,L01.280.975.525.750
16389063,2006-02-01T00:00:00,Prevalence,N01.224.935.597.750
16389063,2006-02-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16389063,2006-02-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16389063,2006-02-01T00:00:00,Primary Health Care,N04.590.233.727
16389063,2006-02-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16389063,2006-02-01T00:00:00,United States,Z01.107.567.875
16389063,2006-02-01T00:00:00,Veterans,M01.930
16394866,2006-02-01T00:00:00,Esophagus,A03.556.875.500
16394866,2006-02-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16394866,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16415699,2006-02-01T00:00:00,Adult,M01.060.116
16415699,2006-02-01T00:00:00,Alcoholism,C21.739.100.250
16415699,2006-02-01T00:00:00,Alcoholism,F03.900.100.350
16415699,2006-02-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
16415699,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16415699,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16415699,2006-02-01T00:00:00,Psychiatric Status Rating Scales,F04.586
16415699,2006-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
16415699,2006-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
16415699,2006-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
16415699,2006-02-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
16415699,2006-02-01T00:00:00,Sertraline,D02.092.705.800
16415699,2006-02-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
16415699,2006-02-01T00:00:00,Sertraline,D04.615.638.845.800
16415699,2006-02-01T00:00:00,Treatment Outcome,E01.789.800
16415699,2006-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16415699,2006-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16427896,2006-02-01T00:00:00,Heart Ventricles,A07.541.560
16427896,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16427896,2006-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
16427896,2006-02-01T00:00:00,"Infant, Premature",M01.060.703.520.520
16427896,2006-02-01T00:00:00,Palliative Care,E02.760.666
16427896,2006-02-01T00:00:00,Palliative Care,N02.421.585.666
16427896,2006-02-01T00:00:00,Stents,E07.695.750
16427896,2006-02-01T00:00:00,Tetralogy of Fallot,C14.240.400.849
16427896,2006-02-01T00:00:00,Tetralogy of Fallot,C14.280.400.849
16427896,2006-02-01T00:00:00,Tetralogy of Fallot,C16.131.240.400.849
16427937,2006-02-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16427937,2006-02-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16427937,2006-02-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16427937,2006-02-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16427937,2006-02-01T00:00:00,Guideline Adherence,N04.761.337
16427937,2006-02-01T00:00:00,Guideline Adherence,N05.715.360.395
16427937,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16427937,2006-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
16427937,2006-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
16427937,2006-02-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
16427937,2006-02-01T00:00:00,"Quality Assurance, Health Care",N05.700
16427937,2006-02-01T00:00:00,United States,Z01.107.567.875
16427986,2006-02-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16427986,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16427986,2006-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
16429324,2006-02-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
16429324,2006-02-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
16429324,2006-02-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
16429324,2006-02-01T00:00:00,Animals,B01.050
16429324,2006-02-01T00:00:00,Bone Resorption,C05.116.264
16429324,2006-02-01T00:00:00,Bone Resorption,G11.427.590.195.150
16429324,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16429324,2006-02-01T00:00:00,Mutation,G05.365.590
16429324,2006-02-01T00:00:00,Osteitis Deformans,C05.116.692
16429324,2006-02-01T00:00:00,Osteoclasts,A11.329.372.700
16429324,2006-02-01T00:00:00,Osteoclasts,A11.627.482.700
16429324,2006-02-01T00:00:00,"Polymorphism, Genetic",G05.365.795
16429324,2006-02-01T00:00:00,Proteins,D12.776
16431262,2006-02-01T00:00:00,"Adaptation, Psychological",F01.058
16431262,2006-02-01T00:00:00,Adolescent,M01.060.057
16431262,2006-02-01T00:00:00,Adult,M01.060.116
16431262,2006-02-01T00:00:00,African Americans,M01.686.508.100.100
16431262,2006-02-01T00:00:00,African Americans,M01.686.754.100
16431262,2006-02-01T00:00:00,Aged,M01.060.116.100
16431262,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16431262,2006-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
16431262,2006-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
16431262,2006-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
16431262,2006-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
16431262,2006-02-01T00:00:00,Kidney Transplantation,E02.870.500
16431262,2006-02-01T00:00:00,Kidney Transplantation,E04.936.450.485
16431262,2006-02-01T00:00:00,Kidney Transplantation,E04.950.774.400
16431262,2006-02-01T00:00:00,Living Donors,M01.898.656
16431262,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16431262,2006-02-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16431262,2006-02-01T00:00:00,Questionnaires,E05.318.308.750
16431262,2006-02-01T00:00:00,Questionnaires,L01.280.800
16431262,2006-02-01T00:00:00,Questionnaires,N05.715.360.300.695
16431262,2006-02-01T00:00:00,Questionnaires,N06.850.520.308.750
16432268,2006-02-01T00:00:00,Adult,M01.060.116
16432268,2006-02-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16432268,2006-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16432268,2006-02-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16432268,2006-02-01T00:00:00,Benzodiazepines,D03.438.079.080
16432268,2006-02-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16432268,2006-02-01T00:00:00,Cross-Over Studies,E05.318.780.150
16432268,2006-02-01T00:00:00,Cross-Over Studies,N05.715.360.780.150
16432268,2006-02-01T00:00:00,Cross-Over Studies,N06.850.520.445.150
16432268,2006-02-01T00:00:00,DNA,D13.444.308
16432268,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16432268,2006-02-01T00:00:00,Mutation,G05.365.590
16434709,2006-02-01T00:00:00,Adult,M01.060.116
16434709,2006-02-01T00:00:00,Aged,M01.060.116.100
16434709,2006-02-01T00:00:00,Animals,B01.050
16434709,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16434709,2006-02-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16434709,2006-02-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16434709,2006-02-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16434709,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,G17.800
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16434709,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16434709,2006-02-01T00:00:00,Serologic Tests,E01.450.495.735
16434709,2006-02-01T00:00:00,Serologic Tests,E05.478.594.760
16436016,2006-02-01T00:00:00,Aged,M01.060.116.100
16436016,2006-02-01T00:00:00,Depression,F01.145.126.350
16436016,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16436016,2006-02-01T00:00:00,"Models, Theoretical",E05.599
16436016,2006-02-01T00:00:00,Questionnaires,E05.318.308.750
16436016,2006-02-01T00:00:00,Questionnaires,L01.280.800
16436016,2006-02-01T00:00:00,Questionnaires,N05.715.360.300.695
16436016,2006-02-01T00:00:00,Questionnaires,N06.850.520.308.750
16436016,2006-02-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16436016,2006-02-01T00:00:00,Risk Assessment,N04.452.871.715
16436016,2006-02-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16436016,2006-02-01T00:00:00,Risk Assessment,N06.850.505.715
16436016,2006-02-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16436410,2006-02-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
16436410,2006-02-01T00:00:00,Health Education,I02.233.332
16436410,2006-02-01T00:00:00,Health Education,N02.421.143.827.407
16436410,2006-02-01T00:00:00,Health Education,N02.421.726.407
16436410,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16436410,2006-02-01T00:00:00,Smoking,F01.145.466.753
16436646,2006-02-01T00:00:00,Adult,M01.060.116
16436646,2006-02-01T00:00:00,Cystic Fibrosis,C06.689.202
16436646,2006-02-01T00:00:00,Cystic Fibrosis,C08.381.187
16436646,2006-02-01T00:00:00,Cystic Fibrosis,C16.320.190
16436646,2006-02-01T00:00:00,Cystic Fibrosis,C16.614.213
16436646,2006-02-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
16436646,2006-02-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
16436646,2006-02-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
16436646,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16436646,2006-02-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16436646,2006-02-01T00:00:00,Mutation,G05.365.590
16436646,2006-02-01T00:00:00,Phenotype,G05.695
16436663,2006-02-01T00:00:00,Animals,B01.050
16436663,2006-02-01T00:00:00,Calcinosis,C18.452.174.130
16436663,2006-02-01T00:00:00,Elastin,D05.750.078.421
16436663,2006-02-01T00:00:00,Elastin,D12.776.860.300.350
16436663,2006-02-01T00:00:00,Fibroblasts,A11.329.228
16436663,2006-02-01T00:00:00,Fibroblasts,A11.872.228
16436663,2006-02-01T00:00:00,Gene Expression Regulation,G05.355.315
16436663,2006-02-01T00:00:00,Heart,A07.541
16436663,2006-02-01T00:00:00,Macrophages,A11.329.372
16436663,2006-02-01T00:00:00,Macrophages,A11.627.482
16436663,2006-02-01T00:00:00,Macrophages,A11.733.397
16436663,2006-02-01T00:00:00,Macrophages,A15.382.680.397
16436663,2006-02-01T00:00:00,Macrophages,A15.382.812.522
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
16436663,2006-02-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
16436663,2006-02-01T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
16436663,2006-02-01T00:00:00,Osteogenesis,G11.427.590.560.100.729
16436663,2006-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
16436663,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16436663,2006-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16436663,2006-02-01T00:00:00,Swine,B01.050.150.900.649.077.880
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
16436663,2006-02-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
16441267,2006-02-01T00:00:00,Alcoholic Intoxication,C21.739.100.175
16441267,2006-02-01T00:00:00,Alcoholic Intoxication,F03.900.100.300
16441267,2006-02-01T00:00:00,Alcoholism,C21.739.100.250
16441267,2006-02-01T00:00:00,Alcoholism,F03.900.100.350
16441267,2006-02-01T00:00:00,Biological Markers,D23.101
16441267,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16441267,2006-02-01T00:00:00,"Liver Diseases, Alcoholic",C06.552.645
16441267,2006-02-01T00:00:00,"Liver Diseases, Alcoholic",C21.739.100.087.645
16441267,2006-02-01T00:00:00,Mass Screening,E01.370.500
16441267,2006-02-01T00:00:00,Mass Screening,E05.318.308.250.580
16441267,2006-02-01T00:00:00,Mass Screening,N02.421.143.827.233.443
16441267,2006-02-01T00:00:00,Mass Screening,N02.421.726.233.443
16441267,2006-02-01T00:00:00,Mass Screening,N05.715.360.300.375.500
16441267,2006-02-01T00:00:00,Mass Screening,N06.850.520.308.250.580
16441267,2006-02-01T00:00:00,Mass Screening,N06.850.780.500
16441267,2006-02-01T00:00:00,Postoperative Complications,C23.550.767
16441267,2006-02-01T00:00:00,Preoperative Care,E02.760.795
16441267,2006-02-01T00:00:00,Preoperative Care,E04.641
16441267,2006-02-01T00:00:00,Preoperative Care,N02.421.585.795
16441267,2006-02-01T00:00:00,Primary Health Care,N04.590.233.727
16441267,2006-02-01T00:00:00,Transferrin,D12.776.124.050.800
16441267,2006-02-01T00:00:00,Transferrin,D12.776.124.790.223.839
16441267,2006-02-01T00:00:00,Transferrin,D12.776.157.427.500
16441267,2006-02-01T00:00:00,Transferrin,D12.776.377.715.182.839
16441267,2006-02-01T00:00:00,Transferrin,D12.776.556.579.500
16441267,2006-02-01T00:00:00,Wounds and Injuries,C21.866
16441269,2006-02-01T00:00:00,Alcoholic Intoxication,C21.739.100.175
16441269,2006-02-01T00:00:00,Alcoholic Intoxication,F03.900.100.300
16441269,2006-02-01T00:00:00,Alcoholism,C21.739.100.250
16441269,2006-02-01T00:00:00,Alcoholism,F03.900.100.350
16441269,2006-02-01T00:00:00,Animals,B01.050
16441269,2006-02-01T00:00:00,Brain,A08.186.211
16441269,2006-02-01T00:00:00,Discrimination Learning,F02.463.425.280
16441269,2006-02-01T00:00:00,Drug Tolerance,G07.690.812.260
16441269,2006-02-01T00:00:00,Drug Tolerance,G07.700.680.260
16441269,2006-02-01T00:00:00,Ethanol,D02.033.375
16441269,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16441269,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16441269,2006-02-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
16441269,2006-02-01T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
16441269,2006-02-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16441284,2006-02-01T00:00:00,Animals,B01.050
16441284,2006-02-01T00:00:00,Brain,A08.186.211
16441284,2006-02-01T00:00:00,Ethanol,D02.033.375
16441284,2006-02-01T00:00:00,Hippocampus,A08.186.211.464.405
16441284,2006-02-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
16441284,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16441284,2006-02-01T00:00:00,Neurons,A08.663
16441284,2006-02-01T00:00:00,Neurons,A11.671
16441284,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16441284,2006-02-01T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
16441284,2006-02-01T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
16441285,2006-02-01T00:00:00,Alcoholism,C21.739.100.250
16441285,2006-02-01T00:00:00,Alcoholism,F03.900.100.350
16441285,2006-02-01T00:00:00,Amygdala,A08.186.211.464.090
16441285,2006-02-01T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
16441285,2006-02-01T00:00:00,Animals,B01.050
16441285,2006-02-01T00:00:00,Brain,A08.186.211
16441285,2006-02-01T00:00:00,Drug Tolerance,G07.690.812.260
16441285,2006-02-01T00:00:00,Drug Tolerance,G07.700.680.260
16441285,2006-02-01T00:00:00,Ethanol,D02.033.375
16441285,2006-02-01T00:00:00,Glutamic Acid,D12.125.067.750
16441285,2006-02-01T00:00:00,Glutamic Acid,D12.125.119.450
16441285,2006-02-01T00:00:00,Glutamic Acid,D12.125.427.300
16441285,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16441285,2006-02-01T00:00:00,Long-Term Potentiation,G11.561.600.635.350
16441285,2006-02-01T00:00:00,Neuronal Plasticity,G11.561.600.635
16441285,2006-02-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
16441285,2006-02-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16441285,2006-02-01T00:00:00,"Stress, Psychological",F01.145.126.990
16441285,2006-02-01T00:00:00,"Stress, Psychological",F02.830.900
16441285,2006-02-01T00:00:00,Substance-Related Disorders,C21.739
16441285,2006-02-01T00:00:00,Substance-Related Disorders,F03.900
16441285,2006-02-01T00:00:00,Synapses,A08.850
16441285,2006-02-01T00:00:00,Synapses,A11.284.149.165.420.780
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,C10.720.112.200
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,C21.613.705.150.200
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,C21.739.100.087.193.200
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,C21.739.835.250
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,F03.900.100.100
16441286,2006-02-01T00:00:00,Alcohol Withdrawal Delirium,F03.900.825.500
16441286,2006-02-01T00:00:00,Alcoholism,C21.739.100.250
16441286,2006-02-01T00:00:00,Alcoholism,F03.900.100.350
16441286,2006-02-01T00:00:00,Amygdala,A08.186.211.464.090
16441286,2006-02-01T00:00:00,Amygdala,A08.186.211.730.885.287.249.152
16441286,2006-02-01T00:00:00,Animals,B01.050
16441286,2006-02-01T00:00:00,Brain,A08.186.211
16441286,2006-02-01T00:00:00,Brain Mapping,E01.370.350.086
16441286,2006-02-01T00:00:00,Brain Mapping,E01.370.376.149
16441286,2006-02-01T00:00:00,Brain Mapping,E05.132
16441286,2006-02-01T00:00:00,Carrier Proteins,D12.776.157
16441286,2006-02-01T00:00:00,Ethanol,D02.033.375
16441286,2006-02-01T00:00:00,Glutamic Acid,D12.125.067.750
16441286,2006-02-01T00:00:00,Glutamic Acid,D12.125.119.450
16441286,2006-02-01T00:00:00,Glutamic Acid,D12.125.427.300
16441286,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16441286,2006-02-01T00:00:00,Neuronal Plasticity,G11.561.600.635
16441286,2006-02-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
16441286,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16441286,2006-02-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16441286,2006-02-01T00:00:00,Synapses,A08.850
16441286,2006-02-01T00:00:00,Synapses,A11.284.149.165.420.780
16442890,2006-02-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
16442890,2006-02-01T00:00:00,Disease Progression,C23.550.291.656
16442890,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16442890,2006-02-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16442890,2006-02-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16442890,2006-02-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16442890,2006-02-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16442890,2006-02-01T00:00:00,Patient Selection,E05.581.500.653
16442890,2006-02-01T00:00:00,Patient Selection,N04.590.731
16442890,2006-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16442890,2006-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16442890,2006-02-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16442890,2006-02-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16442890,2006-02-01T00:00:00,Research Design,E05.581.500
16442890,2006-02-01T00:00:00,Research Design,H01.770.644.728
16442890,2006-02-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16442890,2006-02-01T00:00:00,Ventricular Remodeling,C23.300.985
16442890,2006-02-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16443794,2006-02-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16443794,2006-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
16443794,2006-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
16443794,2006-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16443794,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16443794,2006-02-01T00:00:00,Hypertension,C14.907.489
16443794,2006-02-01T00:00:00,Insulin Resistance,C18.452.394.968.500
16443794,2006-02-01T00:00:00,Insulin Resistance,G07.690.320.617
16443794,2006-02-01T00:00:00,Obesity,C18.654.726.500
16443794,2006-02-01T00:00:00,Obesity,C23.888.144.699.500
16443794,2006-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16443794,2006-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16443794,2006-02-01T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
16446561,2006-02-01T00:00:00,Animals,B01.050
16446561,2006-02-01T00:00:00,Antioxidants,D27.505.519.217
16446561,2006-02-01T00:00:00,Antioxidants,D27.505.696.706.125
16446561,2006-02-01T00:00:00,Antioxidants,D27.720.799.047
16446561,2006-02-01T00:00:00,Apoptosis,G04.299.139.160
16446561,2006-02-01T00:00:00,Cochlea,A09.246.631.246
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A08.663.650.250
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A08.663.650.915.750.600.350
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A08.800.950.750.600.350
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A09.246.631.246.577.325
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A11.671.650.250
16446561,2006-02-01T00:00:00,"Hair Cells, Auditory",A11.671.650.915.750.600.350
16446561,2006-02-01T00:00:00,"Hearing Loss, Noise-Induced",C09.218.458.341.887.460
16446561,2006-02-01T00:00:00,"Hearing Loss, Noise-Induced",C10.597.751.418.341.887.460
16446561,2006-02-01T00:00:00,"Hearing Loss, Noise-Induced",C23.888.592.763.393.341.887.460
16446561,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16446561,2006-02-01T00:00:00,Noise,G01.595.907.567
16446561,2006-02-01T00:00:00,Noise,G16.500.275.600
16446561,2006-02-01T00:00:00,Noise,N06.230.400
16446561,2006-02-01T00:00:00,Noise,N06.850.460.610
16446561,2006-02-01T00:00:00,Oxidative Stress,G03.495.710
16446561,2006-02-01T00:00:00,Oxidative Stress,G07.700.830.750
16446561,2006-02-01T00:00:00,Reactive Oxygen Species,D01.339.431
16446561,2006-02-01T00:00:00,Reactive Oxygen Species,D01.650.775
16447272,2006-02-01T00:00:00,Animals,B01.050
16447272,2006-02-01T00:00:00,Apoptosis,G04.299.139.160
16447272,2006-02-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
16447272,2006-02-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
16447272,2006-02-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16447272,2006-02-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16447272,2006-02-01T00:00:00,Caspases,D12.644.360.075.405
16447272,2006-02-01T00:00:00,Caspases,D12.776.476.075.405
16447272,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16447272,2006-02-01T00:00:00,"Immunity, Innate",G12.450.575
16447272,2006-02-01T00:00:00,Liver,A03.620
16447272,2006-02-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
16447272,2006-02-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
16447272,2006-02-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
16447272,2006-02-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
16447272,2006-02-01T00:00:00,NF-kappa B,D12.776.260.600
16447272,2006-02-01T00:00:00,NF-kappa B,D12.776.660.600
16447272,2006-02-01T00:00:00,NF-kappa B,D12.776.930.600
16447272,2006-02-01T00:00:00,Reperfusion Injury,C14.907.725
16447272,2006-02-01T00:00:00,Reperfusion Injury,C23.550.767.877
16447272,2006-02-01T00:00:00,Signal Transduction,G02.111.087.800
16447272,2006-02-01T00:00:00,Signal Transduction,G02.149.115.800
16447272,2006-02-01T00:00:00,Signal Transduction,G04.299.880
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
16447272,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16447272,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16447288,2006-02-01T00:00:00,Biological Markers,D23.101
16447288,2006-02-01T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
16447288,2006-02-01T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
16447288,2006-02-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
16447288,2006-02-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
16447288,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16447288,2006-02-01T00:00:00,Liver Cirrhosis,C06.552.630
16448042,2006-02-01T00:00:00,Breast Neoplasms,C04.588.180
16448042,2006-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
16448042,2006-02-01T00:00:00,Chemical Fractionation,E05.196.155
16448042,2006-02-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16448042,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16448042,2006-02-01T00:00:00,Neoplasm Proteins,D12.776.624
16448042,2006-02-01T00:00:00,Phosphoproteins,D12.776.744
16448042,2006-02-01T00:00:00,Pyrimidines,D03.383.742
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,G17.800
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16448042,2006-02-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16448884,2006-02-01T00:00:00,Adult,M01.060.116
16448884,2006-02-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16448884,2006-02-01T00:00:00,Blood Pressure,E01.370.600.875.249
16448884,2006-02-01T00:00:00,Blood Pressure,G09.330.380.076
16448884,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16448884,2006-02-01T00:00:00,Hypertension,C14.907.489
16448884,2006-02-01T00:00:00,Primary Health Care,N04.590.233.727
16448884,2006-02-01T00:00:00,Treatment Outcome,E01.789.800
16448884,2006-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16448884,2006-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16448884,2006-02-01T00:00:00,United States,Z01.107.567.875
16450225,2006-02-01T00:00:00,Family Practice,H02.403.280
16450225,2006-02-01T00:00:00,Health Promotion,N02.370
16450225,2006-02-01T00:00:00,Health Promotion,N02.421.726.507
16450225,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16450225,2006-02-01T00:00:00,Primary Prevention,N02.421.726.758
16450225,2006-02-01T00:00:00,Primary Prevention,N06.850.780.680
16450225,2006-02-01T00:00:00,United States,Z01.107.567.875
16450232,2006-02-01T00:00:00,Adult,M01.060.116
16450232,2006-02-01T00:00:00,Aged,M01.060.116.100
16450232,2006-02-01T00:00:00,Family Practice,H02.403.280
16450232,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16450232,2006-02-01T00:00:00,Internal Medicine,H02.403.429
16450232,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16450232,2006-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
16450232,2006-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
16450232,2006-02-01T00:00:00,Piperazines,D03.383.606
16450232,2006-02-01T00:00:00,United States,Z01.107.567.875
16450232,2006-02-01T00:00:00,Urology,H02.403.810.860
16450232,2006-02-01T00:00:00,Vasodilator Agents,D27.505.954.411.918
16452233,2006-02-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
16452233,2006-02-01T00:00:00,Animals,B01.050
16452233,2006-02-01T00:00:00,Apoptosis,G04.299.139.160
16452233,2006-02-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
16452233,2006-02-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
16452233,2006-02-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16452233,2006-02-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16452233,2006-02-01T00:00:00,Caspases,D12.644.360.075.405
16452233,2006-02-01T00:00:00,Caspases,D12.776.476.075.405
16452233,2006-02-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
16452233,2006-02-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
16452233,2006-02-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
16452233,2006-02-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
16452233,2006-02-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
16452233,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16452233,2006-02-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
16452233,2006-02-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16452233,2006-02-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16452233,2006-02-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16452233,2006-02-01T00:00:00,Interferon-gamma,D23.529.718.550
16452233,2006-02-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
16452233,2006-02-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
16452233,2006-02-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16452233,2006-02-01T00:00:00,Mitochondria,A11.284.835.626
16452233,2006-02-01T00:00:00,Recombinant Proteins,D12.776.828
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
16452233,2006-02-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16452233,2006-02-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16452259,2006-02-01T00:00:00,Aged,M01.060.116.100
16452259,2006-02-01T00:00:00,Electromyography,E01.370.405.255
16452259,2006-02-01T00:00:00,Electromyography,E01.370.530.255
16452259,2006-02-01T00:00:00,Functional Laterality,F02.830.297.425
16452259,2006-02-01T00:00:00,Functional Laterality,G11.561.225.425
16452259,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16452259,2006-02-01T00:00:00,Leg,A01.378.610.500
16452259,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16452259,2006-02-01T00:00:00,Movement,G07.700.560
16452259,2006-02-01T00:00:00,Movement,G11.427.590.530
16452259,2006-02-01T00:00:00,"Muscle, Skeletal",A02.633.567
16452259,2006-02-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
16452259,2006-02-01T00:00:00,Paresis,C10.597.636
16452259,2006-02-01T00:00:00,Paresis,C23.888.592.643
16452259,2006-02-01T00:00:00,Periodicity,G01.910.645
16452259,2006-02-01T00:00:00,Periodicity,G07.180.562
16452259,2006-02-01T00:00:00,Stroke,C10.228.140.300.775
16452259,2006-02-01T00:00:00,Stroke,C14.907.253.855
16452259,2006-02-01T00:00:00,Walking,G11.427.590.530.568.900
16452259,2006-02-01T00:00:00,Walking,G11.427.590.530.698.940
16452259,2006-02-01T00:00:00,Walking,I03.450.642.845.940
16452681,2006-02-01T00:00:00,Actins,D05.750.078.730.250
16452681,2006-02-01T00:00:00,Actins,D12.776.210.500.100
16452681,2006-02-01T00:00:00,Actins,D12.776.220.525.255
16452681,2006-02-01T00:00:00,Animals,B01.050
16452681,2006-02-01T00:00:00,"Behavior, Animal",F01.145.113
16452681,2006-02-01T00:00:00,Cocaine,D02.145.074.722.388
16452681,2006-02-01T00:00:00,Cocaine,D03.132.889.354
16452681,2006-02-01T00:00:00,Cocaine,D03.605.869.388
16452681,2006-02-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
16452681,2006-02-01T00:00:00,Cocaine-Related Disorders,C21.739.300
16452681,2006-02-01T00:00:00,Cocaine-Related Disorders,F03.900.300
16452681,2006-02-01T00:00:00,Nerve Tissue Proteins,D12.776.641
16452681,2006-02-01T00:00:00,Neuronal Plasticity,G11.561.600.635
16452681,2006-02-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
16452681,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16452681,2006-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16452681,2006-02-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16452681,2006-02-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16454654,2006-02-01T00:00:00,Animals,B01.050
16454654,2006-02-01T00:00:00,Apoptosis,G04.299.139.160
16454654,2006-02-01T00:00:00,Brain,A08.186.211
16454654,2006-02-01T00:00:00,Brain Infarction,C10.228.140.300.150.477
16454654,2006-02-01T00:00:00,Brain Infarction,C10.228.140.300.775.200
16454654,2006-02-01T00:00:00,Brain Infarction,C14.907.253.092.477
16454654,2006-02-01T00:00:00,Brain Infarction,C14.907.253.855.200
16454654,2006-02-01T00:00:00,Brain Ischemia,C10.228.140.300.150
16454654,2006-02-01T00:00:00,Brain Ischemia,C14.907.253.092
16454654,2006-02-01T00:00:00,Gene Transfer Techniques,E05.393.350
16454654,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16454654,2006-02-01T00:00:00,Inflammation,C23.550.470
16454654,2006-02-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
16454654,2006-02-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
16454654,2006-02-01T00:00:00,Kallikreins,D12.776.124.125.597
16454654,2006-02-01T00:00:00,Kallikreins,D23.119.597
16454654,2006-02-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16454654,2006-02-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16454654,2006-02-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16454654,2006-02-01T00:00:00,Nitric Oxide,D01.339.387
16454654,2006-02-01T00:00:00,Nitric Oxide,D01.625.550.500
16454654,2006-02-01T00:00:00,Nitric Oxide,D01.625.700.500
16454654,2006-02-01T00:00:00,Nitric Oxide,D01.650.550.587.600
16454654,2006-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
16454654,2006-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
16454654,2006-02-01T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
16454654,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16454654,2006-02-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16454654,2006-02-01T00:00:00,Recombinant Proteins,D12.776.828
16454654,2006-02-01T00:00:00,Reperfusion Injury,C14.907.725
16454654,2006-02-01T00:00:00,Reperfusion Injury,C23.550.767.877
16454654,2006-02-01T00:00:00,Stroke,C10.228.140.300.775
16454654,2006-02-01T00:00:00,Stroke,C14.907.253.855
16456323,2006-02-01T00:00:00,Adult,M01.060.116
16456323,2006-02-01T00:00:00,Disease-Free Survival,E01.789.200
16456323,2006-02-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16456323,2006-02-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16456323,2006-02-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16456323,2006-02-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
16456323,2006-02-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
16456323,2006-02-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
16456323,2006-02-01T00:00:00,"Histiocytosis, Langerhans-Cell",C08.381.483.375
16456323,2006-02-01T00:00:00,"Histiocytosis, Langerhans-Cell",C15.604.250.400
16456323,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16456323,2006-02-01T00:00:00,Lymph Nodes,A10.549.400
16456323,2006-02-01T00:00:00,Lymph Nodes,A15.382.520.604.412
16456323,2006-02-01T00:00:00,Remission Induction,E02.860
16456323,2006-02-01T00:00:00,Sarcoma,C04.557.450.795
16456323,2006-02-01T00:00:00,Skin Neoplasms,C04.588.805
16456323,2006-02-01T00:00:00,Skin Neoplasms,C17.800.882
16458794,2006-02-01T00:00:00,Adolescent,M01.060.057
16458794,2006-02-01T00:00:00,Adult,M01.060.116
16458794,2006-02-01T00:00:00,Aged,M01.060.116.100
16458794,2006-02-01T00:00:00,Bias (Epidemiology),N05.715.350.150
16458794,2006-02-01T00:00:00,Bias (Epidemiology),N06.850.490.500
16458794,2006-02-01T00:00:00,Data Collection,E05.318.308
16458794,2006-02-01T00:00:00,Data Collection,L01.280
16458794,2006-02-01T00:00:00,Data Collection,N05.715.360.300
16458794,2006-02-01T00:00:00,Data Collection,N06.850.520.308
16458794,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16458794,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16458794,2006-02-01T00:00:00,Population Surveillance,E05.318.308.250.700
16458794,2006-02-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
16458794,2006-02-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
16458794,2006-02-01T00:00:00,Population Surveillance,N06.850.780.675
16458794,2006-02-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16458794,2006-02-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16458794,2006-02-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16458794,2006-02-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16459189,2006-02-01T00:00:00,Actins,D05.750.078.730.250
16459189,2006-02-01T00:00:00,Actins,D12.776.210.500.100
16459189,2006-02-01T00:00:00,Actins,D12.776.220.525.255
16459189,2006-02-01T00:00:00,Animals,B01.050
16459189,2006-02-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
16459189,2006-02-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16459189,2006-02-01T00:00:00,Fibroblasts,A11.329.228
16459189,2006-02-01T00:00:00,Fibroblasts,A11.872.228
16459189,2006-02-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16459189,2006-02-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
16459189,2006-02-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
16459189,2006-02-01T00:00:00,Hematopoietic Stem Cells,A11.148.378
16459189,2006-02-01T00:00:00,Hematopoietic Stem Cells,A11.872.378
16459189,2006-02-01T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
16459189,2006-02-01T00:00:00,Neoplasms,C04
16459189,2006-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
16459189,2006-02-01T00:00:00,Stromal Cells,A11.329.830
16459190,2006-02-01T00:00:00,Animals,B01.050
16459190,2006-02-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
16459190,2006-02-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16459190,2006-02-01T00:00:00,Fibroblasts,A11.329.228
16459190,2006-02-01T00:00:00,Fibroblasts,A11.872.228
16459190,2006-02-01T00:00:00,Fibronectins,D12.776.377.715.390
16459190,2006-02-01T00:00:00,Fibronectins,D12.776.395.550.350
16459190,2006-02-01T00:00:00,Fibronectins,D12.776.543.550.350
16459190,2006-02-01T00:00:00,Fibronectins,D12.776.860.300.450
16459190,2006-02-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16459190,2006-02-01T00:00:00,Flow Cytometry,E05.200.500.386.350
16459190,2006-02-01T00:00:00,Gene Expression Regulation,G05.355.315
16459190,2006-02-01T00:00:00,Green Fluorescent Proteins,D12.776.532.265
16459190,2006-02-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
16459190,2006-02-01T00:00:00,Hematopoietic Stem Cells,A11.148.378
16459190,2006-02-01T00:00:00,Hematopoietic Stem Cells,A11.872.378
16459190,2006-02-01T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
16459190,2006-02-01T00:00:00,"RNA, Messenger",D13.444.735.544
16465656,2006-02-01T00:00:00,Adult,M01.060.116
16465656,2006-02-01T00:00:00,African Americans,M01.686.508.100.100
16465656,2006-02-01T00:00:00,African Americans,M01.686.754.100
16465656,2006-02-01T00:00:00,Age of Onset,N05.715.350.075.100
16465656,2006-02-01T00:00:00,Age of Onset,N06.850.490.250.100
16465656,2006-02-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
16465656,2006-02-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
16465656,2006-02-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
16465656,2006-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16465656,2006-02-01T00:00:00,"Hospitals, University",N02.278.020.300.310
16465656,2006-02-01T00:00:00,"Hospitals, University",N02.278.421.639.725
16465656,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16465656,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16465656,2006-02-01T00:00:00,"Scleroderma, Systemic",C17.300.799
16465656,2006-02-01T00:00:00,"Scleroderma, Systemic",C17.800.784
16465656,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16465656,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16466529,2006-02-01T00:00:00,Androgens,D27.505.696.399.472.161
16466529,2006-02-01T00:00:00,Animals,B01.050
16466529,2006-02-01T00:00:00,Environmental Exposure,N06.850.460.350
16466529,2006-02-01T00:00:00,Pesticides,D27.720.031.700
16466529,2006-02-01T00:00:00,Pesticides,D27.720.723
16466529,2006-02-01T00:00:00,Pesticides,D27.888.723
16466529,2006-02-01T00:00:00,Pregnancy,G08.686.785.760.769
16466529,2006-02-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16466529,2006-02-01T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
16466529,2006-02-01T00:00:00,"Receptors, Androgen",D12.776.826.750.150
16466529,2006-02-01T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
16466531,2006-02-01T00:00:00,Animals,B01.050
16466531,2006-02-01T00:00:00,Endocrine Disruptors,D27.505.696.353
16466531,2006-02-01T00:00:00,Endocrine Disruptors,D27.888.284.295
16466531,2006-02-01T00:00:00,Environmental Exposure,N06.850.460.350
16466531,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16466531,2006-02-01T00:00:00,Hypospadias,C12.294.494.400
16466531,2006-02-01T00:00:00,Hypospadias,C12.706.516
16466531,2006-02-01T00:00:00,Hypospadias,C13.351.875.466
16466531,2006-02-01T00:00:00,Hypospadias,C16.131.939.516
16466531,2006-02-01T00:00:00,Pregnancy,G08.686.785.760.769
16466531,2006-02-01T00:00:00,Testis,A05.360.444.849
16466531,2006-02-01T00:00:00,Testis,A05.360.576.782
16466531,2006-02-01T00:00:00,Testis,A06.407.312.782
16467284,2006-02-01T00:00:00,Adult,M01.060.116
16467284,2006-02-01T00:00:00,Attitude,F01.100
16467284,2006-02-01T00:00:00,Breast Feeding,G07.610.220.500.500
16467284,2006-02-01T00:00:00,Breast Feeding,G07.610.593.185
16467284,2006-02-01T00:00:00,Breast Feeding,G07.700.620.185
16467284,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16467284,2006-02-01T00:00:00,Personality,F01.752
16472208,2006-02-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
16472208,2006-02-01T00:00:00,Alzheimer Disease,C10.574.945.249
16472208,2006-02-01T00:00:00,Alzheimer Disease,F03.087.400.100
16472208,2006-02-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
16472208,2006-02-01T00:00:00,Animals,B01.050
16472208,2006-02-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
16472208,2006-02-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
16472208,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16472208,2006-02-01T00:00:00,Membrane Proteins,D12.776.543
16475892,2006-02-01T00:00:00,Adolescent,M01.060.057
16475892,2006-02-01T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
16475892,2006-02-01T00:00:00,Child,M01.060.406
16475892,2006-02-01T00:00:00,"Child, Preschool",M01.060.406.448
16475892,2006-02-01T00:00:00,HIV Infections,C02.782.815.616.400
16475892,2006-02-01T00:00:00,HIV Infections,C02.800.801.400
16475892,2006-02-01T00:00:00,HIV Infections,C20.673.480
16475892,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16475892,2006-02-01T00:00:00,Infant,M01.060.703
16475892,2006-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16475892,2006-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16475892,2006-02-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16475892,2006-02-01T00:00:00,Patient Compliance,F01.145.488.500
16475892,2006-02-01T00:00:00,Patient Compliance,N05.300.150.600.600
16475892,2006-02-01T00:00:00,Pilot Projects,E05.318.760.750
16475892,2006-02-01T00:00:00,Pilot Projects,E05.337.737
16475892,2006-02-01T00:00:00,Pilot Projects,N05.715.360.775.625
16475892,2006-02-01T00:00:00,Pilot Projects,N06.850.520.450.720
16475892,2006-02-01T00:00:00,Program Evaluation,E05.337.820
16475892,2006-02-01T00:00:00,Program Evaluation,N04.761.685
16475892,2006-02-01T00:00:00,Program Evaluation,N05.715.360.650
16475892,2006-02-01T00:00:00,Referral and Consultation,N04.452.758.849
16481925,2006-02-01T00:00:00,Adolescent,M01.060.057
16481925,2006-02-01T00:00:00,Analgesics,D27.505.696.663.850.014
16481925,2006-02-01T00:00:00,Analgesics,D27.505.954.427.040
16481925,2006-02-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
16481925,2006-02-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
16481925,2006-02-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
16481925,2006-02-01T00:00:00,Child,M01.060.406
16481925,2006-02-01T00:00:00,"Child, Preschool",M01.060.406.448
16481925,2006-02-01T00:00:00,Conscious Sedation,E03.250
16481925,2006-02-01T00:00:00,Emergency Medical Services,N02.421.297
16481925,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16481925,2006-02-01T00:00:00,Infant,M01.060.703
16481925,2006-02-01T00:00:00,Ketamine,D02.455.426.392.368.367.652
16481925,2006-02-01T00:00:00,Pain,C10.597.617
16481925,2006-02-01T00:00:00,Pain,C23.888.592.612
16481925,2006-02-01T00:00:00,Pain,C23.888.646
16481925,2006-02-01T00:00:00,Pain,F02.830.816.444
16481925,2006-02-01T00:00:00,Pain,G11.561.600.810.444
16490873,2006-02-01T00:00:00,"Child, Preschool",M01.060.406.448
16490873,2006-02-01T00:00:00,Glottis,A04.329.364
16490873,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16490873,2006-02-01T00:00:00,Infant,M01.060.703
16490873,2006-02-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
16490873,2006-02-01T00:00:00,Tracheostomy,E04.579.935
16490873,2006-02-01T00:00:00,Tracheostomy,E04.580.900
16490873,2006-02-01T00:00:00,Tracheostomy,E04.928.780
16490873,2006-02-01T00:00:00,Treatment Outcome,E01.789.800
16490873,2006-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16490873,2006-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16495760,2006-02-01T00:00:00,Animals,B01.050
16495760,2006-02-01T00:00:00,Echocardiography,E01.370.350.850.220
16495760,2006-02-01T00:00:00,Echocardiography,E01.370.370.380.220
16495760,2006-02-01T00:00:00,Fluoroscopy,E01.370.350.700.225
16495760,2006-02-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16495760,2006-02-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16495760,2006-02-01T00:00:00,Myocardial Infarction,C14.280.647.500
16495760,2006-02-01T00:00:00,Myocardial Infarction,C14.907.585.500
16495760,2006-02-01T00:00:00,Myocardium,A02.633.580
16495760,2006-02-01T00:00:00,Myocardium,A07.541.704
16495760,2006-02-01T00:00:00,Myocardium,A10.690.552.750
16495760,2006-02-01T00:00:00,Swine,B01.050.150.900.649.077.880
16495760,2006-02-01T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
16495760,2006-02-01T00:00:00,Ventricular Remodeling,C23.300.985
16495760,2006-02-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16510029,2006-02-01T00:00:00,Algorithms,G17.035
16510029,2006-02-01T00:00:00,Algorithms,L01.224.050
16510029,2006-02-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16510029,2006-02-01T00:00:00,Cardiovascular Agents,D27.505.954.411
16510029,2006-02-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
16510029,2006-02-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
16510029,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16510029,2006-02-01T00:00:00,"Hypertension, Portal",C06.552.494
16510029,2006-02-01T00:00:00,Liver Cirrhosis,C06.552.630
16510029,2006-02-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
16510029,2006-02-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
16511370,2006-02-01T00:00:00,Adolescent,M01.060.057
16511370,2006-02-01T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
16511370,2006-02-01T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
16511370,2006-02-01T00:00:00,Behavior Therapy,F04.754.137
16511370,2006-02-01T00:00:00,Combined Modality Therapy,E02.186
16511370,2006-02-01T00:00:00,Education,I02
16511370,2006-02-01T00:00:00,HIV Infections,C02.782.815.616.400
16511370,2006-02-01T00:00:00,HIV Infections,C02.800.801.400
16511370,2006-02-01T00:00:00,HIV Infections,C20.673.480
16511370,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16511370,2006-02-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
16511370,2006-02-01T00:00:00,Marijuana Abuse,C21.739.635
16511370,2006-02-01T00:00:00,Marijuana Abuse,F03.900.635
16511370,2006-02-01T00:00:00,Peer Group,F01.829.316.483
16511370,2006-02-01T00:00:00,Social Environment,I01.880.656
16511370,2006-02-01T00:00:00,Social Support,I01.880.656.600
16544857,2006-02-01T00:00:00,Aged,M01.060.116.100
16544857,2006-02-01T00:00:00,Aging,G07.700.320.124
16544857,2006-02-01T00:00:00,Delirium,C10.597.606.337.500
16544857,2006-02-01T00:00:00,Delirium,C23.888.592.604.339.500
16544857,2006-02-01T00:00:00,Delirium,F01.700.250.500
16544857,2006-02-01T00:00:00,Delirium,F03.087.350
16544857,2006-02-01T00:00:00,Geriatric Assessment,E05.318.308.225
16544857,2006-02-01T00:00:00,Geriatric Assessment,I01.240.425.350
16544857,2006-02-01T00:00:00,Geriatric Assessment,L01.280.360
16544857,2006-02-01T00:00:00,Geriatric Assessment,N01.224.425.350
16544857,2006-02-01T00:00:00,Geriatric Assessment,N05.715.360.300.360
16544857,2006-02-01T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
16544857,2006-02-01T00:00:00,Geriatric Assessment,N06.850.520.308.225
16544857,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16551142,2006-02-01T00:00:00,Adolescent,M01.060.057
16551142,2006-02-01T00:00:00,Antisocial Personality Disorder,F03.675.050
16551142,2006-02-01T00:00:00,Combined Modality Therapy,E02.186
16551142,2006-02-01T00:00:00,Community Mental Health Services,F04.408.307
16551142,2006-02-01T00:00:00,Community Mental Health Services,N02.421.143.183
16551142,2006-02-01T00:00:00,Community Mental Health Services,N02.421.461.232
16551142,2006-02-01T00:00:00,Crime,I01.198.240
16551142,2006-02-01T00:00:00,Crime,I01.880.735.191
16551142,2006-02-01T00:00:00,Evidence-Based Medicine,H02.249.750
16551142,2006-02-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16551142,2006-02-01T00:00:00,Family Therapy,F04.754.864.581.273
16551142,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16551142,2006-02-01T00:00:00,Juvenile Delinquency,I01.880.735.479
16551142,2006-02-01T00:00:00,Substance-Related Disorders,C21.739
16551142,2006-02-01T00:00:00,Substance-Related Disorders,F03.900
16566882,2006-02-01T00:00:00,Child,M01.060.406
16566882,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16566882,2006-02-01T00:00:00,Hydrocephalus,C10.228.140.602
16566882,2006-02-01T00:00:00,Hydrocephalus,C10.228.140.631.450
16566882,2006-02-01T00:00:00,Hydrocephalus,C16.614.414
16566882,2006-02-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
16566882,2006-02-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
16566882,2006-02-01T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
16566882,2006-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16566882,2006-02-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16566882,2006-02-01T00:00:00,Orbit,A02.835.232.781.324.690
16571856,2006-02-01T00:00:00,Adult,M01.060.116
16571856,2006-02-01T00:00:00,Aged,M01.060.116.100
16571856,2006-02-01T00:00:00,Blood Glucose,D09.546.359.448.500
16571856,2006-02-01T00:00:00,Cardiovascular Diseases,C14
16571856,2006-02-01T00:00:00,Diet,E05.272
16571856,2006-02-01T00:00:00,Diet,G07.610.240
16571856,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16571856,2006-02-01T00:00:00,Insulin,D06.472.699.587.740.625
16571856,2006-02-01T00:00:00,Insulin,D12.644.548.586.740.625
16571856,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16571856,2006-02-01T00:00:00,Nutrition Surveys,E05.318.308.250.600
16571856,2006-02-01T00:00:00,Nutrition Surveys,E05.318.308.585.550
16571856,2006-02-01T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
16571856,2006-02-01T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
16571856,2006-02-01T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
16571856,2006-02-01T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
16571856,2006-02-01T00:00:00,Questionnaires,E05.318.308.750
16571856,2006-02-01T00:00:00,Questionnaires,L01.280.800
16571856,2006-02-01T00:00:00,Questionnaires,N05.715.360.300.695
16571856,2006-02-01T00:00:00,Questionnaires,N06.850.520.308.750
16571856,2006-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16571856,2006-02-01T00:00:00,Risk Factors,N05.715.350.200.700
16571856,2006-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16571856,2006-02-01T00:00:00,Risk Factors,N06.850.490.625.750
16571856,2006-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16573057,2006-02-01T00:00:00,Carbon,D01.268.150
16573057,2006-02-01T00:00:00,Nanotechnology,H01.603
16573057,2006-02-01T00:00:00,Nanotechnology,J01.897.520.600
16573057,2006-02-01T00:00:00,Oxides,D01.248.497.158.685
16573057,2006-02-01T00:00:00,Oxides,D01.650.550
16704179,2006-02-01T00:00:00,Adolescent,M01.060.057
16704179,2006-02-01T00:00:00,Child,M01.060.406
16704179,2006-02-01T00:00:00,Disease Management,N04.590.607
16704179,2006-02-01T00:00:00,Heart Failure,C14.280.434
16704179,2006-02-01T00:00:00,Heart Transplantation,E04.100.376.475
16704179,2006-02-01T00:00:00,Heart Transplantation,E04.928.220.390
16704179,2006-02-01T00:00:00,Heart Transplantation,E04.936.450.475
16704179,2006-02-01T00:00:00,"Hospitals, University",N02.278.020.300.310
16704179,2006-02-01T00:00:00,"Hospitals, University",N02.278.421.639.725
16704179,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16704179,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
16704179,2006-02-01T00:00:00,Patient Selection,E05.581.500.653
16704179,2006-02-01T00:00:00,Patient Selection,N04.590.731
16704179,2006-02-01T00:00:00,Program Development,N04.452.760
16704179,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16704179,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16704180,2006-02-01T00:00:00,Disaster Planning,N06.230.100.035
16704180,2006-02-01T00:00:00,Disasters,N06.230.100
16704180,2006-02-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
16704180,2006-02-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
16704180,2006-02-01T00:00:00,Emergency Medical Services,N02.421.297
16704180,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16704180,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16704180,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16892249,2006-02-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16892249,2006-02-01T00:00:00,Bacterial Proteins,D12.776.097
16892249,2006-02-01T00:00:00,Cell Culture Techniques,E05.200.249.249
16892249,2006-02-01T00:00:00,Glucose,D09.546.359.448
16892249,2006-02-01T00:00:00,Hemoglobins,D12.776.124.400
16892249,2006-02-01T00:00:00,Hemoglobins,D12.776.422.316.762
16892249,2006-02-01T00:00:00,Protein Engineering,E05.393.420.601
16892249,2006-02-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
16892249,2006-02-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
17409839,2006-02-01T00:00:00,Aged,M01.060.116.100
17409839,2006-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17409839,2006-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17409839,2006-02-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17409839,2006-02-01T00:00:00,Disease Progression,C23.550.291.656
17409839,2006-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17409839,2006-02-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17409839,2006-02-01T00:00:00,Lung Neoplasms,C08.381.540
17409839,2006-02-01T00:00:00,Lung Neoplasms,C08.785.520
17409839,2006-02-01T00:00:00,Middle Aged,M01.060.116.630
17409839,2006-02-01T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
17409839,2006-02-01T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
17409839,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17409839,2006-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17409839,2006-02-01T00:00:00,Treatment Outcome,E01.789.800
17409839,2006-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17409839,2006-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16456103,2006-02-02T00:00:00,Animals,B01.050
16456103,2006-02-02T00:00:00,Cell Differentiation,G04.299.151
16456103,2006-02-02T00:00:00,Collagen Type I,D05.750.078.280.300.100
16456103,2006-02-02T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16456103,2006-02-02T00:00:00,Fibroblasts,A11.329.228
16456103,2006-02-02T00:00:00,Fibroblasts,A11.872.228
16456103,2006-02-02T00:00:00,Green Fluorescent Proteins,D12.776.532.265
16456103,2006-02-02T00:00:00,Heart Valves,A07.541.510
16456103,2006-02-02T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
16456103,2006-02-02T00:00:00,"RNA, Messenger",D13.444.735.544
16456121,2006-02-02T00:00:00,Aged,M01.060.116.100
16456121,2006-02-02T00:00:00,Gait,E01.370.600.250
16456121,2006-02-02T00:00:00,Gait,G11.427.590.530.389
16456121,2006-02-02T00:00:00,Hemiplegia,C10.597.622.295
16456121,2006-02-02T00:00:00,Hemiplegia,C23.888.592.636.312
16456121,2006-02-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16456121,2006-02-02T00:00:00,Middle Aged,M01.060.116.630
16456121,2006-02-02T00:00:00,Motor Activity,F01.145.632
16456121,2006-02-02T00:00:00,Motor Activity,G11.427.590.530.698
16456121,2006-02-02T00:00:00,Paresis,C10.597.636
16456121,2006-02-02T00:00:00,Paresis,C23.888.592.643
16456121,2006-02-02T00:00:00,Stroke,C10.228.140.300.775
16456121,2006-02-02T00:00:00,Stroke,C14.907.253.855
16456121,2006-02-02T00:00:00,Walking,G11.427.590.530.568.900
16456121,2006-02-02T00:00:00,Walking,G11.427.590.530.698.940
16456121,2006-02-02T00:00:00,Walking,I03.450.642.845.940
16456107,2006-02-03T00:00:00,Animals,B01.050
16456107,2006-02-03T00:00:00,Calcium,D01.268.552.100
16456107,2006-02-03T00:00:00,Calcium,D01.552.539.288
16456107,2006-02-03T00:00:00,Calcium,D23.119.100
16456107,2006-02-03T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
16456107,2006-02-03T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
16456107,2006-02-03T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
16456107,2006-02-03T00:00:00,Myocardial Contraction,G09.330.190.541
16456107,2006-02-03T00:00:00,Myocardial Contraction,G11.427.590.540.570
16456107,2006-02-03T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16456107,2006-02-03T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16456107,2006-02-03T00:00:00,"Myocytes, Cardiac",A11.620.500
16456107,2006-02-03T00:00:00,Rabbits,B01.050.150.900.649.521.700
16456107,2006-02-03T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
16456107,2006-02-03T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
16456107,2006-02-03T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
16456107,2006-02-03T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
16458957,2006-02-03T00:00:00,Adult,M01.060.116
16458957,2006-02-03T00:00:00,Aged,M01.060.116.100
16458957,2006-02-03T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
16458957,2006-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16458957,2006-02-03T00:00:00,Middle Aged,M01.060.116.630
16458957,2006-02-03T00:00:00,Pancreatic Neoplasms,C04.588.274.761
16458957,2006-02-03T00:00:00,Pancreatic Neoplasms,C04.588.322.421
16458957,2006-02-03T00:00:00,Pancreatic Neoplasms,C06.301.761
16458957,2006-02-03T00:00:00,Pancreatic Neoplasms,C06.689.667
16458957,2006-02-03T00:00:00,Pancreatic Neoplasms,C19.344.421
16458957,2006-02-03T00:00:00,Regression Analysis,E05.318.740.750
16458957,2006-02-03T00:00:00,Regression Analysis,N05.715.360.750.695
16458957,2006-02-03T00:00:00,Regression Analysis,N06.850.520.830.750
16458957,2006-02-03T00:00:00,Risk Assessment,E05.318.740.600.800.715
16458957,2006-02-03T00:00:00,Risk Assessment,N04.452.871.715
16458957,2006-02-03T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16458957,2006-02-03T00:00:00,Risk Assessment,N06.850.505.715
16458957,2006-02-03T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16458957,2006-02-03T00:00:00,Risk Factors,E05.318.740.600.800.725
16458957,2006-02-03T00:00:00,Risk Factors,N05.715.350.200.700
16458957,2006-02-03T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16458957,2006-02-03T00:00:00,Risk Factors,N06.850.490.625.750
16458957,2006-02-03T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16458957,2006-02-03T00:00:00,Smoking,F01.145.466.753
16458957,2006-02-03T00:00:00,Smoking Cessation,F01.145.940.700
16458957,2006-02-03T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
16458957,2006-02-03T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
16459022,2006-02-03T00:00:00,Amphetamine,D02.092.471.683.152.110
16459022,2006-02-03T00:00:00,Amphetamine-Related Disorders,C21.739.225
16459022,2006-02-03T00:00:00,Amphetamine-Related Disorders,F03.900.225
16459022,2006-02-03T00:00:00,Animals,B01.050
16459022,2006-02-03T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
16459022,2006-02-03T00:00:00,Dynorphins,D12.644.400.575.180
16459022,2006-02-03T00:00:00,Dynorphins,D12.644.468.180
16459022,2006-02-03T00:00:00,Dynorphins,D12.776.641.650.575.180
16459022,2006-02-03T00:00:00,Enzyme Inhibitors,D27.505.519.389
16459022,2006-02-03T00:00:00,Gene Expression Regulation,G05.355.315
16459022,2006-02-03T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16459022,2006-02-03T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16459022,2006-02-03T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16459022,2006-02-03T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16459022,2006-02-03T00:00:00,Motor Activity,F01.145.632
16459022,2006-02-03T00:00:00,Motor Activity,G11.427.590.530.698
16459022,2006-02-03T00:00:00,Neuropeptides,D12.644.400
16459022,2006-02-03T00:00:00,Neuropeptides,D12.776.641.650
16459022,2006-02-03T00:00:00,Protein Precursors,D12.776.811
16459022,2006-02-03T00:00:00,"RNA, Messenger",D13.444.735.544
16459022,2006-02-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16459022,2006-02-03T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16459138,2006-02-03T00:00:00,Adult,M01.060.116
16459138,2006-02-03T00:00:00,Central Nervous System Stimulants,D27.505.696.282
16459138,2006-02-03T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
16459138,2006-02-03T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
16459138,2006-02-03T00:00:00,Electroencephalography,E01.370.376.300
16459138,2006-02-03T00:00:00,Electroencephalography,E01.370.405.245
16459138,2006-02-03T00:00:00,Electromyography,E01.370.405.255
16459138,2006-02-03T00:00:00,Electromyography,E01.370.530.255
16459138,2006-02-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16459138,2006-02-03T00:00:00,Sleep Initiation and Maintenance Disorders,C10.886.425.800.800
16459138,2006-02-03T00:00:00,Sleep Initiation and Maintenance Disorders,F03.870.400.800.800
16459138,2006-02-03T00:00:00,"Sleep, REM",F02.830.855.796.671
16459138,2006-02-03T00:00:00,"Sleep, REM",G11.561.600.815.754.671
16455737,2006-02-04T00:00:00,Carbon Monoxide,D01.200.250
16455737,2006-02-04T00:00:00,Carbon Monoxide,D01.362.200
16455737,2006-02-04T00:00:00,Carbon Monoxide,D01.650.550.250
16455737,2006-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16455737,2006-02-04T00:00:00,Nicotine,D03.132.760.570
16455737,2006-02-04T00:00:00,Nicotine,D03.383.725.518
16455737,2006-02-04T00:00:00,Smoking,F01.145.466.753
16455737,2006-02-04T00:00:00,Tobacco,B01.650.388.100.905.900
16461815,2006-02-06T00:00:00,Adult,M01.060.116
16461815,2006-02-06T00:00:00,Aged,M01.060.116.100
16461815,2006-02-06T00:00:00,"Antigens, CD147",D12.776.395.550.045
16461815,2006-02-06T00:00:00,"Antigens, CD147",D12.776.543.550.188
16461815,2006-02-06T00:00:00,"Antigens, CD147",D23.050.285.040
16461815,2006-02-06T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
16461815,2006-02-06T00:00:00,"Antigens, CD147",D23.101.100.110.247
16461815,2006-02-06T00:00:00,Atherosclerosis,C14.907.137.126.307
16461815,2006-02-06T00:00:00,Cell Adhesion,G04.299.117
16461815,2006-02-06T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
16461815,2006-02-06T00:00:00,Gene Expression Regulation,G05.355.315
16461815,2006-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
16461815,2006-02-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
16461815,2006-02-06T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16461815,2006-02-06T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16461815,2006-02-06T00:00:00,Middle Aged,M01.060.116.630
16461815,2006-02-06T00:00:00,Monocytes,A11.118.637.555.652
16461815,2006-02-06T00:00:00,Monocytes,A11.148.580
16461815,2006-02-06T00:00:00,Monocytes,A11.627.624
16461815,2006-02-06T00:00:00,Monocytes,A11.733.547
16461815,2006-02-06T00:00:00,Monocytes,A15.145.229.637.555.652
16461815,2006-02-06T00:00:00,Monocytes,A15.378.316.580
16461815,2006-02-06T00:00:00,Monocytes,A15.382.490.555.652
16461815,2006-02-06T00:00:00,Monocytes,A15.382.680.547
16461815,2006-02-06T00:00:00,Monocytes,A15.382.812.547
16461815,2006-02-06T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
16461815,2006-02-06T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
16461815,2006-02-06T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
16461815,2006-02-06T00:00:00,Myocardial Infarction,C14.280.647.500
16461815,2006-02-06T00:00:00,Myocardial Infarction,C14.907.585.500
16722591,2006-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16722591,2006-02-06T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16722591,2006-02-06T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16722591,2006-02-06T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16722591,2006-02-06T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16722591,2006-02-06T00:00:00,Substance-Related Disorders,C21.739
16722591,2006-02-06T00:00:00,Substance-Related Disorders,F03.900
16455277,2006-02-07T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
16455277,2006-02-07T00:00:00,Amino Acid Sequence,G02.111.570.060
16455277,2006-02-07T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16455277,2006-02-07T00:00:00,Animals,B01.050
16455277,2006-02-07T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
16455277,2006-02-07T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
16455277,2006-02-07T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
16455277,2006-02-07T00:00:00,Gonads,A05.360.576
16455277,2006-02-07T00:00:00,Gonads,A06.407.312
16455277,2006-02-07T00:00:00,Molecular Sequence Data,L01.453.245.667
16455277,2006-02-07T00:00:00,Phylogeny,G05.697
16455277,2006-02-07T00:00:00,Phylogeny,G16.100.275.605
16455277,2006-02-07T00:00:00,Phylogeny,L01.100.697
16465626,2006-02-08T00:00:00,Cross Infection,C01.539.248
16465626,2006-02-08T00:00:00,"Hospitals, University",N02.278.020.300.310
16465626,2006-02-08T00:00:00,"Hospitals, University",N02.278.421.639.725
16465626,2006-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16465626,2006-02-08T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
16465626,2006-02-08T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
16465626,2006-02-08T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
16465626,2006-02-08T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16465626,2006-02-08T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16465626,2006-02-08T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16466871,2006-02-08T00:00:00,Acoustic Stimulation,E02.037
16466871,2006-02-08T00:00:00,Acoustic Stimulation,E02.190.888.030
16466871,2006-02-08T00:00:00,Acoustic Stimulation,E05.723.136
16466871,2006-02-08T00:00:00,"Adaptation, Physiological",G07.700.062
16466871,2006-02-08T00:00:00,"Adaptation, Physiological",G16.100.057.500
16466871,2006-02-08T00:00:00,Animals,B01.050
16466871,2006-02-08T00:00:00,Antioxidants,D27.505.519.217
16466871,2006-02-08T00:00:00,Antioxidants,D27.505.696.706.125
16466871,2006-02-08T00:00:00,Antioxidants,D27.720.799.047
16466871,2006-02-08T00:00:00,Auditory Threshold,F02.463.593.071.173
16466871,2006-02-08T00:00:00,Auditory Threshold,F02.463.593.710.190
16466871,2006-02-08T00:00:00,Cochlea,A09.246.631.246
16466871,2006-02-08T00:00:00,Conditioning (Psychology),F02.463.425.179
16466871,2006-02-08T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
16466871,2006-02-08T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
16466871,2006-02-08T00:00:00,"Hearing Loss, Noise-Induced",C09.218.458.341.887.460
16466871,2006-02-08T00:00:00,"Hearing Loss, Noise-Induced",C10.597.751.418.341.887.460
16466871,2006-02-08T00:00:00,"Hearing Loss, Noise-Induced",C23.888.592.763.393.341.887.460
16466871,2006-02-08T00:00:00,Herbicides,D27.720.031.700.366
16466871,2006-02-08T00:00:00,Herbicides,D27.720.723.366
16466871,2006-02-08T00:00:00,Herbicides,D27.888.723.366
16466871,2006-02-08T00:00:00,Noise,G01.595.907.567
16466871,2006-02-08T00:00:00,Noise,G16.500.275.600
16466871,2006-02-08T00:00:00,Noise,N06.230.400
16466871,2006-02-08T00:00:00,Noise,N06.850.460.610
16466871,2006-02-08T00:00:00,Oxidative Stress,G03.495.710
16466871,2006-02-08T00:00:00,Oxidative Stress,G07.700.830.750
16466871,2006-02-08T00:00:00,Superoxides,D01.248.497.158.685.750.850
16466871,2006-02-08T00:00:00,Superoxides,D01.339.431.374.850
16466871,2006-02-08T00:00:00,Superoxides,D01.339.431.750
16466871,2006-02-08T00:00:00,Superoxides,D01.650.550.750.800
16466872,2006-02-08T00:00:00,Animals,B01.050
16466872,2006-02-08T00:00:00,"Animals, Newborn",B01.050.050.282
16466872,2006-02-08T00:00:00,Cochlea,A09.246.631.246
16466872,2006-02-08T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16466872,2006-02-08T00:00:00,Membrane Proteins,D12.776.543
16466872,2006-02-08T00:00:00,Organ of Corti,A09.246.631.246.577
16466872,2006-02-08T00:00:00,"RNA, Messenger",D13.444.735.544
16466872,2006-02-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16466872,2006-02-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16466872,2006-02-08T00:00:00,Stria Vascularis,A09.246.631.246.292.876
16451080,2006-02-09T00:00:00,Animals,B01.050
16451080,2006-02-09T00:00:00,Antineoplastic Agents,D27.505.954.248
16451080,2006-02-09T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
16451080,2006-02-09T00:00:00,Glutathione,D12.644.456.448
16451080,2006-02-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16451080,2006-02-09T00:00:00,Nitric Oxide,D01.339.387
16451080,2006-02-09T00:00:00,Nitric Oxide,D01.625.550.500
16451080,2006-02-09T00:00:00,Nitric Oxide,D01.625.700.500
16451080,2006-02-09T00:00:00,Nitric Oxide,D01.650.550.587.600
16472931,2006-02-10T00:00:00,Alcoholism,C21.739.100.250
16472931,2006-02-10T00:00:00,Alcoholism,F03.900.100.350
16472931,2006-02-10T00:00:00,Anticonvulsants,D27.505.954.427.080
16472931,2006-02-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16472931,2006-02-10T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16472931,2006-02-10T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16472931,2006-02-10T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16472931,2006-02-10T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16472931,2006-02-10T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16472931,2006-02-10T00:00:00,Research Design,E05.581.500
16472931,2006-02-10T00:00:00,Research Design,H01.770.644.728
16472931,2006-02-10T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16472931,2006-02-10T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16474926,2006-02-11T00:00:00,Brachiocephalic Veins,A07.231.908.130
16474926,2006-02-11T00:00:00,Hepatic Veins,A07.231.908.380
16474926,2006-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16474926,2006-02-11T00:00:00,Middle Aged,M01.060.116.630
16474926,2006-02-11T00:00:00,Subclavian Vein,A07.231.908.877
16474926,2006-02-11T00:00:00,Venous Thrombosis,C14.907.355.830.925
16476928,2006-02-14T00:00:00,Age Factors,N05.715.350.075
16476928,2006-02-14T00:00:00,Age Factors,N06.850.490.250
16476928,2006-02-14T00:00:00,Aged,M01.060.116.100
16476928,2006-02-14T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16476928,2006-02-14T00:00:00,Cardiovascular Diseases,C14
16476928,2006-02-14T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16476928,2006-02-14T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16476928,2006-02-14T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16476928,2006-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16476928,2006-02-14T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
16476928,2006-02-14T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
16476928,2006-02-14T00:00:00,Middle Aged,M01.060.116.630
16476928,2006-02-14T00:00:00,Stroke,C10.228.140.300.775
16476928,2006-02-14T00:00:00,Stroke,C14.907.253.855
16476966,2006-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16476966,2006-02-14T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
16476966,2006-02-14T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
16476966,2006-02-14T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
16476966,2006-02-14T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
16476966,2006-02-14T00:00:00,Metabolic Syndrome X,C18.452.625
16476966,2006-02-14T00:00:00,Stroke,C10.228.140.300.775
16476966,2006-02-14T00:00:00,Stroke,C14.907.253.855
16476968,2006-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16476968,2006-02-14T00:00:00,Internet,L01.224.230.110.500
16476968,2006-02-14T00:00:00,Stroke,C10.228.140.300.775
16476968,2006-02-14T00:00:00,Stroke,C14.907.253.855
16476968,2006-02-14T00:00:00,Telemedicine,H02.403.840
16476968,2006-02-14T00:00:00,Telemedicine,L01.178.847.652
16476968,2006-02-14T00:00:00,Telemedicine,N04.590.374.800
16478623,2006-02-14T00:00:00,Aging,G07.700.320.124
16478623,2006-02-14T00:00:00,Animals,B01.050
16478623,2006-02-14T00:00:00,Body Weight,C23.888.144
16478623,2006-02-14T00:00:00,Body Weight,E01.370.600.115.100.160.120
16478623,2006-02-14T00:00:00,Body Weight,E05.041.124.160.750
16478623,2006-02-14T00:00:00,Body Weight,G07.100.100.160.120
16478623,2006-02-14T00:00:00,Body Weight,G07.700.320.249.314.120
16478623,2006-02-14T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
16478623,2006-02-14T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
16478623,2006-02-14T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
16478623,2006-02-14T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
16478623,2006-02-14T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
16478623,2006-02-14T00:00:00,Gene Expression,G05.355.310
16478623,2006-02-14T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16478623,2006-02-14T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16478623,2006-02-14T00:00:00,Motor Activity,F01.145.632
16478623,2006-02-14T00:00:00,Motor Activity,G11.427.590.530.698
16478623,2006-02-14T00:00:00,Nerve Tissue Proteins,D12.776.641
16478623,2006-02-14T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
16478623,2006-02-14T00:00:00,Substantia Nigra,A08.186.211.653.822.731
16477391,2006-02-15T00:00:00,Bacteriorhodopsins,D12.776.090.200
16477391,2006-02-15T00:00:00,Bacteriorhodopsins,D12.776.157.530.450.250.875.249
16477391,2006-02-15T00:00:00,Bacteriorhodopsins,D12.776.543.585.450.250.875.249
16477391,2006-02-15T00:00:00,Bacteriorhodopsins,D12.776.752.812.249
16477391,2006-02-15T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
16572792,2006-02-15T00:00:00,Adsorption,G02.149.047
16572792,2006-02-15T00:00:00,Adsorption,G02.149.767.029
16572792,2006-02-15T00:00:00,Adsorption,G02.842.750.029
16572792,2006-02-15T00:00:00,Carbon,D01.268.150
16572792,2006-02-15T00:00:00,Porosity,G01.374.710
16572792,2006-02-15T00:00:00,Trichloroethylene,D02.455.526.439.939
16572792,2006-02-15T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
16572792,2006-02-15T00:00:00,Water Purification,N06.850.860.510.900.900
16572792,2006-02-15T00:00:00,Water Purification,N06.850.860.510.915.900
17136158,2006-02-15T00:00:00,Career Choice,F02.463.785.373.346.400
17136158,2006-02-15T00:00:00,Faculty,I02.463
17136158,2006-02-15T00:00:00,Faculty,M01.526.339
17136158,2006-02-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17136158,2006-02-15T00:00:00,"Students, Pharmacy",I02.851.686.768
17136158,2006-02-15T00:00:00,"Students, Pharmacy",M01.848.769.768
17136158,2006-02-15T00:00:00,United States,Z01.107.567.875
16471843,2006-02-16T00:00:00,Binding Sites,G02.111.570.120
16471843,2006-02-16T00:00:00,Molecular Structure,G02.111.570
16471843,2006-02-16T00:00:00,Molecular Structure,G02.575
16471843,2006-02-16T00:00:00,Molecular Structure,G02.842.575
16471843,2006-02-16T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
16471843,2006-02-16T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
16471843,2006-02-16T00:00:00,Phospholipids,D10.570.755
16471843,2006-02-16T00:00:00,Phospholipids,D10.695
16471843,2006-02-16T00:00:00,Surface Properties,G02.842.850
16484453,2006-02-16T00:00:00,Animals,B01.050
16484453,2006-02-16T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
16484453,2006-02-16T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
16484453,2006-02-16T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
16484453,2006-02-16T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
16484453,2006-02-16T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
16484453,2006-02-16T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
16484453,2006-02-16T00:00:00,Antigen-Antibody Complex,D23.050.101
16484453,2006-02-16T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
16484453,2006-02-16T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
16484453,2006-02-16T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
16484453,2006-02-16T00:00:00,Cell Proliferation,G04.299.233.750
16484453,2006-02-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16484453,2006-02-16T00:00:00,Immunologic Memory,G12.450.050.500
16484453,2006-02-16T00:00:00,Interleukin-2,D12.644.276.374.465.502
16484453,2006-02-16T00:00:00,Interleukin-2,D12.644.276.374.480.372
16484453,2006-02-16T00:00:00,Interleukin-2,D12.776.467.374.465.502
16484453,2006-02-16T00:00:00,Interleukin-2,D12.776.467.374.480.372
16484453,2006-02-16T00:00:00,Interleukin-2,D23.529.374.465.502
16484453,2006-02-16T00:00:00,Interleukin-2,D23.529.374.480.372
16484453,2006-02-16T00:00:00,Interleukin-4,D12.644.276.374.465.504
16484453,2006-02-16T00:00:00,Interleukin-4,D12.776.467.374.465.504
16484453,2006-02-16T00:00:00,Interleukin-4,D23.529.374.465.504
16484453,2006-02-16T00:00:00,Lymphocyte Activation,E01.450.495.482
16484453,2006-02-16T00:00:00,Lymphocyte Activation,E05.478.594.530
16484453,2006-02-16T00:00:00,Lymphocyte Activation,G12.425.747
16484453,2006-02-16T00:00:00,Lymphocyte Activation,G12.450.050.400.545
16484453,2006-02-16T00:00:00,Recombinant Proteins,D12.776.828
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
16484453,2006-02-16T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
16484453,2006-02-16T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
16484453,2006-02-16T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
16484453,2006-02-16T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
16487512,2006-02-17T00:00:00,Animals,B01.050
16487512,2006-02-17T00:00:00,B-Lymphocytes,A11.063.438
16487512,2006-02-17T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
16487512,2006-02-17T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
16487512,2006-02-17T00:00:00,B-Lymphocytes,A15.382.032.438
16487512,2006-02-17T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
16487512,2006-02-17T00:00:00,Dendritic Cells,A11.066.270
16487512,2006-02-17T00:00:00,Dendritic Cells,A11.436.270
16487512,2006-02-17T00:00:00,Dendritic Cells,A15.382.066.270
16487512,2006-02-17T00:00:00,Dendritic Cells,A15.382.812.260
16487512,2006-02-17T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16487512,2006-02-17T00:00:00,Flow Cytometry,E05.200.500.386.350
16487512,2006-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16487512,2006-02-17T00:00:00,Molecular Chaperones,D12.776.580
16487512,2006-02-17T00:00:00,Monocytes,A11.118.637.555.652
16487512,2006-02-17T00:00:00,Monocytes,A11.148.580
16487512,2006-02-17T00:00:00,Monocytes,A11.627.624
16487512,2006-02-17T00:00:00,Monocytes,A11.733.547
16487512,2006-02-17T00:00:00,Monocytes,A15.145.229.637.555.652
16487512,2006-02-17T00:00:00,Monocytes,A15.378.316.580
16487512,2006-02-17T00:00:00,Monocytes,A15.382.490.555.652
16487512,2006-02-17T00:00:00,Monocytes,A15.382.680.547
16487512,2006-02-17T00:00:00,Monocytes,A15.382.812.547
16487512,2006-02-17T00:00:00,Polymers,D05.750
16487512,2006-02-17T00:00:00,Polymers,D25.720
16487512,2006-02-17T00:00:00,Polymers,J01.637.051.720
16716889,2006-02-17T00:00:00,Animals,B01.050
16716889,2006-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16716889,2006-02-17T00:00:00,Oxidative Stress,G03.495.710
16716889,2006-02-17T00:00:00,Oxidative Stress,G07.700.830.750
16716889,2006-02-17T00:00:00,Signal Transduction,G02.111.087.800
16716889,2006-02-17T00:00:00,Signal Transduction,G02.149.115.800
16716889,2006-02-17T00:00:00,Signal Transduction,G04.299.880
16716889,2006-02-17T00:00:00,Sphingolipids,D10.570.877
16716889,2006-02-17T00:00:00,Sphingolipids,D10.808
17310215,2006-02-19T00:00:00,Animals,B01.050
17310215,2006-02-19T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
17310215,2006-02-19T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
17310215,2006-02-19T00:00:00,Heart Ventricles,A07.541.560
17310215,2006-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17310215,2006-02-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17310215,2006-02-19T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17310215,2006-02-19T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17310215,2006-02-19T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17310215,2006-02-19T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
17310215,2006-02-19T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
17310215,2006-02-19T00:00:00,Mutation,G05.365.590
17310215,2006-02-19T00:00:00,Myocardium,A02.633.580
17310215,2006-02-19T00:00:00,Myocardium,A07.541.704
17310215,2006-02-19T00:00:00,Myocardium,A10.690.552.750
17310215,2006-02-19T00:00:00,Oxidative Stress,G03.495.710
17310215,2006-02-19T00:00:00,Oxidative Stress,G07.700.830.750
16490823,2006-02-20T00:00:00,Adolescent,M01.060.057
16490823,2006-02-20T00:00:00,Child,M01.060.406
16490823,2006-02-20T00:00:00,"Child, Preschool",M01.060.406.448
16490823,2006-02-20T00:00:00,Fontan Procedure,E04.035.410.295
16490823,2006-02-20T00:00:00,Fontan Procedure,E04.100.376.410.295
16490823,2006-02-20T00:00:00,Fontan Procedure,E04.928.220.370.295
16490823,2006-02-20T00:00:00,Health Status,I01.240.425
16490823,2006-02-20T00:00:00,Health Status,N01.224.425
16490823,2006-02-20T00:00:00,Health Status,N06.850.505.400.425
16490823,2006-02-20T00:00:00,"Heart Defects, Congenital",C14.240.400
16490823,2006-02-20T00:00:00,"Heart Defects, Congenital",C14.280.400
16490823,2006-02-20T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16490823,2006-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16490823,2006-02-20T00:00:00,Infant,M01.060.703
16490823,2006-02-20T00:00:00,Quality of Life,I01.800
16490823,2006-02-20T00:00:00,Quality of Life,K01.752.400.750
16490823,2006-02-20T00:00:00,Questionnaires,E05.318.308.750
16490823,2006-02-20T00:00:00,Questionnaires,L01.280.800
16490823,2006-02-20T00:00:00,Questionnaires,N05.715.360.300.695
16490823,2006-02-20T00:00:00,Questionnaires,N06.850.520.308.750
16499871,2006-02-20T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
16499871,2006-02-20T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
16499871,2006-02-20T00:00:00,Cell Cycle,G04.299.134
16499871,2006-02-20T00:00:00,Cobalt,D01.268.556.185
16499871,2006-02-20T00:00:00,Cobalt,D01.268.956.155
16499871,2006-02-20T00:00:00,Cobalt,D01.552.544.185
16499871,2006-02-20T00:00:00,Head and Neck Neoplasms,C04.588.443
16499871,2006-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16499871,2006-02-20T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
16499871,2006-02-20T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
16499871,2006-02-20T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
16499871,2006-02-20T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
16499871,2006-02-20T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
16499871,2006-02-20T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
16499871,2006-02-20T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
16499871,2006-02-20T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
16499871,2006-02-20T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
16499871,2006-02-20T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
16499871,2006-02-20T00:00:00,"Models, Biological",E05.599.395
16499871,2006-02-20T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
16499871,2006-02-20T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
16499871,2006-02-20T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
16499871,2006-02-20T00:00:00,Signal Transduction,G02.111.087.800
16499871,2006-02-20T00:00:00,Signal Transduction,G02.149.115.800
16499871,2006-02-20T00:00:00,Signal Transduction,G04.299.880
16499871,2006-02-20T00:00:00,Transcriptional Activation,G05.355.315.800
16499871,2006-02-20T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
16499871,2006-02-20T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
16499871,2006-02-20T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
16545482,2006-02-20T00:00:00,Adult,M01.060.116
16545482,2006-02-20T00:00:00,Child,M01.060.406
16545482,2006-02-20T00:00:00,DNA,D13.444.308
16545482,2006-02-20T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
16545482,2006-02-20T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
16545482,2006-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16545482,2006-02-20T00:00:00,Liver Diseases,C06.552
16545482,2006-02-20T00:00:00,Mutation,G05.365.590
16545482,2006-02-20T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16475821,2006-02-21T00:00:00,Amino Acid Sequence,G02.111.570.060
16475821,2006-02-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16475821,2006-02-21T00:00:00,Azides,D01.625.100
16475821,2006-02-21T00:00:00,Azides,D02.159
16475821,2006-02-21T00:00:00,Binding Sites,G02.111.570.120
16475821,2006-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16475821,2006-02-21T00:00:00,Molecular Sequence Data,L01.453.245.667
16475821,2006-02-21T00:00:00,Recombinant Proteins,D12.776.828
16475821,2006-02-21T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
16475827,2006-02-21T00:00:00,"Antigens, Bacterial",D23.050.161
16475827,2006-02-21T00:00:00,Bacterial Toxins,D23.946.123
16475827,2006-02-21T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
16475827,2006-02-21T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
16475827,2006-02-21T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
16475827,2006-02-21T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
16475827,2006-02-21T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
16491105,2006-02-21T00:00:00,Accidental Falls,N06.850.135.122
16491105,2006-02-21T00:00:00,Adolescent,M01.060.057
16491105,2006-02-21T00:00:00,Adult,M01.060.116
16491105,2006-02-21T00:00:00,Aged,M01.060.116.100
16491105,2006-02-21T00:00:00,Health Surveys,E05.318.308.250
16491105,2006-02-21T00:00:00,Health Surveys,N05.715.360.300.375
16491105,2006-02-21T00:00:00,Health Surveys,N06.850.520.308.250
16491105,2006-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16491105,2006-02-21T00:00:00,Incidence,E05.318.308.985.525.375
16491105,2006-02-21T00:00:00,Incidence,L01.280.975.525.375
16491105,2006-02-21T00:00:00,Incidence,N01.224.935.597.500
16491105,2006-02-21T00:00:00,Incidence,N06.850.505.400.975.525.375
16491105,2006-02-21T00:00:00,Incidence,N06.850.520.308.985.525.375
16491105,2006-02-21T00:00:00,Middle Aged,M01.060.116.630
16491105,2006-02-21T00:00:00,Postal Service,I01.451.617
16491105,2006-02-21T00:00:00,South Carolina,Z01.107.567.875.075.662
16491105,2006-02-21T00:00:00,South Carolina,Z01.107.567.875.750.700
16491105,2006-02-21T00:00:00,Spinal Cord Injuries,C10.228.854.770
16491105,2006-02-21T00:00:00,Spinal Cord Injuries,C10.900.850
16491105,2006-02-21T00:00:00,Spinal Cord Injuries,C21.866.819
16492667,2006-02-21T00:00:00,Arrestins,D12.776.306.090
16492667,2006-02-21T00:00:00,Arrestins,D12.776.543.090
16492667,2006-02-21T00:00:00,Cell Line,A11.251.210
16492667,2006-02-21T00:00:00,Cyclic AMP,D03.438.759.646.138.395
16492667,2006-02-21T00:00:00,Cyclic AMP,D13.695.462.200
16492667,2006-02-21T00:00:00,Cyclic AMP,D13.695.667.138.395
16492667,2006-02-21T00:00:00,Cyclic AMP,D13.695.827.068.395
16492667,2006-02-21T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
16492667,2006-02-21T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
16492667,2006-02-21T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
16492667,2006-02-21T00:00:00,DNA,D13.444.308
16492667,2006-02-21T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
16492667,2006-02-21T00:00:00,GTP-Binding Proteins,D12.776.157.325
16492667,2006-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16492667,2006-02-21T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16492667,2006-02-21T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16492667,2006-02-21T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16492667,2006-02-21T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
16492667,2006-02-21T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
16492667,2006-02-21T00:00:00,Mutation,G05.365.590
16492667,2006-02-21T00:00:00,Protein Kinases,D08.811.913.696.620.682
16492667,2006-02-21T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
16492667,2006-02-21T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
16492667,2006-02-21T00:00:00,Signal Transduction,G02.111.087.800
16492667,2006-02-21T00:00:00,Signal Transduction,G02.149.115.800
16492667,2006-02-21T00:00:00,Signal Transduction,G04.299.880
16942964,2006-02-21T00:00:00,Adult,M01.060.116
16942964,2006-02-21T00:00:00,Cognitive Therapy,F04.754.137.428
16942964,2006-02-21T00:00:00,Fear,F01.470.361
16942964,2006-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16942964,2006-02-21T00:00:00,Patient Compliance,F01.145.488.500
16942964,2006-02-21T00:00:00,Patient Compliance,N05.300.150.600.600
16942964,2006-02-21T00:00:00,Psychotherapy,F04.754
16942964,2006-02-21T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16942964,2006-02-21T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16942964,2006-02-21T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16942964,2006-02-21T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16942964,2006-02-21T00:00:00,Treatment Outcome,E01.789.800
16942964,2006-02-21T00:00:00,Treatment Outcome,N04.761.559.590.800
16942964,2006-02-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16497887,2006-02-23T00:00:00,African Americans,M01.686.508.100.100
16497887,2006-02-23T00:00:00,African Americans,M01.686.754.100
16497887,2006-02-23T00:00:00,Antimicrobial Cationic Peptides,D12.644.050
16497887,2006-02-23T00:00:00,Antimicrobial Cationic Peptides,D12.776.543.695.054
16497887,2006-02-23T00:00:00,"Colony Count, Microbial",E05.200.875.220
16497887,2006-02-23T00:00:00,Dendritic Cells,A11.066.270
16497887,2006-02-23T00:00:00,Dendritic Cells,A11.436.270
16497887,2006-02-23T00:00:00,Dendritic Cells,A15.382.066.270
16497887,2006-02-23T00:00:00,Dendritic Cells,A15.382.812.260
16497887,2006-02-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16497887,2006-02-23T00:00:00,"Immunity, Innate",G12.450.575
16497887,2006-02-23T00:00:00,Macrophages,A11.329.372
16497887,2006-02-23T00:00:00,Macrophages,A11.627.482
16497887,2006-02-23T00:00:00,Macrophages,A11.733.397
16497887,2006-02-23T00:00:00,Macrophages,A15.382.680.397
16497887,2006-02-23T00:00:00,Macrophages,A15.382.812.522
16497887,2006-02-23T00:00:00,Monocytes,A11.118.637.555.652
16497887,2006-02-23T00:00:00,Monocytes,A11.148.580
16497887,2006-02-23T00:00:00,Monocytes,A11.627.624
16497887,2006-02-23T00:00:00,Monocytes,A11.733.547
16497887,2006-02-23T00:00:00,Monocytes,A15.145.229.637.555.652
16497887,2006-02-23T00:00:00,Monocytes,A15.378.316.580
16497887,2006-02-23T00:00:00,Monocytes,A15.382.490.555.652
16497887,2006-02-23T00:00:00,Monocytes,A15.382.680.547
16497887,2006-02-23T00:00:00,Monocytes,A15.382.812.547
16497887,2006-02-23T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
16497887,2006-02-23T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16497887,2006-02-23T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16497887,2006-02-23T00:00:00,"RNA, Messenger",D13.444.735.544
16497887,2006-02-23T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
16942963,2006-02-24T00:00:00,Adult,M01.060.116
16942963,2006-02-24T00:00:00,Fear,F01.470.361
16942963,2006-02-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16942963,2006-02-24T00:00:00,Patient Satisfaction,N04.452.822.360.600
16942963,2006-02-24T00:00:00,Patient Satisfaction,N05.300.150.600.630
16942963,2006-02-24T00:00:00,Patient Satisfaction,N05.715.360.600
16942963,2006-02-24T00:00:00,Phobic Disorders,F03.080.725
16942963,2006-02-24T00:00:00,Psychotherapy,F04.754
16942963,2006-02-24T00:00:00,Questionnaires,E05.318.308.750
16942963,2006-02-24T00:00:00,Questionnaires,L01.280.800
16942963,2006-02-24T00:00:00,Questionnaires,N05.715.360.300.695
16942963,2006-02-24T00:00:00,Questionnaires,N06.850.520.308.750
16942963,2006-02-24T00:00:00,Treatment Outcome,E01.789.800
16942963,2006-02-24T00:00:00,Treatment Outcome,N04.761.559.590.800
16942963,2006-02-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16942963,2006-02-24T00:00:00,User-Computer Interface,L01.224.900.910
16503092,2006-02-28T00:00:00,Adolescent,M01.060.057
16503092,2006-02-28T00:00:00,"Depressive Disorder, Major",F03.600.300.375
16503092,2006-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16503092,2006-02-28T00:00:00,Mental Disorders,F03
16503092,2006-02-28T00:00:00,Parent-Child Relations,F01.829.263.370.290
16503092,2006-02-28T00:00:00,Parents,F01.829.263.500.320
16503092,2006-02-28T00:00:00,Parents,I01.880.225.500.340
16503092,2006-02-28T00:00:00,Parents,M01.620
16503092,2006-02-28T00:00:00,Sex Offenses,I01.198.240.748
16503092,2006-02-28T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16503092,2006-02-28T00:00:00,Substance-Related Disorders,C21.739
16503092,2006-02-28T00:00:00,Substance-Related Disorders,F03.900
16503092,2006-02-28T00:00:00,Violence,I01.198.240.856
16503092,2006-02-28T00:00:00,Violence,I01.880.735.900
16504282,2006-02-28T00:00:00,Composite Resins,D05.750.716.822.308
16504282,2006-02-28T00:00:00,Composite Resins,D25.339.816.500
16504282,2006-02-28T00:00:00,Composite Resins,D25.720.716.822.308
16504282,2006-02-28T00:00:00,Composite Resins,J01.637.051.339.816.500
16504282,2006-02-28T00:00:00,Composite Resins,J01.637.051.720.716.822.308
16504282,2006-02-28T00:00:00,Dental Materials,D25.339
16504282,2006-02-28T00:00:00,Dental Materials,D27.720.102.339
16504282,2006-02-28T00:00:00,Dental Materials,J01.637.051.339
16504282,2006-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16504282,2006-02-28T00:00:00,Hydrogen Bonding,G02.149.767.620
16504282,2006-02-28T00:00:00,Hydrogen Bonding,G02.842.750.620
16504282,2006-02-28T00:00:00,Materials Testing,E05.570
16504282,2006-02-28T00:00:00,"Models, Chemical",E05.599.495
16504282,2006-02-28T00:00:00,Polymers,D05.750
16504282,2006-02-28T00:00:00,Polymers,D25.720
16504282,2006-02-28T00:00:00,Polymers,J01.637.051.720
16504282,2006-02-28T00:00:00,Resin Cements,D05.750.716.822.730
16504282,2006-02-28T00:00:00,Resin Cements,D25.339.291.750
16504282,2006-02-28T00:00:00,Resin Cements,D25.720.716.822.730
16504282,2006-02-28T00:00:00,Resin Cements,J01.637.051.339.291.750
16504282,2006-02-28T00:00:00,Resin Cements,J01.637.051.720.716.822.730
16504282,2006-02-28T00:00:00,Water,D01.455.900
16504282,2006-02-28T00:00:00,Water,D01.650.550.925
16504408,2006-02-28T00:00:00,Animals,B01.050
16504408,2006-02-28T00:00:00,"Animals, Newborn",B01.050.050.282
16504408,2006-02-28T00:00:00,Apoptosis,G04.299.139.160
16504408,2006-02-28T00:00:00,Calpain,D08.811.277.656.262.500.120
16504408,2006-02-28T00:00:00,Calpain,D08.811.277.656.300.200.120
16504408,2006-02-28T00:00:00,Caspases,D08.811.277.656.262.500.126
16504408,2006-02-28T00:00:00,Caspases,D08.811.277.656.300.200.126
16504408,2006-02-28T00:00:00,Caspases,D12.644.360.075.405
16504408,2006-02-28T00:00:00,Caspases,D12.776.476.075.405
16504408,2006-02-28T00:00:00,Cell Survival,G04.299.316
16504408,2006-02-28T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16504408,2006-02-28T00:00:00,Drug Interactions,G07.690.812.240
16504408,2006-02-28T00:00:00,Drug Interactions,G07.700.680.240
16504408,2006-02-28T00:00:00,Glutamic Acid,D12.125.067.750
16504408,2006-02-28T00:00:00,Glutamic Acid,D12.125.119.450
16504408,2006-02-28T00:00:00,Glutamic Acid,D12.125.427.300
16504408,2006-02-28T00:00:00,Neurons,A08.663
16504408,2006-02-28T00:00:00,Neurons,A11.671
16504408,2006-02-28T00:00:00,Oligopeptides,D12.644.456
16504408,2006-02-28T00:00:00,Pregnancy,G08.686.785.760.769
16504408,2006-02-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16504408,2006-02-28T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16510135,2006-02-28T00:00:00,Animals,B01.050
16510135,2006-02-28T00:00:00,"Animals, Newborn",B01.050.050.282
16510135,2006-02-28T00:00:00,Corticosterone,D04.808.745.745.654.237
16510135,2006-02-28T00:00:00,Corticosterone,D06.472.040.585.353.237
16510135,2006-02-28T00:00:00,Drug Interactions,G07.690.812.240
16510135,2006-02-28T00:00:00,Drug Interactions,G07.700.680.240
16510135,2006-02-28T00:00:00,Enzyme Inhibitors,D27.505.519.389
16510135,2006-02-28T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
16510135,2006-02-28T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
16510135,2006-02-28T00:00:00,Hippocampus,A08.186.211.464.405
16510135,2006-02-28T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
16510135,2006-02-28T00:00:00,Protein Biosynthesis,G02.111.087.675.871
16510135,2006-02-28T00:00:00,Protein Biosynthesis,G02.149.115.675.871
16510135,2006-02-28T00:00:00,Protein Biosynthesis,G03.495.770.871
16510135,2006-02-28T00:00:00,Protein Biosynthesis,G05.355.310.670
16510135,2006-02-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16510266,2006-02-28T00:00:00,Adult,M01.060.116
16510266,2006-02-28T00:00:00,Brain,A08.186.211
16510266,2006-02-28T00:00:00,"Depressive Disorder, Major",F03.600.300.375
16510266,2006-02-28T00:00:00,Electric Stimulation,E05.723.402
16510266,2006-02-28T00:00:00,"Electrodes, Implanted",E07.305.250.319
16510266,2006-02-28T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
16510266,2006-02-28T00:00:00,Functional Laterality,F02.830.297.425
16510266,2006-02-28T00:00:00,Functional Laterality,G11.561.225.425
16510266,2006-02-28T00:00:00,Gyrus Cinguli,A08.186.211.464.330
16510266,2006-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16510266,2006-02-28T00:00:00,Oxygen,D01.268.185.550
16510266,2006-02-28T00:00:00,Oxygen,D01.362.670
16510266,2006-02-28T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
16510266,2006-02-28T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
16510266,2006-02-28T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
16510266,2006-02-28T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
16510266,2006-02-28T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
16510266,2006-02-28T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
16510266,2006-02-28T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
16510266,2006-02-28T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
16567287,2006-02-28T00:00:00,"Cardiac Pacing, Artificial",E02.145
16567287,2006-02-28T00:00:00,Heart Conduction System,A07.541.409
16567287,2006-02-28T00:00:00,Heart Failure,C14.280.434
16567287,2006-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16567287,2006-02-28T00:00:00,Myocardial Contraction,G09.330.190.541
16567287,2006-02-28T00:00:00,Myocardial Contraction,G11.427.590.540.570
16567287,2006-02-28T00:00:00,Oxygen Consumption,G03.730
16567287,2006-02-28T00:00:00,"Pacemaker, Artificial",E07.858.082.748
16567287,2006-02-28T00:00:00,Stroke Volume,E01.370.370.380.150.700
16567287,2006-02-28T00:00:00,Stroke Volume,G09.330.380.124.882
16567287,2006-02-28T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
15999146,2006-03-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
15999146,2006-03-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
15999146,2006-03-01T00:00:00,Animals,B01.050
15999146,2006-03-01T00:00:00,Catecholamines,D02.092.211.215.311
15999146,2006-03-01T00:00:00,Catecholamines,D02.092.311
15999146,2006-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
15999146,2006-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
15999146,2006-03-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
15999146,2006-03-01T00:00:00,Dopamine,D02.092.211.215.311.342
15999146,2006-03-01T00:00:00,Dopamine,D02.092.311.342
15999146,2006-03-01T00:00:00,Methylphenidate,D02.241.223.601.600
15999146,2006-03-01T00:00:00,Methylphenidate,D03.383.621.460
15999146,2006-03-01T00:00:00,Norepinephrine,D02.033.100.291.502
15999146,2006-03-01T00:00:00,Norepinephrine,D02.092.063.480
15999146,2006-03-01T00:00:00,Norepinephrine,D02.092.211.215.311.560
15999146,2006-03-01T00:00:00,Norepinephrine,D02.092.311.461.484
15999146,2006-03-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
15999146,2006-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16167063,2006-03-01T00:00:00,Adenoviridae,B04.280.030
16167063,2006-03-01T00:00:00,Adenoviridae,B04.909.204.097
16167063,2006-03-01T00:00:00,Apoptosis,G04.299.139.160
16167063,2006-03-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
16167063,2006-03-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
16167063,2006-03-01T00:00:00,Down-Regulation,G02.111.087.225
16167063,2006-03-01T00:00:00,Down-Regulation,G02.149.115.225
16167063,2006-03-01T00:00:00,Down-Regulation,G05.355.315.200
16167063,2006-03-01T00:00:00,Down-Regulation,G07.690.812.230
16167063,2006-03-01T00:00:00,Down-Regulation,G07.700.680.230
16167063,2006-03-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16167063,2006-03-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
16167063,2006-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
16167063,2006-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
16167063,2006-03-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
16167063,2006-03-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
16167063,2006-03-01T00:00:00,"Receptors, Virus",D12.776.543.750.925
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
16167063,2006-03-01T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16167063,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16167063,2006-03-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
16167063,2006-03-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
16167063,2006-03-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
16167063,2006-03-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
16167063,2006-03-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
16392116,2006-03-01T00:00:00,Aged,M01.060.116.100
16392116,2006-03-01T00:00:00,Demyelinating Diseases,C10.314
16392116,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16392116,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16392116,2006-03-01T00:00:00,Mitochondrial Diseases,C18.452.660
16392116,2006-03-01T00:00:00,Multiple Sclerosis,C10.114.375.500
16392116,2006-03-01T00:00:00,Multiple Sclerosis,C10.314.350.500
16392116,2006-03-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
16392116,2006-03-01T00:00:00,Postmortem Changes,C23.550.260.224.617
16392116,2006-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
16392116,2006-03-01T00:00:00,Spinal Cord,A08.186.854
16397516,2006-03-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16397516,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16397516,2006-03-01T00:00:00,Hypertension,C14.907.489
16397516,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16397516,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16397516,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16397516,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16473286,2006-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
16473286,2006-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
16473286,2006-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
16473286,2006-03-01T00:00:00,Antirheumatic Agents,D27.505.954.329
16473286,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16473286,2006-03-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16473286,2006-03-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16473286,2006-03-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16473286,2006-03-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
16473286,2006-03-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
16473286,2006-03-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
16473286,2006-03-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
16473286,2006-03-01T00:00:00,Interleukin-1,D23.529.374.465.501
16473286,2006-03-01T00:00:00,Interleukin-1,D23.529.374.500.400
16473286,2006-03-01T00:00:00,Isoxazoles,D03.383.129.385
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16473286,2006-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16488383,2006-03-01T00:00:00,Health Services Accessibility,N04.590.374.350
16488383,2006-03-01T00:00:00,Health Services Accessibility,N05.300.430
16488383,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16488383,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16488383,2006-03-01T00:00:00,Stroke,C10.228.140.300.775
16488383,2006-03-01T00:00:00,Stroke,C14.907.253.855
16488383,2006-03-01T00:00:00,Telemedicine,H02.403.840
16488383,2006-03-01T00:00:00,Telemedicine,L01.178.847.652
16488383,2006-03-01T00:00:00,Telemedicine,N04.590.374.800
16488759,2006-03-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
16488759,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16488759,2006-03-01T00:00:00,"Societies, Medical",N03.540.828.589
16488759,2006-03-01T00:00:00,Stents,E07.695.750
16488759,2006-03-01T00:00:00,Thoracic Surgical Procedures,E04.928
16490502,2006-03-01T00:00:00,Cataract,C11.510.245
16490502,2006-03-01T00:00:00,Cataract Extraction,E04.540.825.249
16490502,2006-03-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16490502,2006-03-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16490502,2006-03-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16490502,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16490502,2006-03-01T00:00:00,Inflammation,C23.550.470
16490502,2006-03-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
16490502,2006-03-01T00:00:00,Minerals,D01.578
16490502,2006-03-01T00:00:00,Postoperative Complications,C23.550.767
16495705,2006-03-01T00:00:00,Breast Neoplasms,C04.588.180
16495705,2006-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
16495705,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16495705,2006-03-01T00:00:00,Lymph Nodes,A10.549.400
16495705,2006-03-01T00:00:00,Lymph Nodes,A15.382.520.604.412
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,G17.800
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16495705,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16495705,2006-03-01T00:00:00,"Tumor Markers, Biological",D23.101.840
16499494,2006-03-01T00:00:00,Cell Line,A11.251.210
16499494,2006-03-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
16499494,2006-03-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
16499494,2006-03-01T00:00:00,Ethanol,D02.033.375
16499494,2006-03-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
16499494,2006-03-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
16499494,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16499494,2006-03-01T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16499494,2006-03-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16499494,2006-03-01T00:00:00,Recombinant Proteins,D12.776.828
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
16500382,2006-03-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
16500382,2006-03-01T00:00:00,Esophageal Perforation,C06.405.117.468
16500382,2006-03-01T00:00:00,Esophageal Perforation,C21.866.348
16500382,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16500382,2006-03-01T00:00:00,Pancreatitis,C06.689.750
16500382,2006-03-01T00:00:00,Patient Selection,E05.581.500.653
16500382,2006-03-01T00:00:00,Patient Selection,N04.590.731
16500382,2006-03-01T00:00:00,"Sphincterotomy, Endoscopic",E04.210.120.850
16500382,2006-03-01T00:00:00,"Sphincterotomy, Endoscopic",E04.210.240.250.840
16500382,2006-03-01T00:00:00,"Sphincterotomy, Endoscopic",E04.800.250.250.250.840
16500382,2006-03-01T00:00:00,Surgical Wound Infection,C01.539.947.692
16500382,2006-03-01T00:00:00,Surgical Wound Infection,C23.550.767.925
16500382,2006-03-01T00:00:00,United States,Z01.107.567.875
16501083,2006-03-01T00:00:00,Adenoviridae,B04.280.030
16501083,2006-03-01T00:00:00,Adenoviridae,B04.909.204.097
16501083,2006-03-01T00:00:00,Animals,B01.050
16501083,2006-03-01T00:00:00,"Antibodies, Viral",D12.776.124.486.485.114.254
16501083,2006-03-01T00:00:00,"Antibodies, Viral",D12.776.124.790.651.114.254
16501083,2006-03-01T00:00:00,"Antibodies, Viral",D12.776.377.715.548.114.254
16501083,2006-03-01T00:00:00,Cell Line,A11.251.210
16501083,2006-03-01T00:00:00,Hela Cells,A11.251.210.190.400
16501083,2006-03-01T00:00:00,Hela Cells,A11.251.860.180.400
16501083,2006-03-01T00:00:00,Hela Cells,A11.436.340
16501083,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16501083,2006-03-01T00:00:00,Immunization,E02.095.465.425.400
16501083,2006-03-01T00:00:00,Immunization,E05.478.550
16501083,2006-03-01T00:00:00,Immunization,N02.421.726.758.310
16501083,2006-03-01T00:00:00,Immunization,N06.850.780.200.425
16501083,2006-03-01T00:00:00,Immunization,N06.850.780.680.310
16503629,2006-03-01T00:00:00,Bacillus subtilis,B03.300.390.400.158.218.725
16503629,2006-03-01T00:00:00,Bacillus subtilis,B03.510.100.100.218.725
16503629,2006-03-01T00:00:00,Bacillus subtilis,B03.510.415.400.158.218.725
16503629,2006-03-01T00:00:00,Bacillus subtilis,B03.510.460.410.158.218.725
16503629,2006-03-01T00:00:00,Bacterial Physiological Phenomena,G06.099
16503629,2006-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
16503629,2006-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
16503629,2006-03-01T00:00:00,"Spores, Bacterial",A11.870.700
16503629,2006-03-01T00:00:00,"Spores, Bacterial",B05.775.700
16503629,2006-03-01T00:00:00,Temperature,G01.906.595
16503629,2006-03-01T00:00:00,Temperature,G16.500.275.063.725.710
16503629,2006-03-01T00:00:00,Temperature,G16.500.750.775.710
16503629,2006-03-01T00:00:00,Temperature,N06.230.150.450
16503629,2006-03-01T00:00:00,Temperature,N06.230.300.100.725.710
16503729,2006-03-01T00:00:00,Adult,M01.060.116
16503729,2006-03-01T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
16503729,2006-03-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
16503729,2006-03-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
16503729,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16503729,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16503729,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16503729,2006-03-01T00:00:00,Ethanol,D02.033.375
16503729,2006-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
16503729,2006-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16503729,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16503729,2006-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
16503729,2006-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
16503729,2006-03-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16503729,2006-03-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16505133,2006-03-01T00:00:00,Aged,M01.060.116.100
16505133,2006-03-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
16505133,2006-03-01T00:00:00,Alzheimer Disease,C10.574.945.249
16505133,2006-03-01T00:00:00,Alzheimer Disease,F03.087.400.100
16505133,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16505133,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16505133,2006-03-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16505133,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16505133,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16505133,2006-03-01T00:00:00,Nursing Homes,N02.278.825.610
16505133,2006-03-01T00:00:00,Psychotic Disorders,F03.700.675
16505133,2006-03-01T00:00:00,Risperidone,D03.383.742.698.685
16505517,2006-03-01T00:00:00,Adult,M01.060.116
16505517,2006-03-01T00:00:00,Cardiovascular Diseases,C14
16505517,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16505517,2006-03-01T00:00:00,Incidence,E05.318.308.985.525.375
16505517,2006-03-01T00:00:00,Incidence,L01.280.975.525.375
16505517,2006-03-01T00:00:00,Incidence,N01.224.935.597.500
16505517,2006-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16505517,2006-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16505517,2006-03-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
16505517,2006-03-01T00:00:00,Metabolic Syndrome X,C18.452.625
16505517,2006-03-01T00:00:00,Mexican Americans,M01.686.754.441.500
16505517,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16505517,2006-03-01T00:00:00,Prevalence,E05.318.308.985.525.750
16505517,2006-03-01T00:00:00,Prevalence,L01.280.975.525.750
16505517,2006-03-01T00:00:00,Prevalence,N01.224.935.597.750
16505517,2006-03-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16505517,2006-03-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16507474,2006-03-01T00:00:00,Agriculture,J01.040
16507474,2006-03-01T00:00:00,Child,M01.060.406
16507474,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16508641,2006-03-01T00:00:00,Animals,B01.050
16508641,2006-03-01T00:00:00,Autoimmunity,G12.450.192
16508641,2006-03-01T00:00:00,Chemokines,D12.644.276.374.200
16508641,2006-03-01T00:00:00,Chemokines,D12.776.467.374.200
16508641,2006-03-01T00:00:00,Chemokines,D23.125.300
16508641,2006-03-01T00:00:00,Chemokines,D23.469.200
16508641,2006-03-01T00:00:00,Chemokines,D23.529.374.200
16508641,2006-03-01T00:00:00,Disease Progression,C23.550.291.656
16508641,2006-03-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16508641,2006-03-01T00:00:00,Flow Cytometry,E05.200.500.386.350
16508641,2006-03-01T00:00:00,Gene Expression Profiling,E05.393.332
16508641,2006-03-01T00:00:00,Genome,G05.360.340
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16508641,2006-03-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16508641,2006-03-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16508641,2006-03-01T00:00:00,Interferon-gamma,D23.529.718.550
16508641,2006-03-01T00:00:00,Kidney,A05.810.453
16508641,2006-03-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
16508641,2006-03-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
16508641,2006-03-01T00:00:00,Membrane Proteins,D12.776.543
16508641,2006-03-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
16508641,2006-03-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
16508641,2006-03-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16508641,2006-03-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16508641,2006-03-01T00:00:00,Transcription Factors,D12.776.930
16509967,2006-03-01T00:00:00,Birth Weight,C23.888.144.186
16509967,2006-03-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
16509967,2006-03-01T00:00:00,Birth Weight,E05.041.124.160.750.149
16509967,2006-03-01T00:00:00,Birth Weight,G07.100.100.160.120.186
16509967,2006-03-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
16509967,2006-03-01T00:00:00,Decision Making,F02.463.785.373
16509967,2006-03-01T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
16509967,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16509967,2006-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
16509967,2006-03-01T00:00:00,"Infant, Premature",M01.060.703.520.520
16509967,2006-03-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
16509967,2006-03-01T00:00:00,Internet,L01.224.230.110.500
16509967,2006-03-01T00:00:00,"Respiration, Artificial",E02.365.647.729
16509967,2006-03-01T00:00:00,"Respiration, Artificial",E02.880.820
16509967,2006-03-01T00:00:00,Treatment Outcome,E01.789.800
16509967,2006-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16509967,2006-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16509988,2006-03-01T00:00:00,Adult,M01.060.116
16509988,2006-03-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16509988,2006-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16509988,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16509988,2006-03-01T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
16509988,2006-03-01T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
16509988,2006-03-01T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
16509988,2006-03-01T00:00:00,United States,Z01.107.567.875
16510697,2006-03-01T00:00:00,Animals,B01.050
16510697,2006-03-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
16510697,2006-03-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
16510697,2006-03-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
16510697,2006-03-01T00:00:00,Cations,D01.248.497.300
16510697,2006-03-01T00:00:00,Cell Proliferation,G04.299.233.750
16510697,2006-03-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16510697,2006-03-01T00:00:00,Ceramides,D02.065.313
16510697,2006-03-01T00:00:00,Ceramides,D09.400.410.420.525.200
16510697,2006-03-01T00:00:00,Ceramides,D10.390.470.675.200
16510697,2006-03-01T00:00:00,Ceramides,D10.570.877.360.612.200
16510697,2006-03-01T00:00:00,Deoxycytidine,D03.383.742.680.245.500
16510697,2006-03-01T00:00:00,Deoxycytidine,D13.570.230.329
16510697,2006-03-01T00:00:00,Deoxycytidine,D13.570.685.245.500
16510697,2006-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
16510697,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16510724,2006-03-01T00:00:00,Animals,B01.050
16510724,2006-03-01T00:00:00,"Animals, Newborn",B01.050.050.282
16510724,2006-03-01T00:00:00,Benzodiazepines,D03.438.079.080
16510724,2006-03-01T00:00:00,Calcium,D01.268.552.100
16510724,2006-03-01T00:00:00,Calcium,D01.552.539.288
16510724,2006-03-01T00:00:00,Calcium,D23.119.100
16510724,2006-03-01T00:00:00,Cell Movement,G04.299.283
16510724,2006-03-01T00:00:00,Cell Movement,G07.700.560.500.180
16510724,2006-03-01T00:00:00,Drug Interactions,G07.690.812.240
16510724,2006-03-01T00:00:00,Drug Interactions,G07.700.680.240
16510724,2006-03-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16510724,2006-03-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
16510724,2006-03-01T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
16510724,2006-03-01T00:00:00,Fibronectins,D12.776.377.715.390
16510724,2006-03-01T00:00:00,Fibronectins,D12.776.395.550.350
16510724,2006-03-01T00:00:00,Fibronectins,D12.776.543.550.350
16510724,2006-03-01T00:00:00,Fibronectins,D12.776.860.300.450
16510724,2006-03-01T00:00:00,Glutamic Acid,D12.125.067.750
16510724,2006-03-01T00:00:00,Glutamic Acid,D12.125.119.450
16510724,2006-03-01T00:00:00,Glutamic Acid,D12.125.427.300
16510724,2006-03-01T00:00:00,"Models, Biological",E05.599.395
16510724,2006-03-01T00:00:00,Oligodendroglia,A08.637.600
16510724,2006-03-01T00:00:00,Oligodendroglia,A11.650.600
16510724,2006-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16510724,2006-03-01T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D08.811.913.696.620.682.725.400.900.500
16510724,2006-03-01T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.060.625.300
16510724,2006-03-01T00:00:00,"Receptor, Platelet-Derived Growth Factor alpha",D12.776.543.750.750.400.630.300
16510724,2006-03-01T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
16510724,2006-03-01T00:00:00,Stem Cells,A11.872
16510880,2006-03-01T00:00:00,Biomedical Research,H01.770.644.145
16510880,2006-03-01T00:00:00,Diffusion of Innovation,L01.143.320
16510880,2006-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
16510880,2006-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16510880,2006-03-01T00:00:00,Family Practice,H02.403.280
16510880,2006-03-01T00:00:00,Guideline Adherence,N04.761.337
16510880,2006-03-01T00:00:00,Guideline Adherence,N05.715.360.395
16510880,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
16510880,2006-03-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
16510880,2006-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
16510880,2006-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
16510880,2006-03-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
16510880,2006-03-01T00:00:00,"Quality Assurance, Health Care",N05.700
16515901,2006-03-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
16515901,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16515901,2006-03-01T00:00:00,Stents,E07.695.750
16515901,2006-03-01T00:00:00,Thoracic Surgery,H02.403.810.803
16515901,2006-03-01T00:00:00,Vascular Surgical Procedures,E04.100.814
16515923,2006-03-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
16515923,2006-03-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
16515923,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16515923,2006-03-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16515923,2006-03-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16515923,2006-03-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16515923,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16515923,2006-03-01T00:00:00,Postoperative Complications,C23.550.767
16515923,2006-03-01T00:00:00,Preoperative Care,E02.760.795
16515923,2006-03-01T00:00:00,Preoperative Care,E04.641
16515923,2006-03-01T00:00:00,Preoperative Care,N02.421.585.795
16517584,2006-03-01T00:00:00,England,Z01.542.363.300
16517584,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16517584,2006-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
16517584,2006-03-01T00:00:00,Lung Neoplasms,C08.381.540
16517584,2006-03-01T00:00:00,Lung Neoplasms,C08.785.520
16519559,2006-03-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
16519559,2006-03-01T00:00:00,Breast Neoplasms,C04.588.180
16519559,2006-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
16519559,2006-03-01T00:00:00,Data Collection,E05.318.308
16519559,2006-03-01T00:00:00,Data Collection,L01.280
16519559,2006-03-01T00:00:00,Data Collection,N05.715.360.300
16519559,2006-03-01T00:00:00,Data Collection,N06.850.520.308
16519559,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16519559,2006-03-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
16519559,2006-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
16519559,2006-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
16519559,2006-03-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
16519559,2006-03-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
16519559,2006-03-01T00:00:00,"Societies, Medical",N03.540.828.589
16519559,2006-03-01T00:00:00,United States,Z01.107.567.875
16520768,2006-03-01T00:00:00,Animals,B01.050
16520768,2006-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
16520768,2006-03-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
16520768,2006-03-01T00:00:00,Neurons,A08.663
16520768,2006-03-01T00:00:00,Neurons,A11.671
16520768,2006-03-01T00:00:00,Neuropeptides,D12.644.400
16520768,2006-03-01T00:00:00,Neuropeptides,D12.776.641.650
16520768,2006-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16520768,2006-03-01T00:00:00,Substance-Related Disorders,C21.739
16520768,2006-03-01T00:00:00,Substance-Related Disorders,F03.900
16520768,2006-03-01T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
16520768,2006-03-01T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
16524393,2006-03-01T00:00:00,Adolescent,M01.060.057
16524393,2006-03-01T00:00:00,Adult,M01.060.116
16524393,2006-03-01T00:00:00,Child,M01.060.406
16524393,2006-03-01T00:00:00,"Child, Preschool",M01.060.406.448
16524393,2006-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
16524393,2006-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
16524393,2006-03-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
16524393,2006-03-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16524393,2006-03-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16524393,2006-03-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16524393,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16524393,2006-03-01T00:00:00,Infant,M01.060.703
16524393,2006-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
16525003,2006-03-01T00:00:00,African Americans,M01.686.508.100.100
16525003,2006-03-01T00:00:00,African Americans,M01.686.754.100
16525003,2006-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16525003,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16525003,2006-03-01T00:00:00,Mental Disorders,F03
16525003,2006-03-01T00:00:00,Mental Health Services,F04.408
16525003,2006-03-01T00:00:00,Mental Health Services,N02.421.461
16525003,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16525003,2006-03-01T00:00:00,Primary Health Care,N04.590.233.727
16525003,2006-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16525003,2006-03-01T00:00:00,Substance-Related Disorders,C21.739
16525003,2006-03-01T00:00:00,Substance-Related Disorders,F03.900
16525003,2006-03-01T00:00:00,United States,Z01.107.567.875
16525003,2006-03-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
16525003,2006-03-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
16525003,2006-03-01T00:00:00,Veterans,M01.930
16528943,2006-03-01T00:00:00,Behavior Therapy,F04.754.137
16528943,2006-03-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16528943,2006-03-01T00:00:00,Clinical Trials as Topic,E05.337.250
16528943,2006-03-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16528943,2006-03-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16528943,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16528943,2006-03-01T00:00:00,Pregnancy,G08.686.785.760.769
16528943,2006-03-01T00:00:00,Smoking Cessation,F01.145.940.700
16530533,2006-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16530533,2006-03-01T00:00:00,Body Mass Index,E05.041.124.125
16530533,2006-03-01T00:00:00,Body Mass Index,G07.100.100.125
16530533,2006-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16530533,2006-03-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16530533,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16530533,2006-03-01T00:00:00,Manometry,E05.559
16530533,2006-03-01T00:00:00,Obesity,C18.654.726.500
16530533,2006-03-01T00:00:00,Obesity,C23.888.144.699.500
16530533,2006-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16530533,2006-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16530533,2006-03-01T00:00:00,Pressure,G01.374.715
16533782,2006-03-01T00:00:00,Adult,M01.060.116
16533782,2006-03-01T00:00:00,Aged,M01.060.116.100
16533782,2006-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
16533782,2006-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
16533782,2006-03-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
16533782,2006-03-01T00:00:00,"DNA, Mitochondrial",D13.444.308.283.225
16533782,2006-03-01T00:00:00,Gamma Rays,G01.201.875.750.400
16533782,2006-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
16533782,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16533782,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16533782,2006-03-01T00:00:00,Postoperative Care,E02.760.722.700
16533782,2006-03-01T00:00:00,Postoperative Care,E04.624
16533782,2006-03-01T00:00:00,Postoperative Care,N02.421.585.722.700
16533782,2006-03-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
16533782,2006-03-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
16533782,2006-03-01T00:00:00,Saliva,A12.200.666
16533782,2006-03-01T00:00:00,Smoking,F01.145.466.753
16539683,2006-03-01T00:00:00,Amphetamine,D02.092.471.683.152.110
16539683,2006-03-01T00:00:00,Amphetamine-Related Disorders,C21.739.225
16539683,2006-03-01T00:00:00,Amphetamine-Related Disorders,F03.900.225
16539683,2006-03-01T00:00:00,Animals,B01.050
16539683,2006-03-01T00:00:00,Benzazepines,D03.438.079
16539683,2006-03-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16539683,2006-03-01T00:00:00,Dopamine,D02.092.211.215.311.342
16539683,2006-03-01T00:00:00,Dopamine,D02.092.311.342
16539683,2006-03-01T00:00:00,Down-Regulation,G02.111.087.225
16539683,2006-03-01T00:00:00,Down-Regulation,G02.149.115.225
16539683,2006-03-01T00:00:00,Down-Regulation,G05.355.315.200
16539683,2006-03-01T00:00:00,Down-Regulation,G07.690.812.230
16539683,2006-03-01T00:00:00,Down-Regulation,G07.700.680.230
16539683,2006-03-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
16539683,2006-03-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
16539683,2006-03-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
16539683,2006-03-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
16539683,2006-03-01T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
16539683,2006-03-01T00:00:00,RGS Proteins,D12.644.360.325.150.750
16539683,2006-03-01T00:00:00,RGS Proteins,D12.776.402.150.750
16539683,2006-03-01T00:00:00,RGS Proteins,D12.776.476.325.150.750
16539683,2006-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
16539683,2006-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16539683,2006-03-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16539683,2006-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
16539683,2006-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
16539683,2006-03-01T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
16539683,2006-03-01T00:00:00,Signal Transduction,G02.111.087.800
16539683,2006-03-01T00:00:00,Signal Transduction,G02.149.115.800
16539683,2006-03-01T00:00:00,Signal Transduction,G04.299.880
16539691,2006-03-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
16539691,2006-03-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
16539691,2006-03-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
16539691,2006-03-01T00:00:00,Animals,B01.050
16539691,2006-03-01T00:00:00,"Animals, Newborn",B01.050.050.282
16539691,2006-03-01T00:00:00,Brain,A08.186.211
16539691,2006-03-01T00:00:00,Cell Line,A11.251.210
16539691,2006-03-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
16539691,2006-03-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
16539691,2006-03-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16539691,2006-03-01T00:00:00,Cyclic AMP,D03.438.759.646.138.395
16539691,2006-03-01T00:00:00,Cyclic AMP,D13.695.462.200
16539691,2006-03-01T00:00:00,Cyclic AMP,D13.695.667.138.395
16539691,2006-03-01T00:00:00,Cyclic AMP,D13.695.827.068.395
16539691,2006-03-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
16539691,2006-03-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
16539691,2006-03-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
16539691,2006-03-01T00:00:00,Ethanol,D02.033.375
16539691,2006-03-01T00:00:00,Hippocampus,A08.186.211.464.405
16539691,2006-03-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
16539691,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16539691,2006-03-01T00:00:00,Neural Inhibition,G07.265.337.615
16539691,2006-03-01T00:00:00,Neural Inhibition,G07.700.240.615
16539691,2006-03-01T00:00:00,Neural Inhibition,G11.561.600.625
16539691,2006-03-01T00:00:00,Neurons,A08.663
16539691,2006-03-01T00:00:00,Neurons,A11.671
16539691,2006-03-01T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16539691,2006-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16539691,2006-03-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16539691,2006-03-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16540897,2006-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
16540897,2006-03-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
16540897,2006-03-01T00:00:00,Disease Progression,C23.550.291.656
16540897,2006-03-01T00:00:00,Head and Neck Neoplasms,C04.588.443
16540897,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16540897,2006-03-01T00:00:00,Microcirculation,G09.330.190.163.645
16540897,2006-03-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
16540904,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16540904,2006-03-01T00:00:00,"Hyperparathyroidism, Primary",C19.642.355.239
16540904,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16540904,2006-03-01T00:00:00,Parathyroidectomy,E04.270.694
16540904,2006-03-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
16540904,2006-03-01T00:00:00,Treatment Outcome,E01.789.800
16540904,2006-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16540904,2006-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16542281,2006-03-01T00:00:00,Adolescent,M01.060.057
16542281,2006-03-01T00:00:00,Adult,M01.060.116
16542281,2006-03-01T00:00:00,Aged,M01.060.116.100
16542281,2006-03-01T00:00:00,Chest Pain,C23.888.646.215
16542281,2006-03-01T00:00:00,Deglutition Disorders,C06.405.117.119
16542281,2006-03-01T00:00:00,Deglutition Disorders,C09.775.174
16542281,2006-03-01T00:00:00,"Diagnosis, Differential",E01.171
16542281,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16542281,2006-03-01T00:00:00,Manometry,E05.559
16542281,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,G17.800
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16542281,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16542281,2006-03-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
16545154,2006-03-01T00:00:00,Adult,M01.060.116
16545154,2006-03-01T00:00:00,Biological Markers,D23.101
16545154,2006-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16545154,2006-03-01T00:00:00,Body Mass Index,E05.041.124.125
16545154,2006-03-01T00:00:00,Body Mass Index,G07.100.100.125
16545154,2006-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16545154,2006-03-01T00:00:00,Gastroplasty,E02.065.062.750
16545154,2006-03-01T00:00:00,Gastroplasty,E04.062.750
16545154,2006-03-01T00:00:00,Gastroplasty,E04.210.485
16545154,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16545154,2006-03-01T00:00:00,Lymphocytes,A11.118.637.555.567
16545154,2006-03-01T00:00:00,Lymphocytes,A15.145.229.637.555.567
16545154,2006-03-01T00:00:00,Lymphocytes,A15.382.490.555.567
16545154,2006-03-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
16545154,2006-03-01T00:00:00,Metabolic Syndrome X,C18.452.625
16545154,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16545154,2006-03-01T00:00:00,Neutrophils,A11.118.637.415.583
16545154,2006-03-01T00:00:00,Neutrophils,A11.627.340.583
16545154,2006-03-01T00:00:00,Neutrophils,A11.733.689
16545154,2006-03-01T00:00:00,Neutrophils,A15.145.229.637.415.583
16545154,2006-03-01T00:00:00,Neutrophils,A15.382.490.315.583
16545154,2006-03-01T00:00:00,Neutrophils,A15.382.680.689
16545154,2006-03-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
16545154,2006-03-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
16545154,2006-03-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
16545154,2006-03-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
16545154,2006-03-01T00:00:00,Weight Loss,C23.888.144.243.963
16545154,2006-03-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16553090,2006-03-01T00:00:00,Aged,M01.060.116.100
16553090,2006-03-01T00:00:00,Guideline Adherence,N04.761.337
16553090,2006-03-01T00:00:00,Guideline Adherence,N05.715.360.395
16553090,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16553090,2006-03-01T00:00:00,Incidence,E05.318.308.985.525.375
16553090,2006-03-01T00:00:00,Incidence,L01.280.975.525.375
16553090,2006-03-01T00:00:00,Incidence,N01.224.935.597.500
16553090,2006-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16553090,2006-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16553090,2006-03-01T00:00:00,Inpatients,M01.643.470
16553090,2006-03-01T00:00:00,Pneumococcal Vaccines,D20.215.894.135.750.600
16553090,2006-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
16553090,2006-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
16553090,2006-03-01T00:00:00,United States,Z01.107.567.875
16553090,2006-03-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
16553090,2006-03-01T00:00:00,Vaccination,E05.478.550.600.890
16553090,2006-03-01T00:00:00,Vaccination,N02.421.726.758.310.890
16553090,2006-03-01T00:00:00,Vaccination,N06.850.780.200.425.900
16553090,2006-03-01T00:00:00,Vaccination,N06.850.780.680.310.890
16553262,2006-03-01T00:00:00,Albumins,D12.776.034
16553262,2006-03-01T00:00:00,Animals,B01.050
16553262,2006-03-01T00:00:00,Chickens,B01.050.150.900.248.350.150
16553262,2006-03-01T00:00:00,Chickens,B01.050.150.900.248.617.192
16553262,2006-03-01T00:00:00,Liver,A03.620
16553262,2006-03-01T00:00:00,Weight Gain,C23.888.144.243.926
16553262,2006-03-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
16554384,2006-03-01T00:00:00,"Adaptation, Psychological",F01.058
16554384,2006-03-01T00:00:00,Adolescent,M01.060.057
16554384,2006-03-01T00:00:00,Adult,M01.060.116
16554384,2006-03-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16554384,2006-03-01T00:00:00,Blood Pressure,E01.370.600.875.249
16554384,2006-03-01T00:00:00,Blood Pressure,G09.330.380.076
16554384,2006-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16554384,2006-03-01T00:00:00,Body Mass Index,E05.041.124.125
16554384,2006-03-01T00:00:00,Body Mass Index,G07.100.100.125
16554384,2006-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16554384,2006-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16554384,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16554384,2006-03-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.070.300.300.340.725
16554384,2006-03-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.100.150.300.340.725
16554384,2006-03-01T00:00:00,"Receptors, Adrenergic, beta-2",D12.776.543.750.720.300.300.300.340.200
16554384,2006-03-01T00:00:00,"Stress, Physiological",G07.700.830
16554384,2006-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
16554384,2006-03-01T00:00:00,"Stress, Psychological",F02.830.900
16554384,2006-03-01T00:00:00,Video Games,I03.450.642.693.930
16554384,2006-03-01T00:00:00,Video Games,L01.224.900.930
16554422,2006-03-01T00:00:00,Diabetes Complications,C19.246.099
16554422,2006-03-01T00:00:00,Diabetes Mellitus,C18.452.394.750
16554422,2006-03-01T00:00:00,Diabetes Mellitus,C19.246
16554422,2006-03-01T00:00:00,Extracellular Matrix,A11.284.295.310
16554422,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16554422,2006-03-01T00:00:00,Inflammation,C23.550.470
16554422,2006-03-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16554422,2006-03-01T00:00:00,Patient Care Team,N04.590.715
16554422,2006-03-01T00:00:00,Wound Healing,G16.100.856.891
16554422,2006-03-01T00:00:00,Wounds and Injuries,C21.866
16555801,2006-03-01T00:00:00,Adult,M01.060.116
16555801,2006-03-01T00:00:00,Data Collection,E05.318.308
16555801,2006-03-01T00:00:00,Data Collection,L01.280
16555801,2006-03-01T00:00:00,Data Collection,N05.715.360.300
16555801,2006-03-01T00:00:00,Data Collection,N06.850.520.308
16555801,2006-03-01T00:00:00,Health Promotion,N02.370
16555801,2006-03-01T00:00:00,Health Promotion,N02.421.726.507
16555801,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16555801,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16555801,2006-03-01T00:00:00,Program Evaluation,E05.337.820
16555801,2006-03-01T00:00:00,Program Evaluation,N04.761.685
16555801,2006-03-01T00:00:00,Program Evaluation,N05.715.360.650
16555801,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16555801,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16555801,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16555801,2006-03-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16555801,2006-03-01T00:00:00,Smoking Cessation,F01.145.940.700
16555801,2006-03-01T00:00:00,United States,Z01.107.567.875
16569716,2006-03-01T00:00:00,Adolescent,M01.060.057
16569716,2006-03-01T00:00:00,Adult,M01.060.116
16569716,2006-03-01T00:00:00,Age Factors,N05.715.350.075
16569716,2006-03-01T00:00:00,Age Factors,N06.850.490.250
16569716,2006-03-01T00:00:00,Aged,M01.060.116.100
16569716,2006-03-01T00:00:00,Carrier State,N06.850.160
16569716,2006-03-01T00:00:00,Child,M01.060.406
16569716,2006-03-01T00:00:00,"Child, Preschool",M01.060.406.448
16569716,2006-03-01T00:00:00,Health Surveys,E05.318.308.250
16569716,2006-03-01T00:00:00,Health Surveys,N05.715.360.300.375
16569716,2006-03-01T00:00:00,Health Surveys,N06.850.520.308.250
16569716,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16569716,2006-03-01T00:00:00,Infant,M01.060.703
16569716,2006-03-01T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
16569716,2006-03-01T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
16569716,2006-03-01T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
16569716,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16569716,2006-03-01T00:00:00,Nasal Cavity,A04.531.449
16569716,2006-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16569716,2006-03-01T00:00:00,Risk Factors,N05.715.350.200.700
16569716,2006-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16569716,2006-03-01T00:00:00,Risk Factors,N06.850.490.625.750
16569716,2006-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16569716,2006-03-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16569716,2006-03-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16569716,2006-03-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16569716,2006-03-01T00:00:00,United States,Z01.107.567.875
16573295,2006-03-01T00:00:00,African Americans,M01.686.508.100.100
16573295,2006-03-01T00:00:00,African Americans,M01.686.754.100
16573295,2006-03-01T00:00:00,Aged,M01.060.116.100
16573295,2006-03-01T00:00:00,Anticoagulants,D27.505.954.502.119
16573295,2006-03-01T00:00:00,Atrial Fibrillation,C14.280.067.198
16573295,2006-03-01T00:00:00,Atrial Fibrillation,C23.550.073.198
16573295,2006-03-01T00:00:00,Electric Countershock,E02.342.287
16573295,2006-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16573295,2006-03-01T00:00:00,Hispanic Americans,M01.686.754.441
16573295,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16573295,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16573295,2006-03-01T00:00:00,Treatment Outcome,E01.789.800
16573295,2006-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16573295,2006-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16609315,2006-03-01T00:00:00,Human Engineering,F02.784.412
16609315,2006-03-01T00:00:00,Human Engineering,J01.293.556
16609315,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16609315,2006-03-01T00:00:00,Nurses,M01.526.485.650
16609315,2006-03-01T00:00:00,Nurses,N02.360.650
16609315,2006-03-01T00:00:00,Posture,G11.427.695
16609315,2006-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16609315,2006-03-01T00:00:00,Risk Factors,N05.715.350.200.700
16609315,2006-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16609315,2006-03-01T00:00:00,Risk Factors,N06.850.490.625.750
16609315,2006-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16615604,2006-03-01T00:00:00,"Diagnosis, Differential",E01.171
16615604,2006-03-01T00:00:00,Endoscopy,E01.370.388.250
16615604,2006-03-01T00:00:00,Endoscopy,E04.800.250
16615604,2006-03-01T00:00:00,Hamartoma,C04.445
16615604,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16615604,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16615604,2006-03-01T00:00:00,Nasal Cavity,A04.531.449
16615604,2006-03-01T00:00:00,Nose Diseases,C08.460
16615604,2006-03-01T00:00:00,Nose Diseases,C09.603
16615604,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16615604,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16615604,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16615604,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16615604,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16628053,2006-03-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
16628053,2006-03-01T00:00:00,Carotid Stenosis,C14.907.137.230
16628053,2006-03-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
16628053,2006-03-01T00:00:00,Hemodynamics,G09.330.190.400
16628053,2006-03-01T00:00:00,Hemodynamics,G09.330.380
16628053,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16628053,2006-03-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
16628053,2006-03-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
16628053,2006-03-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
16628053,2006-03-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
16628053,2006-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
16628053,2006-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
16628053,2006-03-01T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
16628053,2006-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16628053,2006-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16628053,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16628053,2006-03-01T00:00:00,Stents,E07.695.750
16628053,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16628053,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16628053,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16628053,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16628053,2006-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16628096,2006-03-01T00:00:00,Adolescent,M01.060.057
16628096,2006-03-01T00:00:00,African Americans,M01.686.508.100.100
16628096,2006-03-01T00:00:00,African Americans,M01.686.754.100
16628096,2006-03-01T00:00:00,Child,M01.060.406
16628096,2006-03-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
16628096,2006-03-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
16628096,2006-03-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
16628096,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16628096,2006-03-01T00:00:00,Needs Assessment,I02.594
16628096,2006-03-01T00:00:00,Needs Assessment,N03.349.380.565
16628096,2006-03-01T00:00:00,Needs Assessment,N05.300.537
16628096,2006-03-01T00:00:00,Pediatrics,H02.403.670
16628096,2006-03-01T00:00:00,Social Support,I01.880.656.600
16628096,2006-03-01T00:00:00,Violence,I01.198.240.856
16628096,2006-03-01T00:00:00,Violence,I01.880.735.900
16628096,2006-03-01T00:00:00,Wounds and Injuries,C21.866
16633208,2006-03-01T00:00:00,Adolescent,M01.060.057
16633208,2006-03-01T00:00:00,Adult,M01.060.116
16633208,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16633208,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16633208,2006-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16633208,2006-03-01T00:00:00,Risk Factors,N05.715.350.200.700
16633208,2006-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16633208,2006-03-01T00:00:00,Risk Factors,N06.850.490.625.750
16633208,2006-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16633208,2006-03-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
16633208,2006-03-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
16637521,2006-03-01T00:00:00,Adult,M01.060.116
16637521,2006-03-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
16637521,2006-03-01T00:00:00,Decision Support Techniques,E05.245
16637521,2006-03-01T00:00:00,Decision Support Techniques,L01.700.508.190
16637521,2006-03-01T00:00:00,Drug Delivery Systems,E02.319.300
16637521,2006-03-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
16637521,2006-03-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
16637521,2006-03-01T00:00:00,Heart-Assist Devices,E04.050.430
16637521,2006-03-01T00:00:00,Heart-Assist Devices,E07.695.300.300
16637521,2006-03-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
16637521,2006-03-01T00:00:00,Heparin,D09.698.373.400
16637521,2006-03-01T00:00:00,Hospital Costs,N03.219.151.400.687
16637521,2006-03-01T00:00:00,Hospital Costs,N03.219.262.500
16637521,2006-03-01T00:00:00,Hospital Costs,N05.300.375.500
16637521,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16637521,2006-03-01T00:00:00,Postoperative Care,E02.760.722.700
16637521,2006-03-01T00:00:00,Postoperative Care,E04.624
16637521,2006-03-01T00:00:00,Postoperative Care,N02.421.585.722.700
16638601,2006-03-01T00:00:00,Adult,M01.060.116
16638601,2006-03-01T00:00:00,Aged,M01.060.116.100
16638601,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16638601,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16638601,2006-03-01T00:00:00,New York City,Z01.107.567.875.350.530.530
16638601,2006-03-01T00:00:00,New York City,Z01.107.567.875.500.530.530
16638601,2006-03-01T00:00:00,New York City,Z01.433.741
16638601,2006-03-01T00:00:00,Prevalence,E05.318.308.985.525.750
16638601,2006-03-01T00:00:00,Prevalence,L01.280.975.525.750
16638601,2006-03-01T00:00:00,Prevalence,N01.224.935.597.750
16638601,2006-03-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16638601,2006-03-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16638601,2006-03-01T00:00:00,Sex Factors,N05.715.350.675
16638601,2006-03-01T00:00:00,Sex Factors,N06.850.490.875
16638601,2006-03-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16674209,2006-03-01T00:00:00,Animals,B01.050
16674209,2006-03-01T00:00:00,Computer Simulation,L01.224.160
16674209,2006-03-01T00:00:00,Heart Conduction System,A07.541.409
16674209,2006-03-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
16674209,2006-03-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
16674209,2006-03-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
16674209,2006-03-01T00:00:00,Lighting,N06.230.150.410
16674209,2006-03-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
16674209,2006-03-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
16674209,2006-03-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
16674209,2006-03-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
16674209,2006-03-01T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
16674209,2006-03-01T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
16679937,2006-03-01T00:00:00,Adolescent,M01.060.057
16679937,2006-03-01T00:00:00,Albumins,D12.776.034
16679937,2006-03-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16679937,2006-03-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16679937,2006-03-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16679937,2006-03-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16679937,2006-03-01T00:00:00,Biological Markers,D23.101
16679937,2006-03-01T00:00:00,Child,M01.060.406
16679937,2006-03-01T00:00:00,Hemoglobins,D12.776.124.400
16679937,2006-03-01T00:00:00,Hemoglobins,D12.776.422.316.762
16679937,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16679937,2006-03-01T00:00:00,Kallikreins,D08.811.277.656.300.760.442
16679937,2006-03-01T00:00:00,Kallikreins,D08.811.277.656.959.350.442
16679937,2006-03-01T00:00:00,Kallikreins,D12.776.124.125.597
16679937,2006-03-01T00:00:00,Kallikreins,D23.119.597
16679937,2006-03-01T00:00:00,Kidney Diseases,C12.777.419
16679937,2006-03-01T00:00:00,Kidney Diseases,C13.351.968.419
16679937,2006-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16679937,2006-03-01T00:00:00,Risk Factors,N05.715.350.200.700
16679937,2006-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16679937,2006-03-01T00:00:00,Risk Factors,N06.850.490.625.750
16679937,2006-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16679937,2006-03-01T00:00:00,Sex Factors,N05.715.350.675
16679937,2006-03-01T00:00:00,Sex Factors,N06.850.490.875
16705494,2006-03-01T00:00:00,Adult,M01.060.116
16705494,2006-03-01T00:00:00,Aged,M01.060.116.100
16705494,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16705494,2006-03-01T00:00:00,Middle Aged,M01.060.116.630
16705494,2006-03-01T00:00:00,Psychometrics,F04.711.780
16705494,2006-03-01T00:00:00,Self Concept,F01.752.747.792
16708153,2006-03-01T00:00:00,Catheterization,E02.148
16708153,2006-03-01T00:00:00,Catheterization,E05.157
16708153,2006-03-01T00:00:00,Conscious Sedation,E03.250
16708153,2006-03-01T00:00:00,"Endoscopy, Digestive System",E01.370.372.250
16708153,2006-03-01T00:00:00,"Endoscopy, Digestive System",E01.370.388.250.250
16708153,2006-03-01T00:00:00,"Endoscopy, Digestive System",E04.210.240
16708153,2006-03-01T00:00:00,"Endoscopy, Digestive System",E04.800.250.250
16708153,2006-03-01T00:00:00,Enteral Nutrition,E02.421.360
16708153,2006-03-01T00:00:00,Enteral Nutrition,E02.642.500.360
16708153,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16708153,2006-03-01T00:00:00,Video Recording,L01.240.960
16762154,2006-03-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
16762154,2006-03-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
16762154,2006-03-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
16762154,2006-03-01T00:00:00,Cytomegalovirus,B04.280.382.150.150
16762154,2006-03-01T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
16762154,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16762154,2006-03-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16762154,2006-03-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16762154,2006-03-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16762154,2006-03-01T00:00:00,Phosphoproteins,D12.776.744
16762154,2006-03-01T00:00:00,"Scleroderma, Systemic",C17.300.799
16762154,2006-03-01T00:00:00,"Scleroderma, Systemic",C17.800.784
16762154,2006-03-01T00:00:00,Viral Matrix Proteins,D12.776.964.970.880.940
16878575,2006-03-01T00:00:00,Algorithms,G17.035
16878575,2006-03-01T00:00:00,Algorithms,L01.224.050
16878575,2006-03-01T00:00:00,Artifacts,E05.047
16878575,2006-03-01T00:00:00,Breast Neoplasms,C04.588.180
16878575,2006-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
16878575,2006-03-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16878575,2006-03-01T00:00:00,Clinical Trials as Topic,E05.337.250
16878575,2006-03-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16878575,2006-03-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16878575,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16878575,2006-03-01T00:00:00,Mammography,E01.370.350.700.500
16878575,2006-03-01T00:00:00,"Phantoms, Imaging",E07.671
16878575,2006-03-01T00:00:00,Radiation Dosage,E05.799.513
16878575,2006-03-01T00:00:00,Radiation Dosage,G01.201.875.740
16878575,2006-03-01T00:00:00,Radiation Dosage,N06.850.810.250
16878575,2006-03-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16878575,2006-03-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16878575,2006-03-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,G17.800
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16878575,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16878575,2006-03-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
16878576,2006-03-01T00:00:00,Breast Neoplasms,C04.588.180
16878576,2006-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
16878576,2006-03-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16878576,2006-03-01T00:00:00,Clinical Trials as Topic,E05.337.250
16878576,2006-03-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16878576,2006-03-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16878576,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16878576,2006-03-01T00:00:00,Mammography,E01.370.350.700.500
16878576,2006-03-01T00:00:00,"Phantoms, Imaging",E07.671
16878576,2006-03-01T00:00:00,Radiation Dosage,E05.799.513
16878576,2006-03-01T00:00:00,Radiation Dosage,G01.201.875.740
16878576,2006-03-01T00:00:00,Radiation Dosage,N06.850.810.250
16878576,2006-03-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16878576,2006-03-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16878576,2006-03-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,G17.800
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16878576,2006-03-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16878576,2006-03-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
16889322,2006-03-01T00:00:00,Curriculum,I02.158
16889322,2006-03-01T00:00:00,Guideline Adherence,N04.761.337
16889322,2006-03-01T00:00:00,Guideline Adherence,N05.715.360.395
16889322,2006-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
16889322,2006-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
16889322,2006-03-01T00:00:00,Heart Failure,C14.280.434
16889322,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16889322,2006-03-01T00:00:00,Palliative Care,E02.760.666
16889322,2006-03-01T00:00:00,Palliative Care,N02.421.585.666
16889322,2006-03-01T00:00:00,Professional-Patient Relations,F01.829.401.650
16889322,2006-03-01T00:00:00,Professional-Patient Relations,N05.300.660
16889322,2006-03-01T00:00:00,Program Evaluation,E05.337.820
16889322,2006-03-01T00:00:00,Program Evaluation,N04.761.685
16889322,2006-03-01T00:00:00,Program Evaluation,N05.715.360.650
16889322,2006-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16889322,2006-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16925337,2006-03-01T00:00:00,Bariatric Surgery,E02.065.062
16925337,2006-03-01T00:00:00,Bariatric Surgery,E04.062
16925337,2006-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16925337,2006-03-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
16925337,2006-03-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
16925337,2006-03-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
16925337,2006-03-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
16925337,2006-03-01T00:00:00,Patient Selection,E05.581.500.653
16925337,2006-03-01T00:00:00,Patient Selection,N04.590.731
17409857,2006-03-01T00:00:00,Animals,B01.050
17409857,2006-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17409857,2006-03-01T00:00:00,Lung Neoplasms,C08.381.540
17409857,2006-03-01T00:00:00,Lung Neoplasms,C08.785.520
17409857,2006-03-01T00:00:00,"RNA, Messenger",D13.444.735.544
17409857,2006-03-01T00:00:00,Semaphorins,D12.644.276.923
17409857,2006-03-01T00:00:00,Semaphorins,D12.776.467.923
17409857,2006-03-01T00:00:00,Semaphorins,D23.529.923
17409857,2006-03-01T00:00:00,Signal Transduction,G02.111.087.800
17409857,2006-03-01T00:00:00,Signal Transduction,G02.149.115.800
17409857,2006-03-01T00:00:00,Signal Transduction,G04.299.880
16514058,2006-03-02T00:00:00,Animals,B01.050
16514058,2006-03-02T00:00:00,Gene Expression Profiling,E05.393.332
16514058,2006-03-02T00:00:00,Nitric Oxide,D01.339.387
16514058,2006-03-02T00:00:00,Nitric Oxide,D01.625.550.500
16514058,2006-03-02T00:00:00,Nitric Oxide,D01.625.700.500
16514058,2006-03-02T00:00:00,Nitric Oxide,D01.650.550.587.600
16514058,2006-03-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
16514058,2006-03-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
16514058,2006-03-02T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
16514058,2006-03-02T00:00:00,Risk Factors,E05.318.740.600.800.725
16514058,2006-03-02T00:00:00,Risk Factors,N05.715.350.200.700
16514058,2006-03-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16514058,2006-03-02T00:00:00,Risk Factors,N06.850.490.625.750
16514058,2006-03-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16514058,2006-03-02T00:00:00,Thrombosis,C14.907.355.830
16516223,2006-03-03T00:00:00,Discrimination (Psychology),F02.463.593.257
16516223,2006-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16516223,2006-03-03T00:00:00,Infant,M01.060.703
16516223,2006-03-03T00:00:00,Infant Behavior,F01.145.179.500
16516223,2006-03-03T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
16516223,2006-03-03T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
16516223,2006-03-03T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
16516223,2006-03-03T00:00:00,Visual Perception,F02.463.593.932
16516397,2006-03-03T00:00:00,Adult,M01.060.116
16516397,2006-03-03T00:00:00,Cocaine-Related Disorders,C21.739.300
16516397,2006-03-03T00:00:00,Cocaine-Related Disorders,F03.900.300
16516397,2006-03-03T00:00:00,Computer Simulation,L01.224.160
16516397,2006-03-03T00:00:00,Cues,F02.463.425.234
16516397,2006-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16516397,2006-03-03T00:00:00,Motivation,F01.658
16516397,2006-03-03T00:00:00,Motivation,F01.752.543.500.750
16516482,2006-03-03T00:00:00,Alzheimer Disease,C10.228.140.380.100
16516482,2006-03-03T00:00:00,Alzheimer Disease,C10.574.945.249
16516482,2006-03-03T00:00:00,Alzheimer Disease,F03.087.400.100
16516482,2006-03-03T00:00:00,Animals,B01.050
16516482,2006-03-03T00:00:00,Brain,A08.186.211
16516482,2006-03-03T00:00:00,Brain Chemistry,G02.111.100
16516482,2006-03-03T00:00:00,Brain Chemistry,G03.200
16516482,2006-03-03T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16516482,2006-03-03T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16516482,2006-03-03T00:00:00,Mutation,G05.365.590
16516482,2006-03-03T00:00:00,Neurons,A08.663
16516482,2006-03-03T00:00:00,Neurons,A11.671
16516482,2006-03-03T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16516482,2006-03-03T00:00:00,Sex Factors,N05.715.350.675
16516482,2006-03-03T00:00:00,Sex Factors,N06.850.490.875
16530726,2006-03-03T00:00:00,Animals,B01.050
16530726,2006-03-03T00:00:00,Apoptosis,G04.299.139.160
16530726,2006-03-03T00:00:00,Brain,A08.186.211
16530726,2006-03-03T00:00:00,Down-Regulation,G02.111.087.225
16530726,2006-03-03T00:00:00,Down-Regulation,G02.149.115.225
16530726,2006-03-03T00:00:00,Down-Regulation,G05.355.315.200
16530726,2006-03-03T00:00:00,Down-Regulation,G07.690.812.230
16530726,2006-03-03T00:00:00,Down-Regulation,G07.700.680.230
16530726,2006-03-03T00:00:00,Enzyme Inhibitors,D27.505.519.389
16530726,2006-03-03T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
16530726,2006-03-03T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
16530726,2006-03-03T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
16530726,2006-03-03T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
16530726,2006-03-03T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
16530726,2006-03-03T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
16530726,2006-03-03T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
16530726,2006-03-03T00:00:00,Psychosine,D02.033.100.700.700
16530726,2006-03-03T00:00:00,Psychosine,D02.092.063.700.700
16530726,2006-03-03T00:00:00,Psychosine,D09.400.410.420.806
16530726,2006-03-03T00:00:00,Psychosine,D10.390.470.806
16530726,2006-03-03T00:00:00,Psychosine,D10.570.877.360.806
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16530726,2006-03-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16731464,2006-03-03T00:00:00,Atrial Fibrillation,C14.280.067.198
16731464,2006-03-03T00:00:00,Atrial Fibrillation,C23.550.073.198
16731464,2006-03-03T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
16731464,2006-03-03T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
16731464,2006-03-03T00:00:00,"Defibrillators, Implantable",E07.695.175
16731464,2006-03-03T00:00:00,Electric Countershock,E02.342.287
16731464,2006-03-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16731464,2006-03-03T00:00:00,Middle Aged,M01.060.116.630
16410723,2006-03-06T00:00:00,Azacitidine,D02.145.150
16410723,2006-03-06T00:00:00,Azacitidine,D03.383.742.680.245.217
16410723,2006-03-06T00:00:00,Azacitidine,D13.570.685.245.217
16410723,2006-03-06T00:00:00,Azacitidine,D13.570.800.286.300
16410723,2006-03-06T00:00:00,Breast Neoplasms,C04.588.180
16410723,2006-03-06T00:00:00,Breast Neoplasms,C17.800.090.500
16410723,2006-03-06T00:00:00,Cell Line,A11.251.210
16410723,2006-03-06T00:00:00,DNA Methylation,G02.111.087.029.538.161
16410723,2006-03-06T00:00:00,DNA Methylation,G02.111.087.218
16410723,2006-03-06T00:00:00,DNA Methylation,G02.149.115.029.538.161
16410723,2006-03-06T00:00:00,DNA Methylation,G02.149.115.218
16410723,2006-03-06T00:00:00,DNA Methylation,G03.495.130.538.161
16410723,2006-03-06T00:00:00,DNA Methylation,G05.355.190
16410723,2006-03-06T00:00:00,Down-Regulation,G02.111.087.225
16410723,2006-03-06T00:00:00,Down-Regulation,G02.149.115.225
16410723,2006-03-06T00:00:00,Down-Regulation,G05.355.315.200
16410723,2006-03-06T00:00:00,Down-Regulation,G07.690.812.230
16410723,2006-03-06T00:00:00,Down-Regulation,G07.700.680.230
16410723,2006-03-06T00:00:00,Histones,D12.776.660.470
16410723,2006-03-06T00:00:00,Histones,D12.776.664.469
16410723,2006-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16410723,2006-03-06T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16410723,2006-03-06T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16410723,2006-03-06T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16410723,2006-03-06T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16410723,2006-03-06T00:00:00,Proteins,D12.776
16410723,2006-03-06T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
16516916,2006-03-06T00:00:00,Animals,B01.050
16516916,2006-03-06T00:00:00,Collagen Type I,D05.750.078.280.300.100
16516916,2006-03-06T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16516916,2006-03-06T00:00:00,Extracellular Matrix,A11.284.295.310
16516916,2006-03-06T00:00:00,Fibroblasts,A11.329.228
16516916,2006-03-06T00:00:00,Fibroblasts,A11.872.228
16516916,2006-03-06T00:00:00,Fibronectins,D12.776.377.715.390
16516916,2006-03-06T00:00:00,Fibronectins,D12.776.395.550.350
16516916,2006-03-06T00:00:00,Fibronectins,D12.776.543.550.350
16516916,2006-03-06T00:00:00,Fibronectins,D12.776.860.300.450
16516916,2006-03-06T00:00:00,Myocardium,A02.633.580
16516916,2006-03-06T00:00:00,Myocardium,A07.541.704
16516916,2006-03-06T00:00:00,Myocardium,A10.690.552.750
16516916,2006-03-06T00:00:00,Swine,B01.050.150.900.649.077.880
16516916,2006-03-06T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16516916,2006-03-06T00:00:00,Ventricular Remodeling,C23.300.985
16516916,2006-03-06T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16516991,2006-03-06T00:00:00,Carbon Dioxide,D01.200.200
16516991,2006-03-06T00:00:00,Carbon Dioxide,D01.362.150
16516991,2006-03-06T00:00:00,Carbon Dioxide,D01.650.550.200
16516991,2006-03-06T00:00:00,Ethanol,D02.033.375
16516991,2006-03-06T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16516991,2006-03-06T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16516991,2006-03-06T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16516991,2006-03-06T00:00:00,"Spores, Bacterial",A11.870.700
16516991,2006-03-06T00:00:00,"Spores, Bacterial",B05.775.700
16530190,2006-03-06T00:00:00,Amino Acid Sequence,G02.111.570.060
16530190,2006-03-06T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16530190,2006-03-06T00:00:00,Animals,B01.050
16530190,2006-03-06T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
16530190,2006-03-06T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
16530190,2006-03-06T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
16530190,2006-03-06T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
16530190,2006-03-06T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
16530190,2006-03-06T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
16530190,2006-03-06T00:00:00,GTP-Binding Proteins,D12.776.157.325
16530190,2006-03-06T00:00:00,Molecular Sequence Data,L01.453.245.667
16530190,2006-03-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16530190,2006-03-06T00:00:00,Signal Transduction,G02.111.087.800
16530190,2006-03-06T00:00:00,Signal Transduction,G02.149.115.800
16530190,2006-03-06T00:00:00,Signal Transduction,G04.299.880
16532409,2006-03-06T00:00:00,Cross Infection,C01.539.248
16532409,2006-03-06T00:00:00,"Hospitals, Community",N02.278.421.306
16532409,2006-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16532409,2006-03-06T00:00:00,Incidence,E05.318.308.985.525.375
16532409,2006-03-06T00:00:00,Incidence,L01.280.975.525.375
16532409,2006-03-06T00:00:00,Incidence,N01.224.935.597.500
16532409,2006-03-06T00:00:00,Incidence,N06.850.505.400.975.525.375
16532409,2006-03-06T00:00:00,Incidence,N06.850.520.308.985.525.375
16532409,2006-03-06T00:00:00,Infection Control,N06.850.780.200.450
16532409,2006-03-06T00:00:00,Intensive Care Units,N02.278.388.493
16532409,2006-03-06T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
16532409,2006-03-06T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
16532409,2006-03-06T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
16532409,2006-03-06T00:00:00,Patient Isolation,E02.770
16532409,2006-03-06T00:00:00,Patient Isolation,N06.850.780.200.450.650
16532409,2006-03-06T00:00:00,South Carolina,Z01.107.567.875.075.662
16532409,2006-03-06T00:00:00,South Carolina,Z01.107.567.875.750.700
16532409,2006-03-06T00:00:00,Staphylococcal Infections,C01.252.410.868
16532409,2006-03-06T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16532409,2006-03-06T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16532409,2006-03-06T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16569448,2006-03-06T00:00:00,Animals,B01.050
16569448,2006-03-06T00:00:00,Embryonic Development,G07.700.320.500.325.180
16569448,2006-03-06T00:00:00,Embryonic Development,G08.686.785.760.170.104
16569448,2006-03-06T00:00:00,Environment,G16.500.275
16569448,2006-03-06T00:00:00,Environment,N06.230
16569448,2006-03-06T00:00:00,Environmental Exposure,N06.850.460.350
16569448,2006-03-06T00:00:00,Larva,B05.500.500
16569448,2006-03-06T00:00:00,Larva,G07.700.320.500.550.500.500
16569448,2006-03-06T00:00:00,Water,D01.455.900
16569448,2006-03-06T00:00:00,Water,D01.650.550.925
16569448,2006-03-06T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
16571372,2006-03-06T00:00:00,Animals,B01.050
16571372,2006-03-06T00:00:00,"Animals, Newborn",B01.050.050.282
16571372,2006-03-06T00:00:00,Binding Sites,G02.111.570.120
16571372,2006-03-06T00:00:00,Body Weight,C23.888.144
16571372,2006-03-06T00:00:00,Body Weight,E01.370.600.115.100.160.120
16571372,2006-03-06T00:00:00,Body Weight,E05.041.124.160.750
16571372,2006-03-06T00:00:00,Body Weight,G07.100.100.160.120
16571372,2006-03-06T00:00:00,Body Weight,G07.700.320.249.314.120
16571372,2006-03-06T00:00:00,Cocaine,D02.145.074.722.388
16571372,2006-03-06T00:00:00,Cocaine,D03.132.889.354
16571372,2006-03-06T00:00:00,Cocaine,D03.605.869.388
16571372,2006-03-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
16571372,2006-03-06T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
16571372,2006-03-06T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
16571372,2006-03-06T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
16571372,2006-03-06T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
16571372,2006-03-06T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
16571372,2006-03-06T00:00:00,Iron,D01.268.556.412
16571372,2006-03-06T00:00:00,Iron,D01.268.956.287
16571372,2006-03-06T00:00:00,Iron,D01.552.544.412
16571372,2006-03-06T00:00:00,Motor Activity,F01.145.632
16571372,2006-03-06T00:00:00,Motor Activity,G11.427.590.530.698
16571372,2006-03-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16571372,2006-03-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16522689,2006-03-07T00:00:00,"Antigens, CD147",D12.776.395.550.045
16522689,2006-03-07T00:00:00,"Antigens, CD147",D12.776.543.550.188
16522689,2006-03-07T00:00:00,"Antigens, CD147",D23.050.285.040
16522689,2006-03-07T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
16522689,2006-03-07T00:00:00,"Antigens, CD147",D23.101.100.110.247
16522689,2006-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16522689,2006-03-07T00:00:00,Interleukin-1,D12.644.276.374.465.501
16522689,2006-03-07T00:00:00,Interleukin-1,D12.644.276.374.500.400
16522689,2006-03-07T00:00:00,Interleukin-1,D12.776.467.374.465.501
16522689,2006-03-07T00:00:00,Interleukin-1,D12.776.467.374.500.400
16522689,2006-03-07T00:00:00,Interleukin-1,D23.529.374.465.501
16522689,2006-03-07T00:00:00,Interleukin-1,D23.529.374.500.400
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 3,D08.811.277.656.300.480.525.700.200
16522689,2006-03-07T00:00:00,Matrix Metalloproteinase 3,D08.811.277.656.675.374.525.700.200
16522689,2006-03-07T00:00:00,"RNA, Messenger",D13.444.735.544
16524372,2006-03-08T00:00:00,Animals,B01.050
16524372,2006-03-08T00:00:00,"Animals, Newborn",B01.050.050.282
16524372,2006-03-08T00:00:00,Antioxidants,D27.505.519.217
16524372,2006-03-08T00:00:00,Antioxidants,D27.505.696.706.125
16524372,2006-03-08T00:00:00,Antioxidants,D27.720.799.047
16524372,2006-03-08T00:00:00,Astrocytes,A08.637.200
16524372,2006-03-08T00:00:00,Astrocytes,A11.650.200
16524372,2006-03-08T00:00:00,Cell Survival,G04.299.316
16524372,2006-03-08T00:00:00,Drug Interactions,G07.690.812.240
16524372,2006-03-08T00:00:00,Drug Interactions,G07.700.680.240
16524372,2006-03-08T00:00:00,Glutathione,D12.644.456.448
16524372,2006-03-08T00:00:00,Motor Neurons,A08.663.655.500
16524372,2006-03-08T00:00:00,Motor Neurons,A11.671.655.500
16524372,2006-03-08T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
16524372,2006-03-08T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
16524372,2006-03-08T00:00:00,Nerve Growth Factor,D12.644.276.860.437
16524372,2006-03-08T00:00:00,Nerve Growth Factor,D12.776.467.860.437
16524372,2006-03-08T00:00:00,Nerve Growth Factor,D12.776.641.600.437
16524372,2006-03-08T00:00:00,Nerve Growth Factor,D23.529.850.437
16524372,2006-03-08T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16524372,2006-03-08T00:00:00,Propionates,D02.241.081.751
16524372,2006-03-08T00:00:00,Propionates,D10.251.400.706
16524372,2006-03-08T00:00:00,Pyrimidines,D03.383.742
16524372,2006-03-08T00:00:00,Quinolines,D03.438.810
16524372,2006-03-08T00:00:00,"RNA, Messenger",D13.444.735.544
16524372,2006-03-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16524372,2006-03-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16524372,2006-03-08T00:00:00,Spinal Cord,A08.186.854
16524372,2006-03-08T00:00:00,Superoxide Dismutase,D08.811.682.881
16524750,2006-03-09T00:00:00,Animals,B01.050
16524750,2006-03-09T00:00:00,Brain Chemistry,G02.111.100
16524750,2006-03-09T00:00:00,Brain Chemistry,G03.200
16524750,2006-03-09T00:00:00,Brain Ischemia,C10.228.140.300.150
16524750,2006-03-09T00:00:00,Brain Ischemia,C14.907.253.092
16524750,2006-03-09T00:00:00,Glutathione,D12.644.456.448
16524750,2006-03-09T00:00:00,Glutathione Disulfide,D12.644.456.448.500
16524750,2006-03-09T00:00:00,Lipids,D10
16524750,2006-03-09T00:00:00,Nitric Oxide,D01.339.387
16524750,2006-03-09T00:00:00,Nitric Oxide,D01.625.550.500
16524750,2006-03-09T00:00:00,Nitric Oxide,D01.625.700.500
16524750,2006-03-09T00:00:00,Nitric Oxide,D01.650.550.587.600
16524750,2006-03-09T00:00:00,Oxidative Stress,G03.495.710
16524750,2006-03-09T00:00:00,Oxidative Stress,G07.700.830.750
16524750,2006-03-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16524750,2006-03-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16524750,2006-03-09T00:00:00,Stroke,C10.228.140.300.775
16524750,2006-03-09T00:00:00,Stroke,C14.907.253.855
16524750,2006-03-09T00:00:00,Tyrosine,D12.125.072.050.875
16527273,2006-03-09T00:00:00,Endothelial Cells,A11.436.275
16527273,2006-03-09T00:00:00,"Endothelium, Vascular",A07.231.330
16527273,2006-03-09T00:00:00,"Endothelium, Vascular",A10.272.491.355
16527273,2006-03-09T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
16527273,2006-03-09T00:00:00,GTP-Binding Proteins,D12.776.157.325
16527273,2006-03-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16527273,2006-03-09T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16527273,2006-03-09T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16527273,2006-03-09T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16527273,2006-03-09T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16527273,2006-03-09T00:00:00,RNA Stability,G02.111.780
16527273,2006-03-09T00:00:00,"RNA, Messenger",D13.444.735.544
16527273,2006-03-09T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
16527273,2006-03-09T00:00:00,Sphingosine,D02.033.100.700
16527273,2006-03-09T00:00:00,Sphingosine,D02.033.455.843
16527273,2006-03-09T00:00:00,Sphingosine,D02.092.063.700
16527273,2006-03-09T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
16527273,2006-03-09T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
16527273,2006-03-09T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
16527345,2006-03-09T00:00:00,Animals,B01.050
16527345,2006-03-09T00:00:00,Biocompatible Materials,D25.130
16527345,2006-03-09T00:00:00,Biocompatible Materials,D27.720.102.130
16527345,2006-03-09T00:00:00,Biocompatible Materials,J01.637.051.130
16527345,2006-03-09T00:00:00,Bioprosthesis,E07.695.100
16527345,2006-03-09T00:00:00,Blood Vessels,A07.231
16527345,2006-03-09T00:00:00,Elastin,D05.750.078.421
16527345,2006-03-09T00:00:00,Elastin,D12.776.860.300.350
16527345,2006-03-09T00:00:00,Materials Testing,E05.570
16527345,2006-03-09T00:00:00,Molecular Structure,G02.111.570
16527345,2006-03-09T00:00:00,Molecular Structure,G02.575
16527345,2006-03-09T00:00:00,Molecular Structure,G02.842.575
16527345,2006-03-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16527345,2006-03-09T00:00:00,Swine,B01.050.150.900.649.077.880
16527848,2006-03-09T00:00:00,Animals,B01.050
16527848,2006-03-09T00:00:00,Apoptosis,G04.299.139.160
16527848,2006-03-09T00:00:00,Brain Ischemia,C10.228.140.300.150
16527848,2006-03-09T00:00:00,Brain Ischemia,C14.907.253.092
16527848,2006-03-09T00:00:00,Estradiol,D04.808.365.415.248
16527848,2006-03-09T00:00:00,Estradiol,D06.472.334.851.437.500
16527848,2006-03-09T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
16527848,2006-03-09T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
16527848,2006-03-09T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
16527848,2006-03-09T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16527848,2006-03-09T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16527848,2006-03-09T00:00:00,"RNA, Messenger",D13.444.735.544
16527848,2006-03-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16527848,2006-03-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16527848,2006-03-09T00:00:00,Signal Transduction,G02.111.087.800
16527848,2006-03-09T00:00:00,Signal Transduction,G02.149.115.800
16527848,2006-03-09T00:00:00,Signal Transduction,G04.299.880
16527951,2006-03-10T00:00:00,Animals,B01.050
16527951,2006-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16527951,2006-03-10T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16527951,2006-03-10T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16527951,2006-03-10T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16527951,2006-03-10T00:00:00,"Polymorphism, Genetic",G05.365.795
16527951,2006-03-10T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
16527951,2006-03-10T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
16527951,2006-03-10T00:00:00,"Receptors, IgG",D23.101.100.110.695
16530770,2006-03-10T00:00:00,Adult,M01.060.116
16530770,2006-03-10T00:00:00,Antibodies,D12.776.124.486.485.114
16530770,2006-03-10T00:00:00,Antibodies,D12.776.124.790.651.114
16530770,2006-03-10T00:00:00,Antibodies,D12.776.377.715.548.114
16530770,2006-03-10T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
16530770,2006-03-10T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
16530770,2006-03-10T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
16530770,2006-03-10T00:00:00,Antigen-Antibody Complex,D23.050.101
16530770,2006-03-10T00:00:00,Cholesterol,D04.808.247.222.284
16530770,2006-03-10T00:00:00,Cholesterol,D04.808.247.808.197
16530770,2006-03-10T00:00:00,Cholesterol,D10.570.938.208
16530770,2006-03-10T00:00:00,Cholesterol,D10.851.208
16530770,2006-03-10T00:00:00,"Cholesterol, HDL",D10.532.432.400
16530770,2006-03-10T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
16530770,2006-03-10T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
16530770,2006-03-10T00:00:00,"Cholesterol, LDL",D10.532.515.500
16530770,2006-03-10T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
16530770,2006-03-10T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
16530770,2006-03-10T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
16530770,2006-03-10T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
16530770,2006-03-10T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
16530770,2006-03-10T00:00:00,Diabetic Angiopathies,C14.907.320
16530770,2006-03-10T00:00:00,Diabetic Angiopathies,C19.246.099.500
16530770,2006-03-10T00:00:00,Disease Progression,C23.550.291.656
16530770,2006-03-10T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
16530770,2006-03-10T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
16530770,2006-03-10T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
16530770,2006-03-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16530770,2006-03-10T00:00:00,Lipoproteins,D10.532
16530770,2006-03-10T00:00:00,Lipoproteins,D12.776.521
16530770,2006-03-10T00:00:00,"Lipoproteins, LDL",D10.532.515
16530770,2006-03-10T00:00:00,"Lipoproteins, LDL",D12.776.521.550
16530770,2006-03-10T00:00:00,Middle Aged,M01.060.116.630
16534002,2006-03-13T00:00:00,Animals,B01.050
16534002,2006-03-13T00:00:00,Apoptosis,G04.299.139.160
16534002,2006-03-13T00:00:00,Brain,A08.186.211
16534002,2006-03-13T00:00:00,Brain Ischemia,C10.228.140.300.150
16534002,2006-03-13T00:00:00,Brain Ischemia,C14.907.253.092
16534002,2006-03-13T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16534002,2006-03-13T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16534002,2006-03-13T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16534002,2006-03-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16534002,2006-03-13T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16534002,2006-03-13T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
16534002,2006-03-13T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
16534002,2006-03-13T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
16534002,2006-03-13T00:00:00,Stroke,C10.228.140.300.775
16534002,2006-03-13T00:00:00,Stroke,C14.907.253.855
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16534002,2006-03-13T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16534034,2006-03-13T00:00:00,Caregivers,M01.085
16534034,2006-03-13T00:00:00,Caregivers,M01.526.485.200
16534034,2006-03-13T00:00:00,Caregivers,N02.360.200
16534034,2006-03-13T00:00:00,Decision Making,F02.463.785.373
16534034,2006-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16534034,2006-03-13T00:00:00,Terminal Care,E02.760.905
16534034,2006-03-13T00:00:00,Terminal Care,N02.421.585.905
16550164,2006-03-13T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
16550164,2006-03-13T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
16550164,2006-03-13T00:00:00,Genetic Predisposition to Disease,G05.380.355
16550164,2006-03-13T00:00:00,Glutathione Transferase,D08.811.913.225.500
16550164,2006-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16550164,2006-03-13T00:00:00,Neoplasms,C04
16550164,2006-03-13T00:00:00,"Polymorphism, Genetic",G05.365.795
16550164,2006-03-13T00:00:00,Treatment Outcome,E01.789.800
16550164,2006-03-13T00:00:00,Treatment Outcome,N04.761.559.590.800
16550164,2006-03-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16533589,2006-03-14T00:00:00,Adult,M01.060.116
16533589,2006-03-14T00:00:00,African Americans,M01.686.508.100.100
16533589,2006-03-14T00:00:00,African Americans,M01.686.754.100
16533589,2006-03-14T00:00:00,Breast Neoplasms,C04.588.180
16533589,2006-03-14T00:00:00,Breast Neoplasms,C17.800.090.500
16533589,2006-03-14T00:00:00,Cultural Diversity,I01.076.201.450.350
16533589,2006-03-14T00:00:00,Cultural Diversity,I01.880.143.450
16533589,2006-03-14T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
16533589,2006-03-14T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
16533589,2006-03-14T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
16533589,2006-03-14T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
16533589,2006-03-14T00:00:00,Genetic Counseling,H01.158.273.343.315.384
16533589,2006-03-14T00:00:00,Genetic Counseling,N02.421.308.400
16533589,2006-03-14T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
16533589,2006-03-14T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
16533589,2006-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16533589,2006-03-14T00:00:00,Income,N01.824.417
16533589,2006-03-14T00:00:00,Middle Aged,M01.060.116.630
16533589,2006-03-14T00:00:00,Mutation,G05.365.590
16533589,2006-03-14T00:00:00,Ovarian Neoplasms,C04.588.322.455
16533589,2006-03-14T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
16533589,2006-03-14T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
16533589,2006-03-14T00:00:00,Ovarian Neoplasms,C19.344.410
16533589,2006-03-14T00:00:00,Ovarian Neoplasms,C19.391.630.705
16533589,2006-03-14T00:00:00,Patient Satisfaction,N04.452.822.360.600
16533589,2006-03-14T00:00:00,Patient Satisfaction,N05.300.150.600.630
16533589,2006-03-14T00:00:00,Patient Satisfaction,N05.715.360.600
16533589,2006-03-14T00:00:00,Questionnaires,E05.318.308.750
16533589,2006-03-14T00:00:00,Questionnaires,L01.280.800
16533589,2006-03-14T00:00:00,Questionnaires,N05.715.360.300.695
16533589,2006-03-14T00:00:00,Questionnaires,N06.850.520.308.750
16533589,2006-03-14T00:00:00,Risk Factors,E05.318.740.600.800.725
16533589,2006-03-14T00:00:00,Risk Factors,N05.715.350.200.700
16533589,2006-03-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16533589,2006-03-14T00:00:00,Risk Factors,N06.850.490.625.750
16533589,2006-03-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16534099,2006-03-14T00:00:00,Antiparkinson Agents,D27.505.954.427.090.050
16534099,2006-03-14T00:00:00,Clinical Trials as Topic,E05.318.760.535
16534099,2006-03-14T00:00:00,Clinical Trials as Topic,E05.337.250
16534099,2006-03-14T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16534099,2006-03-14T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16534099,2006-03-14T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
16534099,2006-03-14T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
16534099,2006-03-14T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
16534099,2006-03-14T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
16534099,2006-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16534099,2006-03-14T00:00:00,Parkinson Disease,C10.228.140.079.862.500
16534099,2006-03-14T00:00:00,Parkinson Disease,C10.228.662.600.400
16534099,2006-03-14T00:00:00,Parkinson Disease,C10.574.812
16534099,2006-03-14T00:00:00,Research Design,E05.581.500
16534099,2006-03-14T00:00:00,Research Design,H01.770.644.728
16453370,2006-03-15T00:00:00,Algorithms,G17.035
16453370,2006-03-15T00:00:00,Algorithms,L01.224.050
16453370,2006-03-15T00:00:00,Animals,B01.050
16453370,2006-03-15T00:00:00,Computer Simulation,L01.224.160
16453370,2006-03-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
16453370,2006-03-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16453370,2006-03-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16453370,2006-03-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16453370,2006-03-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16453370,2006-03-15T00:00:00,Disease Outbreaks,N06.850.290
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,E05.318.740.872
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,E05.318.780.800
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,G17.800
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16453370,2006-03-15T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16453372,2006-03-15T00:00:00,California,Z01.107.567.875.580.200
16453372,2006-03-15T00:00:00,California,Z01.107.567.875.760.200
16453372,2006-03-15T00:00:00,Computer Simulation,L01.224.160
16453372,2006-03-15T00:00:00,"Data Interpretation, Statistical",E05.245.380
16453372,2006-03-15T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16453372,2006-03-15T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16453372,2006-03-15T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16453372,2006-03-15T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16453372,2006-03-15T00:00:00,Disease Outbreaks,N06.850.290
16453372,2006-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16453372,2006-03-15T00:00:00,"Infant, Newborn",M01.060.703.520
16453372,2006-03-15T00:00:00,Population Dynamics,I01.240.600
16453372,2006-03-15T00:00:00,Population Dynamics,N01.224.625
16453372,2006-03-15T00:00:00,Population Dynamics,N06.850.505.400.700
16453372,2006-03-15T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
16453377,2006-03-15T00:00:00,Air Pollutants,D27.888.284.101
16453377,2006-03-15T00:00:00,Bayes Theorem,E05.318.740.600.200
16453377,2006-03-15T00:00:00,Bayes Theorem,N05.715.360.750.625.150
16453377,2006-03-15T00:00:00,Bayes Theorem,N06.850.520.830.600.200
16453377,2006-03-15T00:00:00,Case-Control Studies,E05.318.760.500.500
16453377,2006-03-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16453377,2006-03-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16453377,2006-03-15T00:00:00,Disease Outbreaks,N06.850.290
16453377,2006-03-15T00:00:00,England,Z01.542.363.300
16453377,2006-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16453377,2006-03-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
16453377,2006-03-15T00:00:00,Lung Neoplasms,C08.381.540
16453377,2006-03-15T00:00:00,Lung Neoplasms,C08.785.520
16453377,2006-03-15T00:00:00,"Models, Statistical",E05.318.740.500
16453377,2006-03-15T00:00:00,"Models, Statistical",E05.599.835
16453377,2006-03-15T00:00:00,"Models, Statistical",N05.715.360.750.530
16453377,2006-03-15T00:00:00,"Models, Statistical",N06.850.520.830.500
16534468,2006-03-15T00:00:00,Animals,B01.050
16534468,2006-03-15T00:00:00,Bilirubin,D03.383.129.578.840.249.184
16534468,2006-03-15T00:00:00,Bilirubin,D03.549.909.249.184
16534468,2006-03-15T00:00:00,Bilirubin,D04.345.783.249.184
16534468,2006-03-15T00:00:00,Bilirubin,D23.767.193.184
16534468,2006-03-15T00:00:00,Cell Proliferation,G04.299.233.750
16534468,2006-03-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16534468,2006-03-15T00:00:00,Dextrans,D05.750.078.562.272
16534468,2006-03-15T00:00:00,Dextrans,D09.698.365.272
16534468,2006-03-15T00:00:00,Graft Rejection,G12.425.901.545.328
16534468,2006-03-15T00:00:00,Graft Survival,G12.425.901.545.340
16534468,2006-03-15T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
16534468,2006-03-15T00:00:00,Interleukin-2,D12.644.276.374.465.502
16534468,2006-03-15T00:00:00,Interleukin-2,D12.644.276.374.480.372
16534468,2006-03-15T00:00:00,Interleukin-2,D12.776.467.374.465.502
16534468,2006-03-15T00:00:00,Interleukin-2,D12.776.467.374.480.372
16534468,2006-03-15T00:00:00,Interleukin-2,D23.529.374.465.502
16534468,2006-03-15T00:00:00,Interleukin-2,D23.529.374.480.372
16534468,2006-03-15T00:00:00,Liver,A03.620
16534468,2006-03-15T00:00:00,Liver Transplantation,E04.210.650
16534468,2006-03-15T00:00:00,Liver Transplantation,E04.936.450.490
16534468,2006-03-15T00:00:00,Liver Transplantation,E04.936.580.490
16534468,2006-03-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16534468,2006-03-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16539786,2006-03-15T00:00:00,Adolescent,M01.060.057
16539786,2006-03-15T00:00:00,Adult,M01.060.116
16539786,2006-03-15T00:00:00,African Americans,M01.686.508.100.100
16539786,2006-03-15T00:00:00,African Americans,M01.686.754.100
16539786,2006-03-15T00:00:00,Aged,M01.060.116.100
16539786,2006-03-15T00:00:00,Diet,E05.272
16539786,2006-03-15T00:00:00,Diet,G07.610.240
16539786,2006-03-15T00:00:00,Health Behavior,F01.145.488
16539786,2006-03-15T00:00:00,Health Personnel,M01.526.485
16539786,2006-03-15T00:00:00,Health Personnel,N02.360
16539786,2006-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16539786,2006-03-15T00:00:00,Middle Aged,M01.060.116.630
16580527,2006-03-15T00:00:00,Adult,M01.060.116
16580527,2006-03-15T00:00:00,Aged,M01.060.116.100
16580527,2006-03-15T00:00:00,Atrial Fibrillation,C14.280.067.198
16580527,2006-03-15T00:00:00,Atrial Fibrillation,C23.550.073.198
16580527,2006-03-15T00:00:00,Catheter Ablation,E01.370.370.380.410.200
16580527,2006-03-15T00:00:00,Catheter Ablation,E02.148.110
16580527,2006-03-15T00:00:00,Catheter Ablation,E02.148.442.110
16580527,2006-03-15T00:00:00,Catheter Ablation,E02.154.402.110
16580527,2006-03-15T00:00:00,Catheter Ablation,E04.014.170.402.110
16580527,2006-03-15T00:00:00,Catheterization,E02.148
16580527,2006-03-15T00:00:00,Catheterization,E05.157
16580527,2006-03-15T00:00:00,Fluoroscopy,E01.370.350.700.225
16580527,2006-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16580527,2006-03-15T00:00:00,Magnetics,H01.671.493
16580527,2006-03-15T00:00:00,Middle Aged,M01.060.116.630
16580527,2006-03-15T00:00:00,Pliability,G01.374.705
16580527,2006-03-15T00:00:00,Robotics,H01.671.293.643
16580527,2006-03-15T00:00:00,Robotics,J01.897.104.834
16580527,2006-03-15T00:00:00,Robotics,L01.224.065.630
16580527,2006-03-15T00:00:00,Treatment Outcome,E01.789.800
16580527,2006-03-15T00:00:00,Treatment Outcome,N04.761.559.590.800
16580527,2006-03-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16543242,2006-03-16T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16543242,2006-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16543242,2006-03-16T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
16543242,2006-03-16T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
16543242,2006-03-16T00:00:00,Oxygen,D01.268.185.550
16543242,2006-03-16T00:00:00,Oxygen,D01.362.670
16543242,2006-03-16T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16543242,2006-03-16T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16543242,2006-03-16T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16543242,2006-03-16T00:00:00,"Transcription, Genetic",G02.111.087.847
16543242,2006-03-16T00:00:00,"Transcription, Genetic",G02.149.115.847
16543242,2006-03-16T00:00:00,"Transcription, Genetic",G05.355.310.700
16543242,2006-03-16T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
16543242,2006-03-16T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
16543242,2006-03-16T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
16544073,2006-03-16T00:00:00,Adult,M01.060.116
16544073,2006-03-16T00:00:00,Aged,M01.060.116.100
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
16544073,2006-03-16T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
16544073,2006-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16544073,2006-03-16T00:00:00,Middle Aged,M01.060.116.630
16544073,2006-03-16T00:00:00,Postoperative Care,E02.760.722.700
16544073,2006-03-16T00:00:00,Postoperative Care,E04.624
16544073,2006-03-16T00:00:00,Postoperative Care,N02.421.585.722.700
16552103,2006-03-16T00:00:00,Algorithms,G17.035
16552103,2006-03-16T00:00:00,Algorithms,L01.224.050
16552103,2006-03-16T00:00:00,Breast Neoplasms,C04.588.180
16552103,2006-03-16T00:00:00,Breast Neoplasms,C17.800.090.500
16552103,2006-03-16T00:00:00,Computer Simulation,L01.224.160
16552103,2006-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16552103,2006-03-16T00:00:00,"Phantoms, Imaging",E07.671
16552103,2006-03-16T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16552103,2006-03-16T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16552103,2006-03-16T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16642432,2006-03-16T00:00:00,Adult,M01.060.116
16642432,2006-03-16T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
16642432,2006-03-16T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
16642432,2006-03-16T00:00:00,Cocaine-Related Disorders,C21.739.300
16642432,2006-03-16T00:00:00,Cocaine-Related Disorders,F03.900.300
16642432,2006-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16642432,2006-03-16T00:00:00,Opioid-Related Disorders,C21.739.675
16642432,2006-03-16T00:00:00,Opioid-Related Disorders,F03.900.675
16642432,2006-03-16T00:00:00,Phenotype,G05.695
16642432,2006-03-16T00:00:00,Quantitative Trait Loci,G05.360.340.024.380.937
16546284,2006-03-20T00:00:00,Cell Division,G04.299.134.220
16546284,2006-03-20T00:00:00,Cell Division,G04.299.233.750.500
16546284,2006-03-20T00:00:00,Cell Division,G05.355.105
16546284,2006-03-20T00:00:00,Cell Division,G07.700.320.249.410.750.500
16546284,2006-03-20T00:00:00,Escherichia coli,B03.440.450.425.325.300
16546284,2006-03-20T00:00:00,Escherichia coli,B03.660.250.150.180.100
16546284,2006-03-20T00:00:00,Fibroblast Growth Factors,D12.644.276.624
16546284,2006-03-20T00:00:00,Fibroblast Growth Factors,D12.776.467.624
16546284,2006-03-20T00:00:00,Fibroblast Growth Factors,D23.529.624
16546284,2006-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16546284,2006-03-20T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16556669,2006-03-23T00:00:00,Adolescent,M01.060.057
16556669,2006-03-23T00:00:00,Adult,M01.060.116
16556669,2006-03-23T00:00:00,Aged,M01.060.116.100
16556669,2006-03-23T00:00:00,Ambulatory Care,E02.760.106
16556669,2006-03-23T00:00:00,Ambulatory Care,N02.421.585.106
16556669,2006-03-23T00:00:00,Chronic Disease,C23.550.291.500
16556669,2006-03-23T00:00:00,Drug Resistance,G07.690.320
16556669,2006-03-23T00:00:00,Gastric Acid,A12.200.307.603
16556669,2006-03-23T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16556669,2006-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16556669,2006-03-23T00:00:00,Middle Aged,M01.060.116.630
16556669,2006-03-23T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
16556765,2006-03-23T00:00:00,Animals,B01.050
16556765,2006-03-23T00:00:00,Cell Line,A11.251.210
16556765,2006-03-23T00:00:00,Diabetic Nephropathies,C12.777.419.192
16556765,2006-03-23T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
16556765,2006-03-23T00:00:00,Diabetic Nephropathies,C19.246.099.875
16556765,2006-03-23T00:00:00,Gene Expression Regulation,G05.355.315
16556765,2006-03-23T00:00:00,Glomerulonephritis,C12.777.419.570.363
16556765,2006-03-23T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
16556765,2006-03-23T00:00:00,Glucose,D09.546.359.448
16556765,2006-03-23T00:00:00,Insulin Receptor Substrate Proteins,D12.644.360.024.301
16556765,2006-03-23T00:00:00,Insulin Receptor Substrate Proteins,D12.776.157.057.039
16556765,2006-03-23T00:00:00,Insulin Receptor Substrate Proteins,D12.776.476.024.382
16556765,2006-03-23T00:00:00,Insulin-Like Growth Factor Binding Protein 2,D12.776.157.420.260
16556765,2006-03-23T00:00:00,Mesangial Cells,A05.810.453.324.359.620
16556765,2006-03-23T00:00:00,Mesangial Cells,A05.810.453.736.520.620
16556765,2006-03-23T00:00:00,Mesangial Cells,A11.329.228.950
16556765,2006-03-23T00:00:00,Phosphoproteins,D12.776.744
16565827,2006-03-25T00:00:00,Adult,M01.060.116
16565827,2006-03-25T00:00:00,Affect,F01.470.047
16565827,2006-03-25T00:00:00,Alcohol Drinking,F01.145.317.269
16565827,2006-03-25T00:00:00,Drug Interactions,G07.690.812.240
16565827,2006-03-25T00:00:00,Drug Interactions,G07.700.680.240
16565827,2006-03-25T00:00:00,Ethanol,D02.033.375
16565827,2006-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16565827,2006-03-25T00:00:00,Nicotine,D03.132.760.570
16565827,2006-03-25T00:00:00,Nicotine,D03.383.725.518
16565827,2006-03-25T00:00:00,Sex Factors,N05.715.350.675
16565827,2006-03-25T00:00:00,Sex Factors,N06.850.490.875
16567584,2006-03-27T00:00:00,Adolescent,M01.060.057
16567584,2006-03-27T00:00:00,African Americans,M01.686.508.100.100
16567584,2006-03-27T00:00:00,African Americans,M01.686.754.100
16567584,2006-03-27T00:00:00,Aging,G07.700.320.124
16567584,2006-03-27T00:00:00,Blood Pressure,E01.370.600.875.249
16567584,2006-03-27T00:00:00,Blood Pressure,G09.330.380.076
16567584,2006-03-27T00:00:00,Diastole,G09.330.190.541.295
16567584,2006-03-27T00:00:00,Diastole,G11.427.590.540.554.250
16567584,2006-03-27T00:00:00,Diastole,G11.427.590.540.570.295
16567584,2006-03-27T00:00:00,Environment,G16.500.275
16567584,2006-03-27T00:00:00,Environment,N06.230
16567584,2006-03-27T00:00:00,European Continental Ancestry Group,M01.686.508.400
16567584,2006-03-27T00:00:00,Hemodynamics,G09.330.190.400
16567584,2006-03-27T00:00:00,Hemodynamics,G09.330.380
16567584,2006-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16567584,2006-03-27T00:00:00,"Models, Genetic",E05.599.395.397
16942971,2006-03-27T00:00:00,Adolescent,M01.060.057
16942971,2006-03-27T00:00:00,Adult,M01.060.116
16942971,2006-03-27T00:00:00,Aged,M01.060.116.100
16942971,2006-03-27T00:00:00,Disasters,N06.230.100
16942971,2006-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16942971,2006-03-27T00:00:00,Internet,L01.224.230.110.500
16942971,2006-03-27T00:00:00,Mental Disorders,F03
16942971,2006-03-27T00:00:00,Middle Aged,M01.060.116.630
16942971,2006-03-27T00:00:00,Pilot Projects,E05.318.760.750
16942971,2006-03-27T00:00:00,Pilot Projects,E05.337.737
16942971,2006-03-27T00:00:00,Pilot Projects,N05.715.360.775.625
16942971,2006-03-27T00:00:00,Pilot Projects,N06.850.520.450.720
16942971,2006-03-27T00:00:00,Psychotherapy,F04.754
16942971,2006-03-27T00:00:00,Self-Help Groups,N03.540.782
16942971,2006-03-27T00:00:00,Substance-Related Disorders,C21.739
16942971,2006-03-27T00:00:00,Substance-Related Disorders,F03.900
17592447,2006-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17592447,2006-03-27T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17592447,2006-03-27T00:00:00,Radiography,E01.370.350.700
17592447,2006-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17592447,2006-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17592447,2006-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17592447,2006-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17592447,2006-03-27T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16548540,2006-03-28T00:00:00,Fluorescent Dyes,D27.720.233.348
16548540,2006-03-28T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16548540,2006-03-28T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16548540,2006-03-28T00:00:00,Gold,D01.268.556.322
16548540,2006-03-28T00:00:00,Gold,D01.268.956.186
16548540,2006-03-28T00:00:00,Gold,D01.552.544.322
16548540,2006-03-28T00:00:00,Metal Nanoparticles,J01.637.512.600.500
16548540,2006-03-28T00:00:00,Photochemistry,H01.181.529.711
16548540,2006-03-28T00:00:00,Silicon Dioxide,D01.578.750
16548540,2006-03-28T00:00:00,Silicon Dioxide,D01.650.550.825
16548540,2006-03-28T00:00:00,Silicon Dioxide,D01.837.725
16571762,2006-03-29T00:00:00,Aging,G07.700.320.124
16571762,2006-03-29T00:00:00,Animals,B01.050
16571762,2006-03-29T00:00:00,Cochlear Nerve,A08.800.800.120.910.120
16571762,2006-03-29T00:00:00,"Hearing Loss, Noise-Induced",C09.218.458.341.887.460
16571762,2006-03-29T00:00:00,"Hearing Loss, Noise-Induced",C10.597.751.418.341.887.460
16571762,2006-03-29T00:00:00,"Hearing Loss, Noise-Induced",C23.888.592.763.393.341.887.460
16571762,2006-03-29T00:00:00,NF-kappa B,D12.776.260.600
16571762,2006-03-29T00:00:00,NF-kappa B,D12.776.660.600
16571762,2006-03-29T00:00:00,NF-kappa B,D12.776.930.600
16571762,2006-03-29T00:00:00,Spiral Ganglion,A08.340.390.800
16571762,2006-03-29T00:00:00,Spiral Ganglion,A08.800.350.800
16571762,2006-03-29T00:00:00,Spiral Ganglion,A08.800.800.120.910.120.800
16571762,2006-03-29T00:00:00,Spiral Ganglion,A09.246.631.246.900
16605575,2006-03-29T00:00:00,Algorithms,G17.035
16605575,2006-03-29T00:00:00,Algorithms,L01.224.050
16605575,2006-03-29T00:00:00,Animals,B01.050
16605575,2006-03-29T00:00:00,Computer Simulation,L01.224.160
16605575,2006-03-29T00:00:00,Gene Expression Profiling,E05.393.332
16605575,2006-03-29T00:00:00,Gene Expression Regulation,G05.355.315
16605575,2006-03-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16605575,2006-03-29T00:00:00,"Models, Genetic",E05.599.395.397
16605575,2006-03-29T00:00:00,"Models, Statistical",E05.318.740.500
16605575,2006-03-29T00:00:00,"Models, Statistical",E05.599.835
16605575,2006-03-29T00:00:00,"Models, Statistical",N05.715.360.750.530
16605575,2006-03-29T00:00:00,"Models, Statistical",N06.850.520.830.500
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16605575,2006-03-29T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16605575,2006-03-29T00:00:00,Proteome,D12.776.817
16605575,2006-03-29T00:00:00,Signal Transduction,G02.111.087.800
16605575,2006-03-29T00:00:00,Signal Transduction,G02.149.115.800
16605575,2006-03-29T00:00:00,Signal Transduction,G04.299.880
16618494,2006-03-29T00:00:00,Amino Acid Sequence,G02.111.570.060
16618494,2006-03-29T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16618494,2006-03-29T00:00:00,Bacterial Proteins,D12.776.097
16618494,2006-03-29T00:00:00,Binding Sites,G02.111.570.120
16618494,2006-03-29T00:00:00,Carbohydrates,D09
16618494,2006-03-29T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
16618494,2006-03-29T00:00:00,Escherichia coli,B03.440.450.425.325.300
16618494,2006-03-29T00:00:00,Escherichia coli,B03.660.250.150.180.100
16618494,2006-03-29T00:00:00,"Models, Molecular",E05.599.595
16618494,2006-03-29T00:00:00,Molecular Sequence Data,L01.453.245.667
16618494,2006-03-29T00:00:00,Molecular Structure,G02.111.570
16618494,2006-03-29T00:00:00,Molecular Structure,G02.575
16618494,2006-03-29T00:00:00,Molecular Structure,G02.842.575
16618494,2006-03-29T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
16618494,2006-03-29T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
16618494,2006-03-29T00:00:00,Protein Folding,G01.154.100.640
16618494,2006-03-29T00:00:00,Protein Folding,G01.595.100.640
16618494,2006-03-29T00:00:00,Protein Folding,G02.111.087.690
16618494,2006-03-29T00:00:00,Protein Folding,G02.149.115.690
16618494,2006-03-29T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
16160706,2006-04-01T00:00:00,Animals,B01.050
16160706,2006-04-01T00:00:00,"Behavior, Animal",F01.145.113
16160706,2006-04-01T00:00:00,Carrier Proteins,D12.776.157
16160706,2006-04-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16160706,2006-04-01T00:00:00,Cocaine,D02.145.074.722.388
16160706,2006-04-01T00:00:00,Cocaine,D03.132.889.354
16160706,2006-04-01T00:00:00,Cocaine,D03.605.869.388
16160706,2006-04-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
16160706,2006-04-01T00:00:00,Cocaine-Related Disorders,C21.739.300
16160706,2006-04-01T00:00:00,Cocaine-Related Disorders,F03.900.300
16160706,2006-04-01T00:00:00,Dopamine,D02.092.211.215.311.342
16160706,2006-04-01T00:00:00,Dopamine,D02.092.311.342
16160706,2006-04-01T00:00:00,Gene Expression Regulation,G05.355.315
16160706,2006-04-01T00:00:00,Glutamic Acid,D12.125.067.750
16160706,2006-04-01T00:00:00,Glutamic Acid,D12.125.119.450
16160706,2006-04-01T00:00:00,Glutamic Acid,D12.125.427.300
16160706,2006-04-01T00:00:00,Motor Activity,F01.145.632
16160706,2006-04-01T00:00:00,Motor Activity,G11.427.590.530.698
16160706,2006-04-01T00:00:00,Neuronal Plasticity,G11.561.600.635
16160706,2006-04-01T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
16160706,2006-04-01T00:00:00,Protein Isoforms,D12.776.800
16160706,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16160706,2006-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16160706,2006-04-01T00:00:00,Recombinant Proteins,D12.776.828
16231314,2006-04-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16231314,2006-04-01T00:00:00,Aged,M01.060.116.100
16231314,2006-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16231314,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16231314,2006-04-01T00:00:00,Mass Screening,E01.370.500
16231314,2006-04-01T00:00:00,Mass Screening,E05.318.308.250.580
16231314,2006-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
16231314,2006-04-01T00:00:00,Mass Screening,N02.421.726.233.443
16231314,2006-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
16231314,2006-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
16231314,2006-04-01T00:00:00,Mass Screening,N06.850.780.500
16231314,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16231314,2006-04-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
16231314,2006-04-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
16231314,2006-04-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
16231314,2006-04-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
16231314,2006-04-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
16231314,2006-04-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16231314,2006-04-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16231314,2006-04-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16231314,2006-04-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16261623,2006-04-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16261623,2006-04-01T00:00:00,Alleles,G05.360.340.024.340.030
16261623,2006-04-01T00:00:00,Ethnic Groups,M01.686.754
16261623,2006-04-01T00:00:00,Ethnic Groups,N01.224.317
16261623,2006-04-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16261623,2006-04-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
16261623,2006-04-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
16261623,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16261623,2006-04-01T00:00:00,Schizophrenia,F03.700.750
16416417,2006-04-01T00:00:00,Animals,B01.050
16416417,2006-04-01T00:00:00,"Embryo, Nonmammalian",A13.350
16416417,2006-04-01T00:00:00,"Embryo, Nonmammalian",A16.331
16416417,2006-04-01T00:00:00,Uterus,A05.360.319.679
16493702,2006-04-01T00:00:00,Animals,B01.050
16493702,2006-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
16493702,2006-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
16493702,2006-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
16493702,2006-04-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
16493702,2006-04-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
16493702,2006-04-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
16493702,2006-04-01T00:00:00,Proteins,D12.776
16493702,2006-04-01T00:00:00,Proteomics,H01.158.201.843
16493702,2006-04-01T00:00:00,Proteomics,H01.158.273.180.350.700
16493702,2006-04-01T00:00:00,Proteomics,H01.158.273.343.350.700
16493702,2006-04-01T00:00:00,Proteomics,H01.181.122.738
16521095,2006-04-01T00:00:00,Adult,M01.060.116
16521095,2006-04-01T00:00:00,Algorithms,G17.035
16521095,2006-04-01T00:00:00,Algorithms,L01.224.050
16521095,2006-04-01T00:00:00,Brain,A08.186.211
16521095,2006-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
16521095,2006-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
16521095,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16521095,2006-04-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
16521095,2006-04-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
16521095,2006-04-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
16521095,2006-04-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
16521095,2006-04-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
16521095,2006-04-01T00:00:00,Normal Distribution,E05.318.740.994.500
16521095,2006-04-01T00:00:00,Normal Distribution,G17.820.500
16521095,2006-04-01T00:00:00,Normal Distribution,N05.715.360.750.750.565
16521095,2006-04-01T00:00:00,Normal Distribution,N06.850.520.830.994.500
16521095,2006-04-01T00:00:00,"Phantoms, Imaging",E07.671
16521095,2006-04-01T00:00:00,Water,D01.455.900
16521095,2006-04-01T00:00:00,Water,D01.650.550.925
16527986,2006-04-01T00:00:00,Animals,B01.050
16527986,2006-04-01T00:00:00,Cell Lineage,G04.172
16527986,2006-04-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
16527986,2006-04-01T00:00:00,Cell Lineage,G08.686.155
16527986,2006-04-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
16527986,2006-04-01T00:00:00,"Embryo, Nonmammalian",A13.350
16527986,2006-04-01T00:00:00,"Embryo, Nonmammalian",A16.331
16527986,2006-04-01T00:00:00,Fetal Heart,A07.541.278
16527986,2006-04-01T00:00:00,Fetal Heart,A16.378.303
16527986,2006-04-01T00:00:00,Functional Laterality,F02.830.297.425
16527986,2006-04-01T00:00:00,Functional Laterality,G11.561.225.425
16527986,2006-04-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16527986,2006-04-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16527986,2006-04-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16527986,2006-04-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16527986,2006-04-01T00:00:00,Homeodomain Proteins,D12.776.260.400
16527986,2006-04-01T00:00:00,Mesoderm,A16.504.660
16527986,2006-04-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
16527986,2006-04-01T00:00:00,"Microscopy, Confocal",E05.595.395
16527986,2006-04-01T00:00:00,Situs Inversus,C16.131.810
16527986,2006-04-01T00:00:00,Xenopus,B01.050.150.900.090.180.610.500
16530615,2006-04-01T00:00:00,Attitude,F01.100
16530615,2006-04-01T00:00:00,Environmental Exposure,N06.850.460.350
16530615,2006-04-01T00:00:00,Forecasting,I01.320
16530615,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16530615,2006-04-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
16530615,2006-04-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
16530622,2006-04-01T00:00:00,African Americans,M01.686.508.100.100
16530622,2006-04-01T00:00:00,African Americans,M01.686.754.100
16530622,2006-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16530622,2006-04-01T00:00:00,Body Mass Index,E05.041.124.125
16530622,2006-04-01T00:00:00,Body Mass Index,G07.100.100.125
16530622,2006-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16530622,2006-04-01T00:00:00,Diet,E05.272
16530622,2006-04-01T00:00:00,Diet,G07.610.240
16530622,2006-04-01T00:00:00,Fruit,A18.024.500
16530622,2006-04-01T00:00:00,Fruit,J02.500.562
16530622,2006-04-01T00:00:00,Health Status,I01.240.425
16530622,2006-04-01T00:00:00,Health Status,N01.224.425
16530622,2006-04-01T00:00:00,Health Status,N06.850.505.400.425
16530622,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16530622,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16530622,2006-04-01T00:00:00,Motor Activity,F01.145.632
16530622,2006-04-01T00:00:00,Motor Activity,G11.427.590.530.698
16530622,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16530622,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16531374,2006-04-01T00:00:00,Biomedical Research,H01.770.644.145
16531374,2006-04-01T00:00:00,California,Z01.107.567.875.580.200
16531374,2006-04-01T00:00:00,California,Z01.107.567.875.760.200
16531374,2006-04-01T00:00:00,Emergency Medical Services,N02.421.297
16531374,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16531374,2006-04-01T00:00:00,Informed Consent,I01.880.604.473.650.718
16531374,2006-04-01T00:00:00,Informed Consent,I01.880.604.583.427
16531374,2006-04-01T00:00:00,Informed Consent,N03.706.437.650.312
16531374,2006-04-01T00:00:00,Informed Consent,N03.706.535.489
16531374,2006-04-01T00:00:00,Physicians,M01.526.485.810
16531374,2006-04-01T00:00:00,Physicians,N02.360.810
16531374,2006-04-01T00:00:00,Pilot Projects,E05.318.760.750
16531374,2006-04-01T00:00:00,Pilot Projects,E05.337.737
16531374,2006-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
16531374,2006-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
16533338,2006-04-01T00:00:00,Adolescent,M01.060.057
16533338,2006-04-01T00:00:00,Adult,M01.060.116
16533338,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16533338,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16533338,2006-04-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
16533338,2006-04-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16545725,2006-04-01T00:00:00,Adult,M01.060.116
16545725,2006-04-01T00:00:00,Aged,M01.060.116.100
16545725,2006-04-01T00:00:00,Chronic Disease,C23.550.291.500
16545725,2006-04-01T00:00:00,Disease-Free Survival,E01.789.200
16545725,2006-04-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16545725,2006-04-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16545725,2006-04-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16545725,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16545725,2006-04-01T00:00:00,Living Donors,M01.898.656
16545725,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16545725,2006-04-01T00:00:00,Remission Induction,E02.860
16547277,2006-04-01T00:00:00,Animals,B01.050
16547277,2006-04-01T00:00:00,Cell Differentiation,G04.299.151
16547277,2006-04-01T00:00:00,Demyelinating Diseases,C10.314
16547277,2006-04-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
16547277,2006-04-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
16547277,2006-04-01T00:00:00,Interleukin-4,D23.529.374.465.504
16547277,2006-04-01T00:00:00,Lipopolysaccharides,D09.400.500
16547277,2006-04-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16547277,2006-04-01T00:00:00,Lipopolysaccharides,D10.494
16547277,2006-04-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16547277,2006-04-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16547277,2006-04-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16547277,2006-04-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16547277,2006-04-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16547277,2006-04-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16547277,2006-04-01T00:00:00,NF-kappa B,D12.776.260.600
16547277,2006-04-01T00:00:00,NF-kappa B,D12.776.660.600
16547277,2006-04-01T00:00:00,NF-kappa B,D12.776.930.600
16547277,2006-04-01T00:00:00,Neuroglia,A08.637
16547277,2006-04-01T00:00:00,Neuroglia,A11.650
16547277,2006-04-01T00:00:00,Nitric Oxide,D01.339.387
16547277,2006-04-01T00:00:00,Nitric Oxide,D01.625.550.500
16547277,2006-04-01T00:00:00,Nitric Oxide,D01.625.700.500
16547277,2006-04-01T00:00:00,Nitric Oxide,D01.650.550.587.600
16547277,2006-04-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16547277,2006-04-01T00:00:00,Oligodendroglia,A08.637.600
16547277,2006-04-01T00:00:00,Oligodendroglia,A11.650.600
16547277,2006-04-01T00:00:00,Protein Transport,G03.495.166.700
16547277,2006-04-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16547277,2006-04-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16547277,2006-04-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16547277,2006-04-01T00:00:00,Stem Cells,A11.872
16547277,2006-04-01T00:00:00,Transcriptional Activation,G05.355.315.800
16547277,2006-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
16547277,2006-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
16547277,2006-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
16547277,2006-04-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
16553503,2006-04-01T00:00:00,Adult,M01.060.116
16553503,2006-04-01T00:00:00,Aged,M01.060.116.100
16553503,2006-04-01T00:00:00,Anticoagulants,D27.505.954.502.119
16553503,2006-04-01T00:00:00,Heparin,D09.698.373.400
16553503,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16553503,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16553503,2006-04-01T00:00:00,Peptide Fragments,D12.644.541
16553503,2006-04-01T00:00:00,Recombinant Proteins,D12.776.828
16553503,2006-04-01T00:00:00,Thrombin,D08.811.277.656.300.760.855
16553503,2006-04-01T00:00:00,Thrombin,D08.811.277.656.959.350.855
16553503,2006-04-01T00:00:00,Thrombin,D12.776.124.125.890
16553503,2006-04-01T00:00:00,Thrombin,D23.119.960
16553503,2006-04-01T00:00:00,Thrombocytopenia,C15.378.140.855
16553503,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16553503,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16553503,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16553520,2006-04-01T00:00:00,Anticoagulants,D27.505.954.502.119
16553520,2006-04-01T00:00:00,Fatty Acids,D10.251
16553520,2006-04-01T00:00:00,Hematuria,C12.777.934.442
16553520,2006-04-01T00:00:00,Hematuria,C13.351.968.934.442
16553520,2006-04-01T00:00:00,Hematuria,C23.550.414.849
16553520,2006-04-01T00:00:00,Herb-Drug Interactions,G07.690.812.240.755
16553520,2006-04-01T00:00:00,Herb-Drug Interactions,G07.700.680.240.755
16553520,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16553520,2006-04-01T00:00:00,Insect Hormones,D06.472.445.573
16553520,2006-04-01T00:00:00,Warfarin,D03.438.150.446.520.914
16553520,2006-04-01T00:00:00,Warfarin,D03.830.219.446.520.914
16554593,2006-04-01T00:00:00,Adult,M01.060.116
16554593,2006-04-01T00:00:00,Aged,M01.060.116.100
16554593,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16554593,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16554593,2006-04-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
16554593,2006-04-01T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
16554593,2006-04-01T00:00:00,Stents,E07.695.750
16555330,2006-04-01T00:00:00,Adenoviridae,B04.280.030
16555330,2006-04-01T00:00:00,Adenoviridae,B04.909.204.097
16555330,2006-04-01T00:00:00,Animals,B01.050
16555330,2006-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
16555330,2006-04-01T00:00:00,Blood Pressure,G09.330.380.076
16555330,2006-04-01T00:00:00,Genetic Vectors,G05.360.337
16555330,2006-04-01T00:00:00,Liver Regeneration,G10.261.326.520
16555330,2006-04-01T00:00:00,Liver Regeneration,G16.100.856.468
16555330,2006-04-01T00:00:00,Liver Transplantation,E04.210.650
16555330,2006-04-01T00:00:00,Liver Transplantation,E04.936.450.490
16555330,2006-04-01T00:00:00,Liver Transplantation,E04.936.580.490
16555330,2006-04-01T00:00:00,"Models, Animal",E05.598
16555330,2006-04-01T00:00:00,Oxidative Stress,G03.495.710
16555330,2006-04-01T00:00:00,Oxidative Stress,G07.700.830.750
16555330,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16555330,2006-04-01T00:00:00,Superoxide Dismutase,D08.811.682.881
16555330,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16555330,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16555330,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16555330,2006-04-01T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
16564378,2006-04-01T00:00:00,Adult,M01.060.116
16564378,2006-04-01T00:00:00,Bone Resorption,C05.116.264
16564378,2006-04-01T00:00:00,Bone Resorption,G11.427.590.195.150
16564378,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16564378,2006-04-01T00:00:00,Incidence,E05.318.308.985.525.375
16564378,2006-04-01T00:00:00,Incidence,L01.280.975.525.375
16564378,2006-04-01T00:00:00,Incidence,N01.224.935.597.500
16564378,2006-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16564378,2006-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16564378,2006-04-01T00:00:00,Orbit,A02.835.232.781.324.690
16564378,2006-04-01T00:00:00,Sinusitis,C08.460.692.752
16564378,2006-04-01T00:00:00,Sinusitis,C08.730.749
16564378,2006-04-01T00:00:00,Sinusitis,C09.603.692.752
16564378,2006-04-01T00:00:00,Skull Base,A01.456.830
16564378,2006-04-01T00:00:00,Skull Base,A02.835.232.781.750
16564378,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16564378,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16564378,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16564378,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16564378,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16564378,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16564378,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16564857,2006-04-01T00:00:00,Adult,M01.060.116
16564857,2006-04-01T00:00:00,Aged,M01.060.116.100
16564857,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16564857,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16564857,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16564857,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16564857,2006-04-01T00:00:00,Enteral Nutrition,E02.421.360
16564857,2006-04-01T00:00:00,Enteral Nutrition,E02.642.500.360
16564857,2006-04-01T00:00:00,Gastrointestinal Diseases,C06.405
16564857,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16564857,2006-04-01T00:00:00,"Intubation, Gastrointestinal",E05.497.412
16564857,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16564857,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16564857,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16564857,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16565393,2006-04-01T00:00:00,Animals,B01.050
16565393,2006-04-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
16565393,2006-04-01T00:00:00,Cell Membrane,A11.284.149
16565393,2006-04-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16565393,2006-04-01T00:00:00,Eye Proteins,D12.776.306
16565393,2006-04-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
16565393,2006-04-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
16565393,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16565393,2006-04-01T00:00:00,"Lens, Crystalline",A09.371.060.500
16565393,2006-04-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
16565393,2006-04-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
16565393,2006-04-01T00:00:00,Peptide Fragments,D12.644.541
16565393,2006-04-01T00:00:00,Proteomics,H01.158.201.843
16565393,2006-04-01T00:00:00,Proteomics,H01.158.273.180.350.700
16565393,2006-04-01T00:00:00,Proteomics,H01.158.273.343.350.700
16565393,2006-04-01T00:00:00,Proteomics,H01.181.122.738
16565393,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16572087,2006-04-01T00:00:00,Angioplasty,E02.148.050
16572087,2006-04-01T00:00:00,Angioplasty,E04.100.814.050
16572087,2006-04-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
16572087,2006-04-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
16572087,2006-04-01T00:00:00,Filtration,E05.196.454
16572087,2006-04-01T00:00:00,Filtration,G01.595.280
16572087,2006-04-01T00:00:00,Filtration,G02.149.767.600
16572087,2006-04-01T00:00:00,Filtration,G02.842.750.600
16572087,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16572087,2006-04-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
16572087,2006-04-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
16572087,2006-04-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
16572087,2006-04-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
16572087,2006-04-01T00:00:00,Stents,E07.695.750
16572087,2006-04-01T00:00:00,Stroke,C10.228.140.300.775
16572087,2006-04-01T00:00:00,Stroke,C14.907.253.855
16572087,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16572087,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16572087,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16573586,2006-04-01T00:00:00,Alternative Splicing,G02.111.087.750.700.100
16573586,2006-04-01T00:00:00,Alternative Splicing,G02.149.115.750.700.100
16573586,2006-04-01T00:00:00,Alternative Splicing,G03.495.839.700.100
16573586,2006-04-01T00:00:00,Alternative Splicing,G05.355.315.700.700.100
16573586,2006-04-01T00:00:00,Animals,B01.050
16573586,2006-04-01T00:00:00,Cell Line,A11.251.210
16573586,2006-04-01T00:00:00,Ethanol,D02.033.375
16573586,2006-04-01T00:00:00,Gene Expression,G05.355.310
16573586,2006-04-01T00:00:00,Glutamic Acid,D12.125.067.750
16573586,2006-04-01T00:00:00,Glutamic Acid,D12.125.119.450
16573586,2006-04-01T00:00:00,Glutamic Acid,D12.125.427.300
16573586,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16573586,2006-04-01T00:00:00,Kidney,A05.810.453
16573586,2006-04-01T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16573586,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16573586,2006-04-01T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16573586,2006-04-01T00:00:00,Recombinant Proteins,D12.776.828
16573730,2006-04-01T00:00:00,Attitude to Health,F01.100.150
16573730,2006-04-01T00:00:00,Attitude to Health,N05.300.150
16573730,2006-04-01T00:00:00,Child,M01.060.406
16573730,2006-04-01T00:00:00,Health Education,I02.233.332
16573730,2006-04-01T00:00:00,Health Education,N02.421.143.827.407
16573730,2006-04-01T00:00:00,Health Education,N02.421.726.407
16573730,2006-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
16573730,2006-04-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
16573730,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16573730,2006-04-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
16573730,2006-04-01T00:00:00,Nurse Practitioners,N02.360.650.640
16573730,2006-04-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
16573730,2006-04-01T00:00:00,Nurse's Role,N05.300.100.337
16573730,2006-04-01T00:00:00,Parents,F01.829.263.500.320
16573730,2006-04-01T00:00:00,Parents,I01.880.225.500.340
16573730,2006-04-01T00:00:00,Parents,M01.620
16573730,2006-04-01T00:00:00,Prevalence,E05.318.308.985.525.750
16573730,2006-04-01T00:00:00,Prevalence,L01.280.975.525.750
16573730,2006-04-01T00:00:00,Prevalence,N01.224.935.597.750
16573730,2006-04-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16573730,2006-04-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16573730,2006-04-01T00:00:00,Program Evaluation,E05.337.820
16573730,2006-04-01T00:00:00,Program Evaluation,N04.761.685
16573730,2006-04-01T00:00:00,Program Evaluation,N05.715.360.650
16573730,2006-04-01T00:00:00,Questionnaires,E05.318.308.750
16573730,2006-04-01T00:00:00,Questionnaires,L01.280.800
16573730,2006-04-01T00:00:00,Questionnaires,N05.715.360.300.695
16573730,2006-04-01T00:00:00,Questionnaires,N06.850.520.308.750
16573730,2006-04-01T00:00:00,Smoking,F01.145.466.753
16573730,2006-04-01T00:00:00,Smoking Cessation,F01.145.940.700
16575334,2006-04-01T00:00:00,Adult,M01.060.116
16575334,2006-04-01T00:00:00,Aged,M01.060.116.100
16575334,2006-04-01T00:00:00,Brachytherapy,E02.815.150
16575334,2006-04-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
16575334,2006-04-01T00:00:00,Brain Neoplasms,C10.228.140.211
16575334,2006-04-01T00:00:00,Brain Neoplasms,C10.551.240.250
16575334,2006-04-01T00:00:00,Glioma,C04.557.465.625.600.380
16575334,2006-04-01T00:00:00,Glioma,C04.557.470.670.380
16575334,2006-04-01T00:00:00,Glioma,C04.557.580.625.600.380
16575334,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16575334,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16575334,2006-04-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
16575334,2006-04-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
16580428,2006-04-01T00:00:00,Anoxia,C23.888.852.079
16580428,2006-04-01T00:00:00,Critical Illness,C23.550.291.625
16580428,2006-04-01T00:00:00,Extracorporeal Membrane Oxygenation,E02.880.301
16580428,2006-04-01T00:00:00,Extracorporeal Membrane Oxygenation,E04.292.451
16580428,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16580428,2006-04-01T00:00:00,"Infant, Newborn",M01.060.703.520
16580428,2006-04-01T00:00:00,Pulmonary Veins,A07.231.908.713
16580428,2006-04-01T00:00:00,Stents,E07.695.750
16580455,2006-04-01T00:00:00,Adult,M01.060.116
16580455,2006-04-01T00:00:00,Aortic Valve,A07.541.510.110
16580455,2006-04-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
16580455,2006-04-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
16580455,2006-04-01T00:00:00,Heart Valve Prosthesis,E07.695.310
16580455,2006-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
16580455,2006-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
16580455,2006-04-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
16580455,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16580455,2006-04-01T00:00:00,Reoperation,E04.690
16581690,2006-04-01T00:00:00,Adult,M01.060.116
16581690,2006-04-01T00:00:00,Electromyography,E01.370.405.255
16581690,2006-04-01T00:00:00,Electromyography,E01.370.530.255
16581690,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16581690,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16581690,2006-04-01T00:00:00,"Muscle, Skeletal",A02.633.567
16581690,2006-04-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
16582801,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16582801,2006-04-01T00:00:00,Suture Techniques,E04.901
16585867,2006-04-01T00:00:00,Adult,M01.060.116
16585867,2006-04-01T00:00:00,Aged,M01.060.116.100
16585867,2006-04-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16585867,2006-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
16585867,2006-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
16585867,2006-04-01T00:00:00,Cisplatin,D01.210.375
16585867,2006-04-01T00:00:00,Cisplatin,D01.625.125
16585867,2006-04-01T00:00:00,Cisplatin,D01.710.100
16585867,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16585867,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C04.588.443.665.710.485
16585867,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C07.550.745.436
16585867,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.647.710.485
16585867,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.775.549.485
16585867,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16585867,2006-04-01T00:00:00,Mouth Neoplasms,C04.588.443.591
16585867,2006-04-01T00:00:00,Mouth Neoplasms,C07.465.565
16585867,2006-04-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
16585867,2006-04-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
16585867,2006-04-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
16585867,2006-04-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
16585867,2006-04-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
16585867,2006-04-01T00:00:00,Patient Compliance,F01.145.488.500
16585867,2006-04-01T00:00:00,Patient Compliance,N05.300.150.600.600
16585867,2006-04-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
16585867,2006-04-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
16585867,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16585867,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16585867,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16595460,2006-04-01T00:00:00,Aged,M01.060.116.100
16595460,2006-04-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
16595460,2006-04-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
16595460,2006-04-01T00:00:00,Electromyography,E01.370.405.255
16595460,2006-04-01T00:00:00,Electromyography,E01.370.530.255
16595460,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16595460,2006-04-01T00:00:00,Knee Joint,A02.835.583.475
16612398,2006-04-01T00:00:00,Contrast Media,D27.720.259
16612398,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16612398,2006-04-01T00:00:00,Incidence,E05.318.308.985.525.375
16612398,2006-04-01T00:00:00,Incidence,L01.280.975.525.375
16612398,2006-04-01T00:00:00,Incidence,N01.224.935.597.500
16612398,2006-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16612398,2006-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16612398,2006-04-01T00:00:00,Kidney Diseases,C12.777.419
16612398,2006-04-01T00:00:00,Kidney Diseases,C13.351.968.419
16612398,2006-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16612398,2006-04-01T00:00:00,Risk Factors,N05.715.350.200.700
16612398,2006-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16612398,2006-04-01T00:00:00,Risk Factors,N06.850.490.625.750
16612398,2006-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16614983,2006-04-01T00:00:00,Adult,M01.060.116
16614983,2006-04-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
16614983,2006-04-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
16614983,2006-04-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
16614983,2006-04-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
16614983,2006-04-01T00:00:00,"Biopsy, Needle",E04.074.119
16614983,2006-04-01T00:00:00,Chronic Disease,C23.550.291.500
16614983,2006-04-01T00:00:00,Colonic Diseases,C06.405.469.158
16614983,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16614983,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16614983,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16614983,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16614983,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16614983,2006-04-01T00:00:00,Manometry,E05.559
16614983,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16614983,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16614983,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16614983,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16614983,2006-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16618562,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16618562,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16618562,2006-04-01T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
16618562,2006-04-01T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
16618562,2006-04-01T00:00:00,Urinary Incontinence,C12.777.934.852
16618562,2006-04-01T00:00:00,Urinary Incontinence,C13.351.968.934.814
16618562,2006-04-01T00:00:00,Urinary Incontinence,C23.888.942.800
16618907,2006-04-01T00:00:00,Adult,M01.060.116
16618907,2006-04-01T00:00:00,Aged,M01.060.116.100
16618907,2006-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
16618907,2006-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
16618907,2006-04-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
16618907,2006-04-01T00:00:00,Cisplatin,D01.210.375
16618907,2006-04-01T00:00:00,Cisplatin,D01.625.125
16618907,2006-04-01T00:00:00,Cisplatin,D01.710.100
16618907,2006-04-01T00:00:00,Combined Modality Therapy,E02.186
16618907,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16618907,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C04.588.443.665.710.485
16618907,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C07.550.745.436
16618907,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.647.710.485
16618907,2006-04-01T00:00:00,Hypopharyngeal Neoplasms,C09.775.549.485
16618907,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16618907,2006-04-01T00:00:00,Patient Compliance,F01.145.488.500
16618907,2006-04-01T00:00:00,Patient Compliance,N05.300.150.600.600
16618907,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16618907,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16618907,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16623062,2006-04-01T00:00:00,African Americans,M01.686.508.100.100
16623062,2006-04-01T00:00:00,African Americans,M01.686.754.100
16623062,2006-04-01T00:00:00,Age Factors,N05.715.350.075
16623062,2006-04-01T00:00:00,Age Factors,N06.850.490.250
16623062,2006-04-01T00:00:00,Aged,M01.060.116.100
16623062,2006-04-01T00:00:00,Health Behavior,F01.145.488
16623062,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16623062,2006-04-01T00:00:00,Mass Screening,E01.370.500
16623062,2006-04-01T00:00:00,Mass Screening,E05.318.308.250.580
16623062,2006-04-01T00:00:00,Mass Screening,N02.421.143.827.233.443
16623062,2006-04-01T00:00:00,Mass Screening,N02.421.726.233.443
16623062,2006-04-01T00:00:00,Mass Screening,N05.715.360.300.375.500
16623062,2006-04-01T00:00:00,Mass Screening,N06.850.520.308.250.580
16623062,2006-04-01T00:00:00,Mass Screening,N06.850.780.500
16623062,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16623062,2006-04-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16623062,2006-04-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16623062,2006-04-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16623062,2006-04-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16625083,2006-04-01T00:00:00,Adult,M01.060.116
16625083,2006-04-01T00:00:00,Breast Neoplasms,C04.588.180
16625083,2006-04-01T00:00:00,Breast Neoplasms,C17.800.090.500
16625083,2006-04-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
16625083,2006-04-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
16625083,2006-04-01T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
16625083,2006-04-01T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
16625083,2006-04-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
16625083,2006-04-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
16625083,2006-04-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
16625083,2006-04-01T00:00:00,Drug Carriers,D26.255.260
16625083,2006-04-01T00:00:00,Drug Carriers,D27.720.280.260
16625083,2006-04-01T00:00:00,Drug Carriers,E02.319.300.380
16625083,2006-04-01T00:00:00,Epidermis,A10.272.497
16625083,2006-04-01T00:00:00,Epidermis,A17.815.250
16625083,2006-04-01T00:00:00,Exanthema,C17.800.257
16625083,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16625083,2006-04-01T00:00:00,Liposomes,D25.479.517
16625083,2006-04-01T00:00:00,Liposomes,D26.255.260.517
16625083,2006-04-01T00:00:00,Liposomes,D27.720.280.260.517
16625083,2006-04-01T00:00:00,Liposomes,J01.637.051.479.517
16625083,2006-04-01T00:00:00,Liposomes,J01.637.087.500.517
16625083,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16625083,2006-04-01T00:00:00,Palliative Care,E02.760.666
16625083,2006-04-01T00:00:00,Palliative Care,N02.421.585.666
16625083,2006-04-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
16625083,2006-04-01T00:00:00,Polyethylene Glycols,D05.750.741
16625083,2006-04-01T00:00:00,Polyethylene Glycols,D25.720.741
16625083,2006-04-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
16627267,2006-04-01T00:00:00,Adult,M01.060.116
16627267,2006-04-01T00:00:00,Aged,M01.060.116.100
16627267,2006-04-01T00:00:00,Alleles,G05.360.340.024.340.030
16627267,2006-04-01T00:00:00,Anticoagulants,D27.505.954.502.119
16627267,2006-04-01T00:00:00,Fluorescent Dyes,D27.720.233.348
16627267,2006-04-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16627267,2006-04-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16627267,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16627267,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16627267,2006-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16627267,2006-04-01T00:00:00,Warfarin,D03.438.150.446.520.914
16627267,2006-04-01T00:00:00,Warfarin,D03.830.219.446.520.914
16639278,2006-04-01T00:00:00,Action Potentials,G04.580.100
16639278,2006-04-01T00:00:00,Action Potentials,G07.265.750.100
16639278,2006-04-01T00:00:00,Action Potentials,G11.561.570.100
16639278,2006-04-01T00:00:00,Adult,M01.060.116
16639278,2006-04-01T00:00:00,Aged,M01.060.116.100
16639278,2006-04-01T00:00:00,Auditory Threshold,F02.463.593.071.173
16639278,2006-04-01T00:00:00,Auditory Threshold,F02.463.593.710.190
16639278,2006-04-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G07.265.500.370.300
16639278,2006-04-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G11.561.270.370.300
16639278,2006-04-01T00:00:00,Hearing Loss,C09.218.458.341
16639278,2006-04-01T00:00:00,Hearing Loss,C10.597.751.418.341
16639278,2006-04-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
16639278,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16639278,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16639278,2006-04-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
16639278,2006-04-01T00:00:00,"Monitoring, Intraoperative",E04.510
16639278,2006-04-01T00:00:00,Speech Perception,F02.463.593.071.875
16639278,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16639278,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16639278,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16640469,2006-04-01T00:00:00,Activities of Daily Living,E02.831.067
16640469,2006-04-01T00:00:00,Activities of Daily Living,I03.050
16640469,2006-04-01T00:00:00,Activities of Daily Living,N02.421.784.110
16640469,2006-04-01T00:00:00,Adult,M01.060.116
16640469,2006-04-01T00:00:00,Aged,M01.060.116.100
16640469,2006-04-01T00:00:00,Computer Simulation,L01.224.160
16640469,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16640469,2006-04-01T00:00:00,Movement,G07.700.560
16640469,2006-04-01T00:00:00,Movement,G11.427.590.530
16640469,2006-04-01T00:00:00,Photic Stimulation,E05.723.729
16640469,2006-04-01T00:00:00,Physical Therapy Modalities,E02.779
16640469,2006-04-01T00:00:00,Pilot Projects,E05.318.760.750
16640469,2006-04-01T00:00:00,Pilot Projects,E05.337.737
16640469,2006-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
16640469,2006-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
16640469,2006-04-01T00:00:00,"Therapy, Computer-Assisted",E02.950
16640469,2006-04-01T00:00:00,"Therapy, Computer-Assisted",L01.700.508.100.710
16640469,2006-04-01T00:00:00,User-Computer Interface,L01.224.900.910
16640469,2006-04-01T00:00:00,Visual Perception,F02.463.593.932
16640469,2006-04-01T00:00:00,Walking,G11.427.590.530.568.900
16640469,2006-04-01T00:00:00,Walking,G11.427.590.530.698.940
16640469,2006-04-01T00:00:00,Walking,I03.450.642.845.940
16642738,2006-04-01T00:00:00,"Adaptation, Psychological",F01.058
16642738,2006-04-01T00:00:00,Adolescent,M01.060.057
16642738,2006-04-01T00:00:00,Adolescent Behavior,F01.145.022
16642738,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16642738,2006-04-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
16642738,2006-04-01T00:00:00,Questionnaires,E05.318.308.750
16642738,2006-04-01T00:00:00,Questionnaires,L01.280.800
16642738,2006-04-01T00:00:00,Questionnaires,N05.715.360.300.695
16642738,2006-04-01T00:00:00,Questionnaires,N06.850.520.308.750
16642738,2006-04-01T00:00:00,Regression Analysis,E05.318.740.750
16642738,2006-04-01T00:00:00,Regression Analysis,N05.715.360.750.695
16642738,2006-04-01T00:00:00,Regression Analysis,N06.850.520.830.750
16642738,2006-04-01T00:00:00,Social Environment,I01.880.656
16642738,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16642738,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16642738,2006-04-01T00:00:00,Urban Population,N01.600.900
16642738,2006-04-01T00:00:00,Violence,I01.198.240.856
16642738,2006-04-01T00:00:00,Violence,I01.880.735.900
16650249,2006-04-01T00:00:00,Adolescent,M01.060.057
16650249,2006-04-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16650249,2006-04-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16650249,2006-04-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16650249,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16650249,2006-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16650249,2006-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16650249,2006-04-01T00:00:00,Treatment Outcome,E01.789.800
16650249,2006-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16650249,2006-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16650249,2006-04-01T00:00:00,United States,Z01.107.567.875
16678745,2006-04-01T00:00:00,Age Factors,N05.715.350.075
16678745,2006-04-01T00:00:00,Age Factors,N06.850.490.250
16678745,2006-04-01T00:00:00,Cataract Extraction,E04.540.825.249
16678745,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16678745,2006-04-01T00:00:00,Incidence,E05.318.308.985.525.375
16678745,2006-04-01T00:00:00,Incidence,L01.280.975.525.375
16678745,2006-04-01T00:00:00,Incidence,N01.224.935.597.500
16678745,2006-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16678745,2006-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16678745,2006-04-01T00:00:00,Infant,M01.060.703
16678745,2006-04-01T00:00:00,Intraocular Pressure,G14.440
16678745,2006-04-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
16678745,2006-04-01T00:00:00,Pseudophakia,C23.888.681
16678745,2006-04-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16678745,2006-04-01T00:00:00,Risk Factors,N05.715.350.200.700
16678745,2006-04-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16678745,2006-04-01T00:00:00,Risk Factors,N06.850.490.625.750
16678745,2006-04-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16678759,2006-04-01T00:00:00,Cataract,C11.510.245
16678759,2006-04-01T00:00:00,Cataract Extraction,E04.540.825.249
16678759,2006-04-01T00:00:00,Child,M01.060.406
16678759,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16678759,2006-04-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
16678759,2006-04-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
16680066,2006-04-01T00:00:00,Animals,B01.050
16680066,2006-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
16680066,2006-04-01T00:00:00,Blood Pressure,G09.330.380.076
16680066,2006-04-01T00:00:00,Cardiomegaly,C14.280.195
16680066,2006-04-01T00:00:00,Cardiomegaly,C23.300.775.250
16680066,2006-04-01T00:00:00,"Constriction, Pathologic",C23.300.287
16680066,2006-04-01T00:00:00,Diet,E05.272
16680066,2006-04-01T00:00:00,Diet,G07.610.240
16680066,2006-04-01T00:00:00,Lipid Metabolism,G03.495.520
16680066,2006-04-01T00:00:00,Liver,A03.620
16680066,2006-04-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
16680066,2006-04-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
16680066,2006-04-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
16680066,2006-04-01T00:00:00,Oxidative Stress,G03.495.710
16680066,2006-04-01T00:00:00,Oxidative Stress,G07.700.830.750
16680066,2006-04-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
16680066,2006-04-01T00:00:00,Proteins,D12.776
16680066,2006-04-01T00:00:00,RNA,D13.444.735
16680066,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16680066,2006-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16680066,2006-04-01T00:00:00,Serine,D12.125.154.800
16680066,2006-04-01T00:00:00,Serine,D12.125.837
16680066,2006-04-01T00:00:00,Signal Transduction,G02.111.087.800
16680066,2006-04-01T00:00:00,Signal Transduction,G02.149.115.800
16680066,2006-04-01T00:00:00,Signal Transduction,G04.299.880
16680648,2006-04-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
16680648,2006-04-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
16680648,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16680648,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16680648,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16680648,2006-04-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16680648,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16680648,2006-04-01T00:00:00,Telemedicine,H02.403.840
16680648,2006-04-01T00:00:00,Telemedicine,L01.178.847.652
16680648,2006-04-01T00:00:00,Telemedicine,N04.590.374.800
16680648,2006-04-01T00:00:00,Video Recording,L01.240.960
16681217,2006-04-01T00:00:00,Air Pollutants,D27.888.284.101
16681217,2006-04-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
16681217,2006-04-01T00:00:00,United States,Z01.107.567.875
16686812,2006-04-01T00:00:00,Adult,M01.060.116
16686812,2006-04-01T00:00:00,Ambulatory Care,E02.760.106
16686812,2006-04-01T00:00:00,Ambulatory Care,N02.421.585.106
16686812,2006-04-01T00:00:00,Attitude of Health Personnel,F01.100.050
16686812,2006-04-01T00:00:00,Attitude of Health Personnel,N05.300.100
16686812,2006-04-01T00:00:00,Group Processes,F01.829.316
16686812,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16686812,2006-04-01T00:00:00,Internal Medicine,H02.403.429
16686812,2006-04-01T00:00:00,Internship and Residency,I02.358.399.644
16686812,2006-04-01T00:00:00,Patient Education as Topic,I02.233.332.500
16686812,2006-04-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
16686812,2006-04-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
16686812,2006-04-01T00:00:00,Physician Assistants,M01.526.485.067.740
16686812,2006-04-01T00:00:00,Physician Assistants,N02.360.067.740
16686812,2006-04-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
16686812,2006-04-01T00:00:00,Physician-Patient Relations,N05.300.660.625
16686812,2006-04-01T00:00:00,Primary Health Care,N04.590.233.727
16686812,2006-04-01T00:00:00,Program Evaluation,E05.337.820
16686812,2006-04-01T00:00:00,Program Evaluation,N04.761.685
16686812,2006-04-01T00:00:00,Program Evaluation,N05.715.360.650
16686812,2006-04-01T00:00:00,"Students, Medical",I02.851.686.602
16686812,2006-04-01T00:00:00,"Students, Medical",M01.848.769.602
16705612,2006-04-01T00:00:00,Alloys,D01.552.033
16705612,2006-04-01T00:00:00,Alloys,D25.058
16705612,2006-04-01T00:00:00,Alloys,J01.637.051.058
16705612,2006-04-01T00:00:00,Animals,B01.050
16705612,2006-04-01T00:00:00,Biocompatible Materials,D25.130
16705612,2006-04-01T00:00:00,Biocompatible Materials,D27.720.102.130
16705612,2006-04-01T00:00:00,Biocompatible Materials,J01.637.051.130
16705612,2006-04-01T00:00:00,Carbon Dioxide,D01.200.200
16705612,2006-04-01T00:00:00,Carbon Dioxide,D01.362.150
16705612,2006-04-01T00:00:00,Carbon Dioxide,D01.650.550.200
16705612,2006-04-01T00:00:00,Materials Testing,E05.570
16705612,2006-04-01T00:00:00,"Models, Animal",E05.598
16705612,2006-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16705612,2006-04-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16705612,2006-04-01T00:00:00,Surface Properties,G02.842.850
16705612,2006-04-01T00:00:00,Titanium,D01.268.557.800
16705612,2006-04-01T00:00:00,Titanium,D01.268.956.878
16705612,2006-04-01T00:00:00,Titanium,D01.552.547.800
16741266,2006-04-01T00:00:00,Adult,M01.060.116
16741266,2006-04-01T00:00:00,Blood Glucose,D09.546.359.448.500
16741266,2006-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16741266,2006-04-01T00:00:00,Body Mass Index,E05.041.124.125
16741266,2006-04-01T00:00:00,Body Mass Index,G07.100.100.125
16741266,2006-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16741266,2006-04-01T00:00:00,Body Weight,C23.888.144
16741266,2006-04-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
16741266,2006-04-01T00:00:00,Body Weight,E05.041.124.160.750
16741266,2006-04-01T00:00:00,Body Weight,G07.100.100.160.120
16741266,2006-04-01T00:00:00,Body Weight,G07.700.320.249.314.120
16741266,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16741266,2006-04-01T00:00:00,Insulin,D06.472.699.587.740.625
16741266,2006-04-01T00:00:00,Insulin,D12.644.548.586.740.625
16741266,2006-04-01T00:00:00,Insulin Resistance,C18.452.394.968.500
16741266,2006-04-01T00:00:00,Insulin Resistance,G07.690.320.617
16741266,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16741266,2006-04-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
16741266,2006-04-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
16741266,2006-04-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
16741266,2006-04-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
16741266,2006-04-01T00:00:00,"Polymorphism, Genetic",G05.365.795
16741266,2006-04-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16764175,2006-04-01T00:00:00,Aged,M01.060.116.100
16764175,2006-04-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16764175,2006-04-01T00:00:00,Body Mass Index,E05.041.124.125
16764175,2006-04-01T00:00:00,Body Mass Index,G07.100.100.125
16764175,2006-04-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16764175,2006-04-01T00:00:00,Body Weight,C23.888.144
16764175,2006-04-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
16764175,2006-04-01T00:00:00,Body Weight,E05.041.124.160.750
16764175,2006-04-01T00:00:00,Body Weight,G07.100.100.160.120
16764175,2006-04-01T00:00:00,Body Weight,G07.700.320.249.314.120
16764175,2006-04-01T00:00:00,Clinical Nursing Research,H02.478.395.234
16764175,2006-04-01T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
16764175,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16764175,2006-04-01T00:00:00,Leg,A01.378.610.500
16764175,2006-04-01T00:00:00,Middle Aged,M01.060.116.630
16764175,2006-04-01T00:00:00,"Monitoring, Physiologic",E01.370.520
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,G17.800
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16764175,2006-04-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16764175,2006-04-01T00:00:00,Skin Temperature,G07.110.753
16764175,2006-04-01T00:00:00,Skin Temperature,G13.750.844
16764175,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16764175,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16818240,2006-04-01T00:00:00,Animals,B01.050
16818240,2006-04-01T00:00:00,Endocrine Disruptors,D27.505.696.353
16818240,2006-04-01T00:00:00,Endocrine Disruptors,D27.888.284.295
16818240,2006-04-01T00:00:00,Environmental Pollutants,D27.888.284
16818240,2006-04-01T00:00:00,Glucocorticoids,D06.472.040.543
16818240,2006-04-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
16818240,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16818240,2006-04-01T00:00:00,Liver,A03.620
16818240,2006-04-01T00:00:00,Progestins,D27.505.696.399.472.858
16818240,2006-04-01T00:00:00,Uterus,A05.360.319.679
16818249,2006-04-01T00:00:00,Animals,B01.050
16818249,2006-04-01T00:00:00,Body Weight,C23.888.144
16818249,2006-04-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
16818249,2006-04-01T00:00:00,Body Weight,E05.041.124.160.750
16818249,2006-04-01T00:00:00,Body Weight,G07.100.100.160.120
16818249,2006-04-01T00:00:00,Body Weight,G07.700.320.249.314.120
16818249,2006-04-01T00:00:00,"Embryo, Nonmammalian",A13.350
16818249,2006-04-01T00:00:00,"Embryo, Nonmammalian",A16.331
16818249,2006-04-01T00:00:00,Estradiol,D04.808.365.415.248
16818249,2006-04-01T00:00:00,Estradiol,D06.472.334.851.437.500
16818249,2006-04-01T00:00:00,Liver,A03.620
16818249,2006-04-01T00:00:00,Muscles,A02.633
16818249,2006-04-01T00:00:00,Muscles,A10.690
16818249,2006-04-01T00:00:00,Ovary,A05.360.319.114.630
16818249,2006-04-01T00:00:00,Ovary,A05.360.576.497
16818249,2006-04-01T00:00:00,Ovary,A06.407.312.497
16818249,2006-04-01T00:00:00,Reproduction,G08.686.785.760
16818249,2006-04-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
16900931,2006-04-01T00:00:00,Adult,M01.060.116
16900931,2006-04-01T00:00:00,Eye Proteins,D12.776.306
16900931,2006-04-01T00:00:00,Gene Expression,G05.355.310
16900931,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16900931,2006-04-01T00:00:00,Phenotype,G05.695
16900931,2006-04-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16995486,2006-04-01T00:00:00,Cooperative Behavior,F01.145.813.115
16995486,2006-04-01T00:00:00,Delivery of Health Care,N04.590.374
16995486,2006-04-01T00:00:00,Delivery of Health Care,N05.300
16995486,2006-04-01T00:00:00,"Education, Medical",I02.358.399
16995486,2006-04-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
16995486,2006-04-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
16995486,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16995486,2006-04-01T00:00:00,Interprofessional Relations,F01.829.401.205
16995486,2006-04-01T00:00:00,Physicians,M01.526.485.810
16995486,2006-04-01T00:00:00,Physicians,N02.360.810
16995486,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16995486,2006-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16995489,2006-04-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
16995489,2006-04-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
16995489,2006-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16995489,2006-04-01T00:00:00,Patient Care,E02.760
16995489,2006-04-01T00:00:00,Patient Care,N02.421.585
16995489,2006-04-01T00:00:00,Physicians,M01.526.485.810
16995489,2006-04-01T00:00:00,Physicians,N02.360.810
16995489,2006-04-01T00:00:00,United States,Z01.107.567.875
16585627,2006-04-03T00:00:00,Animals,B01.050
16585627,2006-04-03T00:00:00,Nitrogen,D01.268.604
16585627,2006-04-03T00:00:00,Nitrogen,D01.362.625
16585627,2006-04-03T00:00:00,Plant Leaves,A18.024.812
16594897,2006-04-03T00:00:00,Animals,B01.050
16594897,2006-04-03T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16594897,2006-04-03T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16594897,2006-04-03T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16594897,2006-04-03T00:00:00,Interleukin-2,D12.644.276.374.465.502
16594897,2006-04-03T00:00:00,Interleukin-2,D12.644.276.374.480.372
16594897,2006-04-03T00:00:00,Interleukin-2,D12.776.467.374.465.502
16594897,2006-04-03T00:00:00,Interleukin-2,D12.776.467.374.480.372
16594897,2006-04-03T00:00:00,Interleukin-2,D23.529.374.465.502
16594897,2006-04-03T00:00:00,Interleukin-2,D23.529.374.480.372
16594897,2006-04-03T00:00:00,Interleukin-4,D12.644.276.374.465.504
16594897,2006-04-03T00:00:00,Interleukin-4,D12.776.467.374.465.504
16594897,2006-04-03T00:00:00,Interleukin-4,D23.529.374.465.504
16594897,2006-04-03T00:00:00,Lymphocyte Activation,E01.450.495.482
16594897,2006-04-03T00:00:00,Lymphocyte Activation,E05.478.594.530
16594897,2006-04-03T00:00:00,Lymphocyte Activation,G12.425.747
16594897,2006-04-03T00:00:00,Lymphocyte Activation,G12.450.050.400.545
16594897,2006-04-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16594897,2006-04-03T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16594897,2006-04-03T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
16594897,2006-04-03T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
16594897,2006-04-03T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16594897,2006-04-03T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16595781,2006-04-05T00:00:00,Adult,M01.060.116
16595781,2006-04-05T00:00:00,Aged,M01.060.116.100
16595781,2006-04-05T00:00:00,Body Mass Index,E01.370.600.115.100.125
16595781,2006-04-05T00:00:00,Body Mass Index,E05.041.124.125
16595781,2006-04-05T00:00:00,Body Mass Index,G07.100.100.125
16595781,2006-04-05T00:00:00,Body Mass Index,N06.850.505.200.100.175
16595781,2006-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16595781,2006-04-05T00:00:00,Incidence,E05.318.308.985.525.375
16595781,2006-04-05T00:00:00,Incidence,L01.280.975.525.375
16595781,2006-04-05T00:00:00,Incidence,N01.224.935.597.500
16595781,2006-04-05T00:00:00,Incidence,N06.850.505.400.975.525.375
16595781,2006-04-05T00:00:00,Incidence,N06.850.520.308.985.525.375
16595781,2006-04-05T00:00:00,Middle Aged,M01.060.116.630
16595781,2006-04-05T00:00:00,Neoplasms,C04
16595781,2006-04-05T00:00:00,Questionnaires,E05.318.308.750
16595781,2006-04-05T00:00:00,Questionnaires,L01.280.800
16595781,2006-04-05T00:00:00,Questionnaires,N05.715.360.300.695
16595781,2006-04-05T00:00:00,Questionnaires,N06.850.520.308.750
16595781,2006-04-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
16595781,2006-04-05T00:00:00,Risk Assessment,N04.452.871.715
16595781,2006-04-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16595781,2006-04-05T00:00:00,Risk Assessment,N06.850.505.715
16595781,2006-04-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16595781,2006-04-05T00:00:00,Risk Factors,E05.318.740.600.800.725
16595781,2006-04-05T00:00:00,Risk Factors,N05.715.350.200.700
16595781,2006-04-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16595781,2006-04-05T00:00:00,Risk Factors,N06.850.490.625.750
16595781,2006-04-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16595781,2006-04-05T00:00:00,United States,Z01.107.567.875
16595781,2006-04-05T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
16600192,2006-04-05T00:00:00,Animals,B01.050
16600192,2006-04-05T00:00:00,Apoptosis,G04.299.139.160
16600192,2006-04-05T00:00:00,Calcium,D01.268.552.100
16600192,2006-04-05T00:00:00,Calcium,D01.552.539.288
16600192,2006-04-05T00:00:00,Calcium,D23.119.100
16600192,2006-04-05T00:00:00,Caspases,D08.811.277.656.262.500.126
16600192,2006-04-05T00:00:00,Caspases,D08.811.277.656.300.200.126
16600192,2006-04-05T00:00:00,Caspases,D12.644.360.075.405
16600192,2006-04-05T00:00:00,Caspases,D12.776.476.075.405
16600192,2006-04-05T00:00:00,Cell Line,A11.251.210
16600192,2006-04-05T00:00:00,Drug Interactions,G07.690.812.240
16600192,2006-04-05T00:00:00,Drug Interactions,G07.700.680.240
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.644.276.718.550
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D12.776.467.718.550
16600192,2006-04-05T00:00:00,Interferon-gamma,D23.529.374.440.893
16600192,2006-04-05T00:00:00,Interferon-gamma,D23.529.374.480.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16600192,2006-04-05T00:00:00,Interferon-gamma,D23.529.718.550
16600192,2006-04-05T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16600192,2006-04-05T00:00:00,Mitochondria,A11.284.835.626
16600192,2006-04-05T00:00:00,"Models, Biological",E05.599.395
16600192,2006-04-05T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16600192,2006-04-05T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16600192,2006-04-05T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16600192,2006-04-05T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
16600192,2006-04-05T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
16600192,2006-04-05T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
16600192,2006-04-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16600192,2006-04-05T00:00:00,Retinal Ganglion Cells,A08.663.650.850.875
16600192,2006-04-05T00:00:00,Retinal Ganglion Cells,A09.371.729.831.875
16600192,2006-04-05T00:00:00,Retinal Ganglion Cells,A11.671.650.850.875
16600192,2006-04-05T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
16600192,2006-04-05T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
16603075,2006-04-07T00:00:00,Database Management Systems,L01.224.900.280
16603075,2006-04-07T00:00:00,Database Management Systems,L01.700.508.300.680.110
16603075,2006-04-07T00:00:00,Database Management Systems,N04.452.515.110
16603075,2006-04-07T00:00:00,"Databases, Genetic",L01.470.750.750.325
16603075,2006-04-07T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
16603075,2006-04-07T00:00:00,Drosophila Proteins,D12.776.466.462
16603075,2006-04-07T00:00:00,Gene Expression Profiling,E05.393.332
16603075,2006-04-07T00:00:00,Internet,L01.224.230.110.500
16603075,2006-04-07T00:00:00,Protein Interaction Mapping,E05.601.690
16603075,2006-04-07T00:00:00,Software,L01.224.900
16603075,2006-04-07T00:00:00,Systems Integration,H01.770.787
16603075,2006-04-07T00:00:00,Systems Integration,L01.906.787
16603075,2006-04-07T00:00:00,User-Computer Interface,L01.224.900.910
16604083,2006-04-09T00:00:00,Amino Acid Sequence,G02.111.570.060
16604083,2006-04-09T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16604083,2006-04-09T00:00:00,Hela Cells,A11.251.210.190.400
16604083,2006-04-09T00:00:00,Hela Cells,A11.251.860.180.400
16604083,2006-04-09T00:00:00,Hela Cells,A11.436.340
16604083,2006-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16604083,2006-04-09T00:00:00,Molecular Sequence Data,L01.453.245.667
16604083,2006-04-09T00:00:00,Molecular Weight,G02.842.580
16604083,2006-04-09T00:00:00,Nuclear Proteins,D12.776.660
16604083,2006-04-09T00:00:00,"RNA, Messenger",D13.444.735.544
16604083,2006-04-09T00:00:00,Substrate Specificity,G02.111.835
16609153,2006-04-11T00:00:00,Acclimatization,G07.700.062.133
16609153,2006-04-11T00:00:00,Acclimatization,G16.100.057.500.133
16609153,2006-04-11T00:00:00,Animals,B01.050
16609153,2006-04-11T00:00:00,Kidney,A05.810.453
16614049,2006-04-13T00:00:00,Amino Acid Sequence,G02.111.570.060
16614049,2006-04-13T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16614049,2006-04-13T00:00:00,Animals,B01.050
16614049,2006-04-13T00:00:00,Gene Expression Regulation,G05.355.315
16614049,2006-04-13T00:00:00,Kidney,A05.810.453
16614049,2006-04-13T00:00:00,Membrane Transport Proteins,D12.776.157.530
16614049,2006-04-13T00:00:00,Membrane Transport Proteins,D12.776.543.585
16614049,2006-04-13T00:00:00,Molecular Sequence Data,L01.453.245.667
16614372,2006-04-13T00:00:00,Animals,B01.050
16614372,2006-04-13T00:00:00,Carrier Proteins,D12.776.157
16614372,2006-04-13T00:00:00,Immunologic Factors,D27.505.696.477
16614372,2006-04-13T00:00:00,Inflammation,C23.550.470
16614372,2006-04-13T00:00:00,Liver,A03.620
16614372,2006-04-13T00:00:00,Membrane Glycoproteins,D12.776.395.550
16614372,2006-04-13T00:00:00,Membrane Glycoproteins,D12.776.543.550
16614372,2006-04-13T00:00:00,Resuscitation,E02.365.647
16626657,2006-04-13T00:00:00,Animals,B01.050
16626657,2006-04-13T00:00:00,Drug Interactions,G07.690.812.240
16626657,2006-04-13T00:00:00,Drug Interactions,G07.700.680.240
16626657,2006-04-13T00:00:00,Electric Stimulation,E05.723.402
16626657,2006-04-13T00:00:00,Ethanol,D02.033.375
16626657,2006-04-13T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16626657,2006-04-13T00:00:00,Peptides,D12.644
16626657,2006-04-13T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
16626657,2006-04-13T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
16626657,2006-04-13T00:00:00,Solvents,D27.720.844
16626657,2006-04-13T00:00:00,Toluene,D02.455.426.559.389.832
16626657,2006-04-13T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
16617141,2006-04-14T00:00:00,Animals,B01.050
16617141,2006-04-14T00:00:00,Extracellular Matrix,A11.284.295.310
16617141,2006-04-14T00:00:00,Fibroblasts,A11.329.228
16617141,2006-04-14T00:00:00,Fibroblasts,A11.872.228
16617141,2006-04-14T00:00:00,Heart,A07.541
16617141,2006-04-14T00:00:00,Heart Conduction System,A07.541.409
16617141,2006-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16617141,2006-04-14T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16617141,2006-04-14T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16617141,2006-04-14T00:00:00,"Myocytes, Cardiac",A11.620.500
16617141,2006-04-14T00:00:00,Signal Transduction,G02.111.087.800
16617141,2006-04-14T00:00:00,Signal Transduction,G02.149.115.800
16617141,2006-04-14T00:00:00,Signal Transduction,G04.299.880
16365894,2006-04-15T00:00:00,Animals,B01.050
16365894,2006-04-15T00:00:00,Carrier Proteins,D12.776.157
16365894,2006-04-15T00:00:00,Cell Differentiation,G04.299.151
16365894,2006-04-15T00:00:00,Heat-Shock Proteins,D12.776.580.216
16365894,2006-04-15T00:00:00,Membrane Glycoproteins,D12.776.395.550
16365894,2006-04-15T00:00:00,Membrane Glycoproteins,D12.776.543.550
16365894,2006-04-15T00:00:00,Osteoblasts,A11.329.629
16365894,2006-04-15T00:00:00,Osteoclasts,A11.329.372.700
16365894,2006-04-15T00:00:00,Osteoclasts,A11.627.482.700
16365894,2006-04-15T00:00:00,RANK Ligand,D12.644.276.374.750.562
16365894,2006-04-15T00:00:00,RANK Ligand,D12.644.276.972.562
16365894,2006-04-15T00:00:00,RANK Ligand,D12.776.467.374.750.562
16365894,2006-04-15T00:00:00,RANK Ligand,D12.776.467.972.562
16365894,2006-04-15T00:00:00,RANK Ligand,D23.529.374.750.562
16365894,2006-04-15T00:00:00,RANK Ligand,D23.529.972.562
16365894,2006-04-15T00:00:00,Stromal Cells,A11.329.830
16709018,2006-04-15T00:00:00,Blood-Brain Barrier,A07.035
16709018,2006-04-15T00:00:00,Blood-Brain Barrier,A08.186.211.035
16709018,2006-04-15T00:00:00,Brain Neoplasms,C04.588.614.250.195
16709018,2006-04-15T00:00:00,Brain Neoplasms,C10.228.140.211
16709018,2006-04-15T00:00:00,Brain Neoplasms,C10.551.240.250
16709018,2006-04-15T00:00:00,Combined Modality Therapy,E02.186
16709018,2006-04-15T00:00:00,Drug Delivery Systems,E02.319.300
16709018,2006-04-15T00:00:00,Glioma,C04.557.465.625.600.380
16709018,2006-04-15T00:00:00,Glioma,C04.557.470.670.380
16709018,2006-04-15T00:00:00,Glioma,C04.557.580.625.600.380
16709018,2006-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16709018,2006-04-15T00:00:00,Immunotoxins,D12.776.124.486.485.114.580.450
16709018,2006-04-15T00:00:00,Immunotoxins,D12.776.124.790.651.114.580.450
16709018,2006-04-15T00:00:00,Immunotoxins,D12.776.377.715.548.114.580.450
16709018,2006-04-15T00:00:00,Immunotoxins,D27.888.569.271
16709018,2006-04-15T00:00:00,Infusion Pumps,E07.505
16709018,2006-04-15T00:00:00,Infusion Pumps,E07.858.082.505
16709018,2006-04-15T00:00:00,Radioisotopes,D01.496.749
17149409,2006-04-15T00:00:00,Curriculum,I02.158
17149409,2006-04-15T00:00:00,"Education, Graduate",I02.358.337
17149409,2006-04-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17149409,2006-04-15T00:00:00,Minority Groups,I01.880.371
17149409,2006-04-15T00:00:00,South Carolina,Z01.107.567.875.075.662
17149409,2006-04-15T00:00:00,South Carolina,Z01.107.567.875.750.700
17149409,2006-04-15T00:00:00,"Students, Pharmacy",I02.851.686.768
17149409,2006-04-15T00:00:00,"Students, Pharmacy",M01.848.769.768
16616495,2006-04-17T00:00:00,Animals,B01.050
16616495,2006-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16616495,2006-04-17T00:00:00,Molecular Structure,G02.111.570
16616495,2006-04-17T00:00:00,Molecular Structure,G02.575
16616495,2006-04-17T00:00:00,Molecular Structure,G02.842.575
16728214,2006-04-17T00:00:00,Adult,M01.060.116
16728214,2006-04-17T00:00:00,Aged,M01.060.116.100
16728214,2006-04-17T00:00:00,Calcinosis,C18.452.174.130
16728214,2006-04-17T00:00:00,Coronary Disease,C14.280.647.250
16728214,2006-04-17T00:00:00,Coronary Disease,C14.907.585.250
16728214,2006-04-17T00:00:00,Coronary Vessels,A07.231.114.269
16728214,2006-04-17T00:00:00,Coronary Vessels,A07.231.908.194
16728214,2006-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16728214,2006-04-17T00:00:00,Incidence,E05.318.308.985.525.375
16728214,2006-04-17T00:00:00,Incidence,L01.280.975.525.375
16728214,2006-04-17T00:00:00,Incidence,N01.224.935.597.500
16728214,2006-04-17T00:00:00,Incidence,N06.850.505.400.975.525.375
16728214,2006-04-17T00:00:00,Incidence,N06.850.520.308.985.525.375
16728214,2006-04-17T00:00:00,Middle Aged,M01.060.116.630
16728214,2006-04-17T00:00:00,Population Surveillance,E05.318.308.250.700
16728214,2006-04-17T00:00:00,Population Surveillance,N05.715.360.300.375.625
16728214,2006-04-17T00:00:00,Population Surveillance,N06.850.520.308.250.700
16728214,2006-04-17T00:00:00,Population Surveillance,N06.850.780.675
16728214,2006-04-17T00:00:00,Risk Factors,E05.318.740.600.800.725
16728214,2006-04-17T00:00:00,Risk Factors,N05.715.350.200.700
16728214,2006-04-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16728214,2006-04-17T00:00:00,Risk Factors,N06.850.490.625.750
16728214,2006-04-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16728214,2006-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16728214,2006-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16728214,2006-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16728214,2006-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16728214,2006-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16728214,2006-04-17T00:00:00,United States,Z01.107.567.875
16621932,2006-04-18T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
16621932,2006-04-18T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
16621932,2006-04-18T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
16621932,2006-04-18T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
16621932,2006-04-18T00:00:00,Animals,B01.050
16621932,2006-04-18T00:00:00,Blood-Brain Barrier,A07.035
16621932,2006-04-18T00:00:00,Blood-Brain Barrier,A08.186.211.035
16621932,2006-04-18T00:00:00,Brain,A08.186.211
16621932,2006-04-18T00:00:00,Brain Chemistry,G02.111.100
16621932,2006-04-18T00:00:00,Brain Chemistry,G03.200
16621932,2006-04-18T00:00:00,Central Nervous System Stimulants,D27.505.696.282
16621932,2006-04-18T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
16621932,2006-04-18T00:00:00,Dextroamphetamine,D02.092.471.683.152.110.200
16621932,2006-04-18T00:00:00,Methylphenidate,D02.241.223.601.600
16621932,2006-04-18T00:00:00,Methylphenidate,D03.383.621.460
16621932,2006-04-18T00:00:00,Motor Activity,F01.145.632
16621932,2006-04-18T00:00:00,Motor Activity,G11.427.590.530.698
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
16621932,2006-04-18T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
16622040,2006-04-18T00:00:00,"Anesthetics, Inhalation",D27.505.696.277.100.035.060
16622040,2006-04-18T00:00:00,"Anesthetics, Inhalation",D27.505.954.427.210.100.035.060
16622040,2006-04-18T00:00:00,Animals,B01.050
16622040,2006-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16622040,2006-04-18T00:00:00,Mutation,G05.365.590
16622040,2006-04-18T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
16622040,2006-04-18T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
16684509,2006-04-18T00:00:00,Cell Cycle,G04.299.134
16684509,2006-04-18T00:00:00,DNA Replication,G02.111.087.222
16684509,2006-04-18T00:00:00,DNA Replication,G02.149.115.222
16684509,2006-04-18T00:00:00,DNA Replication,G05.355.200
16684509,2006-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16684509,2006-04-18T00:00:00,Insulin-Like Growth Factor Binding Protein 2,D12.776.157.420.260
16684509,2006-04-18T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
16684509,2006-04-18T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
16684509,2006-04-18T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
16684509,2006-04-18T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
16684509,2006-04-18T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16684509,2006-04-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16684509,2006-04-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16684509,2006-04-18T00:00:00,Pyrimidines,D03.383.742
16684509,2006-04-18T00:00:00,Pyrroles,D03.383.129.578
16684509,2006-04-18T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
16684509,2006-04-18T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
16684509,2006-04-18T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
16684509,2006-04-18T00:00:00,Signal Transduction,G02.111.087.800
16684509,2006-04-18T00:00:00,Signal Transduction,G02.149.115.800
16684509,2006-04-18T00:00:00,Signal Transduction,G04.299.880
16713641,2006-04-18T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
16713641,2006-04-18T00:00:00,Amino Acid Sequence,G02.111.570.060
16713641,2006-04-18T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16713641,2006-04-18T00:00:00,Animals,B01.050
16713641,2006-04-18T00:00:00,Dexamethasone,D04.808.745.432.769.344
16713641,2006-04-18T00:00:00,Dexamethasone,D04.808.908.238
16713641,2006-04-18T00:00:00,Gene Expression,G05.355.310
16713641,2006-04-18T00:00:00,Glucocorticoids,D06.472.040.543
16713641,2006-04-18T00:00:00,Glucocorticoids,D27.505.696.399.472.488
16713641,2006-04-18T00:00:00,Molecular Sequence Data,L01.453.245.667
16713641,2006-04-18T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
16713641,2006-04-18T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
16713641,2006-04-18T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
16713641,2006-04-18T00:00:00,Testosterone,D04.808.054.079.429.824
16713641,2006-04-18T00:00:00,Testosterone,D06.472.334.851.968.984
16713641,2006-04-18T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
16626705,2006-04-19T00:00:00,Animals,B01.050
16626705,2006-04-19T00:00:00,Cell Differentiation,G04.299.151
16626705,2006-04-19T00:00:00,Huntington Disease,C10.228.140.079.545
16626705,2006-04-19T00:00:00,Huntington Disease,C10.228.140.380.278
16626705,2006-04-19T00:00:00,Huntington Disease,C10.228.662.262.249.750
16626705,2006-04-19T00:00:00,Huntington Disease,C10.574.500.497
16626705,2006-04-19T00:00:00,Huntington Disease,C16.320.400.430
16626705,2006-04-19T00:00:00,Huntington Disease,F03.087.250.400
16626705,2006-04-19T00:00:00,Huntington Disease,F03.087.400.390
16626705,2006-04-19T00:00:00,Motor Activity,F01.145.632
16626705,2006-04-19T00:00:00,Motor Activity,G11.427.590.530.698
16626705,2006-04-19T00:00:00,Nerve Tissue Proteins,D12.776.641
16626705,2006-04-19T00:00:00,Neurons,A08.663
16626705,2006-04-19T00:00:00,Neurons,A11.671
16626705,2006-04-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16626705,2006-04-19T00:00:00,Transcription Factors,D12.776.930
16626705,2006-04-19T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
16626705,2006-04-19T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
16636603,2006-04-19T00:00:00,Adolescent,M01.060.057
16636603,2006-04-19T00:00:00,Adult,M01.060.116
16636603,2006-04-19T00:00:00,Aged,M01.060.116.100
16636603,2006-04-19T00:00:00,Alleles,G05.360.340.024.340.030
16636603,2006-04-19T00:00:00,Child,M01.060.406
16636603,2006-04-19T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
16636603,2006-04-19T00:00:00,Genetic Predisposition to Disease,G05.380.355
16636603,2006-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636603,2006-04-19T00:00:00,Middle Aged,M01.060.116.630
16636603,2006-04-19T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
16636603,2006-04-19T00:00:00,"Polymorphism, Genetic",G05.365.795
16641939,2006-04-19T00:00:00,Animals,B01.050
16641939,2006-04-19T00:00:00,"Depressive Disorder, Major",F03.600.300.375
16641939,2006-04-19T00:00:00,Drug Resistance,G07.690.320
16641939,2006-04-19T00:00:00,Electric Stimulation Therapy,E02.342
16641939,2006-04-19T00:00:00,Electric Stimulation Therapy,E02.779.468
16641939,2006-04-19T00:00:00,Evaluation Studies as Topic,E05.337
16641939,2006-04-19T00:00:00,Evaluation Studies as Topic,N05.715.360.335
16641939,2006-04-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16627796,2006-04-20T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16627796,2006-04-20T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16627796,2006-04-20T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16627796,2006-04-20T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16627796,2006-04-20T00:00:00,Bilirubin,D03.383.129.578.840.249.184
16627796,2006-04-20T00:00:00,Bilirubin,D03.549.909.249.184
16627796,2006-04-20T00:00:00,Bilirubin,D04.345.783.249.184
16627796,2006-04-20T00:00:00,Bilirubin,D23.767.193.184
16627796,2006-04-20T00:00:00,Blood Transfusion,E02.095.135
16627796,2006-04-20T00:00:00,Child,M01.060.406
16627796,2006-04-20T00:00:00,Hemoglobins,D12.776.124.400
16627796,2006-04-20T00:00:00,Hemoglobins,D12.776.422.316.762
16627796,2006-04-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16627796,2006-04-20T00:00:00,Risk Factors,E05.318.740.600.800.725
16627796,2006-04-20T00:00:00,Risk Factors,N05.715.350.200.700
16627796,2006-04-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16627796,2006-04-20T00:00:00,Risk Factors,N06.850.490.625.750
16627796,2006-04-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16627796,2006-04-20T00:00:00,Stroke,C10.228.140.300.775
16627796,2006-04-20T00:00:00,Stroke,C14.907.253.855
16628383,2006-04-21T00:00:00,Atrial Fibrillation,C14.280.067.198
16628383,2006-04-21T00:00:00,Atrial Fibrillation,C23.550.073.198
16628383,2006-04-21T00:00:00,Catheter Ablation,E01.370.370.380.410.200
16628383,2006-04-21T00:00:00,Catheter Ablation,E02.148.110
16628383,2006-04-21T00:00:00,Catheter Ablation,E02.148.442.110
16628383,2006-04-21T00:00:00,Catheter Ablation,E02.154.402.110
16628383,2006-04-21T00:00:00,Catheter Ablation,E04.014.170.402.110
16628383,2006-04-21T00:00:00,"Diagnosis, Differential",E01.171
16628383,2006-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16628383,2006-04-21T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
16628383,2006-04-21T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
16628383,2006-04-21T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
16628383,2006-04-21T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
16628383,2006-04-21T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
16628383,2006-04-21T00:00:00,Middle Aged,M01.060.116.630
16628383,2006-04-21T00:00:00,Pulmonary Circulation,G09.330.190.163.770
16628383,2006-04-21T00:00:00,Pulmonary Circulation,G09.772.770.690
16628383,2006-04-21T00:00:00,Pulmonary Veins,A07.231.908.713
16628383,2006-04-21T00:00:00,Pulmonary Veno-Occlusive Disease,C08.381.780
16628383,2006-04-21T00:00:00,Pulmonary Veno-Occlusive Disease,C14.907.690
16628383,2006-04-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16628383,2006-04-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16628383,2006-04-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16628383,2006-04-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16628383,2006-04-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16647911,2006-04-21T00:00:00,Adult,M01.060.116
16647911,2006-04-21T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
16647911,2006-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16647911,2006-04-21T00:00:00,Middle Aged,M01.060.116.630
16647911,2006-04-21T00:00:00,Risk Factors,E05.318.740.600.800.725
16647911,2006-04-21T00:00:00,Risk Factors,N05.715.350.200.700
16647911,2006-04-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16647911,2006-04-21T00:00:00,Risk Factors,N06.850.490.625.750
16647911,2006-04-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16647911,2006-04-21T00:00:00,Secondary Prevention,N02.421.726.825
16647911,2006-04-21T00:00:00,Secondary Prevention,N06.850.780.750
16647911,2006-04-21T00:00:00,Treatment Outcome,E01.789.800
16647911,2006-04-21T00:00:00,Treatment Outcome,N04.761.559.590.800
16647911,2006-04-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16647923,2006-04-21T00:00:00,Adolescent,M01.060.057
16647923,2006-04-21T00:00:00,Adult,M01.060.116
16647923,2006-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16647923,2006-04-21T00:00:00,Incidence,E05.318.308.985.525.375
16647923,2006-04-21T00:00:00,Incidence,L01.280.975.525.375
16647923,2006-04-21T00:00:00,Incidence,N01.224.935.597.500
16647923,2006-04-21T00:00:00,Incidence,N06.850.505.400.975.525.375
16647923,2006-04-21T00:00:00,Incidence,N06.850.520.308.985.525.375
16647923,2006-04-21T00:00:00,Pregnancy,G08.686.785.760.769
16647923,2006-04-21T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
16647923,2006-04-21T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
16813756,2006-04-21T00:00:00,Adult,M01.060.116
16813756,2006-04-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16813756,2006-04-21T00:00:00,Pre-Eclampsia,C13.703.395.249
16813756,2006-04-21T00:00:00,Pregnancy,G08.686.785.760.769
16813756,2006-04-21T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D08.811.913.696.620.682.725.400.950.100
16813756,2006-04-21T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.060.750.100
16813756,2006-04-21T00:00:00,Vascular Endothelial Growth Factor Receptor-1,D12.776.543.750.750.400.910.100
16703399,2006-04-22T00:00:00,Amino Acids,D12.125
16703399,2006-04-22T00:00:00,Animals,B01.050
16703399,2006-04-22T00:00:00,"Behavior, Animal",F01.145.113
16703399,2006-04-22T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
16703399,2006-04-22T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
16703399,2006-04-22T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
16703399,2006-04-22T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
16703399,2006-04-22T00:00:00,Cocaine,D02.145.074.722.388
16703399,2006-04-22T00:00:00,Cocaine,D03.132.889.354
16703399,2006-04-22T00:00:00,Cocaine,D03.605.869.388
16703399,2006-04-22T00:00:00,Cocaine,D04.075.080.875.099.722.388
16703399,2006-04-22T00:00:00,Cocaine-Related Disorders,C21.739.300
16703399,2006-04-22T00:00:00,Cocaine-Related Disorders,F03.900.300
16703399,2006-04-22T00:00:00,Feeding Behavior,F01.145.113.547
16703399,2006-04-22T00:00:00,Feeding Behavior,F01.145.407
16703399,2006-04-22T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
16703399,2006-04-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16703399,2006-04-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16703399,2006-04-22T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.100.450
16703399,2006-04-22T00:00:00,"Receptors, Metabotropic Glutamate",D12.776.543.750.720.200.450.500
16703399,2006-04-22T00:00:00,Self Administration,E02.319.890
16703399,2006-04-22T00:00:00,Self Administration,E02.900.890
16636010,2006-04-24T00:00:00,Animals,B01.050
16636010,2006-04-24T00:00:00,Anticonvulsants,D27.505.954.427.080
16636010,2006-04-24T00:00:00,"Behavior, Animal",F01.145.113
16636010,2006-04-24T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16636010,2006-04-24T00:00:00,Electroencephalography,E01.370.376.300
16636010,2006-04-24T00:00:00,Electroencephalography,E01.370.405.245
16636010,2006-04-24T00:00:00,Ethanol,D02.033.375
16636010,2006-04-24T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
16636010,2006-04-24T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
16636010,2006-04-24T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
16636176,2006-04-24T00:00:00,Aged,M01.060.116.100
16636176,2006-04-24T00:00:00,Heart Failure,C14.280.434
16636176,2006-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636176,2006-04-24T00:00:00,Hypertension,C14.907.489
16636176,2006-04-24T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
16636176,2006-04-24T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
16636176,2006-04-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
16636176,2006-04-24T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16636176,2006-04-24T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16636176,2006-04-24T00:00:00,Middle Aged,M01.060.116.630
16636176,2006-04-24T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
16636176,2006-04-24T00:00:00,Ventricular Remodeling,C23.300.985
16636176,2006-04-24T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16636216,2006-04-24T00:00:00,Adult,M01.060.116
16636216,2006-04-24T00:00:00,African Americans,M01.686.508.100.100
16636216,2006-04-24T00:00:00,African Americans,M01.686.754.100
16636216,2006-04-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
16636216,2006-04-24T00:00:00,Health Personnel,M01.526.485
16636216,2006-04-24T00:00:00,Health Personnel,N02.360
16636216,2006-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636216,2006-04-24T00:00:00,Professional-Patient Relations,F01.829.401.650
16636216,2006-04-24T00:00:00,Professional-Patient Relations,N05.300.660
16636216,2006-04-24T00:00:00,Regression Analysis,E05.318.740.750
16636216,2006-04-24T00:00:00,Regression Analysis,N05.715.360.750.695
16636216,2006-04-24T00:00:00,Regression Analysis,N06.850.520.830.750
16636216,2006-04-24T00:00:00,United States,Z01.107.567.875
16635481,2006-04-25T00:00:00,Animals,B01.050
16635481,2006-04-25T00:00:00,Cell Line,A11.251.210
16635481,2006-04-25T00:00:00,"Chemokines, CXC",D12.644.276.374.200.120
16635481,2006-04-25T00:00:00,"Chemokines, CXC",D12.776.467.374.200.120
16635481,2006-04-25T00:00:00,"Chemokines, CXC",D23.125.300.120
16635481,2006-04-25T00:00:00,"Chemokines, CXC",D23.469.200.120
16635481,2006-04-25T00:00:00,"Chemokines, CXC",D23.529.374.200.120
16635481,2006-04-25T00:00:00,Drug Interactions,G07.690.812.240
16635481,2006-04-25T00:00:00,Drug Interactions,G07.700.680.240
16635481,2006-04-25T00:00:00,Enzyme Inhibitors,D27.505.519.389
16635481,2006-04-25T00:00:00,Gene Expression,G05.355.310
16635481,2006-04-25T00:00:00,Gene Expression Regulation,G05.355.315
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.718.550
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.718.550
16635481,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.440.893
16635481,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.480.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16635481,2006-04-25T00:00:00,Interferon-gamma,D23.529.718.550
16635481,2006-04-25T00:00:00,Lipopolysaccharides,D09.400.500
16635481,2006-04-25T00:00:00,Lipopolysaccharides,D09.698.718.450
16635481,2006-04-25T00:00:00,Lipopolysaccharides,D10.494
16635481,2006-04-25T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16635481,2006-04-25T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16635481,2006-04-25T00:00:00,Microglia,A08.637.400
16635481,2006-04-25T00:00:00,Microglia,A11.650.400
16635481,2006-04-25T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
16635481,2006-04-25T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
16635481,2006-04-25T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
16635481,2006-04-25T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
16635481,2006-04-25T00:00:00,"RNA, Messenger",D13.444.735.544
16636184,2006-04-25T00:00:00,Cardiomegaly,C14.280.195
16636184,2006-04-25T00:00:00,Cardiomegaly,C23.300.775.250
16636184,2006-04-25T00:00:00,Diastole,G09.330.190.541.295
16636184,2006-04-25T00:00:00,Diastole,G11.427.590.540.554.250
16636184,2006-04-25T00:00:00,Diastole,G11.427.590.540.570.295
16636184,2006-04-25T00:00:00,Heart Failure,C14.280.434
16636184,2006-04-25T00:00:00,Heart Ventricles,A07.541.560
16636184,2006-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636184,2006-04-25T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16636184,2006-04-25T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16636184,2006-04-25T00:00:00,"Myocytes, Cardiac",A11.620.500
16636184,2006-04-25T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16636231,2006-04-25T00:00:00,Adult,M01.060.116
16636231,2006-04-25T00:00:00,Aged,M01.060.116.100
16636231,2006-04-25T00:00:00,Brain Ischemia,C10.228.140.300.150
16636231,2006-04-25T00:00:00,Brain Ischemia,C14.907.253.092
16636231,2006-04-25T00:00:00,"Cholesterol, LDL",D10.532.515.500
16636231,2006-04-25T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
16636231,2006-04-25T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
16636231,2006-04-25T00:00:00,Folic Acid,D03.438.733.631.400
16636231,2006-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636231,2006-04-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16636231,2006-04-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16636231,2006-04-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16636231,2006-04-25T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16636231,2006-04-25T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16636231,2006-04-25T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16636231,2006-04-25T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16636231,2006-04-25T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
16636231,2006-04-25T00:00:00,Practice Guidelines as Topic,N05.700.350.650
16636231,2006-04-25T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16636231,2006-04-25T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16636231,2006-04-25T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16636231,2006-04-25T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16636231,2006-04-25T00:00:00,Risk Factors,E05.318.740.600.800.725
16636231,2006-04-25T00:00:00,Risk Factors,N05.715.350.200.700
16636231,2006-04-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16636231,2006-04-25T00:00:00,Risk Factors,N06.850.490.625.750
16636231,2006-04-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16636231,2006-04-25T00:00:00,United States,Z01.107.567.875
16636329,2006-04-25T00:00:00,Adult,M01.060.116
16636329,2006-04-25T00:00:00,Animals,B01.050
16636329,2006-04-25T00:00:00,Birth Weight,C23.888.144.186
16636329,2006-04-25T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
16636329,2006-04-25T00:00:00,Birth Weight,E05.041.124.160.750.149
16636329,2006-04-25T00:00:00,Birth Weight,G07.100.100.160.120.186
16636329,2006-04-25T00:00:00,Birth Weight,G07.700.320.249.314.120.186
16636329,2006-04-25T00:00:00,Diet,E05.272
16636329,2006-04-25T00:00:00,Diet,G07.610.240
16636329,2006-04-25T00:00:00,Dietary Supplements,J02.500.456
16636329,2006-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16636329,2006-04-25T00:00:00,"Infant, Newborn",M01.060.703.520
16636329,2006-04-25T00:00:00,Pregnancy,G08.686.785.760.769
16636329,2006-04-25T00:00:00,Vitamin D,D04.808.812.768
16638913,2006-04-25T00:00:00,Animals,B01.050
16638913,2006-04-25T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
16638913,2006-04-25T00:00:00,Down-Regulation,G02.111.087.225
16638913,2006-04-25T00:00:00,Down-Regulation,G02.149.115.225
16638913,2006-04-25T00:00:00,Down-Regulation,G05.355.315.200
16638913,2006-04-25T00:00:00,Down-Regulation,G07.690.812.230
16638913,2006-04-25T00:00:00,Down-Regulation,G07.700.680.230
16638913,2006-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16638913,2006-04-25T00:00:00,Inflammation,C23.550.470
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.644.276.718.550
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D12.776.467.718.550
16638913,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.440.893
16638913,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.480.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16638913,2006-04-25T00:00:00,Interferon-gamma,D23.529.718.550
16638913,2006-04-25T00:00:00,Interleukin-1,D12.644.276.374.465.501
16638913,2006-04-25T00:00:00,Interleukin-1,D12.644.276.374.500.400
16638913,2006-04-25T00:00:00,Interleukin-1,D12.776.467.374.465.501
16638913,2006-04-25T00:00:00,Interleukin-1,D12.776.467.374.500.400
16638913,2006-04-25T00:00:00,Interleukin-1,D23.529.374.465.501
16638913,2006-04-25T00:00:00,Interleukin-1,D23.529.374.500.400
16638913,2006-04-25T00:00:00,Interleukin-6,D12.644.276.374.465.506
16638913,2006-04-25T00:00:00,Interleukin-6,D12.776.467.374.465.506
16638913,2006-04-25T00:00:00,Interleukin-6,D23.529.374.465.506
16638913,2006-04-25T00:00:00,Lipopolysaccharides,D09.400.500
16638913,2006-04-25T00:00:00,Lipopolysaccharides,D09.698.718.450
16638913,2006-04-25T00:00:00,Lipopolysaccharides,D10.494
16638913,2006-04-25T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16638913,2006-04-25T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16638913,2006-04-25T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16638913,2006-04-25T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16638913,2006-04-25T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16638913,2006-04-25T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16712799,2006-04-25T00:00:00,Cell Line,A11.251.210
16712799,2006-04-25T00:00:00,Drug Resistance,G07.690.320
16712799,2006-04-25T00:00:00,Folic Acid,D03.438.733.631.400
16712799,2006-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16712799,2006-04-25T00:00:00,Oxidoreductases Acting on CH-NH Group Donors,D08.811.682.662
16645050,2006-04-27T00:00:00,Gene Deletion,G05.355.600.800.320
16645050,2006-04-27T00:00:00,Gene Deletion,G05.365.590.762.320
16645050,2006-04-27T00:00:00,Plasmids,G05.360.600
16645197,2006-04-27T00:00:00,Animals,B01.050
16645197,2006-04-27T00:00:00,Apoptosis,G04.299.139.160
16645197,2006-04-27T00:00:00,Brain,A08.186.211
16645197,2006-04-27T00:00:00,Cell Line,A11.251.210
16645197,2006-04-27T00:00:00,Enzyme Inhibitors,D27.505.519.389
16645197,2006-04-27T00:00:00,"Fatty Acids, Unsaturated",D10.251.355
16645197,2006-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
16645197,2006-04-27T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
16645197,2006-04-27T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16645197,2006-04-27T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16645197,2006-04-27T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16645197,2006-04-27T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16645197,2006-04-27T00:00:00,"Models, Biological",E05.599.395
16645197,2006-04-27T00:00:00,Oligodendroglia,A08.637.600
16645197,2006-04-27T00:00:00,Oligodendroglia,A11.650.600
16645197,2006-04-27T00:00:00,Psychosine,D02.033.100.700.700
16645197,2006-04-27T00:00:00,Psychosine,D02.092.063.700.700
16645197,2006-04-27T00:00:00,Psychosine,D09.400.410.420.806
16645197,2006-04-27T00:00:00,Psychosine,D10.390.470.806
16645197,2006-04-27T00:00:00,Psychosine,D10.570.877.360.806
16645197,2006-04-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16645197,2006-04-27T00:00:00,Reactive Oxygen Species,D01.339.431
16645197,2006-04-27T00:00:00,Reactive Oxygen Species,D01.650.775
16645197,2006-04-27T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
16645197,2006-04-27T00:00:00,Signal Transduction,G02.111.087.800
16645197,2006-04-27T00:00:00,Signal Transduction,G02.149.115.800
16645197,2006-04-27T00:00:00,Signal Transduction,G04.299.880
16646988,2006-04-28T00:00:00,Animals,B01.050
16646988,2006-04-28T00:00:00,"Arthritis, Experimental",C05.550.114.015
16646988,2006-04-28T00:00:00,"Arthritis, Experimental",E05.598.500.249
16646988,2006-04-28T00:00:00,Folic Acid,D03.438.733.631.400
16646988,2006-04-28T00:00:00,Macrophages,A11.329.372
16646988,2006-04-28T00:00:00,Macrophages,A11.627.482
16646988,2006-04-28T00:00:00,Macrophages,A11.733.397
16646988,2006-04-28T00:00:00,Macrophages,A15.382.680.397
16646988,2006-04-28T00:00:00,Macrophages,A15.382.812.522
16646988,2006-04-28T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
16646988,2006-04-28T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
16646988,2006-04-28T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
16646988,2006-04-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16646988,2006-04-28T00:00:00,Weight-Bearing,G01.374.676.965
16646988,2006-04-28T00:00:00,Weight-Bearing,G01.595.540.965
16648183,2006-04-28T00:00:00,Actins,D05.750.078.730.250
16648183,2006-04-28T00:00:00,Actins,D12.776.210.500.100
16648183,2006-04-28T00:00:00,Actins,D12.776.220.525.255
16648183,2006-04-28T00:00:00,Animals,B01.050
16648183,2006-04-28T00:00:00,Blood Pressure,E01.370.600.875.249
16648183,2006-04-28T00:00:00,Blood Pressure,G09.330.380.076
16648183,2006-04-28T00:00:00,Chick Embryo,A13.350.150
16648183,2006-04-28T00:00:00,Chick Embryo,A16.331.200
16648183,2006-04-28T00:00:00,Collagen Type I,D05.750.078.280.300.100
16648183,2006-04-28T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16648183,2006-04-28T00:00:00,Embryonic Development,G07.700.320.500.325.180
16648183,2006-04-28T00:00:00,Embryonic Development,G08.686.785.760.170.104
16648183,2006-04-28T00:00:00,Gene Expression Regulation,G05.355.315
16648183,2006-04-28T00:00:00,Microcirculation,G09.330.190.163.645
16648183,2006-04-28T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16648183,2006-04-28T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16648183,2006-04-28T00:00:00,"Myocytes, Cardiac",A11.620.500
16750613,2006-04-28T00:00:00,Adsorption,G02.149.047
16750613,2006-04-28T00:00:00,Adsorption,G02.149.767.029
16750613,2006-04-28T00:00:00,Adsorption,G02.842.750.029
16750613,2006-04-28T00:00:00,Biocompatible Materials,D25.130
16750613,2006-04-28T00:00:00,Biocompatible Materials,D27.720.102.130
16750613,2006-04-28T00:00:00,Biocompatible Materials,J01.637.051.130
16750613,2006-04-28T00:00:00,Fluorescent Dyes,D27.720.233.348
16750613,2006-04-28T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16750613,2006-04-28T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16750613,2006-04-28T00:00:00,Glutamine,D12.125.068.330
16750613,2006-04-28T00:00:00,Glutamine,D12.125.095.461
16750613,2006-04-28T00:00:00,Glutamine,D12.125.154.424
16750613,2006-04-28T00:00:00,Materials Testing,E05.570
16750613,2006-04-28T00:00:00,Polyethylenes,D02.455.326.271.665.550
16750613,2006-04-28T00:00:00,Polyethylenes,D05.750.716.507
16750613,2006-04-28T00:00:00,Polyethylenes,D25.720.716.507
16750613,2006-04-28T00:00:00,Polyethylenes,J01.637.051.720.716.507
16750613,2006-04-28T00:00:00,Proteins,D12.776
16750613,2006-04-28T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
16750613,2006-04-28T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
16750613,2006-04-28T00:00:00,Surface Properties,G02.842.850
16368519,2006-05-01T00:00:00,Adenoviridae,B04.280.030
16368519,2006-05-01T00:00:00,Adenoviridae,B04.909.204.097
16368519,2006-05-01T00:00:00,Animals,B01.050
16368519,2006-05-01T00:00:00,Antioxidants,D27.505.519.217
16368519,2006-05-01T00:00:00,Antioxidants,D27.505.696.706.125
16368519,2006-05-01T00:00:00,Antioxidants,D27.720.799.047
16368519,2006-05-01T00:00:00,Apoptosis,G04.299.139.160
16368519,2006-05-01T00:00:00,Bradykinin,D12.644.276.812.169
16368519,2006-05-01T00:00:00,Bradykinin,D12.644.400.090
16368519,2006-05-01T00:00:00,Bradykinin,D12.644.456.193
16368519,2006-05-01T00:00:00,Bradykinin,D12.776.467.812.169
16368519,2006-05-01T00:00:00,Bradykinin,D12.776.641.650.090
16368519,2006-05-01T00:00:00,Bradykinin,D23.469.050.375.110
16368519,2006-05-01T00:00:00,Bradykinin,D23.529.812.169
16368519,2006-05-01T00:00:00,Brain Ischemia,C10.228.140.300.150
16368519,2006-05-01T00:00:00,Brain Ischemia,C14.907.253.092
16368519,2006-05-01T00:00:00,Genetic Vectors,G05.360.337
16368519,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16368519,2006-05-01T00:00:00,Inflammation,C23.550.470
16368519,2006-05-01T00:00:00,Kinins,D12.644.276.812
16368519,2006-05-01T00:00:00,Kinins,D12.776.467.812
16368519,2006-05-01T00:00:00,Kinins,D23.469.050.375
16368519,2006-05-01T00:00:00,Kinins,D23.529.812
16368519,2006-05-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
16368519,2006-05-01T00:00:00,Neurons,A08.663
16368519,2006-05-01T00:00:00,Neurons,A11.671
16368519,2006-05-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16368519,2006-05-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16368519,2006-05-01T00:00:00,Oxidative Stress,G03.495.710
16368519,2006-05-01T00:00:00,Oxidative Stress,G07.700.830.750
16368519,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16368519,2006-05-01T00:00:00,"Receptors, Peptide",D12.776.543.750.750
16368519,2006-05-01T00:00:00,Reperfusion Injury,C14.907.725
16368519,2006-05-01T00:00:00,Reperfusion Injury,C23.550.767.877
16368519,2006-05-01T00:00:00,Signal Transduction,G02.111.087.800
16368519,2006-05-01T00:00:00,Signal Transduction,G02.149.115.800
16368519,2006-05-01T00:00:00,Signal Transduction,G04.299.880
16368519,2006-05-01T00:00:00,Stroke,C10.228.140.300.775
16368519,2006-05-01T00:00:00,Stroke,C14.907.253.855
16368519,2006-05-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
16368519,2006-05-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
16368519,2006-05-01T00:00:00,Tissue Kallikreins,D23.101.840.870
16528716,2006-05-01T00:00:00,Adolescent,M01.060.057
16528716,2006-05-01T00:00:00,Adult,M01.060.116
16528716,2006-05-01T00:00:00,Aged,M01.060.116.100
16528716,2006-05-01T00:00:00,Chronic Disease,C23.550.291.500
16528716,2006-05-01T00:00:00,Creatinine,D03.383.129.308.207
16528716,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16528716,2006-05-01T00:00:00,Incidence,E05.318.308.985.525.375
16528716,2006-05-01T00:00:00,Incidence,L01.280.975.525.375
16528716,2006-05-01T00:00:00,Incidence,N01.224.935.597.500
16528716,2006-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16528716,2006-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16528716,2006-05-01T00:00:00,Kidney,A05.810.453
16528716,2006-05-01T00:00:00,Kidney Diseases,C12.777.419
16528716,2006-05-01T00:00:00,Kidney Diseases,C13.351.968.419
16528716,2006-05-01T00:00:00,Liver Cirrhosis,C06.552.630
16528716,2006-05-01T00:00:00,Liver Transplantation,E04.210.650
16528716,2006-05-01T00:00:00,Liver Transplantation,E04.936.450.490
16528716,2006-05-01T00:00:00,Liver Transplantation,E04.936.580.490
16528716,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16528716,2006-05-01T00:00:00,Patient Selection,E05.581.500.653
16528716,2006-05-01T00:00:00,Patient Selection,N04.590.731
16528716,2006-05-01T00:00:00,Prevalence,E05.318.308.985.525.750
16528716,2006-05-01T00:00:00,Prevalence,L01.280.975.525.750
16528716,2006-05-01T00:00:00,Prevalence,N01.224.935.597.750
16528716,2006-05-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16528716,2006-05-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16528716,2006-05-01T00:00:00,Tissue and Organ Procurement,N02.421.911
16528716,2006-05-01T00:00:00,Waiting Lists,N04.452.095.738
16541466,2006-05-01T00:00:00,Animals,B01.050
16541466,2006-05-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16541466,2006-05-01T00:00:00,Flow Cytometry,E05.200.500.386.350
16541466,2006-05-01T00:00:00,Glomerulonephritis,C12.777.419.570.363
16541466,2006-05-01T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
16541466,2006-05-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16541466,2006-05-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16541466,2006-05-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16541466,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16541466,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16541466,2006-05-01T00:00:00,Interferon-gamma,D23.529.718.550
16541466,2006-05-01T00:00:00,Interleukin-12,D12.644.276.374.465.512
16541466,2006-05-01T00:00:00,Interleukin-12,D12.776.467.374.465.512
16541466,2006-05-01T00:00:00,Interleukin-12,D23.529.374.465.512
16541466,2006-05-01T00:00:00,Kidney,A05.810.453
16541466,2006-05-01T00:00:00,Lipopolysaccharides,D09.400.500
16541466,2006-05-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16541466,2006-05-01T00:00:00,Lipopolysaccharides,D10.494
16541466,2006-05-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16541466,2006-05-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16541466,2006-05-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
16541466,2006-05-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
16541466,2006-05-01T00:00:00,Lupus Nephritis,C17.300.480.680
16541466,2006-05-01T00:00:00,Lupus Nephritis,C20.111.590.560
16541466,2006-05-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
16541466,2006-05-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
16541466,2006-05-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
16541466,2006-05-01T00:00:00,"RNA, Messenger",D13.444.735.544
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
16541466,2006-05-01T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
16541466,2006-05-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
16541466,2006-05-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
16541466,2006-05-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
16596199,2006-05-01T00:00:00,Apoptosis,G04.299.139.160
16596199,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16596199,2006-05-01T00:00:00,NF-kappa B,D12.776.260.600
16596199,2006-05-01T00:00:00,NF-kappa B,D12.776.660.600
16596199,2006-05-01T00:00:00,NF-kappa B,D12.776.930.600
16596199,2006-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16596199,2006-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16596199,2006-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16596199,2006-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16596199,2006-05-01T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
16598194,2006-05-01T00:00:00,Animals,B01.050
16598194,2006-05-01T00:00:00,Cardiovascular Diseases,C14
16598194,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16598194,2006-05-01T00:00:00,Kidney Diseases,C12.777.419
16598194,2006-05-01T00:00:00,Kidney Diseases,C13.351.968.419
16611227,2006-05-01T00:00:00,Animals,B01.050
16611227,2006-05-01T00:00:00,Bacterial Toxins,D23.946.123
16611227,2006-05-01T00:00:00,Calcium,D01.268.552.100
16611227,2006-05-01T00:00:00,Calcium,D01.552.539.288
16611227,2006-05-01T00:00:00,Calcium,D23.119.100
16611227,2006-05-01T00:00:00,Cell Line,A11.251.210
16611227,2006-05-01T00:00:00,Fluorescent Dyes,D27.720.233.348
16611227,2006-05-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16611227,2006-05-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16611227,2006-05-01T00:00:00,Heat-Shock Proteins,D12.776.580.216
16611227,2006-05-01T00:00:00,Intracellular Membranes,A11.284.149.450
16611227,2006-05-01T00:00:00,Intracellular Membranes,A11.284.835.514
16611227,2006-05-01T00:00:00,Macrophages,A11.329.372
16611227,2006-05-01T00:00:00,Macrophages,A11.627.482
16611227,2006-05-01T00:00:00,Macrophages,A11.733.397
16611227,2006-05-01T00:00:00,Macrophages,A15.382.680.397
16611227,2006-05-01T00:00:00,Macrophages,A15.382.812.522
16621991,2006-05-01T00:00:00,Animals,B01.050
16621991,2006-05-01T00:00:00,Antibodies,D12.776.124.486.485.114
16621991,2006-05-01T00:00:00,Antibodies,D12.776.124.790.651.114
16621991,2006-05-01T00:00:00,Antibodies,D12.776.377.715.548.114
16621991,2006-05-01T00:00:00,Autoantigens,D23.050.422
16621991,2006-05-01T00:00:00,Cell Proliferation,G04.299.233.750
16621991,2006-05-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16621991,2006-05-01T00:00:00,Gene Expression Regulation,G05.355.315
16621991,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16621991,2006-05-01T00:00:00,Immune Tolerance,G12.425.746.425
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16621991,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16621991,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16621991,2006-05-01T00:00:00,Interferon-gamma,D23.529.718.550
16621991,2006-05-01T00:00:00,Interleukin-2,D12.644.276.374.465.502
16621991,2006-05-01T00:00:00,Interleukin-2,D12.644.276.374.480.372
16621991,2006-05-01T00:00:00,Interleukin-2,D12.776.467.374.465.502
16621991,2006-05-01T00:00:00,Interleukin-2,D12.776.467.374.480.372
16621991,2006-05-01T00:00:00,Interleukin-2,D23.529.374.465.502
16621991,2006-05-01T00:00:00,Interleukin-2,D23.529.374.480.372
16621991,2006-05-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16621991,2006-05-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16621991,2006-05-01T00:00:00,Neoplasms,C04
16621991,2006-05-01T00:00:00,Signal Transduction,G02.111.087.800
16621991,2006-05-01T00:00:00,Signal Transduction,G02.149.115.800
16621991,2006-05-01T00:00:00,Signal Transduction,G04.299.880
16621991,2006-05-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
16621991,2006-05-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
16621991,2006-05-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
16621991,2006-05-01T00:00:00,Thymus Gland,A10.549.750
16621991,2006-05-01T00:00:00,Thymus Gland,A15.382.520.604.750
16622345,2006-05-01T00:00:00,Aged,M01.060.116.100
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
16622345,2006-05-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
16622345,2006-05-01T00:00:00,"Diagnosis, Differential",E01.171
16622345,2006-05-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
16622345,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16622345,2006-05-01T00:00:00,"Kidney Diseases, Cystic",C12.777.419.403
16622345,2006-05-01T00:00:00,"Kidney Diseases, Cystic",C13.351.968.419.403
16622345,2006-05-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
16622345,2006-05-01T00:00:00,Kidney Neoplasms,C12.758.820.750
16622345,2006-05-01T00:00:00,Kidney Neoplasms,C12.777.419.473
16622345,2006-05-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
16622345,2006-05-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
16622345,2006-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
16622345,2006-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
16622345,2006-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
16622345,2006-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
16622345,2006-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
16622345,2006-05-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
16627203,2006-05-01T00:00:00,Breast Diseases,C17.800.090
16627203,2006-05-01T00:00:00,Breast Neoplasms,C04.588.180
16627203,2006-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
16627203,2006-05-01T00:00:00,Calcinosis,C18.452.174.130
16627203,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16627203,2006-05-01T00:00:00,Incidence,E05.318.308.985.525.375
16627203,2006-05-01T00:00:00,Incidence,L01.280.975.525.375
16627203,2006-05-01T00:00:00,Incidence,N01.224.935.597.500
16627203,2006-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16627203,2006-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16627203,2006-05-01T00:00:00,Mammography,E01.370.350.700.500
16627203,2006-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16627203,2006-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16627203,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
16627203,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
16627203,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
16627203,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
16627203,2006-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16627203,2006-05-01T00:00:00,Risk Assessment,N04.452.871.715
16627203,2006-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16627203,2006-05-01T00:00:00,Risk Assessment,N06.850.505.715
16627203,2006-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16627203,2006-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16627203,2006-05-01T00:00:00,Risk Factors,N05.715.350.200.700
16627203,2006-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16627203,2006-05-01T00:00:00,Risk Factors,N06.850.490.625.750
16627203,2006-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16627203,2006-05-01T00:00:00,United States,Z01.107.567.875
16627882,2006-05-01T00:00:00,Acetylcysteine,D02.886.030.230.259
16627882,2006-05-01T00:00:00,Acetylcysteine,D12.125.166.230.259
16627882,2006-05-01T00:00:00,Animals,B01.050
16627882,2006-05-01T00:00:00,"Animals, Newborn",B01.050.050.282
16627882,2006-05-01T00:00:00,Combined Modality Therapy,E02.186
16627882,2006-05-01T00:00:00,"Hypothermia, Induced",E02.258.750
16627882,2006-05-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.300.150.716
16627882,2006-05-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.624.500
16627882,2006-05-01T00:00:00,"Hypoxia-Ischemia, Brain",C14.907.253.092.716
16627882,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16627882,2006-05-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16635701,2006-05-01T00:00:00,Adolescent,M01.060.057
16635701,2006-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
16635701,2006-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
16635701,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16635701,2006-05-01T00:00:00,Obesity,C18.654.726.500
16635701,2006-05-01T00:00:00,Obesity,C23.888.144.699.500
16635701,2006-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16635701,2006-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16637797,2006-05-01T00:00:00,Adult,M01.060.116
16637797,2006-05-01T00:00:00,Aged,M01.060.116.100
16637797,2006-05-01T00:00:00,Coronary Disease,C14.280.647.250
16637797,2006-05-01T00:00:00,Coronary Disease,C14.907.585.250
16637797,2006-05-01T00:00:00,Evaluation Studies as Topic,E05.337
16637797,2006-05-01T00:00:00,Evaluation Studies as Topic,N05.715.360.335
16637797,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16637797,2006-05-01T00:00:00,Lipids,D10
16637797,2006-05-01T00:00:00,"Lipoproteins, LDL",D10.532.515
16637797,2006-05-01T00:00:00,"Lipoproteins, LDL",D12.776.521.550
16637797,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16637797,2006-05-01T00:00:00,Patient Compliance,F01.145.488.500
16637797,2006-05-01T00:00:00,Patient Compliance,N05.300.150.600.600
16637797,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16637797,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16637797,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16637798,2006-05-01T00:00:00,"Internship, Nonmedical",I02.358.750
16637798,2006-05-01T00:00:00,Patient Care,E02.760
16637798,2006-05-01T00:00:00,Patient Care,N02.421.585
16637798,2006-05-01T00:00:00,Pharmacists,M01.526.485.780
16637798,2006-05-01T00:00:00,Pharmacists,N02.360.780
16637798,2006-05-01T00:00:00,United States,Z01.107.567.875
16639192,2006-05-01T00:00:00,Academic Medical Centers,N02.278.020
16639192,2006-05-01T00:00:00,Clinical Competence,I02.399.630.210
16639192,2006-05-01T00:00:00,Clinical Competence,N04.761.210
16639192,2006-05-01T00:00:00,Curriculum,I02.158
16639192,2006-05-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
16639192,2006-05-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
16639192,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16639192,2006-05-01T00:00:00,Internship and Residency,I02.358.399.644
16639192,2006-05-01T00:00:00,Organizational Objectives,N04.452.615
16639192,2006-05-01T00:00:00,Program Evaluation,E05.337.820
16639192,2006-05-01T00:00:00,Program Evaluation,N04.761.685
16639192,2006-05-01T00:00:00,Program Evaluation,N05.715.360.650
16639192,2006-05-01T00:00:00,Software,L01.224.900
16639192,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16639192,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16639192,2006-05-01T00:00:00,Systems Integration,H01.770.787
16639192,2006-05-01T00:00:00,Systems Integration,L01.906.787
16640145,2006-05-01T00:00:00,Adolescent,M01.060.057
16640145,2006-05-01T00:00:00,Adult,M01.060.116
16640145,2006-05-01T00:00:00,Diabetes Complications,C19.246.099
16640145,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16640145,2006-05-01T00:00:00,Hypertension,C14.907.489
16640145,2006-05-01T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
16640145,2006-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
16640145,2006-05-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
16640145,2006-05-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
16640145,2006-05-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
16640145,2006-05-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
16640145,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16640145,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16640145,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16640145,2006-05-01T00:00:00,United States,Z01.107.567.875
16641304,2006-05-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
16641304,2006-05-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
16641304,2006-05-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
16641304,2006-05-01T00:00:00,Hepacivirus,B04.450.410
16641304,2006-05-01T00:00:00,Hepacivirus,B04.820.250.475
16641304,2006-05-01T00:00:00,Hepacivirus,B04.909.777.310.475
16641304,2006-05-01T00:00:00,Hepatitis C,C02.440.440
16641304,2006-05-01T00:00:00,Hepatitis C,C02.782.350.350
16641304,2006-05-01T00:00:00,Hepatitis C,C06.552.380.705.440
16641304,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
16641304,2006-05-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
16643482,2006-05-01T00:00:00,Adolescent,M01.060.057
16643482,2006-05-01T00:00:00,Adult,M01.060.116
16643482,2006-05-01T00:00:00,Aged,M01.060.116.100
16643482,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16643482,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16643482,2006-05-01T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
16643482,2006-05-01T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
16643482,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16643482,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16643482,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16643482,2006-05-01T00:00:00,Urinary Incontinence,C12.777.934.852
16643482,2006-05-01T00:00:00,Urinary Incontinence,C13.351.968.934.814
16643482,2006-05-01T00:00:00,Urinary Incontinence,C23.888.942.800
16644682,2006-05-01T00:00:00,Adult,M01.060.116
16644682,2006-05-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
16644682,2006-05-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
16644682,2006-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16644682,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16644682,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16644682,2006-05-01T00:00:00,Obesity,C18.654.726.500
16644682,2006-05-01T00:00:00,Obesity,C23.888.144.699.500
16644682,2006-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16644682,2006-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16644682,2006-05-01T00:00:00,"Polymorphism, Genetic",G05.365.795
16647352,2006-05-01T00:00:00,Aged,M01.060.116.100
16647352,2006-05-01T00:00:00,Breast Neoplasms,C04.588.180
16647352,2006-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
16647352,2006-05-01T00:00:00,"Diagnosis, Differential",E01.171
16647352,2006-05-01T00:00:00,"Hospitals, Community",N02.278.421.306
16647352,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16647352,2006-05-01T00:00:00,Incidence,E05.318.308.985.525.375
16647352,2006-05-01T00:00:00,Incidence,L01.280.975.525.375
16647352,2006-05-01T00:00:00,Incidence,N01.224.935.597.500
16647352,2006-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16647352,2006-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16647352,2006-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
16647352,2006-05-01T00:00:00,Lung Neoplasms,C08.381.540
16647352,2006-05-01T00:00:00,Lung Neoplasms,C08.785.520
16647352,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16647352,2006-05-01T00:00:00,Pneumonectomy,E04.928.600.600
16647352,2006-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16647352,2006-05-01T00:00:00,Risk Factors,N05.715.350.200.700
16647352,2006-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16647352,2006-05-01T00:00:00,Risk Factors,N06.850.490.625.750
16647352,2006-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16647353,2006-05-01T00:00:00,Aged,M01.060.116.100
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
16647353,2006-05-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
16647353,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16647353,2006-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16647353,2006-05-01T00:00:00,Risk Factors,N05.715.350.200.700
16647353,2006-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16647353,2006-05-01T00:00:00,Risk Factors,N06.850.490.625.750
16647353,2006-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16647353,2006-05-01T00:00:00,"Tumor Markers, Biological",D23.101.840
16651497,2006-05-01T00:00:00,Adolescent,M01.060.057
16651497,2006-05-01T00:00:00,Attitude to Health,F01.100.150
16651497,2006-05-01T00:00:00,Attitude to Health,N05.300.150
16651497,2006-05-01T00:00:00,Child,M01.060.406
16651497,2006-05-01T00:00:00,"Child, Preschool",M01.060.406.448
16651497,2006-05-01T00:00:00,Confidentiality,F04.096.544.335.240
16651497,2006-05-01T00:00:00,Confidentiality,I01.880.604.473.650.500
16651497,2006-05-01T00:00:00,Confidentiality,I01.880.604.583.080
16651497,2006-05-01T00:00:00,Confidentiality,N03.706.437.650.124
16651497,2006-05-01T00:00:00,Confidentiality,N03.706.535.230
16651497,2006-05-01T00:00:00,Genetic Testing,E01.370.427
16651497,2006-05-01T00:00:00,Genetic Testing,E05.393.435
16651497,2006-05-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
16651497,2006-05-01T00:00:00,Genetic Testing,N02.421.308.430
16651497,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16651497,2006-05-01T00:00:00,Infant,M01.060.703
16651497,2006-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
16651497,2006-05-01T00:00:00,Minors,M01.416
16651497,2006-05-01T00:00:00,Parents,F01.829.263.500.320
16651497,2006-05-01T00:00:00,Parents,I01.880.225.500.340
16651497,2006-05-01T00:00:00,Parents,M01.620
16651497,2006-05-01T00:00:00,Questionnaires,E05.318.308.750
16651497,2006-05-01T00:00:00,Questionnaires,L01.280.800
16651497,2006-05-01T00:00:00,Questionnaires,N05.715.360.300.695
16651497,2006-05-01T00:00:00,Questionnaires,N06.850.520.308.750
16651497,2006-05-01T00:00:00,Self Care,E02.900
16651497,2006-05-01T00:00:00,Self Care,N02.421.784.680
16651497,2006-05-01T00:00:00,United States,Z01.107.567.875
16651497,2006-05-01T00:00:00,alpha 1-Antitrypsin Deficiency,C17.300.050
16652089,2006-05-01T00:00:00,Aged,M01.060.116.100
16652089,2006-05-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
16652089,2006-05-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
16652089,2006-05-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
16652089,2006-05-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
16652089,2006-05-01T00:00:00,"Biopsy, Needle",E04.074.119
16652089,2006-05-01T00:00:00,Cause of Death,E05.318.308.985.550.250
16652089,2006-05-01T00:00:00,Cause of Death,L01.280.975.550.250
16652089,2006-05-01T00:00:00,Cause of Death,N01.224.935.698.100
16652089,2006-05-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
16652089,2006-05-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
16652089,2006-05-01T00:00:00,Combined Modality Therapy,E02.186
16652089,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16652089,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16652089,2006-05-01T00:00:00,Neoplasm Invasiveness,C04.697.645
16652089,2006-05-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
16652089,2006-05-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
16652089,2006-05-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
16652089,2006-05-01T00:00:00,Probability,E05.318.740.600
16652089,2006-05-01T00:00:00,Probability,G17.680
16652089,2006-05-01T00:00:00,Probability,N05.715.360.750.625
16652089,2006-05-01T00:00:00,Probability,N06.850.520.830.600
16652089,2006-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16652089,2006-05-01T00:00:00,Risk Assessment,N04.452.871.715
16652089,2006-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16652089,2006-05-01T00:00:00,Risk Assessment,N06.850.505.715
16652089,2006-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16652089,2006-05-01T00:00:00,Skin Neoplasms,C04.588.805
16652089,2006-05-01T00:00:00,Skin Neoplasms,C17.800.882
16652089,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16652089,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16652089,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16670553,2006-05-01T00:00:00,Artifacts,E05.047
16670553,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16670553,2006-05-01T00:00:00,Knee Joint,A02.835.583.475
16670553,2006-05-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16670553,2006-05-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16670553,2006-05-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16670553,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
16670553,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
16670553,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
16670553,2006-05-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,G17.800
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16670553,2006-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16672529,2006-05-01T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
16672529,2006-05-01T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
16672529,2006-05-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16672529,2006-05-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16672529,2006-05-01T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
16672529,2006-05-01T00:00:00,Vinyl Chloride,D02.455.326.271.884.750
16672529,2006-05-01T00:00:00,Vinyl Chloride,D02.455.526.439.975
16673758,2006-05-01T00:00:00,Age Factors,N05.715.350.075
16673758,2006-05-01T00:00:00,Age Factors,N06.850.490.250
16673758,2006-05-01T00:00:00,Aging,G07.700.320.124
16673758,2006-05-01T00:00:00,Animals,B01.050
16673758,2006-05-01T00:00:00,Chickens,B01.050.150.900.248.350.150
16673758,2006-05-01T00:00:00,Chickens,B01.050.150.900.248.617.192
16673758,2006-05-01T00:00:00,Liver,A03.620
16673758,2006-05-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
16673758,2006-05-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
16673758,2006-05-01T00:00:00,Ovary,A05.360.319.114.630
16673758,2006-05-01T00:00:00,Ovary,A05.360.576.497
16673758,2006-05-01T00:00:00,Ovary,A06.407.312.497
16673758,2006-05-01T00:00:00,Poultry Diseases,C22.131.728
16678542,2006-05-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
16678542,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16678542,2006-05-01T00:00:00,Membrane Proteins,D12.776.543
16678542,2006-05-01T00:00:00,Pain,C10.597.617
16678542,2006-05-01T00:00:00,Pain,C23.888.592.612
16678542,2006-05-01T00:00:00,Pain,C23.888.646
16678542,2006-05-01T00:00:00,Pain,F02.830.816.444
16678542,2006-05-01T00:00:00,Pain,G11.561.600.810.444
16678542,2006-05-01T00:00:00,Pharmacogenetics,H01.158.273.343.750
16678542,2006-05-01T00:00:00,Pharmacogenetics,H01.158.703.052
16678542,2006-05-01T00:00:00,Pharmacogenetics,H02.628.479
16678542,2006-05-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16678569,2006-05-01T00:00:00,"Anastomosis, Surgical",E04.035
16678569,2006-05-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
16678569,2006-05-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
16678569,2006-05-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
16678569,2006-05-01T00:00:00,Heart Arrest,C14.280.383
16678569,2006-05-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16678569,2006-05-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16678569,2006-05-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16678569,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16678569,2006-05-01T00:00:00,Incidence,E05.318.308.985.525.375
16678569,2006-05-01T00:00:00,Incidence,L01.280.975.525.375
16678569,2006-05-01T00:00:00,Incidence,N01.224.935.597.500
16678569,2006-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16678569,2006-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16678569,2006-05-01T00:00:00,Infant,M01.060.703
16678569,2006-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
16678569,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16678569,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16678569,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16686656,2006-05-01T00:00:00,Adolescent,M01.060.057
16686656,2006-05-01T00:00:00,Age of Onset,N05.715.350.075.100
16686656,2006-05-01T00:00:00,Age of Onset,N06.850.490.250.100
16686656,2006-05-01T00:00:00,Brain,A08.186.211
16686656,2006-05-01T00:00:00,Brain Mapping,E01.370.350.086
16686656,2006-05-01T00:00:00,Brain Mapping,E01.370.376.149
16686656,2006-05-01T00:00:00,Brain Mapping,E05.132
16686656,2006-05-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16686656,2006-05-01T00:00:00,Child,M01.060.406
16686656,2006-05-01T00:00:00,Epilepsy,C10.228.140.490
16686656,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16686656,2006-05-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16686656,2006-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16686656,2006-05-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16686656,2006-05-01T00:00:00,Neurosurgical Procedures,E04.525
16686656,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16686656,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16686656,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16687542,2006-05-01T00:00:00,Animals,B01.050
16687542,2006-05-01T00:00:00,Brain,A08.186.211
16687542,2006-05-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
16687542,2006-05-01T00:00:00,Stroke,C10.228.140.300.775
16687542,2006-05-01T00:00:00,Stroke,C14.907.253.855
16688061,2006-05-01T00:00:00,"Accidents, Traffic",N06.850.135.392
16688061,2006-05-01T00:00:00,Adolescent,M01.060.057
16688061,2006-05-01T00:00:00,Adult,M01.060.116
16688061,2006-05-01T00:00:00,Aged,M01.060.116.100
16688061,2006-05-01T00:00:00,Brain Injuries,C10.228.140.199
16688061,2006-05-01T00:00:00,Brain Injuries,C10.900.300.087
16688061,2006-05-01T00:00:00,Brain Injuries,C21.866.260.118
16688061,2006-05-01T00:00:00,Brain Injuries,C21.866.915.300.200
16688061,2006-05-01T00:00:00,Carbon Dioxide,D01.200.200
16688061,2006-05-01T00:00:00,Carbon Dioxide,D01.362.150
16688061,2006-05-01T00:00:00,Carbon Dioxide,D01.650.550.200
16688061,2006-05-01T00:00:00,Child,M01.060.406
16688061,2006-05-01T00:00:00,Craniocerebral Trauma,C10.900.300
16688061,2006-05-01T00:00:00,Craniocerebral Trauma,C21.866.260
16688061,2006-05-01T00:00:00,Craniocerebral Trauma,C21.866.915.300
16688061,2006-05-01T00:00:00,"Efficiency, Organizational",N04.452.227
16688061,2006-05-01T00:00:00,Emergency Medical Services,N02.421.297
16688061,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16688061,2006-05-01T00:00:00,Inservice Training,I02.574
16688061,2006-05-01T00:00:00,"Intubation, Intratracheal",E05.497.578
16688061,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16688061,2006-05-01T00:00:00,Multiple Trauma,C21.866.640
16688061,2006-05-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16688061,2006-05-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16688061,2006-05-01T00:00:00,Oxygen,D01.268.185.550
16688061,2006-05-01T00:00:00,Oxygen,D01.362.670
16688061,2006-05-01T00:00:00,Program Development,N04.452.760
16688061,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16688061,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16688061,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16699363,2006-05-01T00:00:00,Clinical Competence,I02.399.630.210
16699363,2006-05-01T00:00:00,Clinical Competence,N04.761.210
16699363,2006-05-01T00:00:00,Communication,F01.145.209
16699363,2006-05-01T00:00:00,Communication,L01.143
16699363,2006-05-01T00:00:00,"Education, Nursing, Continuing",I02.358.212.450
16699363,2006-05-01T00:00:00,"Education, Nursing, Continuing",I02.358.462.399
16699363,2006-05-01T00:00:00,Educational Measurement,I02.399
16699363,2006-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
16699363,2006-05-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
16699363,2006-05-01T00:00:00,Heart Failure,C14.280.434
16699363,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16699363,2006-05-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
16699363,2006-05-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
16699363,2006-05-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
16699363,2006-05-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
16699363,2006-05-01T00:00:00,Pilot Projects,E05.318.760.750
16699363,2006-05-01T00:00:00,Pilot Projects,E05.337.737
16699363,2006-05-01T00:00:00,Pilot Projects,N05.715.360.775.625
16699363,2006-05-01T00:00:00,Pilot Projects,N06.850.520.450.720
16699363,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16699363,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16699363,2006-05-01T00:00:00,Terminal Care,E02.760.905
16699363,2006-05-01T00:00:00,Terminal Care,N02.421.585.905
16707366,2006-05-01T00:00:00,Lymphoproliferative Disorders,C15.604.515
16707366,2006-05-01T00:00:00,Lymphoproliferative Disorders,C20.683.515
16707366,2006-05-01T00:00:00,Organ Transplantation,E04.936.450
16707366,2006-05-01T00:00:00,Postoperative Complications,C23.550.767
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,G17.800
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16707366,2006-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16716111,2006-05-01T00:00:00,Actins,D05.750.078.730.250
16716111,2006-05-01T00:00:00,Actins,D12.776.210.500.100
16716111,2006-05-01T00:00:00,Actins,D12.776.220.525.255
16716111,2006-05-01T00:00:00,Animals,B01.050
16716111,2006-05-01T00:00:00,Collagen,D05.750.078.280
16716111,2006-05-01T00:00:00,Collagen,D12.776.860.300.250
16716111,2006-05-01T00:00:00,Fibrosis,C23.550.355
16716111,2006-05-01T00:00:00,Inflammation,C23.550.470
16716111,2006-05-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
16716111,2006-05-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
16716111,2006-05-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
16716111,2006-05-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
16716111,2006-05-01T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
16716111,2006-05-01T00:00:00,Kidney,A05.810.453
16716111,2006-05-01T00:00:00,Kidney Glomerulus,A05.810.453.324.359
16716111,2006-05-01T00:00:00,Kidney Glomerulus,A05.810.453.736.520
16716111,2006-05-01T00:00:00,Oxidative Stress,G03.495.710
16716111,2006-05-01T00:00:00,Oxidative Stress,G07.700.830.750
16716111,2006-05-01T00:00:00,Proteinuria,C12.777.934.734
16716111,2006-05-01T00:00:00,Proteinuria,C13.351.968.934.734
16716111,2006-05-01T00:00:00,Proteinuria,C23.888.942.750
16716111,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16716111,2006-05-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
16716111,2006-05-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
16716111,2006-05-01T00:00:00,Tissue Kallikreins,D23.101.840.870
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
16716111,2006-05-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16721215,2006-05-01T00:00:00,Chronic Disease,C23.550.291.500
16721215,2006-05-01T00:00:00,Disease Progression,C23.550.291.656
16721215,2006-05-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16721215,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16735527,2006-05-01T00:00:00,Adult,M01.060.116
16735527,2006-05-01T00:00:00,African Americans,M01.686.508.100.100
16735527,2006-05-01T00:00:00,African Americans,M01.686.754.100
16735527,2006-05-01T00:00:00,Biomedical Research,H01.770.644.145
16735527,2006-05-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16735527,2006-05-01T00:00:00,Clinical Trials as Topic,E05.337.250
16735527,2006-05-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16735527,2006-05-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16735527,2006-05-01T00:00:00,Data Collection,E05.318.308
16735527,2006-05-01T00:00:00,Data Collection,L01.280
16735527,2006-05-01T00:00:00,Data Collection,N05.715.360.300
16735527,2006-05-01T00:00:00,Data Collection,N06.850.520.308
16735527,2006-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16735527,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16735527,2006-05-01T00:00:00,Patient Selection,E05.581.500.653
16735527,2006-05-01T00:00:00,Patient Selection,N04.590.731
16735527,2006-05-01T00:00:00,Psychometrics,F04.711.780
16735527,2006-05-01T00:00:00,Questionnaires,E05.318.308.750
16735527,2006-05-01T00:00:00,Questionnaires,L01.280.800
16735527,2006-05-01T00:00:00,Questionnaires,N05.715.360.300.695
16735527,2006-05-01T00:00:00,Questionnaires,N06.850.520.308.750
16735534,2006-05-01T00:00:00,Health Policy,I01.880.604.825.608.400
16735534,2006-05-01T00:00:00,Health Policy,N03.706.825.608.428
16735534,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16735534,2006-05-01T00:00:00,Primary Health Care,N04.590.233.727
16735534,2006-05-01T00:00:00,Quality of Health Care,N04.761
16735534,2006-05-01T00:00:00,Quality of Health Care,N05.715
16735534,2006-05-01T00:00:00,United States,Z01.107.567.875
16735846,2006-05-01T00:00:00,Academic Medical Centers,N02.278.020
16735846,2006-05-01T00:00:00,Aged,M01.060.116.100
16735846,2006-05-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
16735846,2006-05-01T00:00:00,Cooperative Behavior,F01.145.813.115
16735846,2006-05-01T00:00:00,Critical Pathways,N04.590.233.624.625
16735846,2006-05-01T00:00:00,Critical Pathways,N04.590.275
16735846,2006-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
16735846,2006-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16735846,2006-05-01T00:00:00,Geriatric Nursing,H02.478.676.236
16735846,2006-05-01T00:00:00,Geriatric Nursing,N02.421.533.245
16735846,2006-05-01T00:00:00,Hip Fractures,C21.866.404.061.425
16735846,2006-05-01T00:00:00,Hip Fractures,C21.866.404.484
16735846,2006-05-01T00:00:00,Hip Fractures,C21.866.531.750
16735846,2006-05-01T00:00:00,Hip Fractures,C21.866.558.276.425
16735846,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16735846,2006-05-01T00:00:00,Needs Assessment,I02.594
16735846,2006-05-01T00:00:00,Needs Assessment,N03.349.380.565
16735846,2006-05-01T00:00:00,Needs Assessment,N05.300.537
16735846,2006-05-01T00:00:00,North Carolina,Z01.107.567.875.075.475
16735846,2006-05-01T00:00:00,North Carolina,Z01.107.567.875.750.530
16735846,2006-05-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
16735846,2006-05-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
16735846,2006-05-01T00:00:00,Patient Care Team,N04.590.715
16735846,2006-05-01T00:00:00,Patient Discharge,E02.760.400.610
16735846,2006-05-01T00:00:00,Patient Discharge,N02.421.585.400.610
16735846,2006-05-01T00:00:00,Patient Education as Topic,I02.233.332.500
16735846,2006-05-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
16735846,2006-05-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
16735846,2006-05-01T00:00:00,Perioperative Care,E02.760.722
16735846,2006-05-01T00:00:00,Perioperative Care,E04.604
16735846,2006-05-01T00:00:00,Perioperative Care,N02.421.585.722
16735846,2006-05-01T00:00:00,Program Evaluation,E05.337.820
16735846,2006-05-01T00:00:00,Program Evaluation,N04.761.685
16735846,2006-05-01T00:00:00,Program Evaluation,N05.715.360.650
16735846,2006-05-01T00:00:00,Total Quality Management,N04.452.955
16735846,2006-05-01T00:00:00,Total Quality Management,N04.761.700.675
16735846,2006-05-01T00:00:00,Total Quality Management,N05.700.792
16739542,2006-05-01T00:00:00,"Diagnosis, Differential",E01.171
16739542,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E01.450.495.435.375.300
16739542,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.200.750.551.512.240.300
16739542,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.478.594.430.375.300
16739542,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16739542,2006-05-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16739542,2006-05-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16739542,2006-05-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16749643,2006-05-01T00:00:00,Adolescent,M01.060.057
16749643,2006-05-01T00:00:00,Adult,M01.060.116
16749643,2006-05-01T00:00:00,African Americans,M01.686.508.100.100
16749643,2006-05-01T00:00:00,African Americans,M01.686.754.100
16749643,2006-05-01T00:00:00,Aged,M01.060.116.100
16749643,2006-05-01T00:00:00,Child,M01.060.406
16749643,2006-05-01T00:00:00,"Child, Preschool",M01.060.406.448
16749643,2006-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16749643,2006-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
16749643,2006-05-01T00:00:00,Health Services Accessibility,N05.300.430
16749643,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16749643,2006-05-01T00:00:00,Infant,M01.060.703
16749643,2006-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
16749643,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16749643,2006-05-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16749643,2006-05-01T00:00:00,Patient Admission,E02.760.400.600
16749643,2006-05-01T00:00:00,Patient Admission,N02.421.585.400.600
16749643,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16749643,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16760702,2006-05-01T00:00:00,Blood Pressure,E01.370.600.875.249
16760702,2006-05-01T00:00:00,Blood Pressure,G09.330.380.076
16760702,2006-05-01T00:00:00,Diastole,G09.330.190.541.295
16760702,2006-05-01T00:00:00,Diastole,G11.427.590.540.554.250
16760702,2006-05-01T00:00:00,Diastole,G11.427.590.540.570.295
16760702,2006-05-01T00:00:00,Heart Failure,C14.280.434
16760702,2006-05-01T00:00:00,Heart Ventricles,A07.541.560
16760702,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760702,2006-05-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
16760702,2006-05-01T00:00:00,Stroke Volume,G09.330.380.124.882
16760702,2006-05-01T00:00:00,Syndrome,C23.550.288.500
16760702,2006-05-01T00:00:00,Terminology as Topic,L01.143.506.598.400
16760702,2006-05-01T00:00:00,Ventricular Remodeling,C23.300.985
16760702,2006-05-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16771676,2006-05-01T00:00:00,Animals,B01.050
16771676,2006-05-01T00:00:00,Central Nervous System,A08.186
16771676,2006-05-01T00:00:00,Central Nervous System Diseases,C10.228
16771676,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16771676,2006-05-01T00:00:00,Neuroglia,A08.637
16771676,2006-05-01T00:00:00,Neuroglia,A11.650
16771676,2006-05-01T00:00:00,Nitric Oxide,D01.339.387
16771676,2006-05-01T00:00:00,Nitric Oxide,D01.625.550.500
16771676,2006-05-01T00:00:00,Nitric Oxide,D01.625.700.500
16771676,2006-05-01T00:00:00,Nitric Oxide,D01.650.550.587.600
16771680,2006-05-01T00:00:00,Animals,B01.050
16771680,2006-05-01T00:00:00,Astrocytes,A08.637.200
16771680,2006-05-01T00:00:00,Astrocytes,A11.650.200
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16771680,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16771680,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16771680,2006-05-01T00:00:00,Interferon-gamma,D23.529.718.550
16771680,2006-05-01T00:00:00,Lipopolysaccharides,D09.400.500
16771680,2006-05-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16771680,2006-05-01T00:00:00,Lipopolysaccharides,D10.494
16771680,2006-05-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16771680,2006-05-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16771680,2006-05-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16771680,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16771680,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16771681,2006-05-01T00:00:00,Animals,B01.050
16771681,2006-05-01T00:00:00,Astrocytes,A08.637.200
16771681,2006-05-01T00:00:00,Astrocytes,A11.650.200
16771681,2006-05-01T00:00:00,Cell Death,G04.299.139
16771681,2006-05-01T00:00:00,Microglia,A08.637.400
16771681,2006-05-01T00:00:00,Microglia,A11.650.400
16771681,2006-05-01T00:00:00,NF-kappa B,D12.776.260.600
16771681,2006-05-01T00:00:00,NF-kappa B,D12.776.660.600
16771681,2006-05-01T00:00:00,NF-kappa B,D12.776.930.600
16771681,2006-05-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16771681,2006-05-01T00:00:00,Oxygen,D01.268.185.550
16771681,2006-05-01T00:00:00,Oxygen,D01.362.670
16771681,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16771681,2006-05-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16771681,2006-05-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
16771681,2006-05-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
16771681,2006-05-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
16771681,2006-05-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
16776054,2006-05-01T00:00:00,Animals,B01.050
16776054,2006-05-01T00:00:00,"Behavior, Animal",F01.145.113
16776054,2006-05-01T00:00:00,Columbidae,B01.050.150.900.248.165.150
16776054,2006-05-01T00:00:00,Conditioning (Psychology),F02.463.425.179
16776054,2006-05-01T00:00:00,Reinforcement (Psychology),F02.463.425.770
16776054,2006-05-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
16784079,2006-05-01T00:00:00,Adolescent,M01.060.057
16784079,2006-05-01T00:00:00,Adult,M01.060.116
16784079,2006-05-01T00:00:00,Anticoagulants,D27.505.954.502.119
16784079,2006-05-01T00:00:00,Child,M01.060.406
16784079,2006-05-01T00:00:00,"Child, Preschool",M01.060.406.448
16784079,2006-05-01T00:00:00,Disease-Free Survival,E01.789.200
16784079,2006-05-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16784079,2006-05-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16784079,2006-05-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16784079,2006-05-01T00:00:00,Embolism,C14.907.355.350
16784079,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
16784079,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
16784079,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
16784079,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16784079,2006-05-01T00:00:00,Infant,M01.060.703
16784079,2006-05-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
16784079,2006-05-01T00:00:00,Postoperative Complications,C23.550.767
16784079,2006-05-01T00:00:00,Thrombosis,C14.907.355.830
16784079,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16784079,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16784079,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16784079,2006-05-01T00:00:00,Warfarin,D03.438.150.446.520.914
16784079,2006-05-01T00:00:00,Warfarin,D03.830.219.446.520.914
16784088,2006-05-01T00:00:00,Bioprosthesis,E07.695.100
16784088,2006-05-01T00:00:00,Disease-Free Survival,E01.789.200
16784088,2006-05-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16784088,2006-05-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16784088,2006-05-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16784088,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
16784088,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
16784088,2006-05-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
16784088,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16784088,2006-05-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
16784088,2006-05-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
16784088,2006-05-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
16784088,2006-05-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
16808070,2006-05-01T00:00:00,Animals,B01.050
16808070,2006-05-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
16808070,2006-05-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
16808070,2006-05-01T00:00:00,Biocompatible Materials,D25.130
16808070,2006-05-01T00:00:00,Biocompatible Materials,D27.720.102.130
16808070,2006-05-01T00:00:00,Biocompatible Materials,J01.637.051.130
16808070,2006-05-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
16808070,2006-05-01T00:00:00,Equipment Failure Analysis,E05.325.192
16808070,2006-05-01T00:00:00,Hyaluronic Acid,D09.698.373.475
16808070,2006-05-01T00:00:00,Materials Testing,E05.570
16808070,2006-05-01T00:00:00,Polyethylenes,D02.455.326.271.665.550
16808070,2006-05-01T00:00:00,Polyethylenes,D05.750.716.507
16808070,2006-05-01T00:00:00,Polyethylenes,D25.720.716.507
16808070,2006-05-01T00:00:00,Polyethylenes,J01.637.051.720.716.507
16808070,2006-05-01T00:00:00,Surface Properties,G02.842.850
16809229,2006-05-01T00:00:00,Animals,B01.050
16809229,2006-05-01T00:00:00,Collagen,D05.750.078.280
16809229,2006-05-01T00:00:00,Collagen,D12.776.860.300.250
16809229,2006-05-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
16809229,2006-05-01T00:00:00,"Muscle, Skeletal",A02.633.567
16809229,2006-05-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
16809229,2006-05-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16809229,2006-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16809229,2006-05-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.635.500.700
16809229,2006-05-01T00:00:00,"Satellite Cells, Skeletal Muscle",A11.872.645.500.700
16809229,2006-05-01T00:00:00,Surgical Flaps,A10.850.710
16809229,2006-05-01T00:00:00,Surgical Flaps,E07.862.710
16809229,2006-05-01T00:00:00,Tissue Engineering,E05.200.249.750
16809229,2006-05-01T00:00:00,Wound Healing,G16.100.856.891
16809878,2006-05-01T00:00:00,Adult,M01.060.116
16809878,2006-05-01T00:00:00,African Americans,M01.686.508.100.100
16809878,2006-05-01T00:00:00,African Americans,M01.686.754.100
16809878,2006-05-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16809878,2006-05-01T00:00:00,Body Mass Index,E05.041.124.125
16809878,2006-05-01T00:00:00,Body Mass Index,G07.100.100.125
16809878,2006-05-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16809878,2006-05-01T00:00:00,Diabetes Mellitus,C18.452.394.750
16809878,2006-05-01T00:00:00,Diabetes Mellitus,C19.246
16809878,2006-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16809878,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16809878,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16809878,2006-05-01T00:00:00,Obesity,C18.654.726.500
16809878,2006-05-01T00:00:00,Obesity,C23.888.144.699.500
16809878,2006-05-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16809878,2006-05-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16809878,2006-05-01T00:00:00,Prevalence,E05.318.308.985.525.750
16809878,2006-05-01T00:00:00,Prevalence,L01.280.975.525.750
16809878,2006-05-01T00:00:00,Prevalence,N01.224.935.597.750
16809878,2006-05-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16809878,2006-05-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16809878,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16809878,2006-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16861094,2006-05-01T00:00:00,Adult,M01.060.116
16861094,2006-05-01T00:00:00,Algorithms,G17.035
16861094,2006-05-01T00:00:00,Algorithms,L01.224.050
16861094,2006-05-01T00:00:00,Benzimidazoles,D03.438.103
16861094,2006-05-01T00:00:00,Cross-Over Studies,E05.318.780.150
16861094,2006-05-01T00:00:00,Cross-Over Studies,N05.715.360.780.150
16861094,2006-05-01T00:00:00,Cross-Over Studies,N06.850.520.445.150
16861094,2006-05-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16861094,2006-05-01T00:00:00,Gastric Acid,A12.200.307.603
16861094,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16861094,2006-05-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
16861094,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16861094,2006-05-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
16870106,2006-05-01T00:00:00,Adolescent,M01.060.057
16870106,2006-05-01T00:00:00,Biological Markers,D23.101
16870106,2006-05-01T00:00:00,Child,M01.060.406
16870106,2006-05-01T00:00:00,"Child, Preschool",M01.060.406.448
16870106,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E01.450.495.435.375.300
16870106,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.200.750.551.512.240.300
16870106,2006-05-01T00:00:00,"Fluorescent Antibody Technique, Direct",E05.478.594.430.375.300
16870106,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16870106,2006-05-01T00:00:00,Infant,M01.060.703
16870106,2006-05-01T00:00:00,"Muscle, Skeletal",A02.633.567
16870106,2006-05-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
16870106,2006-05-01T00:00:00,Pediatrics,H02.403.670
16870106,2006-05-01T00:00:00,Rheumatology,H02.403.429.730
16871936,2006-05-01T00:00:00,Chronic Disease,C23.550.291.500
16871936,2006-05-01T00:00:00,Endoscopy,E01.370.388.250
16871936,2006-05-01T00:00:00,Endoscopy,E04.800.250
16871936,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16871936,2006-05-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
16871936,2006-05-01T00:00:00,Maxilla,A14.521.645
16871936,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16871936,2006-05-01T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,C10.720.112.200
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,C21.613.705.150.200
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,C21.739.100.087.193.200
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,C21.739.835.250
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,F03.900.100.100
16923667,2006-05-01T00:00:00,Alcohol Withdrawal Delirium,F03.900.825.500
16923667,2006-05-01T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16923667,2006-05-01T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16923667,2006-05-01T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16923667,2006-05-01T00:00:00,Benzodiazepines,D03.438.079.080
16923667,2006-05-01T00:00:00,Creatinine,D03.383.129.308.207
16923667,2006-05-01T00:00:00,Ethanol,D02.033.375
16923667,2006-05-01T00:00:00,Hospitalization,E02.760.400
16923667,2006-05-01T00:00:00,Hospitalization,N02.421.585.400
16923667,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16923667,2006-05-01T00:00:00,Length of Stay,E02.760.400.480
16923667,2006-05-01T00:00:00,Length of Stay,N02.421.585.400.480
16923667,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16923667,2006-05-01T00:00:00,Patient Admission,E02.760.400.600
16923667,2006-05-01T00:00:00,Patient Admission,N02.421.585.400.600
16923667,2006-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16923667,2006-05-01T00:00:00,Risk Factors,N05.715.350.200.700
16923667,2006-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16923667,2006-05-01T00:00:00,Risk Factors,N06.850.490.625.750
16923667,2006-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16923667,2006-05-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16923667,2006-05-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16956483,2006-05-01T00:00:00,Adult,M01.060.116
16956483,2006-05-01T00:00:00,Aged,M01.060.116.100
16956483,2006-05-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
16956483,2006-05-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
16956483,2006-05-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.200.345
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C10.228.140.300.350.500
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C10.900.250.300
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C14.907.253.123.345
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C14.907.253.535.500
16956483,2006-05-01T00:00:00,Carotid Artery Injuries,C21.866.915.200.200
16956483,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16956483,2006-05-01T00:00:00,Middle Aged,M01.060.116.630
16956483,2006-05-01T00:00:00,Stents,E07.695.750
16956483,2006-05-01T00:00:00,Treatment Outcome,E01.789.800
16956483,2006-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16956483,2006-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17409884,2006-05-01T00:00:00,Aged,M01.060.116.100
17409884,2006-05-01T00:00:00,"Biopsy, Fine-Needle",E01.370.388.100.100.500
17409884,2006-05-01T00:00:00,"Biopsy, Fine-Needle",E01.450.230.100.100.500
17409884,2006-05-01T00:00:00,"Biopsy, Fine-Needle",E01.450.865.100.100.500
17409884,2006-05-01T00:00:00,"Biopsy, Fine-Needle",E04.074.119.500
17409884,2006-05-01T00:00:00,Bronchoscopy,E01.370.386.105
17409884,2006-05-01T00:00:00,Bronchoscopy,E01.370.388.250.100
17409884,2006-05-01T00:00:00,Bronchoscopy,E04.800.250.100
17409884,2006-05-01T00:00:00,Bronchoscopy,E04.928.600.080
17409884,2006-05-01T00:00:00,Endosonography,E01.370.350.850.280
17409884,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17409884,2006-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17409884,2006-05-01T00:00:00,Lung Neoplasms,C08.381.540
17409884,2006-05-01T00:00:00,Lung Neoplasms,C08.785.520
17409884,2006-05-01T00:00:00,Pulmonary Artery,A07.231.114.715
17764205,2006-05-01T00:00:00,Calcium,D01.268.552.100
17764205,2006-05-01T00:00:00,Calcium,D01.552.539.288
17764205,2006-05-01T00:00:00,Calcium,D23.119.100
17764205,2006-05-01T00:00:00,Chronic Disease,C23.550.291.500
17764205,2006-05-01T00:00:00,Dietary Supplements,J02.500.456
17764205,2006-05-01T00:00:00,Folic Acid,D03.438.733.631.400
17764205,2006-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17764205,2006-05-01T00:00:00,Selenium,D01.268.185.850
17764205,2006-05-01T00:00:00,Selenium,D01.578.700
17764205,2006-05-01T00:00:00,Vitamin D,D04.808.812.768
16650460,2006-05-02T00:00:00,Actins,D05.750.078.730.250
16650460,2006-05-02T00:00:00,Actins,D12.776.210.500.100
16650460,2006-05-02T00:00:00,Actins,D12.776.220.525.255
16650460,2006-05-02T00:00:00,Cell Line,A11.251.210
16650460,2006-05-02T00:00:00,Child,M01.060.406
16650460,2006-05-02T00:00:00,"Child, Preschool",M01.060.406.448
16650460,2006-05-02T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
16650460,2006-05-02T00:00:00,Fibroblasts,A11.329.228
16650460,2006-05-02T00:00:00,Fibroblasts,A11.872.228
16650460,2006-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,E05.318.740.475
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,E05.318.780.485
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,N05.715.360.750.500
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,N05.715.360.780.500
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,N06.850.520.445.485
16650460,2006-05-02T00:00:00,Matched-Pair Analysis,N06.850.520.830.475
16650460,2006-05-02T00:00:00,"RNA, Messenger",D13.444.735.544
16650460,2006-05-02T00:00:00,Skin,A17.815
16652219,2006-05-02T00:00:00,Animals,B01.050
16652219,2006-05-02T00:00:00,Gene Expression Regulation,G05.355.315
16652219,2006-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16652219,2006-05-02T00:00:00,Immunity,G12.450
16652219,2006-05-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
16652219,2006-05-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
16652219,2006-05-02T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
16670094,2006-05-02T00:00:00,Arrestins,D12.776.306.090
16670094,2006-05-02T00:00:00,Arrestins,D12.776.543.090
16670094,2006-05-02T00:00:00,Cell Line,A11.251.210
16670094,2006-05-02T00:00:00,Cell Membrane,A11.284.149
16670094,2006-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
16670094,2006-05-02T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
16670094,2006-05-02T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
16670094,2006-05-02T00:00:00,Signal Transduction,G02.111.087.800
16670094,2006-05-02T00:00:00,Signal Transduction,G02.149.115.800
16670094,2006-05-02T00:00:00,Signal Transduction,G04.299.880
16670131,2006-05-02T00:00:00,Adult,M01.060.116
16670131,2006-05-02T00:00:00,Anti-Obesity Agents,D27.505.954.427.140
16670131,2006-05-02T00:00:00,Behavior Therapy,F04.754.137
16670131,2006-05-02T00:00:00,Body Mass Index,E01.370.600.115.100.125
16670131,2006-05-02T00:00:00,Body Mass Index,E05.041.124.125
16670131,2006-05-02T00:00:00,Body Mass Index,G07.100.100.125
16670131,2006-05-02T00:00:00,Body Mass Index,N06.850.505.200.100.175
16670131,2006-05-02T00:00:00,"Diet, Reducing",E02.642.249.285
16670131,2006-05-02T00:00:00,"Diet, Reducing",G07.610.240.285
16670131,2006-05-02T00:00:00,Exercise Therapy,E02.779.483
16670131,2006-05-02T00:00:00,Exercise Therapy,E02.831.387
16670131,2006-05-02T00:00:00,Gastroplasty,E02.065.062.750
16670131,2006-05-02T00:00:00,Gastroplasty,E04.062.750
16670131,2006-05-02T00:00:00,Gastroplasty,E04.210.485
16670131,2006-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16670131,2006-05-02T00:00:00,Lactones,D02.540
16670131,2006-05-02T00:00:00,Laparoscopy,E01.370.388.250.520
16670131,2006-05-02T00:00:00,Laparoscopy,E04.800.250.520
16670131,2006-05-02T00:00:00,Middle Aged,M01.060.116.630
16670131,2006-05-02T00:00:00,Obesity,C18.654.726.500
16670131,2006-05-02T00:00:00,Obesity,C23.888.144.699.500
16670131,2006-05-02T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16670131,2006-05-02T00:00:00,Obesity,G07.100.100.160.120.699.500
16670131,2006-05-02T00:00:00,Quality of Life,I01.800
16670131,2006-05-02T00:00:00,Quality of Life,K01.752.400.750
16670131,2006-05-02T00:00:00,Weight Loss,C23.888.144.243.963
16670131,2006-05-02T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16704888,2006-05-02T00:00:00,Animals,B01.050
16704888,2006-05-02T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
16704888,2006-05-02T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
16704888,2006-05-02T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
16704888,2006-05-02T00:00:00,Chemokines,D12.644.276.374.200
16704888,2006-05-02T00:00:00,Chemokines,D12.776.467.374.200
16704888,2006-05-02T00:00:00,Chemokines,D23.125.300
16704888,2006-05-02T00:00:00,Chemokines,D23.469.200
16704888,2006-05-02T00:00:00,Chemokines,D23.529.374.200
16704888,2006-05-02T00:00:00,Cytokines,D12.644.276.374
16704888,2006-05-02T00:00:00,Cytokines,D12.776.467.374
16704888,2006-05-02T00:00:00,Cytokines,D23.529.374
16704888,2006-05-02T00:00:00,Interferon Type I,D12.644.276.374.440.890
16704888,2006-05-02T00:00:00,Interferon Type I,D12.644.276.718.500
16704888,2006-05-02T00:00:00,Interferon Type I,D12.776.467.374.440.890
16704888,2006-05-02T00:00:00,Interferon Type I,D12.776.467.718.500
16704888,2006-05-02T00:00:00,Interferon Type I,D23.529.374.440.890
16704888,2006-05-02T00:00:00,Interferon Type I,D23.529.718.500
16704888,2006-05-02T00:00:00,Macrophages,A11.329.372
16704888,2006-05-02T00:00:00,Macrophages,A11.627.482
16704888,2006-05-02T00:00:00,Macrophages,A11.733.397
16704888,2006-05-02T00:00:00,Macrophages,A15.382.680.397
16704888,2006-05-02T00:00:00,Macrophages,A15.382.812.522
16704888,2006-05-02T00:00:00,Peptides,D12.644
16704888,2006-05-02T00:00:00,Vaccination,E02.095.465.425.400.530.890
16704888,2006-05-02T00:00:00,Vaccination,E05.478.550.600.890
16704888,2006-05-02T00:00:00,Vaccination,N02.421.726.758.310.890
16704888,2006-05-02T00:00:00,Vaccination,N06.850.780.200.425.900
16704888,2006-05-02T00:00:00,Vaccination,N06.850.780.680.310.890
16670409,2006-05-03T00:00:00,Adult,M01.060.116
16670409,2006-05-03T00:00:00,Alcoholism,C21.739.100.250
16670409,2006-05-03T00:00:00,Alcoholism,F03.900.100.350
16670409,2006-05-03T00:00:00,Behavior Therapy,F04.754.137
16670409,2006-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16670409,2006-05-03T00:00:00,Middle Aged,M01.060.116.630
16670409,2006-05-03T00:00:00,Naltrexone,D03.132.577.249.706.550
16670409,2006-05-03T00:00:00,Naltrexone,D03.549.686.750.550
16670409,2006-05-03T00:00:00,Naltrexone,D03.605.497.750.550
16670409,2006-05-03T00:00:00,Naltrexone,D04.615.723.795.706.550
16670409,2006-05-03T00:00:00,Narcotic Antagonists,D27.505.696.543
16670409,2006-05-03T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
16670409,2006-05-03T00:00:00,Narcotic Antagonists,D27.505.954.427.550
16670409,2006-05-03T00:00:00,Taurine,D02.455.326.146.100.850
16670409,2006-05-03T00:00:00,Taurine,D02.886.645.600.055.850
16672362,2006-05-03T00:00:00,Animals,B01.050
16672362,2006-05-03T00:00:00,Biological Markers,D23.101
16672362,2006-05-03T00:00:00,Carrier Proteins,D12.776.157
16672362,2006-05-03T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
16672362,2006-05-03T00:00:00,Membrane Proteins,D12.776.543
16675025,2006-05-03T00:00:00,"Adaptation, Physiological",G07.700.062
16675025,2006-05-03T00:00:00,"Adaptation, Physiological",G16.100.057.500
16675025,2006-05-03T00:00:00,Animals,B01.050
16675025,2006-05-03T00:00:00,Attention,F02.830.104.214
16675025,2006-05-03T00:00:00,"Behavior, Animal",F01.145.113
16675025,2006-05-03T00:00:00,Brain,A08.186.211
16675025,2006-05-03T00:00:00,Brain Mapping,E01.370.350.086
16675025,2006-05-03T00:00:00,Brain Mapping,E01.370.376.149
16675025,2006-05-03T00:00:00,Brain Mapping,E05.132
16675025,2006-05-03T00:00:00,Eye Movements,G11.427.590.530.140
16675025,2006-05-03T00:00:00,Eye Movements,G14.640.260
16675025,2006-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16675025,2006-05-03T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16675025,2006-05-03T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
16675025,2006-05-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16675025,2006-05-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16675025,2006-05-03T00:00:00,Oxygen,D01.268.185.550
16675025,2006-05-03T00:00:00,Oxygen,D01.362.670
16675025,2006-05-03T00:00:00,Photic Stimulation,E05.723.729
16675714,2006-05-04T00:00:00,Adolescent,M01.060.057
16675714,2006-05-04T00:00:00,Blood Glucose,D09.546.359.448.500
16675714,2006-05-04T00:00:00,Child,M01.060.406
16675714,2006-05-04T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
16675714,2006-05-04T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
16675714,2006-05-04T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
16675714,2006-05-04T00:00:00,Family Therapy,F04.754.864.581.273
16675714,2006-05-04T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
16675714,2006-05-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
16675714,2006-05-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
16675714,2006-05-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16675714,2006-05-04T00:00:00,Patient Compliance,F01.145.488.500
16675714,2006-05-04T00:00:00,Patient Compliance,N05.300.150.600.600
16675714,2006-05-04T00:00:00,Social Support,I01.880.656.600
16675714,2006-05-04T00:00:00,Treatment Outcome,E01.789.800
16675714,2006-05-04T00:00:00,Treatment Outcome,N04.761.559.590.800
16675714,2006-05-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16679393,2006-05-05T00:00:00,Animals,B01.050
16679393,2006-05-05T00:00:00,Chick Embryo,A13.350.150
16679393,2006-05-05T00:00:00,Chick Embryo,A16.331.200
16679393,2006-05-05T00:00:00,Heart Atria,A07.541.358
16679393,2006-05-05T00:00:00,Heart Conduction System,A07.541.409
16679393,2006-05-05T00:00:00,Myocardial Contraction,G09.330.190.541
16679393,2006-05-05T00:00:00,Myocardial Contraction,G11.427.590.540.570
16679393,2006-05-05T00:00:00,Myocardium,A02.633.580
16679393,2006-05-05T00:00:00,Myocardium,A07.541.704
16679393,2006-05-05T00:00:00,Myocardium,A10.690.552.750
16679393,2006-05-05T00:00:00,Sinoatrial Node,A07.541.409.819
16680459,2006-05-06T00:00:00,Cell Culture Techniques,E05.200.249.249
16680459,2006-05-06T00:00:00,Escherichia coli,B03.440.450.425.325.300
16680459,2006-05-06T00:00:00,Escherichia coli,B03.660.250.150.180.100
16680459,2006-05-06T00:00:00,Gene Expression Profiling,E05.393.332
16680459,2006-05-06T00:00:00,Heat-Shock Proteins,D12.776.580.216
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16680459,2006-05-06T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16680459,2006-05-06T00:00:00,Recombinant Proteins,D12.776.828
16680459,2006-05-06T00:00:00,"Transcription, Genetic",G02.111.087.847
16680459,2006-05-06T00:00:00,"Transcription, Genetic",G02.149.115.847
16680459,2006-05-06T00:00:00,"Transcription, Genetic",G05.355.310.700
16682453,2006-05-08T00:00:00,Anoxia,C23.888.852.079
16682453,2006-05-08T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
16682453,2006-05-08T00:00:00,Cell Line,A11.251.210
16682453,2006-05-08T00:00:00,Cobalt,D01.268.556.185
16682453,2006-05-08T00:00:00,Cobalt,D01.268.956.155
16682453,2006-05-08T00:00:00,Cobalt,D01.552.544.185
16682453,2006-05-08T00:00:00,Gene Expression Regulation,G05.355.315
16682453,2006-05-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16682453,2006-05-08T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
16682453,2006-05-08T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
16682453,2006-05-08T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
16682453,2006-05-08T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
16682453,2006-05-08T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16682453,2006-05-08T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16682453,2006-05-08T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16682453,2006-05-08T00:00:00,"RNA, Messenger",D13.444.735.544
16682453,2006-05-08T00:00:00,Signal Transduction,G02.111.087.800
16682453,2006-05-08T00:00:00,Signal Transduction,G02.149.115.800
16682453,2006-05-08T00:00:00,Signal Transduction,G04.299.880
16682453,2006-05-08T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
16682453,2006-05-08T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
16682453,2006-05-08T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
16682805,2006-05-08T00:00:00,Animals,B01.050
16682805,2006-05-08T00:00:00,Cattle,B01.050.150.900.649.077.380.271
16682805,2006-05-08T00:00:00,Cell Line,A11.251.210
16682805,2006-05-08T00:00:00,Cell Movement,G04.299.283
16682805,2006-05-08T00:00:00,Cell Movement,G07.700.560.500.180
16682805,2006-05-08T00:00:00,Chick Embryo,A13.350.150
16682805,2006-05-08T00:00:00,Chick Embryo,A16.331.200
16682805,2006-05-08T00:00:00,Chorioallantoic Membrane,A10.615.284.375
16682805,2006-05-08T00:00:00,Chorioallantoic Membrane,A13.350.575
16682805,2006-05-08T00:00:00,Chorioallantoic Membrane,A16.331.400
16682805,2006-05-08T00:00:00,Endothelial Cells,A11.436.275
16682805,2006-05-08T00:00:00,Gene Expression Regulation,G05.355.315
16682805,2006-05-08T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
16682805,2006-05-08T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
16682805,2006-05-08T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
16682805,2006-05-08T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
16682805,2006-05-08T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16682805,2006-05-08T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
16682805,2006-05-08T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
16682805,2006-05-08T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
16682805,2006-05-08T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16682805,2006-05-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16682805,2006-05-08T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16682805,2006-05-08T00:00:00,"RNA, Messenger",D13.444.735.544
16682805,2006-05-08T00:00:00,Signal Transduction,G02.111.087.800
16682805,2006-05-08T00:00:00,Signal Transduction,G02.149.115.800
16682805,2006-05-08T00:00:00,Signal Transduction,G04.299.880
16682665,2006-05-09T00:00:00,Aged,M01.060.116.100
16682665,2006-05-09T00:00:00,Brain Ischemia,C10.228.140.300.150
16682665,2006-05-09T00:00:00,Brain Ischemia,C14.907.253.092
16682665,2006-05-09T00:00:00,Continental Population Groups,M01.686.508
16682665,2006-05-09T00:00:00,Disease Progression,C23.550.291.656
16682665,2006-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16682665,2006-05-09T00:00:00,Incidence,E05.318.308.985.525.375
16682665,2006-05-09T00:00:00,Incidence,L01.280.975.525.375
16682665,2006-05-09T00:00:00,Incidence,N01.224.935.597.500
16682665,2006-05-09T00:00:00,Incidence,N06.850.505.400.975.525.375
16682665,2006-05-09T00:00:00,Incidence,N06.850.520.308.985.525.375
16682665,2006-05-09T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
16682665,2006-05-09T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
16682665,2006-05-09T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
16682665,2006-05-09T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
16682665,2006-05-09T00:00:00,Metabolic Syndrome X,C18.452.625
16682665,2006-05-09T00:00:00,Middle Aged,M01.060.116.630
16682665,2006-05-09T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16682665,2006-05-09T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16682665,2006-05-09T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16682665,2006-05-09T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16682665,2006-05-09T00:00:00,Myocardial Infarction,C14.280.647.500
16682665,2006-05-09T00:00:00,Myocardial Infarction,C14.907.585.500
16682665,2006-05-09T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16682665,2006-05-09T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16682665,2006-05-09T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16682665,2006-05-09T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16682665,2006-05-09T00:00:00,Risk Factors,E05.318.740.600.800.725
16682665,2006-05-09T00:00:00,Risk Factors,N05.715.350.200.700
16682665,2006-05-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16682665,2006-05-09T00:00:00,Risk Factors,N06.850.490.625.750
16682665,2006-05-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16682665,2006-05-09T00:00:00,Warfarin,D03.438.150.446.520.914
16682665,2006-05-09T00:00:00,Warfarin,D03.830.219.446.520.914
16685119,2006-05-09T00:00:00,Age Factors,N05.715.350.075
16685119,2006-05-09T00:00:00,Age Factors,N06.850.490.250
16685119,2006-05-09T00:00:00,Aged,M01.060.116.100
16685119,2006-05-09T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16685119,2006-05-09T00:00:00,Atherosclerosis,C14.907.137.126.307
16685119,2006-05-09T00:00:00,Brain,A08.186.211
16685119,2006-05-09T00:00:00,Clinical Trials as Topic,E05.318.760.535
16685119,2006-05-09T00:00:00,Clinical Trials as Topic,E05.337.250
16685119,2006-05-09T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16685119,2006-05-09T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16685119,2006-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16685119,2006-05-09T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16685119,2006-05-09T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16685119,2006-05-09T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16685119,2006-05-09T00:00:00,Hypertension,C14.907.489
16685119,2006-05-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16685119,2006-05-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16685119,2006-05-09T00:00:00,Middle Aged,M01.060.116.630
16685119,2006-05-09T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
16685119,2006-05-09T00:00:00,Risk Factors,E05.318.740.600.800.725
16685119,2006-05-09T00:00:00,Risk Factors,N05.715.350.200.700
16685119,2006-05-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16685119,2006-05-09T00:00:00,Risk Factors,N06.850.490.625.750
16685119,2006-05-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16685119,2006-05-09T00:00:00,Stroke,C10.228.140.300.775
16685119,2006-05-09T00:00:00,Stroke,C14.907.253.855
16538683,2006-05-10T00:00:00,Animals,B01.050
16538683,2006-05-10T00:00:00,"Animals, Newborn",B01.050.050.282
16538683,2006-05-10T00:00:00,Cell Differentiation,G04.299.151
16538683,2006-05-10T00:00:00,"Ear, Inner",A09.246.631
16538683,2006-05-10T00:00:00,Fibroblasts,A11.329.228
16538683,2006-05-10T00:00:00,Fibroblasts,A11.872.228
16538683,2006-05-10T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16538683,2006-05-10T00:00:00,Flow Cytometry,E05.200.500.386.350
16538683,2006-05-10T00:00:00,Green Fluorescent Proteins,D12.776.532.265
16538683,2006-05-10T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
16538683,2006-05-10T00:00:00,Hematopoietic Stem Cells,A11.148.378
16538683,2006-05-10T00:00:00,Hematopoietic Stem Cells,A11.872.378
16538683,2006-05-10T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
16538683,2006-05-10T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16538683,2006-05-10T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16538683,2006-05-10T00:00:00,Neurons,A08.663
16538683,2006-05-10T00:00:00,Neurons,A11.671
16538683,2006-05-10T00:00:00,Sodium-Potassium-Exchanging ATPase,D08.811.277.040.025.810
16538683,2006-05-10T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.162.780
16538683,2006-05-10T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.157.530.450.250.880
16538683,2006-05-10T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.162.800
16538683,2006-05-10T00:00:00,Sodium-Potassium-Exchanging ATPase,D12.776.543.585.450.250.890
16682735,2006-05-10T00:00:00,Continental Population Groups,M01.686.508
16682735,2006-05-10T00:00:00,Ethnic Groups,M01.686.754
16682735,2006-05-10T00:00:00,Ethnic Groups,N01.224.317
16682735,2006-05-10T00:00:00,Health Services Accessibility,N04.590.374.350
16682735,2006-05-10T00:00:00,Health Services Accessibility,N05.300.430
16682735,2006-05-10T00:00:00,Health Status,I01.240.425
16682735,2006-05-10T00:00:00,Health Status,N01.224.425
16682735,2006-05-10T00:00:00,Health Status,N06.850.505.400.425
16682735,2006-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16682735,2006-05-10T00:00:00,Neoplasms,C04
16682735,2006-05-10T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
16682735,2006-05-10T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
16682735,2006-05-10T00:00:00,Phenotype,G05.695
16690718,2006-05-11T00:00:00,Alzheimer Disease,C10.228.140.380.100
16690718,2006-05-11T00:00:00,Alzheimer Disease,C10.574.945.249
16690718,2006-05-11T00:00:00,Alzheimer Disease,F03.087.400.100
16690718,2006-05-11T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
16690718,2006-05-11T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
16690718,2006-05-11T00:00:00,Animals,B01.050
16690718,2006-05-11T00:00:00,Cell Survival,G04.299.316
16690718,2006-05-11T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
16690718,2006-05-11T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
16690718,2006-05-11T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
16690718,2006-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16690718,2006-05-11T00:00:00,Nerve Tissue Proteins,D12.776.641
16690718,2006-05-11T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16690718,2006-05-11T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16690718,2006-05-11T00:00:00,Physostigmine,D02.241.081.251.583.682
16690718,2006-05-11T00:00:00,Physostigmine,D03.132.436.545
16690718,2006-05-11T00:00:00,Physostigmine,D03.438.473.402.545
16690718,2006-05-11T00:00:00,"RNA, Messenger",D13.444.735.544
16690898,2006-05-11T00:00:00,Emergency Medical Services,N02.421.297
16690898,2006-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16690898,2006-05-11T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
16690898,2006-05-11T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
16690898,2006-05-11T00:00:00,Stroke,C10.228.140.300.775
16690898,2006-05-11T00:00:00,Stroke,C14.907.253.855
16697453,2006-05-12T00:00:00,Adolescent,M01.060.057
16697453,2006-05-12T00:00:00,Adult,M01.060.116
16697453,2006-05-12T00:00:00,Brain,A08.186.211
16697453,2006-05-12T00:00:00,Brain Mapping,E01.370.350.086
16697453,2006-05-12T00:00:00,Brain Mapping,E01.370.376.149
16697453,2006-05-12T00:00:00,Brain Mapping,E05.132
16697453,2006-05-12T00:00:00,Functional Laterality,F02.830.297.425
16697453,2006-05-12T00:00:00,Functional Laterality,G11.561.225.425
16697453,2006-05-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16697453,2006-05-12T00:00:00,Language,F01.145.209.399
16697453,2006-05-12T00:00:00,Language,L01.143.506
16697453,2006-05-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16697453,2006-05-12T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16697453,2006-05-12T00:00:00,Questionnaires,E05.318.308.750
16697453,2006-05-12T00:00:00,Questionnaires,L01.280.800
16697453,2006-05-12T00:00:00,Questionnaires,N05.715.360.300.695
16697453,2006-05-12T00:00:00,Questionnaires,N06.850.520.308.750
16697453,2006-05-12T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
16669954,2006-05-15T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
16669954,2006-05-15T00:00:00,Chest Pain,C23.888.646.215
16669954,2006-05-15T00:00:00,Dilatation,E05.284
16669954,2006-05-15T00:00:00,Esophagus,A03.556.875.500
16669954,2006-05-15T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16669954,2006-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16669954,2006-05-15T00:00:00,Manometry,E05.559
16669954,2006-05-15T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
16669954,2006-05-15T00:00:00,Vasodilator Agents,D27.505.954.411.918
16701815,2006-05-15T00:00:00,Adult,M01.060.116
16701815,2006-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16701815,2006-05-15T00:00:00,Middle Aged,M01.060.116.630
16701815,2006-05-15T00:00:00,Papillomavirus Infections,C02.256.650
16701815,2006-05-15T00:00:00,Papillomavirus Infections,C02.928.725
16701815,2006-05-15T00:00:00,Patient Education as Topic,I02.233.332.500
16701815,2006-05-15T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
16701815,2006-05-15T00:00:00,Patient Education as Topic,N02.421.726.407.680
16701815,2006-05-15T00:00:00,Rural Health Services,N02.421.816
16701815,2006-05-15T00:00:00,South Carolina,Z01.107.567.875.075.662
16701815,2006-05-15T00:00:00,South Carolina,Z01.107.567.875.750.700
16701815,2006-05-15T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
16701815,2006-05-15T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
16701815,2006-05-15T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
16701815,2006-05-15T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
16702223,2006-05-15T00:00:00,GTP-Binding Protein beta Subunits,D12.644.360.375.520
16702223,2006-05-15T00:00:00,GTP-Binding Protein beta Subunits,D12.776.157.325.332.520
16702223,2006-05-15T00:00:00,GTP-Binding Protein beta Subunits,D12.776.476.375.520
16702223,2006-05-15T00:00:00,GTP-Binding Protein beta Subunits,D12.776.543.325.450
16702223,2006-05-15T00:00:00,GTP-Binding Protein gamma Subunits,D12.644.360.375.730
16702223,2006-05-15T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.157.325.332.730
16702223,2006-05-15T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.476.375.730
16702223,2006-05-15T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.543.325.625
16702223,2006-05-15T00:00:00,"Models, Molecular",E05.599.595
16702223,2006-05-15T00:00:00,Protein Biosynthesis,G02.111.087.675.871
16702223,2006-05-15T00:00:00,Protein Biosynthesis,G02.149.115.675.871
16702223,2006-05-15T00:00:00,Protein Biosynthesis,G03.495.770.871
16702223,2006-05-15T00:00:00,Protein Biosynthesis,G05.355.310.670
16702223,2006-05-15T00:00:00,Protein Conformation,G02.111.570.790.709
16702223,2006-05-15T00:00:00,Protein Isoforms,D12.776.800
16702223,2006-05-15T00:00:00,Recombinant Proteins,D12.776.828
16702223,2006-05-15T00:00:00,"Transcription, Genetic",G02.111.087.847
16702223,2006-05-15T00:00:00,"Transcription, Genetic",G02.149.115.847
16702223,2006-05-15T00:00:00,"Transcription, Genetic",G05.355.310.700
16704932,2006-05-15T00:00:00,Animals,B01.050
16704932,2006-05-15T00:00:00,Brain,A08.186.211
16704932,2006-05-15T00:00:00,Carrier Proteins,D12.776.157
16704932,2006-05-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
16704932,2006-05-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
16704932,2006-05-15T00:00:00,Glutamic Acid,D12.125.067.750
16704932,2006-05-15T00:00:00,Glutamic Acid,D12.125.119.450
16704932,2006-05-15T00:00:00,Glutamic Acid,D12.125.427.300
16704932,2006-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16704932,2006-05-15T00:00:00,Mental Disorders,F03
16704932,2006-05-15T00:00:00,Neural Pathways,A08.612
16704932,2006-05-15T00:00:00,"Polymorphism, Genetic",G05.365.795
16704932,2006-05-15T00:00:00,Protein Isoforms,D12.776.800
16704932,2006-05-15T00:00:00,Synaptic Transmission,G02.111.087.800.850
16704932,2006-05-15T00:00:00,Synaptic Transmission,G02.149.115.800.850
16704932,2006-05-15T00:00:00,Synaptic Transmission,G04.299.880.850
16704932,2006-05-15T00:00:00,Synaptic Transmission,G07.265.337.900
16704932,2006-05-15T00:00:00,Synaptic Transmission,G07.700.240.900
16704932,2006-05-15T00:00:00,Synaptic Transmission,G11.561.600.835
16707460,2006-05-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
16707460,2006-05-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
16707460,2006-05-15T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
16707460,2006-05-15T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
16707460,2006-05-15T00:00:00,Homeodomain Proteins,D12.776.260.400
16707460,2006-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16707460,2006-05-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
16707460,2006-05-15T00:00:00,Lung Neoplasms,C08.381.540
16707460,2006-05-15T00:00:00,Lung Neoplasms,C08.785.520
16707460,2006-05-15T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16707460,2006-05-15T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16707460,2006-05-15T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16707460,2006-05-15T00:00:00,Transcription Factors,D12.776.930
16717107,2006-05-22T00:00:00,Animals,B01.050
16717107,2006-05-22T00:00:00,Bradykinin,D12.644.276.812.169
16717107,2006-05-22T00:00:00,Bradykinin,D12.644.400.090
16717107,2006-05-22T00:00:00,Bradykinin,D12.644.456.193
16717107,2006-05-22T00:00:00,Bradykinin,D12.776.467.812.169
16717107,2006-05-22T00:00:00,Bradykinin,D12.776.641.650.090
16717107,2006-05-22T00:00:00,Bradykinin,D23.469.050.375.110
16717107,2006-05-22T00:00:00,Bradykinin,D23.529.812.169
16717107,2006-05-22T00:00:00,Calcium,D01.268.552.100
16717107,2006-05-22T00:00:00,Calcium,D01.552.539.288
16717107,2006-05-22T00:00:00,Calcium,D23.119.100
16717107,2006-05-22T00:00:00,"Kidney Tubules, Collecting",A05.810.453.736.560.510
16717107,2006-05-22T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
16717107,2006-05-22T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
16717107,2006-05-22T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
16717107,2006-05-22T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
16717107,2006-05-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
16717107,2006-05-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
16717107,2006-05-22T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
16717107,2006-05-22T00:00:00,Transcriptional Activation,G05.355.315.800
16718284,2006-05-23T00:00:00,Adult,M01.060.116
16718284,2006-05-23T00:00:00,Aged,M01.060.116.100
16718284,2006-05-23T00:00:00,Attitude to Health,F01.100.150
16718284,2006-05-23T00:00:00,Attitude to Health,N05.300.150
16718284,2006-05-23T00:00:00,Body Mass Index,E01.370.600.115.100.125
16718284,2006-05-23T00:00:00,Body Mass Index,E05.041.124.125
16718284,2006-05-23T00:00:00,Body Mass Index,G07.100.100.125
16718284,2006-05-23T00:00:00,Body Mass Index,N06.850.505.200.100.175
16718284,2006-05-23T00:00:00,Health Promotion,N02.370
16718284,2006-05-23T00:00:00,Health Promotion,N02.421.726.507
16718284,2006-05-23T00:00:00,Hispanic Americans,M01.686.754.441
16718284,2006-05-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16718284,2006-05-23T00:00:00,Middle Aged,M01.060.116.630
16718284,2006-05-23T00:00:00,Obesity,C18.654.726.500
16718284,2006-05-23T00:00:00,Obesity,C23.888.144.699.500
16718284,2006-05-23T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16718284,2006-05-23T00:00:00,Obesity,G07.100.100.160.120.699.500
16718284,2006-05-23T00:00:00,Qualitative Research,H01.770.644.241.850
16718284,2006-05-23T00:00:00,Weight Loss,C23.888.144.243.963
16718284,2006-05-23T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16815092,2006-05-23T00:00:00,Animals,B01.050
16815092,2006-05-23T00:00:00,Lung,A04.411
16815092,2006-05-23T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16815092,2006-05-23T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16815092,2006-05-23T00:00:00,Peroxidases,D08.811.682.732
16815092,2006-05-23T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
16815092,2006-05-23T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
16815092,2006-05-23T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
16815092,2006-05-23T00:00:00,Peroxiredoxins,D08.811.682.732.850
16815092,2006-05-23T00:00:00,Phospholipids,D10.570.755
16815092,2006-05-23T00:00:00,Phospholipids,D10.695
16815092,2006-05-23T00:00:00,Pulmonary Surfactants,D27.505.954.796.600
16728409,2006-05-24T00:00:00,Animals,B01.050
16728409,2006-05-24T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
16728409,2006-05-24T00:00:00,Liver,A03.620
16728409,2006-05-24T00:00:00,Liver Regeneration,G10.261.326.520
16728409,2006-05-24T00:00:00,Liver Regeneration,G16.100.856.468
16728409,2006-05-24T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16728409,2006-05-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16728409,2006-05-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16728409,2006-05-24T00:00:00,Signal Transduction,G02.111.087.800
16728409,2006-05-24T00:00:00,Signal Transduction,G02.149.115.800
16728409,2006-05-24T00:00:00,Signal Transduction,G04.299.880
16728409,2006-05-24T00:00:00,Wound Healing,G16.100.856.891
16781659,2006-05-24T00:00:00,Animals,B01.050
16781659,2006-05-24T00:00:00,Binding Sites,G02.111.570.120
16781659,2006-05-24T00:00:00,Biological Markers,D23.101
16781659,2006-05-24T00:00:00,Extracellular Matrix,A11.284.295.310
16781659,2006-05-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16781659,2006-05-24T00:00:00,Intracellular Membranes,A11.284.149.450
16781659,2006-05-24T00:00:00,Intracellular Membranes,A11.284.835.514
16781659,2006-05-24T00:00:00,Liver,A03.620
16781659,2006-05-24T00:00:00,Molecular Weight,G02.842.580
16781659,2006-05-24T00:00:00,Peptide Fragments,D12.644.541
16781659,2006-05-24T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
16781659,2006-05-24T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
16781659,2006-05-24T00:00:00,Proteome,D12.776.817
16781659,2006-05-24T00:00:00,Proteomics,H01.158.201.843
16781659,2006-05-24T00:00:00,Proteomics,H01.158.273.180.350.700
16781659,2006-05-24T00:00:00,Proteomics,H01.158.273.343.350.700
16781659,2006-05-24T00:00:00,Proteomics,H01.181.122.738
16781659,2006-05-24T00:00:00,RNA Interference,G05.355.315.203.374.790
16781659,2006-05-24T00:00:00,"RNA, Messenger",D13.444.735.544
16781659,2006-05-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16781659,2006-05-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,E05.318.740.872
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,E05.318.780.800
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,G17.800
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16781659,2006-05-24T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16706527,2006-05-25T00:00:00,Molecular Structure,G02.111.570
16706527,2006-05-25T00:00:00,Molecular Structure,G02.575
16706527,2006-05-25T00:00:00,Molecular Structure,G02.842.575
16706527,2006-05-25T00:00:00,Quinones,D02.806
16706527,2006-05-25T00:00:00,Spiro Compounds,D02.455.426.559.847.885
16706527,2006-05-25T00:00:00,Spiro Compounds,D04.615.885
16724177,2006-05-25T00:00:00,Adult,M01.060.116
16724177,2006-05-25T00:00:00,Electromyography,E01.370.405.255
16724177,2006-05-25T00:00:00,Electromyography,E01.370.530.255
16724177,2006-05-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16724177,2006-05-25T00:00:00,Movement,G07.700.560
16724177,2006-05-25T00:00:00,Movement,G11.427.590.530
16724177,2006-05-25T00:00:00,Postural Balance,G11.427.690
16724177,2006-05-25T00:00:00,Postural Balance,G11.561.600.810.541.595
16724177,2006-05-25T00:00:00,Posture,G11.427.695
16724177,2006-05-25T00:00:00,Pressure,G01.374.715
16724177,2006-05-25T00:00:00,Rectus Abdominis,A02.633.567.050.800
16724177,2006-05-25T00:00:00,"Restraint, Physical",E02.085.700
16724177,2006-05-25T00:00:00,"Restraint, Physical",E05.472.760
16731635,2006-05-26T00:00:00,Adult,M01.060.116
16731635,2006-05-26T00:00:00,Aged,M01.060.116.100
16731635,2006-05-26T00:00:00,C-Reactive Protein,D12.776.034.145
16731635,2006-05-26T00:00:00,C-Reactive Protein,D12.776.124.050.120
16731635,2006-05-26T00:00:00,C-Reactive Protein,D12.776.124.486.157
16731635,2006-05-26T00:00:00,Cardiovascular Diseases,C14
16731635,2006-05-26T00:00:00,Gene Expression Regulation,G05.355.315
16731635,2006-05-26T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
16731635,2006-05-26T00:00:00,Genetic Predisposition to Disease,G05.380.355
16731635,2006-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16731635,2006-05-26T00:00:00,Middle Aged,M01.060.116.630
16731635,2006-05-26T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16731635,2006-05-26T00:00:00,Risk Factors,E05.318.740.600.800.725
16731635,2006-05-26T00:00:00,Risk Factors,N05.715.350.200.700
16731635,2006-05-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16731635,2006-05-26T00:00:00,Risk Factors,N06.850.490.625.750
16731635,2006-05-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16731635,2006-05-26T00:00:00,United States,Z01.107.567.875
16931313,2006-05-30T00:00:00,Calcinosis,C18.452.174.130
16931313,2006-05-30T00:00:00,Cysts,C04.182
16931313,2006-05-30T00:00:00,Cysts,C23.300.306
16931313,2006-05-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16931313,2006-05-30T00:00:00,"Infant, Newborn",M01.060.703.520
16737974,2006-05-31T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
16737974,2006-05-31T00:00:00,ADAM Proteins,D09.400.430.500
16737974,2006-05-31T00:00:00,ADAM Proteins,D12.776.395.033
16737974,2006-05-31T00:00:00,Animals,B01.050
16737974,2006-05-31T00:00:00,Cell Proliferation,G04.299.233.750
16737974,2006-05-31T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16737974,2006-05-31T00:00:00,Epidermal Growth Factor,D06.472.317.350
16737974,2006-05-31T00:00:00,Epidermal Growth Factor,D12.644.276.561
16737974,2006-05-31T00:00:00,Epidermal Growth Factor,D12.776.467.561
16737974,2006-05-31T00:00:00,Epidermal Growth Factor,D23.529.561
16737974,2006-05-31T00:00:00,Heparin,D09.698.373.400
16737974,2006-05-31T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
16737974,2006-05-31T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
16737974,2006-05-31T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
16737974,2006-05-31T00:00:00,Mesangial Cells,A05.810.453.324.359.620
16737974,2006-05-31T00:00:00,Mesangial Cells,A05.810.453.736.520.620
16737974,2006-05-31T00:00:00,Mesangial Cells,A11.329.228.950
16737974,2006-05-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16737974,2006-05-31T00:00:00,"Receptor, Serotonin, 5-HT2A",D12.776.543.750.070.800.200.100
16737974,2006-05-31T00:00:00,"Receptor, Serotonin, 5-HT2A",D12.776.543.750.100.800.200.100
16737974,2006-05-31T00:00:00,"Receptor, Serotonin, 5-HT2A",D12.776.543.750.720.300.800.200.100
16737974,2006-05-31T00:00:00,Transcriptional Activation,G05.355.315.800
16502418,2006-06-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16502418,2006-06-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16502418,2006-06-01T00:00:00,Animals,B01.050
16502418,2006-06-01T00:00:00,Calcium-Binding Proteins,D12.776.157.125
16502418,2006-06-01T00:00:00,Chick Embryo,A13.350.150
16502418,2006-06-01T00:00:00,Chick Embryo,A16.331.200
16502418,2006-06-01T00:00:00,Endocardium,A07.541.207
16502418,2006-06-01T00:00:00,Heart,A07.541
16502418,2006-06-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16502418,2006-06-01T00:00:00,Myocardium,A02.633.580
16502418,2006-06-01T00:00:00,Myocardium,A07.541.704
16502418,2006-06-01T00:00:00,Myocardium,A10.690.552.750
16543864,2006-06-01T00:00:00,Adolescent,M01.060.057
16543864,2006-06-01T00:00:00,Adult,M01.060.116
16543864,2006-06-01T00:00:00,Education,I02
16543864,2006-06-01T00:00:00,Ethnic Groups,M01.686.754
16543864,2006-06-01T00:00:00,Ethnic Groups,N01.224.317
16543864,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16543864,2006-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16543864,2006-06-01T00:00:00,Risk Factors,N05.715.350.200.700
16543864,2006-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16543864,2006-06-01T00:00:00,Risk Factors,N06.850.490.625.750
16543864,2006-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16543864,2006-06-01T00:00:00,United States,Z01.107.567.875
16543864,2006-06-01T00:00:00,Vaginal Smears,E01.370.378.900
16543864,2006-06-01T00:00:00,Vaginal Smears,E01.450.230.900
16543864,2006-06-01T00:00:00,Vaginal Smears,E01.450.865.900
16686779,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16686779,2006-06-01T00:00:00,Laparoscopy,E01.370.388.250.520
16686779,2006-06-01T00:00:00,Laparoscopy,E04.800.250.520
16686779,2006-06-01T00:00:00,Living Donors,M01.898.656
16686779,2006-06-01T00:00:00,Nephrectomy,E04.950.774.435
16686779,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16686779,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16686779,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16686779,2006-06-01T00:00:00,Wounds and Injuries,C21.866
16690991,2006-06-01T00:00:00,Age Factors,N05.715.350.075
16690991,2006-06-01T00:00:00,Age Factors,N06.850.490.250
16690991,2006-06-01T00:00:00,Aged,M01.060.116.100
16690991,2006-06-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
16690991,2006-06-01T00:00:00,Alzheimer Disease,C10.574.945.249
16690991,2006-06-01T00:00:00,Alzheimer Disease,F03.087.400.100
16690991,2006-06-01T00:00:00,Bipolar Disorder,F03.600.150.150
16690991,2006-06-01T00:00:00,Dementia,C10.228.140.380
16690991,2006-06-01T00:00:00,Dementia,F03.087.400
16690991,2006-06-01T00:00:00,Hospitalization,E02.760.400
16690991,2006-06-01T00:00:00,Hospitalization,N02.421.585.400
16690991,2006-06-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
16690991,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16690991,2006-06-01T00:00:00,Length of Stay,E02.760.400.480
16690991,2006-06-01T00:00:00,Length of Stay,N02.421.585.400.480
16690991,2006-06-01T00:00:00,Mental Health Services,F04.408
16690991,2006-06-01T00:00:00,Mental Health Services,N02.421.461
16690991,2006-06-01T00:00:00,Patient Readmission,E02.760.400.620
16690991,2006-06-01T00:00:00,Patient Readmission,N02.421.585.400.620
16690991,2006-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16690991,2006-06-01T00:00:00,Risk Factors,N05.715.350.200.700
16690991,2006-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16690991,2006-06-01T00:00:00,Risk Factors,N06.850.490.625.750
16690991,2006-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16690991,2006-06-01T00:00:00,Substance-Related Disorders,C21.739
16690991,2006-06-01T00:00:00,Substance-Related Disorders,F03.900
16690991,2006-06-01T00:00:00,United States,Z01.107.567.875
16696826,2006-06-01T00:00:00,Adult,M01.060.116
16696826,2006-06-01T00:00:00,Attention,F02.830.104.214
16696826,2006-06-01T00:00:00,Bipolar Disorder,F03.600.150.150
16696826,2006-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
16696826,2006-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16696826,2006-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16696826,2006-06-01T00:00:00,Depression,F01.145.126.350
16696826,2006-06-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
16696826,2006-06-01T00:00:00,Health Status,I01.240.425
16696826,2006-06-01T00:00:00,Health Status,N01.224.425
16696826,2006-06-01T00:00:00,Health Status,N06.850.505.400.425
16696826,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16696826,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16696826,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16696826,2006-06-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
16696826,2006-06-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
16696826,2006-06-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
16696826,2006-06-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
16696826,2006-06-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
16696826,2006-06-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
16696826,2006-06-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
16697865,2006-06-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16697865,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16697865,2006-06-01T00:00:00,Microtubule-Associated Proteins,D12.776.220.600.450
16697865,2006-06-01T00:00:00,Microtubule-Associated Proteins,D12.776.641.560
16697865,2006-06-01T00:00:00,Neoplasm Proteins,D12.776.624
16697865,2006-06-01T00:00:00,"RNA, Messenger",D13.444.735.544
16697865,2006-06-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
16697865,2006-06-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
16697865,2006-06-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
16697865,2006-06-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
16697865,2006-06-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
16700026,2006-06-01T00:00:00,Algorithms,G17.035
16700026,2006-06-01T00:00:00,Algorithms,L01.224.050
16700026,2006-06-01T00:00:00,Brain,A08.186.211
16700026,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16700026,2006-06-01T00:00:00,Image Enhancement,E01.370.350.600.350
16700026,2006-06-01T00:00:00,Image Enhancement,L01.224.308.380
16700026,2006-06-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
16700026,2006-06-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
16700026,2006-06-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
16700026,2006-06-01T00:00:00,Iron,D01.268.556.412
16700026,2006-06-01T00:00:00,Iron,D01.268.956.287
16700026,2006-06-01T00:00:00,Iron,D01.552.544.412
16700026,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16700026,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16700026,2006-06-01T00:00:00,Magnetics,H01.671.493
16700026,2006-06-01T00:00:00,"Phantoms, Imaging",E07.671
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,G17.800
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16700026,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16712640,2006-06-01T00:00:00,Algorithms,G17.035
16712640,2006-06-01T00:00:00,Algorithms,L01.224.050
16712640,2006-06-01T00:00:00,Autistic Disorder,F03.550.325.125
16712640,2006-06-01T00:00:00,"Child, Preschool",M01.060.406.448
16712640,2006-06-01T00:00:00,Developmental Disabilities,F03.550.362
16712640,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16712640,2006-06-01T00:00:00,Infant,M01.060.703
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C02.256.466.313.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C02.928.313.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C04.557.386.480.100
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C04.557.386.480.150.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C04.619.935.313.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C04.925.313.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.100
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.150.165
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.100
16713488,2006-06-01T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.150.165
16713488,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16713488,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16713488,2006-06-01T00:00:00,Skin Neoplasms,C04.588.805
16713488,2006-06-01T00:00:00,Skin Neoplasms,C17.800.882
16713922,2006-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16713922,2006-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16713922,2006-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16713922,2006-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16713922,2006-06-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
16713922,2006-06-01T00:00:00,Coronary Angiography,E01.370.370.050.200
16713922,2006-06-01T00:00:00,Coronary Angiography,E01.370.370.380.200
16713922,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16713922,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16713922,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16713922,2006-06-01T00:00:00,"Models, Biological",E05.599.395
16713922,2006-06-01T00:00:00,Stroke,C10.228.140.300.775
16713922,2006-06-01T00:00:00,Stroke,C14.907.253.855
16716134,2006-06-01T00:00:00,Adult,M01.060.116
16716134,2006-06-01T00:00:00,Creatinine,D03.383.129.308.207
16716134,2006-06-01T00:00:00,Gout Suppressants,D27.505.954.329.337
16716134,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16716134,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16716134,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16716134,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16716134,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16716815,2006-06-01T00:00:00,Animals,B01.050
16716815,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16716815,2006-06-01T00:00:00,Manometry,E05.559
16716815,2006-06-01T00:00:00,"Models, Animal",E05.598
16716815,2006-06-01T00:00:00,Paracentesis,E01.450.865.632.600
16716815,2006-06-01T00:00:00,Paracentesis,E02.800.550
16716815,2006-06-01T00:00:00,Paracentesis,E04.581
16716815,2006-06-01T00:00:00,Pleural Effusion,C08.528.652
16716815,2006-06-01T00:00:00,Pressure,G01.374.715
16720123,2006-06-01T00:00:00,Adult,M01.060.116
16720123,2006-06-01T00:00:00,Aged,M01.060.116.100
16720123,2006-06-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16720123,2006-06-01T00:00:00,Body Mass Index,E05.041.124.125
16720123,2006-06-01T00:00:00,Body Mass Index,G07.100.100.125
16720123,2006-06-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16720123,2006-06-01T00:00:00,Body Weight,C23.888.144
16720123,2006-06-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
16720123,2006-06-01T00:00:00,Body Weight,E05.041.124.160.750
16720123,2006-06-01T00:00:00,Body Weight,G07.100.100.160.120
16720123,2006-06-01T00:00:00,Body Weight,G07.700.320.249.314.120
16720123,2006-06-01T00:00:00,Ghrelin,D06.472.699.301
16720123,2006-06-01T00:00:00,Ghrelin,D12.644.548.322
16720123,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16720123,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16723572,2006-06-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
16723572,2006-06-01T00:00:00,Anti-Infective Agents,D27.505.954.122
16723572,2006-06-01T00:00:00,Cross Infection,C01.539.248
16723572,2006-06-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
16723572,2006-06-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
16723572,2006-06-01T00:00:00,Fluoroquinolones,D03.438.810.835.322
16723572,2006-06-01T00:00:00,Formularies as Topic,L01.178.682.192.836.535
16723572,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16723572,2006-06-01T00:00:00,Methicillin Resistance,G06.099.225.500.600.525
16723572,2006-06-01T00:00:00,Methicillin Resistance,G06.225.347.500.600.525
16723572,2006-06-01T00:00:00,Methicillin Resistance,G07.690.320.269.347.500.600.525
16723572,2006-06-01T00:00:00,Ofloxacin,D03.438.810.835.322.500
16723572,2006-06-01T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
16723572,2006-06-01T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
16723572,2006-06-01T00:00:00,Regression Analysis,E05.318.740.750
16723572,2006-06-01T00:00:00,Regression Analysis,N05.715.360.750.695
16723572,2006-06-01T00:00:00,Regression Analysis,N06.850.520.830.750
16723572,2006-06-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16723572,2006-06-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16723572,2006-06-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16725061,2006-06-01T00:00:00,Cardiology,H02.403.429.163
16725061,2006-06-01T00:00:00,"History, 20th Century",K01.400.504.968
16725061,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16725061,2006-06-01T00:00:00,Pediatrics,H02.403.670
16731113,2006-06-01T00:00:00,Adult,M01.060.116
16731113,2006-06-01T00:00:00,Aged,M01.060.116.100
16731113,2006-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
16731113,2006-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
16731113,2006-06-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
16731113,2006-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
16731113,2006-06-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
16731113,2006-06-01T00:00:00,Combined Modality Therapy,E02.186
16731113,2006-06-01T00:00:00,Disease-Free Survival,E01.789.200
16731113,2006-06-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16731113,2006-06-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16731113,2006-06-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16731113,2006-06-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
16731113,2006-06-01T00:00:00,Hospital Mortality,L01.280.975.550.400
16731113,2006-06-01T00:00:00,Hospital Mortality,N01.224.935.698.400
16731113,2006-06-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
16731113,2006-06-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
16731113,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16731113,2006-06-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
16731113,2006-06-01T00:00:00,Lung Neoplasms,C08.381.540
16731113,2006-06-01T00:00:00,Lung Neoplasms,C08.785.520
16731113,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16731113,2006-06-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
16731113,2006-06-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
16731113,2006-06-01T00:00:00,Pleura,A04.716
16731113,2006-06-01T00:00:00,Pleura,A10.615.789.736
16731113,2006-06-01T00:00:00,Pneumonectomy,E04.928.600.600
16731113,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16731113,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16731113,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16731211,2006-06-01T00:00:00,Adult,M01.060.116
16731211,2006-06-01T00:00:00,Case-Control Studies,E05.318.760.500.500
16731211,2006-06-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16731211,2006-06-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16731211,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16731211,2006-06-01T00:00:00,Lower Extremity,A01.378.610
16731211,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16731211,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16731211,2006-06-01T00:00:00,"Muscle, Skeletal",A02.633.567
16731211,2006-06-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
16731211,2006-06-01T00:00:00,Muscular Atrophy,C10.597.613.612
16731211,2006-06-01T00:00:00,Muscular Atrophy,C23.300.070.500
16731211,2006-06-01T00:00:00,Muscular Atrophy,C23.888.592.608.612
16731211,2006-06-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
16731211,2006-06-01T00:00:00,Spinal Cord Injuries,C10.900.850
16731211,2006-06-01T00:00:00,Spinal Cord Injuries,C21.866.819
16733125,2006-06-01T00:00:00,Animals,B01.050
16733125,2006-06-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16733125,2006-06-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16733125,2006-06-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16733125,2006-06-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16733125,2006-06-01T00:00:00,Gastrostomy,E04.210.496
16733125,2006-06-01T00:00:00,Gastrostomy,E04.579.408
16733125,2006-06-01T00:00:00,Jejunostomy,E04.210.338.523
16733125,2006-06-01T00:00:00,Jejunostomy,E04.579.338.523
16733125,2006-06-01T00:00:00,Laparoscopy,E01.370.388.250.520
16733125,2006-06-01T00:00:00,Laparoscopy,E04.800.250.520
16733125,2006-06-01T00:00:00,Swine,B01.050.150.900.649.077.880
16735890,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16735890,2006-06-01T00:00:00,Oxygen,D01.268.185.550
16735890,2006-06-01T00:00:00,Oxygen,D01.362.670
16735890,2006-06-01T00:00:00,Polysomnography,E01.370.520.625
16735890,2006-06-01T00:00:00,Sleep,F02.830.855
16735890,2006-06-01T00:00:00,Sleep,G11.561.600.815
16735890,2006-06-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
16735890,2006-06-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
16737403,2006-06-01T00:00:00,Aged,M01.060.116.100
16737403,2006-06-01T00:00:00,Disability Evaluation,E01.370.400
16737403,2006-06-01T00:00:00,Gait,E01.370.600.250
16737403,2006-06-01T00:00:00,Gait,G11.427.590.530.389
16737403,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16737403,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16737403,2006-06-01T00:00:00,"Models, Statistical",E05.318.740.500
16737403,2006-06-01T00:00:00,"Models, Statistical",E05.599.835
16737403,2006-06-01T00:00:00,"Models, Statistical",N05.715.360.750.530
16737403,2006-06-01T00:00:00,"Models, Statistical",N06.850.520.830.500
16737403,2006-06-01T00:00:00,Postural Balance,G11.427.690
16737403,2006-06-01T00:00:00,Postural Balance,G11.561.600.810.541.595
16737403,2006-06-01T00:00:00,Psychometrics,F04.711.780
16737408,2006-06-01T00:00:00,Adult,M01.060.116
16737408,2006-06-01T00:00:00,Age Factors,N05.715.350.075
16737408,2006-06-01T00:00:00,Age Factors,N06.850.490.250
16737408,2006-06-01T00:00:00,Aged,M01.060.116.100
16737408,2006-06-01T00:00:00,Hemiplegia,C10.597.622.295
16737408,2006-06-01T00:00:00,Hemiplegia,C23.888.592.636.312
16737408,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16737408,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16737408,2006-06-01T00:00:00,Movement,G07.700.560
16737408,2006-06-01T00:00:00,Movement,G11.427.590.530
16737408,2006-06-01T00:00:00,Physical Therapy Modalities,E02.779
16737408,2006-06-01T00:00:00,Stroke,C10.228.140.300.775
16737408,2006-06-01T00:00:00,Stroke,C14.907.253.855
16737408,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16737408,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16737408,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16737451,2006-06-01T00:00:00,Adrenal Glands,A06.407.071
16737451,2006-06-01T00:00:00,Adult,M01.060.116
16737451,2006-06-01T00:00:00,Alcoholism,C21.739.100.250
16737451,2006-06-01T00:00:00,Alcoholism,F03.900.100.350
16737451,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16737451,2006-06-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
16737451,2006-06-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
16737451,2006-06-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
16737451,2006-06-01T00:00:00,Hypothalamus,A08.186.211.464.482
16737451,2006-06-01T00:00:00,Hypothalamus,A08.186.211.730.317.357
16737451,2006-06-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16737451,2006-06-01T00:00:00,"Stress, Physiological",G07.700.830
16737467,2006-06-01T00:00:00,Alcoholism,C21.739.100.250
16737467,2006-06-01T00:00:00,Alcoholism,F03.900.100.350
16737467,2006-06-01T00:00:00,Animals,B01.050
16737467,2006-06-01T00:00:00,Anxiety,F01.470.132
16737467,2006-06-01T00:00:00,"Behavior, Animal",F01.145.113
16737467,2006-06-01T00:00:00,Brain,A08.186.211
16737467,2006-06-01T00:00:00,Dopamine,D02.092.211.215.311.342
16737467,2006-06-01T00:00:00,Dopamine,D02.092.311.342
16737467,2006-06-01T00:00:00,Environment,G16.500.275
16737467,2006-06-01T00:00:00,Environment,N06.230
16737467,2006-06-01T00:00:00,Ethanol,D02.033.375
16737467,2006-06-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
16737467,2006-06-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
16737467,2006-06-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
16737467,2006-06-01T00:00:00,Phenotype,G05.695
16737467,2006-06-01T00:00:00,Self Administration,E02.319.890
16737467,2006-06-01T00:00:00,Self Administration,E02.900.890
16737467,2006-06-01T00:00:00,"Stress, Physiological",G07.700.830
16740595,2006-06-01T00:00:00,Adult,M01.060.116
16740595,2006-06-01T00:00:00,African Americans,M01.686.508.100.100
16740595,2006-06-01T00:00:00,African Americans,M01.686.754.100
16740595,2006-06-01T00:00:00,Alleles,G05.360.340.024.340.030
16740595,2006-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16740595,2006-06-01T00:00:00,Genetic Variation,G05.365
16740595,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16740595,2006-06-01T00:00:00,Linkage Disequilibrium,G05.540.500
16740595,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16740595,2006-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16740595,2006-06-01T00:00:00,Tobacco Use Disorder,C21.739.912
16740595,2006-06-01T00:00:00,Tobacco Use Disorder,F03.900.912
16740595,2006-06-01T00:00:00,United States,Z01.107.567.875
16740633,2006-06-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16740633,2006-06-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16740633,2006-06-01T00:00:00,Animals,B01.050
16740633,2006-06-01T00:00:00,Cell Line,A11.251.210
16740633,2006-06-01T00:00:00,Down-Regulation,G02.111.087.225
16740633,2006-06-01T00:00:00,Down-Regulation,G02.149.115.225
16740633,2006-06-01T00:00:00,Down-Regulation,G05.355.315.200
16740633,2006-06-01T00:00:00,Down-Regulation,G07.690.812.230
16740633,2006-06-01T00:00:00,Down-Regulation,G07.700.680.230
16740633,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16740633,2006-06-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16740633,2006-06-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.186
16740633,2006-06-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.750
16740633,2006-06-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.186
16740633,2006-06-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.750
16740633,2006-06-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
16740633,2006-06-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16740633,2006-06-01T00:00:00,Serine,D12.125.154.800
16740633,2006-06-01T00:00:00,Serine,D12.125.837
16740633,2006-06-01T00:00:00,Threonine,D12.125.142.815
16740633,2006-06-01T00:00:00,Threonine,D12.125.154.900
16740633,2006-06-01T00:00:00,Threonine,D12.125.901
16740751,2006-06-01T00:00:00,Body Fluids,A12.207
16740751,2006-06-01T00:00:00,Breast Neoplasms,C04.588.180
16740751,2006-06-01T00:00:00,Breast Neoplasms,C17.800.090.500
16740751,2006-06-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
16740751,2006-06-01T00:00:00,DNA Methylation,G02.111.087.218
16740751,2006-06-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
16740751,2006-06-01T00:00:00,DNA Methylation,G02.149.115.218
16740751,2006-06-01T00:00:00,DNA Methylation,G03.495.130.538.161
16740751,2006-06-01T00:00:00,DNA Methylation,G05.355.190
16740751,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16740751,2006-06-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
16740751,2006-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16740751,2006-06-01T00:00:00,Risk Factors,N05.715.350.200.700
16740751,2006-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16740751,2006-06-01T00:00:00,Risk Factors,N06.850.490.625.750
16740751,2006-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,G17.800
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16740751,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16755188,2006-06-01T00:00:00,Aged,M01.060.116.100
16755188,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16755188,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16755188,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16755188,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16757229,2006-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
16757229,2006-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
16757229,2006-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
16757229,2006-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
16757229,2006-06-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
16757229,2006-06-01T00:00:00,Craniocerebral Trauma,C10.900.300
16757229,2006-06-01T00:00:00,Craniocerebral Trauma,C21.866.260
16757229,2006-06-01T00:00:00,Craniocerebral Trauma,C21.866.915.300
16757229,2006-06-01T00:00:00,Endoscopy,E01.370.388.250
16757229,2006-06-01T00:00:00,Endoscopy,E04.800.250
16757229,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16757229,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16757229,2006-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16757229,2006-06-01T00:00:00,Neoplasms,C04
16757229,2006-06-01T00:00:00,Perioperative Care,E02.760.722
16757229,2006-06-01T00:00:00,Perioperative Care,E04.604
16757229,2006-06-01T00:00:00,Perioperative Care,N02.421.585.722
16757229,2006-06-01T00:00:00,Skull,A02.835.232.781
16757229,2006-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16757229,2006-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16757229,2006-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16757229,2006-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16757229,2006-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16760682,2006-06-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
16760682,2006-06-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16760682,2006-06-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16760682,2006-06-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16760682,2006-06-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16760682,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760682,2006-06-01T00:00:00,Hypertension,C14.907.489
16760682,2006-06-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16760682,2006-06-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16760682,2006-06-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16760682,2006-06-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16760682,2006-06-01T00:00:00,Patient Selection,E05.581.500.653
16760682,2006-06-01T00:00:00,Patient Selection,N04.590.731
16760682,2006-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16760682,2006-06-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16760682,2006-06-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16760682,2006-06-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16760682,2006-06-01T00:00:00,Research Design,E05.581.500
16760682,2006-06-01T00:00:00,Research Design,H01.770.644.728
16763965,2006-06-01T00:00:00,"Diagnosis, Computer-Assisted",E01.158
16763965,2006-06-01T00:00:00,"Diagnosis, Computer-Assisted",L01.700.508.100.158
16763965,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16763965,2006-06-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
16763965,2006-06-01T00:00:00,Neoplasms,C04
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,G17.800
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16763965,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16763965,2006-06-01T00:00:00,"Tumor Markers, Biological",D23.101.840
16763965,2006-06-01T00:00:00,United States,Z01.107.567.875
16765822,2006-06-01T00:00:00,Adult,M01.060.116
16765822,2006-06-01T00:00:00,Child,M01.060.406
16765822,2006-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16765822,2006-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
16765822,2006-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16765822,2006-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16765822,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16765822,2006-06-01T00:00:00,Research Design,E05.581.500
16765822,2006-06-01T00:00:00,Research Design,H01.770.644.728
16765822,2006-06-01T00:00:00,Stroke,C10.228.140.300.775
16765822,2006-06-01T00:00:00,Stroke,C14.907.253.855
16765823,2006-06-01T00:00:00,Adolescent,M01.060.057
16765823,2006-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16765823,2006-06-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16765823,2006-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16765823,2006-06-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16765823,2006-06-01T00:00:00,Blood Transfusion,E02.095.135
16765823,2006-06-01T00:00:00,Child,M01.060.406
16765823,2006-06-01T00:00:00,"Child, Preschool",M01.060.406.448
16765823,2006-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16765823,2006-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
16765823,2006-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16765823,2006-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16765823,2006-06-01T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
16765823,2006-06-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16765823,2006-06-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16765823,2006-06-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16765823,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16765823,2006-06-01T00:00:00,Stroke,C10.228.140.300.775
16765823,2006-06-01T00:00:00,Stroke,C14.907.253.855
16769406,2006-06-01T00:00:00,Blood Glucose,D09.546.359.448.500
16769406,2006-06-01T00:00:00,Child,M01.060.406
16769406,2006-06-01T00:00:00,Critical Illness,C23.550.291.625
16769406,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16769406,2006-06-01T00:00:00,Hyperglycemia,C18.452.394.952
16769406,2006-06-01T00:00:00,"Intensive Care Units, Pediatric",N02.278.388.493.390
16769406,2006-06-01T00:00:00,Length of Stay,E02.760.400.480
16769406,2006-06-01T00:00:00,Length of Stay,N02.421.585.400.480
16775903,2006-06-01T00:00:00,African Americans,M01.686.508.100.100
16775903,2006-06-01T00:00:00,African Americans,M01.686.754.100
16775903,2006-06-01T00:00:00,Attitude of Health Personnel,F01.100.050
16775903,2006-06-01T00:00:00,Attitude of Health Personnel,N05.300.100
16775903,2006-06-01T00:00:00,Attitude to Health,F01.100.150
16775903,2006-06-01T00:00:00,Attitude to Health,N05.300.150
16775903,2006-06-01T00:00:00,Awareness,F02.463.188.150
16775903,2006-06-01T00:00:00,Cultural Diversity,I01.076.201.450.350
16775903,2006-06-01T00:00:00,Cultural Diversity,I01.880.143.450
16775903,2006-06-01T00:00:00,Fear,F01.470.361
16775903,2006-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
16775903,2006-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
16775903,2006-06-01T00:00:00,Health Services Accessibility,N04.590.374.350
16775903,2006-06-01T00:00:00,Health Services Accessibility,N05.300.430
16775903,2006-06-01T00:00:00,"Hospitals, University",N02.278.020.300.310
16775903,2006-06-01T00:00:00,"Hospitals, University",N02.278.421.639.725
16775903,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16775903,2006-06-01T00:00:00,Kidney Transplantation,E02.870.500
16775903,2006-06-01T00:00:00,Kidney Transplantation,E04.936.450.485
16775903,2006-06-01T00:00:00,Kidney Transplantation,E04.950.774.400
16775903,2006-06-01T00:00:00,Living Donors,M01.898.656
16775903,2006-06-01T00:00:00,Social Perception,F02.463.593.752
16775903,2006-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16775903,2006-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16775903,2006-06-01T00:00:00,Tissue and Organ Procurement,N02.421.911
16778281,2006-06-01T00:00:00,Adult,M01.060.116
16778281,2006-06-01T00:00:00,Aged,M01.060.116.100
16778281,2006-06-01T00:00:00,"Hospitals, University",N02.278.020.300.310
16778281,2006-06-01T00:00:00,"Hospitals, University",N02.278.421.639.725
16778281,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16778281,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16778281,2006-06-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.035.380
16778281,2006-06-01T00:00:00,"Outpatient Clinics, Hospital",N02.278.354.422.527
16778281,2006-06-01T00:00:00,"Outpatient Clinics, Hospital",N04.452.442.422.527
16778281,2006-06-01T00:00:00,Pleural Effusion,C08.528.652
16778281,2006-06-01T00:00:00,Prevalence,E05.318.308.985.525.750
16778281,2006-06-01T00:00:00,Prevalence,L01.280.975.525.750
16778281,2006-06-01T00:00:00,Prevalence,N01.224.935.597.750
16778281,2006-06-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16778281,2006-06-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16778281,2006-06-01T00:00:00,Proteins,D12.776
16778281,2006-06-01T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
16778281,2006-06-01T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
16785355,2006-06-01T00:00:00,Algorithms,G17.035
16785355,2006-06-01T00:00:00,Algorithms,L01.224.050
16785355,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16785355,2006-06-01T00:00:00,Hyperparathyroidism,C19.642.355
16785355,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16785355,2006-06-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
16785355,2006-06-01T00:00:00,"Monitoring, Intraoperative",E04.510
16785355,2006-06-01T00:00:00,Parathyroid Hormone,D06.472.699.590
16785355,2006-06-01T00:00:00,Parathyroid Hormone,D12.644.548.587
16785355,2006-06-01T00:00:00,Parathyroidectomy,E04.270.694
16785355,2006-06-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
16785405,2006-06-01T00:00:00,Animals,B01.050
16785405,2006-06-01T00:00:00,Antiviral Agents,D27.505.954.122.388
16785405,2006-06-01T00:00:00,"Evoked Potentials, Auditory",G07.265.500.370
16785405,2006-06-01T00:00:00,"Evoked Potentials, Auditory",G11.561.270.370
16785405,2006-06-01T00:00:00,Hearing Loss,C09.218.458.341
16785405,2006-06-01T00:00:00,Hearing Loss,C10.597.751.418.341
16785405,2006-06-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
16786687,2006-06-01T00:00:00,Minerals,D01.578
16786687,2006-06-01T00:00:00,Oxides,D01.248.497.158.685
16786687,2006-06-01T00:00:00,Oxides,D01.650.550
16786687,2006-06-01T00:00:00,Plutonium,D01.268.033.700
16786687,2006-06-01T00:00:00,Plutonium,D01.268.271.100.700
16786687,2006-06-01T00:00:00,Plutonium,D01.268.556.700
16786687,2006-06-01T00:00:00,Plutonium,D01.552.020.734
16786687,2006-06-01T00:00:00,Plutonium,D01.552.544.700
16786687,2006-06-01T00:00:00,Radioactive Waste,D20.693.638
16786687,2006-06-01T00:00:00,Radioactive Waste,D20.944.380.638
16786687,2006-06-01T00:00:00,Radioactive Waste,N06.850.460.710.380.638
16786687,2006-06-01T00:00:00,Radioactive Waste,N06.850.810.485
16786687,2006-06-01T00:00:00,Soil Pollutants,D27.888.284.756
16790149,2006-06-01T00:00:00,Adolescent,M01.060.057
16790149,2006-06-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16790149,2006-06-01T00:00:00,Alleles,G05.360.340.024.340.030
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.644.456.073.070
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.644.822.750.020
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.644.861.020
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.776.645.750.020
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.776.811.070
16790149,2006-06-01T00:00:00,Angiotensinogen,D12.776.872.020
16790149,2006-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
16790149,2006-06-01T00:00:00,Blood Pressure,G09.330.380.076
16790149,2006-06-01T00:00:00,Child,M01.060.406
16790149,2006-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16790149,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16790149,2006-06-01T00:00:00,Hypertension,C14.907.489
16790149,2006-06-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
16790149,2006-06-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
16790149,2006-06-01T00:00:00,"Models, Statistical",E05.318.740.500
16790149,2006-06-01T00:00:00,"Models, Statistical",E05.599.835
16790149,2006-06-01T00:00:00,"Models, Statistical",N05.715.360.750.530
16790149,2006-06-01T00:00:00,"Models, Statistical",N06.850.520.830.500
16790149,2006-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16790149,2006-06-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
16790149,2006-06-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
16790149,2006-06-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
16790149,2006-06-01T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
16790149,2006-06-01T00:00:00,Sex Factors,N05.715.350.675
16790149,2006-06-01T00:00:00,Sex Factors,N06.850.490.875
16790149,2006-06-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
16794312,2006-06-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16794312,2006-06-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16794312,2006-06-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16794312,2006-06-01T00:00:00,Glycopeptides,D09.400.420
16794312,2006-06-01T00:00:00,Glycopeptides,D12.644.233
16794312,2006-06-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16800727,2006-06-01T00:00:00,Animals,B01.050
16800727,2006-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
16800727,2006-06-01T00:00:00,Blood Pressure,G09.330.380.076
16800727,2006-06-01T00:00:00,Cardiovascular Diseases,C14
16800727,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16800727,2006-06-01T00:00:00,Kidney Diseases,C12.777.419
16800727,2006-06-01T00:00:00,Kidney Diseases,C13.351.968.419
16800727,2006-06-01T00:00:00,Stroke,C10.228.140.300.775
16800727,2006-06-01T00:00:00,Stroke,C14.907.253.855
16800727,2006-06-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
16800727,2006-06-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
16800727,2006-06-01T00:00:00,Tissue Kallikreins,D23.101.840.870
16801827,2006-06-01T00:00:00,Adolescent,M01.060.057
16801827,2006-06-01T00:00:00,Adult,M01.060.116
16801827,2006-06-01T00:00:00,Aged,M01.060.116.100
16801827,2006-06-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
16801827,2006-06-01T00:00:00,Depressive Disorder,F03.600.300
16801827,2006-06-01T00:00:00,Drug Resistance,G07.690.320
16801827,2006-06-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
16801827,2006-06-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
16801827,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16801827,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16808759,2006-06-01T00:00:00,Continental Population Groups,M01.686.508
16808759,2006-06-01T00:00:00,Delivery of Health Care,N04.590.374
16808759,2006-06-01T00:00:00,Delivery of Health Care,N05.300
16808759,2006-06-01T00:00:00,Ethnic Groups,M01.686.754
16808759,2006-06-01T00:00:00,Ethnic Groups,N01.224.317
16808759,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16808759,2006-06-01T00:00:00,United States,Z01.107.567.875
16814700,2006-06-01T00:00:00,Adolescent,M01.060.057
16814700,2006-06-01T00:00:00,Algorithms,G17.035
16814700,2006-06-01T00:00:00,Algorithms,L01.224.050
16814700,2006-06-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
16814700,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16814700,2006-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16814700,2006-06-01T00:00:00,Risk Factors,N05.715.350.200.700
16814700,2006-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16814700,2006-06-01T00:00:00,Risk Factors,N06.850.490.625.750
16814700,2006-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16814700,2006-06-01T00:00:00,Substance Abuse Detection,E05.885
16814700,2006-06-01T00:00:00,Substance Abuse Detection,N06.850.780.500.765
16814700,2006-06-01T00:00:00,Substance-Related Disorders,C21.739
16814700,2006-06-01T00:00:00,Substance-Related Disorders,F03.900
16818511,2006-06-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16818511,2006-06-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16818511,2006-06-01T00:00:00,Caspases,D12.644.360.075.405
16818511,2006-06-01T00:00:00,Caspases,D12.776.476.075.405
16818511,2006-06-01T00:00:00,Cations,D01.248.497.300
16818511,2006-06-01T00:00:00,Cell Death,G04.299.139
16818511,2006-06-01T00:00:00,Ceramides,D02.065.313
16818511,2006-06-01T00:00:00,Ceramides,D09.400.410.420.525.200
16818511,2006-06-01T00:00:00,Ceramides,D10.390.470.675.200
16818511,2006-06-01T00:00:00,Ceramides,D10.570.877.360.612.200
16818511,2006-06-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
16818511,2006-06-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
16818511,2006-06-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
16818511,2006-06-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
16818511,2006-06-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
16818511,2006-06-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
16818511,2006-06-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
16818511,2006-06-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
16818511,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16818511,2006-06-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16818511,2006-06-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16818511,2006-06-01T00:00:00,Mitochondria,A11.284.835.626
16818511,2006-06-01T00:00:00,Sphingosine,D02.033.100.700
16818511,2006-06-01T00:00:00,Sphingosine,D02.033.455.843
16818511,2006-06-01T00:00:00,Sphingosine,D02.092.063.700
16822107,2006-06-01T00:00:00,Adult,M01.060.116
16822107,2006-06-01T00:00:00,Aggression,F01.145.126.125
16822107,2006-06-01T00:00:00,Aggression,F01.145.813.045
16822107,2006-06-01T00:00:00,Antisocial Personality Disorder,F03.675.050
16822107,2006-06-01T00:00:00,Attention Deficit and Disruptive Behavior Disorders,F03.550.150
16822107,2006-06-01T00:00:00,Child,M01.060.406
16822107,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16822107,2006-06-01T00:00:00,Prevalence,E05.318.308.985.525.750
16822107,2006-06-01T00:00:00,Prevalence,L01.280.975.525.750
16822107,2006-06-01T00:00:00,Prevalence,N01.224.935.597.750
16822107,2006-06-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16822107,2006-06-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16822107,2006-06-01T00:00:00,Sex Factors,N05.715.350.675
16822107,2006-06-01T00:00:00,Sex Factors,N06.850.490.875
16828308,2006-06-01T00:00:00,Animals,B01.050
16828308,2006-06-01T00:00:00,Carbon Isotopes,D01.496.123
16828308,2006-06-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,G17.800
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16828308,2006-06-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16828308,2006-06-01T00:00:00,Solvents,D27.720.844
16828308,2006-06-01T00:00:00,Sphingolipids,D10.570.877
16828308,2006-06-01T00:00:00,Sphingolipids,D10.808
16828308,2006-06-01T00:00:00,Terminology as Topic,L01.143.506.598.400
16836709,2006-06-01T00:00:00,Aged,M01.060.116.100
16836709,2006-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
16836709,2006-06-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
16836709,2006-06-01T00:00:00,"Defibrillators, Implantable",E07.695.175
16836709,2006-06-01T00:00:00,Electric Countershock,E02.342.287
16836709,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16836709,2006-06-01T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
16836709,2006-06-01T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
16836709,2006-06-01T00:00:00,Ventricular Fibrillation,C14.280.067.922
16836709,2006-06-01T00:00:00,Ventricular Fibrillation,C23.550.073.922
16845909,2006-06-01T00:00:00,Bayes Theorem,E05.318.740.600.200
16845909,2006-06-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
16845909,2006-06-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
16845909,2006-06-01T00:00:00,Biometry,E05.318.740.225
16845909,2006-06-01T00:00:00,Biometry,N06.850.505.200
16845909,2006-06-01T00:00:00,Computer Simulation,L01.224.160
16845909,2006-06-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
16845909,2006-06-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16845909,2006-06-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16845909,2006-06-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16845909,2006-06-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16845909,2006-06-01T00:00:00,Disease Outbreaks,N06.850.290
16845909,2006-06-01T00:00:00,"Models, Biological",E05.599.395
16845909,2006-06-01T00:00:00,"Models, Statistical",E05.318.740.500
16845909,2006-06-01T00:00:00,"Models, Statistical",E05.599.835
16845909,2006-06-01T00:00:00,"Models, Statistical",N05.715.360.750.530
16845909,2006-06-01T00:00:00,"Models, Statistical",N06.850.520.830.500
16845909,2006-06-01T00:00:00,Population Surveillance,E05.318.308.250.700
16845909,2006-06-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
16845909,2006-06-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
16845909,2006-06-01T00:00:00,Population Surveillance,N06.850.780.675
16848646,2006-06-01T00:00:00,Adult,M01.060.116
16848646,2006-06-01T00:00:00,Anxiety Disorders,F03.080
16848646,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16848646,2006-06-01T00:00:00,Middle Aged,M01.060.116.630
16848646,2006-06-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
16848646,2006-06-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
16848646,2006-06-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
16848646,2006-06-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
16848646,2006-06-01T00:00:00,Sertraline,D02.092.705.800
16848646,2006-06-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
16848646,2006-06-01T00:00:00,Sertraline,D04.615.638.845.800
16848646,2006-06-01T00:00:00,Treatment Outcome,E01.789.800
16848646,2006-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16848646,2006-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16875461,2006-06-01T00:00:00,Age Factors,N05.715.350.075
16875461,2006-06-01T00:00:00,Age Factors,N06.850.490.250
16875461,2006-06-01T00:00:00,Evidence-Based Medicine,H02.249.750
16875461,2006-06-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16875461,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16875461,2006-06-01T00:00:00,Splenectomy,E04.726
16875461,2006-06-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
16875461,2006-06-01T00:00:00,Vaccination,E05.478.550.600.890
16875461,2006-06-01T00:00:00,Vaccination,N02.421.726.758.310.890
16875461,2006-06-01T00:00:00,Vaccination,N06.850.780.200.425.900
16875461,2006-06-01T00:00:00,Vaccination,N06.850.780.680.310.890
16875461,2006-06-01T00:00:00,Vaccines,D20.215.894
16875461,2006-06-01T00:00:00,Wounds and Injuries,C21.866
16891274,2006-06-01T00:00:00,Activities of Daily Living,E02.831.067
16891274,2006-06-01T00:00:00,Activities of Daily Living,I03.050
16891274,2006-06-01T00:00:00,Activities of Daily Living,N02.421.784.110
16891274,2006-06-01T00:00:00,Child,M01.060.406
16891274,2006-06-01T00:00:00,Child Behavior Disorders,F03.550.300
16891274,2006-06-01T00:00:00,"Child, Preschool",M01.060.406.448
16891274,2006-06-01T00:00:00,Developmental Disabilities,F03.550.362
16891274,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16891274,2006-06-01T00:00:00,Intelligence,F01.752.543
16891274,2006-06-01T00:00:00,Needs Assessment,I02.594
16891274,2006-06-01T00:00:00,Needs Assessment,N03.349.380.565
16891274,2006-06-01T00:00:00,Needs Assessment,N05.300.537
16891274,2006-06-01T00:00:00,Neural Tube Defects,C10.500.680
16891274,2006-06-01T00:00:00,Neural Tube Defects,C16.131.666.680
16891274,2006-06-01T00:00:00,Parents,F01.829.263.500.320
16891274,2006-06-01T00:00:00,Parents,I01.880.225.500.340
16891274,2006-06-01T00:00:00,Parents,M01.620
16891274,2006-06-01T00:00:00,"Stress, Psychological",F01.145.126.990
16891274,2006-06-01T00:00:00,"Stress, Psychological",F02.830.900
17062546,2006-06-01T00:00:00,Alcohol-Related Disorders,C21.739.100
17062546,2006-06-01T00:00:00,Alcohol-Related Disorders,F03.900.100
17062546,2006-06-01T00:00:00,Attitude of Health Personnel,F01.100.050
17062546,2006-06-01T00:00:00,Attitude of Health Personnel,N05.300.100
17062546,2006-06-01T00:00:00,Cooperative Behavior,F01.145.813.115
17062546,2006-06-01T00:00:00,Guideline Adherence,N04.761.337
17062546,2006-06-01T00:00:00,Guideline Adherence,N05.715.360.395
17062546,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17062546,2006-06-01T00:00:00,Hypertension,C14.907.489
17062546,2006-06-01T00:00:00,Mass Screening,E01.370.500
17062546,2006-06-01T00:00:00,Mass Screening,E05.318.308.250.580
17062546,2006-06-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17062546,2006-06-01T00:00:00,Mass Screening,N02.421.726.233.443
17062546,2006-06-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17062546,2006-06-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17062546,2006-06-01T00:00:00,Mass Screening,N06.850.780.500
17062546,2006-06-01T00:00:00,Patient Education as Topic,I02.233.332.500
17062546,2006-06-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17062546,2006-06-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17062546,2006-06-01T00:00:00,Physician Assistants,M01.526.485.067.740
17062546,2006-06-01T00:00:00,Physician Assistants,N02.360.067.740
17062546,2006-06-01T00:00:00,Primary Health Care,N04.590.233.727
17062546,2006-06-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
17062546,2006-06-01T00:00:00,"Quality Assurance, Health Care",N05.700
17315517,2006-06-01T00:00:00,Carotid Arteries,A07.231.114.186
17315517,2006-06-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
17315517,2006-06-01T00:00:00,Carotid Stenosis,C14.907.137.230
17315517,2006-06-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
17315517,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17315517,2006-06-01T00:00:00,"Radiography, Interventional",E01.370.350.700.725
17315517,2006-06-01T00:00:00,"Radiography, Interventional",E02.148.694
17315517,2006-06-01T00:00:00,"Radiography, Interventional",E04.800.780
17315517,2006-06-01T00:00:00,Stents,E07.695.750
17764211,2006-06-01T00:00:00,Adolescent,M01.060.057
17764211,2006-06-01T00:00:00,Adult,M01.060.116
17764211,2006-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17764211,2006-06-01T00:00:00,Mental Disorders,F03
17764211,2006-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17764211,2006-06-01T00:00:00,Risk Factors,N05.715.350.200.700
17764211,2006-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17764211,2006-06-01T00:00:00,Risk Factors,N06.850.490.625.750
17764211,2006-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17764211,2006-06-01T00:00:00,Smoking,F01.145.466.753
17764211,2006-06-01T00:00:00,Smoking Cessation,F01.145.940.700
17764211,2006-06-01T00:00:00,Substance-Related Disorders,C21.739
17764211,2006-06-01T00:00:00,Substance-Related Disorders,F03.900
16750396,2006-06-05T00:00:00,Adult,M01.060.116
16750396,2006-06-05T00:00:00,Attention,F02.830.104.214
16750396,2006-06-05T00:00:00,Brain Mapping,E01.370.350.086
16750396,2006-06-05T00:00:00,Brain Mapping,E01.370.376.149
16750396,2006-06-05T00:00:00,Brain Mapping,E05.132
16750396,2006-06-05T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16750396,2006-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16750396,2006-06-05T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16750396,2006-06-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16750396,2006-06-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16750396,2006-06-05T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
16750396,2006-06-05T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
16750396,2006-06-05T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
16750396,2006-06-05T00:00:00,Semantics,L01.143.506.598.745
16750521,2006-06-05T00:00:00,Animals,B01.050
16750521,2006-06-05T00:00:00,"Animals, Newborn",B01.050.050.282
16750521,2006-06-05T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
16750521,2006-06-05T00:00:00,"Microscopy, Confocal",E05.595.395
16750521,2006-06-05T00:00:00,Microtubule-Associated Proteins,D12.776.220.600.450
16750521,2006-06-05T00:00:00,Microtubule-Associated Proteins,D12.776.641.560
16750521,2006-06-05T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16750521,2006-06-05T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16750521,2006-06-05T00:00:00,"Myocytes, Cardiac",A11.620.500
16750521,2006-06-05T00:00:00,"RNA, Messenger",D13.444.735.544
16750521,2006-06-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16750521,2006-06-05T00:00:00,Ribonucleoproteins,D12.776.157.725.500
16750521,2006-06-05T00:00:00,Ribonucleoproteins,D12.776.664.962.500
16750683,2006-06-06T00:00:00,Aged,M01.060.116.100
16750683,2006-06-06T00:00:00,Coronary Circulation,G09.330.190.163.324
16750683,2006-06-06T00:00:00,Coronary Vessels,A07.231.114.269
16750683,2006-06-06T00:00:00,Coronary Vessels,A07.231.908.194
16750683,2006-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16750683,2006-06-06T00:00:00,Middle Aged,M01.060.116.630
16750683,2006-06-06T00:00:00,Myocardial Infarction,C14.280.647.500
16750683,2006-06-06T00:00:00,Myocardial Infarction,C14.907.585.500
16750683,2006-06-06T00:00:00,Myocardial Ischemia,C14.280.647
16750683,2006-06-06T00:00:00,Myocardial Ischemia,C14.907.585
16750683,2006-06-06T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
16750683,2006-06-06T00:00:00,Recovery of Function,G16.757
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,E05.318.740.872
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,E05.318.780.800
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,G17.800
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16750683,2006-06-06T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16750683,2006-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
16750683,2006-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
16750683,2006-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
16750683,2006-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
16750683,2006-06-06T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
16753292,2006-06-06T00:00:00,Adsorption,G02.149.047
16753292,2006-06-06T00:00:00,Adsorption,G02.149.767.029
16753292,2006-06-06T00:00:00,Adsorption,G02.842.750.029
16753292,2006-06-06T00:00:00,Amino Acids,D12.125
16753292,2006-06-06T00:00:00,Binding Sites,G02.111.570.120
16753292,2006-06-06T00:00:00,Biosensing Techniques,E05.601.123
16753292,2006-06-06T00:00:00,"Coated Materials, Biocompatible",D25.130.420
16753292,2006-06-06T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
16753292,2006-06-06T00:00:00,Computer Simulation,L01.224.160
16753292,2006-06-06T00:00:00,Materials Testing,E05.570
16753292,2006-06-06T00:00:00,"Models, Chemical",E05.599.495
16753292,2006-06-06T00:00:00,Polymers,D05.750
16753292,2006-06-06T00:00:00,Polymers,D25.720
16753292,2006-06-06T00:00:00,Polymers,J01.637.051.720
16753292,2006-06-06T00:00:00,Surface Properties,G02.842.850
16757539,2006-06-06T00:00:00,Animals,B01.050
16757539,2006-06-06T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16757539,2006-06-06T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16757539,2006-06-06T00:00:00,Myocardial Infarction,C14.280.647.500
16757539,2006-06-06T00:00:00,Myocardial Infarction,C14.907.585.500
16757539,2006-06-06T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
16757539,2006-06-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
16757539,2006-06-06T00:00:00,Ventricular Remodeling,C23.300.985
16757539,2006-06-06T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16757567,2006-06-06T00:00:00,Animals,B01.050
16757567,2006-06-06T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
16757567,2006-06-06T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
16757567,2006-06-06T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
16757567,2006-06-06T00:00:00,Cell Proliferation,G04.299.233.750
16757567,2006-06-06T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16757567,2006-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16757567,2006-06-06T00:00:00,Interleukin-15,D12.644.276.374.465.515
16757567,2006-06-06T00:00:00,Interleukin-15,D12.776.467.374.465.515
16757567,2006-06-06T00:00:00,Interleukin-15,D23.529.374.465.515
16757567,2006-06-06T00:00:00,Interleukin-2,D12.644.276.374.465.502
16757567,2006-06-06T00:00:00,Interleukin-2,D12.644.276.374.480.372
16757567,2006-06-06T00:00:00,Interleukin-2,D12.776.467.374.465.502
16757567,2006-06-06T00:00:00,Interleukin-2,D12.776.467.374.480.372
16757567,2006-06-06T00:00:00,Interleukin-2,D23.529.374.465.502
16757567,2006-06-06T00:00:00,Interleukin-2,D23.529.374.480.372
16757567,2006-06-06T00:00:00,Protein Isoforms,D12.776.800
16757567,2006-06-06T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16757567,2006-06-06T00:00:00,Recombinant Proteins,D12.776.828
16757682,2006-06-06T00:00:00,Animals,B01.050
16757682,2006-06-06T00:00:00,Binding Sites,G02.111.570.120
16757682,2006-06-06T00:00:00,Liver,A03.620
16757682,2006-06-06T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16757682,2006-06-06T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
16757682,2006-06-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
16757682,2006-06-06T00:00:00,"Transcription, Genetic",G02.111.087.847
16757682,2006-06-06T00:00:00,"Transcription, Genetic",G02.149.115.847
16757682,2006-06-06T00:00:00,"Transcription, Genetic",G05.355.310.700
16760247,2006-06-07T00:00:00,Adult,M01.060.116
16760247,2006-06-07T00:00:00,African Americans,M01.686.508.100.100
16760247,2006-06-07T00:00:00,African Americans,M01.686.754.100
16760247,2006-06-07T00:00:00,Age Factors,N05.715.350.075
16760247,2006-06-07T00:00:00,Age Factors,N06.850.490.250
16760247,2006-06-07T00:00:00,Consumer Participation,N02.421.143.262
16760247,2006-06-07T00:00:00,Consumer Participation,N03.540.245.360
16760247,2006-06-07T00:00:00,Diabetes Mellitus,C18.452.394.750
16760247,2006-06-07T00:00:00,Diabetes Mellitus,C19.246
16760247,2006-06-07T00:00:00,Health Education,I02.233.332
16760247,2006-06-07T00:00:00,Health Education,N02.421.143.827.407
16760247,2006-06-07T00:00:00,Health Education,N02.421.726.407
16760247,2006-06-07T00:00:00,Health Services Accessibility,N04.590.374.350
16760247,2006-06-07T00:00:00,Health Services Accessibility,N05.300.430
16760247,2006-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760247,2006-06-07T00:00:00,Internet,L01.224.230.110.500
16760247,2006-06-07T00:00:00,Middle Aged,M01.060.116.630
16760247,2006-06-07T00:00:00,Needs Assessment,I02.594
16760247,2006-06-07T00:00:00,Needs Assessment,N03.349.380.565
16760247,2006-06-07T00:00:00,Needs Assessment,N05.300.537
16760247,2006-06-07T00:00:00,Sex Factors,N05.715.350.675
16760247,2006-06-07T00:00:00,Sex Factors,N06.850.490.875
16760247,2006-06-07T00:00:00,South Carolina,Z01.107.567.875.075.662
16760247,2006-06-07T00:00:00,South Carolina,Z01.107.567.875.750.700
16760258,2006-06-07T00:00:00,Amino Acid Sequence,G02.111.570.060
16760258,2006-06-07T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16760258,2006-06-07T00:00:00,Biological Markers,D23.101
16760258,2006-06-07T00:00:00,Glycoproteins,D09.400.430
16760258,2006-06-07T00:00:00,Glycoproteins,D12.776.395
16760258,2006-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760258,2006-06-07T00:00:00,Molecular Sequence Data,L01.453.245.667
16760258,2006-06-07T00:00:00,Proteomics,H01.158.201.843
16760258,2006-06-07T00:00:00,Proteomics,H01.158.273.180.350.700
16760258,2006-06-07T00:00:00,Proteomics,H01.158.273.343.350.700
16760258,2006-06-07T00:00:00,Proteomics,H01.181.122.738
16760258,2006-06-07T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
16844155,2006-06-08T00:00:00,Adolescent,M01.060.057
16844155,2006-06-08T00:00:00,Adult,M01.060.116
16844155,2006-06-08T00:00:00,Aged,M01.060.116.100
16844155,2006-06-08T00:00:00,Cell Survival,G04.299.316
16844155,2006-06-08T00:00:00,DNA,D13.444.308
16844155,2006-06-08T00:00:00,DNA-Binding Proteins,D12.776.260
16844155,2006-06-08T00:00:00,Environmental Pollutants,D27.888.284
16844155,2006-06-08T00:00:00,Gene Expression,G05.355.310
16844155,2006-06-08T00:00:00,Gene Expression Profiling,E05.393.332
16844155,2006-06-08T00:00:00,Glucose,D09.546.359.448
16844155,2006-06-08T00:00:00,Glutathione,D12.644.456.448
16844155,2006-06-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16844155,2006-06-08T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
16844155,2006-06-08T00:00:00,Middle Aged,M01.060.116.630
16844155,2006-06-08T00:00:00,"RNA, Messenger",D13.444.735.544
16844155,2006-06-08T00:00:00,Transcription Factors,D12.776.930
16844155,2006-06-08T00:00:00,Trichloroethylene,D02.455.526.439.939
16763610,2006-06-09T00:00:00,Adenoviridae,B04.280.030
16763610,2006-06-09T00:00:00,Adenoviridae,B04.909.204.097
16763610,2006-06-09T00:00:00,Animals,B01.050
16763610,2006-06-09T00:00:00,Antineoplastic Agents,D27.505.954.248
16763610,2006-06-09T00:00:00,Ceramides,D02.065.313
16763610,2006-06-09T00:00:00,Ceramides,D09.400.410.420.525.200
16763610,2006-06-09T00:00:00,Ceramides,D10.390.470.675.200
16763610,2006-06-09T00:00:00,Ceramides,D10.570.877.360.612.200
16763610,2006-06-09T00:00:00,Clinical Trials as Topic,E05.318.760.535
16763610,2006-06-09T00:00:00,Clinical Trials as Topic,E05.337.250
16763610,2006-06-09T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16763610,2006-06-09T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.644.276.972.249
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.776.395.550.312
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.776.467.972.249
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D12.776.543.550.312
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D23.101.100.110.282
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D23.529.374.750.249
16763610,2006-06-09T00:00:00,Fas Ligand Protein,D23.529.972.249
16763610,2006-06-09T00:00:00,Genetic Vectors,G05.360.337
16763610,2006-06-09T00:00:00,Head and Neck Neoplasms,C04.588.443
16763610,2006-06-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16763610,2006-06-09T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16763610,2006-06-09T00:00:00,Prostatic Neoplasms,C12.294.260.750
16763610,2006-06-09T00:00:00,Prostatic Neoplasms,C12.294.565.625
16763610,2006-06-09T00:00:00,Prostatic Neoplasms,C12.758.409.750
16763610,2006-06-09T00:00:00,Recombinant Proteins,D12.776.828
16763610,2006-06-09T00:00:00,Signal Transduction,G02.111.087.800
16763610,2006-06-09T00:00:00,Signal Transduction,G02.149.115.800
16763610,2006-06-09T00:00:00,Signal Transduction,G04.299.880
16766634,2006-06-09T00:00:00,Animals,B01.050
16766634,2006-06-09T00:00:00,Echocardiography,E01.370.350.850.220
16766634,2006-06-09T00:00:00,Echocardiography,E01.370.370.380.220
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
16766634,2006-06-09T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
16766634,2006-06-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16766634,2006-06-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16766634,2006-06-09T00:00:00,Myocardial Infarction,C14.280.647.500
16766634,2006-06-09T00:00:00,Myocardial Infarction,C14.907.585.500
16766634,2006-06-09T00:00:00,Myocardium,A02.633.580
16766634,2006-06-09T00:00:00,Myocardium,A07.541.704
16766634,2006-06-09T00:00:00,Myocardium,A10.690.552.750
16766634,2006-06-09T00:00:00,"Transcription, Genetic",G02.111.087.847
16766634,2006-06-09T00:00:00,"Transcription, Genetic",G02.149.115.847
16766634,2006-06-09T00:00:00,"Transcription, Genetic",G05.355.310.700
16766634,2006-06-09T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
16766634,2006-06-09T00:00:00,Ventricular Remodeling,C23.300.985
16766634,2006-06-09T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16766634,2006-06-09T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
16767507,2006-06-10T00:00:00,Adult,M01.060.116
16767507,2006-06-10T00:00:00,Forecasting,I01.320
16767507,2006-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16767507,2006-06-10T00:00:00,Mental Health Services,F04.408
16767507,2006-06-10T00:00:00,Mental Health Services,N02.421.461
16767507,2006-06-10T00:00:00,Middle Aged,M01.060.116.630
16767507,2006-06-10T00:00:00,Salaries and Fringe Benefits,N01.824.417.700
16767507,2006-06-10T00:00:00,Salaries and Fringe Benefits,N04.452.677.800
16767507,2006-06-10T00:00:00,United States,Z01.107.567.875
16767507,2006-06-10T00:00:00,Workload,N04.452.677.950
16765486,2006-06-12T00:00:00,Animals,B01.050
16765486,2006-06-12T00:00:00,Antioxidants,D27.505.519.217
16765486,2006-06-12T00:00:00,Antioxidants,D27.505.696.706.125
16765486,2006-06-12T00:00:00,Antioxidants,D27.720.799.047
16765486,2006-06-12T00:00:00,Brain,A08.186.211
16765486,2006-06-12T00:00:00,Encephalitis,C02.182.500
16765486,2006-06-12T00:00:00,Encephalitis,C10.228.140.430
16765486,2006-06-12T00:00:00,Encephalitis,C10.228.228.210.150
16765486,2006-06-12T00:00:00,Encephalitis,C10.228.228.245
16765486,2006-06-12T00:00:00,Enzyme Inhibitors,D27.505.519.389
16765486,2006-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16765486,2006-06-12T00:00:00,Neurodegenerative Diseases,C10.574
16765486,2006-06-12T00:00:00,Nitric Oxide,D01.339.387
16765486,2006-06-12T00:00:00,Nitric Oxide,D01.625.550.500
16765486,2006-06-12T00:00:00,Nitric Oxide,D01.625.700.500
16765486,2006-06-12T00:00:00,Nitric Oxide,D01.650.550.587.600
16765486,2006-06-12T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16765486,2006-06-12T00:00:00,Reactive Nitrogen Species,D01.625.700
16765486,2006-06-12T00:00:00,Reactive Nitrogen Species,D02.654.846
16765523,2006-06-12T00:00:00,Apoptosis,G04.299.139.160
16765523,2006-06-12T00:00:00,Calcium,D01.268.552.100
16765523,2006-06-12T00:00:00,Calcium,D01.552.539.288
16765523,2006-06-12T00:00:00,Calcium,D23.119.100
16765523,2006-06-12T00:00:00,Caspases,D08.811.277.656.262.500.126
16765523,2006-06-12T00:00:00,Caspases,D08.811.277.656.300.200.126
16765523,2006-06-12T00:00:00,Caspases,D12.644.360.075.405
16765523,2006-06-12T00:00:00,Caspases,D12.776.476.075.405
16765523,2006-06-12T00:00:00,Cell Survival,G04.299.316
16765523,2006-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16765523,2006-06-12T00:00:00,"Models, Biological",E05.599.395
16765523,2006-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.644.360.075.718
16765523,2006-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.476.075.718
16765523,2006-06-12T00:00:00,Proto-Oncogene Proteins c-bcl-2,D12.776.624.664.700.169
16765523,2006-06-12T00:00:00,Signal Transduction,G02.111.087.800
16765523,2006-06-12T00:00:00,Signal Transduction,G02.149.115.800
16765523,2006-06-12T00:00:00,Signal Transduction,G04.299.880
16765523,2006-06-12T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
16765523,2006-06-12T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
16769014,2006-06-12T00:00:00,Adult,M01.060.116
16769014,2006-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16769014,2006-06-12T00:00:00,Pregnancy,G08.686.785.760.769
16769014,2006-06-12T00:00:00,"Pregnancy, Multiple",G08.686.710
16769014,2006-06-12T00:00:00,"Pregnancy, Multiple",G08.686.785.760.769.525
16769014,2006-06-12T00:00:00,Premature Birth,C13.703.420.491.500
16769014,2006-06-12T00:00:00,Uterine Contraction,G08.686.785.760.769.326.700
16769014,2006-06-12T00:00:00,Uterine Contraction,G11.427.590.540.890
16769909,2006-06-12T00:00:00,Amino Acid Sequence,G02.111.570.060
16769909,2006-06-12T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16769909,2006-06-12T00:00:00,Animals,B01.050
16769909,2006-06-12T00:00:00,Connexin 43,D12.776.543.585.250.200
16769909,2006-06-12T00:00:00,Gap Junctions,A11.284.149.165.420.471
16769909,2006-06-12T00:00:00,Gene Deletion,G05.355.600.800.320
16769909,2006-06-12T00:00:00,Gene Deletion,G05.365.590.762.320
16769909,2006-06-12T00:00:00,Heart Conduction System,A07.541.409
16769909,2006-06-12T00:00:00,Macrophages,A11.329.372
16769909,2006-06-12T00:00:00,Macrophages,A11.627.482
16769909,2006-06-12T00:00:00,Macrophages,A11.733.397
16769909,2006-06-12T00:00:00,Macrophages,A15.382.680.397
16769909,2006-06-12T00:00:00,Macrophages,A15.382.812.522
16769909,2006-06-12T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.300.480.525.700.250
16769909,2006-06-12T00:00:00,Matrix Metalloproteinase 7,D08.811.277.656.675.374.525.700.250
16769909,2006-06-12T00:00:00,Molecular Sequence Data,L01.453.245.667
16769909,2006-06-12T00:00:00,Myocardial Infarction,C14.280.647.500
16769909,2006-06-12T00:00:00,Myocardial Infarction,C14.907.585.500
16769909,2006-06-12T00:00:00,Myocardium,A02.633.580
16769909,2006-06-12T00:00:00,Myocardium,A07.541.704
16769909,2006-06-12T00:00:00,Myocardium,A10.690.552.750
16769909,2006-06-12T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16769909,2006-06-12T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16769909,2006-06-12T00:00:00,"Myocytes, Cardiac",A11.620.500
16769909,2006-06-12T00:00:00,Recombinant Proteins,D12.776.828
16769909,2006-06-12T00:00:00,Ventricular Remodeling,C23.300.985
16769909,2006-06-12T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16829336,2006-06-12T00:00:00,Cost-Benefit Analysis,N03.219.151.125
16829336,2006-06-12T00:00:00,Health Promotion,N02.370
16829336,2006-06-12T00:00:00,Health Promotion,N02.421.726.507
16829336,2006-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16829336,2006-06-12T00:00:00,New York City,Z01.107.567.875.350.530.530
16829336,2006-06-12T00:00:00,New York City,Z01.107.567.875.500.530.530
16829336,2006-06-12T00:00:00,New York City,Z01.433.741
16829336,2006-06-12T00:00:00,Nicotine,D03.132.760.570
16829336,2006-06-12T00:00:00,Nicotine,D03.383.725.518
16829336,2006-06-12T00:00:00,Prevalence,E05.318.308.985.525.750
16829336,2006-06-12T00:00:00,Prevalence,L01.280.975.525.750
16829336,2006-06-12T00:00:00,Prevalence,N01.224.935.597.750
16829336,2006-06-12T00:00:00,Prevalence,N06.850.505.400.975.525.750
16829336,2006-06-12T00:00:00,Prevalence,N06.850.520.308.985.525.750
16829336,2006-06-12T00:00:00,Program Evaluation,E05.337.820
16829336,2006-06-12T00:00:00,Program Evaluation,N04.761.685
16829336,2006-06-12T00:00:00,Program Evaluation,N05.715.360.650
16829336,2006-06-12T00:00:00,Smoking,F01.145.466.753
16829336,2006-06-12T00:00:00,Smoking Cessation,F01.145.940.700
16860028,2006-06-12T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16860028,2006-06-12T00:00:00,Blood Pressure,E01.370.600.875.249
16860028,2006-06-12T00:00:00,Blood Pressure,G09.330.380.076
16860028,2006-06-12T00:00:00,Diastole,G09.330.190.541.295
16860028,2006-06-12T00:00:00,Diastole,G11.427.590.540.554.250
16860028,2006-06-12T00:00:00,Diastole,G11.427.590.540.570.295
16860028,2006-06-12T00:00:00,Exercise Tolerance,G11.427.680.270
16860028,2006-06-12T00:00:00,Heart Ventricles,A07.541.560
16860028,2006-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16860028,2006-06-12T00:00:00,Hypertension,C14.907.489
16860028,2006-06-12T00:00:00,Middle Aged,M01.060.116.630
16860028,2006-06-12T00:00:00,Myocardial Contraction,G09.330.190.541
16860028,2006-06-12T00:00:00,Myocardial Contraction,G11.427.590.540.570
16860028,2006-06-12T00:00:00,Physical Exertion,G11.427.590.780
16860028,2006-06-12T00:00:00,Treatment Outcome,E01.789.800
16860028,2006-06-12T00:00:00,Treatment Outcome,N04.761.559.590.800
16860028,2006-06-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16860028,2006-06-12T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16769954,2006-06-13T00:00:00,Aged,M01.060.116.100
16769954,2006-06-13T00:00:00,Brain Ischemia,C10.228.140.300.150
16769954,2006-06-13T00:00:00,Brain Ischemia,C14.907.253.092
16769954,2006-06-13T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16769954,2006-06-13T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16769954,2006-06-13T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16769954,2006-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16769954,2006-06-13T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16769954,2006-06-13T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16769954,2006-06-13T00:00:00,Risk Assessment,E05.318.740.600.800.715
16769954,2006-06-13T00:00:00,Risk Assessment,N04.452.871.715
16769954,2006-06-13T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16769954,2006-06-13T00:00:00,Risk Assessment,N06.850.505.715
16769954,2006-06-13T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16769954,2006-06-13T00:00:00,Risk Factors,E05.318.740.600.800.725
16769954,2006-06-13T00:00:00,Risk Factors,N05.715.350.200.700
16769954,2006-06-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16769954,2006-06-13T00:00:00,Risk Factors,N06.850.490.625.750
16769954,2006-06-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16769954,2006-06-13T00:00:00,Sex Factors,N05.715.350.675
16769954,2006-06-13T00:00:00,Sex Factors,N06.850.490.875
16769954,2006-06-13T00:00:00,Stroke,C10.228.140.300.775
16769954,2006-06-13T00:00:00,Stroke,C14.907.253.855
16769954,2006-06-13T00:00:00,Thrombolytic Therapy,E02.319.913
16769954,2006-06-13T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16769954,2006-06-13T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16769954,2006-06-13T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16769954,2006-06-13T00:00:00,Tissue Plasminogen Activator,D23.119.970
16769954,2006-06-13T00:00:00,Treatment Outcome,E01.789.800
16769954,2006-06-13T00:00:00,Treatment Outcome,N04.761.559.590.800
16769954,2006-06-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16769954,2006-06-13T00:00:00,United States,Z01.107.567.875
16911897,2006-06-13T00:00:00,Adolescent,M01.060.057
16911897,2006-06-13T00:00:00,Adult,M01.060.116
16911897,2006-06-13T00:00:00,Aged,M01.060.116.100
16911897,2006-06-13T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
16911897,2006-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16911897,2006-06-13T00:00:00,Middle Aged,M01.060.116.630
16911897,2006-06-13T00:00:00,Plant Extracts,D20.215.784.500
16911897,2006-06-13T00:00:00,Plant Extracts,D26.667
16911897,2006-06-13T00:00:00,Smoking Cessation,F01.145.940.700
16773436,2006-06-14T00:00:00,Biomedical Research,H01.770.644.145
16773436,2006-06-14T00:00:00,Breast Neoplasms,C04.588.180
16773436,2006-06-14T00:00:00,Breast Neoplasms,C17.800.090.500
16773436,2006-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16773436,2006-06-14T00:00:00,Research Design,E05.581.500
16773436,2006-06-14T00:00:00,Research Design,H01.770.644.728
16773436,2006-06-14T00:00:00,"Tumor Markers, Biological",D23.101.840
16773491,2006-06-14T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
16773491,2006-06-14T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
16773491,2006-06-14T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
16773491,2006-06-14T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
16773491,2006-06-14T00:00:00,Clostridium Infections,C01.252.410.222
16773491,2006-06-14T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
16773491,2006-06-14T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
16773491,2006-06-14T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
16773491,2006-06-14T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
16773491,2006-06-14T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
16773491,2006-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16773491,2006-06-14T00:00:00,Polytetrafluoroethylene,D05.750.395.616
16773491,2006-06-14T00:00:00,Polytetrafluoroethylene,D25.720.395.616
16773491,2006-06-14T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
16773491,2006-06-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16773491,2006-06-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16773491,2006-06-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16773491,2006-06-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16773491,2006-06-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16773491,2006-06-14T00:00:00,Treatment Outcome,E01.789.800
16773491,2006-06-14T00:00:00,Treatment Outcome,N04.761.559.590.800
16773491,2006-06-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16777202,2006-06-14T00:00:00,Adolescent,M01.060.057
16777202,2006-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16777202,2006-06-14T00:00:00,Internet,L01.224.230.110.500
16777202,2006-06-14T00:00:00,New York,Z01.107.567.875.075.437
16777202,2006-06-14T00:00:00,New York,Z01.107.567.875.350.530
16777202,2006-06-14T00:00:00,New York,Z01.107.567.875.500.530
16777202,2006-06-14T00:00:00,Smoking,F01.145.466.753
16739206,2006-06-15T00:00:00,Adolescent,M01.060.057
16739206,2006-06-15T00:00:00,Child,M01.060.406
16739206,2006-06-15T00:00:00,Disability Evaluation,E01.370.400
16739206,2006-06-15T00:00:00,Health Services Accessibility,N04.590.374.350
16739206,2006-06-15T00:00:00,Health Services Accessibility,N05.300.430
16739206,2006-06-15T00:00:00,Health Status,I01.240.425
16739206,2006-06-15T00:00:00,Health Status,N01.224.425
16739206,2006-06-15T00:00:00,Health Status,N06.850.505.400.425
16739206,2006-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16739206,2006-06-15T00:00:00,Private Sector,I01.791
16739206,2006-06-15T00:00:00,Private Sector,N04.452.633.390
16739206,2006-06-15T00:00:00,Quality of Life,I01.800
16739206,2006-06-15T00:00:00,Quality of Life,K01.752.400.750
16739206,2006-06-15T00:00:00,Questionnaires,E05.318.308.750
16739206,2006-06-15T00:00:00,Questionnaires,L01.280.800
16739206,2006-06-15T00:00:00,Questionnaires,N05.715.360.300.695
16739206,2006-06-15T00:00:00,Questionnaires,N06.850.520.308.750
16778201,2006-06-15T00:00:00,Animals,B01.050
16778201,2006-06-15T00:00:00,Complement C3,D12.776.124.050.140
16778201,2006-06-15T00:00:00,Complement C3,D12.776.124.486.274.250
16778201,2006-06-15T00:00:00,Complement Inactivator Proteins,D12.776.124.486.274.920
16778201,2006-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16778201,2006-06-15T00:00:00,Lung Neoplasms,C04.588.894.797.520
16778201,2006-06-15T00:00:00,Lung Neoplasms,C08.381.540
16778201,2006-06-15T00:00:00,Lung Neoplasms,C08.785.520
16778201,2006-06-15T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
16778201,2006-06-15T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
16778201,2006-06-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16778201,2006-06-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16780878,2006-06-15T00:00:00,Aged,M01.060.116.100
16780878,2006-06-15T00:00:00,Aging,G07.700.320.124
16780878,2006-06-15T00:00:00,Association Learning,F02.463.425.069.296
16780878,2006-06-15T00:00:00,Face,A01.456.505
16780878,2006-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16780878,2006-06-15T00:00:00,Imagination,F02.463.188.634
16780878,2006-06-15T00:00:00,"Memory, Short-Term",F02.463.425.540.407
16780878,2006-06-15T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
16780878,2006-06-15T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
16780878,2006-06-15T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
16780878,2006-06-15T00:00:00,Practice (Psychology),F02.463.425.674
17136167,2006-06-15T00:00:00,Data Collection,E05.318.308
17136167,2006-06-15T00:00:00,Data Collection,L01.280
17136167,2006-06-15T00:00:00,Data Collection,N05.715.360.300
17136167,2006-06-15T00:00:00,Data Collection,N06.850.520.308
17136167,2006-06-15T00:00:00,"Education, Pharmacy",I02.358.525
17136167,2006-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17136167,2006-06-15T00:00:00,"Schools, Pharmacy",I02.783.660.694
17136167,2006-06-15T00:00:00,"Students, Pharmacy",I02.851.686.768
17136167,2006-06-15T00:00:00,"Students, Pharmacy",M01.848.769.768
17136167,2006-06-15T00:00:00,United States,Z01.107.567.875
16782791,2006-06-16T00:00:00,Binding Sites,G02.111.570.120
16782791,2006-06-16T00:00:00,Computer Simulation,L01.224.160
16782791,2006-06-16T00:00:00,"Models, Chemical",E05.599.495
16782791,2006-06-16T00:00:00,"Models, Molecular",E05.599.595
16782791,2006-06-16T00:00:00,Multiprotein Complexes,D05.500
16782791,2006-06-16T00:00:00,Protein Interaction Mapping,E05.601.690
16782791,2006-06-16T00:00:00,Proteins,D12.776
16782791,2006-06-16T00:00:00,Static Electricity,G01.201.249.820
16785288,2006-06-19T00:00:00,"Child, Preschool",M01.060.406.448
16785288,2006-06-19T00:00:00,Heart Arrest,C14.280.383
16785288,2006-06-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16785288,2006-06-19T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.619.393.536
16785288,2006-06-19T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.632
16785288,2006-06-19T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.790.651.114.632
16785288,2006-06-19T00:00:00,"Immunoglobulins, Intravenous",D12.776.377.715.548.114.632
16785288,2006-06-19T00:00:00,"Influenza, Human",C02.782.620.365
16785288,2006-06-19T00:00:00,"Influenza, Human",C08.730.310
16785288,2006-06-19T00:00:00,"Lymphohistiocytosis, Hemophagocytic",C15.604.250.410.575
16787536,2006-06-20T00:00:00,Animals,B01.050
16787536,2006-06-20T00:00:00,Embryonic Development,G07.700.320.500.325.180
16787536,2006-06-20T00:00:00,Embryonic Development,G08.686.785.760.170.104
16787536,2006-06-20T00:00:00,"Lipoproteins, HDL",D10.532.432
16787536,2006-06-20T00:00:00,"Lipoproteins, HDL",D12.776.521.479
16787536,2006-06-20T00:00:00,Mesoderm,A16.504.660
16787536,2006-06-20T00:00:00,"Receptors, Cell Surface",D12.776.543.750
16790502,2006-06-21T00:00:00,3T3 Cells,A11.251.210.700
16790502,2006-06-21T00:00:00,3T3 Cells,A11.329.228.900
16790502,2006-06-21T00:00:00,Amino Acid Sequence,G02.111.570.060
16790502,2006-06-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16790502,2006-06-21T00:00:00,Animals,B01.050
16790502,2006-06-21T00:00:00,Calcium,D01.268.552.100
16790502,2006-06-21T00:00:00,Calcium,D01.552.539.288
16790502,2006-06-21T00:00:00,Calcium,D23.119.100
16790502,2006-06-21T00:00:00,Calpain,D08.811.277.656.262.500.120
16790502,2006-06-21T00:00:00,Calpain,D08.811.277.656.300.200.120
16790502,2006-06-21T00:00:00,Cyclosporine,D04.345.566.235.300
16790502,2006-06-21T00:00:00,Cyclosporine,D12.644.641.235.300
16790502,2006-06-21T00:00:00,Enzyme Inhibitors,D27.505.519.389
16790502,2006-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16790502,2006-06-21T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16790502,2006-06-21T00:00:00,Mitochondria,A11.284.835.626
16790502,2006-06-21T00:00:00,Mitochondrial Diseases,C18.452.660
16790502,2006-06-21T00:00:00,Molecular Sequence Data,L01.453.245.667
16790502,2006-06-21T00:00:00,Rabbits,B01.050.150.900.649.521.700
16790502,2006-06-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16790502,2006-06-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16790698,2006-06-22T00:00:00,Adult,M01.060.116
16790698,2006-06-22T00:00:00,Aged,M01.060.116.100
16790698,2006-06-22T00:00:00,Autoimmune Diseases,C20.111
16790698,2006-06-22T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
16790698,2006-06-22T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
16790698,2006-06-22T00:00:00,Cyclophosphamide,D02.705.670.243
16790698,2006-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16790698,2006-06-22T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
16790698,2006-06-22T00:00:00,"Lung Diseases, Interstitial",C08.381.483
16790698,2006-06-22T00:00:00,Middle Aged,M01.060.116.630
16790698,2006-06-22T00:00:00,Regression Analysis,E05.318.740.750
16790698,2006-06-22T00:00:00,Regression Analysis,N05.715.360.750.695
16790698,2006-06-22T00:00:00,Regression Analysis,N06.850.520.830.750
16790698,2006-06-22T00:00:00,"Scleroderma, Systemic",C17.300.799
16790698,2006-06-22T00:00:00,"Scleroderma, Systemic",C17.800.784
16790698,2006-06-22T00:00:00,Treatment Outcome,E01.789.800
16790698,2006-06-22T00:00:00,Treatment Outcome,N04.761.559.590.800
16790698,2006-06-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16791769,2006-06-22T00:00:00,Agriculture,J01.040
16791769,2006-06-22T00:00:00,Light,G01.201.875.770.578
16791769,2006-06-22T00:00:00,Light,G01.590.540
16791769,2006-06-22T00:00:00,Plant Leaves,A18.024.812
16794209,2006-06-22T00:00:00,Adolescent,M01.060.057
16794209,2006-06-22T00:00:00,Adult,M01.060.116
16794209,2006-06-22T00:00:00,Aged,M01.060.116.100
16794209,2006-06-22T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16794209,2006-06-22T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16794209,2006-06-22T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16794209,2006-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16794209,2006-06-22T00:00:00,Middle Aged,M01.060.116.630
16794209,2006-06-22T00:00:00,Stroke,C10.228.140.300.775
16794209,2006-06-22T00:00:00,Stroke,C14.907.253.855
16794209,2006-06-22T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16794209,2006-06-22T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16794209,2006-06-22T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16794209,2006-06-22T00:00:00,Tissue Plasminogen Activator,D23.119.970
16794216,2006-06-22T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
16794216,2006-06-22T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
16794216,2006-06-22T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
16794216,2006-06-22T00:00:00,Hematoma,C23.550.414.838
16794216,2006-06-22T00:00:00,Hemodynamics,G09.330.190.400
16794216,2006-06-22T00:00:00,Hemodynamics,G09.330.380
16794216,2006-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16794216,2006-06-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16794216,2006-06-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16794216,2006-06-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16794216,2006-06-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16794216,2006-06-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16798724,2006-06-22T00:00:00,Adenoviridae,B04.280.030
16798724,2006-06-22T00:00:00,Adenoviridae,B04.909.204.097
16798724,2006-06-22T00:00:00,Animals,B01.050
16798724,2006-06-22T00:00:00,Cell Separation,E05.200.500.363
16798724,2006-06-22T00:00:00,DNA,D13.444.308
16798724,2006-06-22T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16798724,2006-06-22T00:00:00,Liver,A03.620
16798724,2006-06-22T00:00:00,Liver Cirrhosis,C06.552.630
16798724,2006-06-22T00:00:00,Phenotype,G05.695
16798724,2006-06-22T00:00:00,"RNA, Messenger",D13.444.735.544
16798724,2006-06-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16798724,2006-06-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
16798724,2006-06-22T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
16843185,2006-06-22T00:00:00,Aged,M01.060.116.100
16843185,2006-06-22T00:00:00,Atrial Fibrillation,C14.280.067.198
16843185,2006-06-22T00:00:00,Atrial Fibrillation,C23.550.073.198
16843185,2006-06-22T00:00:00,Catheter Ablation,E01.370.370.380.410.200
16843185,2006-06-22T00:00:00,Catheter Ablation,E02.148.110
16843185,2006-06-22T00:00:00,Catheter Ablation,E02.148.442.110
16843185,2006-06-22T00:00:00,Catheter Ablation,E02.154.402.110
16843185,2006-06-22T00:00:00,Catheter Ablation,E04.014.170.402.110
16843185,2006-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16843185,2006-06-22T00:00:00,Middle Aged,M01.060.116.630
16843185,2006-06-22T00:00:00,Pulmonary Veins,A07.231.908.713
16843185,2006-06-22T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
16843185,2006-06-22T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
16843185,2006-06-22T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
16801453,2006-06-26T00:00:00,Animals,B01.050
16801453,2006-06-26T00:00:00,Apoptosis,G04.299.139.160
16801453,2006-06-26T00:00:00,Cell Death,G04.299.139
16801453,2006-06-26T00:00:00,Cell Survival,G04.299.316
16801453,2006-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16801453,2006-06-26T00:00:00,Signal Transduction,G02.111.087.800
16801453,2006-06-26T00:00:00,Signal Transduction,G02.149.115.800
16801453,2006-06-26T00:00:00,Signal Transduction,G04.299.880
16801477,2006-06-26T00:00:00,Adult,M01.060.116
16801477,2006-06-26T00:00:00,Aged,M01.060.116.100
16801477,2006-06-26T00:00:00,Blood Pressure,E01.370.600.875.249
16801477,2006-06-26T00:00:00,Blood Pressure,G09.330.380.076
16801477,2006-06-26T00:00:00,Diet,E05.272
16801477,2006-06-26T00:00:00,Diet,G07.610.240
16801477,2006-06-26T00:00:00,Dietary Fats,D10.212.302
16801477,2006-06-26T00:00:00,Dietary Fats,J02.500.375
16801477,2006-06-26T00:00:00,Fatty Acids,D10.251
16801477,2006-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16801477,2006-06-26T00:00:00,Hypertension,C14.907.489
16801477,2006-06-26T00:00:00,Middle Aged,M01.060.116.630
16801477,2006-06-26T00:00:00,Prevalence,E05.318.308.985.525.750
16801477,2006-06-26T00:00:00,Prevalence,L01.280.975.525.750
16801477,2006-06-26T00:00:00,Prevalence,N01.224.935.597.750
16801477,2006-06-26T00:00:00,Prevalence,N06.850.505.400.975.525.750
16801477,2006-06-26T00:00:00,Prevalence,N06.850.520.308.985.525.750
16801477,2006-06-26T00:00:00,United States,Z01.107.567.875
16801528,2006-06-26T00:00:00,Animals,B01.050
16801528,2006-06-26T00:00:00,Endocytosis,G04.299.482
16801528,2006-06-26T00:00:00,Protein Transport,G03.495.166.700
16801528,2006-06-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16801528,2006-06-26T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16801528,2006-06-26T00:00:00,"Receptors, Cell Surface",D12.776.543.750
16801528,2006-06-26T00:00:00,Trans-Activators,D12.776.260.755
16801528,2006-06-26T00:00:00,Trans-Activators,D12.776.930.900
16801528,2006-06-26T00:00:00,Trans-Activators,D12.776.964.925.984
16794534,2006-06-27T00:00:00,Animals,B01.050
16794534,2006-06-27T00:00:00,Cell Lineage,G04.172
16794534,2006-06-27T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
16794534,2006-06-27T00:00:00,Cell Lineage,G08.686.155
16794534,2006-06-27T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
16794534,2006-06-27T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
16794534,2006-06-27T00:00:00,Swine,B01.050.150.900.649.077.880
16794534,2006-06-27T00:00:00,Thymus Gland,A10.549.750
16794534,2006-06-27T00:00:00,Thymus Gland,A15.382.520.604.750
16794534,2006-06-27T00:00:00,Transplantation Conditioning,E02.095.465.425.450.800
16794534,2006-06-27T00:00:00,Transplantation Conditioning,E05.478.610.800
16794534,2006-06-27T00:00:00,Treatment Outcome,E01.789.800
16794534,2006-06-27T00:00:00,Treatment Outcome,N04.761.559.590.800
16794534,2006-06-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16794535,2006-06-27T00:00:00,Animals,B01.050
16794535,2006-06-27T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
16794535,2006-06-27T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
16794535,2006-06-27T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
16794535,2006-06-27T00:00:00,Blood Coagulation,G09.188.124.560.150
16794535,2006-06-27T00:00:00,Blood Pressure,E01.370.600.875.249
16794535,2006-06-27T00:00:00,Blood Pressure,G09.330.380.076
16794535,2006-06-27T00:00:00,Graft Rejection,G12.425.901.545.328
16794535,2006-06-27T00:00:00,Graft Survival,G12.425.901.545.340
16794535,2006-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16794535,2006-06-27T00:00:00,Lung Transplantation,E04.928.600.495
16794535,2006-06-27T00:00:00,Lung Transplantation,E04.936.450.495
16794535,2006-06-27T00:00:00,Papio,B01.050.150.900.649.801.400.112.199.120.610
16794535,2006-06-27T00:00:00,Swine,B01.050.150.900.649.077.880
16801470,2006-06-27T00:00:00,Catheter Ablation,E01.370.370.380.410.200
16801470,2006-06-27T00:00:00,Catheter Ablation,E02.148.110
16801470,2006-06-27T00:00:00,Catheter Ablation,E02.148.442.110
16801470,2006-06-27T00:00:00,Catheter Ablation,E02.154.402.110
16801470,2006-06-27T00:00:00,Catheter Ablation,E04.014.170.402.110
16801470,2006-06-27T00:00:00,Echocardiography,E01.370.350.850.220
16801470,2006-06-27T00:00:00,Echocardiography,E01.370.370.380.220
16801470,2006-06-27T00:00:00,Electrodes,E07.305.250
16801470,2006-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16801470,2006-06-27T00:00:00,Incidence,E05.318.308.985.525.375
16801470,2006-06-27T00:00:00,Incidence,L01.280.975.525.375
16801470,2006-06-27T00:00:00,Incidence,N01.224.935.597.500
16801470,2006-06-27T00:00:00,Incidence,N06.850.505.400.975.525.375
16801470,2006-06-27T00:00:00,Incidence,N06.850.520.308.985.525.375
16801470,2006-06-27T00:00:00,"Muscle, Skeletal",A02.633.567
16801470,2006-06-27T00:00:00,"Muscle, Skeletal",A10.690.552.500
16801470,2006-06-27T00:00:00,Research Design,E05.581.500
16801470,2006-06-27T00:00:00,Research Design,H01.770.644.728
16801470,2006-06-27T00:00:00,Risk Factors,E05.318.740.600.800.725
16801470,2006-06-27T00:00:00,Risk Factors,N05.715.350.200.700
16801470,2006-06-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16801470,2006-06-27T00:00:00,Risk Factors,N06.850.490.625.750
16801470,2006-06-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16801470,2006-06-27T00:00:00,Temperature,G01.906.595
16801470,2006-06-27T00:00:00,Temperature,G16.500.275.063.725.710
16801470,2006-06-27T00:00:00,Temperature,G16.500.750.775.710
16801470,2006-06-27T00:00:00,Temperature,N06.230.150.450
16801470,2006-06-27T00:00:00,Temperature,N06.230.300.100.725.710
16801470,2006-06-27T00:00:00,Thrombosis,C14.907.355.830
16803890,2006-06-27T00:00:00,Animals,B01.050
16803890,2006-06-27T00:00:00,Cell Line,A11.251.210
16803890,2006-06-27T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
16803890,2006-06-27T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16803890,2006-06-27T00:00:00,"Models, Molecular",E05.599.595
16803890,2006-06-27T00:00:00,RNA Interference,G05.355.315.203.374.790
16803890,2006-06-27T00:00:00,Signal Transduction,G02.111.087.800
16803890,2006-06-27T00:00:00,Signal Transduction,G02.149.115.800
16803890,2006-06-27T00:00:00,Signal Transduction,G04.299.880
16803890,2006-06-27T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
16803890,2006-06-27T00:00:00,Sphingosine,D02.033.100.700
16803890,2006-06-27T00:00:00,Sphingosine,D02.033.455.843
16803890,2006-06-27T00:00:00,Sphingosine,D02.092.063.700
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16803890,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16804192,2006-06-27T00:00:00,Antibodies,D12.776.124.486.485.114
16804192,2006-06-27T00:00:00,Antibodies,D12.776.124.790.651.114
16804192,2006-06-27T00:00:00,Antibodies,D12.776.377.715.548.114
16804192,2006-06-27T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
16804192,2006-06-27T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
16804192,2006-06-27T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
16804192,2006-06-27T00:00:00,Antigen-Antibody Complex,D23.050.101
16804192,2006-06-27T00:00:00,Cell Line,A11.251.210
16804192,2006-06-27T00:00:00,Complement Activation,G12.425.255
16804192,2006-06-27T00:00:00,Complement System Proteins,D12.776.124.486.274
16804192,2006-06-27T00:00:00,Cytokines,D12.644.276.374
16804192,2006-06-27T00:00:00,Cytokines,D12.776.467.374
16804192,2006-06-27T00:00:00,Cytokines,D23.529.374
16804192,2006-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16804192,2006-06-27T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16804192,2006-06-27T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16804192,2006-06-27T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16804192,2006-06-27T00:00:00,Interleukin-1,D12.644.276.374.465.501
16804192,2006-06-27T00:00:00,Interleukin-1,D12.644.276.374.500.400
16804192,2006-06-27T00:00:00,Interleukin-1,D12.776.467.374.465.501
16804192,2006-06-27T00:00:00,Interleukin-1,D12.776.467.374.500.400
16804192,2006-06-27T00:00:00,Interleukin-1,D23.529.374.465.501
16804192,2006-06-27T00:00:00,Interleukin-1,D23.529.374.500.400
16804192,2006-06-27T00:00:00,Interleukin-10,D12.644.276.374.465.510
16804192,2006-06-27T00:00:00,Interleukin-10,D12.776.467.374.465.510
16804192,2006-06-27T00:00:00,Interleukin-10,D23.529.374.465.510
16804192,2006-06-27T00:00:00,Interleukin-12,D12.644.276.374.465.512
16804192,2006-06-27T00:00:00,Interleukin-12,D12.776.467.374.465.512
16804192,2006-06-27T00:00:00,Interleukin-12,D23.529.374.465.512
16804192,2006-06-27T00:00:00,Interleukin-6,D12.644.276.374.465.506
16804192,2006-06-27T00:00:00,Interleukin-6,D12.776.467.374.465.506
16804192,2006-06-27T00:00:00,Interleukin-6,D23.529.374.465.506
16804192,2006-06-27T00:00:00,"Lipoproteins, LDL",D10.532.515
16804192,2006-06-27T00:00:00,"Lipoproteins, LDL",D12.776.521.550
16804192,2006-06-27T00:00:00,Macrophages,A11.329.372
16804192,2006-06-27T00:00:00,Macrophages,A11.627.482
16804192,2006-06-27T00:00:00,Macrophages,A11.733.397
16804192,2006-06-27T00:00:00,Macrophages,A15.382.680.397
16804192,2006-06-27T00:00:00,Macrophages,A15.382.812.522
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16804192,2006-06-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16806978,2006-06-27T00:00:00,Adult,M01.060.116
16806978,2006-06-27T00:00:00,Brain,A08.186.211
16806978,2006-06-27T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
16806978,2006-06-27T00:00:00,Functional Laterality,F02.830.297.425
16806978,2006-06-27T00:00:00,Functional Laterality,G11.561.225.425
16806978,2006-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16806978,2006-06-27T00:00:00,Hypothalamus,A08.186.211.464.482
16806978,2006-06-27T00:00:00,Hypothalamus,A08.186.211.730.317.357
16806978,2006-06-27T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16806978,2006-06-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16806978,2006-06-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16806978,2006-06-27T00:00:00,Orbit,A02.835.232.781.324.690
16806978,2006-06-27T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
16806978,2006-06-27T00:00:00,Signal Transduction,G02.111.087.800
16806978,2006-06-27T00:00:00,Signal Transduction,G02.149.115.800
16806978,2006-06-27T00:00:00,Signal Transduction,G04.299.880
16787053,2006-06-28T00:00:00,Polymers,D05.750
16787053,2006-06-28T00:00:00,Polymers,D25.720
16787053,2006-06-28T00:00:00,Polymers,J01.637.051.720
16787053,2006-06-28T00:00:00,Surface Properties,G02.842.850
16807330,2006-06-28T00:00:00,Adolescent,M01.060.057
16807330,2006-06-28T00:00:00,Adult,M01.060.116
16807330,2006-06-28T00:00:00,Brain,A08.186.211
16807330,2006-06-28T00:00:00,Case-Control Studies,E05.318.760.500.500
16807330,2006-06-28T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16807330,2006-06-28T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16807330,2006-06-28T00:00:00,Child,M01.060.406
16807330,2006-06-28T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
16807330,2006-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16807330,2006-06-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16807330,2006-06-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16807330,2006-06-28T00:00:00,Movement Disorders,C10.228.662
16807330,2006-06-28T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
16807330,2006-06-28T00:00:00,Space Perception,F02.463.593.778
16807330,2006-06-28T00:00:00,Space Perception,F02.463.593.932.869
16807330,2006-06-28T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
16807330,2006-06-28T00:00:00,Visual Perception,F02.463.593.932
16809570,2006-06-29T00:00:00,Aged,M01.060.116.100
16809570,2006-06-29T00:00:00,Albumins,D12.776.034
16809570,2006-06-29T00:00:00,Brain Ischemia,C10.228.140.300.150
16809570,2006-06-29T00:00:00,Brain Ischemia,C14.907.253.092
16809570,2006-06-29T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
16809570,2006-06-29T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
16809570,2006-06-29T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
16809570,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16809570,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16809570,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16809570,2006-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16809570,2006-06-29T00:00:00,Middle Aged,M01.060.116.630
16809570,2006-06-29T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16809570,2006-06-29T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16809570,2006-06-29T00:00:00,Pilot Projects,E05.318.760.750
16809570,2006-06-29T00:00:00,Pilot Projects,E05.337.737
16809570,2006-06-29T00:00:00,Pilot Projects,N05.715.360.775.625
16809570,2006-06-29T00:00:00,Pilot Projects,N06.850.520.450.720
16809570,2006-06-29T00:00:00,Serum Albumin,D12.776.034.841
16809570,2006-06-29T00:00:00,Serum Albumin,D12.776.124.050.700
16809570,2006-06-29T00:00:00,Serum Albumin,D12.776.124.727
16809570,2006-06-29T00:00:00,Stroke,C10.228.140.300.775
16809570,2006-06-29T00:00:00,Stroke,C14.907.253.855
16809570,2006-06-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16809570,2006-06-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16809570,2006-06-29T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16809570,2006-06-29T00:00:00,Tissue Plasminogen Activator,D23.119.970
16809570,2006-06-29T00:00:00,Treatment Outcome,E01.789.800
16809570,2006-06-29T00:00:00,Treatment Outcome,N04.761.559.590.800
16809570,2006-06-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16809571,2006-06-29T00:00:00,Aged,M01.060.116.100
16809571,2006-06-29T00:00:00,Albumins,D12.776.034
16809571,2006-06-29T00:00:00,Brain Ischemia,C10.228.140.300.150
16809571,2006-06-29T00:00:00,Brain Ischemia,C14.907.253.092
16809571,2006-06-29T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
16809571,2006-06-29T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
16809571,2006-06-29T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
16809571,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16809571,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16809571,2006-06-29T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16809571,2006-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16809571,2006-06-29T00:00:00,Middle Aged,M01.060.116.630
16809571,2006-06-29T00:00:00,Neuroprotective Agents,D27.505.696.706.548
16809571,2006-06-29T00:00:00,Neuroprotective Agents,D27.505.954.427.575
16809571,2006-06-29T00:00:00,Pilot Projects,E05.318.760.750
16809571,2006-06-29T00:00:00,Pilot Projects,E05.337.737
16809571,2006-06-29T00:00:00,Pilot Projects,N05.715.360.775.625
16809571,2006-06-29T00:00:00,Pilot Projects,N06.850.520.450.720
16809571,2006-06-29T00:00:00,Serum Albumin,D12.776.034.841
16809571,2006-06-29T00:00:00,Serum Albumin,D12.776.124.050.700
16809571,2006-06-29T00:00:00,Serum Albumin,D12.776.124.727
16809571,2006-06-29T00:00:00,Stroke,C10.228.140.300.775
16809571,2006-06-29T00:00:00,Stroke,C14.907.253.855
16809571,2006-06-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16809571,2006-06-29T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16809571,2006-06-29T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16809571,2006-06-29T00:00:00,Tissue Plasminogen Activator,D23.119.970
16809571,2006-06-29T00:00:00,Treatment Outcome,E01.789.800
16809571,2006-06-29T00:00:00,Treatment Outcome,N04.761.559.590.800
16809571,2006-06-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16810505,2006-06-30T00:00:00,Animals,B01.050
16810505,2006-06-30T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16810505,2006-06-30T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16810505,2006-06-30T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16810505,2006-06-30T00:00:00,Benzodiazepines,D03.438.079.080
16810505,2006-06-30T00:00:00,Clozapine,D03.494.240.220
16810505,2006-06-30T00:00:00,Dibenzothiazepines,D02.886.680.702.500
16810505,2006-06-30T00:00:00,Dibenzothiazepines,D03.494.276
16810505,2006-06-30T00:00:00,Drug Interactions,G07.690.812.240
16810505,2006-06-30T00:00:00,Drug Interactions,G07.700.680.240
16810505,2006-06-30T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16810505,2006-06-30T00:00:00,Flow Cytometry,E05.200.500.386.350
16810505,2006-06-30T00:00:00,Fluorescent Dyes,D27.720.233.348
16810505,2006-06-30T00:00:00,Fluorescent Dyes,D27.720.470.330.348
16810505,2006-06-30T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
16810505,2006-06-30T00:00:00,Isoxazoles,D03.383.129.385
16810505,2006-06-30T00:00:00,Kidney,A05.810.453
16810505,2006-06-30T00:00:00,Liver,A03.620
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
16810505,2006-06-30T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
16810505,2006-06-30T00:00:00,Pyrimidines,D03.383.742
16810505,2006-06-30T00:00:00,Risperidone,D03.383.742.698.685
16810505,2006-06-30T00:00:00,Swine,B01.050.150.900.649.077.880
16444766,2006-07-01T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
16444766,2006-07-01T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
16444766,2006-07-01T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
16444766,2006-07-01T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
16444766,2006-07-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16444766,2006-07-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16444766,2006-07-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
16444766,2006-07-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
16444766,2006-07-01T00:00:00,Genetic Variation,G05.365
16444766,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16444766,2006-07-01T00:00:00,Mexican Americans,M01.686.754.441.500
16444766,2006-07-01T00:00:00,"Mutation, Missense",G05.365.590.650
16703584,2006-07-01T00:00:00,Adult,M01.060.116
16703584,2006-07-01T00:00:00,"Catheters, Indwelling",E07.150
16703584,2006-07-01T00:00:00,Cystic Fibrosis,C06.689.202
16703584,2006-07-01T00:00:00,Cystic Fibrosis,C08.381.187
16703584,2006-07-01T00:00:00,Cystic Fibrosis,C16.320.190
16703584,2006-07-01T00:00:00,Cystic Fibrosis,C16.614.213
16703584,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16703584,2006-07-01T00:00:00,Superior Vena Cava Syndrome,C14.907.800
16761281,2006-07-01T00:00:00,Animals,B01.050
16761281,2006-07-01T00:00:00,Chick Embryo,A13.350.150
16761281,2006-07-01T00:00:00,Chick Embryo,A16.331.200
16761281,2006-07-01T00:00:00,"Endothelium, Vascular",A07.231.330
16761281,2006-07-01T00:00:00,"Endothelium, Vascular",A10.272.491.355
16761281,2006-07-01T00:00:00,Pericardium,A07.541.795
16761281,2006-07-01T00:00:00,Pericardium,A10.615.789.470
16761281,2006-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16761281,2006-07-01T00:00:00,"Spheroids, Cellular",A11.251.800
16761281,2006-07-01T00:00:00,Stem Cells,A11.872
16761281,2006-07-01T00:00:00,Tissue Engineering,E05.200.249.750
16768548,2006-07-01T00:00:00,"Adaptation, Physiological",G07.700.062
16768548,2006-07-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
16768548,2006-07-01T00:00:00,Adolescent,M01.060.057
16768548,2006-07-01T00:00:00,Adult,M01.060.116
16768548,2006-07-01T00:00:00,Altitude,G16.500.275.058
16768548,2006-07-01T00:00:00,Altitude,N06.230.058
16768548,2006-07-01T00:00:00,Anoxia,C23.888.852.079
16768548,2006-07-01T00:00:00,Carbon Dioxide,D01.200.200
16768548,2006-07-01T00:00:00,Carbon Dioxide,D01.362.150
16768548,2006-07-01T00:00:00,Carbon Dioxide,D01.650.550.200
16768548,2006-07-01T00:00:00,Gene Expression Regulation,G05.355.315
16768548,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16768548,2006-07-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
16768548,2006-07-01T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
16768548,2006-07-01T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
16768548,2006-07-01T00:00:00,Iron,D01.268.556.412
16768548,2006-07-01T00:00:00,Iron,D01.268.956.287
16768548,2006-07-01T00:00:00,Iron,D01.552.544.412
16768548,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16768548,2006-07-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16768548,2006-07-01T00:00:00,Oxygen,D01.268.185.550
16768548,2006-07-01T00:00:00,Oxygen,D01.362.670
16768548,2006-07-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
16768548,2006-07-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
16768548,2006-07-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
16772125,2006-07-01T00:00:00,Child,M01.060.406
16772125,2006-07-01T00:00:00,Gene Deletion,G05.355.600.800.320
16772125,2006-07-01T00:00:00,Gene Deletion,G05.365.590.762.320
16772125,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16772125,2006-07-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
16772125,2006-07-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
16772125,2006-07-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
16772125,2006-07-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
16772125,2006-07-01T00:00:00,"Translocation, Genetic",C23.550.210.870
16772125,2006-07-01T00:00:00,"Translocation, Genetic",G05.355.600.860
16772125,2006-07-01T00:00:00,"Translocation, Genetic",G05.365.590.175.870
16783195,2006-07-01T00:00:00,Animals,B01.050
16783195,2006-07-01T00:00:00,Lipopolysaccharides,D09.400.500
16783195,2006-07-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16783195,2006-07-01T00:00:00,Lipopolysaccharides,D10.494
16783195,2006-07-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16783195,2006-07-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16783195,2006-07-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
16783195,2006-07-01T00:00:00,Signal Transduction,G02.111.087.800
16783195,2006-07-01T00:00:00,Signal Transduction,G02.149.115.800
16783195,2006-07-01T00:00:00,Signal Transduction,G04.299.880
16783195,2006-07-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16783195,2006-07-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16783195,2006-07-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16783195,2006-07-01T00:00:00,Thromboxane B2,D10.251.355.255.100.825.810
16783195,2006-07-01T00:00:00,Thromboxane B2,D23.469.050.175.800.810
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16783195,2006-07-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16784498,2006-07-01T00:00:00,Adult,M01.060.116
16784498,2006-07-01T00:00:00,African Americans,M01.686.508.100.100
16784498,2006-07-01T00:00:00,African Americans,M01.686.754.100
16784498,2006-07-01T00:00:00,Child Development,F01.525.200
16784498,2006-07-01T00:00:00,Child Development,G07.700.320.374.750
16784498,2006-07-01T00:00:00,"Child, Preschool",M01.060.406.448
16784498,2006-07-01T00:00:00,Cognition,F02.463.188
16784498,2006-07-01T00:00:00,Education,I02
16784498,2006-07-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
16784498,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16784498,2006-07-01T00:00:00,Pregnancy,G08.686.785.760.769
16784498,2006-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16784498,2006-07-01T00:00:00,Risk Factors,N05.715.350.200.700
16784498,2006-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16784498,2006-07-01T00:00:00,Risk Factors,N06.850.490.625.750
16784498,2006-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16784498,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16784498,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16785271,2006-07-01T00:00:00,Drug Monitoring,E01.370.520.200
16785271,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16785271,2006-07-01T00:00:00,Mental Disorders,F03
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
16785271,2006-07-01T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
16785271,2006-07-01T00:00:00,Pharmacogenetics,H01.158.273.343.750
16785271,2006-07-01T00:00:00,Pharmacogenetics,H01.158.703.052
16785271,2006-07-01T00:00:00,Pharmacogenetics,H02.628.479
16785271,2006-07-01T00:00:00,Pregnancy,G08.686.785.760.769
16785271,2006-07-01T00:00:00,Pregnancy Complications,C13.703
16792570,2006-07-01T00:00:00,Animals,B01.050
16792570,2006-07-01T00:00:00,Sleep,F02.830.855
16792570,2006-07-01T00:00:00,Sleep,G11.561.600.815
16792570,2006-07-01T00:00:00,"Sleep, REM",F02.830.855.796.671
16792570,2006-07-01T00:00:00,"Sleep, REM",G11.561.600.815.754.671
16792570,2006-07-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16792570,2006-07-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16793972,2006-07-01T00:00:00,Albumins,D12.776.034
16793972,2006-07-01T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
16793972,2006-07-01T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
16793972,2006-07-01T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
16793972,2006-07-01T00:00:00,Animals,B01.050
16793972,2006-07-01T00:00:00,Contrast Media,D27.720.259
16793972,2006-07-01T00:00:00,Fluorocarbons,D02.455.526.510.435
16793972,2006-07-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16793972,2006-07-01T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
16793972,2006-07-01T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
16793972,2006-07-01T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
16793972,2006-07-01T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
16793972,2006-07-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
16793972,2006-07-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
16793972,2006-07-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
16793972,2006-07-01T00:00:00,Retroperitoneal Neoplasms,C04.588.033.731
16793972,2006-07-01T00:00:00,"Ultrasonography, Doppler, Color",E01.370.350.850.850.850.850
16794154,2006-07-01T00:00:00,Breast Neoplasms,C04.588.180
16794154,2006-07-01T00:00:00,Breast Neoplasms,C17.800.090.500
16794154,2006-07-01T00:00:00,Calcinosis,C18.452.174.130
16794154,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16794154,2006-07-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16794154,2006-07-01T00:00:00,Mammography,E01.370.350.700.500
16794154,2006-07-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16794154,2006-07-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16794154,2006-07-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,G17.800
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16794154,2006-07-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16794906,2006-07-01T00:00:00,Adolescent,M01.060.057
16794906,2006-07-01T00:00:00,Adult,M01.060.116
16794906,2006-07-01T00:00:00,Aged,M01.060.116.100
16794906,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16794906,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16794906,2006-07-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
16794906,2006-07-01T00:00:00,Postoperative Complications,C23.550.767
16794906,2006-07-01T00:00:00,Regression Analysis,E05.318.740.750
16794906,2006-07-01T00:00:00,Regression Analysis,N05.715.360.750.695
16794906,2006-07-01T00:00:00,Regression Analysis,N06.850.520.830.750
16794906,2006-07-01T00:00:00,Reoperation,E04.690
16794906,2006-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16794906,2006-07-01T00:00:00,Risk Factors,N05.715.350.200.700
16794906,2006-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16794906,2006-07-01T00:00:00,Risk Factors,N06.850.490.625.750
16794906,2006-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16794906,2006-07-01T00:00:00,Salvage Therapy,E02.186.800
16794906,2006-07-01T00:00:00,Salvage Therapy,E02.895
16794906,2006-07-01T00:00:00,Treatment Outcome,E01.789.800
16794906,2006-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16794906,2006-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16798178,2006-07-01T00:00:00,Bibliometrics,L01.178.682.099.325
16798178,2006-07-01T00:00:00,Bibliometrics,L01.453.183.291
16798178,2006-07-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16798178,2006-07-01T00:00:00,Clinical Trials as Topic,E05.337.250
16798178,2006-07-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16798178,2006-07-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16798178,2006-07-01T00:00:00,Confidentiality,F04.096.544.335.240
16798178,2006-07-01T00:00:00,Confidentiality,I01.880.604.473.650.500
16798178,2006-07-01T00:00:00,Confidentiality,I01.880.604.583.080
16798178,2006-07-01T00:00:00,Confidentiality,N03.706.437.650.124
16798178,2006-07-01T00:00:00,Confidentiality,N03.706.535.230
16798178,2006-07-01T00:00:00,Data Collection,E05.318.308
16798178,2006-07-01T00:00:00,Data Collection,L01.280
16798178,2006-07-01T00:00:00,Data Collection,N05.715.360.300
16798178,2006-07-01T00:00:00,Data Collection,N06.850.520.308
16798178,2006-07-01T00:00:00,Guideline Adherence,N04.761.337
16798178,2006-07-01T00:00:00,Guideline Adherence,N05.715.360.395
16798178,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16798178,2006-07-01T00:00:00,Informed Consent,I01.880.604.473.650.718
16798178,2006-07-01T00:00:00,Informed Consent,I01.880.604.583.427
16798178,2006-07-01T00:00:00,Informed Consent,N03.706.437.650.312
16798178,2006-07-01T00:00:00,Informed Consent,N03.706.535.489
16798178,2006-07-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
16798178,2006-07-01T00:00:00,Personal Autonomy,F02.600
16798178,2006-07-01T00:00:00,Personal Autonomy,I01.880.604.473.380.500
16798178,2006-07-01T00:00:00,Personal Autonomy,K01.316.756.650
16798178,2006-07-01T00:00:00,Personal Autonomy,K01.752.256.830.650
16798178,2006-07-01T00:00:00,Personal Autonomy,N03.706.437.380.500
16798178,2006-07-01T00:00:00,Publishing,L01.737
16798178,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16798178,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16798178,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16798178,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16798178,2006-07-01T00:00:00,Research Design,E05.581.500
16798178,2006-07-01T00:00:00,Research Design,H01.770.644.728
16798178,2006-07-01T00:00:00,Thoracic Surgery,H02.403.810.803
16798240,2006-07-01T00:00:00,Aortic Valve,A07.541.510.110
16798240,2006-07-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
16798240,2006-07-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
16798240,2006-07-01T00:00:00,Heart Failure,C14.280.434
16798240,2006-07-01T00:00:00,Heart Valve Prosthesis,E07.695.310
16798240,2006-07-01T00:00:00,Heart-Assist Devices,E04.050.430
16798240,2006-07-01T00:00:00,Heart-Assist Devices,E07.695.300.300
16798240,2006-07-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
16798240,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16798240,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16798240,2006-07-01T00:00:00,Multiple Organ Failure,C23.550.835.525
16798240,2006-07-01T00:00:00,Postoperative Complications,C23.550.767
16798240,2006-07-01T00:00:00,Suture Techniques,E04.901
16802360,2006-07-01T00:00:00,Adolescent,M01.060.057
16802360,2006-07-01T00:00:00,Bone Resorption,C05.116.264
16802360,2006-07-01T00:00:00,Bone Resorption,G11.427.590.195.150
16802360,2006-07-01T00:00:00,Bone and Bones,A02.835.232
16802360,2006-07-01T00:00:00,Bone and Bones,A10.165.265
16802360,2006-07-01T00:00:00,Calcium,D01.268.552.100
16802360,2006-07-01T00:00:00,Calcium,D01.552.539.288
16802360,2006-07-01T00:00:00,Calcium,D23.119.100
16802360,2006-07-01T00:00:00,Child,M01.060.406
16802360,2006-07-01T00:00:00,Dietary Supplements,J02.500.456
16802360,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16802360,2006-07-01T00:00:00,Vitamin D,D04.808.812.768
16803614,2006-07-01T00:00:00,Adult,M01.060.116
16803614,2006-07-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16803614,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16803614,2006-07-01T00:00:00,Manometry,E05.559
16803614,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16804811,2006-07-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
16804811,2006-07-01T00:00:00,Animals,B01.050
16804811,2006-07-01T00:00:00,Environmental Pollutants,D27.888.284
16804811,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16804811,2006-07-01T00:00:00,Pregnancy,G08.686.785.760.769
16804811,2006-07-01T00:00:00,Signal Transduction,G02.111.087.800
16804811,2006-07-01T00:00:00,Signal Transduction,G02.149.115.800
16804811,2006-07-01T00:00:00,Signal Transduction,G04.299.880
16804897,2006-07-01T00:00:00,Animals,B01.050
16804897,2006-07-01T00:00:00,"Chemokines, CXC",D12.644.276.374.200.120
16804897,2006-07-01T00:00:00,"Chemokines, CXC",D12.776.467.374.200.120
16804897,2006-07-01T00:00:00,"Chemokines, CXC",D23.125.300.120
16804897,2006-07-01T00:00:00,"Chemokines, CXC",D23.469.200.120
16804897,2006-07-01T00:00:00,"Chemokines, CXC",D23.529.374.200.120
16804897,2006-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
16804897,2006-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
16804897,2006-07-01T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
16804897,2006-07-01T00:00:00,Kidney Diseases,C12.777.419
16804897,2006-07-01T00:00:00,Kidney Diseases,C13.351.968.419
16804897,2006-07-01T00:00:00,Membrane Proteins,D12.776.543
16804897,2006-07-01T00:00:00,Mesangial Cells,A05.810.453.324.359.620
16804897,2006-07-01T00:00:00,Mesangial Cells,A05.810.453.736.520.620
16804897,2006-07-01T00:00:00,Mesangial Cells,A11.329.228.950
16804897,2006-07-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
16804897,2006-07-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
16804897,2006-07-01T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
16804897,2006-07-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16804897,2006-07-01T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
16804897,2006-07-01T00:00:00,"RNA, Messenger",D13.444.735.544
16804897,2006-07-01T00:00:00,Serpins,D12.644.822.750
16804897,2006-07-01T00:00:00,Serpins,D12.644.861
16804897,2006-07-01T00:00:00,Serpins,D12.776.645.750
16804897,2006-07-01T00:00:00,Serpins,D12.776.872
16805674,2006-07-01T00:00:00,Adolescent,M01.060.057
16805674,2006-07-01T00:00:00,Adult,M01.060.116
16805674,2006-07-01T00:00:00,Dental Research,H02.163.090
16805674,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16805674,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16805674,2006-07-01T00:00:00,Periodontal Pocket,C07.465.714.533.750
16805674,2006-07-01T00:00:00,Pilot Projects,E05.318.760.750
16805674,2006-07-01T00:00:00,Pilot Projects,E05.337.737
16805674,2006-07-01T00:00:00,Pilot Projects,N05.715.360.775.625
16805674,2006-07-01T00:00:00,Pilot Projects,N06.850.520.450.720
16805674,2006-07-01T00:00:00,Research Design,E05.581.500
16805674,2006-07-01T00:00:00,Research Design,H01.770.644.728
16805674,2006-07-01T00:00:00,Space-Time Clustering,E05.318.740.250.700
16805674,2006-07-01T00:00:00,Space-Time Clustering,N05.715.360.750.200.775
16805674,2006-07-01T00:00:00,Space-Time Clustering,N06.850.520.830.250.700
16805712,2006-07-01T00:00:00,Anatomy,H01.158.100
16805712,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16805712,2006-07-01T00:00:00,"Societies, Medical",N03.540.828.589
16805712,2006-07-01T00:00:00,Stem Cells,A11.872
16805712,2006-07-01T00:00:00,Tissue Engineering,E05.200.249.750
16805712,2006-07-01T00:00:00,United States,Z01.107.567.875
16805722,2006-07-01T00:00:00,Adult,M01.060.116
16805722,2006-07-01T00:00:00,Aged,M01.060.116.100
16805722,2006-07-01T00:00:00,Child,M01.060.406
16805722,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16805722,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16805722,2006-07-01T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
16805722,2006-07-01T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
16805722,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16805722,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16805722,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16805722,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16805722,2006-07-01T00:00:00,Urinary Bladder,A05.810.890
16805722,2006-07-01T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
16805722,2006-07-01T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
16805722,2006-07-01T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
16807656,2006-07-01T00:00:00,Adult,M01.060.116
16807656,2006-07-01T00:00:00,Aged,M01.060.116.100
16807656,2006-07-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
16807656,2006-07-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
16807656,2006-07-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
16807656,2006-07-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
16807656,2006-07-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
16807656,2006-07-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
16807656,2006-07-01T00:00:00,Hemorrhage,C23.550.414
16807656,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16807656,2006-07-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
16807656,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16807656,2006-07-01T00:00:00,Thrombosis,C14.907.355.830
16810599,2006-07-01T00:00:00,Adult,M01.060.116
16810599,2006-07-01T00:00:00,Diagnostic Errors,E01.354
16810599,2006-07-01T00:00:00,Diagnostic Errors,N02.421.450.280
16810599,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16810599,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16810599,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16810599,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16810599,2006-07-01T00:00:00,Enteral Nutrition,E02.421.360
16810599,2006-07-01T00:00:00,Enteral Nutrition,E02.642.500.360
16810599,2006-07-01T00:00:00,Gastrostomy,E04.210.496
16810599,2006-07-01T00:00:00,Gastrostomy,E04.579.408
16810599,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16810599,2006-07-01T00:00:00,"Intubation, Gastrointestinal",E05.497.412
16810599,2006-07-01T00:00:00,Jejunostomy,E04.210.338.523
16810599,2006-07-01T00:00:00,Jejunostomy,E04.579.338.523
16810599,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16813783,2006-07-01T00:00:00,Adolescent,M01.060.057
16813783,2006-07-01T00:00:00,Adult,M01.060.116
16813783,2006-07-01T00:00:00,Aged,M01.060.116.100
16813783,2006-07-01T00:00:00,Brain Injuries,C10.228.140.199
16813783,2006-07-01T00:00:00,Brain Injuries,C10.900.300.087
16813783,2006-07-01T00:00:00,Brain Injuries,C21.866.260.118
16813783,2006-07-01T00:00:00,Brain Injuries,C21.866.915.300.200
16813783,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16813783,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16813783,2006-07-01T00:00:00,Quality of Life,I01.800
16813783,2006-07-01T00:00:00,Quality of Life,K01.752.400.750
16813815,2006-07-01T00:00:00,Animals,B01.050
16813815,2006-07-01T00:00:00,Colon,A03.556.124.526.356
16813815,2006-07-01T00:00:00,Colon,A03.556.249.249.356
16813815,2006-07-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
16813815,2006-07-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
16813815,2006-07-01T00:00:00,Colonoscopy,E04.210.240.250.160
16813815,2006-07-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
16813815,2006-07-01T00:00:00,Intestinal Perforation,C06.405.469.557
16813815,2006-07-01T00:00:00,"Models, Animal",E05.598
16813815,2006-07-01T00:00:00,Suture Techniques,E04.901
16813815,2006-07-01T00:00:00,Swine,B01.050.150.900.649.077.880
16816059,2006-07-01T00:00:00,Adult,M01.060.116
16816059,2006-07-01T00:00:00,Asthma,C08.127.108
16816059,2006-07-01T00:00:00,Asthma,C08.381.495.108
16816059,2006-07-01T00:00:00,Asthma,C08.674.095
16816059,2006-07-01T00:00:00,Asthma,C20.543.480.680.095
16816059,2006-07-01T00:00:00,Birth Weight,C23.888.144.186
16816059,2006-07-01T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
16816059,2006-07-01T00:00:00,Birth Weight,E05.041.124.160.750.149
16816059,2006-07-01T00:00:00,Birth Weight,G07.100.100.160.120.186
16816059,2006-07-01T00:00:00,Birth Weight,G07.700.320.249.314.120.186
16816059,2006-07-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
16816059,2006-07-01T00:00:00,Body Mass Index,E05.041.124.125
16816059,2006-07-01T00:00:00,Body Mass Index,G07.100.100.125
16816059,2006-07-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
16816059,2006-07-01T00:00:00,Cesarean Section,E04.520.252.500
16816059,2006-07-01T00:00:00,"Diabetes, Gestational",C13.703.170
16816059,2006-07-01T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
16816059,2006-07-01T00:00:00,"Diabetes, Gestational",C19.246.200
16816059,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16816059,2006-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
16816059,2006-07-01T00:00:00,Lung Diseases,C08.381
16816059,2006-07-01T00:00:00,Obesity,C18.654.726.500
16816059,2006-07-01T00:00:00,Obesity,C23.888.144.699.500
16816059,2006-07-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16816059,2006-07-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16816059,2006-07-01T00:00:00,Pre-Eclampsia,C13.703.395.249
16816059,2006-07-01T00:00:00,Pregnancy,G08.686.785.760.769
16816059,2006-07-01T00:00:00,Pregnancy Complications,C13.703
16816059,2006-07-01T00:00:00,Pregnancy Outcome,E01.789.700
16816059,2006-07-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
16816059,2006-07-01T00:00:00,Regression Analysis,E05.318.740.750
16816059,2006-07-01T00:00:00,Regression Analysis,N05.715.360.750.695
16816059,2006-07-01T00:00:00,Regression Analysis,N06.850.520.830.750
16816289,2006-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
16816289,2006-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
16816289,2006-07-01T00:00:00,Cognitive Therapy,F04.754.137.428
16816289,2006-07-01T00:00:00,Feedback,L01.143.283.425
16816289,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16816289,2006-07-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16816289,2006-07-01T00:00:00,Professional-Patient Relations,F01.829.401.650
16816289,2006-07-01T00:00:00,Professional-Patient Relations,N05.300.660
16816289,2006-07-01T00:00:00,Psychotic Disorders,F03.700.675
16816289,2006-07-01T00:00:00,Sex Factors,N05.715.350.675
16816289,2006-07-01T00:00:00,Sex Factors,N06.850.490.875
16816289,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16816289,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16816289,2006-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16816289,2006-07-01T00:00:00,Treatment Outcome,E01.789.800
16816289,2006-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16816289,2006-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16816750,2006-07-01T00:00:00,Bone Cements,D05.750.716.822.300
16816750,2006-07-01T00:00:00,Bone Cements,D25.720.716.822.300
16816750,2006-07-01T00:00:00,Bone Cements,D27.720.102.158
16816750,2006-07-01T00:00:00,Bone Cements,J01.637.051.720.716.822.300
16816750,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16816750,2006-07-01T00:00:00,Lumbar Vertebrae,A02.835.232.834.519
16816750,2006-07-01T00:00:00,Osteoporosis,C05.116.198.579
16816750,2006-07-01T00:00:00,Spinal Fractures,C21.866.117.500.500
16816750,2006-07-01T00:00:00,Spinal Fractures,C21.866.404.812
16816750,2006-07-01T00:00:00,Spinal Fractures,C21.866.831.600
16816750,2006-07-01T00:00:00,Thoracic Vertebrae,A02.835.232.834.892
16818657,2006-07-01T00:00:00,Actins,D05.750.078.730.250
16818657,2006-07-01T00:00:00,Actins,D12.776.210.500.100
16818657,2006-07-01T00:00:00,Actins,D12.776.220.525.255
16818657,2006-07-01T00:00:00,Glutathione,D12.644.456.448
16818657,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16818657,2006-07-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16818657,2006-07-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16818657,2006-07-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16818657,2006-07-01T00:00:00,Oxidative Stress,G03.495.710
16818657,2006-07-01T00:00:00,Oxidative Stress,G07.700.830.750
16818657,2006-07-01T00:00:00,Oxidoreductases,D08.811.682
16822381,2006-07-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
16822381,2006-07-01T00:00:00,Chronic Disease,C23.550.291.500
16822381,2006-07-01T00:00:00,Dermatologic Agents,D27.505.954.444
16822381,2006-07-01T00:00:00,Eye Diseases,C11
16822381,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16825932,2006-07-01T00:00:00,Adolescent,M01.060.057
16825932,2006-07-01T00:00:00,Adult,M01.060.116
16825932,2006-07-01T00:00:00,Aged,M01.060.116.100
16825932,2006-07-01T00:00:00,Chest Pain,C23.888.646.215
16825932,2006-07-01T00:00:00,Deglutition,G10.261.326.215
16825932,2006-07-01T00:00:00,Endosonography,E01.370.350.850.280
16825932,2006-07-01T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
16825932,2006-07-01T00:00:00,Esophagus,A03.556.875.500
16825932,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16825932,2006-07-01T00:00:00,Manometry,E05.559
16825932,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16825932,2006-07-01T00:00:00,Muscle Contraction,G11.427.590.540
16825932,2006-07-01T00:00:00,"Muscle, Smooth",A02.633.570
16825932,2006-07-01T00:00:00,"Muscle, Smooth",A10.690.467
16827899,2006-07-01T00:00:00,Animals,B01.050
16827899,2006-07-01T00:00:00,Apoptosis,G04.299.139.160
16827899,2006-07-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
16827899,2006-07-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
16827899,2006-07-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
16827899,2006-07-01T00:00:00,Cell Proliferation,G04.299.233.750
16827899,2006-07-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16827899,2006-07-01T00:00:00,Cytokines,D12.644.276.374
16827899,2006-07-01T00:00:00,Cytokines,D12.776.467.374
16827899,2006-07-01T00:00:00,Cytokines,D23.529.374
16827899,2006-07-01T00:00:00,Disease Progression,C23.550.291.656
16827899,2006-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
16827899,2006-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
16827899,2006-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
16827899,2006-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
16827899,2006-07-01T00:00:00,"Immunity, Innate",G12.450.575
16827899,2006-07-01T00:00:00,Immunologic Memory,G12.450.050.500
16827899,2006-07-01T00:00:00,Spinal Cord,A08.186.854
16827899,2006-07-01T00:00:00,Transcription Factors,D12.776.930
16831047,2006-07-01T00:00:00,Chromosome Aberrations,C23.550.210
16831047,2006-07-01T00:00:00,Chromosome Aberrations,G05.365.590.175
16831047,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16831047,2006-07-01T00:00:00,"Polymorphism, Genetic",G05.365.795
16831047,2006-07-01T00:00:00,Questionnaires,E05.318.308.750
16831047,2006-07-01T00:00:00,Questionnaires,L01.280.800
16831047,2006-07-01T00:00:00,Questionnaires,N05.715.360.300.695
16831047,2006-07-01T00:00:00,Questionnaires,N06.850.520.308.750
16831047,2006-07-01T00:00:00,"Societies, Medical",N03.540.828.589
16831047,2006-07-01T00:00:00,United States,Z01.107.567.875
16831151,2006-07-01T00:00:00,Adult,M01.060.116
16831151,2006-07-01T00:00:00,Aged,M01.060.116.100
16831151,2006-07-01T00:00:00,"Catheters, Indwelling",E07.150
16831151,2006-07-01T00:00:00,Dilatation,E05.284
16831151,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16831151,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16831151,2006-07-01T00:00:00,Reoperation,E04.690
16831151,2006-07-01T00:00:00,Self Care,E02.900
16831151,2006-07-01T00:00:00,Self Care,N02.421.784.680
16831151,2006-07-01T00:00:00,Treatment Outcome,E01.789.800
16831151,2006-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16831151,2006-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16831151,2006-07-01T00:00:00,Urinary Catheterization,E01.370.390.820
16831151,2006-07-01T00:00:00,Urinary Catheterization,E02.148.947
16832842,2006-07-01T00:00:00,Adult,M01.060.116
16832842,2006-07-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
16832842,2006-07-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
16832842,2006-07-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
16832842,2006-07-01T00:00:00,"Diagnosis, Differential",E01.171
16832842,2006-07-01T00:00:00,Glomerulonephritis,C12.777.419.570.363
16832842,2006-07-01T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
16832842,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16832842,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16832842,2006-07-01T00:00:00,Renal Insufficiency,C12.777.419.780
16832842,2006-07-01T00:00:00,Renal Insufficiency,C13.351.968.419.780
16832842,2006-07-01T00:00:00,"Scleroderma, Systemic",C17.300.799
16832842,2006-07-01T00:00:00,"Scleroderma, Systemic",C17.800.784
16836672,2006-07-01T00:00:00,Algorithms,G17.035
16836672,2006-07-01T00:00:00,Algorithms,L01.224.050
16836672,2006-07-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
16836672,2006-07-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
16836672,2006-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
16836672,2006-07-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
16836672,2006-07-01T00:00:00,"Defibrillators, Implantable",E07.695.175
16836672,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16836672,2006-07-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16836672,2006-07-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16836672,2006-07-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16836672,2006-07-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16836672,2006-07-01T00:00:00,Prosthesis Design,E05.320.550
16836672,2006-07-01T00:00:00,Prosthesis Design,E07.695.680
16836672,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16836672,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16836672,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16836672,2006-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16839387,2006-07-01T00:00:00,Adult,M01.060.116
16839387,2006-07-01T00:00:00,"Diagnosis, Differential",E01.171
16839387,2006-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
16839387,2006-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
16839387,2006-07-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
16839387,2006-07-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16839387,2006-07-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16839387,2006-07-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16839387,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16839387,2006-07-01T00:00:00,Infant,M01.060.703
16839387,2006-07-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
16842082,2006-07-01T00:00:00,Animals,B01.050
16842082,2006-07-01T00:00:00,Brain,A08.186.211
16843766,2006-07-01T00:00:00,Depression,F01.145.126.350
16843766,2006-07-01T00:00:00,Diabetes Complications,C19.246.099
16843766,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16843766,2006-07-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
16843766,2006-07-01T00:00:00,"Quality Assurance, Health Care",N05.700
16843766,2006-07-01T00:00:00,Quality of Life,I01.800
16843766,2006-07-01T00:00:00,Quality of Life,K01.752.400.750
16843766,2006-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16843766,2006-07-01T00:00:00,Risk Assessment,N04.452.871.715
16843766,2006-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16843766,2006-07-01T00:00:00,Risk Assessment,N06.850.505.715
16843766,2006-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16843766,2006-07-01T00:00:00,Self Care,E02.900
16843766,2006-07-01T00:00:00,Self Care,N02.421.784.680
16849987,2006-07-01T00:00:00,Hospital Administration,H02.309
16849987,2006-07-01T00:00:00,Hospital Administration,N02.278.354
16849987,2006-07-01T00:00:00,Hospital Administration,N04.452.442
16849987,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16849987,2006-07-01T00:00:00,Medical Records,E05.318.308.940.968
16849987,2006-07-01T00:00:00,Medical Records,L01.280.900.968
16849987,2006-07-01T00:00:00,Medical Records,N04.452.859.564
16849987,2006-07-01T00:00:00,Medical Records,N05.715.360.300.715.500
16849987,2006-07-01T00:00:00,Medical Records,N06.850.520.308.940.968
16849987,2006-07-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
16849987,2006-07-01T00:00:00,"Quality Assurance, Health Care",N05.700
16849987,2006-07-01T00:00:00,United States,Z01.107.567.875
16857511,2006-07-01T00:00:00,Animals,B01.050
16857511,2006-07-01T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
16857511,2006-07-01T00:00:00,"Models, Animal",E05.598
16857511,2006-07-01T00:00:00,Swine,B01.050.150.900.649.077.880
16870710,2006-07-01T00:00:00,Animals,B01.050
16870710,2006-07-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
16870710,2006-07-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
16870710,2006-07-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
16870710,2006-07-01T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
16870710,2006-07-01T00:00:00,Heart Ventricles,A07.541.560
16870710,2006-07-01T00:00:00,Myocardium,A02.633.580
16870710,2006-07-01T00:00:00,Myocardium,A07.541.704
16870710,2006-07-01T00:00:00,Myocardium,A10.690.552.750
16870710,2006-07-01T00:00:00,Proteomics,H01.158.201.843
16870710,2006-07-01T00:00:00,Proteomics,H01.158.273.180.350.700
16870710,2006-07-01T00:00:00,Proteomics,H01.158.273.343.350.700
16870710,2006-07-01T00:00:00,Proteomics,H01.181.122.738
16870710,2006-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16875080,2006-07-01T00:00:00,Adolescent,M01.060.057
16875080,2006-07-01T00:00:00,Adult,M01.060.116
16875080,2006-07-01T00:00:00,Age Factors,N05.715.350.075
16875080,2006-07-01T00:00:00,Age Factors,N06.850.490.250
16875080,2006-07-01T00:00:00,Aged,M01.060.116.100
16875080,2006-07-01T00:00:00,Cause of Death,E05.318.308.985.550.250
16875080,2006-07-01T00:00:00,Cause of Death,L01.280.975.550.250
16875080,2006-07-01T00:00:00,Cause of Death,N01.224.935.698.100
16875080,2006-07-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
16875080,2006-07-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
16875080,2006-07-01T00:00:00,Chronic Disease,C23.550.291.500
16875080,2006-07-01T00:00:00,Health Status,I01.240.425
16875080,2006-07-01T00:00:00,Health Status,N01.224.425
16875080,2006-07-01T00:00:00,Health Status,N06.850.505.400.425
16875080,2006-07-01T00:00:00,Heart Diseases,C14.280
16875080,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16875080,2006-07-01T00:00:00,Intensive Care,E02.760.190.400
16875080,2006-07-01T00:00:00,Intensive Care,N02.421.585.190.400
16875080,2006-07-01T00:00:00,Length of Stay,E02.760.400.480
16875080,2006-07-01T00:00:00,Length of Stay,N02.421.585.400.480
16875080,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16875080,2006-07-01T00:00:00,Pancreatectomy,E04.210.752
16875080,2006-07-01T00:00:00,Pancreaticoduodenectomy,E04.210.760
16875080,2006-07-01T00:00:00,Pancreaticojejunostomy,E04.035.703
16875080,2006-07-01T00:00:00,Pancreaticojejunostomy,E04.210.762
16875080,2006-07-01T00:00:00,Pancreatitis,C06.689.750
16875080,2006-07-01T00:00:00,Postoperative Complications,C23.550.767
16875080,2006-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16875080,2006-07-01T00:00:00,Risk Factors,N05.715.350.200.700
16875080,2006-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16875080,2006-07-01T00:00:00,Risk Factors,N06.850.490.625.750
16875080,2006-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16875080,2006-07-01T00:00:00,Treatment Outcome,E01.789.800
16875080,2006-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16875080,2006-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16875228,2006-07-01T00:00:00,Adolescent,M01.060.057
16875228,2006-07-01T00:00:00,Adult,M01.060.116
16875228,2006-07-01T00:00:00,Age Factors,N05.715.350.075
16875228,2006-07-01T00:00:00,Age Factors,N06.850.490.250
16875228,2006-07-01T00:00:00,Aged,M01.060.116.100
16875228,2006-07-01T00:00:00,Auditory Threshold,F02.463.593.071.173
16875228,2006-07-01T00:00:00,Auditory Threshold,F02.463.593.710.190
16875228,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16875228,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16875228,2006-07-01T00:00:00,Noise,G01.595.907.567
16875228,2006-07-01T00:00:00,Noise,G16.500.275.600
16875228,2006-07-01T00:00:00,Noise,N06.230.400
16875228,2006-07-01T00:00:00,Noise,N06.850.460.610
16875228,2006-07-01T00:00:00,Perceptual Masking,F02.463.593.071.594
16875228,2006-07-01T00:00:00,Perceptual Masking,F02.463.593.932.733
16875228,2006-07-01T00:00:00,Regression Analysis,E05.318.740.750
16875228,2006-07-01T00:00:00,Regression Analysis,N05.715.360.750.695
16875228,2006-07-01T00:00:00,Regression Analysis,N06.850.520.830.750
16875228,2006-07-01T00:00:00,Speech Perception,F02.463.593.071.875
16876727,2006-07-01T00:00:00,Clinical Competence,I02.399.630.210
16876727,2006-07-01T00:00:00,Clinical Competence,N04.761.210
16876727,2006-07-01T00:00:00,Computer Simulation,L01.224.160
16876727,2006-07-01T00:00:00,"Education, Medical",I02.358.399
16876727,2006-07-01T00:00:00,Endoscopy,E01.370.388.250
16876727,2006-07-01T00:00:00,Endoscopy,E04.800.250
16876727,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16876727,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16876727,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16876727,2006-07-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16876727,2006-07-01T00:00:00,Gastroenterology,H02.403.429.405
16876727,2006-07-01T00:00:00,Guideline Adherence,N04.761.337
16876727,2006-07-01T00:00:00,Guideline Adherence,N05.715.360.395
16876727,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16876727,2006-07-01T00:00:00,United States,Z01.107.567.875
16884155,2006-07-01T00:00:00,Adult,M01.060.116
16884155,2006-07-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
16884155,2006-07-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
16884155,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16884155,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16884155,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16884155,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16884155,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16884155,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16891574,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16891574,2006-07-01T00:00:00,Social Environment,I01.880.656
16891574,2006-07-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16898218,2006-07-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
16898218,2006-07-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
16898218,2006-07-01T00:00:00,Biocompatible Materials,D25.130
16898218,2006-07-01T00:00:00,Biocompatible Materials,D27.720.102.130
16898218,2006-07-01T00:00:00,Biocompatible Materials,J01.637.051.130
16898218,2006-07-01T00:00:00,Biomimetic Materials,J01.637.087
16898218,2006-07-01T00:00:00,Equipment Failure Analysis,E05.325.192
16898218,2006-07-01T00:00:00,Hyaluronic Acid,D09.698.373.475
16898218,2006-07-01T00:00:00,Knee Joint,A02.835.583.475
16898218,2006-07-01T00:00:00,Knee Prosthesis,E07.695.400.410
16898218,2006-07-01T00:00:00,Materials Testing,E05.570
16898218,2006-07-01T00:00:00,Polyethylenes,D02.455.326.271.665.550
16898218,2006-07-01T00:00:00,Polyethylenes,D05.750.716.507
16898218,2006-07-01T00:00:00,Polyethylenes,D25.720.716.507
16898218,2006-07-01T00:00:00,Polyethylenes,J01.637.051.720.716.507
16898218,2006-07-01T00:00:00,Prosthesis Design,E05.320.550
16898218,2006-07-01T00:00:00,Prosthesis Design,E07.695.680
16900803,2006-07-01T00:00:00,Adult,M01.060.116
16900803,2006-07-01T00:00:00,Aged,M01.060.116.100
16900803,2006-07-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.597.267
16900803,2006-07-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C10.900.300.153
16900803,2006-07-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.260.207
16900803,2006-07-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C21.866.915.300.300
16900803,2006-07-01T00:00:00,Cerebrospinal Fluid Rhinorrhea,C23.888.592.264
16900803,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16900803,2006-07-01T00:00:00,Intracranial Hypertension,C10.228.140.631
16900803,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16900803,2006-07-01T00:00:00,Spinal Puncture,E01.370.376.700
16900803,2006-07-01T00:00:00,Spinal Puncture,E01.450.230.700
16900803,2006-07-01T00:00:00,Spinal Puncture,E01.450.865.632.700
16900803,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16900803,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16900803,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16900803,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16900803,2006-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16925454,2006-07-01T00:00:00,Diabetes Mellitus,C18.452.394.750
16925454,2006-07-01T00:00:00,Diabetes Mellitus,C19.246
16925454,2006-07-01T00:00:00,Disease Management,N04.590.607
16925454,2006-07-01T00:00:00,Evaluation Studies as Topic,E05.337
16925454,2006-07-01T00:00:00,Evaluation Studies as Topic,N05.715.360.335
16925454,2006-07-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
16925454,2006-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
16925454,2006-07-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
16925454,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16925454,2006-07-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
16925454,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
16925454,2006-07-01T00:00:00,Patient Compliance,F01.145.488.500
16925454,2006-07-01T00:00:00,Patient Compliance,N05.300.150.600.600
16925454,2006-07-01T00:00:00,Research Design,E05.581.500
16925454,2006-07-01T00:00:00,Research Design,H01.770.644.728
16925454,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
16925454,2006-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
16925454,2006-07-01T00:00:00,Treatment Outcome,E01.789.800
16925454,2006-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16925454,2006-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16933305,2006-07-01T00:00:00,Animals,B01.050
16933305,2006-07-01T00:00:00,Chick Embryo,A13.350.150
16933305,2006-07-01T00:00:00,Chick Embryo,A16.331.200
16933305,2006-07-01T00:00:00,Endocardium,A07.541.207
16933305,2006-07-01T00:00:00,Heart Atria,A07.541.358
16933305,2006-07-01T00:00:00,Heart Ventricles,A07.541.560
16933305,2006-07-01T00:00:00,Mesoderm,A16.504.660
16933305,2006-07-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
16933305,2006-07-01T00:00:00,"Microscopy, Confocal",E05.595.395
16933305,2006-07-01T00:00:00,Trichloroethylene,D02.455.526.439.939
16944647,2006-07-01T00:00:00,Behavior,F01.145
16944647,2006-07-01T00:00:00,"Data Interpretation, Statistical",E05.245.380
16944647,2006-07-01T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16944647,2006-07-01T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16944647,2006-07-01T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16944647,2006-07-01T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16944647,2006-07-01T00:00:00,Health Facilities,N02.278
16944647,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16944647,2006-07-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
16944647,2006-07-01T00:00:00,"Quality Assurance, Health Care",N05.700
16944647,2006-07-01T00:00:00,United States,Z01.107.567.875
16955780,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16955780,2006-07-01T00:00:00,Nasal Mucosa,A04.531.520
16955780,2006-07-01T00:00:00,Nasal Mucosa,A04.760.600
16955780,2006-07-01T00:00:00,Nasal Mucosa,A10.615.550.760.600
16955780,2006-07-01T00:00:00,Paranasal Sinuses,A04.531.621
16955780,2006-07-01T00:00:00,Rhinitis,C08.460.799
16955780,2006-07-01T00:00:00,Rhinitis,C08.730.674
16955780,2006-07-01T00:00:00,Rhinitis,C09.603.799
16955780,2006-07-01T00:00:00,Sinusitis,C08.460.692.752
16955780,2006-07-01T00:00:00,Sinusitis,C08.730.749
16955780,2006-07-01T00:00:00,Sinusitis,C09.603.692.752
17219502,2006-07-01T00:00:00,Aged,M01.060.116.100
17219502,2006-07-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17219502,2006-07-01T00:00:00,Brain Ischemia,C14.907.253.092
17219502,2006-07-01T00:00:00,"Cholesterol, LDL",D10.532.515.500
17219502,2006-07-01T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
17219502,2006-07-01T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
17219502,2006-07-01T00:00:00,Hospitalization,E02.760.400
17219502,2006-07-01T00:00:00,Hospitalization,N02.421.585.400
17219502,2006-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17219502,2006-07-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
17219502,2006-07-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
17219502,2006-07-01T00:00:00,Lipids,D10
17219502,2006-07-01T00:00:00,Middle Aged,M01.060.116.630
17219502,2006-07-01T00:00:00,Stroke,C10.228.140.300.775
17219502,2006-07-01T00:00:00,Stroke,C14.907.253.855
16818801,2006-07-03T00:00:00,Animals,B01.050
16818801,2006-07-03T00:00:00,Arrestin,D12.776.306.090.050
16818801,2006-07-03T00:00:00,Arrestin,D12.776.543.090.050
16818801,2006-07-03T00:00:00,Arrestin,D23.050.301.280
16818801,2006-07-03T00:00:00,Blood Vessels,A07.231
16818801,2006-07-03T00:00:00,Cardiovascular Diseases,C14
16818801,2006-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16818801,2006-07-03T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16818801,2006-07-03T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16818801,2006-07-03T00:00:00,"Myocytes, Cardiac",A11.620.500
16818801,2006-07-03T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
16818801,2006-07-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
16818801,2006-07-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
16818801,2006-07-03T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
16818801,2006-07-03T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
16818801,2006-07-03T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
16818801,2006-07-03T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
16818801,2006-07-03T00:00:00,Signal Transduction,G02.111.087.800
16818801,2006-07-03T00:00:00,Signal Transduction,G02.149.115.800
16818801,2006-07-03T00:00:00,Signal Transduction,G04.299.880
16820184,2006-07-03T00:00:00,Adenoviridae,B04.280.030
16820184,2006-07-03T00:00:00,Adenoviridae,B04.909.204.097
16820184,2006-07-03T00:00:00,Amino Acid Sequence,G02.111.570.060
16820184,2006-07-03T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16820184,2006-07-03T00:00:00,Animals,B01.050
16820184,2006-07-03T00:00:00,"Antibodies, Viral",D12.776.124.486.485.114.254
16820184,2006-07-03T00:00:00,"Antibodies, Viral",D12.776.124.790.651.114.254
16820184,2006-07-03T00:00:00,"Antibodies, Viral",D12.776.377.715.548.114.254
16820184,2006-07-03T00:00:00,Cell Line,A11.251.210
16820184,2006-07-03T00:00:00,Genetic Vectors,G05.360.337
16820184,2006-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16820184,2006-07-03T00:00:00,Molecular Sequence Data,L01.453.245.667
16820184,2006-07-03T00:00:00,Recombinant Proteins,D12.776.828
16820184,2006-07-03T00:00:00,Vaccination,E02.095.465.425.400.530.890
16820184,2006-07-03T00:00:00,Vaccination,E05.478.550.600.890
16820184,2006-07-03T00:00:00,Vaccination,N02.421.726.758.310.890
16820184,2006-07-03T00:00:00,Vaccination,N06.850.780.200.425.900
16820184,2006-07-03T00:00:00,Vaccination,N06.850.780.680.310.890
16820184,2006-07-03T00:00:00,"Vaccines, Synthetic",D12.776.828.868
16820184,2006-07-03T00:00:00,"Vaccines, Synthetic",D20.215.894.865
16820184,2006-07-03T00:00:00,"Vaccines, Synthetic",D23.050.865
16800688,2006-07-04T00:00:00,Adsorption,G02.149.047
16800688,2006-07-04T00:00:00,Adsorption,G02.149.767.029
16800688,2006-07-04T00:00:00,Adsorption,G02.842.750.029
16800688,2006-07-04T00:00:00,Animals,B01.050
16800688,2006-07-04T00:00:00,Polyesters,D05.750.728
16800688,2006-07-04T00:00:00,Polyesters,D25.720.728
16800688,2006-07-04T00:00:00,Polyesters,J01.637.051.720.728
16800688,2006-07-04T00:00:00,Solvents,D27.720.844
16800688,2006-07-04T00:00:00,Static Electricity,G01.201.249.820
16820591,2006-07-04T00:00:00,Animals,B01.050
16820591,2006-07-04T00:00:00,Endothelin-1,D12.644.276.400.225
16820591,2006-07-04T00:00:00,Endothelin-1,D12.776.467.400.225
16820591,2006-07-04T00:00:00,Endothelin-1,D23.529.400.225
16820591,2006-07-04T00:00:00,"Heart Arrest, Induced",E04.100.376.374
16820591,2006-07-04T00:00:00,"Heart Arrest, Induced",E04.928.220.360
16820591,2006-07-04T00:00:00,Myocardial Contraction,G09.330.190.541
16820591,2006-07-04T00:00:00,Myocardial Contraction,G11.427.590.540.570
16820591,2006-07-04T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
16820591,2006-07-04T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
16820591,2006-07-04T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
16820591,2006-07-04T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
16820591,2006-07-04T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
16820591,2006-07-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16820591,2006-07-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16820591,2006-07-04T00:00:00,"Myocytes, Cardiac",A11.620.500
16820591,2006-07-04T00:00:00,Peptides,D12.644
16820591,2006-07-04T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
16820591,2006-07-04T00:00:00,Temperature,G01.906.595
16820591,2006-07-04T00:00:00,Temperature,G16.500.275.063.725.710
16820591,2006-07-04T00:00:00,Temperature,G16.500.750.775.710
16820591,2006-07-04T00:00:00,Temperature,N06.230.150.450
16820591,2006-07-04T00:00:00,Temperature,N06.230.300.100.725.710
16820601,2006-07-04T00:00:00,Adult,M01.060.116
16820601,2006-07-04T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
16820601,2006-07-04T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
16820601,2006-07-04T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
16820601,2006-07-04T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
16820601,2006-07-04T00:00:00,Gene Expression Profiling,E05.393.332
16820601,2006-07-04T00:00:00,Gene Expression Regulation,G05.355.315
16820601,2006-07-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16820601,2006-07-04T00:00:00,Marfan Syndrome,C05.116.099.674
16820601,2006-07-04T00:00:00,Marfan Syndrome,C14.240.400.725
16820601,2006-07-04T00:00:00,Marfan Syndrome,C14.280.400.725
16820601,2006-07-04T00:00:00,Marfan Syndrome,C16.131.077.550
16820601,2006-07-04T00:00:00,Marfan Syndrome,C16.131.240.400.720
16820601,2006-07-04T00:00:00,Marfan Syndrome,C16.320.540
16820601,2006-07-04T00:00:00,Marfan Syndrome,C17.300.500
16820601,2006-07-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16820601,2006-07-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16820601,2006-07-04T00:00:00,Middle Aged,M01.060.116.630
16820601,2006-07-04T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16820601,2006-07-04T00:00:00,Signal Transduction,G02.111.087.800
16820601,2006-07-04T00:00:00,Signal Transduction,G02.149.115.800
16820601,2006-07-04T00:00:00,Signal Transduction,G04.299.880
16820601,2006-07-04T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D23.529.374.687
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
16820601,2006-07-04T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16822822,2006-07-05T00:00:00,Adult,M01.060.116
16822822,2006-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16822822,2006-07-05T00:00:00,Hypoglycemic Agents,D27.505.696.422
16822822,2006-07-05T00:00:00,"Muscle, Skeletal",A02.633.567
16822822,2006-07-05T00:00:00,"Muscle, Skeletal",A10.690.552.500
16822822,2006-07-05T00:00:00,Obesity,C18.654.726.500
16822822,2006-07-05T00:00:00,Obesity,C23.888.144.699.500
16822822,2006-07-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16822822,2006-07-05T00:00:00,Obesity,G07.100.100.160.120.699.500
16822822,2006-07-05T00:00:00,"RNA, Messenger",D13.444.735.544
16822822,2006-07-05T00:00:00,Signal Transduction,G02.111.087.800
16822822,2006-07-05T00:00:00,Signal Transduction,G02.149.115.800
16822822,2006-07-05T00:00:00,Signal Transduction,G04.299.880
16822822,2006-07-05T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
16822822,2006-07-05T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
16822822,2006-07-05T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
16923450,2006-07-05T00:00:00,Adolescent,M01.060.057
16923450,2006-07-05T00:00:00,Adult,M01.060.116
16923450,2006-07-05T00:00:00,Aged,M01.060.116.100
16923450,2006-07-05T00:00:00,Alcohol Drinking,F01.145.317.269
16923450,2006-07-05T00:00:00,Biological Markers,D23.101
16923450,2006-07-05T00:00:00,Blood Pressure,E01.370.600.875.249
16923450,2006-07-05T00:00:00,Blood Pressure,G09.330.380.076
16923450,2006-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16923450,2006-07-05T00:00:00,Hypertension,C14.907.489
16923450,2006-07-05T00:00:00,Middle Aged,M01.060.116.630
16923450,2006-07-05T00:00:00,Risk Factors,E05.318.740.600.800.725
16923450,2006-07-05T00:00:00,Risk Factors,N05.715.350.200.700
16923450,2006-07-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16923450,2006-07-05T00:00:00,Risk Factors,N06.850.490.625.750
16923450,2006-07-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16815330,2006-07-06T00:00:00,Alzheimer Disease,C10.228.140.380.100
16815330,2006-07-06T00:00:00,Alzheimer Disease,C10.574.945.249
16815330,2006-07-06T00:00:00,Alzheimer Disease,F03.087.400.100
16815330,2006-07-06T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
16815330,2006-07-06T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
16815330,2006-07-06T00:00:00,Animals,B01.050
16815330,2006-07-06T00:00:00,Down Syndrome,C10.597.606.643.220
16815330,2006-07-06T00:00:00,Down Syndrome,C16.131.077.327
16815330,2006-07-06T00:00:00,Down Syndrome,C16.131.260.260
16815330,2006-07-06T00:00:00,Down Syndrome,C16.320.180.260
16815330,2006-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16815330,2006-07-06T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16815330,2006-07-06T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16815330,2006-07-06T00:00:00,Nerve Growth Factor,D12.644.276.860.437
16815330,2006-07-06T00:00:00,Nerve Growth Factor,D12.776.467.860.437
16815330,2006-07-06T00:00:00,Nerve Growth Factor,D12.776.641.600.437
16815330,2006-07-06T00:00:00,Nerve Growth Factor,D23.529.850.437
16815330,2006-07-06T00:00:00,Protein Transport,G03.495.166.700
16829517,2006-07-06T00:00:00,Adenoviridae,B04.280.030
16829517,2006-07-06T00:00:00,Adenoviridae,B04.909.204.097
16829517,2006-07-06T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
16829517,2006-07-06T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
16829517,2006-07-06T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
16829517,2006-07-06T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
16829517,2006-07-06T00:00:00,Extracellular Matrix,A11.284.295.310
16829517,2006-07-06T00:00:00,Fibroblasts,A11.329.228
16829517,2006-07-06T00:00:00,Fibroblasts,A11.872.228
16829517,2006-07-06T00:00:00,Fibrosis,C23.550.355
16829517,2006-07-06T00:00:00,Gene Expression Regulation,G05.355.315
16829517,2006-07-06T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16829517,2006-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16829517,2006-07-06T00:00:00,Immediate-Early Proteins,D12.776.460
16829517,2006-07-06T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
16829517,2006-07-06T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
16829517,2006-07-06T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
16829517,2006-07-06T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
16829517,2006-07-06T00:00:00,Neoplasms,C04
16829517,2006-07-06T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16829517,2006-07-06T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16829517,2006-07-06T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.260.665.100
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.624.664.700.175.100
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-ets-1,D12.776.930.635.100
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
16829517,2006-07-06T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
16829517,2006-07-06T00:00:00,Transcription Factors,D12.776.930
16826243,2006-07-07T00:00:00,Adult,M01.060.116
16826243,2006-07-07T00:00:00,Aged,M01.060.116.100
16826243,2006-07-07T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
16826243,2006-07-07T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
16826243,2006-07-07T00:00:00,Case-Control Studies,E05.318.760.500.500
16826243,2006-07-07T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16826243,2006-07-07T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16826243,2006-07-07T00:00:00,Cataract Extraction,E04.540.825.249
16826243,2006-07-07T00:00:00,Cross Infection,C01.539.248
16826243,2006-07-07T00:00:00,Endophthalmitis,C01.252.354.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C01.539.375.354.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C01.539.375.450.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C01.703.343.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C11.294.354.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C11.294.450.900.350
16826243,2006-07-07T00:00:00,Endophthalmitis,C11.941.879.960.380
16826243,2006-07-07T00:00:00,Hospitalization,E02.760.400
16826243,2006-07-07T00:00:00,Hospitalization,N02.421.585.400
16826243,2006-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16826243,2006-07-07T00:00:00,"Lens Capsule, Crystalline",A09.371.060.500.155
16826243,2006-07-07T00:00:00,Masks,E07.700.500
16826243,2006-07-07T00:00:00,Masks,J01.637.708.500
16826243,2006-07-07T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
16826243,2006-07-07T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
16826243,2006-07-07T00:00:00,"Medical Staff, Hospital",N02.360.630.490
16826243,2006-07-07T00:00:00,"Medical Staff, Hospital",N02.360.740.422
16826243,2006-07-07T00:00:00,Middle Aged,M01.060.116.630
16826243,2006-07-07T00:00:00,Risk Factors,E05.318.740.600.800.725
16826243,2006-07-07T00:00:00,Risk Factors,N05.715.350.200.700
16826243,2006-07-07T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16826243,2006-07-07T00:00:00,Risk Factors,N06.850.490.625.750
16826243,2006-07-07T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16826243,2006-07-07T00:00:00,Surgical Wound Infection,C01.539.947.692
16826243,2006-07-07T00:00:00,Surgical Wound Infection,C23.550.767.925
16836629,2006-07-07T00:00:00,Adult,M01.060.116
16836629,2006-07-07T00:00:00,Aged,M01.060.116.100
16836629,2006-07-07T00:00:00,Health Care Rationing,I01.261.750.500
16836629,2006-07-07T00:00:00,Health Care Rationing,N03.349.270
16836629,2006-07-07T00:00:00,Health Care Rationing,N05.300.430.375
16836629,2006-07-07T00:00:00,Health Surveys,E05.318.308.250
16836629,2006-07-07T00:00:00,Health Surveys,N05.715.360.300.375
16836629,2006-07-07T00:00:00,Health Surveys,N06.850.520.308.250
16836629,2006-07-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16836629,2006-07-07T00:00:00,Middle Aged,M01.060.116.630
16836629,2006-07-07T00:00:00,Physicians,M01.526.485.810
16836629,2006-07-07T00:00:00,Physicians,N02.360.810
16836629,2006-07-07T00:00:00,"Physicians, Family",M01.526.485.810.770
16836629,2006-07-07T00:00:00,"Physicians, Family",N02.360.810.770
16836629,2006-07-07T00:00:00,Prevalence,E05.318.308.985.525.750
16836629,2006-07-07T00:00:00,Prevalence,L01.280.975.525.750
16836629,2006-07-07T00:00:00,Prevalence,N01.224.935.597.750
16836629,2006-07-07T00:00:00,Prevalence,N06.850.505.400.975.525.750
16836629,2006-07-07T00:00:00,Prevalence,N06.850.520.308.985.525.750
16836629,2006-07-07T00:00:00,Resource Allocation,I01.261.750
16835220,2006-07-10T00:00:00,3T3 Cells,A11.251.210.700
16835220,2006-07-10T00:00:00,3T3 Cells,A11.329.228.900
16835220,2006-07-10T00:00:00,Animals,B01.050
16835220,2006-07-10T00:00:00,Cell Differentiation,G04.299.151
16835220,2006-07-10T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16835220,2006-07-10T00:00:00,Hair Follicle,A10.272.497.500
16835220,2006-07-10T00:00:00,Hair Follicle,A17.360.710
16835220,2006-07-10T00:00:00,Hair Follicle,A17.815.250.500
16835220,2006-07-10T00:00:00,Homeodomain Proteins,D12.776.260.400
16835220,2006-07-10T00:00:00,"Models, Genetic",E05.599.395.397
16835220,2006-07-10T00:00:00,Mutation,G05.365.590
16832104,2006-07-11T00:00:00,Adolescent,M01.060.057
16832104,2006-07-11T00:00:00,Adult,M01.060.116
16832104,2006-07-11T00:00:00,Aged,M01.060.116.100
16832104,2006-07-11T00:00:00,Calcium,D01.268.552.100
16832104,2006-07-11T00:00:00,Calcium,D01.552.539.288
16832104,2006-07-11T00:00:00,Calcium,D23.119.100
16832104,2006-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16832104,2006-07-11T00:00:00,Middle Aged,M01.060.116.630
16832104,2006-07-11T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
16832104,2006-07-11T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
16832104,2006-07-11T00:00:00,Patient Admission,E02.760.400.600
16832104,2006-07-11T00:00:00,Patient Admission,N02.421.585.400.600
16832104,2006-07-11T00:00:00,Stroke,C10.228.140.300.775
16832104,2006-07-11T00:00:00,Stroke,C14.907.253.855
16832686,2006-07-11T00:00:00,Animals,B01.050
16832686,2006-07-11T00:00:00,Temperature,G01.906.595
16832686,2006-07-11T00:00:00,Temperature,G16.500.275.063.725.710
16832686,2006-07-11T00:00:00,Temperature,G16.500.750.775.710
16832686,2006-07-11T00:00:00,Temperature,N06.230.150.450
16832686,2006-07-11T00:00:00,Temperature,N06.230.300.100.725.710
16832686,2006-07-11T00:00:00,Uterine Contraction,G08.686.785.760.769.326.700
16832686,2006-07-11T00:00:00,Uterine Contraction,G11.427.590.540.890
16832686,2006-07-11T00:00:00,Uterus,A05.360.319.679
16839697,2006-07-12T00:00:00,Adolescent,M01.060.057
16839697,2006-07-12T00:00:00,Adult,M01.060.116
16839697,2006-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16839697,2006-07-12T00:00:00,Nicotine,D03.132.760.570
16839697,2006-07-12T00:00:00,Nicotine,D03.383.725.518
16839697,2006-07-12T00:00:00,Pilot Projects,E05.318.760.750
16839697,2006-07-12T00:00:00,Pilot Projects,E05.337.737
16839697,2006-07-12T00:00:00,Pilot Projects,N05.715.360.775.625
16839697,2006-07-12T00:00:00,Pilot Projects,N06.850.520.450.720
16839697,2006-07-12T00:00:00,Smoking,F01.145.466.753
16838122,2006-07-13T00:00:00,Adolescent,M01.060.057
16838122,2006-07-13T00:00:00,Antisocial Personality Disorder,F03.675.050
16838122,2006-07-13T00:00:00,Cognitive Therapy,F04.754.137.428
16838122,2006-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16838122,2006-07-13T00:00:00,Parent-Child Relations,F01.829.263.370.290
16838122,2006-07-13T00:00:00,Parents,F01.829.263.500.320
16838122,2006-07-13T00:00:00,Parents,I01.880.225.500.340
16838122,2006-07-13T00:00:00,Parents,M01.620
16838122,2006-07-13T00:00:00,Teaching,I02.903
16840726,2006-07-13T00:00:00,Fetal Blood,A12.207.152.200
16840726,2006-07-13T00:00:00,Fetal Blood,A15.145.300
16840726,2006-07-13T00:00:00,Fetal Blood,A16.378.200
16840726,2006-07-13T00:00:00,Fibroblasts,A11.329.228
16840726,2006-07-13T00:00:00,Fibroblasts,A11.872.228
16840726,2006-07-13T00:00:00,Hematopoietic Stem Cells,A11.148.378
16840726,2006-07-13T00:00:00,Hematopoietic Stem Cells,A11.872.378
16840726,2006-07-13T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
16840726,2006-07-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16844690,2006-07-14T00:00:00,"Antigens, CD59",D12.776.395.550.035
16844690,2006-07-14T00:00:00,"Antigens, CD59",D12.776.543.550.159
16844690,2006-07-14T00:00:00,"Antigens, CD59",D23.050.301.264.035.159
16844690,2006-07-14T00:00:00,"Antigens, CD59",D23.101.100.110.159
16844690,2006-07-14T00:00:00,Binding Sites,G02.111.570.120
16844690,2006-07-14T00:00:00,Computational Biology,H01.158.273.180
16844690,2006-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16844690,2006-07-14T00:00:00,"Models, Molecular",E05.599.595
16844690,2006-07-14T00:00:00,Peptides,D12.644
16844690,2006-07-14T00:00:00,Recombinant Proteins,D12.776.828
16844690,2006-07-14T00:00:00,Software,L01.224.900
16844694,2006-07-14T00:00:00,Amino Acid Sequence,G02.111.570.060
16844694,2006-07-14T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16844694,2006-07-14T00:00:00,Animals,B01.050
16844694,2006-07-14T00:00:00,Cell Line,A11.251.210
16844694,2006-07-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16844694,2006-07-14T00:00:00,Insulin,D06.472.699.587.740.625
16844694,2006-07-14T00:00:00,Insulin,D12.644.548.586.740.625
16844694,2006-07-14T00:00:00,Molecular Sequence Data,L01.453.245.667
16844694,2006-07-14T00:00:00,Peptides,D12.644
16844694,2006-07-14T00:00:00,Proteins,D12.776
16844694,2006-07-14T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
16844694,2006-07-14T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
16840490,2006-07-15T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
16840490,2006-07-15T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
16840490,2006-07-15T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
16840490,2006-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16840490,2006-07-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16840490,2006-07-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16840490,2006-07-15T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16840490,2006-07-15T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
16840490,2006-07-15T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16840490,2006-07-15T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16840490,2006-07-15T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16840490,2006-07-15T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16840490,2006-07-15T00:00:00,Risk Factors,E05.318.740.600.800.725
16840490,2006-07-15T00:00:00,Risk Factors,N05.715.350.200.700
16840490,2006-07-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16840490,2006-07-15T00:00:00,Risk Factors,N06.850.490.625.750
16840490,2006-07-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16840490,2006-07-15T00:00:00,Stroke,C10.228.140.300.775
16840490,2006-07-15T00:00:00,Stroke,C14.907.253.855
16845593,2006-07-15T00:00:00,Adult,M01.060.116
16845593,2006-07-15T00:00:00,Brain Mapping,E01.370.350.086
16845593,2006-07-15T00:00:00,Brain Mapping,E01.370.376.149
16845593,2006-07-15T00:00:00,Brain Mapping,E05.132
16845593,2006-07-15T00:00:00,Energy Metabolism,G03.495.335
16845593,2006-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16845593,2006-07-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16845593,2006-07-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16845593,2006-07-15T00:00:00,Middle Aged,M01.060.116.630
16845593,2006-07-15T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
16845593,2006-07-15T00:00:00,Movement,G07.700.560
16845593,2006-07-15T00:00:00,Movement,G11.427.590.530
16845593,2006-07-15T00:00:00,Neural Pathways,A08.612
16845593,2006-07-15T00:00:00,Psychomotor Performance,F02.808
16845593,2006-07-15T00:00:00,Psychomotor Performance,G11.427.700
16845593,2006-07-15T00:00:00,Psychomotor Performance,G11.561.623
17015177,2006-07-15T00:00:00,Animals,B01.050
17015177,2006-07-15T00:00:00,Apoptosis,G04.299.139.160
17015177,2006-07-15T00:00:00,Blood Pressure,E01.370.600.875.249
17015177,2006-07-15T00:00:00,Blood Pressure,G09.330.380.076
17015177,2006-07-15T00:00:00,Inflammation,C23.550.470
17015177,2006-07-15T00:00:00,Kallikreins,D08.811.277.656.300.760.442
17015177,2006-07-15T00:00:00,Kallikreins,D08.811.277.656.959.350.442
17015177,2006-07-15T00:00:00,Kallikreins,D12.776.124.125.597
17015177,2006-07-15T00:00:00,Kallikreins,D23.119.597
17015177,2006-07-15T00:00:00,Kidney,A05.810.453
17015177,2006-07-15T00:00:00,Kidney Tubules,A05.810.453.736.560
17015177,2006-07-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17015177,2006-07-15T00:00:00,Reactive Oxygen Species,D01.339.431
17015177,2006-07-15T00:00:00,Reactive Oxygen Species,D01.650.775
17015177,2006-07-15T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
17015177,2006-07-15T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
17015177,2006-07-15T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
17015177,2006-07-15T00:00:00,Reperfusion Injury,C14.907.725
17015177,2006-07-15T00:00:00,Reperfusion Injury,C23.550.767.877
17015177,2006-07-15T00:00:00,Sodium,D01.268.549.750
17015177,2006-07-15T00:00:00,Sodium,D01.552.528.850
16791097,2006-07-17T00:00:00,Adolescent,M01.060.057
16791097,2006-07-17T00:00:00,Adult,M01.060.116
16791097,2006-07-17T00:00:00,Brain Mapping,E01.370.350.086
16791097,2006-07-17T00:00:00,Brain Mapping,E01.370.376.149
16791097,2006-07-17T00:00:00,Brain Mapping,E05.132
16791097,2006-07-17T00:00:00,Functional Laterality,F02.830.297.425
16791097,2006-07-17T00:00:00,Functional Laterality,G11.561.225.425
16791097,2006-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16791097,2006-07-17T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16791097,2006-07-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16791097,2006-07-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16847079,2006-07-17T00:00:00,Child,M01.060.406
16847079,2006-07-17T00:00:00,"Child, Preschool",M01.060.406.448
16847079,2006-07-17T00:00:00,Combined Modality Therapy,E02.186
16847079,2006-07-17T00:00:00,Deglutition Disorders,C06.405.117.119
16847079,2006-07-17T00:00:00,Deglutition Disorders,C09.775.174
16847079,2006-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16847079,2006-07-17T00:00:00,Muscle Fatigue,G11.427.550
16847079,2006-07-17T00:00:00,Myasthenia Gravis,C10.114.656
16847079,2006-07-17T00:00:00,Myasthenia Gravis,C10.668.758.725
16847079,2006-07-17T00:00:00,Myasthenia Gravis,C20.111.258.500
16847079,2006-07-17T00:00:00,Neurologic Examination,E01.370.376.550
16847079,2006-07-17T00:00:00,Neurologic Examination,E01.370.600.550
16847079,2006-07-17T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16847079,2006-07-17T00:00:00,"Pneumonia, Aspiration",C08.381.677.529
16847079,2006-07-17T00:00:00,"Pneumonia, Aspiration",C08.730.610.529
16847079,2006-07-17T00:00:00,Point-of-Care Systems,N04.452.442.452.680
16847079,2006-07-17T00:00:00,Point-of-Care Systems,N04.452.515.360.652
16847079,2006-07-17T00:00:00,Point-of-Care Systems,N04.590.874
16847079,2006-07-17T00:00:00,Thymectomy,E04.928.770
16847097,2006-07-17T00:00:00,Animals,B01.050
16847097,2006-07-17T00:00:00,Eye Proteins,D12.776.306
16847097,2006-07-17T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
16847097,2006-07-17T00:00:00,"Microscopy, Fluorescence",E05.595.458
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
16847097,2006-07-17T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
16847097,2006-07-17T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
16847097,2006-07-17T00:00:00,Retinaldehyde,D02.047.850
16847097,2006-07-17T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
16847097,2006-07-17T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
16847097,2006-07-17T00:00:00,Retinaldehyde,D02.455.849.131.495.690
16847097,2006-07-17T00:00:00,Retinaldehyde,D23.767.261.700.690
16847097,2006-07-17T00:00:00,Rhodopsin,D12.776.543.750.100.955
16847097,2006-07-17T00:00:00,Rhodopsin,D23.767.930.750.500.500
16861886,2006-07-17T00:00:00,Cell Division,G04.299.134.220
16861886,2006-07-17T00:00:00,Cell Division,G04.299.233.750.500
16861886,2006-07-17T00:00:00,Cell Division,G05.355.105
16861886,2006-07-17T00:00:00,Cell Division,G07.700.320.249.410.750.500
16861886,2006-07-17T00:00:00,Cell Proliferation,G04.299.233.750
16861886,2006-07-17T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16861886,2006-07-17T00:00:00,Chlorambucil,D02.455.526.728.650.156
16861886,2006-07-17T00:00:00,Gene Expression Regulation,G05.355.315
16861886,2006-07-17T00:00:00,Histones,D12.776.660.470
16861886,2006-07-17T00:00:00,Histones,D12.776.664.469
16861886,2006-07-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16861886,2006-07-17T00:00:00,"Models, Biological",E05.599.395
16861886,2006-07-17T00:00:00,Neoplasms,C04
16861886,2006-07-17T00:00:00,Polymers,D05.750
16861886,2006-07-17T00:00:00,Polymers,D25.720
16861886,2006-07-17T00:00:00,Polymers,J01.637.051.720
16849412,2006-07-18T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
16849412,2006-07-18T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
16849412,2006-07-18T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
16849412,2006-07-18T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
16849412,2006-07-18T00:00:00,Adult,M01.060.116
16849412,2006-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16849412,2006-07-18T00:00:00,Mutation,G05.365.590
16885921,2006-07-20T00:00:00,Cataract,C11.510.245
16885921,2006-07-20T00:00:00,Hispanic Americans,M01.686.754.441
16885921,2006-07-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16885921,2006-07-20T00:00:00,"Mutation, Missense",G05.365.590.650
16885921,2006-07-20T00:00:00,Tyrosine,D12.125.072.050.875
16861328,2006-07-21T00:00:00,Adult,M01.060.116
16861328,2006-07-21T00:00:00,Aged,M01.060.116.100
16861328,2006-07-21T00:00:00,Bayes Theorem,E05.318.740.600.200
16861328,2006-07-21T00:00:00,Bayes Theorem,N05.715.360.750.625.150
16861328,2006-07-21T00:00:00,Bayes Theorem,N06.850.520.830.600.200
16861328,2006-07-21T00:00:00,Calcium,D01.268.552.100
16861328,2006-07-21T00:00:00,Calcium,D01.552.539.288
16861328,2006-07-21T00:00:00,Calcium,D23.119.100
16861328,2006-07-21T00:00:00,Eating,G07.610.593.260
16861328,2006-07-21T00:00:00,Eating,G07.700.620.260
16861328,2006-07-21T00:00:00,Eating,G10.261.326.240
16861328,2006-07-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16861328,2006-07-21T00:00:00,Insulin Resistance,C18.452.394.968.500
16861328,2006-07-21T00:00:00,Insulin Resistance,G07.690.320.617
16861328,2006-07-21T00:00:00,Middle Aged,M01.060.116.630
16860380,2006-07-24T00:00:00,African Americans,M01.686.508.100.100
16860380,2006-07-24T00:00:00,African Americans,M01.686.754.100
16860380,2006-07-24T00:00:00,Breast Neoplasms,C04.588.180
16860380,2006-07-24T00:00:00,Breast Neoplasms,C17.800.090.500
16860380,2006-07-24T00:00:00,Health Behavior,F01.145.488
16860380,2006-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16860380,2006-07-24T00:00:00,Mammography,E01.370.350.700.500
16860380,2006-07-24T00:00:00,Middle Aged,M01.060.116.630
16860782,2006-07-24T00:00:00,"Alcohol-Induced Disorders, Nervous System",C10.720.112
16860782,2006-07-24T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.613.705.150
16860782,2006-07-24T00:00:00,"Alcohol-Induced Disorders, Nervous System",C21.739.100.087.193
16860782,2006-07-24T00:00:00,Animals,B01.050
16860782,2006-07-24T00:00:00,Calcium Signaling,G02.111.087.800.800.100
16860782,2006-07-24T00:00:00,Calcium Signaling,G02.149.115.800.800.100
16860782,2006-07-24T00:00:00,Calcium Signaling,G03.495.166.500.100
16860782,2006-07-24T00:00:00,Calcium Signaling,G04.299.880.800.100
16860782,2006-07-24T00:00:00,Down-Regulation,G02.111.087.225
16860782,2006-07-24T00:00:00,Down-Regulation,G02.149.115.225
16860782,2006-07-24T00:00:00,Down-Regulation,G05.355.315.200
16860782,2006-07-24T00:00:00,Down-Regulation,G07.690.812.230
16860782,2006-07-24T00:00:00,Down-Regulation,G07.700.680.230
16860782,2006-07-24T00:00:00,Neurons,A08.663
16860782,2006-07-24T00:00:00,Neurons,A11.671
16860782,2006-07-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16860782,2006-07-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16860782,2006-07-24T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16860782,2006-07-24T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16861040,2006-07-24T00:00:00,Animals,B01.050
16861040,2006-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16861040,2006-07-24T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
16861040,2006-07-24T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
16861040,2006-07-24T00:00:00,Nitric Oxide,D01.339.387
16861040,2006-07-24T00:00:00,Nitric Oxide,D01.625.550.500
16861040,2006-07-24T00:00:00,Nitric Oxide,D01.625.700.500
16861040,2006-07-24T00:00:00,Nitric Oxide,D01.650.550.587.600
16861040,2006-07-24T00:00:00,Nitric Oxide Synthase,D08.811.682.664.500.772
16861040,2006-07-24T00:00:00,Reactive Nitrogen Species,D01.625.700
16861040,2006-07-24T00:00:00,Reactive Nitrogen Species,D02.654.846
16861040,2006-07-24T00:00:00,Reactive Oxygen Species,D01.339.431
16861040,2006-07-24T00:00:00,Reactive Oxygen Species,D01.650.775
16863682,2006-07-24T00:00:00,Adult,M01.060.116
16863682,2006-07-24T00:00:00,Alcohol Drinking,F01.145.317.269
16863682,2006-07-24T00:00:00,Cocaine-Related Disorders,C21.739.300
16863682,2006-07-24T00:00:00,Cocaine-Related Disorders,F03.900.300
16863682,2006-07-24T00:00:00,Emotions,F01.470
16863682,2006-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16863682,2006-07-24T00:00:00,Pain,C10.597.617
16863682,2006-07-24T00:00:00,Pain,C23.888.592.612
16863682,2006-07-24T00:00:00,Pain,C23.888.646
16863682,2006-07-24T00:00:00,Pain,F02.830.816.444
16863682,2006-07-24T00:00:00,Pain,G11.561.600.810.444
16863682,2006-07-24T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16864724,2006-07-24T00:00:00,Aged,M01.060.116.100
16864724,2006-07-24T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
16864724,2006-07-24T00:00:00,Blood Pressure,E01.370.600.875.249
16864724,2006-07-24T00:00:00,Blood Pressure,G09.330.380.076
16864724,2006-07-24T00:00:00,Cardiotonic Agents,D27.505.954.411.222
16864724,2006-07-24T00:00:00,Cardiotonic Agents,D27.720.799.080
16864724,2006-07-24T00:00:00,Digoxin,D04.808.155.160.349
16864724,2006-07-24T00:00:00,Digoxin,D04.808.155.580.130.500.436
16864724,2006-07-24T00:00:00,Digoxin,D09.408.180.261.436
16864724,2006-07-24T00:00:00,Heart Failure,C14.280.434
16864724,2006-07-24T00:00:00,Hospitalization,E02.760.400
16864724,2006-07-24T00:00:00,Hospitalization,N02.421.585.400
16864724,2006-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16864724,2006-07-24T00:00:00,Middle Aged,M01.060.116.630
16864724,2006-07-24T00:00:00,Sinoatrial Node,A07.541.409.819
16864724,2006-07-24T00:00:00,Stroke Volume,E01.370.370.380.150.700
16864724,2006-07-24T00:00:00,Stroke Volume,G09.330.380.124.882
16864724,2006-07-24T00:00:00,Treatment Outcome,E01.789.800
16864724,2006-07-24T00:00:00,Treatment Outcome,N04.761.559.590.800
16864724,2006-07-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16864749,2006-07-24T00:00:00,African Continental Ancestry Group,M01.686.508.100
16864749,2006-07-24T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
16864749,2006-07-24T00:00:00,Blood Glucose,D09.546.359.448.500
16864749,2006-07-24T00:00:00,Blood Pressure,E01.370.600.875.249
16864749,2006-07-24T00:00:00,Blood Pressure,G09.330.380.076
16864749,2006-07-24T00:00:00,Cardiovascular Diseases,C14
16864749,2006-07-24T00:00:00,Coronary Disease,C14.280.647.250
16864749,2006-07-24T00:00:00,Coronary Disease,C14.907.585.250
16864749,2006-07-24T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
16864749,2006-07-24T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
16864749,2006-07-24T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
16864749,2006-07-24T00:00:00,Glomerular Filtration Rate,G08.852.357
16864749,2006-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16864749,2006-07-24T00:00:00,Hypertension,C14.907.489
16864749,2006-07-24T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
16864749,2006-07-24T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
16864749,2006-07-24T00:00:00,Incidence,E05.318.308.985.525.375
16864749,2006-07-24T00:00:00,Incidence,L01.280.975.525.375
16864749,2006-07-24T00:00:00,Incidence,N01.224.935.597.500
16864749,2006-07-24T00:00:00,Incidence,N06.850.505.400.975.525.375
16864749,2006-07-24T00:00:00,Incidence,N06.850.520.308.985.525.375
16864749,2006-07-24T00:00:00,Middle Aged,M01.060.116.630
16864749,2006-07-24T00:00:00,Myocardial Infarction,C14.280.647.500
16864749,2006-07-24T00:00:00,Myocardial Infarction,C14.907.585.500
16870268,2006-07-25T00:00:00,Cell Differentiation,G04.299.151
16870268,2006-07-25T00:00:00,Cytokines,D12.644.276.374
16870268,2006-07-25T00:00:00,Cytokines,D12.776.467.374
16870268,2006-07-25T00:00:00,Cytokines,D23.529.374
16870268,2006-07-25T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
16870268,2006-07-25T00:00:00,Flow Cytometry,E05.200.500.386.350
16870268,2006-07-25T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
16870268,2006-07-25T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
16870268,2006-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16870268,2006-07-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16870268,2006-07-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16870268,2006-07-25T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16870268,2006-07-25T00:00:00,Lymphocyte Activation,E01.450.495.482
16870268,2006-07-25T00:00:00,Lymphocyte Activation,E05.478.594.530
16870268,2006-07-25T00:00:00,Lymphocyte Activation,G12.425.747
16870268,2006-07-25T00:00:00,Lymphocyte Activation,G12.450.050.400.545
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
16870268,2006-07-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
16872843,2006-07-25T00:00:00,Adolescent,M01.060.057
16872843,2006-07-25T00:00:00,Adult,M01.060.116
16872843,2006-07-25T00:00:00,Aging,G07.700.320.124
16872843,2006-07-25T00:00:00,Anticonvulsants,D27.505.954.427.080
16872843,2006-07-25T00:00:00,Brain,A08.186.211
16872843,2006-07-25T00:00:00,Child,M01.060.406
16872843,2006-07-25T00:00:00,Disease Progression,C23.550.291.656
16872843,2006-07-25T00:00:00,Drug Resistance,G07.690.320
16872843,2006-07-25T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
16872843,2006-07-25T00:00:00,Hippocampus,A08.186.211.464.405
16872843,2006-07-25T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
16872843,2006-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16872843,2006-07-25T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16872843,2006-07-25T00:00:00,Limbic System,A08.186.211.464
16872843,2006-07-25T00:00:00,Middle Aged,M01.060.116.630
16872843,2006-07-25T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
16868841,2006-07-26T00:00:00,Adult,M01.060.116
16868841,2006-07-26T00:00:00,Chronic Disease,C23.550.291.500
16868841,2006-07-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16868841,2006-07-26T00:00:00,Mental Disorders,F03
16868841,2006-07-26T00:00:00,Middle Aged,M01.060.116.630
16868841,2006-07-26T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16868841,2006-07-26T00:00:00,United States,Z01.107.567.875
16868841,2006-07-26T00:00:00,Wounds and Injuries,C21.866
16854113,2006-07-27T00:00:00,Energy Transfer,G01.154.100.240
16854113,2006-07-27T00:00:00,Energy Transfer,G01.595.100.240
16854113,2006-07-27T00:00:00,Energy Transfer,G02.111.087.242
16854113,2006-07-27T00:00:00,Energy Transfer,G02.149.115.242
16854113,2006-07-27T00:00:00,Energy Transfer,G02.149.767.580
16854113,2006-07-27T00:00:00,Energy Transfer,G02.842.750.580
16854113,2006-07-27T00:00:00,Fluorenes,D02.455.426.559.847.389
16854113,2006-07-27T00:00:00,Fluorenes,D04.615.389
16854113,2006-07-27T00:00:00,Molecular Structure,G02.111.570
16854113,2006-07-27T00:00:00,Molecular Structure,G02.575
16854113,2006-07-27T00:00:00,Molecular Structure,G02.842.575
16854113,2006-07-27T00:00:00,Nanoparticles,J01.637.512.600
16854113,2006-07-27T00:00:00,Optics and Photonics,H01.671.617
16854113,2006-07-27T00:00:00,Optics and Photonics,J01.293.688
16854113,2006-07-27T00:00:00,Polymers,D05.750
16854113,2006-07-27T00:00:00,Polymers,D25.720
16854113,2006-07-27T00:00:00,Polymers,J01.637.051.720
16858288,2006-07-27T00:00:00,Animals,B01.050
16858288,2006-07-27T00:00:00,Energy Metabolism,G03.495.335
16858288,2006-07-27T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
16858288,2006-07-27T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
16858288,2006-07-27T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
16858288,2006-07-27T00:00:00,Interleukin-6,D12.644.276.374.465.506
16858288,2006-07-27T00:00:00,Interleukin-6,D12.776.467.374.465.506
16858288,2006-07-27T00:00:00,Interleukin-6,D23.529.374.465.506
16858288,2006-07-27T00:00:00,Liver Regeneration,G10.261.326.520
16858288,2006-07-27T00:00:00,Liver Regeneration,G16.100.856.468
16858288,2006-07-27T00:00:00,Liver Transplantation,E04.210.650
16858288,2006-07-27T00:00:00,Liver Transplantation,E04.936.450.490
16858288,2006-07-27T00:00:00,Liver Transplantation,E04.936.580.490
16858288,2006-07-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16858288,2006-07-27T00:00:00,Stem Cells,A11.872
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16858288,2006-07-27T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16870914,2006-07-27T00:00:00,Birth Weight,C23.888.144.186
16870914,2006-07-27T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
16870914,2006-07-27T00:00:00,Birth Weight,E05.041.124.160.750.149
16870914,2006-07-27T00:00:00,Birth Weight,G07.100.100.160.120.186
16870914,2006-07-27T00:00:00,Birth Weight,G07.700.320.249.314.120.186
16870914,2006-07-27T00:00:00,Bronchopulmonary Dysplasia,C08.381.520.750.500
16870914,2006-07-27T00:00:00,Bronchopulmonary Dysplasia,C16.614.521.125
16870914,2006-07-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16870914,2006-07-27T00:00:00,"Infant, Newborn",M01.060.703.520
16870914,2006-07-27T00:00:00,"Infant, Premature",M01.060.703.520.520
16870914,2006-07-27T00:00:00,"Infant, Very Low Birth Weight",M01.060.703.520.460.600
16870914,2006-07-27T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
16870914,2006-07-27T00:00:00,Intracranial Hemorrhages,C14.907.253.573
16870914,2006-07-27T00:00:00,Intracranial Hemorrhages,C23.550.414.913
16870914,2006-07-27T00:00:00,Lung Diseases,C08.381
16870914,2006-07-27T00:00:00,Nitric Oxide,D01.339.387
16870914,2006-07-27T00:00:00,Nitric Oxide,D01.625.550.500
16870914,2006-07-27T00:00:00,Nitric Oxide,D01.625.700.500
16870914,2006-07-27T00:00:00,Nitric Oxide,D01.650.550.587.600
16870914,2006-07-27T00:00:00,"Respiration, Artificial",E02.365.647.729
16870914,2006-07-27T00:00:00,"Respiration, Artificial",E02.880.820
16876437,2006-07-28T00:00:00,Adult,M01.060.116
16876437,2006-07-28T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16876437,2006-07-28T00:00:00,Functional Laterality,F02.830.297.425
16876437,2006-07-28T00:00:00,Functional Laterality,G11.561.225.425
16876437,2006-07-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16876437,2006-07-28T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16876437,2006-07-28T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
16876437,2006-07-28T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
16876437,2006-07-28T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
16876437,2006-07-28T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
16876437,2006-07-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16876437,2006-07-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16876437,2006-07-28T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17071214,2006-07-28T00:00:00,Adult,M01.060.116
17071214,2006-07-28T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17071214,2006-07-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17071214,2006-07-28T00:00:00,Prevalence,E05.318.308.985.525.750
17071214,2006-07-28T00:00:00,Prevalence,L01.280.975.525.750
17071214,2006-07-28T00:00:00,Prevalence,N01.224.935.597.750
17071214,2006-07-28T00:00:00,Prevalence,N06.850.505.400.975.525.750
17071214,2006-07-28T00:00:00,Prevalence,N06.850.520.308.985.525.750
17071214,2006-07-28T00:00:00,Questionnaires,E05.318.308.750
17071214,2006-07-28T00:00:00,Questionnaires,L01.280.800
17071214,2006-07-28T00:00:00,Questionnaires,N05.715.360.300.695
17071214,2006-07-28T00:00:00,Questionnaires,N06.850.520.308.750
17071214,2006-07-28T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17071214,2006-07-28T00:00:00,United States,Z01.107.567.875
16880453,2006-07-31T00:00:00,Adult,M01.060.116
16880453,2006-07-31T00:00:00,Chronic Disease,C23.550.291.500
16880453,2006-07-31T00:00:00,Dietary Supplements,J02.500.456
16880453,2006-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16880453,2006-07-31T00:00:00,Minerals,D01.578
16880453,2006-07-31T00:00:00,Neoplasms,C04
16880453,2006-07-31T00:00:00,Primary Prevention,N02.421.726.758
16880453,2006-07-31T00:00:00,Primary Prevention,N06.850.780.680
16880453,2006-07-31T00:00:00,United States,Z01.107.567.875
16691565,2006-08-01T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
16691565,2006-08-01T00:00:00,ADAM Proteins,D09.400.430.500
16691565,2006-08-01T00:00:00,ADAM Proteins,D12.776.395.033
16691565,2006-08-01T00:00:00,Animals,B01.050
16691565,2006-08-01T00:00:00,Calcium-Binding Proteins,D12.776.157.125
16691565,2006-08-01T00:00:00,Gene Expression Regulation,G05.355.315
16691565,2006-08-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16691565,2006-08-01T00:00:00,Heart,A07.541
16691565,2006-08-01T00:00:00,Myocardium,A02.633.580
16691565,2006-08-01T00:00:00,Myocardium,A07.541.704
16691565,2006-08-01T00:00:00,Myocardium,A10.690.552.750
16691565,2006-08-01T00:00:00,Protein Isoforms,D12.776.800
16691565,2006-08-01T00:00:00,Ventricular Remodeling,C23.300.985
16691565,2006-08-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16691565,2006-08-01T00:00:00,Versicans,D09.698.735.830.750
16691565,2006-08-01T00:00:00,Versicans,D12.776.395.650.750.750
16691565,2006-08-01T00:00:00,Versicans,D12.776.503.280.625
16760803,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760803,2006-08-01T00:00:00,Internship and Residency,I02.358.399.644
16760803,2006-08-01T00:00:00,Interprofessional Relations,F01.829.401.205
16760803,2006-08-01T00:00:00,Orthopedics,H02.403.810.494
16760803,2006-08-01T00:00:00,Professional Role,F01.829.316.616.625
16760811,2006-08-01T00:00:00,Biomedical Research,H01.770.644.145
16760811,2006-08-01T00:00:00,Career Choice,F02.463.785.373.346.400
16760811,2006-08-01T00:00:00,Case-Control Studies,E05.318.760.500.500
16760811,2006-08-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16760811,2006-08-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16760811,2006-08-01T00:00:00,Curriculum,I02.158
16760811,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16760811,2006-08-01T00:00:00,Internship and Residency,I02.358.399.644
16760811,2006-08-01T00:00:00,Orthopedics,H02.403.810.494
16760811,2006-08-01T00:00:00,Program Evaluation,E05.337.820
16760811,2006-08-01T00:00:00,Program Evaluation,N04.761.685
16760811,2006-08-01T00:00:00,Program Evaluation,N05.715.360.650
16810457,2006-08-01T00:00:00,Brain,A08.186.211
16810457,2006-08-01T00:00:00,Cognition,F02.463.188
16810457,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16810457,2006-08-01T00:00:00,Language,F01.145.209.399
16810457,2006-08-01T00:00:00,Language,L01.143.506
16810457,2006-08-01T00:00:00,Vision Disorders,C10.597.751.941
16810457,2006-08-01T00:00:00,Vision Disorders,C11.966
16810457,2006-08-01T00:00:00,Vision Disorders,C23.888.592.763.941
16810457,2006-08-01T00:00:00,Visual Perception,F02.463.593.932
16821235,2006-08-01T00:00:00,Animals,B01.050
16821235,2006-08-01T00:00:00,B-Lymphocytes,A11.063.438
16821235,2006-08-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
16821235,2006-08-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
16821235,2006-08-01T00:00:00,B-Lymphocytes,A15.382.032.438
16821235,2006-08-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
16821235,2006-08-01T00:00:00,Cell Adhesion,G04.299.117
16821235,2006-08-01T00:00:00,"Chemokines, CXC",D12.644.276.374.200.120
16821235,2006-08-01T00:00:00,"Chemokines, CXC",D12.776.467.374.200.120
16821235,2006-08-01T00:00:00,"Chemokines, CXC",D23.125.300.120
16821235,2006-08-01T00:00:00,"Chemokines, CXC",D23.469.200.120
16821235,2006-08-01T00:00:00,"Chemokines, CXC",D23.529.374.200.120
16821235,2006-08-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
16821235,2006-08-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
16821235,2006-08-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
16821235,2006-08-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
16821235,2006-08-01T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
16821235,2006-08-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
16821235,2006-08-01T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
16821235,2006-08-01T00:00:00,"Receptors, Lysosphingolipid",D12.776.543.750.100.420.500
16821235,2006-08-01T00:00:00,Sphingosine,D02.033.100.700
16821235,2006-08-01T00:00:00,Sphingosine,D02.033.455.843
16821235,2006-08-01T00:00:00,Sphingosine,D02.092.063.700
16847446,2006-08-01T00:00:00,Animals,B01.050
16847446,2006-08-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
16847446,2006-08-01T00:00:00,Drug Interactions,G07.690.812.240
16847446,2006-08-01T00:00:00,Drug Interactions,G07.700.680.240
16847446,2006-08-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16847446,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16848777,2006-08-01T00:00:00,Adolescent,M01.060.057
16848777,2006-08-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16848777,2006-08-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16848777,2006-08-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16848777,2006-08-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16848777,2006-08-01T00:00:00,Blood Flow Velocity,E01.370.370.130
16848777,2006-08-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
16848777,2006-08-01T00:00:00,Blood Transfusion,E02.095.135
16848777,2006-08-01T00:00:00,Child,M01.060.406
16848777,2006-08-01T00:00:00,"Child, Preschool",M01.060.406.448
16848777,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16848777,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16848777,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16848777,2006-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16848777,2006-08-01T00:00:00,Risk Assessment,N04.452.871.715
16848777,2006-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16848777,2006-08-01T00:00:00,Risk Assessment,N06.850.505.715
16848777,2006-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16848777,2006-08-01T00:00:00,Stroke,C10.228.140.300.775
16848777,2006-08-01T00:00:00,Stroke,C14.907.253.855
16848777,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
16848777,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
16848777,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
16848777,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
16850504,2006-08-01T00:00:00,"Electrophoresis, Capillary",E05.196.401.190
16850504,2006-08-01T00:00:00,"Electrophoresis, Capillary",E05.301.300.190
16850504,2006-08-01T00:00:00,"Models, Chemical",E05.599.495
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,G17.800
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16850504,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16857575,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16857575,2006-08-01T00:00:00,Movement Disorders,C10.228.662
16857575,2006-08-01T00:00:00,Psychophysiologic Disorders,C23.888.592.700
16857575,2006-08-01T00:00:00,Somatoform Disorders,F03.875
16861341,2006-08-01T00:00:00,Adolescent,M01.060.057
16861341,2006-08-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16861341,2006-08-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16861341,2006-08-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16861341,2006-08-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16861341,2006-08-01T00:00:00,Blood Transfusion,E02.095.135
16861341,2006-08-01T00:00:00,Child,M01.060.406
16861341,2006-08-01T00:00:00,"Child, Preschool",M01.060.406.448
16861341,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16861341,2006-08-01T00:00:00,Iron Overload,C18.452.565.500
16861341,2006-08-01T00:00:00,Stroke,C10.228.140.300.775
16861341,2006-08-01T00:00:00,Stroke,C14.907.253.855
16861341,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
16861341,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
16861341,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
16861341,2006-08-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
16861512,2006-08-01T00:00:00,Adult,M01.060.116
16861512,2006-08-01T00:00:00,Contrast Media,D27.720.259
16861512,2006-08-01T00:00:00,Exanthema,C17.800.257
16861512,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16863782,2006-08-01T00:00:00,Animals,B01.050
16863782,2006-08-01T00:00:00,"Heart Arrest, Induced",E04.100.376.374
16863782,2006-08-01T00:00:00,"Heart Arrest, Induced",E04.928.220.360
16863782,2006-08-01T00:00:00,Myocardial Contraction,G09.330.190.541
16863782,2006-08-01T00:00:00,Myocardial Contraction,G11.427.590.540.570
16863782,2006-08-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16863782,2006-08-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16863782,2006-08-01T00:00:00,"Myocytes, Cardiac",A11.620.500
16863782,2006-08-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
16863782,2006-08-01T00:00:00,"Receptors, Cell Surface",D12.776.543.750
16863782,2006-08-01T00:00:00,Swine,B01.050.150.900.649.077.880
16863806,2006-08-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
16863806,2006-08-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
16863806,2006-08-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
16863806,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16863806,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C04.557.580.600.580.590.650
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C04.700.645.650
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C10.562.600.500
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C10.574.500.549.400
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C10.668.829.675
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C16.320.400.560.400
16863806,2006-08-01T00:00:00,Neurofibromatosis 1,C16.320.700.645.650
16863806,2006-08-01T00:00:00,Pulmonary Artery,A07.231.114.715
16863806,2006-08-01T00:00:00,Pulmonary Valve Stenosis,C14.280.484.716
16863806,2006-08-01T00:00:00,Pulmonary Valve Stenosis,C14.280.955.750
16868980,2006-08-01T00:00:00,Adolescent,M01.060.057
16868980,2006-08-01T00:00:00,Biological Markers,D23.101
16868980,2006-08-01T00:00:00,Child,M01.060.406
16868980,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16868980,2006-08-01T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
16868980,2006-08-01T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
16868980,2006-08-01T00:00:00,Lupus Nephritis,C17.300.480.680
16868980,2006-08-01T00:00:00,Lupus Nephritis,C20.111.590.560
16868980,2006-08-01T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
16870959,2006-08-01T00:00:00,Adult,M01.060.116
16870959,2006-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
16870959,2006-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
16870959,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16870959,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16870959,2006-08-01T00:00:00,Psychiatry,F04.096.544
16870959,2006-08-01T00:00:00,Psychiatry,H02.403.690
16870959,2006-08-01T00:00:00,Schizophrenia,F03.700.750
16870959,2006-08-01T00:00:00,Treatment Outcome,E01.789.800
16870959,2006-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16870959,2006-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16870959,2006-08-01T00:00:00,United States,Z01.107.567.875
16872943,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16872943,2006-08-01T00:00:00,Publishing,L01.737
16872943,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16872943,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16872943,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16872943,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16872943,2006-08-01T00:00:00,Research Design,E05.581.500
16872943,2006-08-01T00:00:00,Research Design,H01.770.644.728
16872943,2006-08-01T00:00:00,Thoracic Surgery,H02.403.810.803
16874178,2006-08-01T00:00:00,Adolescent,M01.060.057
16874178,2006-08-01T00:00:00,Attitude to Health,F01.100.150
16874178,2006-08-01T00:00:00,Attitude to Health,N05.300.150
16874178,2006-08-01T00:00:00,Child,M01.060.406
16874178,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16874178,2006-08-01T00:00:00,Parents,F01.829.263.500.320
16874178,2006-08-01T00:00:00,Parents,I01.880.225.500.340
16874178,2006-08-01T00:00:00,Parents,M01.620
16874178,2006-08-01T00:00:00,Questionnaires,E05.318.308.750
16874178,2006-08-01T00:00:00,Questionnaires,L01.280.800
16874178,2006-08-01T00:00:00,Questionnaires,N05.715.360.300.695
16874178,2006-08-01T00:00:00,Questionnaires,N06.850.520.308.750
16874178,2006-08-01T00:00:00,"Sexually Transmitted Diseases, Viral",C02.800.801
16874736,2006-08-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
16874736,2006-08-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
16874736,2006-08-01T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
16874736,2006-08-01T00:00:00,"Adaptor Proteins, Vesicular Transport",D12.776.543.990.150
16874736,2006-08-01T00:00:00,Animals,B01.050
16874736,2006-08-01T00:00:00,Cell Movement,G04.299.283
16874736,2006-08-01T00:00:00,Cell Movement,G07.700.560.500.180
16874736,2006-08-01T00:00:00,Cell Proliferation,G04.299.233.750
16874736,2006-08-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16874736,2006-08-01T00:00:00,Gene Deletion,G05.355.600.800.320
16874736,2006-08-01T00:00:00,Gene Deletion,G05.365.590.762.320
16874736,2006-08-01T00:00:00,Graft Rejection,G12.425.901.545.328
16874736,2006-08-01T00:00:00,Lymph Nodes,A10.549.400
16874736,2006-08-01T00:00:00,Lymph Nodes,A15.382.520.604.412
16874736,2006-08-01T00:00:00,Myeloid Differentiation Factor 88,D12.644.360.024.305
16874736,2006-08-01T00:00:00,Myeloid Differentiation Factor 88,D12.776.157.057.064
16874736,2006-08-01T00:00:00,Myeloid Differentiation Factor 88,D12.776.476.024.390
16874736,2006-08-01T00:00:00,Signal Transduction,G02.111.087.800
16874736,2006-08-01T00:00:00,Signal Transduction,G02.149.115.800
16874736,2006-08-01T00:00:00,Signal Transduction,G04.299.880
16874736,2006-08-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
16874736,2006-08-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
16874736,2006-08-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
16874736,2006-08-01T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
16875902,2006-08-01T00:00:00,Atrial Fibrillation,C14.280.067.198
16875902,2006-08-01T00:00:00,Atrial Fibrillation,C23.550.073.198
16875902,2006-08-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
16875902,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16875902,2006-08-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16875902,2006-08-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16875902,2006-08-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16875902,2006-08-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16875902,2006-08-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
16875902,2006-08-01T00:00:00,Patient Selection,E05.581.500.653
16875902,2006-08-01T00:00:00,Patient Selection,N04.590.731
16875902,2006-08-01T00:00:00,Quality of Life,I01.800
16875902,2006-08-01T00:00:00,Quality of Life,K01.752.400.750
16875902,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16875902,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16875902,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16875902,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16875902,2006-08-01T00:00:00,Research Design,E05.581.500
16875902,2006-08-01T00:00:00,Research Design,H01.770.644.728
16875904,2006-08-01T00:00:00,Diastole,G09.330.190.541.295
16875904,2006-08-01T00:00:00,Diastole,G11.427.590.540.554.250
16875904,2006-08-01T00:00:00,Diastole,G11.427.590.540.570.295
16875904,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16875904,2006-08-01T00:00:00,Hypertension,C14.907.489
16875904,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16875904,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16875904,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16875904,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16875904,2006-08-01T00:00:00,Research Design,E05.581.500
16875904,2006-08-01T00:00:00,Research Design,H01.770.644.728
16876683,2006-08-01T00:00:00,Adolescent,M01.060.057
16876683,2006-08-01T00:00:00,Alleles,G05.360.340.024.340.030
16876683,2006-08-01T00:00:00,Blood Pressure,E01.370.600.875.249
16876683,2006-08-01T00:00:00,Blood Pressure,G09.330.380.076
16876683,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16876683,2006-08-01T00:00:00,"Polymorphism, Genetic",G05.365.795
16876683,2006-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
16876683,2006-08-01T00:00:00,"Stress, Psychological",F02.830.900
16877671,2006-08-01T00:00:00,Fear,F01.470.361
16877671,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16877671,2006-08-01T00:00:00,Panic Disorder,F03.080.700
16877671,2006-08-01T00:00:00,Questionnaires,E05.318.308.750
16877671,2006-08-01T00:00:00,Questionnaires,L01.280.800
16877671,2006-08-01T00:00:00,Questionnaires,N05.715.360.300.695
16877671,2006-08-01T00:00:00,Questionnaires,N06.850.520.308.750
16878022,2006-08-01T00:00:00,Animals,B01.050
16878022,2006-08-01T00:00:00,DNA-Binding Proteins,D12.776.260
16878022,2006-08-01T00:00:00,Hydroxycholesterols,D04.808.247.222.284.478
16878022,2006-08-01T00:00:00,Hydroxycholesterols,D04.808.247.808.197.561
16878022,2006-08-01T00:00:00,Hydroxycholesterols,D10.570.938.208.603
16878022,2006-08-01T00:00:00,Inflammation,C23.550.470
16878022,2006-08-01T00:00:00,Lipopolysaccharides,D09.400.500
16878022,2006-08-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16878022,2006-08-01T00:00:00,Lipopolysaccharides,D10.494
16878022,2006-08-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16878022,2006-08-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16878022,2006-08-01T00:00:00,Macrophages,A11.329.372
16878022,2006-08-01T00:00:00,Macrophages,A11.627.482
16878022,2006-08-01T00:00:00,Macrophages,A11.733.397
16878022,2006-08-01T00:00:00,Macrophages,A15.382.680.397
16878022,2006-08-01T00:00:00,Macrophages,A15.382.812.522
16878022,2006-08-01T00:00:00,NF-kappa B,D12.776.260.600
16878022,2006-08-01T00:00:00,NF-kappa B,D12.776.660.600
16878022,2006-08-01T00:00:00,NF-kappa B,D12.776.930.600
16878022,2006-08-01T00:00:00,Nitric Oxide,D01.339.387
16878022,2006-08-01T00:00:00,Nitric Oxide,D01.625.550.500
16878022,2006-08-01T00:00:00,Nitric Oxide,D01.625.700.500
16878022,2006-08-01T00:00:00,Nitric Oxide,D01.650.550.587.600
16878022,2006-08-01T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
16878022,2006-08-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
16878022,2006-08-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
16878022,2006-08-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
16878022,2006-08-01T00:00:00,Signal Transduction,G02.111.087.800
16878022,2006-08-01T00:00:00,Signal Transduction,G02.149.115.800
16878022,2006-08-01T00:00:00,Signal Transduction,G04.299.880
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16878022,2006-08-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16878906,2006-08-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16878906,2006-08-01T00:00:00,Molecular Weight,G02.842.580
16878906,2006-08-01T00:00:00,Muramidase,D08.811.277.450.642
16878906,2006-08-01T00:00:00,Polypropylenes,D02.455.326.271.665.590
16878906,2006-08-01T00:00:00,Polypropylenes,D05.750.716.550
16878906,2006-08-01T00:00:00,Polypropylenes,D25.720.716.550
16878906,2006-08-01T00:00:00,Polypropylenes,J01.637.051.720.716.550
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,G17.800
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16878906,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16879664,2006-08-01T00:00:00,Child,M01.060.406
16879664,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16879664,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16879664,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16879664,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16879664,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16879664,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16879664,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16879664,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16879792,2006-08-01T00:00:00,Animals,B01.050
16879792,2006-08-01T00:00:00,Anxiety Disorders,F03.080
16879792,2006-08-01T00:00:00,Brain,A08.186.211
16879792,2006-08-01T00:00:00,Electrophoresis,E05.196.401
16879792,2006-08-01T00:00:00,Electrophoresis,E05.301.300
16879792,2006-08-01T00:00:00,Electrophoresis,G02.149.767.570
16879792,2006-08-01T00:00:00,Electrophoresis,G02.842.750.570
16879792,2006-08-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
16879792,2006-08-01T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
16879792,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16879792,2006-08-01T00:00:00,Mental Disorders,F03
16879792,2006-08-01T00:00:00,Proteomics,H01.158.201.843
16879792,2006-08-01T00:00:00,Proteomics,H01.158.273.180.350.700
16879792,2006-08-01T00:00:00,Proteomics,H01.158.273.343.350.700
16879792,2006-08-01T00:00:00,Proteomics,H01.181.122.738
16879794,2006-08-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
16879794,2006-08-01T00:00:00,Cognitive Therapy,F04.754.137.428
16879794,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16879794,2006-08-01T00:00:00,Phobic Disorders,F03.080.725
16879794,2006-08-01T00:00:00,Questionnaires,E05.318.308.750
16879794,2006-08-01T00:00:00,Questionnaires,L01.280.800
16879794,2006-08-01T00:00:00,Questionnaires,N05.715.360.300.695
16879794,2006-08-01T00:00:00,Questionnaires,N06.850.520.308.750
16882532,2006-08-01T00:00:00,Adult,M01.060.116
16882532,2006-08-01T00:00:00,Aged,M01.060.116.100
16882532,2006-08-01T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
16882532,2006-08-01T00:00:00,Animals,B01.050
16882532,2006-08-01T00:00:00,Chloral Hydrate,D02.033.455.250.130
16882532,2006-08-01T00:00:00,Hepatocytes,A11.436.348
16882532,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16882532,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16882532,2006-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16882532,2006-08-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16882532,2006-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16882532,2006-08-01T00:00:00,Risk Assessment,N04.452.871.715
16882532,2006-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16882532,2006-08-01T00:00:00,Risk Assessment,N06.850.505.715
16882532,2006-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16882532,2006-08-01T00:00:00,Solvents,D27.720.844
16882532,2006-08-01T00:00:00,Trichloroacetic Acid,D02.241.081.038.866
16882532,2006-08-01T00:00:00,Trichloroethylene,D02.455.526.439.939
16882813,2006-08-01T00:00:00,Adult,M01.060.116
16882813,2006-08-01T00:00:00,Age Factors,N05.715.350.075
16882813,2006-08-01T00:00:00,Age Factors,N06.850.490.250
16882813,2006-08-01T00:00:00,Breast Feeding,G07.610.220.500.500
16882813,2006-08-01T00:00:00,Breast Feeding,G07.610.593.185
16882813,2006-08-01T00:00:00,Breast Feeding,G07.700.620.185
16882813,2006-08-01T00:00:00,Continental Population Groups,M01.686.508
16882813,2006-08-01T00:00:00,Dietary Supplements,J02.500.456
16882813,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16882813,2006-08-01T00:00:00,Infant,M01.060.703
16882813,2006-08-01T00:00:00,"Infant, Newborn",M01.060.703.520
16882813,2006-08-01T00:00:00,Parathyroid Hormone,D06.472.699.590
16882813,2006-08-01T00:00:00,Parathyroid Hormone,D12.644.548.587
16882813,2006-08-01T00:00:00,Prevalence,E05.318.308.985.525.750
16882813,2006-08-01T00:00:00,Prevalence,L01.280.975.525.750
16882813,2006-08-01T00:00:00,Prevalence,N01.224.935.597.750
16882813,2006-08-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16882813,2006-08-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16882813,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16882813,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16882813,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16882813,2006-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16882813,2006-08-01T00:00:00,Seasons,G01.910.645.661
16882813,2006-08-01T00:00:00,Seasons,G16.500.275.071.590
16882813,2006-08-01T00:00:00,Seasons,N06.230.300.100.250.525
16882813,2006-08-01T00:00:00,Vitamin D,D04.808.812.768
16882813,2006-08-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
16882877,2006-08-01T00:00:00,Apoptosis,G04.299.139.160
16882877,2006-08-01T00:00:00,Cell Aging,G04.299.119
16882877,2006-08-01T00:00:00,DNA Damage,C21.111
16882877,2006-08-01T00:00:00,DNA Damage,G05.355.180
16882877,2006-08-01T00:00:00,Fibroblasts,A11.329.228
16882877,2006-08-01T00:00:00,Fibroblasts,A11.872.228
16882877,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16882877,2006-08-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16882877,2006-08-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16882877,2006-08-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16882877,2006-08-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16882877,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
16882877,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
16882877,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
16882877,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
16882877,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
16882877,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
16882877,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
16882877,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
16882907,2006-08-01T00:00:00,Aged,M01.060.116.100
16882907,2006-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
16882907,2006-08-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
16882907,2006-08-01T00:00:00,Hip Prosthesis,E07.695.400.400
16882907,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16882907,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16882907,2006-08-01T00:00:00,Prosthesis Design,E05.320.550
16882907,2006-08-01T00:00:00,Prosthesis Design,E07.695.680
16882907,2006-08-01T00:00:00,Prosthesis Failure,C23.550.767.865
16882907,2006-08-01T00:00:00,Prosthesis Failure,E05.325.771
16884722,2006-08-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
16884722,2006-08-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16884722,2006-08-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16884722,2006-08-01T00:00:00,Animals,B01.050
16884722,2006-08-01T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
16884722,2006-08-01T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
16884722,2006-08-01T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
16884722,2006-08-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16884722,2006-08-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16884722,2006-08-01T00:00:00,Phylogeny,G05.697
16884722,2006-08-01T00:00:00,Phylogeny,G16.100.275.605
16884722,2006-08-01T00:00:00,Phylogeny,L01.100.697
16884722,2006-08-01T00:00:00,"RNA, Messenger",D13.444.735.544
16885155,2006-08-01T00:00:00,Adenoviridae,B04.280.030
16885155,2006-08-01T00:00:00,Adenoviridae,B04.909.204.097
16885155,2006-08-01T00:00:00,Animals,B01.050
16885155,2006-08-01T00:00:00,Apoptosis,G04.299.139.160
16885155,2006-08-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16885155,2006-08-01T00:00:00,Epithelial Cells,A11.436
16885155,2006-08-01T00:00:00,Histones,D12.776.660.470
16885155,2006-08-01T00:00:00,Histones,D12.776.664.469
16885155,2006-08-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
16885155,2006-08-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
16885155,2006-08-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
16885155,2006-08-01T00:00:00,Kidney,A05.810.453
16885155,2006-08-01T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
16885155,2006-08-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
16885155,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
16885155,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
16885155,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
16885155,2006-08-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
16885370,2006-08-01T00:00:00,Animals,B01.050
16885370,2006-08-01T00:00:00,Cell Line,A11.251.210
16885370,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16885370,2006-08-01T00:00:00,Pyrimidines,D03.383.742
16885370,2006-08-01T00:00:00,Substrate Specificity,G02.111.835
16886238,2006-08-01T00:00:00,Graft Rejection,G12.425.901.545.328
16886238,2006-08-01T00:00:00,Hepatitis C,C02.440.440
16886238,2006-08-01T00:00:00,Hepatitis C,C02.782.350.350
16886238,2006-08-01T00:00:00,Hepatitis C,C06.552.380.705.440
16886238,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16886238,2006-08-01T00:00:00,Liver Transplantation,E04.210.650
16886238,2006-08-01T00:00:00,Liver Transplantation,E04.936.450.490
16886238,2006-08-01T00:00:00,Liver Transplantation,E04.936.580.490
16886736,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16886736,2006-08-01T00:00:00,"Models, Statistical",E05.318.740.500
16886736,2006-08-01T00:00:00,"Models, Statistical",E05.599.835
16886736,2006-08-01T00:00:00,"Models, Statistical",N05.715.360.750.530
16886736,2006-08-01T00:00:00,"Models, Statistical",N06.850.520.830.500
16886736,2006-08-01T00:00:00,Monte Carlo Method,E05.318.740.525
16886736,2006-08-01T00:00:00,Monte Carlo Method,L01.906.575.422
16886736,2006-08-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
16886736,2006-08-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
16886736,2006-08-01T00:00:00,Population Surveillance,E05.318.308.250.700
16886736,2006-08-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
16886736,2006-08-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
16886736,2006-08-01T00:00:00,Population Surveillance,N06.850.780.675
16886736,2006-08-01T00:00:00,Regression Analysis,E05.318.740.750
16886736,2006-08-01T00:00:00,Regression Analysis,N05.715.360.750.695
16886736,2006-08-01T00:00:00,Regression Analysis,N06.850.520.830.750
16886736,2006-08-01T00:00:00,Space-Time Clustering,E05.318.740.250.700
16886736,2006-08-01T00:00:00,Space-Time Clustering,N05.715.360.750.200.775
16886736,2006-08-01T00:00:00,Space-Time Clustering,N06.850.520.830.250.700
16887394,2006-08-01T00:00:00,Adenoviridae,B04.280.030
16887394,2006-08-01T00:00:00,Adenoviridae,B04.909.204.097
16887394,2006-08-01T00:00:00,Animals,B01.050
16887394,2006-08-01T00:00:00,Apoptosis,G04.299.139.160
16887394,2006-08-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16887394,2006-08-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16887394,2006-08-01T00:00:00,Caspases,D12.644.360.075.405
16887394,2006-08-01T00:00:00,Caspases,D12.776.476.075.405
16887394,2006-08-01T00:00:00,Ceramides,D02.065.313
16887394,2006-08-01T00:00:00,Ceramides,D09.400.410.420.525.200
16887394,2006-08-01T00:00:00,Ceramides,D10.390.470.675.200
16887394,2006-08-01T00:00:00,Ceramides,D10.570.877.360.612.200
16887394,2006-08-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16887394,2006-08-01T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
16887394,2006-08-01T00:00:00,Gene Expression Regulation,G05.355.315
16887394,2006-08-01T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16887394,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16887394,2006-08-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16887394,2006-08-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16887394,2006-08-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16887394,2006-08-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16887394,2006-08-01T00:00:00,Sphingolipids,D10.570.877
16887394,2006-08-01T00:00:00,Sphingolipids,D10.808
16887394,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
16887394,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
16887394,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
16887394,2006-08-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
16888526,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16888526,2006-08-01T00:00:00,Internship and Residency,I02.358.399.644
16888526,2006-08-01T00:00:00,Orthopedics,H02.403.810.494
16888526,2006-08-01T00:00:00,United States,Z01.107.567.875
16890856,2006-08-01T00:00:00,Aged,M01.060.116.100
16890856,2006-08-01T00:00:00,Endoscopy,E01.370.388.250
16890856,2006-08-01T00:00:00,Endoscopy,E04.800.250
16890856,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16890856,2006-08-01T00:00:00,Lower Extremity,A01.378.610
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
16890856,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
16890856,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16890856,2006-08-01T00:00:00,Peripheral Vascular Diseases,C14.907.617
16890856,2006-08-01T00:00:00,Treatment Outcome,E01.789.800
16890856,2006-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16890856,2006-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16890856,2006-08-01T00:00:00,Vascular Patency,G09.330.920
16894245,2006-08-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16894245,2006-08-01T00:00:00,Cardiovascular Diseases,C14
16894245,2006-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16894245,2006-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
16894245,2006-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16894245,2006-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16894245,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16894245,2006-08-01T00:00:00,Hypertension,C14.907.489
16894245,2006-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16894245,2006-08-01T00:00:00,Risk Factors,N05.715.350.200.700
16894245,2006-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16894245,2006-08-01T00:00:00,Risk Factors,N06.850.490.625.750
16894245,2006-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16895872,2006-08-01T00:00:00,Biological Markers,D23.101
16895872,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16895872,2006-08-01T00:00:00,Pregnancy,G08.686.785.760.769
16895872,2006-08-01T00:00:00,Pregnancy Complications,C13.703
16895872,2006-08-01T00:00:00,Vitamin D,D04.808.812.768
16895872,2006-08-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
16895876,2006-08-01T00:00:00,Adult,M01.060.116
16895876,2006-08-01T00:00:00,"Diet, Reducing",E02.642.249.285
16895876,2006-08-01T00:00:00,"Diet, Reducing",G07.610.240.285
16895876,2006-08-01T00:00:00,Energy Intake,G07.610.240.340
16895876,2006-08-01T00:00:00,Fatty Liver,C06.552.241
16895876,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16895876,2006-08-01T00:00:00,Liver,A03.620
16895876,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16895876,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16895876,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16895876,2006-08-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
16895876,2006-08-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
16895876,2006-08-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
16895876,2006-08-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
16895876,2006-08-01T00:00:00,Patient Compliance,F01.145.488.500
16895876,2006-08-01T00:00:00,Patient Compliance,N05.300.150.600.600
16895876,2006-08-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
16895876,2006-08-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
16895876,2006-08-01T00:00:00,Patient Satisfaction,N05.715.360.600
16895876,2006-08-01T00:00:00,Postoperative Complications,C23.550.767
16895876,2006-08-01T00:00:00,Preoperative Care,E02.760.795
16895876,2006-08-01T00:00:00,Preoperative Care,E04.641
16895876,2006-08-01T00:00:00,Preoperative Care,N02.421.585.795
16895876,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16895876,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16895876,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16895876,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16895876,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16895876,2006-08-01T00:00:00,Weight Loss,C23.888.144.243.963
16895876,2006-08-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16896039,2006-08-01T00:00:00,Adult,M01.060.116
16896039,2006-08-01T00:00:00,Environmental Exposure,N06.850.460.350
16896039,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16896039,2006-08-01T00:00:00,Nicotine,D03.132.760.570
16896039,2006-08-01T00:00:00,Nicotine,D03.383.725.518
16896039,2006-08-01T00:00:00,Saliva,A12.200.666
16896039,2006-08-01T00:00:00,Smoking,F01.145.466.753
16899836,2006-08-01T00:00:00,Adolescent,M01.060.057
16899836,2006-08-01T00:00:00,Adult,M01.060.116
16899836,2006-08-01T00:00:00,Aged,M01.060.116.100
16899836,2006-08-01T00:00:00,Child,M01.060.406
16899836,2006-08-01T00:00:00,"Child, Preschool",M01.060.406.448
16899836,2006-08-01T00:00:00,Chronic Disease,C23.550.291.500
16899836,2006-08-01T00:00:00,Cough,C08.618.248
16899836,2006-08-01T00:00:00,Cough,C23.888.852.293
16899836,2006-08-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16899836,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16899836,2006-08-01T00:00:00,Infant,M01.060.703
16899836,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16899836,2006-08-01T00:00:00,Treatment Outcome,E01.789.800
16899836,2006-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16899836,2006-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16901357,2006-08-01T00:00:00,Bariatric Surgery,E02.065.062
16901357,2006-08-01T00:00:00,Bariatric Surgery,E04.062
16901357,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16901357,2006-08-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
16901357,2006-08-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
16901357,2006-08-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
16901357,2006-08-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
16901357,2006-08-01T00:00:00,Weight Loss,C23.888.144.243.963
16901357,2006-08-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
16903485,2006-08-01T00:00:00,Aging,G07.700.320.124
16903485,2006-08-01T00:00:00,Animals,B01.050
16903485,2006-08-01T00:00:00,Chickens,B01.050.150.900.248.350.150
16903485,2006-08-01T00:00:00,Chickens,B01.050.150.900.248.617.192
16903485,2006-08-01T00:00:00,Cholesterol,D04.808.247.222.284
16903485,2006-08-01T00:00:00,Cholesterol,D04.808.247.808.197
16903485,2006-08-01T00:00:00,Cholesterol,D10.570.938.208
16903485,2006-08-01T00:00:00,Cholesterol,D10.851.208
16903485,2006-08-01T00:00:00,Lipids,D10
16903485,2006-08-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
16903485,2006-08-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
16903485,2006-08-01T00:00:00,Poultry Diseases,C22.131.728
16904446,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16904446,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16904446,2006-08-01T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
16904446,2006-08-01T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
16904446,2006-08-01T00:00:00,Urinary Incontinence,C12.777.934.852
16904446,2006-08-01T00:00:00,Urinary Incontinence,C13.351.968.934.814
16904446,2006-08-01T00:00:00,Urinary Incontinence,C23.888.942.800
16908594,2006-08-01T00:00:00,Apoptosis,G04.299.139.160
16908594,2006-08-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16908594,2006-08-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16908594,2006-08-01T00:00:00,Caspases,D12.644.360.075.405
16908594,2006-08-01T00:00:00,Caspases,D12.776.476.075.405
16908594,2006-08-01T00:00:00,Down-Regulation,G02.111.087.225
16908594,2006-08-01T00:00:00,Down-Regulation,G02.149.115.225
16908594,2006-08-01T00:00:00,Down-Regulation,G05.355.315.200
16908594,2006-08-01T00:00:00,Down-Regulation,G07.690.812.230
16908594,2006-08-01T00:00:00,Down-Regulation,G07.700.680.230
16908594,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16908594,2006-08-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
16908594,2006-08-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
16908594,2006-08-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
16908594,2006-08-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
16908594,2006-08-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16908594,2006-08-01T00:00:00,Mitochondria,A11.284.835.626
16908594,2006-08-01T00:00:00,Protein Kinases,D08.811.913.696.620.682
16908594,2006-08-01T00:00:00,Protein Transport,G03.495.166.700
16908732,2006-08-01T00:00:00,Adult,M01.060.116
16908732,2006-08-01T00:00:00,Aged,M01.060.116.100
16908732,2006-08-01T00:00:00,Cholesterol,D04.808.247.222.284
16908732,2006-08-01T00:00:00,Cholesterol,D04.808.247.808.197
16908732,2006-08-01T00:00:00,Cholesterol,D10.570.938.208
16908732,2006-08-01T00:00:00,Cholesterol,D10.851.208
16908732,2006-08-01T00:00:00,Hospitalization,E02.760.400
16908732,2006-08-01T00:00:00,Hospitalization,N02.421.585.400
16908732,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16908732,2006-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16908732,2006-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16908732,2006-08-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16908732,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16908732,2006-08-01T00:00:00,Patient Compliance,F01.145.488.500
16908732,2006-08-01T00:00:00,Patient Compliance,N05.300.150.600.600
16908732,2006-08-01T00:00:00,Stroke,C10.228.140.300.775
16908732,2006-08-01T00:00:00,Stroke,C14.907.253.855
16915579,2006-08-01T00:00:00,Adult,M01.060.116
16915579,2006-08-01T00:00:00,Affect,F01.470.047
16915579,2006-08-01T00:00:00,Alcoholism,C21.739.100.250
16915579,2006-08-01T00:00:00,Alcoholism,F03.900.100.350
16915579,2006-08-01T00:00:00,Case-Control Studies,E05.318.760.500.500
16915579,2006-08-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16915579,2006-08-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16915579,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16915579,2006-08-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
16915579,2006-08-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
16915579,2006-08-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
16915579,2006-08-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
16915579,2006-08-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
16915579,2006-08-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
16915579,2006-08-01T00:00:00,Pituitary-Adrenal System,A06.407.691
16915579,2006-08-01T00:00:00,Social Environment,I01.880.656
16915579,2006-08-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16915579,2006-08-01T00:00:00,"Stress, Psychological",F01.145.126.990
16915579,2006-08-01T00:00:00,"Stress, Psychological",F02.830.900
16917401,2006-08-01T00:00:00,Adolescent,M01.060.057
16917401,2006-08-01T00:00:00,Adult,M01.060.116
16917401,2006-08-01T00:00:00,Aged,M01.060.116.100
16917401,2006-08-01T00:00:00,Child,M01.060.406
16917401,2006-08-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16917401,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16917401,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16917401,2006-08-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
16917401,2006-08-01T00:00:00,Treatment Outcome,E01.789.800
16917401,2006-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16917401,2006-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16917403,2006-08-01T00:00:00,Adult,M01.060.116
16917403,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16917403,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16917403,2006-08-01T00:00:00,Posture,G11.427.695
16921009,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
16921009,2006-08-01T00:00:00,African Americans,M01.686.754.100
16921009,2006-08-01T00:00:00,Aged,M01.060.116.100
16921009,2006-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
16921009,2006-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
16921009,2006-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16921009,2006-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16921009,2006-08-01T00:00:00,Culture,I01.076.201.450
16921009,2006-08-01T00:00:00,Culture,I01.880.143
16921009,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16921009,2006-08-01T00:00:00,Mass Screening,E01.370.500
16921009,2006-08-01T00:00:00,Mass Screening,E05.318.308.250.580
16921009,2006-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
16921009,2006-08-01T00:00:00,Mass Screening,N02.421.726.233.443
16921009,2006-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
16921009,2006-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
16921009,2006-08-01T00:00:00,Mass Screening,N06.850.780.500
16921009,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
16921009,2006-08-01T00:00:00,Neoplasms,C04
16921009,2006-08-01T00:00:00,Patient Compliance,F01.145.488.500
16921009,2006-08-01T00:00:00,Patient Compliance,N05.300.150.600.600
16921009,2006-08-01T00:00:00,Patient Dropouts,M01.643.673
16921009,2006-08-01T00:00:00,Patient Selection,E05.581.500.653
16921009,2006-08-01T00:00:00,Patient Selection,N04.590.731
16921009,2006-08-01T00:00:00,Social Support,I01.880.656.600
16924869,2006-08-01T00:00:00,Adolescent,M01.060.057
16924869,2006-08-01T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
16924869,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16924869,2006-08-01T00:00:00,Tibial Fractures,C21.866.404.875
16924869,2006-08-01T00:00:00,Tibial Fractures,C21.866.558.857
16929888,2006-08-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
16929888,2006-08-01T00:00:00,Disease Progression,C23.550.291.656
16929888,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16929888,2006-08-01T00:00:00,Kyphosis,C05.116.900.800.500
16929888,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16929888,2006-08-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16929888,2006-08-01T00:00:00,Spinal Fusion,E04.555.100.700
16929888,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16929888,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16929888,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16929888,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16929888,2006-08-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16953162,2006-08-01T00:00:00,Angiography,E01.370.350.700.060
16953162,2006-08-01T00:00:00,Angiography,E01.370.370.050
16953162,2006-08-01T00:00:00,Animals,B01.050
16953162,2006-08-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
16953162,2006-08-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
16953162,2006-08-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
16953162,2006-08-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
16953162,2006-08-01T00:00:00,"Embolization, Therapeutic",E02.520.360
16953162,2006-08-01T00:00:00,Stents,E07.695.750
16953162,2006-08-01T00:00:00,Swine,B01.050.150.900.649.077.880
16953162,2006-08-01T00:00:00,Treatment Outcome,E01.789.800
16953162,2006-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16953162,2006-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16981488,2006-08-01T00:00:00,Goals,F01.658.500
16981488,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16981488,2006-08-01T00:00:00,Psychotherapy,F04.754
16981488,2006-08-01T00:00:00,Substance-Related Disorders,C21.739
16981488,2006-08-01T00:00:00,Substance-Related Disorders,F03.900
17000590,2006-08-01T00:00:00,Depression,F01.145.126.350
17000590,2006-08-01T00:00:00,Electric Stimulation Therapy,E02.342
17000590,2006-08-01T00:00:00,Electric Stimulation Therapy,E02.779.468
17000590,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17000590,2006-08-01T00:00:00,Middle Aged,M01.060.116.630
17000590,2006-08-01T00:00:00,Pain Measurement,E01.370.376.550.600
17000590,2006-08-01T00:00:00,Pain Threshold,F02.463.593.710.560
17000590,2006-08-01T00:00:00,Pain Threshold,F02.830.816.444.700
17000590,2006-08-01T00:00:00,Pain Threshold,G11.561.600.810.444.700
17105932,2006-08-01T00:00:00,Animals,B01.050
17105932,2006-08-01T00:00:00,Apoptosis,G04.299.139.160
17105932,2006-08-01T00:00:00,Calpain,D08.811.277.656.262.500.120
17105932,2006-08-01T00:00:00,Calpain,D08.811.277.656.300.200.120
17105932,2006-08-01T00:00:00,Cell Culture Techniques,E05.200.249.249
17105932,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17105932,2006-08-01T00:00:00,Motor Neurons,A08.663.655.500
17105932,2006-08-01T00:00:00,Motor Neurons,A11.671.655.500
17105932,2006-08-01T00:00:00,Parkinsonian Disorders,C10.228.140.079.862
17105932,2006-08-01T00:00:00,Parkinsonian Disorders,C10.228.662.600
17105932,2006-08-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17162223,2006-08-01T00:00:00,Collagen,D05.750.078.280
17162223,2006-08-01T00:00:00,Collagen,D12.776.860.300.250
17162223,2006-08-01T00:00:00,Cytokines,D12.644.276.374
17162223,2006-08-01T00:00:00,Cytokines,D12.776.467.374
17162223,2006-08-01T00:00:00,Cytokines,D23.529.374
17162223,2006-08-01T00:00:00,Extracellular Matrix,A11.284.295.310
17162223,2006-08-01T00:00:00,Hepatocytes,A11.436.348
17162223,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17162223,2006-08-01T00:00:00,"Hypertension, Portal",C06.552.494
17162223,2006-08-01T00:00:00,Liver Cirrhosis,C06.552.630
17319229,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319229,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319229,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319229,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319229,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319229,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319229,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319229,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319229,2006-08-01T00:00:00,Incidence,E05.318.308.985.525.375
17319229,2006-08-01T00:00:00,Incidence,L01.280.975.525.375
17319229,2006-08-01T00:00:00,Incidence,N01.224.935.597.500
17319229,2006-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17319229,2006-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17319229,2006-08-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17319229,2006-08-01T00:00:00,Lung Neoplasms,C08.381.540
17319229,2006-08-01T00:00:00,Lung Neoplasms,C08.785.520
17319229,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319229,2006-08-01T00:00:00,Smoking,F01.145.466.753
17319229,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319229,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17319230,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319230,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319230,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319230,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319230,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319230,2006-08-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17319230,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319230,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319230,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319230,2006-08-01T00:00:00,Incidence,E05.318.308.985.525.375
17319230,2006-08-01T00:00:00,Incidence,L01.280.975.525.375
17319230,2006-08-01T00:00:00,Incidence,N01.224.935.597.500
17319230,2006-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17319230,2006-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17319230,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319230,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319230,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17319231,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319231,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319231,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319231,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319231,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319231,2006-08-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
17319231,2006-08-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
17319231,2006-08-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
17319231,2006-08-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
17319231,2006-08-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
17319231,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319231,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319231,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319231,2006-08-01T00:00:00,Incidence,E05.318.308.985.525.375
17319231,2006-08-01T00:00:00,Incidence,L01.280.975.525.375
17319231,2006-08-01T00:00:00,Incidence,N01.224.935.597.500
17319231,2006-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17319231,2006-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17319231,2006-08-01T00:00:00,Prevalence,E05.318.308.985.525.750
17319231,2006-08-01T00:00:00,Prevalence,L01.280.975.525.750
17319231,2006-08-01T00:00:00,Prevalence,N01.224.935.597.750
17319231,2006-08-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17319231,2006-08-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17319231,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319231,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319231,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17319235,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319235,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319235,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319235,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319235,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319235,2006-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17319235,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319235,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319235,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319235,2006-08-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
17319235,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319235,2006-08-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17319235,2006-08-01T00:00:00,Risk Assessment,N04.452.871.715
17319235,2006-08-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17319235,2006-08-01T00:00:00,Risk Assessment,N06.850.505.715
17319235,2006-08-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17319235,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319235,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17319235,2006-08-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
17319235,2006-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
17319235,2006-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
17319235,2006-08-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
17319236,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319236,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319236,2006-08-01T00:00:00,Breast Neoplasms,C04.588.180
17319236,2006-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17319236,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319236,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319236,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319236,2006-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17319236,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319236,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319236,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319236,2006-08-01T00:00:00,Incidence,E05.318.308.985.525.375
17319236,2006-08-01T00:00:00,Incidence,L01.280.975.525.375
17319236,2006-08-01T00:00:00,Incidence,N01.224.935.597.500
17319236,2006-08-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17319236,2006-08-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17319236,2006-08-01T00:00:00,Mass Screening,E01.370.500
17319236,2006-08-01T00:00:00,Mass Screening,E05.318.308.250.580
17319236,2006-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17319236,2006-08-01T00:00:00,Mass Screening,N02.421.726.233.443
17319236,2006-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17319236,2006-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17319236,2006-08-01T00:00:00,Mass Screening,N06.850.780.500
17319236,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319236,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319236,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17319238,2006-08-01T00:00:00,African Americans,M01.686.508.100.100
17319238,2006-08-01T00:00:00,African Americans,M01.686.754.100
17319238,2006-08-01T00:00:00,Community Networks,I01.880.656.300
17319238,2006-08-01T00:00:00,Community Networks,L01.700.508.300.184
17319238,2006-08-01T00:00:00,Community Networks,N02.421.143.202
17319238,2006-08-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17319238,2006-08-01T00:00:00,Health Services Accessibility,N04.590.374.350
17319238,2006-08-01T00:00:00,Health Services Accessibility,N05.300.430
17319238,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319238,2006-08-01T00:00:00,Preventive Medicine,H02.403.720.750
17319238,2006-08-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17319238,2006-08-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17319238,2006-08-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17319238,2006-08-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17319238,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17319238,2006-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17412132,2006-08-01T00:00:00,Adult,M01.060.116
17412132,2006-08-01T00:00:00,Breast Neoplasms,C04.588.180
17412132,2006-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17412132,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17412132,2006-08-01T00:00:00,Mammography,E01.370.350.700.500
17412132,2006-08-01T00:00:00,Mass Screening,E01.370.500
17412132,2006-08-01T00:00:00,Mass Screening,E05.318.308.250.580
17412132,2006-08-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17412132,2006-08-01T00:00:00,Mass Screening,N02.421.726.233.443
17412132,2006-08-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17412132,2006-08-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17412132,2006-08-01T00:00:00,Mass Screening,N06.850.780.500
17412132,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17412132,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17412132,2006-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,G17.800
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17412132,2006-08-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17412134,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17412134,2006-08-01T00:00:00,Mammography,E01.370.350.700.500
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17412134,2006-08-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17412134,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17412134,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17412134,2006-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17412134,2006-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
17412134,2006-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
17412134,2006-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
17412134,2006-08-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
17412134,2006-08-01T00:00:00,"Societies, Medical",N03.540.828.589
17412134,2006-08-01T00:00:00,United States,Z01.107.567.875
17412135,2006-08-01T00:00:00,Breast Neoplasms,C04.588.180
17412135,2006-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17412135,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17412135,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17412135,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17412135,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17412135,2006-08-01T00:00:00,Mammography,E01.370.350.700.500
17412135,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17412135,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17412135,2006-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17412135,2006-08-01T00:00:00,"Societies, Medical",N03.540.828.589
17412135,2006-08-01T00:00:00,United States,Z01.107.567.875
17412136,2006-08-01T00:00:00,Breast Neoplasms,C04.588.180
17412136,2006-08-01T00:00:00,Breast Neoplasms,C17.800.090.500
17412136,2006-08-01T00:00:00,Data Display,F02.784.412.221
17412136,2006-08-01T00:00:00,Data Display,L01.296
17412136,2006-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17412136,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17412136,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17412136,2006-08-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17412136,2006-08-01T00:00:00,Mammography,E01.370.350.700.500
17412136,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17412136,2006-08-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17412136,2006-08-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16885223,2006-08-02T00:00:00,Action Potentials,G04.580.100
16885223,2006-08-02T00:00:00,Action Potentials,G07.265.750.100
16885223,2006-08-02T00:00:00,Action Potentials,G11.561.570.100
16885223,2006-08-02T00:00:00,Adenosine,D03.438.759.590.138
16885223,2006-08-02T00:00:00,Adenosine,D13.570.583.138
16885223,2006-08-02T00:00:00,Adenosine,D13.570.800.096
16885223,2006-08-02T00:00:00,Animals,B01.050
16885223,2006-08-02T00:00:00,Electroencephalography,E01.370.376.300
16885223,2006-08-02T00:00:00,Electroencephalography,E01.370.405.245
16885223,2006-08-02T00:00:00,Homeostasis,G07.700.360
16885223,2006-08-02T00:00:00,Neurons,A08.663
16885223,2006-08-02T00:00:00,Neurons,A11.671
16885223,2006-08-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16885223,2006-08-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16885223,2006-08-02T00:00:00,Sleep,F02.830.855
16885223,2006-08-02T00:00:00,Sleep,G11.561.600.815
16885511,2006-08-02T00:00:00,Adolescent,M01.060.057
16885511,2006-08-02T00:00:00,Adult,M01.060.116
16885511,2006-08-02T00:00:00,African Americans,M01.686.508.100.100
16885511,2006-08-02T00:00:00,African Americans,M01.686.754.100
16885511,2006-08-02T00:00:00,Aged,M01.060.116.100
16885511,2006-08-02T00:00:00,Health Promotion,N02.370
16885511,2006-08-02T00:00:00,Health Promotion,N02.421.726.507
16885511,2006-08-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16885511,2006-08-02T00:00:00,Middle Aged,M01.060.116.630
16885511,2006-08-02T00:00:00,Motor Activity,F01.145.632
16885511,2006-08-02T00:00:00,Motor Activity,G11.427.590.530.698
16885511,2006-08-02T00:00:00,Program Development,N04.452.760
16885511,2006-08-02T00:00:00,Program Evaluation,E05.337.820
16885511,2006-08-02T00:00:00,Program Evaluation,N04.761.685
16885511,2006-08-02T00:00:00,Program Evaluation,N05.715.360.650
16885511,2006-08-02T00:00:00,Questionnaires,E05.318.308.750
16885511,2006-08-02T00:00:00,Questionnaires,L01.280.800
16885511,2006-08-02T00:00:00,Questionnaires,N05.715.360.300.695
16885511,2006-08-02T00:00:00,Questionnaires,N06.850.520.308.750
16885511,2006-08-02T00:00:00,South Carolina,Z01.107.567.875.075.662
16885511,2006-08-02T00:00:00,South Carolina,Z01.107.567.875.750.700
16889771,2006-08-02T00:00:00,Age Factors,N05.715.350.075
16889771,2006-08-02T00:00:00,Age Factors,N06.850.490.250
16889771,2006-08-02T00:00:00,Aging,G07.700.320.124
16889771,2006-08-02T00:00:00,Animals,B01.050
16889771,2006-08-02T00:00:00,"Behavior, Animal",F01.145.113
16889771,2006-08-02T00:00:00,Body Weight,C23.888.144
16889771,2006-08-02T00:00:00,Body Weight,E01.370.600.115.100.160.120
16889771,2006-08-02T00:00:00,Body Weight,E05.041.124.160.750
16889771,2006-08-02T00:00:00,Body Weight,G07.100.100.160.120
16889771,2006-08-02T00:00:00,Body Weight,G07.700.320.249.314.120
16889771,2006-08-02T00:00:00,Creatinine,D03.383.129.308.207
16889771,2006-08-02T00:00:00,Gene Expression,G05.355.310
16889771,2006-08-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
16889771,2006-08-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
16889771,2006-08-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
16889771,2006-08-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
16889771,2006-08-02T00:00:00,Kidney,A05.810.453
16889771,2006-08-02T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16889771,2006-08-02T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16889771,2006-08-02T00:00:00,Motor Activity,F01.145.632
16889771,2006-08-02T00:00:00,Motor Activity,G11.427.590.530.698
16889771,2006-08-02T00:00:00,"RNA, Messenger",D13.444.735.544
16889771,2006-08-02T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
16889771,2006-08-02T00:00:00,Substantia Nigra,A08.186.211.653.822.731
16889771,2006-08-02T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
16889771,2006-08-02T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
16887891,2006-08-03T00:00:00,Adult,M01.060.116
16887891,2006-08-03T00:00:00,Body Mass Index,E01.370.600.115.100.125
16887891,2006-08-03T00:00:00,Body Mass Index,E05.041.124.125
16887891,2006-08-03T00:00:00,Body Mass Index,G07.100.100.125
16887891,2006-08-03T00:00:00,Body Mass Index,N06.850.505.200.100.175
16887891,2006-08-03T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16887891,2006-08-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16887891,2006-08-03T00:00:00,Middle Aged,M01.060.116.630
16887891,2006-08-03T00:00:00,Nicotine,D03.132.760.570
16887891,2006-08-03T00:00:00,Nicotine,D03.383.725.518
16887891,2006-08-03T00:00:00,Nutrition Surveys,E05.318.308.250.600
16887891,2006-08-03T00:00:00,Nutrition Surveys,E05.318.308.585.550
16887891,2006-08-03T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
16887891,2006-08-03T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
16887891,2006-08-03T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
16887891,2006-08-03T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
16887891,2006-08-03T00:00:00,Smoking,F01.145.466.753
16887891,2006-08-03T00:00:00,United States,Z01.107.567.875
16888379,2006-08-04T00:00:00,Adult,M01.060.116
16888379,2006-08-04T00:00:00,Aged,M01.060.116.100
16888379,2006-08-04T00:00:00,Antihypertensive Agents,D27.505.954.411.162
16888379,2006-08-04T00:00:00,Atrial Fibrillation,C14.280.067.198
16888379,2006-08-04T00:00:00,Atrial Fibrillation,C23.550.073.198
16888379,2006-08-04T00:00:00,Brain Ischemia,C10.228.140.300.150
16888379,2006-08-04T00:00:00,Brain Ischemia,C14.907.253.092
16888379,2006-08-04T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
16888379,2006-08-04T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
16888379,2006-08-04T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
16888379,2006-08-04T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
16888379,2006-08-04T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
16888379,2006-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16888379,2006-08-04T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
16888379,2006-08-04T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
16888379,2006-08-04T00:00:00,Middle Aged,M01.060.116.630
16888379,2006-08-04T00:00:00,Prevalence,E05.318.308.985.525.750
16888379,2006-08-04T00:00:00,Prevalence,L01.280.975.525.750
16888379,2006-08-04T00:00:00,Prevalence,N01.224.935.597.750
16888379,2006-08-04T00:00:00,Prevalence,N06.850.505.400.975.525.750
16888379,2006-08-04T00:00:00,Prevalence,N06.850.520.308.985.525.750
16888379,2006-08-04T00:00:00,Risk Factors,E05.318.740.600.800.725
16888379,2006-08-04T00:00:00,Risk Factors,N05.715.350.200.700
16888379,2006-08-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16888379,2006-08-04T00:00:00,Risk Factors,N06.850.490.625.750
16888379,2006-08-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16888379,2006-08-04T00:00:00,Smoking,F01.145.466.753
16888379,2006-08-04T00:00:00,Stroke,C10.228.140.300.775
16888379,2006-08-04T00:00:00,Stroke,C14.907.253.855
16890221,2006-08-04T00:00:00,Animals,B01.050
16890221,2006-08-04T00:00:00,Endocrine Disruptors,D27.505.696.353
16890221,2006-08-04T00:00:00,Endocrine Disruptors,D27.888.284.295
16890221,2006-08-04T00:00:00,Fishes,B01.050.150.900.493
16890221,2006-08-04T00:00:00,Reptiles,B01.050.150.900.833
16890221,2006-08-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
16890221,2006-08-04T00:00:00,Risk Assessment,N04.452.871.715
16890221,2006-08-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16890221,2006-08-04T00:00:00,Risk Assessment,N06.850.505.715
16890221,2006-08-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16890221,2006-08-04T00:00:00,Sex Characteristics,G08.686.815
16891407,2006-08-04T00:00:00,Actins,D05.750.078.730.250
16891407,2006-08-04T00:00:00,Actins,D12.776.210.500.100
16891407,2006-08-04T00:00:00,Actins,D12.776.220.525.255
16891407,2006-08-04T00:00:00,Animals,B01.050
16891407,2006-08-04T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
16891407,2006-08-04T00:00:00,Cell Culture Techniques,E05.200.249.249
16891407,2006-08-04T00:00:00,Cell Differentiation,G04.299.151
16891407,2006-08-04T00:00:00,Cell Proliferation,G04.299.233.750
16891407,2006-08-04T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16891407,2006-08-04T00:00:00,Collagen Type I,D05.750.078.280.300.100
16891407,2006-08-04T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
16891407,2006-08-04T00:00:00,Extracellular Matrix,A11.284.295.310
16891407,2006-08-04T00:00:00,Fibroblasts,A11.329.228
16891407,2006-08-04T00:00:00,Fibroblasts,A11.872.228
16891407,2006-08-04T00:00:00,Fibronectins,D12.776.377.715.390
16891407,2006-08-04T00:00:00,Fibronectins,D12.776.395.550.350
16891407,2006-08-04T00:00:00,Fibronectins,D12.776.543.550.350
16891407,2006-08-04T00:00:00,Fibronectins,D12.776.860.300.450
16891407,2006-08-04T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16891407,2006-08-04T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16891407,2006-08-04T00:00:00,"Myocytes, Cardiac",A11.620.500
16891407,2006-08-04T00:00:00,Phenotype,G05.695
16891407,2006-08-04T00:00:00,Procollagen,D12.776.811.690
16891407,2006-08-04T00:00:00,Procollagen,D12.776.860.300.250.600
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D23.529.374.687
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
16891407,2006-08-04T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16901483,2006-08-04T00:00:00,Enzyme Inhibitors,D27.505.519.389
16901483,2006-08-04T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
16901483,2006-08-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16901483,2006-08-04T00:00:00,Sphingolipids,D10.570.877
16901483,2006-08-04T00:00:00,Sphingolipids,D10.808
16962188,2006-08-05T00:00:00,Animals,B01.050
16962188,2006-08-05T00:00:00,Chemokines,D12.644.276.374.200
16962188,2006-08-05T00:00:00,Chemokines,D12.776.467.374.200
16962188,2006-08-05T00:00:00,Chemokines,D23.125.300
16962188,2006-08-05T00:00:00,Chemokines,D23.469.200
16962188,2006-08-05T00:00:00,Chemokines,D23.529.374.200
16962188,2006-08-05T00:00:00,Cytokines,D12.644.276.374
16962188,2006-08-05T00:00:00,Cytokines,D12.776.467.374
16962188,2006-08-05T00:00:00,Cytokines,D23.529.374
16962188,2006-08-05T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
16962188,2006-08-05T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
16962188,2006-08-05T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
16962188,2006-08-05T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
16962188,2006-08-05T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
16962188,2006-08-05T00:00:00,Gene Expression Regulation,G05.355.315
16962188,2006-08-05T00:00:00,Lipopolysaccharides,D09.400.500
16962188,2006-08-05T00:00:00,Lipopolysaccharides,D09.698.718.450
16962188,2006-08-05T00:00:00,Lipopolysaccharides,D10.494
16962188,2006-08-05T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16962188,2006-08-05T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16962188,2006-08-05T00:00:00,Protein Isoforms,D12.776.800
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,E05.318.740.872
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,E05.318.780.800
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,G17.800
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16962188,2006-08-05T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16962188,2006-08-05T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16962188,2006-08-05T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16962188,2006-08-05T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16962188,2006-08-05T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
16878931,2006-08-07T00:00:00,Nitric Oxide,D01.339.387
16878931,2006-08-07T00:00:00,Nitric Oxide,D01.625.550.500
16878931,2006-08-07T00:00:00,Nitric Oxide,D01.625.700.500
16878931,2006-08-07T00:00:00,Nitric Oxide,D01.650.550.587.600
16878931,2006-08-07T00:00:00,Polymers,D05.750
16878931,2006-08-07T00:00:00,Polymers,D25.720
16878931,2006-08-07T00:00:00,Polymers,J01.637.051.720
16893906,2006-08-07T00:00:00,Gene Expression,G05.355.310
16893906,2006-08-07T00:00:00,Genetic Variation,G05.365
16893906,2006-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16893906,2006-08-07T00:00:00,Linkage Disequilibrium,G05.540.500
16893906,2006-08-07T00:00:00,Obesity,C18.654.726.500
16893906,2006-08-07T00:00:00,Obesity,C23.888.144.699.500
16893906,2006-08-07T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16893906,2006-08-07T00:00:00,Obesity,G07.100.100.160.120.699.500
16893906,2006-08-07T00:00:00,Phenotype,G05.695
16893906,2006-08-07T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16893906,2006-08-07T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
16893906,2006-08-07T00:00:00,"RNA, Messenger",D13.444.735.544
16895927,2006-08-07T00:00:00,Algorithms,G17.035
16895927,2006-08-07T00:00:00,Algorithms,L01.224.050
16895927,2006-08-07T00:00:00,Computer Graphics,L01.224.108
16895927,2006-08-07T00:00:00,Computer Graphics,L01.296.110
16895927,2006-08-07T00:00:00,Database Management Systems,L01.224.900.280
16895927,2006-08-07T00:00:00,Database Management Systems,L01.700.508.300.680.110
16895927,2006-08-07T00:00:00,Database Management Systems,N04.452.515.110
16895927,2006-08-07T00:00:00,Gene Expression Profiling,E05.393.332
16895927,2006-08-07T00:00:00,Proteome,D12.776.817
16895927,2006-08-07T00:00:00,Software,L01.224.900
16895927,2006-08-07T00:00:00,User-Computer Interface,L01.224.900.910
16895901,2006-08-08T00:00:00,Animals,B01.050
16895901,2006-08-08T00:00:00,Bone Marrow Cells,A11.148
16895901,2006-08-08T00:00:00,Bone Marrow Cells,A15.378.316
16895901,2006-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16895901,2006-08-08T00:00:00,Molecular Sequence Data,L01.453.245.667
16895901,2006-08-08T00:00:00,Osteoclasts,A11.329.372.700
16895901,2006-08-08T00:00:00,Osteoclasts,A11.627.482.700
16895901,2006-08-08T00:00:00,"Receptors, Peptide",D12.776.543.750.750
16895901,2006-08-08T00:00:00,Stromal Cells,A11.329.830
16896059,2006-08-08T00:00:00,Acetylcysteine,D02.886.030.230.259
16896059,2006-08-08T00:00:00,Acetylcysteine,D12.125.166.230.259
16896059,2006-08-08T00:00:00,Animals,B01.050
16896059,2006-08-08T00:00:00,Benzimidazoles,D03.438.103
16896059,2006-08-08T00:00:00,Carrier Proteins,D12.776.157
16896059,2006-08-08T00:00:00,Cell Survival,G04.299.316
16896059,2006-08-08T00:00:00,Hepatocytes,A11.436.348
16896059,2006-08-08T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
16896059,2006-08-08T00:00:00,"Microscopy, Fluorescence",E05.595.458
16896059,2006-08-08T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16896059,2006-08-08T00:00:00,Mitochondria,A11.284.835.626
16896059,2006-08-08T00:00:00,Mitochondrial Proteins,D12.776.575
16896933,2006-08-08T00:00:00,Adult,M01.060.116
16896933,2006-08-08T00:00:00,Diabetes Mellitus,C18.452.394.750
16896933,2006-08-08T00:00:00,Diabetes Mellitus,C19.246
16896933,2006-08-08T00:00:00,Ethnic Groups,M01.686.754
16896933,2006-08-08T00:00:00,Ethnic Groups,N01.224.317
16896933,2006-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16896933,2006-08-08T00:00:00,Hypertension,C14.907.489
16896933,2006-08-08T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
16896933,2006-08-08T00:00:00,Metabolic Syndrome X,C18.452.625
16896933,2006-08-08T00:00:00,Middle Aged,M01.060.116.630
16896933,2006-08-08T00:00:00,Parents,F01.829.263.500.320
16896933,2006-08-08T00:00:00,Parents,I01.880.225.500.340
16896933,2006-08-08T00:00:00,Parents,M01.620
16896933,2006-08-08T00:00:00,Regression Analysis,E05.318.740.750
16896933,2006-08-08T00:00:00,Regression Analysis,N05.715.360.750.695
16896933,2006-08-08T00:00:00,Regression Analysis,N06.850.520.830.750
16896933,2006-08-08T00:00:00,Smoking,F01.145.466.753
16901490,2006-08-09T00:00:00,Animals,B01.050
16901490,2006-08-09T00:00:00,Atherosclerosis,C14.907.137.126.307
16901490,2006-08-09T00:00:00,Connective Tissue Growth Factor,D12.644.276.200.100
16901490,2006-08-09T00:00:00,Connective Tissue Growth Factor,D12.776.467.200.100
16901490,2006-08-09T00:00:00,Connective Tissue Growth Factor,D12.776.860.300.200.100
16901490,2006-08-09T00:00:00,Connective Tissue Growth Factor,D23.529.237.100
16901490,2006-08-09T00:00:00,Down-Regulation,G02.111.087.225
16901490,2006-08-09T00:00:00,Down-Regulation,G02.149.115.225
16901490,2006-08-09T00:00:00,Down-Regulation,G05.355.315.200
16901490,2006-08-09T00:00:00,Down-Regulation,G07.690.812.230
16901490,2006-08-09T00:00:00,Down-Regulation,G07.700.680.230
16901490,2006-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16901490,2006-08-09T00:00:00,Hypoglycemic Agents,D27.505.696.422
16901490,2006-08-09T00:00:00,Immediate-Early Proteins,D12.776.460
16901490,2006-08-09T00:00:00,Immediate-Early Proteins,D12.776.964.925.968
16901490,2006-08-09T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
16901490,2006-08-09T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
16901490,2006-08-09T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
16901490,2006-08-09T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D23.529.374.687
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
16901490,2006-08-09T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16963323,2006-08-10T00:00:00,Algorithms,G17.035
16963323,2006-08-10T00:00:00,Algorithms,L01.224.050
16963323,2006-08-10T00:00:00,Genomics,H01.158.273.180.350
16963323,2006-08-10T00:00:00,Genomics,H01.158.273.343.350
16963323,2006-08-10T00:00:00,"Models, Molecular",E05.599.595
16963323,2006-08-10T00:00:00,Protein Interaction Mapping,E05.601.690
16963323,2006-08-10T00:00:00,Proteins,D12.776
16997623,2006-08-10T00:00:00,Animals,B01.050
16997623,2006-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16997623,2006-08-10T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
16997623,2006-08-10T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
16997623,2006-08-10T00:00:00,Sphingolipids,D10.570.877
16997623,2006-08-10T00:00:00,Sphingolipids,D10.808
16905684,2006-08-11T00:00:00,Aged,M01.060.116.100
16905684,2006-08-11T00:00:00,Alzheimer Disease,C10.228.140.380.100
16905684,2006-08-11T00:00:00,Alzheimer Disease,C10.574.945.249
16905684,2006-08-11T00:00:00,Alzheimer Disease,F03.087.400.100
16905684,2006-08-11T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16905684,2006-08-11T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16905684,2006-08-11T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16905684,2006-08-11T00:00:00,Brain,A08.186.211
16905684,2006-08-11T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
16905684,2006-08-11T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
16905684,2006-08-11T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
16905684,2006-08-11T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
16905684,2006-08-11T00:00:00,Dibenzothiazepines,D02.886.680.702.500
16905684,2006-08-11T00:00:00,Dibenzothiazepines,D03.494.276
16905684,2006-08-11T00:00:00,Drug Tolerance,G07.690.812.260
16905684,2006-08-11T00:00:00,Drug Tolerance,G07.700.680.260
16905684,2006-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16905684,2006-08-11T00:00:00,Middle Aged,M01.060.116.630
16905684,2006-08-11T00:00:00,Neuropsychological Tests,F04.711.513
16905684,2006-08-11T00:00:00,Psychomotor Agitation,C10.597.350.600
16905684,2006-08-11T00:00:00,Psychomotor Agitation,C10.597.606.881.700
16905684,2006-08-11T00:00:00,Psychomotor Agitation,C23.888.592.350.600
16905684,2006-08-11T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
16905684,2006-08-11T00:00:00,Psychomotor Agitation,F01.700.875.700
16905684,2006-08-11T00:00:00,Psychotic Disorders,F03.700.675
16905684,2006-08-11T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16905684,2006-08-11T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16906385,2006-08-12T00:00:00,"Membranes, Artificial",D25.479
16906385,2006-08-12T00:00:00,"Membranes, Artificial",J01.637.051.479
16906385,2006-08-12T00:00:00,"Membranes, Artificial",J01.637.087.500
16906385,2006-08-12T00:00:00,Optics and Photonics,H01.671.617
16906385,2006-08-12T00:00:00,Optics and Photonics,J01.293.688
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,E05.318.740.872
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,E05.318.780.800
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,G17.800
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16906385,2006-08-12T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16906137,2006-08-13T00:00:00,Animals,B01.050
16906137,2006-08-13T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
16906137,2006-08-13T00:00:00,"Models, Neurological",E05.599.395.642
16906137,2006-08-13T00:00:00,Morphogenesis,G07.700.320.500
16906137,2006-08-13T00:00:00,Neurons,A08.663
16906137,2006-08-13T00:00:00,Neurons,A11.671
16906137,2006-08-13T00:00:00,Photic Stimulation,E05.723.729
16906137,2006-08-13T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
16598774,2006-08-15T00:00:00,Apoptosis,G04.299.139.160
16598774,2006-08-15T00:00:00,Bone Marrow Cells,A11.148
16598774,2006-08-15T00:00:00,Bone Marrow Cells,A15.378.316
16598774,2006-08-15T00:00:00,Cell Proliferation,G04.299.233.750
16598774,2006-08-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16598774,2006-08-15T00:00:00,Heat-Shock Proteins,D12.776.580.216
16598774,2006-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16598774,2006-08-15T00:00:00,Neoplasm Proteins,D12.776.624
16598774,2006-08-15T00:00:00,Osteitis Deformans,C05.116.692
16770773,2006-08-15T00:00:00,Animals,B01.050
16770773,2006-08-15T00:00:00,Blood-Brain Barrier,A07.035
16770773,2006-08-15T00:00:00,Blood-Brain Barrier,A08.186.211.035
16770773,2006-08-15T00:00:00,Cell Adhesion,G04.299.117
16770773,2006-08-15T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
16770773,2006-08-15T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
16770773,2006-08-15T00:00:00,Cell Adhesion Molecules,D23.050.301.350
16770773,2006-08-15T00:00:00,Down-Regulation,G02.111.087.225
16770773,2006-08-15T00:00:00,Down-Regulation,G02.149.115.225
16770773,2006-08-15T00:00:00,Down-Regulation,G05.355.315.200
16770773,2006-08-15T00:00:00,Down-Regulation,G07.690.812.230
16770773,2006-08-15T00:00:00,Down-Regulation,G07.700.680.230
16770773,2006-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
16770773,2006-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
16770773,2006-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
16770773,2006-08-15T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
16770773,2006-08-15T00:00:00,Endothelial Cells,A11.436.275
16770773,2006-08-15T00:00:00,Monocytes,A11.118.637.555.652
16770773,2006-08-15T00:00:00,Monocytes,A11.148.580
16770773,2006-08-15T00:00:00,Monocytes,A11.627.624
16770773,2006-08-15T00:00:00,Monocytes,A11.733.547
16770773,2006-08-15T00:00:00,Monocytes,A15.145.229.637.555.652
16770773,2006-08-15T00:00:00,Monocytes,A15.378.316.580
16770773,2006-08-15T00:00:00,Monocytes,A15.382.490.555.652
16770773,2006-08-15T00:00:00,Monocytes,A15.382.680.547
16770773,2006-08-15T00:00:00,Monocytes,A15.382.812.547
16770773,2006-08-15T00:00:00,NF-kappa B,D12.776.260.600
16770773,2006-08-15T00:00:00,NF-kappa B,D12.776.660.600
16770773,2006-08-15T00:00:00,NF-kappa B,D12.776.930.600
16770773,2006-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
16770773,2006-08-15T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
16874771,2006-08-15T00:00:00,Chronic Disease,C23.550.291.500
16874771,2006-08-15T00:00:00,Communication,F01.145.209
16874771,2006-08-15T00:00:00,Communication,L01.143
16874771,2006-08-15T00:00:00,Empathy,F01.752.355
16874771,2006-08-15T00:00:00,Empathy,F01.752.543.500.500
16874771,2006-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16874771,2006-08-15T00:00:00,Interpersonal Relations,F01.829.401
16874771,2006-08-15T00:00:00,Motivation,F01.658
16874771,2006-08-15T00:00:00,Motivation,F01.752.543.500.750
16888000,2006-08-15T00:00:00,Animals,B01.050
16888000,2006-08-15T00:00:00,Bone Resorption,C05.116.264
16888000,2006-08-15T00:00:00,Bone Resorption,G11.427.590.195.150
16888000,2006-08-15T00:00:00,Cell Differentiation,G04.299.151
16888000,2006-08-15T00:00:00,Cell Line,A11.251.210
16888000,2006-08-15T00:00:00,Cell Proliferation,G04.299.233.750
16888000,2006-08-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16888000,2006-08-15T00:00:00,Cell Survival,G04.299.316
16888000,2006-08-15T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
16888000,2006-08-15T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
16888000,2006-08-15T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
16888000,2006-08-15T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16888000,2006-08-15T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16888000,2006-08-15T00:00:00,Monocytes,A11.118.637.555.652
16888000,2006-08-15T00:00:00,Monocytes,A11.148.580
16888000,2006-08-15T00:00:00,Monocytes,A11.627.624
16888000,2006-08-15T00:00:00,Monocytes,A11.733.547
16888000,2006-08-15T00:00:00,Monocytes,A15.145.229.637.555.652
16888000,2006-08-15T00:00:00,Monocytes,A15.378.316.580
16888000,2006-08-15T00:00:00,Monocytes,A15.382.490.555.652
16888000,2006-08-15T00:00:00,Monocytes,A15.382.680.547
16888000,2006-08-15T00:00:00,Monocytes,A15.382.812.547
16888000,2006-08-15T00:00:00,NFATC Transcription Factors,D12.776.930.608
16888000,2006-08-15T00:00:00,Osteoclasts,A11.329.372.700
16888000,2006-08-15T00:00:00,Osteoclasts,A11.627.482.700
16888000,2006-08-15T00:00:00,Signal Transduction,G02.111.087.800
16888000,2006-08-15T00:00:00,Signal Transduction,G02.149.115.800
16888000,2006-08-15T00:00:00,Signal Transduction,G04.299.880
16996247,2006-08-15T00:00:00,Brain Mapping,E01.370.350.086
16996247,2006-08-15T00:00:00,Brain Mapping,E01.370.376.149
16996247,2006-08-15T00:00:00,Brain Mapping,E05.132
16996247,2006-08-15T00:00:00,Child,M01.060.406
16996247,2006-08-15T00:00:00,Ethanol,D02.033.375
16996247,2006-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996247,2006-08-15T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16996247,2006-08-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16996247,2006-08-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16996247,2006-08-15T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
16996247,2006-08-15T00:00:00,Pregnancy,G08.686.785.760.769
17145551,2006-08-15T00:00:00,Animals,B01.050
17145551,2006-08-15T00:00:00,Apoptosis,G04.299.139.160
17145551,2006-08-15T00:00:00,Motor Neurons,A08.663.655.500
17145551,2006-08-15T00:00:00,Motor Neurons,A11.671.655.500
17145551,2006-08-15T00:00:00,Nerve Growth Factor,D12.644.276.860.437
17145551,2006-08-15T00:00:00,Nerve Growth Factor,D12.776.467.860.437
17145551,2006-08-15T00:00:00,Nerve Growth Factor,D12.776.641.600.437
17145551,2006-08-15T00:00:00,Nerve Growth Factor,D23.529.850.437
17145551,2006-08-15T00:00:00,Peroxynitrous Acid,D01.625.600.800
17145551,2006-08-15T00:00:00,Peroxynitrous Acid,D01.625.700.750
17145551,2006-08-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17145551,2006-08-15T00:00:00,Reactive Nitrogen Species,D01.625.700
17145551,2006-08-15T00:00:00,Reactive Nitrogen Species,D02.654.846
17145551,2006-08-15T00:00:00,Reactive Oxygen Species,D01.339.431
17145551,2006-08-15T00:00:00,Reactive Oxygen Species,D01.650.775
17145551,2006-08-15T00:00:00,Tyrosine,D12.125.072.050.875
16914560,2006-08-16T00:00:00,Animals,B01.050
16914560,2006-08-16T00:00:00,Cues,F02.463.425.234
16914560,2006-08-16T00:00:00,Discrimination Learning,F02.463.425.280
16914560,2006-08-16T00:00:00,Drug Tolerance,G07.690.812.260
16914560,2006-08-16T00:00:00,Drug Tolerance,G07.700.680.260
16914560,2006-08-16T00:00:00,Ethanol,D02.033.375
16898724,2006-08-17T00:00:00,"Membranes, Artificial",D25.479
16898724,2006-08-17T00:00:00,"Membranes, Artificial",J01.637.051.479
16898724,2006-08-17T00:00:00,"Membranes, Artificial",J01.637.087.500
16898724,2006-08-17T00:00:00,"Models, Chemical",E05.599.495
16898724,2006-08-17T00:00:00,Photochemistry,H01.181.529.711
16898724,2006-08-17T00:00:00,Quantum Theory,H01.671.579.800
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,E05.318.740.872
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,E05.318.780.800
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,G17.800
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16898724,2006-08-17T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16898724,2006-08-17T00:00:00,Surface Properties,G02.842.850
16919388,2006-08-17T00:00:00,Amino Acid Sequence,G02.111.570.060
16919388,2006-08-17T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16919388,2006-08-17T00:00:00,Animals,B01.050
16919388,2006-08-17T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
16919388,2006-08-17T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
16919388,2006-08-17T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
16919388,2006-08-17T00:00:00,Molecular Sequence Data,L01.453.245.667
16919388,2006-08-17T00:00:00,Phylogeny,G05.697
16919388,2006-08-17T00:00:00,Phylogeny,G16.100.275.605
16919388,2006-08-17T00:00:00,Phylogeny,L01.100.697
16919388,2006-08-17T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
16919388,2006-08-17T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
16919388,2006-08-17T00:00:00,Transcriptional Activation,G05.355.315.800
16919460,2006-08-17T00:00:00,Antineoplastic Agents,D27.505.954.248
16919460,2006-08-17T00:00:00,Breast Neoplasms,C04.588.180
16919460,2006-08-17T00:00:00,Breast Neoplasms,C17.800.090.500
16919460,2006-08-17T00:00:00,Cations,D01.248.497.300
16919460,2006-08-17T00:00:00,Ceramides,D02.065.313
16919460,2006-08-17T00:00:00,Ceramides,D09.400.410.420.525.200
16919460,2006-08-17T00:00:00,Ceramides,D10.390.470.675.200
16919460,2006-08-17T00:00:00,Ceramides,D10.570.877.360.612.200
16919460,2006-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16919460,2006-08-17T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
16929097,2006-08-19T00:00:00,Amino Acid Sequence,G02.111.570.060
16929097,2006-08-19T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16929097,2006-08-19T00:00:00,"Antigens, CD",D23.050.301.264.035
16929097,2006-08-19T00:00:00,"Antigens, CD",D23.101.100.110
16929097,2006-08-19T00:00:00,Cell Adhesion,G04.299.117
16929097,2006-08-19T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
16929097,2006-08-19T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
16929097,2006-08-19T00:00:00,Cell Adhesion Molecules,D23.050.301.350
16929097,2006-08-19T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
16929097,2006-08-19T00:00:00,Gonorrhea,C01.252.400.625.391
16929097,2006-08-19T00:00:00,Gonorrhea,C01.252.810.401
16929097,2006-08-19T00:00:00,Gonorrhea,C01.539.778.281.401
16929097,2006-08-19T00:00:00,Gonorrhea,C12.294.668.281.401
16929097,2006-08-19T00:00:00,Gonorrhea,C13.351.500.711.281.401
16929097,2006-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16929097,2006-08-19T00:00:00,Meningococcal Infections,C01.252.400.625.549
16929097,2006-08-19T00:00:00,Molecular Sequence Data,L01.453.245.667
16929097,2006-08-19T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
16929097,2006-08-19T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
16929097,2006-08-19T00:00:00,Neisseria meningitidis,B03.440.400.425.550.550.641
16929097,2006-08-19T00:00:00,Neisseria meningitidis,B03.660.075.525.520.500
16929097,2006-08-19T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
16929097,2006-08-19T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
16929097,2006-08-19T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
16923753,2006-08-21T00:00:00,Biological Markers,D23.101
16923753,2006-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16923753,2006-08-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
16923753,2006-08-21T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
16923753,2006-08-21T00:00:00,Middle Aged,M01.060.116.630
16923753,2006-08-21T00:00:00,Myocardial Infarction,C14.280.647.500
16923753,2006-08-21T00:00:00,Myocardial Infarction,C14.907.585.500
16923753,2006-08-21T00:00:00,Thrombolytic Therapy,E02.319.913
16923753,2006-08-21T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
16923753,2006-08-21T00:00:00,Ventricular Remodeling,C23.300.985
16923753,2006-08-21T00:00:00,Ventricular Remodeling,G09.330.190.962.975
16926151,2006-08-21T00:00:00,Apoptosis,G04.299.139.160
16926151,2006-08-21T00:00:00,Cell Line,A11.251.210
16926151,2006-08-21T00:00:00,Cell Survival,G04.299.316
16926151,2006-08-21T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16926151,2006-08-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16926151,2006-08-21T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16926151,2006-08-21T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16926151,2006-08-21T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16926151,2006-08-21T00:00:00,Serine,D12.125.154.800
16926151,2006-08-21T00:00:00,Serine,D12.125.837
16926151,2006-08-21T00:00:00,Transcription Factor RelA,D12.776.260.600.249
16926151,2006-08-21T00:00:00,Transcription Factor RelA,D12.776.660.600.249
16926151,2006-08-21T00:00:00,Transcription Factor RelA,D12.776.930.600.249
16926151,2006-08-21T00:00:00,Transcriptional Activation,G05.355.315.800
16924006,2006-08-22T00:00:00,Adult,M01.060.116
16924006,2006-08-22T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
16924006,2006-08-22T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
16924006,2006-08-22T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
16924006,2006-08-22T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
16924006,2006-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16924006,2006-08-22T00:00:00,Incidence,E05.318.308.985.525.375
16924006,2006-08-22T00:00:00,Incidence,L01.280.975.525.375
16924006,2006-08-22T00:00:00,Incidence,N01.224.935.597.500
16924006,2006-08-22T00:00:00,Incidence,N06.850.505.400.975.525.375
16924006,2006-08-22T00:00:00,Incidence,N06.850.520.308.985.525.375
16924006,2006-08-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
16924006,2006-08-22T00:00:00,Risk Assessment,N04.452.871.715
16924006,2006-08-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16924006,2006-08-22T00:00:00,Risk Assessment,N06.850.505.715
16924006,2006-08-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16924006,2006-08-22T00:00:00,Risk Factors,E05.318.740.600.800.725
16924006,2006-08-22T00:00:00,Risk Factors,N05.715.350.200.700
16924006,2006-08-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16924006,2006-08-22T00:00:00,Risk Factors,N06.850.490.625.750
16924006,2006-08-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16924006,2006-08-22T00:00:00,Stroke,C10.228.140.300.775
16924006,2006-08-22T00:00:00,Stroke,C14.907.253.855
16924006,2006-08-22T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
16924006,2006-08-22T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
16924006,2006-08-22T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
16924006,2006-08-22T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
16926120,2006-08-22T00:00:00,Adenoviridae,B04.280.030
16926120,2006-08-22T00:00:00,Adenoviridae,B04.909.204.097
16926120,2006-08-22T00:00:00,Apoptosis,G04.299.139.160
16926120,2006-08-22T00:00:00,Cell Membrane,A11.284.149
16926120,2006-08-22T00:00:00,Ceramides,D02.065.313
16926120,2006-08-22T00:00:00,Ceramides,D09.400.410.420.525.200
16926120,2006-08-22T00:00:00,Ceramides,D10.390.470.675.200
16926120,2006-08-22T00:00:00,Ceramides,D10.570.877.360.612.200
16926120,2006-08-22T00:00:00,Down-Regulation,G02.111.087.225
16926120,2006-08-22T00:00:00,Down-Regulation,G02.149.115.225
16926120,2006-08-22T00:00:00,Down-Regulation,G05.355.315.200
16926120,2006-08-22T00:00:00,Down-Regulation,G07.690.812.230
16926120,2006-08-22T00:00:00,Down-Regulation,G07.700.680.230
16926120,2006-08-22T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
16926120,2006-08-22T00:00:00,Gene Expression,G05.355.310
16926120,2006-08-22T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16926120,2006-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16926120,2006-08-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16926120,2006-08-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
16926120,2006-08-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
16926120,2006-08-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
16926120,2006-08-22T00:00:00,Protein Transport,G03.495.166.700
16926120,2006-08-22T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16926120,2006-08-22T00:00:00,Sphingolipids,D10.570.877
16926120,2006-08-22T00:00:00,Sphingolipids,D10.808
16926120,2006-08-22T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
16926156,2006-08-22T00:00:00,Animals,B01.050
16926156,2006-08-22T00:00:00,Green Fluorescent Proteins,D12.776.532.265
16926156,2006-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16926156,2006-08-22T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
16926156,2006-08-22T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
16926156,2006-08-22T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
16926156,2006-08-22T00:00:00,Signal Transduction,G02.111.087.800
16926156,2006-08-22T00:00:00,Signal Transduction,G02.149.115.800
16926156,2006-08-22T00:00:00,Signal Transduction,G04.299.880
16926156,2006-08-22T00:00:00,Sphingosine,D02.033.100.700
16926156,2006-08-22T00:00:00,Sphingosine,D02.033.455.843
16926156,2006-08-22T00:00:00,Sphingosine,D02.092.063.700
16926156,2006-08-22T00:00:00,Transcriptional Activation,G05.355.315.800
16928382,2006-08-22T00:00:00,Animals,B01.050
16928382,2006-08-22T00:00:00,Apoptosis,G04.299.139.160
16928382,2006-08-22T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
16928382,2006-08-22T00:00:00,Heart Ventricles,A07.541.560
16928382,2006-08-22T00:00:00,Myocardium,A02.633.580
16928382,2006-08-22T00:00:00,Myocardium,A07.541.704
16928382,2006-08-22T00:00:00,Myocardium,A10.690.552.750
16928382,2006-08-22T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16928382,2006-08-22T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16928382,2006-08-22T00:00:00,"Myocytes, Cardiac",A11.620.500
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
16928382,2006-08-22T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
16928382,2006-08-22T00:00:00,Ubiquitin,D12.776.947.500
16928382,2006-08-22T00:00:00,Ubiquitin-Protein Ligases,D08.811.464.938.750
16928382,2006-08-22T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
16928382,2006-08-22T00:00:00,Ventricular Pressure,G09.330.190.962.950
16928382,2006-08-22T00:00:00,Ventricular Pressure,G09.330.380.937
16928978,2006-08-23T00:00:00,Animals,B01.050
16928978,2006-08-23T00:00:00,Catheter Ablation,E01.370.370.380.410.200
16928978,2006-08-23T00:00:00,Catheter Ablation,E02.148.110
16928978,2006-08-23T00:00:00,Catheter Ablation,E02.148.442.110
16928978,2006-08-23T00:00:00,Catheter Ablation,E02.154.402.110
16928978,2006-08-23T00:00:00,Catheter Ablation,E04.014.170.402.110
16928978,2006-08-23T00:00:00,Electrodes,E07.305.250
16928978,2006-08-23T00:00:00,Liver,A03.620
16928978,2006-08-23T00:00:00,Swine,B01.050.150.900.649.077.880
16930623,2006-08-23T00:00:00,Animals,B01.050
16930623,2006-08-23T00:00:00,"Behavior, Animal",F01.145.113
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
16930623,2006-08-23T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
16930623,2006-08-23T00:00:00,Liver Neoplasms,C04.588.274.623
16930623,2006-08-23T00:00:00,Liver Neoplasms,C06.301.623
16930623,2006-08-23T00:00:00,Liver Neoplasms,C06.552.697
16930623,2006-08-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16936711,2006-08-23T00:00:00,Animals,B01.050
16936711,2006-08-23T00:00:00,"Animals, Newborn",B01.050.050.282
16936711,2006-08-23T00:00:00,Antipsychotic Agents,D27.505.696.277.950.040
16936711,2006-08-23T00:00:00,Antipsychotic Agents,D27.505.954.427.210.950.040
16936711,2006-08-23T00:00:00,Antipsychotic Agents,D27.505.954.427.700.872.331
16936711,2006-08-23T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
16936711,2006-08-23T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16936711,2006-08-23T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
16936711,2006-08-23T00:00:00,Doxorubicin,D04.615.562.050.200.175
16936711,2006-08-23T00:00:00,Doxorubicin,D09.408.051.059.200.175
16936711,2006-08-23T00:00:00,Drug Interactions,G07.690.812.240
16936711,2006-08-23T00:00:00,Drug Interactions,G07.700.680.240
16936711,2006-08-23T00:00:00,Epithelial Cells,A11.436
16936711,2006-08-23T00:00:00,Isoxazoles,D03.383.129.385
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.157.530.100.652.500
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.157.530.450.074.500.500.750
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.395.550.020.610.610
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.543.550.192.610.610
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.543.585.100.610.500
16936711,2006-08-23T00:00:00,P-Glycoprotein,D12.776.543.585.450.074.500.500.750
16936711,2006-08-23T00:00:00,Protein Transport,G03.495.166.700
16936711,2006-08-23T00:00:00,Pyrimidines,D03.383.742
16936711,2006-08-23T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16936711,2006-08-23T00:00:00,Risperidone,D03.383.742.698.685
16936711,2006-08-23T00:00:00,Swine,B01.050.150.900.649.077.880
17011834,2006-08-23T00:00:00,Adolescent,M01.060.057
17011834,2006-08-23T00:00:00,Adolescent Health Services,N02.421.044
17011834,2006-08-23T00:00:00,Adult,M01.060.116
17011834,2006-08-23T00:00:00,Arteries,A07.231.114
17011834,2006-08-23T00:00:00,Biological Markers,D23.101
17011834,2006-08-23T00:00:00,Cardiovascular Diseases,C14
17011834,2006-08-23T00:00:00,Child,M01.060.406
17011834,2006-08-23T00:00:00,Child Health Services,N02.421.143.130
17011834,2006-08-23T00:00:00,"Endothelium, Vascular",A07.231.330
17011834,2006-08-23T00:00:00,"Endothelium, Vascular",A10.272.491.355
17011834,2006-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17011834,2006-08-23T00:00:00,Nitric Oxide,D01.339.387
17011834,2006-08-23T00:00:00,Nitric Oxide,D01.625.550.500
17011834,2006-08-23T00:00:00,Nitric Oxide,D01.625.700.500
17011834,2006-08-23T00:00:00,Nitric Oxide,D01.650.550.587.600
16931779,2006-08-24T00:00:00,Bibliometrics,L01.178.682.099.325
16931779,2006-08-24T00:00:00,Bibliometrics,L01.453.183.291
16931779,2006-08-24T00:00:00,Clinical Trials as Topic,E05.318.760.535
16931779,2006-08-24T00:00:00,Clinical Trials as Topic,E05.337.250
16931779,2006-08-24T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
16931779,2006-08-24T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
16931779,2006-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16931779,2006-08-24T00:00:00,Internationality,I01.615
16931779,2006-08-24T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16931779,2006-08-24T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16931779,2006-08-24T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16931779,2006-08-24T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16931779,2006-08-24T00:00:00,Peer Review,F01.829.316.549
16931779,2006-08-24T00:00:00,Peer Review,I01.880.604.640
16931779,2006-08-24T00:00:00,Peer Review,N03.706.700
16931779,2006-08-24T00:00:00,Periodicals as Topic,L01.178.682.829.678
16931779,2006-08-24T00:00:00,Publishing,L01.737
16931779,2006-08-24T00:00:00,Questionnaires,E05.318.308.750
16931779,2006-08-24T00:00:00,Questionnaires,L01.280.800
16931779,2006-08-24T00:00:00,Questionnaires,N05.715.360.300.695
16931779,2006-08-24T00:00:00,Questionnaires,N06.850.520.308.750
16931779,2006-08-24T00:00:00,Research Design,E05.581.500
16931779,2006-08-24T00:00:00,Research Design,H01.770.644.728
16931779,2006-08-24T00:00:00,Stroke,C10.228.140.300.775
16931779,2006-08-24T00:00:00,Stroke,C14.907.253.855
16931779,2006-08-24T00:00:00,United States,Z01.107.567.875
16940176,2006-08-28T00:00:00,DNA Replication,G02.111.087.222
16940176,2006-08-28T00:00:00,DNA Replication,G02.149.115.222
16940176,2006-08-28T00:00:00,DNA Replication,G05.355.200
16940176,2006-08-28T00:00:00,"DNA, Fungal",D13.444.308.300
16940176,2006-08-28T00:00:00,DNA-Binding Proteins,D12.776.260
16940176,2006-08-28T00:00:00,"Models, Molecular",E05.599.595
16940176,2006-08-28T00:00:00,Molecular Sequence Data,L01.453.245.667
16940176,2006-08-28T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
16940176,2006-08-28T00:00:00,Nucleic Acid Conformation,G05.360.580
16940176,2006-08-28T00:00:00,Protein Conformation,G02.111.570.790.709
16940176,2006-08-28T00:00:00,RNA,D13.444.735
16940176,2006-08-28T00:00:00,Schizosaccharomyces,B01.300.107.797
16940176,2006-08-28T00:00:00,Schizosaccharomyces,B01.300.930.720
16940176,2006-08-28T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
16940176,2006-08-28T00:00:00,Telomerase,D12.776.157.725.500.921
16940176,2006-08-28T00:00:00,Telomerase,D12.776.664.962.500.921
16940246,2006-08-28T00:00:00,Adolescent,M01.060.057
16940246,2006-08-28T00:00:00,African Continental Ancestry Group,M01.686.508.100
16940246,2006-08-28T00:00:00,Blood Pressure,E01.370.600.875.249
16940246,2006-08-28T00:00:00,Blood Pressure,G09.330.380.076
16940246,2006-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16940246,2006-08-28T00:00:00,"Polymorphism, Genetic",G05.365.795
16940246,2006-08-28T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16940246,2006-08-28T00:00:00,Sodium,D01.268.549.750
16940246,2006-08-28T00:00:00,Sodium,D01.552.528.850
16940246,2006-08-28T00:00:00,"Stress, Psychological",F01.145.126.990
16940246,2006-08-28T00:00:00,"Stress, Psychological",F02.830.900
17045450,2006-08-28T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
17045450,2006-08-28T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
17045450,2006-08-28T00:00:00,United States,Z01.107.567.875
16922500,2006-08-29T00:00:00,Bacterial Proteins,D12.776.097
16922500,2006-08-29T00:00:00,DNA,D13.444.308
16922500,2006-08-29T00:00:00,Metals,D01.552
16922500,2006-08-29T00:00:00,"Models, Chemical",E05.599.495
16922500,2006-08-29T00:00:00,Point Mutation,G05.365.590.675
16940199,2006-08-29T00:00:00,Brain,A08.186.211
16940199,2006-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16940199,2006-08-29T00:00:00,Middle Aged,M01.060.116.630
16940199,2006-08-29T00:00:00,Myocardial Ischemia,C14.280.647
16940199,2006-08-29T00:00:00,Myocardial Ischemia,C14.907.585
16940199,2006-08-29T00:00:00,Stroke,C10.228.140.300.775
16940199,2006-08-29T00:00:00,Stroke,C14.907.253.855
16940199,2006-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16940199,2006-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16940199,2006-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16940199,2006-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16940199,2006-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16940415,2006-08-29T00:00:00,Animals,B01.050
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.644.276.374.750.249
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.644.276.972.249
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.776.395.550.312
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.776.467.374.750.249
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.776.467.972.249
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D12.776.543.550.312
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D23.050.301.264.035.283
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D23.101.100.110.282
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D23.529.374.750.249
16940415,2006-08-29T00:00:00,Fas Ligand Protein,D23.529.972.249
16940415,2006-08-29T00:00:00,Gene Expression Regulation,G05.355.315
16940415,2006-08-29T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16940415,2006-08-29T00:00:00,Molecular Sequence Data,L01.453.245.667
16940415,2006-08-29T00:00:00,NF-kappa B,D12.776.260.600
16940415,2006-08-29T00:00:00,NF-kappa B,D12.776.660.600
16940415,2006-08-29T00:00:00,NF-kappa B,D12.776.930.600
16940415,2006-08-29T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16940415,2006-08-29T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16940415,2006-08-29T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16940415,2006-08-29T00:00:00,Tetrachlorodibenzodioxin,D03.383.231.900
16940435,2006-08-29T00:00:00,Animals,B01.050
16940435,2006-08-29T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
16940435,2006-08-29T00:00:00,Gene Expression Regulation,G05.355.315
16940435,2006-08-29T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
16940435,2006-08-29T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
16940435,2006-08-29T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16940435,2006-08-29T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16940435,2006-08-29T00:00:00,"Myocytes, Cardiac",A11.620.500
16940435,2006-08-29T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16940435,2006-08-29T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
16940435,2006-08-29T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
16940435,2006-08-29T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
16940435,2006-08-29T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
16940435,2006-08-29T00:00:00,RNA Stability,G02.111.780
16940435,2006-08-29T00:00:00,"RNA, Messenger",D13.444.735.544
16944158,2006-08-31T00:00:00,Adult,M01.060.116
16944158,2006-08-31T00:00:00,Case-Control Studies,E05.318.760.500.500
16944158,2006-08-31T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16944158,2006-08-31T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16944158,2006-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
16944158,2006-08-31T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
16944158,2006-08-31T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
16944158,2006-08-31T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
16944158,2006-08-31T00:00:00,Middle Aged,M01.060.116.630
17029687,2006-08-31T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
17029687,2006-08-31T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
17029687,2006-08-31T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
17029687,2006-08-31T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
17029687,2006-08-31T00:00:00,Alzheimer Disease,C10.228.140.380.100
17029687,2006-08-31T00:00:00,Alzheimer Disease,C10.574.945.249
17029687,2006-08-31T00:00:00,Alzheimer Disease,F03.087.400.100
17029687,2006-08-31T00:00:00,Amino Acid Sequence,G02.111.570.060
17029687,2006-08-31T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17029687,2006-08-31T00:00:00,Animals,B01.050
17029687,2006-08-31T00:00:00,Cholesterol,D04.808.247.222.284
17029687,2006-08-31T00:00:00,Cholesterol,D04.808.247.808.197
17029687,2006-08-31T00:00:00,Cholesterol,D10.570.938.208
17029687,2006-08-31T00:00:00,Cholesterol,D10.851.208
17029687,2006-08-31T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
17029687,2006-08-31T00:00:00,Homeostasis,G07.700.360
17029687,2006-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17029687,2006-08-31T00:00:00,Molecular Sequence Data,L01.453.245.667
16570274,2006-09-01T00:00:00,Adult,M01.060.116
16570274,2006-09-01T00:00:00,Carcinoma,C04.557.470.200
16570274,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16570274,2006-09-01T00:00:00,Incidence,E05.318.308.985.525.375
16570274,2006-09-01T00:00:00,Incidence,L01.280.975.525.375
16570274,2006-09-01T00:00:00,Incidence,N01.224.935.597.500
16570274,2006-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16570274,2006-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16570274,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C04.588.443.665.710.650
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C07.550.350.650
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C07.550.745.650
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C09.647.710.650
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C09.775.350.650
16570274,2006-09-01T00:00:00,Nasopharyngeal Neoplasms,C09.775.549.650
16570274,2006-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16570274,2006-09-01T00:00:00,Risk Assessment,N04.452.871.715
16570274,2006-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16570274,2006-09-01T00:00:00,Risk Assessment,N06.850.505.715
16570274,2006-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16570274,2006-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16570274,2006-09-01T00:00:00,Risk Factors,N05.715.350.200.700
16570274,2006-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16570274,2006-09-01T00:00:00,Risk Factors,N06.850.490.625.750
16570274,2006-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16720313,2006-09-01T00:00:00,Cell Culture Techniques,E05.200.249.249
16720313,2006-09-01T00:00:00,Cytokines,D12.644.276.374
16720313,2006-09-01T00:00:00,Cytokines,D12.776.467.374
16720313,2006-09-01T00:00:00,Cytokines,D23.529.374
16720313,2006-09-01T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
16720313,2006-09-01T00:00:00,GTP-Binding Proteins,D12.776.157.325
16720313,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16720313,2006-09-01T00:00:00,Inflammation,C23.550.470
16720313,2006-09-01T00:00:00,Lipopolysaccharides,D09.400.500
16720313,2006-09-01T00:00:00,Lipopolysaccharides,D09.698.718.450
16720313,2006-09-01T00:00:00,Lipopolysaccharides,D10.494
16720313,2006-09-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
16720313,2006-09-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
16720313,2006-09-01T00:00:00,Monocytes,A11.118.637.555.652
16720313,2006-09-01T00:00:00,Monocytes,A11.148.580
16720313,2006-09-01T00:00:00,Monocytes,A11.627.624
16720313,2006-09-01T00:00:00,Monocytes,A11.733.547
16720313,2006-09-01T00:00:00,Monocytes,A15.145.229.637.555.652
16720313,2006-09-01T00:00:00,Monocytes,A15.378.316.580
16720313,2006-09-01T00:00:00,Monocytes,A15.382.490.555.652
16720313,2006-09-01T00:00:00,Monocytes,A15.382.680.547
16720313,2006-09-01T00:00:00,Monocytes,A15.382.812.547
16720313,2006-09-01T00:00:00,"Shock, Septic",C01.539.757.800
16720313,2006-09-01T00:00:00,"Shock, Septic",C23.550.470.790.500.800
16720313,2006-09-01T00:00:00,"Shock, Septic",C23.550.835.900.712
16720313,2006-09-01T00:00:00,Signal Transduction,G02.111.087.800
16720313,2006-09-01T00:00:00,Signal Transduction,G02.149.115.800
16720313,2006-09-01T00:00:00,Signal Transduction,G04.299.880
16720313,2006-09-01T00:00:00,Staphylococcal Infections,C01.252.410.868
16720313,2006-09-01T00:00:00,Staphylococcus aureus,B03.300.390.400.800.750.100
16720313,2006-09-01T00:00:00,Staphylococcus aureus,B03.510.100.750.750.100
16720313,2006-09-01T00:00:00,Staphylococcus aureus,B03.510.400.790.750.100
16732602,2006-09-01T00:00:00,Adult,M01.060.116
16732602,2006-09-01T00:00:00,Aged,M01.060.116.100
16732602,2006-09-01T00:00:00,Head,A01.456
16732602,2006-09-01T00:00:00,Head and Neck Neoplasms,C04.588.443
16732602,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16732602,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16732602,2006-09-01T00:00:00,Reconstructive Surgical Procedures,E04.680
16732602,2006-09-01T00:00:00,Rectus Abdominis,A02.633.567.050.800
16732602,2006-09-01T00:00:00,Surgical Flaps,A10.850.710
16732602,2006-09-01T00:00:00,Surgical Flaps,E07.862.710
16804919,2006-09-01T00:00:00,Adolescent,M01.060.057
16804919,2006-09-01T00:00:00,Animals,B01.050
16804919,2006-09-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
16804919,2006-09-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
16804919,2006-09-01T00:00:00,Child,M01.060.406
16804919,2006-09-01T00:00:00,Homeodomain Proteins,D12.776.260.400
16804919,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16804919,2006-09-01T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
16841260,2006-09-01T00:00:00,Adolescent,M01.060.057
16841260,2006-09-01T00:00:00,Adult,M01.060.116
16841260,2006-09-01T00:00:00,Aged,M01.060.116.100
16841260,2006-09-01T00:00:00,Child,M01.060.406
16841260,2006-09-01T00:00:00,"Child, Preschool",M01.060.406.448
16841260,2006-09-01T00:00:00,Ethnic Groups,M01.686.754
16841260,2006-09-01T00:00:00,Ethnic Groups,N01.224.317
16841260,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16841260,2006-09-01T00:00:00,Incidence,E05.318.308.985.525.375
16841260,2006-09-01T00:00:00,Incidence,L01.280.975.525.375
16841260,2006-09-01T00:00:00,Incidence,N01.224.935.597.500
16841260,2006-09-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16841260,2006-09-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16841260,2006-09-01T00:00:00,Infant,M01.060.703
16841260,2006-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
16841260,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16841260,2006-09-01T00:00:00,Multiple Myeloma,C04.557.595.500
16841260,2006-09-01T00:00:00,Multiple Myeloma,C14.907.454.460
16841260,2006-09-01T00:00:00,Multiple Myeloma,C15.378.147.780.650
16841260,2006-09-01T00:00:00,Multiple Myeloma,C15.378.463.835.460
16841260,2006-09-01T00:00:00,Multiple Myeloma,C20.683.515.845
16841260,2006-09-01T00:00:00,Multiple Myeloma,C20.683.780.650
16841260,2006-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16841260,2006-09-01T00:00:00,Risk Factors,N05.715.350.200.700
16841260,2006-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16841260,2006-09-01T00:00:00,Risk Factors,N06.850.490.625.750
16841260,2006-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16847538,2006-09-01T00:00:00,Adolescent,M01.060.057
16847538,2006-09-01T00:00:00,Adult,M01.060.116
16847538,2006-09-01T00:00:00,Alcoholism,C21.739.100.250
16847538,2006-09-01T00:00:00,Alcoholism,F03.900.100.350
16847538,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16847538,2006-09-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
16847538,2006-09-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
16847538,2006-09-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
16847538,2006-09-01T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
16847538,2006-09-01T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
16847538,2006-09-01T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
16847538,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16847538,2006-09-01T00:00:00,Naltrexone,D03.132.577.249.706.550
16847538,2006-09-01T00:00:00,Naltrexone,D03.549.686.750.550
16847538,2006-09-01T00:00:00,Naltrexone,D03.605.497.750.550
16847538,2006-09-01T00:00:00,Naltrexone,D04.615.723.795.706.550
16847538,2006-09-01T00:00:00,Narcotic Antagonists,D27.505.696.543
16847538,2006-09-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
16847538,2006-09-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
16847538,2006-09-01T00:00:00,Pituitary-Adrenal System,A06.407.691
16847538,2006-09-01T00:00:00,Psychomotor Performance,F02.808
16847538,2006-09-01T00:00:00,Psychomotor Performance,G11.427.700
16847538,2006-09-01T00:00:00,Psychomotor Performance,G11.561.623
16847538,2006-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16881058,2006-09-01T00:00:00,Animals,B01.050
16881058,2006-09-01T00:00:00,Anoxia,C23.888.852.079
16881058,2006-09-01T00:00:00,Apoptosis,G04.299.139.160
16881058,2006-09-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16881058,2006-09-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16881058,2006-09-01T00:00:00,Caspases,D12.644.360.075.405
16881058,2006-09-01T00:00:00,Caspases,D12.776.476.075.405
16881058,2006-09-01T00:00:00,Chick Embryo,A13.350.150
16881058,2006-09-01T00:00:00,Chick Embryo,A16.331.200
16881058,2006-09-01T00:00:00,Fetal Heart,A07.541.278
16881058,2006-09-01T00:00:00,Fetal Heart,A16.378.303
16881058,2006-09-01T00:00:00,Heart,A07.541
16881058,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16881058,2006-09-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16881058,2006-09-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16881058,2006-09-01T00:00:00,Pregnancy,G08.686.785.760.769
16885672,2006-09-01T00:00:00,Catheterization,E02.148
16885672,2006-09-01T00:00:00,Catheterization,E05.157
16885672,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16885672,2006-09-01T00:00:00,"Labor, Induced",E04.520.252.968
16885672,2006-09-01T00:00:00,Pregnancy,G08.686.785.760.769
16885672,2006-09-01T00:00:00,Vaginal Birth after Cesarean,E04.520.252.992
16892191,2006-09-01T00:00:00,Animals,B01.050
16892191,2006-09-01T00:00:00,Contrast Media,D27.720.259
16892191,2006-09-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
16892191,2006-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
16892191,2006-09-01T00:00:00,Ischemia,C23.550.513
16892191,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16892191,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16892191,2006-09-01T00:00:00,"Models, Chemical",E05.599.495
16892191,2006-09-01T00:00:00,Myocardium,A02.633.580
16892191,2006-09-01T00:00:00,Myocardium,A07.541.704
16892191,2006-09-01T00:00:00,Myocardium,A10.690.552.750
16892191,2006-09-01T00:00:00,Organometallic Compounds,D01.632
16892191,2006-09-01T00:00:00,Organometallic Compounds,D02.691
16892191,2006-09-01T00:00:00,Perfusion,E05.680
16892191,2006-09-01T00:00:00,Reperfusion Injury,C14.907.725
16892191,2006-09-01T00:00:00,Reperfusion Injury,C23.550.767.877
16892431,2006-09-01T00:00:00,Age Factors,N05.715.350.075
16892431,2006-09-01T00:00:00,Age Factors,N06.850.490.250
16892431,2006-09-01T00:00:00,Aged,M01.060.116.100
16892431,2006-09-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
16892431,2006-09-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
16892431,2006-09-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
16892431,2006-09-01T00:00:00,Coronary Angiography,E01.370.370.050.200
16892431,2006-09-01T00:00:00,Coronary Angiography,E01.370.370.380.200
16892431,2006-09-01T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
16892431,2006-09-01T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
16892431,2006-09-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
16892431,2006-09-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
16892431,2006-09-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
16892431,2006-09-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
16892431,2006-09-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
16892431,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16892431,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16892431,2006-09-01T00:00:00,Prevalence,E05.318.308.985.525.750
16892431,2006-09-01T00:00:00,Prevalence,L01.280.975.525.750
16892431,2006-09-01T00:00:00,Prevalence,N01.224.935.597.750
16892431,2006-09-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16892431,2006-09-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16892431,2006-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16892431,2006-09-01T00:00:00,Risk Factors,N05.715.350.200.700
16892431,2006-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16892431,2006-09-01T00:00:00,Risk Factors,N06.850.490.625.750
16892431,2006-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16892431,2006-09-01T00:00:00,Stents,E07.695.750
16892431,2006-09-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
16892431,2006-09-01T00:00:00,Stroke Volume,G09.330.380.124.882
16892431,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16892431,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16892431,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16897373,2006-09-01T00:00:00,Health Behavior,F01.145.488
16897373,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16897373,2006-09-01T00:00:00,Pregnancy,G08.686.785.760.769
16897373,2006-09-01T00:00:00,Risk-Taking,F01.145.722
16897373,2006-09-01T00:00:00,Smoking,F01.145.466.753
16897373,2006-09-01T00:00:00,Tobacco Use Disorder,C21.739.912
16897373,2006-09-01T00:00:00,Tobacco Use Disorder,F03.900.912
16914627,2006-09-01T00:00:00,Certification,N03.706.110.120
16914627,2006-09-01T00:00:00,Certification,N05.700.200.190
16914627,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16914627,2006-09-01T00:00:00,Patient Care,E02.760
16914627,2006-09-01T00:00:00,Patient Care,N02.421.585
16914627,2006-09-01T00:00:00,Pharmaceutical Services,N02.421.668
16914627,2006-09-01T00:00:00,Pharmacists,M01.526.485.780
16914627,2006-09-01T00:00:00,Pharmacists,N02.360.780
16920563,2006-09-01T00:00:00,Adolescent,M01.060.057
16920563,2006-09-01T00:00:00,Adult,M01.060.116
16920563,2006-09-01T00:00:00,Aged,M01.060.116.100
16920563,2006-09-01T00:00:00,Bone Marrow Transplantation,E04.936.580.040
16920563,2006-09-01T00:00:00,Disease-Free Survival,E01.789.200
16920563,2006-09-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
16920563,2006-09-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
16920563,2006-09-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
16920563,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16920563,2006-09-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C04.557.386.480.150.585
16920563,2006-09-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C15.604.515.569.480.150.585
16920563,2006-09-01T00:00:00,"Lymphoma, Large B-Cell, Diffuse",C20.683.515.761.480.150.585
16920563,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16920956,2006-09-01T00:00:00,Animals,B01.050
16920956,2006-09-01T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
16920956,2006-09-01T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
16920956,2006-09-01T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
16920956,2006-09-01T00:00:00,Cell Line,A11.251.210
16920956,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16920956,2006-09-01T00:00:00,Interleukin-2,D12.644.276.374.465.502
16920956,2006-09-01T00:00:00,Interleukin-2,D12.644.276.374.480.372
16920956,2006-09-01T00:00:00,Interleukin-2,D12.776.467.374.465.502
16920956,2006-09-01T00:00:00,Interleukin-2,D12.776.467.374.480.372
16920956,2006-09-01T00:00:00,Interleukin-2,D23.529.374.465.502
16920956,2006-09-01T00:00:00,Interleukin-2,D23.529.374.480.372
16920956,2006-09-01T00:00:00,Membrane Proteins,D12.776.543
16920956,2006-09-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16920956,2006-09-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16920956,2006-09-01T00:00:00,Superantigens,D23.050.820
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
16920956,2006-09-01T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
16922701,2006-09-01T00:00:00,Adult,M01.060.116
16922701,2006-09-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
16922701,2006-09-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
16922701,2006-09-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
16922701,2006-09-01T00:00:00,Diabetic Angiopathies,C14.907.320
16922701,2006-09-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
16922701,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16922701,2006-09-01T00:00:00,Lipoproteins,D10.532
16922701,2006-09-01T00:00:00,Lipoproteins,D12.776.521
16922701,2006-09-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
16922701,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16923410,2006-09-01T00:00:00,Aged,M01.060.116.100
16923410,2006-09-01T00:00:00,Atrial Fibrillation,C14.280.067.198
16923410,2006-09-01T00:00:00,Atrial Fibrillation,C23.550.073.198
16923410,2006-09-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
16923410,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16923410,2006-09-01T00:00:00,Hypertension,C14.907.489
16923410,2006-09-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16923410,2006-09-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16923410,2006-09-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16923410,2006-09-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16923410,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16923410,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16923410,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16923410,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16923410,2006-09-01T00:00:00,Stroke,C10.228.140.300.775
16923410,2006-09-01T00:00:00,Stroke,C14.907.253.855
16923489,2006-09-01T00:00:00,Diagnostic Imaging,E01.370.350
16923489,2006-09-01T00:00:00,Drug Design,E05.295.500
16923489,2006-09-01T00:00:00,Drug Design,H01.158.703.007.675.500
16923489,2006-09-01T00:00:00,Drug Design,H01.181.466.675.500
16923489,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16923489,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16923489,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16923489,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16923489,2006-09-01T00:00:00,Gastrointestinal Diseases,C06.405
16923489,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16930207,2006-09-01T00:00:00,Alcoholism,C21.739.100.250
16930207,2006-09-01T00:00:00,Alcoholism,F03.900.100.350
16930207,2006-09-01T00:00:00,Animals,B01.050
16930207,2006-09-01T00:00:00,Cues,F02.463.425.234
16930207,2006-09-01T00:00:00,Dopamine,D02.092.211.215.311.342
16930207,2006-09-01T00:00:00,Dopamine,D02.092.311.342
16930207,2006-09-01T00:00:00,Glutamic Acid,D12.125.067.750
16930207,2006-09-01T00:00:00,Glutamic Acid,D12.125.119.450
16930207,2006-09-01T00:00:00,Glutamic Acid,D12.125.427.300
16930207,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16930207,2006-09-01T00:00:00,Neurons,A08.663
16930207,2006-09-01T00:00:00,Neurons,A11.671
16930207,2006-09-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
16930207,2006-09-01T00:00:00,Synaptic Transmission,G02.111.087.800.850
16930207,2006-09-01T00:00:00,Synaptic Transmission,G02.149.115.800.850
16930207,2006-09-01T00:00:00,Synaptic Transmission,G04.299.880.850
16930207,2006-09-01T00:00:00,Synaptic Transmission,G07.265.337.900
16930207,2006-09-01T00:00:00,Synaptic Transmission,G07.700.240.900
16930207,2006-09-01T00:00:00,Synaptic Transmission,G11.561.600.835
16930207,2006-09-01T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
16930207,2006-09-01T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
16931989,2006-09-01T00:00:00,Adult,M01.060.116
16931989,2006-09-01T00:00:00,"Analgesia, Patient-Controlled",E03.091.120
16931989,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16931989,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16931989,2006-09-01T00:00:00,Morphine,D03.132.577.249.547
16931989,2006-09-01T00:00:00,Morphine,D03.549.686.575
16931989,2006-09-01T00:00:00,Morphine,D03.605.497.575
16931989,2006-09-01T00:00:00,Morphine,D04.615.723.795.547
16931989,2006-09-01T00:00:00,"Pain, Postoperative",C23.550.767.700
16931989,2006-09-01T00:00:00,"Pain, Postoperative",C23.888.646.530
16931989,2006-09-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
16931989,2006-09-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
16931989,2006-09-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
16936207,2006-09-01T00:00:00,Animals,B01.050
16936207,2006-09-01T00:00:00,Ceramides,D02.065.313
16936207,2006-09-01T00:00:00,Ceramides,D09.400.410.420.525.200
16936207,2006-09-01T00:00:00,Ceramides,D10.390.470.675.200
16936207,2006-09-01T00:00:00,Ceramides,D10.570.877.360.612.200
16936207,2006-09-01T00:00:00,Chemokines,D12.644.276.374.200
16936207,2006-09-01T00:00:00,Chemokines,D12.776.467.374.200
16936207,2006-09-01T00:00:00,Chemokines,D23.125.300
16936207,2006-09-01T00:00:00,Chemokines,D23.469.200
16936207,2006-09-01T00:00:00,Chemokines,D23.529.374.200
16936207,2006-09-01T00:00:00,"Chemokines, CXC",D12.644.276.374.200.120
16936207,2006-09-01T00:00:00,"Chemokines, CXC",D12.776.467.374.200.120
16936207,2006-09-01T00:00:00,"Chemokines, CXC",D23.125.300.120
16936207,2006-09-01T00:00:00,"Chemokines, CXC",D23.469.200.120
16936207,2006-09-01T00:00:00,"Chemokines, CXC",D23.529.374.200.120
16936207,2006-09-01T00:00:00,Galactosylgalactosylglucosylceramidase,D08.811.277.450.410.150
16936207,2006-09-01T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
16936207,2006-09-01T00:00:00,Obesity,C18.654.726.500
16936207,2006-09-01T00:00:00,Obesity,C23.888.144.699.500
16936207,2006-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16936207,2006-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16936207,2006-09-01T00:00:00,Sphingolipids,D10.570.877
16936207,2006-09-01T00:00:00,Sphingolipids,D10.808
16936207,2006-09-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
16936274,2006-09-01T00:00:00,Animals,B01.050
16936274,2006-09-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
16936274,2006-09-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
16936274,2006-09-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
16936274,2006-09-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
16936274,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16936274,2006-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
16936274,2006-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
16936274,2006-09-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
16936274,2006-09-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
16936274,2006-09-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
16936274,2006-09-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
16936274,2006-09-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
16936274,2006-09-01T00:00:00,Immunologic Factors,D27.505.696.477
16936274,2006-09-01T00:00:00,Lovastatin,D02.455.426.559.847.638.400
16936274,2006-09-01T00:00:00,Lovastatin,D04.615.638.400
16936274,2006-09-01T00:00:00,Multiple Sclerosis,C10.114.375.500
16936274,2006-09-01T00:00:00,Multiple Sclerosis,C10.314.350.500
16936274,2006-09-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
16936274,2006-09-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
16936274,2006-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16936276,2006-09-01T00:00:00,Animals,B01.050
16936276,2006-09-01T00:00:00,Complement Activation,G12.425.255
16936276,2006-09-01T00:00:00,Complement C3,D12.776.124.050.140
16936276,2006-09-01T00:00:00,Complement C3,D12.776.124.486.274.250
16936276,2006-09-01T00:00:00,Demyelinating Diseases,C10.314
16936276,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16936276,2006-09-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16936276,2006-09-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
16936276,2006-09-01T00:00:00,Spinal Cord Injuries,C10.900.850
16936276,2006-09-01T00:00:00,Spinal Cord Injuries,C21.866.819
16936558,2006-09-01T00:00:00,Adult,M01.060.116
16936558,2006-09-01T00:00:00,Aged,M01.060.116.100
16936558,2006-09-01T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
16936558,2006-09-01T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
16936558,2006-09-01T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
16936558,2006-09-01T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
16936558,2006-09-01T00:00:00,Demography,I01.240
16936558,2006-09-01T00:00:00,Demography,N01.224
16936558,2006-09-01T00:00:00,Demography,N06.850.505.400
16936558,2006-09-01T00:00:00,HIV Infections,C02.782.815.616.400
16936558,2006-09-01T00:00:00,HIV Infections,C02.800.801.400
16936558,2006-09-01T00:00:00,HIV Infections,C20.673.480
16936558,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16936558,2006-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
16936558,2006-09-01T00:00:00,Lung Neoplasms,C08.381.540
16936558,2006-09-01T00:00:00,Lung Neoplasms,C08.785.520
16936558,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16936558,2006-09-01T00:00:00,Urban Population,N01.600.900
16939430,2006-09-01T00:00:00,Ambulatory Care,E02.760.106
16939430,2006-09-01T00:00:00,Ambulatory Care,N02.421.585.106
16939430,2006-09-01T00:00:00,Catheterization,E02.148
16939430,2006-09-01T00:00:00,Catheterization,E05.157
16939430,2006-09-01T00:00:00,Esophagus,A03.556.875.500
16939430,2006-09-01T00:00:00,Gastric Acid,A12.200.307.603
16939430,2006-09-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16939430,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16940153,2006-09-01T00:00:00,Alkaline Ceramidase,D08.811.277.087.250.300
16940153,2006-09-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16940153,2006-09-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16940153,2006-09-01T00:00:00,Cell Division,G04.299.134.220
16940153,2006-09-01T00:00:00,Cell Division,G04.299.233.750.500
16940153,2006-09-01T00:00:00,Cell Division,G05.355.105
16940153,2006-09-01T00:00:00,Cell Division,G07.700.320.249.410.750.500
16940153,2006-09-01T00:00:00,Golgi Apparatus,A11.284.430.214.190.875.336
16940153,2006-09-01T00:00:00,Hela Cells,A11.251.210.190.400
16940153,2006-09-01T00:00:00,Hela Cells,A11.251.860.180.400
16940153,2006-09-01T00:00:00,Hela Cells,A11.436.340
16940153,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16940153,2006-09-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
16940153,2006-09-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16940153,2006-09-01T00:00:00,Peptide Fragments,D12.644.541
16940153,2006-09-01T00:00:00,Plasmids,G05.360.600
16940153,2006-09-01T00:00:00,RNA Interference,G05.355.315.203.374.790
16940153,2006-09-01T00:00:00,"RNA, Messenger",D13.444.735.544
16940153,2006-09-01T00:00:00,Sphingosine,D02.033.100.700
16940153,2006-09-01T00:00:00,Sphingosine,D02.033.455.843
16940153,2006-09-01T00:00:00,Sphingosine,D02.092.063.700
16941443,2006-09-01T00:00:00,Animals,B01.050
16941443,2006-09-01T00:00:00,Biocompatible Materials,D25.130
16941443,2006-09-01T00:00:00,Biocompatible Materials,D27.720.102.130
16941443,2006-09-01T00:00:00,Biocompatible Materials,J01.637.051.130
16941443,2006-09-01T00:00:00,Biotechnology,H01.158.550
16941443,2006-09-01T00:00:00,Biotechnology,J01.897.120
16941443,2006-09-01T00:00:00,Cell Culture Techniques,E05.200.249.249
16941443,2006-09-01T00:00:00,Cell Survival,G04.299.316
16941443,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16941443,2006-09-01T00:00:00,Hydrogels,D20.280.320.375
16941443,2006-09-01T00:00:00,Hydrogels,D26.255.165.320.375
16941443,2006-09-01T00:00:00,Materials Testing,E05.570
16941443,2006-09-01T00:00:00,Printing,L01.737.787
16941443,2006-09-01T00:00:00,Tissue Engineering,E05.200.249.750
16941447,2006-09-01T00:00:00,Animals,B01.050
16941447,2006-09-01T00:00:00,Biotechnology,H01.158.550
16941447,2006-09-01T00:00:00,Biotechnology,J01.897.120
16941447,2006-09-01T00:00:00,Cell Adhesion,G04.299.117
16941447,2006-09-01T00:00:00,Cell Survival,G04.299.316
16941447,2006-09-01T00:00:00,Chickens,B01.050.150.900.248.350.150
16941447,2006-09-01T00:00:00,Chickens,B01.050.150.900.248.617.192
16941447,2006-09-01T00:00:00,Extracellular Matrix,A11.284.295.310
16941447,2006-09-01T00:00:00,Neurons,A08.663
16941447,2006-09-01T00:00:00,Neurons,A11.671
16941447,2006-09-01T00:00:00,Polymers,D05.750
16941447,2006-09-01T00:00:00,Polymers,D25.720
16941447,2006-09-01T00:00:00,Polymers,J01.637.051.720
16941447,2006-09-01T00:00:00,Software,L01.224.900
16945060,2006-09-01T00:00:00,Critical Pathways,N04.590.233.624.625
16945060,2006-09-01T00:00:00,Critical Pathways,N04.590.275
16945060,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16945060,2006-09-01T00:00:00,Patient Care Team,N04.590.715
16945060,2006-09-01T00:00:00,Pharmaceutical Services,N02.421.668
16945060,2006-09-01T00:00:00,Pharmacists,M01.526.485.780
16945060,2006-09-01T00:00:00,Pharmacists,N02.360.780
16945060,2006-09-01T00:00:00,Quality of Health Care,N04.761
16945060,2006-09-01T00:00:00,Quality of Health Care,N05.715
16946390,2006-09-01T00:00:00,Adult,M01.060.116
16946390,2006-09-01T00:00:00,Aged,M01.060.116.100
16946390,2006-09-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
16946390,2006-09-01T00:00:00,Diabetes Mellitus,C18.452.394.750
16946390,2006-09-01T00:00:00,Diabetes Mellitus,C19.246
16946390,2006-09-01T00:00:00,England,Z01.542.363.300
16946390,2006-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
16946390,2006-09-01T00:00:00,Health Services Accessibility,N05.300.430
16946390,2006-09-01T00:00:00,Health Surveys,E05.318.308.250
16946390,2006-09-01T00:00:00,Health Surveys,N05.715.360.300.375
16946390,2006-09-01T00:00:00,Health Surveys,N06.850.520.308.250
16946390,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16946390,2006-09-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
16946390,2006-09-01T00:00:00,Insulin,D06.472.699.587.740.625
16946390,2006-09-01T00:00:00,Insulin,D12.644.548.586.740.625
16946390,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16946390,2006-09-01T00:00:00,Prevalence,E05.318.308.985.525.750
16946390,2006-09-01T00:00:00,Prevalence,L01.280.975.525.750
16946390,2006-09-01T00:00:00,Prevalence,N01.224.935.597.750
16946390,2006-09-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16946390,2006-09-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16946390,2006-09-01T00:00:00,United States,Z01.107.567.875
16947022,2006-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
16947022,2006-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
16947022,2006-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
16947022,2006-09-01T00:00:00,Apoptosis,G04.299.139.160
16947022,2006-09-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
16947022,2006-09-01T00:00:00,Brain Neoplasms,C10.228.140.211
16947022,2006-09-01T00:00:00,Brain Neoplasms,C10.551.240.250
16947022,2006-09-01T00:00:00,Cell Proliferation,G04.299.233.750
16947022,2006-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16947022,2006-09-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
16947022,2006-09-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
16947022,2006-09-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
16947022,2006-09-01T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
16947022,2006-09-01T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
16947022,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.644.276.718.550
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D12.776.467.718.550
16947022,2006-09-01T00:00:00,Interferon-gamma,D23.529.374.440.893
16947022,2006-09-01T00:00:00,Interferon-gamma,D23.529.374.480.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
16947022,2006-09-01T00:00:00,Interferon-gamma,D23.529.718.550
16948136,2006-09-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
16948136,2006-09-01T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
16948136,2006-09-01T00:00:00,"Arthritis, Rheumatoid",C05.799.114
16948136,2006-09-01T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
16948136,2006-09-01T00:00:00,"Arthritis, Rheumatoid",C20.111.199
16948136,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16948136,2006-09-01T00:00:00,Peptides,D12.644
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,G17.800
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16948136,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16949054,2006-09-01T00:00:00,Animals,B01.050
16949054,2006-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16949054,2006-09-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16949054,2006-09-01T00:00:00,Gene Expression Profiling,E05.393.332
16949054,2006-09-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16949054,2006-09-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
16949054,2006-09-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
16949054,2006-09-01T00:00:00,"Mice, Inbred Strains",B01.050.050.157.520
16949054,2006-09-01T00:00:00,"Mice, Inbred Strains",B01.050.050.199.520.520
16949054,2006-09-01T00:00:00,"Mice, Inbred Strains",B01.050.150.900.649.865.635.505.500.400
16949054,2006-09-01T00:00:00,Neoplasm Proteins,D12.776.624
16949054,2006-09-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16949054,2006-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16949054,2006-09-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16949054,2006-09-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16949054,2006-09-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
16949054,2006-09-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
16949054,2006-09-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
16949054,2006-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16949054,2006-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16949054,2006-09-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16949208,2006-09-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16949208,2006-09-01T00:00:00,Apoptosis,G04.299.139.160
16949208,2006-09-01T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
16949208,2006-09-01T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
16949208,2006-09-01T00:00:00,Cell Survival,G04.299.316
16949208,2006-09-01T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
16949208,2006-09-01T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
16949208,2006-09-01T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
16949208,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16949208,2006-09-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
16949208,2006-09-01T00:00:00,Mitochondria,A11.284.835.626
16949208,2006-09-01T00:00:00,Mitochondrial Proteins,D12.776.575
16949208,2006-09-01T00:00:00,Molecular Weight,G02.842.580
16949208,2006-09-01T00:00:00,"Receptors, Cell Surface",D12.776.543.750
16949894,2006-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.050.601
16949894,2006-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.519.625.600.050
16949894,2006-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.050.601
16949894,2006-09-01T00:00:00,Adrenergic Uptake Inhibitors,D27.505.696.577.600.050
16949894,2006-09-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
16949894,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16949894,2006-09-01T00:00:00,Propylamines,D02.092.831
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,G17.800
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16949894,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16949894,2006-09-01T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
16949894,2006-09-01T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
16950374,2006-09-01T00:00:00,Adult,M01.060.116
16950374,2006-09-01T00:00:00,Aged,M01.060.116.100
16950374,2006-09-01T00:00:00,Cause of Death,E05.318.308.985.550.250
16950374,2006-09-01T00:00:00,Cause of Death,L01.280.975.550.250
16950374,2006-09-01T00:00:00,Cause of Death,N01.224.935.698.100
16950374,2006-09-01T00:00:00,Cause of Death,N06.850.505.400.975.550.250
16950374,2006-09-01T00:00:00,Cause of Death,N06.850.520.308.985.550.250
16950374,2006-09-01T00:00:00,Depressive Disorder,F03.600.300
16950374,2006-09-01T00:00:00,Health Surveys,E05.318.308.250
16950374,2006-09-01T00:00:00,Health Surveys,N05.715.360.300.375
16950374,2006-09-01T00:00:00,Health Surveys,N06.850.520.308.250
16950374,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16950374,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16950374,2006-09-01T00:00:00,Neoplasms,C04
16950374,2006-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16950374,2006-09-01T00:00:00,Risk Assessment,N04.452.871.715
16950374,2006-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16950374,2006-09-01T00:00:00,Risk Assessment,N06.850.505.715
16950374,2006-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16950374,2006-09-01T00:00:00,United States,Z01.107.567.875
16951113,2006-09-01T00:00:00,Aged,M01.060.116.100
16951113,2006-09-01T00:00:00,Diphosphonates,D02.705.206
16951113,2006-09-01T00:00:00,"Fractures, Bone",C21.866.404
16951113,2006-09-01T00:00:00,Hip Fractures,C21.866.404.061.425
16951113,2006-09-01T00:00:00,Hip Fractures,C21.866.404.484
16951113,2006-09-01T00:00:00,Hip Fractures,C21.866.531.750
16951113,2006-09-01T00:00:00,Hip Fractures,C21.866.558.276.425
16951113,2006-09-01T00:00:00,Hospitalization,E02.760.400
16951113,2006-09-01T00:00:00,Hospitalization,N02.421.585.400
16951113,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16951113,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16951113,2006-09-01T00:00:00,Osteoporosis,C05.116.198.579
16951113,2006-09-01T00:00:00,Referral and Consultation,N04.452.758.849
16951403,2006-09-01T00:00:00,Amino Acid Sequence,G02.111.570.060
16951403,2006-09-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16951403,2006-09-01T00:00:00,Animals,B01.050
16951403,2006-09-01T00:00:00,Ceramides,D02.065.313
16951403,2006-09-01T00:00:00,Ceramides,D09.400.410.420.525.200
16951403,2006-09-01T00:00:00,Ceramides,D10.390.470.675.200
16951403,2006-09-01T00:00:00,Ceramides,D10.570.877.360.612.200
16951403,2006-09-01T00:00:00,Hela Cells,A11.251.210.190.400
16951403,2006-09-01T00:00:00,Hela Cells,A11.251.860.180.400
16951403,2006-09-01T00:00:00,Hela Cells,A11.436.340
16951403,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16951403,2006-09-01T00:00:00,Membrane Proteins,D12.776.543
16951403,2006-09-01T00:00:00,Molecular Sequence Data,L01.453.245.667
16951403,2006-09-01T00:00:00,Oxidoreductases,D08.811.682
16951403,2006-09-01T00:00:00,Point Mutation,G05.365.590.675
16951403,2006-09-01T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
16951403,2006-09-01T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
16951403,2006-09-01T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
16952784,2006-09-01T00:00:00,Aged,M01.060.116.100
16952784,2006-09-01T00:00:00,Heart,A07.541
16952784,2006-09-01T00:00:00,Heart Ventricles,A07.541.560
16952784,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
16952784,2006-09-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
16952784,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16952784,2006-09-01T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16952784,2006-09-01T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16952784,2006-09-01T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16952784,2006-09-01T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16952784,2006-09-01T00:00:00,Pilot Projects,E05.318.760.750
16952784,2006-09-01T00:00:00,Pilot Projects,E05.337.737
16952784,2006-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
16952784,2006-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
16952784,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16952784,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16952784,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16952784,2006-09-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16952784,2006-09-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
16952784,2006-09-01T00:00:00,Stroke Volume,G09.330.380.124.882
16952784,2006-09-01T00:00:00,Tissue Inhibitor of Metalloproteinase-1,D12.776.926.450
16957531,2006-09-01T00:00:00,Computer Simulation,L01.224.160
16957531,2006-09-01T00:00:00,"Models, Neurological",E05.599.395.642
16957531,2006-09-01T00:00:00,Monte Carlo Method,E05.318.740.525
16957531,2006-09-01T00:00:00,Monte Carlo Method,L01.906.575.422
16957531,2006-09-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
16957531,2006-09-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
16957531,2006-09-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
16957531,2006-09-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
16957797,2006-09-01T00:00:00,Adult,M01.060.116
16957797,2006-09-01T00:00:00,Gingival Diseases,C07.465.714.258
16957797,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16957797,2006-09-01T00:00:00,Mandible,A02.835.232.781.324.502.632
16957797,2006-09-01T00:00:00,Mandible,A14.521.632
16962511,2006-09-01T00:00:00,Child,M01.060.406
16962511,2006-09-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16962511,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16962511,2006-09-01T00:00:00,"Monitoring, Physiologic",E01.370.520
16962530,2006-09-01T00:00:00,Adult,M01.060.116
16962530,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16962530,2006-09-01T00:00:00,Operating Rooms,N02.278.388.700
16966082,2006-09-01T00:00:00,Adolescent,M01.060.057
16966082,2006-09-01T00:00:00,Adult,M01.060.116
16966082,2006-09-01T00:00:00,Aged,M01.060.116.100
16966082,2006-09-01T00:00:00,Child,M01.060.406
16966082,2006-09-01T00:00:00,"Child, Preschool",M01.060.406.448
16966082,2006-09-01T00:00:00,Data Collection,E05.318.308
16966082,2006-09-01T00:00:00,Data Collection,L01.280
16966082,2006-09-01T00:00:00,Data Collection,N05.715.360.300
16966082,2006-09-01T00:00:00,Data Collection,N06.850.520.308
16966082,2006-09-01T00:00:00,Demography,I01.240
16966082,2006-09-01T00:00:00,Demography,N01.224
16966082,2006-09-01T00:00:00,Demography,N06.850.505.400
16966082,2006-09-01T00:00:00,Environmental Health,H02.229
16966082,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16966082,2006-09-01T00:00:00,Infant,M01.060.703
16966082,2006-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
16966082,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16966082,2006-09-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16966082,2006-09-01T00:00:00,Risk Assessment,N04.452.871.715
16966082,2006-09-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16966082,2006-09-01T00:00:00,Risk Assessment,N06.850.505.715
16966082,2006-09-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16966082,2006-09-01T00:00:00,United States,Z01.107.567.875
16966201,2006-09-01T00:00:00,Adult,M01.060.116
16966201,2006-09-01T00:00:00,Anti-Anxiety Agents,D27.505.696.277.950.015
16966201,2006-09-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.210.950.015
16966201,2006-09-01T00:00:00,Anti-Anxiety Agents,D27.505.954.427.700.872.015
16966201,2006-09-01T00:00:00,Anxiety,F01.470.132
16966201,2006-09-01T00:00:00,Cannabinoids,D02.455.849.090
16966201,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16966201,2006-09-01T00:00:00,Marijuana Abuse,C21.739.635
16966201,2006-09-01T00:00:00,Marijuana Abuse,F03.900.635
16966201,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16966201,2006-09-01T00:00:00,Pilot Projects,E05.318.760.750
16966201,2006-09-01T00:00:00,Pilot Projects,E05.337.737
16966201,2006-09-01T00:00:00,Pilot Projects,N05.715.360.775.625
16966201,2006-09-01T00:00:00,Pilot Projects,N06.850.520.450.720
16966201,2006-09-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
16966201,2006-09-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
16966201,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16966201,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16966201,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16966735,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16966735,2006-09-01T00:00:00,Lactones,D02.540
16966735,2006-09-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
16966735,2006-09-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
16966735,2006-09-01T00:00:00,Patient Satisfaction,N05.715.360.600
16966735,2006-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
16966735,2006-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
16966735,2006-09-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
16966735,2006-09-01T00:00:00,Physician-Patient Relations,N05.300.660.625
16966735,2006-09-01T00:00:00,Primary Health Care,N04.590.233.727
16966735,2006-09-01T00:00:00,Pyrazoles,D03.383.129.539
16966735,2006-09-01T00:00:00,United States,Z01.107.567.875
16968502,2006-09-01T00:00:00,Adult,M01.060.116
16968502,2006-09-01T00:00:00,Benzimidazoles,D03.438.103
16968502,2006-09-01T00:00:00,Esophagus,A03.556.875.500
16968502,2006-09-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
16968502,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16968502,2006-09-01T00:00:00,Manometry,E05.559
16968502,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16968502,2006-09-01T00:00:00,Pressure,G01.374.715
16968502,2006-09-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
16968502,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16968502,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16968502,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16971597,2006-09-01T00:00:00,Aged,M01.060.116.100
16971597,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16971597,2006-09-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
16971597,2006-09-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
16971597,2006-09-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
16971597,2006-09-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
16971597,2006-09-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
16971597,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16971597,2006-09-01T00:00:00,Patient Selection,E05.581.500.653
16971597,2006-09-01T00:00:00,Patient Selection,N04.590.731
16971597,2006-09-01T00:00:00,Thrombolytic Therapy,E02.319.913
16971597,2006-09-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16971597,2006-09-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16971597,2006-09-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16971597,2006-09-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
16971597,2006-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16971597,2006-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16971597,2006-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16971597,2006-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16971597,2006-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16971597,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16971597,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16971597,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16971821,2006-09-01T00:00:00,Adolescent,M01.060.057
16971821,2006-09-01T00:00:00,Adult,M01.060.116
16971821,2006-09-01T00:00:00,Aged,M01.060.116.100
16971821,2006-09-01T00:00:00,Alcohol Drinking,F01.145.317.269
16971821,2006-09-01T00:00:00,Alcoholism,C21.739.100.250
16971821,2006-09-01T00:00:00,Alcoholism,F03.900.100.350
16971821,2006-09-01T00:00:00,Ambulatory Care,E02.760.106
16971821,2006-09-01T00:00:00,Ambulatory Care,N02.421.585.106
16971821,2006-09-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
16971821,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16971821,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16971821,2006-09-01T00:00:00,Personality Inventory,F04.711.647.513
16971821,2006-09-01T00:00:00,Psychiatric Status Rating Scales,F04.586
16971821,2006-09-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
16971821,2006-09-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
16971821,2006-09-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
16971821,2006-09-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
16971821,2006-09-01T00:00:00,Sertraline,D02.092.705.800
16971821,2006-09-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
16971821,2006-09-01T00:00:00,Sertraline,D04.615.638.845.800
16971821,2006-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16971821,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16971821,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16971821,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16978064,2006-09-01T00:00:00,Animals,B01.050
16978064,2006-09-01T00:00:00,Gene Transfer Techniques,E05.393.350
16978064,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16978064,2006-09-01T00:00:00,Interleukin-12,D12.644.276.374.465.512
16978064,2006-09-01T00:00:00,Interleukin-12,D12.776.467.374.465.512
16978064,2006-09-01T00:00:00,Interleukin-12,D23.529.374.465.512
16978064,2006-09-01T00:00:00,Liposomes,D25.479.517
16978064,2006-09-01T00:00:00,Liposomes,D26.255.260.517
16978064,2006-09-01T00:00:00,Liposomes,D27.720.280.260.517
16978064,2006-09-01T00:00:00,Liposomes,J01.637.051.479.517
16978064,2006-09-01T00:00:00,Liposomes,J01.637.087.500.517
16978064,2006-09-01T00:00:00,Neoplasms,C04
16980814,2006-09-01T00:00:00,Adult,M01.060.116
16980814,2006-09-01T00:00:00,African Americans,M01.686.508.100.100
16980814,2006-09-01T00:00:00,African Americans,M01.686.754.100
16980814,2006-09-01T00:00:00,Aged,M01.060.116.100
16980814,2006-09-01T00:00:00,Breast Neoplasms,C04.588.180
16980814,2006-09-01T00:00:00,Breast Neoplasms,C17.800.090.500
16980814,2006-09-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
16980814,2006-09-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
16980814,2006-09-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
16980814,2006-09-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
16980814,2006-09-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
16980814,2006-09-01T00:00:00,Genetic Counseling,N02.421.308.400
16980814,2006-09-01T00:00:00,Genetic Testing,E01.370.427
16980814,2006-09-01T00:00:00,Genetic Testing,E05.393.435
16980814,2006-09-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
16980814,2006-09-01T00:00:00,Genetic Testing,N02.421.308.430
16980814,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16980814,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16980814,2006-09-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
16980814,2006-09-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
16980814,2006-09-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
16980814,2006-09-01T00:00:00,Ovarian Neoplasms,C19.344.410
16980814,2006-09-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
16980814,2006-09-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
16980814,2006-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16980814,2006-09-01T00:00:00,Risk Factors,N05.715.350.200.700
16980814,2006-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16980814,2006-09-01T00:00:00,Risk Factors,N06.850.490.625.750
16980814,2006-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16981113,2006-09-01T00:00:00,Animals,B01.050
16981113,2006-09-01T00:00:00,Clinical Competence,I02.399.630.210
16981113,2006-09-01T00:00:00,Clinical Competence,N04.761.210
16981113,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
16981113,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
16981113,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
16981113,2006-09-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
16981113,2006-09-01T00:00:00,Endosonography,E01.370.350.850.280
16981113,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16981113,2006-09-01T00:00:00,"Models, Animal",E05.598
16983029,2006-09-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
16983029,2006-09-01T00:00:00,Aged,M01.060.116.100
16983029,2006-09-01T00:00:00,"Anastomosis, Surgical",E04.035
16983029,2006-09-01T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
16983029,2006-09-01T00:00:00,Esophageal Neoplasms,C04.588.443.353
16983029,2006-09-01T00:00:00,Esophageal Neoplasms,C06.301.371.205
16983029,2006-09-01T00:00:00,Esophageal Neoplasms,C06.405.117.430
16983029,2006-09-01T00:00:00,Esophageal Neoplasms,C06.405.249.205
16983029,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16983029,2006-09-01T00:00:00,Laparoscopy,E01.370.388.250.520
16983029,2006-09-01T00:00:00,Laparoscopy,E04.800.250.520
16983029,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16983029,2006-09-01T00:00:00,Postoperative Complications,C23.550.767
16983029,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
16983029,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16983029,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16986103,2006-09-01T00:00:00,Animals,B01.050
16986103,2006-09-01T00:00:00,Biocompatible Materials,D25.130
16986103,2006-09-01T00:00:00,Biocompatible Materials,D27.720.102.130
16986103,2006-09-01T00:00:00,Biocompatible Materials,J01.637.051.130
16986103,2006-09-01T00:00:00,Biomedical Engineering,H02.070
16986103,2006-09-01T00:00:00,Biomedical Engineering,J01.293.140
16986103,2006-09-01T00:00:00,Biotechnology,H01.158.550
16986103,2006-09-01T00:00:00,Biotechnology,J01.897.120
16986103,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16986103,2006-09-01T00:00:00,Kidney,A05.810.453
16986103,2006-09-01T00:00:00,Stem Cells,A11.872
16986103,2006-09-01T00:00:00,Tissue Engineering,E05.200.249.750
16986384,2006-09-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
16986384,2006-09-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
16986384,2006-09-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
16986384,2006-09-01T00:00:00,Animals,B01.050
16986384,2006-09-01T00:00:00,Body Weight,C23.888.144
16986384,2006-09-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
16986384,2006-09-01T00:00:00,Body Weight,E05.041.124.160.750
16986384,2006-09-01T00:00:00,Body Weight,G07.100.100.160.120
16986384,2006-09-01T00:00:00,Body Weight,G07.700.320.249.314.120
16986384,2006-09-01T00:00:00,Ion Channels,D12.776.157.530.400
16986384,2006-09-01T00:00:00,Ion Channels,D12.776.543.550.425
16986384,2006-09-01T00:00:00,Ion Channels,D12.776.543.585.400
16986384,2006-09-01T00:00:00,Mammaplasty,E02.218.565
16986384,2006-09-01T00:00:00,Mammaplasty,E04.680.500
16986384,2006-09-01T00:00:00,Membrane Transport Proteins,D12.776.157.530
16986384,2006-09-01T00:00:00,Membrane Transport Proteins,D12.776.543.585
16986384,2006-09-01T00:00:00,Mitochondrial Proteins,D12.776.575
16986384,2006-09-01T00:00:00,Obesity,C18.654.726.500
16986384,2006-09-01T00:00:00,Obesity,C23.888.144.699.500
16986384,2006-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16986384,2006-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
16986384,2006-09-01T00:00:00,Postoperative Complications,C23.550.767
16986384,2006-09-01T00:00:00,"RNA, Messenger",D13.444.735.544
16986384,2006-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16986384,2006-09-01T00:00:00,Surgical Flaps,A10.850.710
16986384,2006-09-01T00:00:00,Surgical Flaps,E07.862.710
16986397,2006-09-01T00:00:00,Adolescent,M01.060.057
16986397,2006-09-01T00:00:00,Adult,M01.060.116
16986397,2006-09-01T00:00:00,Data Collection,E05.318.308
16986397,2006-09-01T00:00:00,Data Collection,L01.280
16986397,2006-09-01T00:00:00,Data Collection,N05.715.360.300
16986397,2006-09-01T00:00:00,Data Collection,N06.850.520.308
16986397,2006-09-01T00:00:00,Funnel Chest,C05.116.099.386
16986397,2006-09-01T00:00:00,Funnel Chest,C05.660.386
16986397,2006-09-01T00:00:00,Funnel Chest,C16.131.621.386
16986397,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16986397,2006-09-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
16986397,2006-09-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
16986397,2006-09-01T00:00:00,Patient Satisfaction,N05.715.360.600
16986397,2006-09-01T00:00:00,"Societies, Medical",N03.540.828.589
16986397,2006-09-01T00:00:00,United States,Z01.107.567.875
16988475,2006-09-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
16988475,2006-09-01T00:00:00,Alzheimer Disease,C10.574.945.249
16988475,2006-09-01T00:00:00,Alzheimer Disease,F03.087.400.100
16988475,2006-09-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
16988475,2006-09-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
16988475,2006-09-01T00:00:00,Cell Culture Techniques,E05.200.249.249
16988475,2006-09-01T00:00:00,Cell Death,G04.299.139
16988475,2006-09-01T00:00:00,Cell Proliferation,G04.299.233.750
16988475,2006-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16988475,2006-09-01T00:00:00,Cell Survival,G04.299.316
16988475,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16988475,2006-09-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
16988475,2006-09-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
16988475,2006-09-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
16988475,2006-09-01T00:00:00,Neurons,A08.663
16988475,2006-09-01T00:00:00,Neurons,A11.671
16989552,2006-09-01T00:00:00,Adolescent,M01.060.057
16989552,2006-09-01T00:00:00,Adult,M01.060.116
16989552,2006-09-01T00:00:00,Brain Mapping,E01.370.350.086
16989552,2006-09-01T00:00:00,Brain Mapping,E01.370.376.149
16989552,2006-09-01T00:00:00,Brain Mapping,E05.132
16989552,2006-09-01T00:00:00,Discrimination (Psychology),F02.463.593.257
16989552,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16989552,2006-09-01T00:00:00,Judgment,F02.463.785.626
16989552,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16989552,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16989552,2006-09-01T00:00:00,Mathematics,H01.548
16989552,2006-09-01T00:00:00,Mental Processes,F02.463
16989552,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
16989552,2006-09-01T00:00:00,Parietal Lobe,A08.186.211.730.885.287.500.670
16989552,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
16989552,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
16989552,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
16989552,2006-09-01T00:00:00,Visual Perception,F02.463.593.932
16990741,2006-09-01T00:00:00,Adult,M01.060.116
16990741,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16990741,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16990741,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17003602,2006-09-01T00:00:00,Aged,M01.060.116.100
17003602,2006-09-01T00:00:00,Blood Pressure,E01.370.600.875.249
17003602,2006-09-01T00:00:00,Blood Pressure,G09.330.380.076
17003602,2006-09-01T00:00:00,Exercise Therapy,E02.779.483
17003602,2006-09-01T00:00:00,Exercise Therapy,E02.831.387
17003602,2006-09-01T00:00:00,Exercise Tolerance,G11.427.680.270
17003602,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17003602,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
17003602,2006-09-01T00:00:00,Muscle Contraction,G11.427.590.540
17003602,2006-09-01T00:00:00,Oxygen Consumption,G03.730
17003602,2006-09-01T00:00:00,Physical Endurance,G11.427.680
17003602,2006-09-01T00:00:00,Physical Endurance,I03.450.642.845.054.600
17003602,2006-09-01T00:00:00,Physical Exertion,G11.427.590.780
17003602,2006-09-01T00:00:00,Physical Fitness,I03.621
17003602,2006-09-01T00:00:00,Physical Fitness,N01.400.545
17003602,2006-09-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
17003602,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
17003602,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17003602,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17004539,2006-09-01T00:00:00,"Anemia, Hemolytic",C15.378.071.141
17004539,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17004539,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
17004921,2006-09-01T00:00:00,Animals,B01.050
17004921,2006-09-01T00:00:00,"Animals, Newborn",B01.050.050.282
17004921,2006-09-01T00:00:00,Astrocytes,A08.637.200
17004921,2006-09-01T00:00:00,Astrocytes,A11.650.200
17004921,2006-09-01T00:00:00,Cell Death,G04.299.139
17004921,2006-09-01T00:00:00,Drug Interactions,G07.690.812.240
17004921,2006-09-01T00:00:00,Drug Interactions,G07.700.680.240
17004921,2006-09-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
17004921,2006-09-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
17004921,2006-09-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
17004921,2006-09-01T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
17004921,2006-09-01T00:00:00,Lipopolysaccharides,D09.400.500
17004921,2006-09-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17004921,2006-09-01T00:00:00,Lipopolysaccharides,D10.494
17004921,2006-09-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17004921,2006-09-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17004921,2006-09-01T00:00:00,Motor Neurons,A08.663.655.500
17004921,2006-09-01T00:00:00,Motor Neurons,A11.671.655.500
17004921,2006-09-01T00:00:00,Nerve Growth Factor,D12.644.276.860.437
17004921,2006-09-01T00:00:00,Nerve Growth Factor,D12.776.467.860.437
17004921,2006-09-01T00:00:00,Nerve Growth Factor,D12.776.641.600.437
17004921,2006-09-01T00:00:00,Nerve Growth Factor,D23.529.850.437
17004921,2006-09-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17004921,2006-09-01T00:00:00,Spinal Cord,A08.186.854
17017840,2006-09-01T00:00:00,Adult,M01.060.116
17017840,2006-09-01T00:00:00,Crime Victims,M01.135
17017840,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17017840,2006-09-01T00:00:00,Interpersonal Relations,F01.829.401
17017840,2006-09-01T00:00:00,Mental Disorders,F03
17017840,2006-09-01T00:00:00,Sex Offenses,I01.198.240.748
17017840,2006-09-01T00:00:00,Violence,I01.198.240.856
17017840,2006-09-01T00:00:00,Violence,I01.880.735.900
17017867,2006-09-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17017867,2006-09-01T00:00:00,Alzheimer Disease,C10.574.945.249
17017867,2006-09-01T00:00:00,Alzheimer Disease,F03.087.400.100
17017867,2006-09-01T00:00:00,Animals,B01.050
17017867,2006-09-01T00:00:00,Apoptosis,G04.299.139.160
17017867,2006-09-01T00:00:00,Brain,A08.186.211
17017867,2006-09-01T00:00:00,DNA Damage,C21.111
17017867,2006-09-01T00:00:00,DNA Damage,G05.355.180
17017867,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17017867,2006-09-01T00:00:00,Mutation,G05.365.590
17017867,2006-09-01T00:00:00,Oxidative Stress,G03.495.710
17017867,2006-09-01T00:00:00,Oxidative Stress,G07.700.830.750
17017867,2006-09-01T00:00:00,Signal Transduction,G02.111.087.800
17017867,2006-09-01T00:00:00,Signal Transduction,G02.149.115.800
17017867,2006-09-01T00:00:00,Signal Transduction,G04.299.880
17017867,2006-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
17017867,2006-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
17017867,2006-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
17017867,2006-09-01T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
17029517,2006-09-01T00:00:00,Adolescent,M01.060.057
17029517,2006-09-01T00:00:00,Adult,M01.060.116
17029517,2006-09-01T00:00:00,Dislocations,C21.866.289
17029517,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17029517,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17029517,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17029517,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,G17.800
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17029517,2006-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17029517,2006-09-01T00:00:00,Temporomandibular Joint Disorders,C05.500.607.221.897
17029517,2006-09-01T00:00:00,Temporomandibular Joint Disorders,C05.550.905
17029517,2006-09-01T00:00:00,Temporomandibular Joint Disorders,C05.651.243.897
17029517,2006-09-01T00:00:00,Temporomandibular Joint Disorders,C07.320.610.291.897
17029517,2006-09-01T00:00:00,Temporomandibular Joint Disorders,C07.678
17040017,2006-09-01T00:00:00,Chronic Disease,C23.550.291.500
17040017,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17040017,2006-09-01T00:00:00,Nasal Mucosa,A04.531.520
17040017,2006-09-01T00:00:00,Nasal Mucosa,A04.760.600
17040017,2006-09-01T00:00:00,Nasal Mucosa,A10.615.550.760.600
17040017,2006-09-01T00:00:00,Phospholipids,D10.570.755
17040017,2006-09-01T00:00:00,Phospholipids,D10.695
17040017,2006-09-01T00:00:00,Sinusitis,C08.460.692.752
17040017,2006-09-01T00:00:00,Sinusitis,C08.730.749
17040017,2006-09-01T00:00:00,Sinusitis,C09.603.692.752
17055861,2006-09-01T00:00:00,Abdominal Pain,C23.888.646.100
17055861,2006-09-01T00:00:00,Abdominal Pain,C23.888.821.030
17055861,2006-09-01T00:00:00,Adolescent,M01.060.057
17055861,2006-09-01T00:00:00,Adult,M01.060.116
17055861,2006-09-01T00:00:00,Aged,M01.060.116.100
17055861,2006-09-01T00:00:00,Child,M01.060.406
17055861,2006-09-01T00:00:00,"Child, Preschool",M01.060.406.448
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
17055861,2006-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
17055861,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17055861,2006-09-01T00:00:00,Middle Aged,M01.060.116.630
17055861,2006-09-01T00:00:00,Pancreatitis,C06.689.750
17055861,2006-09-01T00:00:00,Postoperative Complications,C23.550.767
17055861,2006-09-01T00:00:00,Reoperation,E04.690
17055861,2006-09-01T00:00:00,"Sphincterotomy, Endoscopic",E04.210.120.850
17055861,2006-09-01T00:00:00,"Sphincterotomy, Endoscopic",E04.210.240.250.840
17055861,2006-09-01T00:00:00,"Sphincterotomy, Endoscopic",E04.800.250.250.250.840
17055861,2006-09-01T00:00:00,Stents,E07.695.750
17055861,2006-09-01T00:00:00,Treatment Outcome,E01.789.800
17055861,2006-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17055861,2006-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17119211,2006-09-01T00:00:00,Adult,M01.060.116
17119211,2006-09-01T00:00:00,Animals,B01.050
17119211,2006-09-01T00:00:00,Cardiovascular Diseases,C14
17119211,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17119211,2006-09-01T00:00:00,Occupational Exposure,N06.850.460.350.600
17136696,2006-09-01T00:00:00,Aged,M01.060.116.100
17136696,2006-09-01T00:00:00,Blood Platelets,A11.118.188
17136696,2006-09-01T00:00:00,Blood Platelets,A15.145.229.188
17136696,2006-09-01T00:00:00,Cell Proliferation,G04.299.233.750
17136696,2006-09-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17136696,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17136696,2006-09-01T00:00:00,Proteinuria,C12.777.934.734
17136696,2006-09-01T00:00:00,Proteinuria,C13.351.968.934.734
17136696,2006-09-01T00:00:00,Proteinuria,C23.888.942.750
17136696,2006-09-01T00:00:00,Syndrome,C23.550.288.500
17181934,2006-09-01T00:00:00,Antirheumatic Agents,D27.505.954.329
17181934,2006-09-01T00:00:00,Child,M01.060.406
17181934,2006-09-01T00:00:00,Cyclosporine,D04.345.566.235.300
17181934,2006-09-01T00:00:00,Cyclosporine,D12.644.641.235.300
17181934,2006-09-01T00:00:00,Health Status,I01.240.425
17181934,2006-09-01T00:00:00,Health Status,N01.224.425
17181934,2006-09-01T00:00:00,Health Status,N06.850.505.400.425
17181934,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17181934,2006-09-01T00:00:00,Remission Induction,E02.860
17243358,2006-09-01T00:00:00,Adult,M01.060.116
17243358,2006-09-01T00:00:00,Age Factors,N05.715.350.075
17243358,2006-09-01T00:00:00,Age Factors,N06.850.490.250
17243358,2006-09-01T00:00:00,Brain,A08.186.211
17243358,2006-09-01T00:00:00,Brain Mapping,E01.370.350.086
17243358,2006-09-01T00:00:00,Brain Mapping,E01.370.376.149
17243358,2006-09-01T00:00:00,Brain Mapping,E05.132
17243358,2006-09-01T00:00:00,Child,M01.060.406
17243358,2006-09-01T00:00:00,"Child, Preschool",M01.060.406.448
17243358,2006-09-01T00:00:00,Face,A01.456.505
17243358,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17243358,2006-09-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17243358,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17243358,2006-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17243358,2006-09-01T00:00:00,Oxygen,D01.268.185.550
17243358,2006-09-01T00:00:00,Oxygen,D01.362.670
17243358,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
17243358,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
17243358,2006-09-01T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
17243358,2006-09-01T00:00:00,Photic Stimulation,E05.723.729
17243358,2006-09-01T00:00:00,Reaction Time,F02.830.650
17243358,2006-09-01T00:00:00,Reaction Time,F04.669.817
17243358,2006-09-01T00:00:00,Reaction Time,G11.561.677
17302016,2006-09-01T00:00:00,African Americans,M01.686.508.100.100
17302016,2006-09-01T00:00:00,African Americans,M01.686.754.100
17302016,2006-09-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
17302016,2006-09-01T00:00:00,Attitude to Health,F01.100.150
17302016,2006-09-01T00:00:00,Attitude to Health,N05.300.150
17302016,2006-09-01T00:00:00,Breast Neoplasms,C04.588.180
17302016,2006-09-01T00:00:00,Breast Neoplasms,C17.800.090.500
17302016,2006-09-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.375.249.100
17302016,2006-09-01T00:00:00,"Genes, BRCA1",G05.360.340.024.340.415.400.100
17302016,2006-09-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.375.249.105
17302016,2006-09-01T00:00:00,"Genes, BRCA2",G05.360.340.024.340.415.400.105
17302016,2006-09-01T00:00:00,Genetic Counseling,H01.158.273.343.315.384
17302016,2006-09-01T00:00:00,Genetic Counseling,N02.421.308.400
17302016,2006-09-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17302016,2006-09-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17302016,2006-09-01T00:00:00,Genetic Testing,E01.370.427
17302016,2006-09-01T00:00:00,Genetic Testing,E05.393.435
17302016,2006-09-01T00:00:00,Genetic Testing,N02.421.143.827.233.221
17302016,2006-09-01T00:00:00,Genetic Testing,N02.421.308.430
17302016,2006-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17302016,2006-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17302016,2006-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17302016,2006-09-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17302016,2006-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17302016,2006-09-01T00:00:00,Risk Factors,N05.715.350.200.700
17302016,2006-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17302016,2006-09-01T00:00:00,Risk Factors,N06.850.490.625.750
17302016,2006-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17302016,2006-09-01T00:00:00,United States,Z01.107.567.875
16948631,2006-09-04T00:00:00,Curriculum,I02.158
16948631,2006-09-04T00:00:00,Data Collection,E05.318.308
16948631,2006-09-04T00:00:00,Data Collection,L01.280
16948631,2006-09-04T00:00:00,Data Collection,N05.715.360.300
16948631,2006-09-04T00:00:00,Data Collection,N06.850.520.308
16948631,2006-09-04T00:00:00,"Education, Medical",I02.358.399
16948631,2006-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16948631,2006-09-04T00:00:00,Nutritional Sciences,H02.533
16948631,2006-09-04T00:00:00,Obesity,C18.654.726.500
16948631,2006-09-04T00:00:00,Obesity,C23.888.144.699.500
16948631,2006-09-04T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
16948631,2006-09-04T00:00:00,Obesity,G07.100.100.160.120.699.500
16954352,2006-09-05T00:00:00,Adolescent,M01.060.057
16954352,2006-09-05T00:00:00,Adult,M01.060.116
16954352,2006-09-05T00:00:00,Biomedical Research,H01.770.644.145
16954352,2006-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16954352,2006-09-05T00:00:00,Smoking,F01.145.466.753
16954352,2006-09-05T00:00:00,Smoking Cessation,F01.145.940.700
16954352,2006-09-05T00:00:00,Tobacco Use Disorder,C21.739.912
16954352,2006-09-05T00:00:00,Tobacco Use Disorder,F03.900.912
16954352,2006-09-05T00:00:00,United States,Z01.107.567.875
16957054,2006-09-06T00:00:00,Animals,B01.050
16957054,2006-09-06T00:00:00,Caenorhabditis elegans,B01.050.500.500.294.700.700.660.250.250
16957054,2006-09-06T00:00:00,Caenorhabditis elegans Proteins,D12.776.419.500
16957054,2006-09-06T00:00:00,Carrier Proteins,D12.776.157
16957054,2006-09-06T00:00:00,Cilia,A11.284.180.165
16957054,2006-09-06T00:00:00,Flagella,A11.284.180.290
16957054,2006-09-06T00:00:00,Gene Expression Profiling,E05.393.332
16957054,2006-09-06T00:00:00,Gene Expression Regulation,G05.355.315
16957054,2006-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16957054,2006-09-06T00:00:00,"Models, Biological",E05.599.395
16957054,2006-09-06T00:00:00,Molecular Sequence Data,L01.453.245.667
16957054,2006-09-06T00:00:00,Mutation,G05.365.590
16957054,2006-09-06T00:00:00,Protein Transport,G03.495.166.700
16957054,2006-09-06T00:00:00,Proteins,D12.776
16957054,2006-09-06T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
16957054,2006-09-06T00:00:00,"Transcription, Genetic",G02.111.087.847
16957054,2006-09-06T00:00:00,"Transcription, Genetic",G02.149.115.847
16957054,2006-09-06T00:00:00,"Transcription, Genetic",G05.355.310.700
16956674,2006-09-07T00:00:00,Animals,B01.050
16956674,2006-09-07T00:00:00,Central Nervous System Stimulants,D27.505.696.282
16956674,2006-09-07T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
16956674,2006-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16956674,2006-09-07T00:00:00,Neuronal Plasticity,G11.561.600.635
16956674,2006-09-07T00:00:00,Neurons,A08.663
16956674,2006-09-07T00:00:00,Neurons,A11.671
16956674,2006-09-07T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
16956674,2006-09-07T00:00:00,Substance-Related Disorders,C21.739
16956674,2006-09-07T00:00:00,Substance-Related Disorders,F03.900
16956674,2006-09-07T00:00:00,Synaptic Transmission,G02.111.087.800.850
16956674,2006-09-07T00:00:00,Synaptic Transmission,G02.149.115.800.850
16956674,2006-09-07T00:00:00,Synaptic Transmission,G04.299.880.850
16956674,2006-09-07T00:00:00,Synaptic Transmission,G07.265.337.900
16956674,2006-09-07T00:00:00,Synaptic Transmission,G07.700.240.900
16956674,2006-09-07T00:00:00,Synaptic Transmission,G11.561.600.835
16959784,2006-09-07T00:00:00,Breast Neoplasms,C04.588.180
16959784,2006-09-07T00:00:00,Breast Neoplasms,C17.800.090.500
16959784,2006-09-07T00:00:00,Carcinoma,C04.557.470.200
16959784,2006-09-07T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
16959784,2006-09-07T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
16959784,2006-09-07T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
16959784,2006-09-07T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
16959784,2006-09-07T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
16959784,2006-09-07T00:00:00,Epithelial Cells,A11.436
16959784,2006-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16959784,2006-09-07T00:00:00,Hyaluronic Acid,D09.698.373.475
16959784,2006-09-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
16959784,2006-09-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
16959784,2006-09-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
16959784,2006-09-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
16959784,2006-09-07T00:00:00,Signal Transduction,G02.111.087.800
16959784,2006-09-07T00:00:00,Signal Transduction,G02.149.115.800
16959784,2006-09-07T00:00:00,Signal Transduction,G04.299.880
16960091,2006-09-07T00:00:00,Adult,M01.060.116
16960091,2006-09-07T00:00:00,Aged,M01.060.116.100
16960091,2006-09-07T00:00:00,Biological Markers,D23.101
16960091,2006-09-07T00:00:00,Brain Infarction,C10.228.140.300.150.477
16960091,2006-09-07T00:00:00,Brain Infarction,C10.228.140.300.775.200
16960091,2006-09-07T00:00:00,Brain Infarction,C14.907.253.092.477
16960091,2006-09-07T00:00:00,Brain Infarction,C14.907.253.855.200
16960091,2006-09-07T00:00:00,Brain Ischemia,C10.228.140.300.150
16960091,2006-09-07T00:00:00,Brain Ischemia,C14.907.253.092
16960091,2006-09-07T00:00:00,Endothelial Cells,A11.436.275
16960091,2006-09-07T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
16960091,2006-09-07T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
16960091,2006-09-07T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
16960091,2006-09-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16960091,2006-09-07T00:00:00,Middle Aged,M01.060.116.630
16960091,2006-09-07T00:00:00,Neuroglia,A08.637
16960091,2006-09-07T00:00:00,Neuroglia,A11.650
16960091,2006-09-07T00:00:00,Neurons,A08.663
16960091,2006-09-07T00:00:00,Neurons,A11.671
16960091,2006-09-07T00:00:00,Phosphopyruvate Hydratase,D08.811.520.241.300.500
16960091,2006-09-07T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16960091,2006-09-07T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16960091,2006-09-07T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16960091,2006-09-07T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16960091,2006-09-07T00:00:00,Recombinant Proteins,D12.776.828
16960091,2006-09-07T00:00:00,S100 Proteins,D12.776.157.125.750
16960091,2006-09-07T00:00:00,S100 Proteins,D12.776.641.655
16960091,2006-09-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
16960091,2006-09-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
16960091,2006-09-07T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
16960091,2006-09-07T00:00:00,Tissue Plasminogen Activator,D23.119.970
16960091,2006-09-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16960091,2006-09-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16960091,2006-09-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16960091,2006-09-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16960091,2006-09-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16960091,2006-09-07T00:00:00,Treatment Outcome,E01.789.800
16960091,2006-09-07T00:00:00,Treatment Outcome,N04.761.559.590.800
16960091,2006-09-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17145552,2006-09-09T00:00:00,Animals,B01.050
17145552,2006-09-09T00:00:00,Antioxidants,D27.505.519.217
17145552,2006-09-09T00:00:00,Antioxidants,D27.505.696.706.125
17145552,2006-09-09T00:00:00,Antioxidants,D27.720.799.047
17145552,2006-09-09T00:00:00,Apoptosis,G04.299.139.160
17145552,2006-09-09T00:00:00,Caspases,D08.811.277.656.262.500.126
17145552,2006-09-09T00:00:00,Caspases,D08.811.277.656.300.200.126
17145552,2006-09-09T00:00:00,Caspases,D12.644.360.075.405
17145552,2006-09-09T00:00:00,Caspases,D12.776.476.075.405
17145552,2006-09-09T00:00:00,Hepatocytes,A11.436.348
17145552,2006-09-09T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
17145552,2006-09-09T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
17145552,2006-09-09T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
17145552,2006-09-09T00:00:00,Liver Cirrhosis,C06.552.630
17145552,2006-09-09T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17145552,2006-09-09T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17145552,2006-09-09T00:00:00,Reactive Oxygen Species,D01.339.431
17145552,2006-09-09T00:00:00,Reactive Oxygen Species,D01.650.775
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D23.529.374.687
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
17145552,2006-09-09T00:00:00,Transforming Growth Factor beta,D23.529.960.720
16966329,2006-09-10T00:00:00,Adenoviridae,B04.280.030
16966329,2006-09-10T00:00:00,Adenoviridae,B04.909.204.097
16966329,2006-09-10T00:00:00,Animals,B01.050
16966329,2006-09-10T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
16966329,2006-09-10T00:00:00,Chromatin Immunoprecipitation,E05.393.170
16966329,2006-09-10T00:00:00,Chromatin Immunoprecipitation,E05.478.605.160
16966329,2006-09-10T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
16966329,2006-09-10T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
16966329,2006-09-10T00:00:00,Heart,A07.541
16966329,2006-09-10T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
16966329,2006-09-10T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
16966329,2006-09-10T00:00:00,Molecular Sequence Data,L01.453.245.667
16966329,2006-09-10T00:00:00,Mutation,G05.365.590
16966329,2006-09-10T00:00:00,Myocardium,A02.633.580
16966329,2006-09-10T00:00:00,Myocardium,A07.541.704
16966329,2006-09-10T00:00:00,Myocardium,A10.690.552.750
16966329,2006-09-10T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16966329,2006-09-10T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16966329,2006-09-10T00:00:00,"Myocytes, Cardiac",A11.620.500
16966329,2006-09-10T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16966329,2006-09-10T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16966329,2006-09-10T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16966329,2006-09-10T00:00:00,"RNA, Messenger",D13.444.735.544
16966329,2006-09-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16966329,2006-09-10T00:00:00,Sodium-Calcium Exchanger,D12.776.157.530.450.162.442
16966329,2006-09-10T00:00:00,Sodium-Calcium Exchanger,D12.776.543.585.450.162.442
16968739,2006-09-12T00:00:00,Amino Acid Sequence,G02.111.570.060
16968739,2006-09-12T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16968739,2006-09-12T00:00:00,Animals,B01.050
16968739,2006-09-12T00:00:00,Caenorhabditis elegans,B01.050.500.500.294.700.700.660.250.250
16968739,2006-09-12T00:00:00,Caenorhabditis elegans Proteins,D12.776.419.500
16968739,2006-09-12T00:00:00,Cilia,A11.284.180.165
16968739,2006-09-12T00:00:00,"Models, Biological",E05.599.395
16968739,2006-09-12T00:00:00,Molecular Sequence Data,L01.453.245.667
16968739,2006-09-12T00:00:00,"Mutation, Missense",G05.365.590.650
16968739,2006-09-12T00:00:00,Phenotype,G05.695
16968739,2006-09-12T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
16968739,2006-09-12T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
16968739,2006-09-12T00:00:00,Signal Transduction,G02.111.087.800
16968739,2006-09-12T00:00:00,Signal Transduction,G02.149.115.800
16968739,2006-09-12T00:00:00,Signal Transduction,G04.299.880
16968739,2006-09-12T00:00:00,Transcription Factors,D12.776.930
16968739,2006-09-12T00:00:00,rab GTP-Binding Proteins,D08.811.277.040.330.300.400.400
16968739,2006-09-12T00:00:00,rab GTP-Binding Proteins,D12.644.360.525.400
16968739,2006-09-12T00:00:00,rab GTP-Binding Proteins,D12.776.157.325.515.400
16968739,2006-09-12T00:00:00,rab GTP-Binding Proteins,D12.776.476.525.400
16971680,2006-09-13T00:00:00,Algorithms,G17.035
16971680,2006-09-13T00:00:00,Algorithms,L01.224.050
16971680,2006-09-13T00:00:00,Animals,B01.050
16971680,2006-09-13T00:00:00,Brain Mapping,E01.370.350.086
16971680,2006-09-13T00:00:00,Brain Mapping,E01.370.376.149
16971680,2006-09-13T00:00:00,Brain Mapping,E05.132
16971680,2006-09-13T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
16971680,2006-09-13T00:00:00,"Models, Neurological",E05.599.395.642
16971680,2006-09-13T00:00:00,"Models, Statistical",E05.318.740.500
16971680,2006-09-13T00:00:00,"Models, Statistical",E05.599.835
16971680,2006-09-13T00:00:00,"Models, Statistical",N05.715.360.750.530
16971680,2006-09-13T00:00:00,"Models, Statistical",N06.850.520.830.500
16971680,2006-09-13T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
16971680,2006-09-13T00:00:00,Motor Neurons,A08.663.655.500
16971680,2006-09-13T00:00:00,Motor Neurons,A11.671.655.500
16971680,2006-09-13T00:00:00,Neuronal Plasticity,G11.561.600.635
16971680,2006-09-13T00:00:00,Psychomotor Performance,F02.808
16971680,2006-09-13T00:00:00,Psychomotor Performance,G11.427.700
16971680,2006-09-13T00:00:00,Psychomotor Performance,G11.561.623
16971680,2006-09-13T00:00:00,Space Perception,F02.463.593.778
16971680,2006-09-13T00:00:00,Space Perception,F02.463.593.932.869
16971681,2006-09-13T00:00:00,Algorithms,G17.035
16971681,2006-09-13T00:00:00,Algorithms,L01.224.050
16971681,2006-09-13T00:00:00,Animals,B01.050
16971681,2006-09-13T00:00:00,"Data Interpretation, Statistical",E05.245.380
16971681,2006-09-13T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
16971681,2006-09-13T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
16971681,2006-09-13T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
16971681,2006-09-13T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
16971681,2006-09-13T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
16971681,2006-09-13T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
16971681,2006-09-13T00:00:00,Motor Neurons,A08.663.655.500
16971681,2006-09-13T00:00:00,Motor Neurons,A11.671.655.500
16971681,2006-09-13T00:00:00,Neurons,A08.663
16971681,2006-09-13T00:00:00,Neurons,A11.671
16971681,2006-09-13T00:00:00,Patch-Clamp Techniques,E05.200.500.800
16971681,2006-09-13T00:00:00,Psychomotor Performance,F02.808
16971681,2006-09-13T00:00:00,Psychomotor Performance,G11.427.700
16971681,2006-09-13T00:00:00,Psychomotor Performance,G11.561.623
16971681,2006-09-13T00:00:00,Space Perception,F02.463.593.778
16971681,2006-09-13T00:00:00,Space Perception,F02.463.593.932.869
16973927,2006-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16973927,2006-09-14T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
16973927,2006-09-14T00:00:00,Multicenter Studies as Topic,E05.337.250.500
16973927,2006-09-14T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
16973927,2006-09-14T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
16973927,2006-09-14T00:00:00,Stroke,C10.228.140.300.775
16973927,2006-09-14T00:00:00,Stroke,C14.907.253.855
16832826,2006-09-15T00:00:00,Adsorption,G02.149.047
16832826,2006-09-15T00:00:00,Adsorption,G02.149.767.029
16832826,2006-09-15T00:00:00,Adsorption,G02.842.750.029
16832826,2006-09-15T00:00:00,Hydrogen Bonding,G02.149.767.620
16832826,2006-09-15T00:00:00,Hydrogen Bonding,G02.842.750.620
16832826,2006-09-15T00:00:00,Proteins,D12.776
16832826,2006-09-15T00:00:00,Surface Properties,G02.842.850
17007129,2006-09-15T00:00:00,Bacteria,B03
17007129,2006-09-15T00:00:00,Environmental Pollutants,D27.888.284
17007129,2006-09-15T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
17007129,2006-09-15T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
17007129,2006-09-15T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17029345,2006-09-15T00:00:00,Adult,M01.060.116
17029345,2006-09-15T00:00:00,Aged,M01.060.116.100
17029345,2006-09-15T00:00:00,Brain Mapping,E01.370.350.086
17029345,2006-09-15T00:00:00,Brain Mapping,E01.370.376.149
17029345,2006-09-15T00:00:00,Brain Mapping,E05.132
17029345,2006-09-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17029345,2006-09-15T00:00:00,Middle Aged,M01.060.116.630
17029345,2006-09-15T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
17029345,2006-09-15T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
17029345,2006-09-15T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
17029345,2006-09-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17029345,2006-09-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17029345,2006-09-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17029345,2006-09-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17029345,2006-09-15T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16982649,2006-09-18T00:00:00,Adult,M01.060.116
16982649,2006-09-18T00:00:00,African Americans,M01.686.508.100.100
16982649,2006-09-18T00:00:00,African Americans,M01.686.754.100
16982649,2006-09-18T00:00:00,Diet,E05.272
16982649,2006-09-18T00:00:00,Diet,G07.610.240
16982649,2006-09-18T00:00:00,Dietary Fats,D10.212.302
16982649,2006-09-18T00:00:00,Dietary Fats,J02.500.375
16982649,2006-09-18T00:00:00,Fruit,A18.024.500
16982649,2006-09-18T00:00:00,Fruit,J02.500.562
16982649,2006-09-18T00:00:00,Health Education,I02.233.332
16982649,2006-09-18T00:00:00,Health Education,N02.421.143.827.407
16982649,2006-09-18T00:00:00,Health Education,N02.421.726.407
16982649,2006-09-18T00:00:00,Health Promotion,N02.370
16982649,2006-09-18T00:00:00,Health Promotion,N02.421.726.507
16982649,2006-09-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16982649,2006-09-18T00:00:00,Intervention Studies,E05.318.760.565
16982649,2006-09-18T00:00:00,Intervention Studies,N05.715.360.775.390
16982649,2006-09-18T00:00:00,Intervention Studies,N06.850.520.450.565
16982649,2006-09-18T00:00:00,Middle Aged,M01.060.116.630
16982649,2006-09-18T00:00:00,Program Evaluation,E05.337.820
16982649,2006-09-18T00:00:00,Program Evaluation,N04.761.685
16982649,2006-09-18T00:00:00,Program Evaluation,N05.715.360.650
16989884,2006-09-20T00:00:00,Animals,B01.050
16989884,2006-09-20T00:00:00,Cattle,B01.050.150.900.649.077.380.271
16989884,2006-09-20T00:00:00,"Chromatography, Ion Exchange",E05.196.181.400.383
16989884,2006-09-20T00:00:00,Molecular Sequence Data,L01.453.245.667
16989884,2006-09-20T00:00:00,Recombinant Proteins,D12.776.828
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
16989884,2006-09-20T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
16989884,2006-09-20T00:00:00,Rhodopsin,D12.776.543.750.100.955
16989884,2006-09-20T00:00:00,Rhodopsin,D23.767.930.750.500.500
16989884,2006-09-20T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
17084893,2006-09-20T00:00:00,Animals,B01.050
17084893,2006-09-20T00:00:00,Epithelial Cells,A11.436
17084893,2006-09-20T00:00:00,Gene Expression Profiling,E05.393.332
17084893,2006-09-20T00:00:00,Immune System,A15.382
17084893,2006-09-20T00:00:00,Immunity,G12.450
17084893,2006-09-20T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
17084893,2006-09-20T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
17084893,2006-09-20T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17084893,2006-09-20T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17084893,2006-09-20T00:00:00,"Stress, Physiological",G07.700.830
16996205,2006-09-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
16996205,2006-09-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
16996205,2006-09-22T00:00:00,Cell Proliferation,G04.299.233.750
16996205,2006-09-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
16996205,2006-09-22T00:00:00,Head and Neck Neoplasms,C04.588.443
16996205,2006-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996205,2006-09-22T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
16996205,2006-09-22T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
16996205,2006-09-22T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
16996205,2006-09-22T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
16996205,2006-09-22T00:00:00,"Receptor, IGF Type 1",D08.811.913.696.620.682.725.400.185
16996205,2006-09-22T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.060.468
16996205,2006-09-22T00:00:00,"Receptor, IGF Type 1",D12.776.543.750.750.400.780.400
16998236,2006-09-23T00:00:00,Amino Acid Sequence,G02.111.570.060
16998236,2006-09-23T00:00:00,Amino Acid Sequence,L01.453.245.667.060
16998236,2006-09-23T00:00:00,Animals,B01.050
16998236,2006-09-23T00:00:00,"Animals, Newborn",B01.050.050.282
16998236,2006-09-23T00:00:00,Brain,A08.186.211
16998236,2006-09-23T00:00:00,Fatty Acids,D10.251
16998236,2006-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16998236,2006-09-23T00:00:00,Molecular Sequence Data,L01.453.245.667
16998236,2006-09-23T00:00:00,"RNA, Messenger",D13.444.735.544
16996488,2006-09-25T00:00:00,Adolescent,M01.060.057
16996488,2006-09-25T00:00:00,Adult,M01.060.116
16996488,2006-09-25T00:00:00,Attention,F02.830.104.214
16996488,2006-09-25T00:00:00,Brain Mapping,E01.370.350.086
16996488,2006-09-25T00:00:00,Brain Mapping,E01.370.376.149
16996488,2006-09-25T00:00:00,Brain Mapping,E05.132
16996488,2006-09-25T00:00:00,Case-Control Studies,E05.318.760.500.500
16996488,2006-09-25T00:00:00,Case-Control Studies,N05.715.360.775.175.200
16996488,2006-09-25T00:00:00,Case-Control Studies,N06.850.520.450.500.500
16996488,2006-09-25T00:00:00,Discrimination Learning,F02.463.425.280
16996488,2006-09-25T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
16996488,2006-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996488,2006-09-25T00:00:00,Inhibition (Psychology),F01.145.544
16996488,2006-09-25T00:00:00,Inhibition (Psychology),F02.463.425.475
16996488,2006-09-25T00:00:00,Inhibition (Psychology),F02.739.794.405
16996488,2006-09-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16996488,2006-09-25T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,E05.318.740.475
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,E05.318.780.485
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,N05.715.360.750.500
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,N05.715.360.780.500
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,N06.850.520.445.485
16996488,2006-09-25T00:00:00,Matched-Pair Analysis,N06.850.520.830.475
16996488,2006-09-25T00:00:00,Middle Aged,M01.060.116.630
16996488,2006-09-25T00:00:00,Neural Inhibition,G07.265.337.615
16996488,2006-09-25T00:00:00,Neural Inhibition,G07.700.240.615
16996488,2006-09-25T00:00:00,Neural Inhibition,G11.561.600.625
16996488,2006-09-25T00:00:00,Neural Pathways,A08.612
16996488,2006-09-25T00:00:00,Reaction Time,F02.830.650
16996488,2006-09-25T00:00:00,Reaction Time,F04.669.817
16996488,2006-09-25T00:00:00,Reaction Time,G11.561.677
17000907,2006-09-25T00:00:00,Adult,M01.060.116
17000907,2006-09-25T00:00:00,Alleles,G05.360.340.024.340.030
17000907,2006-09-25T00:00:00,Bilirubin,D03.383.129.578.840.249.184
17000907,2006-09-25T00:00:00,Bilirubin,D03.549.909.249.184
17000907,2006-09-25T00:00:00,Bilirubin,D04.345.783.249.184
17000907,2006-09-25T00:00:00,Bilirubin,D23.767.193.184
17000907,2006-09-25T00:00:00,Coronary Disease,C14.280.647.250
17000907,2006-09-25T00:00:00,Coronary Disease,C14.907.585.250
17000907,2006-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17000907,2006-09-25T00:00:00,Middle Aged,M01.060.116.630
17000907,2006-09-25T00:00:00,Risk Factors,E05.318.740.600.800.725
17000907,2006-09-25T00:00:00,Risk Factors,N05.715.350.200.700
17000907,2006-09-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17000907,2006-09-25T00:00:00,Risk Factors,N06.850.490.625.750
17000907,2006-09-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17001077,2006-09-25T00:00:00,Animals,B01.050
17001077,2006-09-25T00:00:00,Cell Proliferation,G04.299.233.750
17001077,2006-09-25T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17001077,2006-09-25T00:00:00,Colon,A03.556.124.526.356
17001077,2006-09-25T00:00:00,Colon,A03.556.249.249.356
17001077,2006-09-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
17001077,2006-09-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
17001077,2006-09-25T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
17001077,2006-09-25T00:00:00,"Models, Biological",E05.599.395
17001077,2006-09-25T00:00:00,Sodium-Hydrogen Antiporter,D12.776.157.530.450.162.775
17001077,2006-09-25T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.550.190.775
17001077,2006-09-25T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.585.450.162.775
17001308,2006-09-25T00:00:00,Breast Neoplasms,C04.588.180
17001308,2006-09-25T00:00:00,Breast Neoplasms,C17.800.090.500
17001308,2006-09-25T00:00:00,Cell Proliferation,G04.299.233.750
17001308,2006-09-25T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17001308,2006-09-25T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
17001308,2006-09-25T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
17001308,2006-09-25T00:00:00,Gene Expression Profiling,E05.393.332
17001308,2006-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17001308,2006-09-25T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
17001308,2006-09-25T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
17001308,2006-09-25T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
17001308,2006-09-25T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
17001308,2006-09-25T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
17001308,2006-09-25T00:00:00,RNA-Binding Proteins,D12.776.157.725
17001308,2006-09-25T00:00:00,RNA-Binding Proteins,D12.776.664.962
16981761,2006-09-26T00:00:00,Adsorption,G02.149.047
16981761,2006-09-26T00:00:00,Adsorption,G02.149.767.029
16981761,2006-09-26T00:00:00,Adsorption,G02.842.750.029
16981761,2006-09-26T00:00:00,"Membranes, Artificial",D25.479
16981761,2006-09-26T00:00:00,"Membranes, Artificial",J01.637.051.479
16981761,2006-09-26T00:00:00,"Membranes, Artificial",J01.637.087.500
16981761,2006-09-26T00:00:00,Peptides,D12.644
16981761,2006-09-26T00:00:00,Polymers,D05.750
16981761,2006-09-26T00:00:00,Polymers,D25.720
16981761,2006-09-26T00:00:00,Polymers,J01.637.051.720
17000024,2006-09-26T00:00:00,Animals,B01.050
17000024,2006-09-26T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
17000024,2006-09-26T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
17000024,2006-09-26T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
17000024,2006-09-26T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
17000024,2006-09-26T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
17000024,2006-09-26T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
17000024,2006-09-26T00:00:00,GTP-Binding Proteins,D12.776.157.325
17000024,2006-09-26T00:00:00,Gene Expression Regulation,G05.355.315
17000024,2006-09-26T00:00:00,Glycine,D12.125.481
17000024,2006-09-26T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17000024,2006-09-26T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17000024,2006-09-26T00:00:00,Mitosis,G04.299.134.220.220.781
17000024,2006-09-26T00:00:00,Mitosis,G05.355.105.220.781
17000964,2006-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17000964,2006-09-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17000964,2006-09-26T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17000964,2006-09-26T00:00:00,Medical Records,E05.318.308.940.968
17000964,2006-09-26T00:00:00,Medical Records,L01.280.900.968
17000964,2006-09-26T00:00:00,Medical Records,N04.452.859.564
17000964,2006-09-26T00:00:00,Medical Records,N05.715.360.300.715.500
17000964,2006-09-26T00:00:00,Medical Records,N06.850.520.308.940.968
17000964,2006-09-26T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17000964,2006-09-26T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17000964,2006-09-26T00:00:00,Recovery of Function,G16.757
17000964,2006-09-26T00:00:00,Stroke,C10.228.140.300.775
17000964,2006-09-26T00:00:00,Stroke,C14.907.253.855
17000964,2006-09-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17000964,2006-09-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17000964,2006-09-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17000964,2006-09-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17000964,2006-09-26T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17000992,2006-09-26T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
17000992,2006-09-26T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
17000992,2006-09-26T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
17000992,2006-09-26T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
17000992,2006-09-26T00:00:00,Child,M01.060.406
17000992,2006-09-26T00:00:00,"Child, Preschool",M01.060.406.448
17000992,2006-09-26T00:00:00,Data Collection,E05.318.308
17000992,2006-09-26T00:00:00,Data Collection,L01.280
17000992,2006-09-26T00:00:00,Data Collection,N05.715.360.300
17000992,2006-09-26T00:00:00,Data Collection,N06.850.520.308
17000992,2006-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17000992,2006-09-26T00:00:00,Primary Prevention,N02.421.726.758
17000992,2006-09-26T00:00:00,Primary Prevention,N06.850.780.680
17000992,2006-09-26T00:00:00,Stroke,C10.228.140.300.775
17000992,2006-09-26T00:00:00,Stroke,C14.907.253.855
17003227,2006-09-26T00:00:00,Alzheimer Disease,C10.228.140.380.100
17003227,2006-09-26T00:00:00,Alzheimer Disease,C10.574.945.249
17003227,2006-09-26T00:00:00,Alzheimer Disease,F03.087.400.100
17003227,2006-09-26T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
17003227,2006-09-26T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
17003227,2006-09-26T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
17003227,2006-09-26T00:00:00,Animals,B01.050
17003227,2006-09-26T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17003227,2006-09-26T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
17003227,2006-09-26T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
17003227,2006-09-26T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
17003227,2006-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17003227,2006-09-26T00:00:00,Physostigmine,D02.241.081.251.583.682
17003227,2006-09-26T00:00:00,Physostigmine,D03.132.436.545
17003227,2006-09-26T00:00:00,Physostigmine,D03.438.473.402.545
17003227,2006-09-26T00:00:00,"RNA, Messenger",D13.444.735.544
17145370,2006-09-26T00:00:00,Carrier Proteins,D12.776.157
17145370,2006-09-26T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17145370,2006-09-26T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17145370,2006-09-26T00:00:00,"Epistasis, Genetic",G05.355.315.207
17145370,2006-09-26T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17145370,2006-09-26T00:00:00,Genetic Predisposition to Disease,G05.380.355
17145370,2006-09-26T00:00:00,Hispanic Americans,M01.686.754.441
17145370,2006-09-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17145370,2006-09-26T00:00:00,Immunoglobulin Allotypes,D12.776.124.486.485.114.606
17145370,2006-09-26T00:00:00,Immunoglobulin Allotypes,D12.776.124.790.651.114.606
17145370,2006-09-26T00:00:00,Immunoglobulin Allotypes,D12.776.377.715.548.114.606
17145370,2006-09-26T00:00:00,Immunoglobulin Allotypes,G12.500.400
17145370,2006-09-26T00:00:00,Middle Aged,M01.060.116.630
17145370,2006-09-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17145370,2006-09-26T00:00:00,United States,Z01.107.567.875
17008029,2006-09-27T00:00:00,Adult,M01.060.116
17008029,2006-09-27T00:00:00,Alcoholism,C21.739.100.250
17008029,2006-09-27T00:00:00,Alcoholism,F03.900.100.350
17008029,2006-09-27T00:00:00,Cocaine-Related Disorders,C21.739.300
17008029,2006-09-27T00:00:00,Cocaine-Related Disorders,F03.900.300
17008029,2006-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17008029,2006-09-27T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17008029,2006-09-27T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17008029,2006-09-27T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17010671,2006-09-28T00:00:00,Adult,M01.060.116
17010671,2006-09-28T00:00:00,Epilepsy,C10.228.140.490
17010671,2006-09-28T00:00:00,Health Services Accessibility,N04.590.374.350
17010671,2006-09-28T00:00:00,Health Services Accessibility,N05.300.430
17010671,2006-09-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17010671,2006-09-28T00:00:00,Middle Aged,M01.060.116.630
17010671,2006-09-28T00:00:00,Qualitative Research,H01.770.644.241.850
17010671,2006-09-28T00:00:00,Quality of Life,I01.800
17010671,2006-09-28T00:00:00,Quality of Life,K01.752.400.750
17010671,2006-09-28T00:00:00,South Carolina,Z01.107.567.875.075.662
17010671,2006-09-28T00:00:00,South Carolina,Z01.107.567.875.750.700
17012292,2006-09-29T00:00:00,Adolescent,M01.060.057
17012292,2006-09-29T00:00:00,Brain,A08.186.211
17012292,2006-09-29T00:00:00,Cerebellum,A08.186.211.132.810.428.200
17012292,2006-09-29T00:00:00,Cerebellum,A08.186.211.865.428.200
17012292,2006-09-29T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17012292,2006-09-29T00:00:00,Child,M01.060.406
17012292,2006-09-29T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
17012292,2006-09-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17012292,2006-09-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17012292,2006-09-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17012292,2006-09-29T00:00:00,Risk Factors,E05.318.740.600.800.725
17012292,2006-09-29T00:00:00,Risk Factors,N05.715.350.200.700
17012292,2006-09-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17012292,2006-09-29T00:00:00,Risk Factors,N06.850.490.625.750
17012292,2006-09-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17012292,2006-09-29T00:00:00,Speech Disorders,C10.597.606.150.500.800
17012292,2006-09-29T00:00:00,Speech Disorders,C23.888.592.604.150.500.800
17012292,2006-09-29T00:00:00,Speech Perception,F02.463.593.071.875
17012292,2006-09-29T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
17013587,2006-09-30T00:00:00,Adolescent,M01.060.057
17013587,2006-09-30T00:00:00,Adult,M01.060.116
17013587,2006-09-30T00:00:00,Aged,M01.060.116.100
17013587,2006-09-30T00:00:00,Brain Neoplasms,C04.588.614.250.195
17013587,2006-09-30T00:00:00,Brain Neoplasms,C10.228.140.211
17013587,2006-09-30T00:00:00,Brain Neoplasms,C10.551.240.250
17013587,2006-09-30T00:00:00,Child,M01.060.406
17013587,2006-09-30T00:00:00,"Child, Preschool",M01.060.406.448
17013587,2006-09-30T00:00:00,Contrast Media,D27.720.259
17013587,2006-09-30T00:00:00,Gadolinium DTPA,D01.632.400
17013587,2006-09-30T00:00:00,Gadolinium DTPA,D02.092.782.590.401
17013587,2006-09-30T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
17013587,2006-09-30T00:00:00,Gadolinium DTPA,D02.691.400
17013587,2006-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17013587,2006-09-30T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17013587,2006-09-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17013587,2006-09-30T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17013587,2006-09-30T00:00:00,Middle Aged,M01.060.116.630
16862561,2006-10-01T00:00:00,Animals,B01.050
16862561,2006-10-01T00:00:00,"Animals, Newborn",B01.050.050.282
16862561,2006-10-01T00:00:00,Astrocytes,A08.637.200
16862561,2006-10-01T00:00:00,Astrocytes,A11.650.200
16862561,2006-10-01T00:00:00,Cell Survival,G04.299.316
16862561,2006-10-01T00:00:00,Drug Interactions,G07.690.812.240
16862561,2006-10-01T00:00:00,Drug Interactions,G07.700.680.240
16862561,2006-10-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
16862561,2006-10-01T00:00:00,Gene Expression,G05.355.310
16862561,2006-10-01T00:00:00,Hippocampus,A08.186.211.464.405
16862561,2006-10-01T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
16862561,2006-10-01T00:00:00,Nerve Growth Factor,D12.644.276.860.437
16862561,2006-10-01T00:00:00,Nerve Growth Factor,D12.776.467.860.437
16862561,2006-10-01T00:00:00,Nerve Growth Factor,D12.776.641.600.437
16862561,2006-10-01T00:00:00,Nerve Growth Factor,D23.529.850.437
16862561,2006-10-01T00:00:00,Neurons,A08.663
16862561,2006-10-01T00:00:00,Neurons,A11.671
16862561,2006-10-01T00:00:00,Peptide Fragments,D12.644.541
16862561,2006-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16862561,2006-10-01T00:00:00,tau Proteins,D12.776.220.600.450.510
16862561,2006-10-01T00:00:00,tau Proteins,D12.776.641.560.510
16902996,2006-10-01T00:00:00,Animals,B01.050
16902996,2006-10-01T00:00:00,Apoptosis,G04.299.139.160
16902996,2006-10-01T00:00:00,Calpain,D08.811.277.656.262.500.120
16902996,2006-10-01T00:00:00,Calpain,D08.811.277.656.300.200.120
16902996,2006-10-01T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
16902996,2006-10-01T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
16902996,2006-10-01T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
16902996,2006-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16902996,2006-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16902996,2006-10-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
16902996,2006-10-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
16902996,2006-10-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
16902996,2006-10-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
16902996,2006-10-01T00:00:00,Spinal Cord Injuries,C10.900.850
16902996,2006-10-01T00:00:00,Spinal Cord Injuries,C21.866.819
16906072,2006-10-01T00:00:00,Bacterial Infections,C01.252
16906072,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16906072,2006-10-01T00:00:00,Joint Prosthesis,E07.695.400
16906072,2006-10-01T00:00:00,Prosthesis-Related Infections,C01.539.685
16906072,2006-10-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
16906078,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16906078,2006-10-01T00:00:00,Joint Prosthesis,E07.695.400
16906078,2006-10-01T00:00:00,Prosthesis-Related Infections,C01.539.685
16906078,2006-10-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
16923686,2006-10-01T00:00:00,Adult,M01.060.116
16923686,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16923686,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16923686,2006-10-01T00:00:00,Neuropsychological Tests,F04.711.513
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,G17.800
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16923686,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16940399,2006-10-01T00:00:00,Adolescent,M01.060.057
16940399,2006-10-01T00:00:00,Adolescent Behavior,F01.145.022
16940399,2006-10-01T00:00:00,Crime Victims,M01.135
16940399,2006-10-01T00:00:00,Depression,F01.145.126.350
16940399,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16940399,2006-10-01T00:00:00,Interpersonal Relations,F01.829.401
16940399,2006-10-01T00:00:00,Juvenile Delinquency,I01.880.735.479
16940399,2006-10-01T00:00:00,Questionnaires,E05.318.308.750
16940399,2006-10-01T00:00:00,Questionnaires,L01.280.800
16940399,2006-10-01T00:00:00,Questionnaires,N05.715.360.300.695
16940399,2006-10-01T00:00:00,Questionnaires,N06.850.520.308.750
16940399,2006-10-01T00:00:00,Regression Analysis,E05.318.740.750
16940399,2006-10-01T00:00:00,Regression Analysis,N05.715.360.750.695
16940399,2006-10-01T00:00:00,Regression Analysis,N06.850.520.830.750
16940399,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16940399,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
16940399,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16940399,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
16940399,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16940399,2006-10-01T00:00:00,Social Environment,I01.880.656
16940399,2006-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
16940399,2006-10-01T00:00:00,Substance-Related Disorders,C21.739
16940399,2006-10-01T00:00:00,Substance-Related Disorders,F03.900
16940399,2006-10-01T00:00:00,United States,Z01.107.567.875
16957501,2006-10-01T00:00:00,Animals,B01.050
16957501,2006-10-01T00:00:00,Auditory Threshold,F02.463.593.071.173
16957501,2006-10-01T00:00:00,Auditory Threshold,F02.463.593.710.190
16957501,2006-10-01T00:00:00,"Diagnosis, Differential",E01.171
16957501,2006-10-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G07.265.500.370.300
16957501,2006-10-01T00:00:00,"Evoked Potentials, Auditory, Brain Stem",G11.561.270.370.300
16957501,2006-10-01T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
16957501,2006-10-01T00:00:00,Hearing Loss,C09.218.458.341
16957501,2006-10-01T00:00:00,Hearing Loss,C10.597.751.418.341
16957501,2006-10-01T00:00:00,Hearing Loss,C23.888.592.763.393.341
16957501,2006-10-01T00:00:00,"Otoacoustic Emissions, Spontaneous",G11.561.600.810.263.570
16957501,2006-10-01T00:00:00,Regression Analysis,E05.318.740.750
16957501,2006-10-01T00:00:00,Regression Analysis,N05.715.360.750.695
16957501,2006-10-01T00:00:00,Regression Analysis,N06.850.520.830.750
16957501,2006-10-01T00:00:00,Stria Vascularis,A09.246.631.246.292.876
16958076,2006-10-01T00:00:00,Artifacts,E05.047
16958076,2006-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
16958076,2006-10-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
16958076,2006-10-01T00:00:00,Helium,D01.268.613.350
16958076,2006-10-01T00:00:00,Helium,D01.362.641.352
16958076,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16958076,2006-10-01T00:00:00,Lung,A04.411
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,G17.800
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16958076,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16962422,2006-10-01T00:00:00,Arthralgia,C05.550.091
16962422,2006-10-01T00:00:00,Arthralgia,C23.888.646.130
16962422,2006-10-01T00:00:00,Arthralgia,F02.830.816.444.350
16962422,2006-10-01T00:00:00,Arthralgia,G11.561.600.810.444.350
16962422,2006-10-01T00:00:00,Athletic Injuries,C21.866.115
16962422,2006-10-01T00:00:00,"Fractures, Stress",C21.866.404.437
16962422,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16962422,2006-10-01T00:00:00,Joint Diseases,C05.550
16962422,2006-10-01T00:00:00,Knee Injuries,C21.866.558.554
16962422,2006-10-01T00:00:00,Knee Joint,A02.835.583.475
16962422,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16962422,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16962422,2006-10-01T00:00:00,"Osteoarthritis, Knee",C05.550.114.606.500
16962422,2006-10-01T00:00:00,"Osteoarthritis, Knee",C05.799.613.500
16962422,2006-10-01T00:00:00,Radiography,E01.370.350.700
16962422,2006-10-01T00:00:00,Tendon Injuries,C21.866.874
16962422,2006-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
16962422,2006-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
16962422,2006-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
16962422,2006-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
16962422,2006-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
16969492,2006-10-01T00:00:00,Animals,B01.050
16969492,2006-10-01T00:00:00,Antineoplastic Agents,D27.505.954.248
16969492,2006-10-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
16969492,2006-10-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
16969492,2006-10-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
16969492,2006-10-01T00:00:00,Combined Modality Therapy,E02.186
16969492,2006-10-01T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
16969492,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16969492,2006-10-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
16969492,2006-10-01T00:00:00,Lung Neoplasms,C08.381.540
16969492,2006-10-01T00:00:00,Lung Neoplasms,C08.785.520
16969492,2006-10-01T00:00:00,NF-kappa B,D12.776.260.600
16969492,2006-10-01T00:00:00,NF-kappa B,D12.776.660.600
16969492,2006-10-01T00:00:00,NF-kappa B,D12.776.930.600
16969847,2006-10-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
16969847,2006-10-01T00:00:00,Coronary Angiography,E01.370.370.050.200
16969847,2006-10-01T00:00:00,Coronary Angiography,E01.370.370.380.200
16969847,2006-10-01T00:00:00,Coronary Circulation,G09.330.190.163.324
16969847,2006-10-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
16969847,2006-10-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
16969847,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16969847,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16969847,2006-10-01T00:00:00,Syndrome,C23.550.288.500
16969847,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
16969847,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16969847,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16978163,2006-10-01T00:00:00,Adolescent,M01.060.057
16978163,2006-10-01T00:00:00,Child,M01.060.406
16978163,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16978163,2006-10-01T00:00:00,Parent-Child Relations,F01.829.263.370.290
16978163,2006-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
16978163,2006-10-01T00:00:00,Prevalence,L01.280.975.525.750
16978163,2006-10-01T00:00:00,Prevalence,N01.224.935.597.750
16978163,2006-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16978163,2006-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16978163,2006-10-01T00:00:00,Questionnaires,E05.318.308.750
16978163,2006-10-01T00:00:00,Questionnaires,L01.280.800
16978163,2006-10-01T00:00:00,Questionnaires,N05.715.360.300.695
16978163,2006-10-01T00:00:00,Questionnaires,N06.850.520.308.750
16978163,2006-10-01T00:00:00,Smoking,F01.145.466.753
16978951,2006-10-01T00:00:00,Breast Neoplasms,C04.588.180
16978951,2006-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
16978951,2006-10-01T00:00:00,Complementary Therapies,E02.190
16978951,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16978951,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16978951,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
16978951,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16978951,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16979070,2006-10-01T00:00:00,Adult,M01.060.116
16979070,2006-10-01T00:00:00,Aged,M01.060.116.100
16979070,2006-10-01T00:00:00,Breast Neoplasms,C04.588.180
16979070,2006-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
16979070,2006-10-01T00:00:00,Carcinoma,C04.557.470.200
16979070,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16979070,2006-10-01T00:00:00,Incidence,E05.318.308.985.525.375
16979070,2006-10-01T00:00:00,Incidence,L01.280.975.525.375
16979070,2006-10-01T00:00:00,Incidence,N01.224.935.597.500
16979070,2006-10-01T00:00:00,Incidence,N06.850.505.400.975.525.375
16979070,2006-10-01T00:00:00,Incidence,N06.850.520.308.985.525.375
16979070,2006-10-01T00:00:00,Mammography,E01.370.350.700.500
16979070,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16979070,2006-10-01T00:00:00,Neoplasm Proteins,D12.776.624
16979070,2006-10-01T00:00:00,North Carolina,Z01.107.567.875.075.475
16979070,2006-10-01T00:00:00,North Carolina,Z01.107.567.875.750.530
16979070,2006-10-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
16979070,2006-10-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
16979070,2006-10-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
16979070,2006-10-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
16979070,2006-10-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
16979070,2006-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16979070,2006-10-01T00:00:00,Risk Assessment,N04.452.871.715
16979070,2006-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16979070,2006-10-01T00:00:00,Risk Assessment,N06.850.505.715
16979070,2006-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16979070,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16979070,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
16979070,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16979070,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
16979070,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,G17.800
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16979070,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16979070,2006-10-01T00:00:00,"Tumor Markers, Biological",D23.101.840
16979072,2006-10-01T00:00:00,Adult,M01.060.116
16979072,2006-10-01T00:00:00,Aged,M01.060.116.100
16979072,2006-10-01T00:00:00,Breast Neoplasms,C04.588.180
16979072,2006-10-01T00:00:00,Breast Neoplasms,C17.800.090.500
16979072,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16979072,2006-10-01T00:00:00,Mammography,E01.370.350.700.500
16979072,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16979072,2006-10-01T00:00:00,North Carolina,Z01.107.567.875.075.475
16979072,2006-10-01T00:00:00,North Carolina,Z01.107.567.875.750.530
16979072,2006-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
16979072,2006-10-01T00:00:00,Prevalence,L01.280.975.525.750
16979072,2006-10-01T00:00:00,Prevalence,N01.224.935.597.750
16979072,2006-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
16979072,2006-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
16979072,2006-10-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
16979072,2006-10-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
16979072,2006-10-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
16979072,2006-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
16979072,2006-10-01T00:00:00,Risk Assessment,N04.452.871.715
16979072,2006-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
16979072,2006-10-01T00:00:00,Risk Assessment,N06.850.505.715
16979072,2006-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
16979072,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16979072,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
16979072,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16979072,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
16979072,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,G17.800
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
16979072,2006-10-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16982258,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16982258,2006-10-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
16984665,2006-10-01T00:00:00,Animals,B01.050
16984665,2006-10-01T00:00:00,Cell Adhesion,G04.299.117
16984665,2006-10-01T00:00:00,Cell Movement,G04.299.283
16984665,2006-10-01T00:00:00,Cell Movement,G07.700.560.500.180
16984665,2006-10-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
16984665,2006-10-01T00:00:00,"Microscopy, Confocal",E05.595.395
16984665,2006-10-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
16984665,2006-10-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
16984665,2006-10-01T00:00:00,"Myocytes, Cardiac",A11.620.500
16984665,2006-10-01T00:00:00,Pericardium,A07.541.795
16984665,2006-10-01T00:00:00,Pericardium,A10.615.789.470
16984665,2006-10-01T00:00:00,Pregnancy,G08.686.785.760.769
16984665,2006-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
16984665,2006-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
16990669,2006-10-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
16990669,2006-10-01T00:00:00,Alzheimer Disease,C10.574.945.249
16990669,2006-10-01T00:00:00,Alzheimer Disease,F03.087.400.100
16990669,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16990669,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
16990669,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
16996902,2006-10-01T00:00:00,Biomedical Research,H01.770.644.145
16996902,2006-10-01T00:00:00,General Surgery,H02.403.810.300
16996902,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996902,2006-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
16996902,2006-10-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
16996902,2006-10-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
16996902,2006-10-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
16996902,2006-10-01T00:00:00,Research Design,E05.581.500
16996902,2006-10-01T00:00:00,Research Design,H01.770.644.728
16996910,2006-10-01T00:00:00,Adult,M01.060.116
16996910,2006-10-01T00:00:00,Graft Rejection,G12.425.901.545.328
16996910,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996910,2006-10-01T00:00:00,Lung Transplantation,E04.928.600.495
16996910,2006-10-01T00:00:00,Lung Transplantation,E04.936.450.495
16996910,2006-10-01T00:00:00,Microcirculation,G09.330.190.163.645
16996910,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16996910,2006-10-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
16996921,2006-10-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
16996921,2006-10-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
16996921,2006-10-01T00:00:00,Heart Atria,A07.541.358
16996921,2006-10-01T00:00:00,"Heart Defects, Congenital",C14.240.400
16996921,2006-10-01T00:00:00,"Heart Defects, Congenital",C14.280.400
16996921,2006-10-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
16996921,2006-10-01T00:00:00,Hemodynamics,G09.330.190.400
16996921,2006-10-01T00:00:00,Hemodynamics,G09.330.380
16996921,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16996921,2006-10-01T00:00:00,Infant,M01.060.703
16996921,2006-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
16996921,2006-10-01T00:00:00,Oxygen,D01.268.185.550
16996921,2006-10-01T00:00:00,Oxygen,D01.362.670
16996921,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
16996921,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
16996921,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
16996921,2006-10-01T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
16998179,2006-10-01T00:00:00,Decision Making,F02.463.785.373
16998179,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16998179,2006-10-01T00:00:00,Smoking Cessation,F01.145.940.700
16999649,2006-10-01T00:00:00,Albuterol,D02.033.100.291.057
16999649,2006-10-01T00:00:00,Albuterol,D02.092.063.291.057
16999649,2006-10-01T00:00:00,Albuterol,D02.092.471.683.061
16999649,2006-10-01T00:00:00,Bronchodilator Agents,D27.505.696.663.050.110
16999649,2006-10-01T00:00:00,Bronchodilator Agents,D27.505.954.796.050.100
16999649,2006-10-01T00:00:00,Child,M01.060.406
16999649,2006-10-01T00:00:00,Helium,D01.268.613.350
16999649,2006-10-01T00:00:00,Helium,D01.362.641.352
16999649,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16999649,2006-10-01T00:00:00,Infant,M01.060.703
16999649,2006-10-01T00:00:00,Lung,A04.411
16999649,2006-10-01T00:00:00,Metered Dose Inhalers,E07.605.500
16999649,2006-10-01T00:00:00,Oxygen,D01.268.185.550
16999649,2006-10-01T00:00:00,Oxygen,D01.362.670
16999649,2006-10-01T00:00:00,"Respiration, Artificial",E02.365.647.729
16999649,2006-10-01T00:00:00,"Respiration, Artificial",E02.880.820
16999650,2006-10-01T00:00:00,Adult,M01.060.116
16999650,2006-10-01T00:00:00,Complementary Therapies,E02.190
16999650,2006-10-01T00:00:00,Health Surveys,E05.318.308.250
16999650,2006-10-01T00:00:00,Health Surveys,N05.715.360.300.375
16999650,2006-10-01T00:00:00,Health Surveys,N06.850.520.308.250
16999650,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16999650,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
16999650,2006-10-01T00:00:00,Patient Compliance,F01.145.488.500
16999650,2006-10-01T00:00:00,Patient Compliance,N05.300.150.600.600
16999650,2006-10-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
16999650,2006-10-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
16999650,2006-10-01T00:00:00,Patient Satisfaction,N05.715.360.600
16999650,2006-10-01T00:00:00,Qualitative Research,H01.770.644.241.850
16999650,2006-10-01T00:00:00,Quality of Life,I01.800
16999650,2006-10-01T00:00:00,Quality of Life,K01.752.400.750
17000289,2006-10-01T00:00:00,Animals,B01.050
17000289,2006-10-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
17000289,2006-10-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
17000289,2006-10-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
17000289,2006-10-01T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
17000289,2006-10-01T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
17001142,2006-10-01T00:00:00,Community Health Services,N02.421.143
17001142,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17001142,2006-10-01T00:00:00,"Schools, Medical",I02.783.660.552
17001142,2006-10-01T00:00:00,"Schools, Medical",N02.278.020.578
17001142,2006-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17001142,2006-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17001142,2006-10-01T00:00:00,"Students, Medical",I02.851.686.602
17001142,2006-10-01T00:00:00,"Students, Medical",M01.848.769.602
17003736,2006-10-01T00:00:00,Adolescent,M01.060.057
17003736,2006-10-01T00:00:00,Adult,M01.060.116
17003736,2006-10-01T00:00:00,Aged,M01.060.116.100
17003736,2006-10-01T00:00:00,Attitude to Health,F01.100.150
17003736,2006-10-01T00:00:00,Attitude to Health,N05.300.150
17003736,2006-10-01T00:00:00,Body Image,F02.463.593.112
17003736,2006-10-01T00:00:00,Depression,F01.145.126.350
17003736,2006-10-01T00:00:00,Graft Rejection,G12.425.901.545.328
17003736,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17003736,2006-10-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17003736,2006-10-01T00:00:00,Life Change Events,F01.829.458.410
17003736,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17003736,2006-10-01T00:00:00,Organ Transplantation,E04.936.450
17003736,2006-10-01T00:00:00,Quality of Life,I01.800
17003736,2006-10-01T00:00:00,Quality of Life,K01.752.400.750
17003736,2006-10-01T00:00:00,Questionnaires,E05.318.308.750
17003736,2006-10-01T00:00:00,Questionnaires,L01.280.800
17003736,2006-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17003736,2006-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17003736,2006-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17003736,2006-10-01T00:00:00,Risk Assessment,N04.452.871.715
17003736,2006-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17003736,2006-10-01T00:00:00,Risk Assessment,N06.850.505.715
17003736,2006-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17003736,2006-10-01T00:00:00,Risk-Taking,F01.145.722
17003736,2006-10-01T00:00:00,Self Concept,F01.752.747.792
17003736,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
17003736,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17003736,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17008190,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17008190,2006-10-01T00:00:00,Smoking Cessation,F01.145.940.700
17008190,2006-10-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17008190,2006-10-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17008190,2006-10-01T00:00:00,Tobacco,B01.650.388.100.905.900
17010884,2006-10-01T00:00:00,Cysts,C04.182
17010884,2006-10-01T00:00:00,Cysts,C23.300.306
17010884,2006-10-01T00:00:00,"Diagnosis, Differential",E01.171
17010884,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17010884,2006-10-01T00:00:00,Infant,M01.060.703
17011428,2006-10-01T00:00:00,Endoscopy,E01.370.388.250
17011428,2006-10-01T00:00:00,Endoscopy,E04.800.250
17011428,2006-10-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17011428,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17011428,2006-10-01T00:00:00,Neurilemmoma,C04.557.465.625.650.595
17011428,2006-10-01T00:00:00,Neurilemmoma,C04.557.580.600.290
17011428,2006-10-01T00:00:00,Neurilemmoma,C04.557.580.600.610.595
17011428,2006-10-01T00:00:00,Neurilemmoma,C04.557.580.625.650.595
17011428,2006-10-01T00:00:00,Neurilemmoma,C10.551.775.500.500
17011428,2006-10-01T00:00:00,Neurilemmoma,C10.668.829.725.500.500
17011428,2006-10-01T00:00:00,Skull Base,A01.456.830
17011428,2006-10-01T00:00:00,Skull Base,A02.835.232.781.750
17012175,2006-10-01T00:00:00,Animals,B01.050
17012175,2006-10-01T00:00:00,Meat,J02.500.600
17012645,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17012645,2006-10-01T00:00:00,"Models, Neurological",E05.599.395.642
17012645,2006-10-01T00:00:00,Neuronal Plasticity,G11.561.600.635
17012645,2006-10-01T00:00:00,Recovery of Function,G16.757
17012645,2006-10-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
17012645,2006-10-01T00:00:00,Spinal Cord Injuries,C10.900.850
17012645,2006-10-01T00:00:00,Spinal Cord Injuries,C21.866.819
17012645,2006-10-01T00:00:00,Walking,G11.427.590.530.568.900
17012645,2006-10-01T00:00:00,Walking,G11.427.590.530.698.940
17012645,2006-10-01T00:00:00,Walking,I03.450.642.845.940
17023240,2006-10-01T00:00:00,Adult,M01.060.116
17023240,2006-10-01T00:00:00,Aged,M01.060.116.100
17023240,2006-10-01T00:00:00,Demography,I01.240
17023240,2006-10-01T00:00:00,Demography,N01.224
17023240,2006-10-01T00:00:00,Demography,N06.850.505.400
17023240,2006-10-01T00:00:00,Employment,N01.824.245
17023240,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17023240,2006-10-01T00:00:00,Income,N01.824.417
17023240,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17023240,2006-10-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
17023240,2006-10-01T00:00:00,Spinal Cord Injuries,C10.900.850
17023240,2006-10-01T00:00:00,Spinal Cord Injuries,C21.866.819
17023594,2006-10-01T00:00:00,Animals,B01.050
17023594,2006-10-01T00:00:00,Brain,A08.186.211
17023594,2006-10-01T00:00:00,Larva,B05.500.500
17023594,2006-10-01T00:00:00,Larva,G07.700.320.500.550.500.500
17023594,2006-10-01T00:00:00,Manduca,B01.050.500.131.617.561.650.525
17023594,2006-10-01T00:00:00,Neuropeptides,D12.644.400
17023594,2006-10-01T00:00:00,Neuropeptides,D12.776.641.650
17032166,2006-10-01T00:00:00,Animals,B01.050
17032166,2006-10-01T00:00:00,Bone Marrow Cells,A11.148
17032166,2006-10-01T00:00:00,Bone Marrow Cells,A15.378.316
17032166,2006-10-01T00:00:00,Carrier Proteins,D12.776.157
17032166,2006-10-01T00:00:00,Cell Differentiation,G04.299.151
17032166,2006-10-01T00:00:00,Cell Line,A11.251.210
17032166,2006-10-01T00:00:00,Cytokines,D12.644.276.374
17032166,2006-10-01T00:00:00,Cytokines,D12.776.467.374
17032166,2006-10-01T00:00:00,Cytokines,D23.529.374
17032166,2006-10-01T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
17032166,2006-10-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
17032166,2006-10-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
17032166,2006-10-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
17032166,2006-10-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
17032166,2006-10-01T00:00:00,Interleukin-1,D23.529.374.465.501
17032166,2006-10-01T00:00:00,Interleukin-1,D23.529.374.500.400
17032166,2006-10-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17032166,2006-10-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17032166,2006-10-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17032166,2006-10-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17032166,2006-10-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
17032166,2006-10-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
17032166,2006-10-01T00:00:00,Mutation,G05.365.590
17032166,2006-10-01T00:00:00,Osteoclasts,A11.329.372.700
17032166,2006-10-01T00:00:00,Osteoclasts,A11.627.482.700
17032166,2006-10-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17032166,2006-10-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
17032166,2006-10-01T00:00:00,RANK Ligand,D12.644.276.972.562
17032166,2006-10-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
17032166,2006-10-01T00:00:00,RANK Ligand,D12.776.467.972.562
17032166,2006-10-01T00:00:00,RANK Ligand,D23.529.374.750.562
17032166,2006-10-01T00:00:00,RANK Ligand,D23.529.972.562
17032166,2006-10-01T00:00:00,"RNA, Messenger",D13.444.735.544
17032166,2006-10-01T00:00:00,Stromal Cells,A11.329.830
17032166,2006-10-01T00:00:00,Transcriptional Activation,G05.355.315.800
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17032166,2006-10-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17032166,2006-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17032166,2006-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17032166,2006-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17032166,2006-10-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17032183,2006-10-01T00:00:00,Adolescent,M01.060.057
17032183,2006-10-01T00:00:00,Adult,M01.060.116
17032183,2006-10-01T00:00:00,Aged,M01.060.116.100
17032183,2006-10-01T00:00:00,"Endoscopy, Digestive System",E01.370.372.250
17032183,2006-10-01T00:00:00,"Endoscopy, Digestive System",E01.370.388.250.250
17032183,2006-10-01T00:00:00,"Endoscopy, Digestive System",E04.210.240
17032183,2006-10-01T00:00:00,"Endoscopy, Digestive System",E04.800.250.250
17032183,2006-10-01T00:00:00,Gastric Bypass,E02.065.062.249
17032183,2006-10-01T00:00:00,Gastric Bypass,E04.035.398.385
17032183,2006-10-01T00:00:00,Gastric Bypass,E04.062.249
17032183,2006-10-01T00:00:00,Gastric Bypass,E04.210.457.430
17032183,2006-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D08.811.277.040.025.325.625
17032183,2006-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.157.530.450.250.875.500.625
17032183,2006-10-01T00:00:00,H(+)-K(+)-Exchanging ATPase,D12.776.543.585.450.250.875.500.625
17032183,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17032183,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17032183,2006-10-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17032183,2006-10-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17032183,2006-10-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17032183,2006-10-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17032183,2006-10-01T00:00:00,Peptic Ulcer,C06.405.469.275.800
17032183,2006-10-01T00:00:00,Peptic Ulcer,C06.405.608
17032183,2006-10-01T00:00:00,Peptic Ulcer,C06.405.748.586
17032183,2006-10-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
17032183,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17032183,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17032183,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17032183,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17032183,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17032183,2006-10-01T00:00:00,Smoking,F01.145.466.753
17032214,2006-10-01T00:00:00,Catheterization,E02.148
17032214,2006-10-01T00:00:00,Catheterization,E05.157
17032214,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17032214,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
17032214,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17032214,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17035453,2006-10-01T00:00:00,Drainage,E02.309
17035453,2006-10-01T00:00:00,Drainage,E04.237
17035453,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17035453,2006-10-01T00:00:00,Iatrogenic Disease,C23.550.291.875
17035453,2006-10-01T00:00:00,Lung Diseases,C08.381
17035453,2006-10-01T00:00:00,Manometry,E05.559
17035453,2006-10-01T00:00:00,"Models, Theoretical",E05.599
17035453,2006-10-01T00:00:00,Pleura,A04.716
17035453,2006-10-01T00:00:00,Pleura,A10.615.789.736
17035453,2006-10-01T00:00:00,Pleural Diseases,C08.528
17035453,2006-10-01T00:00:00,Pneumothorax,C08.528.778
17035453,2006-10-01T00:00:00,Postoperative Complications,C23.550.767
17035453,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17035453,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17035453,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17035453,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17035453,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17035453,2006-10-01T00:00:00,"Surgery, Computer-Assisted",E02.950.875
17035453,2006-10-01T00:00:00,"Surgery, Computer-Assisted",E04.749
17035453,2006-10-01T00:00:00,"Surgery, Computer-Assisted",L01.700.508.100.710.800
17035453,2006-10-01T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
17042890,2006-10-01T00:00:00,Adolescent,M01.060.057
17042890,2006-10-01T00:00:00,Bipolar Disorder,F03.600.150.150
17042890,2006-10-01T00:00:00,Child,M01.060.406
17042890,2006-10-01T00:00:00,Cognitive Therapy,F04.754.137.428
17042890,2006-10-01T00:00:00,Combined Modality Therapy,E02.186
17042890,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17042890,2006-10-01T00:00:00,Pilot Projects,E05.318.760.750
17042890,2006-10-01T00:00:00,Pilot Projects,E05.337.737
17042890,2006-10-01T00:00:00,Pilot Projects,N05.715.360.775.625
17042890,2006-10-01T00:00:00,Pilot Projects,N06.850.520.450.720
17044560,2006-10-01T00:00:00,Adolescent,M01.060.057
17044560,2006-10-01T00:00:00,Adult,M01.060.116
17044560,2006-10-01T00:00:00,Advanced Cardiac Life Support,E02.365.647.110.500
17044560,2006-10-01T00:00:00,Blood Pressure,E01.370.600.875.249
17044560,2006-10-01T00:00:00,Blood Pressure,G09.330.380.076
17044560,2006-10-01T00:00:00,Brain,A08.186.211
17044560,2006-10-01T00:00:00,Critical Care,E02.760.190
17044560,2006-10-01T00:00:00,Critical Care,N02.421.585.190
17044560,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17044560,2006-10-01T00:00:00,Intracranial Pressure,G11.561.170.505
17044560,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17044560,2006-10-01T00:00:00,"Monitoring, Physiologic",E01.370.520
17044560,2006-10-01T00:00:00,Oxygen,D01.268.185.550
17044560,2006-10-01T00:00:00,Oxygen,D01.362.670
17044560,2006-10-01T00:00:00,"Respiration, Artificial",E02.365.647.729
17044560,2006-10-01T00:00:00,"Respiration, Artificial",E02.880.820
17044560,2006-10-01T00:00:00,Resuscitation,E02.365.647
17047475,2006-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
17047475,2006-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
17047475,2006-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
17047475,2006-10-01T00:00:00,Bone Neoplasms,C04.588.149
17047475,2006-10-01T00:00:00,Bone Neoplasms,C05.116.231
17047475,2006-10-01T00:00:00,Child,M01.060.406
17047475,2006-10-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17047475,2006-10-01T00:00:00,Cyclophosphamide,D02.705.670.243
17047475,2006-10-01T00:00:00,Facial Paralysis,C07.465.327
17047475,2006-10-01T00:00:00,Facial Paralysis,C10.597.622.214
17047475,2006-10-01T00:00:00,Facial Paralysis,C23.888.592.636.214
17047475,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17047475,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17047475,2006-10-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17047475,2006-10-01T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
17047475,2006-10-01T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
17047475,2006-10-01T00:00:00,Temporal Bone,A02.835.232.781.885
17051782,2006-10-01T00:00:00,Adsorption,G02.149.047
17051782,2006-10-01T00:00:00,Adsorption,G02.149.767.029
17051782,2006-10-01T00:00:00,Adsorption,G02.842.750.029
17051782,2006-10-01T00:00:00,Geologic Sediments,G01.311.500
17051782,2006-10-01T00:00:00,Geologic Sediments,G16.500.320
17051782,2006-10-01T00:00:00,Plutonium,D01.268.033.700
17051782,2006-10-01T00:00:00,Plutonium,D01.268.271.100.700
17051782,2006-10-01T00:00:00,Plutonium,D01.268.556.700
17051782,2006-10-01T00:00:00,Plutonium,D01.552.020.734
17051782,2006-10-01T00:00:00,Plutonium,D01.552.544.700
17051782,2006-10-01T00:00:00,"Water Pollutants, Radioactive",D20.693.903
17051782,2006-10-01T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
17059735,2006-10-01T00:00:00,Adult,M01.060.116
17059735,2006-10-01T00:00:00,Fatty Liver,C06.552.241
17059735,2006-10-01T00:00:00,Fibrosis,C23.550.355
17059735,2006-10-01T00:00:00,Gastric Bypass,E02.065.062.249
17059735,2006-10-01T00:00:00,Gastric Bypass,E04.035.398.385
17059735,2006-10-01T00:00:00,Gastric Bypass,E04.062.249
17059735,2006-10-01T00:00:00,Gastric Bypass,E04.210.457.430
17059735,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17059735,2006-10-01T00:00:00,Liver,A03.620
17059735,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17059735,2006-10-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17059735,2006-10-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17059735,2006-10-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17059735,2006-10-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17059735,2006-10-01T00:00:00,Weight Loss,C23.888.144.243.963
17059735,2006-10-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17067305,2006-10-01T00:00:00,Animals,B01.050
17067305,2006-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17067305,2006-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17067305,2006-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17067305,2006-10-01T00:00:00,Brain Injuries,C10.228.140.199
17067305,2006-10-01T00:00:00,Brain Injuries,C10.900.300.087
17067305,2006-10-01T00:00:00,Brain Injuries,C21.866.260.118
17067305,2006-10-01T00:00:00,Brain Injuries,C21.866.915.300.200
17067305,2006-10-01T00:00:00,Immunotoxins,D12.776.124.486.485.114.580.450
17067305,2006-10-01T00:00:00,Immunotoxins,D12.776.124.790.651.114.580.450
17067305,2006-10-01T00:00:00,Immunotoxins,D12.776.377.715.548.114.580.450
17067305,2006-10-01T00:00:00,Immunotoxins,D27.888.569.271
17067305,2006-10-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17067305,2006-10-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17067305,2006-10-01T00:00:00,Neuropeptides,D12.644.400
17067305,2006-10-01T00:00:00,Neuropeptides,D12.776.641.650
17067305,2006-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17067305,2006-10-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17067305,2006-10-01T00:00:00,Reaction Time,F02.830.650
17067305,2006-10-01T00:00:00,Reaction Time,F04.669.817
17067305,2006-10-01T00:00:00,Reaction Time,G11.561.677
17067305,2006-10-01T00:00:00,Sleep,F02.830.855
17067305,2006-10-01T00:00:00,Sleep,G11.561.600.815
17067305,2006-10-01T00:00:00,Walking,G11.427.590.530.568.900
17067305,2006-10-01T00:00:00,Walking,G11.427.590.530.698.940
17067305,2006-10-01T00:00:00,Walking,I03.450.642.845.940
17075907,2006-10-01T00:00:00,Adult,M01.060.116
17075907,2006-10-01T00:00:00,Aged,M01.060.116.100
17075907,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17075907,2006-10-01T00:00:00,Mental Health Services,F04.408
17075907,2006-10-01T00:00:00,Mental Health Services,N02.421.461
17075907,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17075907,2006-10-01T00:00:00,Needs Assessment,I02.594
17075907,2006-10-01T00:00:00,Needs Assessment,N03.349.380.565
17075907,2006-10-01T00:00:00,Needs Assessment,N05.300.537
17075907,2006-10-01T00:00:00,New York City,Z01.107.567.875.350.530.530
17075907,2006-10-01T00:00:00,New York City,Z01.107.567.875.500.530.530
17075907,2006-10-01T00:00:00,New York City,Z01.433.741
17075907,2006-10-01T00:00:00,Personality Inventory,F04.711.647.513
17075907,2006-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17076624,2006-10-01T00:00:00,Animals,B01.050
17076624,2006-10-01T00:00:00,Aqueous Humor,A09.371.060.067.070
17076624,2006-10-01T00:00:00,Aqueous Humor,A12.207.270.040
17076624,2006-10-01T00:00:00,Bradykinin,D12.644.276.812.169
17076624,2006-10-01T00:00:00,Bradykinin,D12.644.400.090
17076624,2006-10-01T00:00:00,Bradykinin,D12.644.456.193
17076624,2006-10-01T00:00:00,Bradykinin,D12.776.467.812.169
17076624,2006-10-01T00:00:00,Bradykinin,D12.776.641.650.090
17076624,2006-10-01T00:00:00,Bradykinin,D23.469.050.375.110
17076624,2006-10-01T00:00:00,Bradykinin,D23.529.812.169
17076624,2006-10-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17076624,2006-10-01T00:00:00,Eye,A01.456.505.420
17076624,2006-10-01T00:00:00,Eye,A09.371
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
17076624,2006-10-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
17076624,2006-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
17076624,2006-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
17076624,2006-10-01T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
17089947,2006-10-01T00:00:00,Algorithms,G17.035
17089947,2006-10-01T00:00:00,Algorithms,L01.224.050
17089947,2006-10-01T00:00:00,Communicable Diseases,C01.539.221
17089947,2006-10-01T00:00:00,Computer Simulation,L01.224.160
17089947,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17089947,2006-10-01T00:00:00,Markov Chains,E05.318.740.600.500
17089947,2006-10-01T00:00:00,Markov Chains,E05.318.740.996.500
17089947,2006-10-01T00:00:00,Markov Chains,G17.830.500
17089947,2006-10-01T00:00:00,Markov Chains,N05.715.360.750.625.500
17089947,2006-10-01T00:00:00,Markov Chains,N05.715.360.750.770.500
17089947,2006-10-01T00:00:00,Markov Chains,N06.850.520.830.600.500
17089947,2006-10-01T00:00:00,Markov Chains,N06.850.520.830.996.500
17089947,2006-10-01T00:00:00,"Models, Statistical",E05.318.740.500
17089947,2006-10-01T00:00:00,"Models, Statistical",E05.599.835
17089947,2006-10-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17089947,2006-10-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17089947,2006-10-01T00:00:00,Monte Carlo Method,E05.318.740.525
17089947,2006-10-01T00:00:00,Monte Carlo Method,L01.906.575.422
17089947,2006-10-01T00:00:00,Monte Carlo Method,N05.715.360.750.540
17089947,2006-10-01T00:00:00,Monte Carlo Method,N06.850.520.830.525
17089947,2006-10-01T00:00:00,Space-Time Clustering,E05.318.740.250.700
17089947,2006-10-01T00:00:00,Space-Time Clustering,N05.715.360.750.200.775
17089947,2006-10-01T00:00:00,Space-Time Clustering,N06.850.520.830.250.700
17094645,2006-10-01T00:00:00,Adult,M01.060.116
17094645,2006-10-01T00:00:00,Health Status,I01.240.425
17094645,2006-10-01T00:00:00,Health Status,N01.224.425
17094645,2006-10-01T00:00:00,Health Status,N06.850.505.400.425
17094645,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17094645,2006-10-01T00:00:00,Internet,L01.224.230.110.500
17094645,2006-10-01T00:00:00,Medical Informatics,L01.313.500
17094645,2006-10-01T00:00:00,Medical Informatics,L01.700
17094645,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17094645,2006-10-01T00:00:00,Questionnaires,E05.318.308.750
17094645,2006-10-01T00:00:00,Questionnaires,L01.280.800
17094645,2006-10-01T00:00:00,Questionnaires,N05.715.360.300.695
17094645,2006-10-01T00:00:00,Questionnaires,N06.850.520.308.750
17094645,2006-10-01T00:00:00,United States,Z01.107.567.875
17107242,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17107242,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17107242,2006-10-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17107242,2006-10-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
17107242,2006-10-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
17107242,2006-10-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
17107242,2006-10-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
17107242,2006-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17107242,2006-10-01T00:00:00,Treatment Outcome,E01.789.800
17107242,2006-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17107242,2006-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17107242,2006-10-01T00:00:00,Veterans,M01.930
17112003,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17112003,2006-10-01T00:00:00,"Kidney Diseases, Cystic",C12.777.419.403
17112003,2006-10-01T00:00:00,"Kidney Diseases, Cystic",C13.351.968.419.403
17112003,2006-10-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
17112003,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17132772,2006-10-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17132772,2006-10-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17132772,2006-10-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17132772,2006-10-01T00:00:00,Cell Differentiation,G04.299.151
17132772,2006-10-01T00:00:00,Heart,A07.541
17132772,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17132772,2006-10-01T00:00:00,Morphogenesis,G07.700.320.500
17132772,2006-10-01T00:00:00,Myocardium,A02.633.580
17132772,2006-10-01T00:00:00,Myocardium,A07.541.704
17132772,2006-10-01T00:00:00,Myocardium,A10.690.552.750
17132772,2006-10-01T00:00:00,Phenotype,G05.695
17132772,2006-10-01T00:00:00,Stem Cells,A11.872
17132774,2006-10-01T00:00:00,Connexin 43,D12.776.543.585.250.200
17132774,2006-10-01T00:00:00,Gap Junctions,A11.284.149.165.420.471
17132774,2006-10-01T00:00:00,Heart,A07.541
17132774,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17132774,2006-10-01T00:00:00,Membrane Proteins,D12.776.543
17132774,2006-10-01T00:00:00,Phosphoproteins,D12.776.744
17132774,2006-10-01T00:00:00,Wound Healing,G16.100.856.891
17132776,2006-10-01T00:00:00,Animals,B01.050
17132776,2006-10-01T00:00:00,Extracellular Matrix,A11.284.295.310
17132776,2006-10-01T00:00:00,Fibroblasts,A11.329.228
17132776,2006-10-01T00:00:00,Fibroblasts,A11.872.228
17132776,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17132776,2006-10-01T00:00:00,Myocardium,A02.633.580
17132776,2006-10-01T00:00:00,Myocardium,A07.541.704
17132776,2006-10-01T00:00:00,Myocardium,A10.690.552.750
17132782,2006-10-01T00:00:00,Animals,B01.050
17132782,2006-10-01T00:00:00,Calcium Signaling,G02.111.087.800.800.100
17132782,2006-10-01T00:00:00,Calcium Signaling,G02.149.115.800.800.100
17132782,2006-10-01T00:00:00,Calcium Signaling,G03.495.166.500.100
17132782,2006-10-01T00:00:00,Calcium Signaling,G04.299.880.800.100
17132782,2006-10-01T00:00:00,Cell Differentiation,G04.299.151
17132782,2006-10-01T00:00:00,Heart,A07.541
17132782,2006-10-01T00:00:00,Myocardium,A02.633.580
17132782,2006-10-01T00:00:00,Myocardium,A07.541.704
17132782,2006-10-01T00:00:00,Myocardium,A10.690.552.750
17132782,2006-10-01T00:00:00,Pluripotent Stem Cells,A11.872.700
17132782,2006-10-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17133056,2006-10-01T00:00:00,Adolescent,M01.060.057
17133056,2006-10-01T00:00:00,Adult,M01.060.116
17133056,2006-10-01T00:00:00,Aged,M01.060.116.100
17133056,2006-10-01T00:00:00,Animals,B01.050
17133056,2006-10-01T00:00:00,Child,M01.060.406
17133056,2006-10-01T00:00:00,Corneal Stroma,A09.371.060.217.228
17133056,2006-10-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17133056,2006-10-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17133056,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17133056,2006-10-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17133056,2006-10-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17133056,2006-10-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17133056,2006-10-01T00:00:00,Middle Aged,M01.060.116.630
17133056,2006-10-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17135555,2006-10-01T00:00:00,Animals,B01.050
17135555,2006-10-01T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
17135555,2006-10-01T00:00:00,Dog Diseases,C22.268
17135555,2006-10-01T00:00:00,Dogs,B01.050.150.900.649.147.153.200
17135555,2006-10-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17135555,2006-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
17135555,2006-10-01T00:00:00,Prevalence,L01.280.975.525.750
17135555,2006-10-01T00:00:00,Prevalence,N01.224.935.597.750
17135555,2006-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17135555,2006-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17193583,2006-10-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
17193583,2006-10-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
17193583,2006-10-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
17193583,2006-10-01T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
17193583,2006-10-01T00:00:00,Electrons,G01.201.750
17193583,2006-10-01T00:00:00,Electrons,G01.249.335
17193583,2006-10-01T00:00:00,Micelles,D05.374
17193583,2006-10-01T00:00:00,Micelles,D26.255.560
17193583,2006-10-01T00:00:00,Micelles,D27.720.280.560
17193583,2006-10-01T00:00:00,Molecular Conformation,G02.111.570.790
17193583,2006-10-01T00:00:00,Molecular Conformation,G02.575.500
17193583,2006-10-01T00:00:00,Molecular Conformation,G02.842.575.500
17193583,2006-10-01T00:00:00,Nanoparticles,J01.637.512.600
17193583,2006-10-01T00:00:00,Nanostructures,J01.637.512
17193583,2006-10-01T00:00:00,Nanotechnology,H01.603
17193583,2006-10-01T00:00:00,Nanotechnology,J01.897.520.600
17193583,2006-10-01T00:00:00,Polymers,D05.750
17193583,2006-10-01T00:00:00,Polymers,D25.720
17193583,2006-10-01T00:00:00,Polymers,J01.637.051.720
17193583,2006-10-01T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
17193583,2006-10-01T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
17193583,2006-10-01T00:00:00,Surface-Active Agents,D27.720.877
17193583,2006-10-01T00:00:00,Temperature,G01.906.595
17193583,2006-10-01T00:00:00,Temperature,G16.500.275.063.725.710
17193583,2006-10-01T00:00:00,Temperature,G16.500.750.775.710
17193583,2006-10-01T00:00:00,Temperature,N06.230.150.450
17193583,2006-10-01T00:00:00,Temperature,N06.230.300.100.725.710
17255445,2006-10-01T00:00:00,Animals,B01.050
17255445,2006-10-01T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17255445,2006-10-01T00:00:00,Turtles,B01.050.150.900.833.848
17319240,2006-10-01T00:00:00,Adolescent,M01.060.057
17319240,2006-10-01T00:00:00,Age Factors,N05.715.350.075
17319240,2006-10-01T00:00:00,Age Factors,N06.850.490.250
17319240,2006-10-01T00:00:00,Asperger Syndrome,F03.550.325.100
17319240,2006-10-01T00:00:00,Autistic Disorder,F03.550.325.125
17319240,2006-10-01T00:00:00,Child,M01.060.406
17319240,2006-10-01T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
17319240,2006-10-01T00:00:00,"Child, Preschool",M01.060.406.448
17319240,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319240,2006-10-01T00:00:00,Incidence,E05.318.308.985.525.375
17319240,2006-10-01T00:00:00,Incidence,L01.280.975.525.375
17319240,2006-10-01T00:00:00,Incidence,N01.224.935.597.500
17319240,2006-10-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17319240,2006-10-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17319240,2006-10-01T00:00:00,Infant,M01.060.703
17319240,2006-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
17319240,2006-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
17319240,2006-10-01T00:00:00,Prevalence,L01.280.975.525.750
17319240,2006-10-01T00:00:00,Prevalence,N01.224.935.597.750
17319240,2006-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17319240,2006-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17319240,2006-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17319240,2006-10-01T00:00:00,Risk Factors,N05.715.350.200.700
17319240,2006-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17319240,2006-10-01T00:00:00,Risk Factors,N06.850.490.625.750
17319240,2006-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17319240,2006-10-01T00:00:00,United States,Z01.107.567.875
17319241,2006-10-01T00:00:00,Adolescent,M01.060.057
17319241,2006-10-01T00:00:00,Age Factors,N05.715.350.075
17319241,2006-10-01T00:00:00,Age Factors,N06.850.490.250
17319241,2006-10-01T00:00:00,Autistic Disorder,F03.550.325.125
17319241,2006-10-01T00:00:00,Child,M01.060.406
17319241,2006-10-01T00:00:00,"Child, Preschool",M01.060.406.448
17319241,2006-10-01T00:00:00,"Diagnosis, Differential",E01.171
17319241,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17319241,2006-10-01T00:00:00,Infant,M01.060.703
17319241,2006-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
17319241,2006-10-01T00:00:00,Mass Screening,E01.370.500
17319241,2006-10-01T00:00:00,Mass Screening,E05.318.308.250.580
17319241,2006-10-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17319241,2006-10-01T00:00:00,Mass Screening,N02.421.726.233.443
17319241,2006-10-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17319241,2006-10-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17319241,2006-10-01T00:00:00,Mass Screening,N06.850.780.500
17319241,2006-10-01T00:00:00,Population Surveillance,E05.318.308.250.700
17319241,2006-10-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
17319241,2006-10-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
17319241,2006-10-01T00:00:00,Population Surveillance,N06.850.780.675
17319241,2006-10-01T00:00:00,United States,Z01.107.567.875
17494269,2006-10-01T00:00:00,"Air Pollution, Indoor",N06.850.460.100.080
17494269,2006-10-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
17494269,2006-10-01T00:00:00,Environmental Monitoring,N06.850.780.375
17494269,2006-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17494269,2006-10-01T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17494269,2006-10-01T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17494269,2006-10-01T00:00:00,Workplace,N01.824.245.925
17494269,2006-10-01T00:00:00,Workplace,N04.452.677.975
17015637,2006-10-02T00:00:00,Adenosine,D03.438.759.590.138
17015637,2006-10-02T00:00:00,Adenosine,D13.570.583.138
17015637,2006-10-02T00:00:00,Adenosine,D13.570.800.096
17015637,2006-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
17015637,2006-10-02T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
17015637,2006-10-02T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17015637,2006-10-02T00:00:00,Trabecular Meshwork,A09.371.060.932
17015830,2006-10-02T00:00:00,Animals,B01.050
17015830,2006-10-02T00:00:00,"Animals, Newborn",B01.050.050.282
17015830,2006-10-02T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17015830,2006-10-02T00:00:00,Fluorescent Dyes,D27.720.233.348
17015830,2006-10-02T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17015830,2006-10-02T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17015830,2006-10-02T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17015830,2006-10-02T00:00:00,"Microscopy, Confocal",E05.595.395
17015830,2006-10-02T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17015830,2006-10-02T00:00:00,Mitochondria,A11.284.835.626
17015830,2006-10-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17015830,2006-10-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17015830,2006-10-02T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
17015830,2006-10-02T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
17015830,2006-10-02T00:00:00,Superoxides,D01.248.497.158.685.750.850
17015830,2006-10-02T00:00:00,Superoxides,D01.339.431.374.850
17015830,2006-10-02T00:00:00,Superoxides,D01.339.431.750
17015830,2006-10-02T00:00:00,Superoxides,D01.650.550.750.800
17016439,2006-10-02T00:00:00,Amino Acid Sequence,G02.111.570.060
17016439,2006-10-02T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17016439,2006-10-02T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17016439,2006-10-02T00:00:00,Cell Cycle,G04.299.134
17016439,2006-10-02T00:00:00,Cell Division,G04.299.134.220
17016439,2006-10-02T00:00:00,Cell Division,G04.299.233.750.500
17016439,2006-10-02T00:00:00,Cell Division,G05.355.105
17016439,2006-10-02T00:00:00,Cell Division,G07.700.320.249.410.750.500
17016439,2006-10-02T00:00:00,Cholesterol,D04.808.247.222.284
17016439,2006-10-02T00:00:00,Cholesterol,D04.808.247.808.197
17016439,2006-10-02T00:00:00,Cholesterol,D10.570.938.208
17016439,2006-10-02T00:00:00,Cholesterol,D10.851.208
17016439,2006-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17016439,2006-10-02T00:00:00,Kidney,A05.810.453
17016439,2006-10-02T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17016439,2006-10-02T00:00:00,Kidney Neoplasms,C12.758.820.750
17016439,2006-10-02T00:00:00,Kidney Neoplasms,C12.777.419.473
17016439,2006-10-02T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17016439,2006-10-02T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17016439,2006-10-02T00:00:00,Molecular Sequence Data,L01.453.245.667
17016439,2006-10-02T00:00:00,"Receptors, Cell Surface",D12.776.543.750
17134638,2006-10-02T00:00:00,Aged,M01.060.116.100
17134638,2006-10-02T00:00:00,Coronary Vessels,A07.231.114.269
17134638,2006-10-02T00:00:00,Coronary Vessels,A07.231.908.194
17134638,2006-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17134638,2006-10-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17134638,2006-10-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17134638,2006-10-02T00:00:00,Middle Aged,M01.060.116.630
17134638,2006-10-02T00:00:00,Stroke Volume,E01.370.370.380.150.700
17134638,2006-10-02T00:00:00,Stroke Volume,G09.330.380.124.882
17018687,2006-10-03T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17018687,2006-10-03T00:00:00,Cystic Fibrosis,C06.689.202
17018687,2006-10-03T00:00:00,Cystic Fibrosis,C08.381.187
17018687,2006-10-03T00:00:00,Cystic Fibrosis,C16.320.190
17018687,2006-10-03T00:00:00,Cystic Fibrosis,C16.614.213
17018687,2006-10-03T00:00:00,"Hospitals, Teaching",N02.278.020.300
17018687,2006-10-03T00:00:00,"Hospitals, Teaching",N02.278.421.639
17018687,2006-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17018687,2006-10-03T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
17018687,2006-10-03T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
17018687,2006-10-03T00:00:00,Pseudomonas Infections,C01.252.400.739
17018687,2006-10-03T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
17018687,2006-10-03T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
17002334,2006-10-04T00:00:00,Bacillus subtilis,B03.300.390.400.158.218.725
17002334,2006-10-04T00:00:00,Bacillus subtilis,B03.510.100.100.218.725
17002334,2006-10-04T00:00:00,Bacillus subtilis,B03.510.415.400.158.218.725
17002334,2006-10-04T00:00:00,Bacillus subtilis,B03.510.460.410.158.218.725
17002334,2006-10-04T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
17002334,2006-10-04T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
17002334,2006-10-04T00:00:00,"Spores, Bacterial",A11.870.700
17002334,2006-10-04T00:00:00,"Spores, Bacterial",B05.775.700
17070513,2006-10-04T00:00:00,Adenoviridae,B04.280.030
17070513,2006-10-04T00:00:00,Adenoviridae,B04.909.204.097
17070513,2006-10-04T00:00:00,Animals,B01.050
17070513,2006-10-04T00:00:00,Cell Adhesion,G04.299.117
17070513,2006-10-04T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17070513,2006-10-04T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17070513,2006-10-04T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17070513,2006-10-04T00:00:00,Cell Line,A11.251.210
17070513,2006-10-04T00:00:00,Chick Embryo,A13.350.150
17070513,2006-10-04T00:00:00,Chick Embryo,A16.331.200
17070513,2006-10-04T00:00:00,Collagen,D05.750.078.280
17070513,2006-10-04T00:00:00,Collagen,D12.776.860.300.250
17070513,2006-10-04T00:00:00,Extracellular Matrix,A11.284.295.310
17070513,2006-10-04T00:00:00,Heart Valves,A07.541.510
17070513,2006-10-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17070513,2006-10-04T00:00:00,Integrins,D12.776.543.750.705.408
17070513,2006-10-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17070513,2006-10-04T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17070513,2006-10-04T00:00:00,Mesoderm,A16.504.660
17070513,2006-10-04T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
17098212,2006-10-04T00:00:00,Animals,B01.050
17098212,2006-10-04T00:00:00,Glutathione,D12.644.456.448
17098212,2006-10-04T00:00:00,Glutathione Transferase,D08.811.913.225.500
17098212,2006-10-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
17098212,2006-10-04T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
17098212,2006-10-04T00:00:00,Signal Transduction,G02.111.087.800
17098212,2006-10-04T00:00:00,Signal Transduction,G02.149.115.800
17098212,2006-10-04T00:00:00,Signal Transduction,G04.299.880
17078922,2006-10-05T00:00:00,Glycoproteins,D09.400.430
17078922,2006-10-05T00:00:00,Glycoproteins,D12.776.395
17078922,2006-10-05T00:00:00,HIV-1,B04.820.650.589.650.350.400
17078922,2006-10-05T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
17078922,2006-10-05T00:00:00,Hela Cells,A11.251.210.190.400
17078922,2006-10-05T00:00:00,Hela Cells,A11.251.860.180.400
17078922,2006-10-05T00:00:00,Hela Cells,A11.436.340
17078922,2006-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17078922,2006-10-05T00:00:00,Recombinant Proteins,D12.776.828
17027754,2006-10-06T00:00:00,Animals,B01.050
17027754,2006-10-06T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17027754,2006-10-06T00:00:00,Intraocular Pressure,G14.440
17027754,2006-10-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17028160,2006-10-06T00:00:00,"Adaptation, Physiological",G07.700.062
17028160,2006-10-06T00:00:00,"Adaptation, Physiological",G16.100.057.500
17028160,2006-10-06T00:00:00,Animals,B01.050
17028160,2006-10-06T00:00:00,Myocardium,A02.633.580
17028160,2006-10-06T00:00:00,Myocardium,A07.541.704
17028160,2006-10-06T00:00:00,Myocardium,A10.690.552.750
17028160,2006-10-06T00:00:00,Oxygen,D01.268.185.550
17028160,2006-10-06T00:00:00,Oxygen,D01.362.670
17028160,2006-10-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17028160,2006-10-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17028160,2006-10-06T00:00:00,Reactive Oxygen Species,D01.339.431
17028160,2006-10-06T00:00:00,Reactive Oxygen Species,D01.650.775
17030447,2006-10-06T00:00:00,Adult,M01.060.116
17030447,2006-10-06T00:00:00,Attitude,F01.100
17030447,2006-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17030447,2006-10-06T00:00:00,Nicotine,D03.132.760.570
17030447,2006-10-06T00:00:00,Nicotine,D03.383.725.518
17030447,2006-10-06T00:00:00,Questionnaires,E05.318.308.750
17030447,2006-10-06T00:00:00,Questionnaires,L01.280.800
17030447,2006-10-06T00:00:00,Questionnaires,N05.715.360.300.695
17030447,2006-10-06T00:00:00,Questionnaires,N06.850.520.308.750
17030447,2006-10-06T00:00:00,Smoking,F01.145.466.753
17030447,2006-10-06T00:00:00,Students,I02.233.748
17030447,2006-10-06T00:00:00,Students,I02.851
17030447,2006-10-06T00:00:00,Students,M01.848
17030447,2006-10-06T00:00:00,Universities,I02.783.850
17084841,2006-10-06T00:00:00,Animals,B01.050
17084841,2006-10-06T00:00:00,Cell Differentiation,G04.299.151
17084841,2006-10-06T00:00:00,Cell Line,A11.251.210
17084841,2006-10-06T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
17084841,2006-10-06T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
17084841,2006-10-06T00:00:00,NFATC Transcription Factors,D12.776.930.608
17084841,2006-10-06T00:00:00,Osteoclasts,A11.329.372.700
17084841,2006-10-06T00:00:00,Osteoclasts,A11.627.482.700
17084841,2006-10-06T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17084841,2006-10-06T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17084841,2006-10-06T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17084841,2006-10-06T00:00:00,RANK Ligand,D12.644.276.374.750.562
17084841,2006-10-06T00:00:00,RANK Ligand,D12.644.276.972.562
17084841,2006-10-06T00:00:00,RANK Ligand,D12.776.467.374.750.562
17084841,2006-10-06T00:00:00,RANK Ligand,D12.776.467.972.562
17084841,2006-10-06T00:00:00,RANK Ligand,D23.529.374.750.562
17084841,2006-10-06T00:00:00,RANK Ligand,D23.529.972.562
17084841,2006-10-06T00:00:00,Recombinant Proteins,D12.776.828
17084841,2006-10-06T00:00:00,Signal Transduction,G02.111.087.800
17084841,2006-10-06T00:00:00,Signal Transduction,G02.149.115.800
17084841,2006-10-06T00:00:00,Signal Transduction,G04.299.880
17028045,2006-10-09T00:00:00,Acoustic Stimulation,E02.037
17028045,2006-10-09T00:00:00,Acoustic Stimulation,E02.190.888.030
17028045,2006-10-09T00:00:00,Acoustic Stimulation,E05.723.136
17028045,2006-10-09T00:00:00,Animals,B01.050
17028045,2006-10-09T00:00:00,"Behavior, Animal",F01.145.113
17028045,2006-10-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17028045,2006-10-09T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17028045,2006-10-09T00:00:00,Neuropeptides,D12.644.400
17028045,2006-10-09T00:00:00,Neuropeptides,D12.776.641.650
17028045,2006-10-09T00:00:00,Noise,G01.595.907.567
17028045,2006-10-09T00:00:00,Noise,G16.500.275.600
17028045,2006-10-09T00:00:00,Noise,N06.230.400
17028045,2006-10-09T00:00:00,Noise,N06.850.460.610
17028045,2006-10-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17028045,2006-10-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17030363,2006-10-09T00:00:00,Animals,B01.050
17030363,2006-10-09T00:00:00,Aortic Valve,A07.541.510.110
17030363,2006-10-09T00:00:00,Bioprosthesis,E07.695.100
17030363,2006-10-09T00:00:00,Calcium,D01.268.552.100
17030363,2006-10-09T00:00:00,Calcium,D01.552.539.288
17030363,2006-10-09T00:00:00,Calcium,D23.119.100
17030363,2006-10-09T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17030363,2006-10-09T00:00:00,Collagen,D05.750.078.280
17030363,2006-10-09T00:00:00,Collagen,D12.776.860.300.250
17030363,2006-10-09T00:00:00,Glycosaminoglycans,D09.698.373
17030363,2006-10-09T00:00:00,Heart Valve Prosthesis,E07.695.310
17030363,2006-10-09T00:00:00,Heart Valves,A07.541.510
17030363,2006-10-09T00:00:00,"Models, Chemical",E05.599.495
17030363,2006-10-09T00:00:00,Temperature,G01.906.595
17030363,2006-10-09T00:00:00,Temperature,G16.500.275.063.725.710
17030363,2006-10-09T00:00:00,Temperature,G16.500.750.775.710
17030363,2006-10-09T00:00:00,Temperature,N06.230.150.450
17030363,2006-10-09T00:00:00,Temperature,N06.230.300.100.725.710
17030510,2006-10-09T00:00:00,Catalytic Domain,G02.111.570.120.704
17030510,2006-10-09T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
17030510,2006-10-09T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17030510,2006-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17030510,2006-10-09T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17030510,2006-10-09T00:00:00,Mitochondria,A11.284.835.626
17030510,2006-10-09T00:00:00,"Models, Biological",E05.599.395
17030510,2006-10-09T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
17030510,2006-10-09T00:00:00,Protein Phosphatase 1,D08.811.277.352.650.625.687
17030510,2006-10-09T00:00:00,Signal Transduction,G02.111.087.800
17030510,2006-10-09T00:00:00,Signal Transduction,G02.149.115.800
17030510,2006-10-09T00:00:00,Signal Transduction,G04.299.880
17030510,2006-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17030510,2006-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17030510,2006-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17030510,2006-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17030828,2006-10-09T00:00:00,Adult,M01.060.116
17030828,2006-10-09T00:00:00,Aged,M01.060.116.100
17030828,2006-10-09T00:00:00,Case-Control Studies,E05.318.760.500.500
17030828,2006-10-09T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17030828,2006-10-09T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17030828,2006-10-09T00:00:00,Environmental Exposure,N06.850.460.350
17030828,2006-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17030828,2006-10-09T00:00:00,Middle Aged,M01.060.116.630
17030828,2006-10-09T00:00:00,Myocardial Infarction,C14.280.647.500
17030828,2006-10-09T00:00:00,Myocardial Infarction,C14.907.585.500
17030828,2006-10-09T00:00:00,New York,Z01.107.567.875.075.437
17030828,2006-10-09T00:00:00,New York,Z01.107.567.875.350.530
17030828,2006-10-09T00:00:00,New York,Z01.107.567.875.500.530
17030828,2006-10-09T00:00:00,Occupational Exposure,N06.850.460.350.600
17030828,2006-10-09T00:00:00,Risk Factors,E05.318.740.600.800.725
17030828,2006-10-09T00:00:00,Risk Factors,N05.715.350.200.700
17030828,2006-10-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17030828,2006-10-09T00:00:00,Risk Factors,N06.850.490.625.750
17030828,2006-10-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17030828,2006-10-09T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
17030828,2006-10-09T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
17031638,2006-10-09T00:00:00,Anthraquinones,D02.455.426.559.847.117.159
17031638,2006-10-09T00:00:00,Anthraquinones,D02.806.100
17031638,2006-10-09T00:00:00,Anthraquinones,D04.615.117.159
17031638,2006-10-09T00:00:00,Electrodes,E07.305.250
17031638,2006-10-09T00:00:00,Ethanol,D02.033.375
17031638,2006-10-09T00:00:00,Formates,D02.241.081.504.435
17031638,2006-10-09T00:00:00,Lactic Acid,D02.241.511.459.450
17030766,2006-10-10T00:00:00,Aged,M01.060.116.100
17030766,2006-10-10T00:00:00,Anticoagulants,D27.505.954.502.119
17030766,2006-10-10T00:00:00,Cerebral Arterial Diseases,C10.228.140.300.510.200
17030766,2006-10-10T00:00:00,Cerebral Arterial Diseases,C14.907.253.560.200
17030766,2006-10-10T00:00:00,"Constriction, Pathologic",C23.300.287
17030766,2006-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17030766,2006-10-10T00:00:00,Middle Aged,M01.060.116.630
17030766,2006-10-10T00:00:00,Risk Assessment,E05.318.740.600.800.715
17030766,2006-10-10T00:00:00,Risk Assessment,N04.452.871.715
17030766,2006-10-10T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17030766,2006-10-10T00:00:00,Risk Assessment,N06.850.505.715
17030766,2006-10-10T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17030766,2006-10-10T00:00:00,Risk Factors,E05.318.740.600.800.725
17030766,2006-10-10T00:00:00,Risk Factors,N05.715.350.200.700
17030766,2006-10-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17030766,2006-10-10T00:00:00,Risk Factors,N06.850.490.625.750
17030766,2006-10-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17030766,2006-10-10T00:00:00,Treatment Outcome,E01.789.800
17030766,2006-10-10T00:00:00,Treatment Outcome,N04.761.559.590.800
17030766,2006-10-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17030766,2006-10-10T00:00:00,United States,Z01.107.567.875
17030766,2006-10-10T00:00:00,Warfarin,D03.438.150.446.520.914
17030766,2006-10-10T00:00:00,Warfarin,D03.830.219.446.520.914
17032723,2006-10-10T00:00:00,Adolescent,M01.060.057
17032723,2006-10-10T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
17032723,2006-10-10T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
17032723,2006-10-10T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
17032723,2006-10-10T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
17032723,2006-10-10T00:00:00,Adult,M01.060.116
17032723,2006-10-10T00:00:00,Biological Markers,D23.101
17032723,2006-10-10T00:00:00,Child,M01.060.406
17032723,2006-10-10T00:00:00,"Child, Preschool",M01.060.406.448
17032723,2006-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17032723,2006-10-10T00:00:00,Infant,M01.060.703
17032723,2006-10-10T00:00:00,Renin,D08.811.277.656.074.500.780
17032723,2006-10-10T00:00:00,Renin,D08.811.277.656.300.048.780
17032723,2006-10-10T00:00:00,Renin,D08.811.277.656.837.750
17035230,2006-10-10T00:00:00,Breast Neoplasms,C04.588.180
17035230,2006-10-10T00:00:00,Breast Neoplasms,C17.800.090.500
17035230,2006-10-10T00:00:00,Cell Line,A11.251.210
17035230,2006-10-10T00:00:00,Cell Movement,G04.299.283
17035230,2006-10-10T00:00:00,Cell Movement,G07.700.560.500.180
17035230,2006-10-10T00:00:00,Cell Proliferation,G04.299.233.750
17035230,2006-10-10T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17035230,2006-10-10T00:00:00,Epithelial Cells,A11.436
17035230,2006-10-10T00:00:00,Glycoproteins,D09.400.430
17035230,2006-10-10T00:00:00,Glycoproteins,D12.776.395
17035230,2006-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17035230,2006-10-10T00:00:00,Intercellular Signaling Peptides and Proteins,D12.644.276
17035230,2006-10-10T00:00:00,Intercellular Signaling Peptides and Proteins,D12.776.467
17035230,2006-10-10T00:00:00,Intercellular Signaling Peptides and Proteins,D23.529
17035230,2006-10-10T00:00:00,Neoplasm Invasiveness,C04.697.645
17035230,2006-10-10T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17035230,2006-10-10T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17035230,2006-10-10T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17035230,2006-10-10T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17035230,2006-10-10T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17035356,2006-10-11T00:00:00,Adult,M01.060.116
17035356,2006-10-11T00:00:00,Aged,M01.060.116.100
17035356,2006-10-11T00:00:00,Aging,G07.700.320.124
17035356,2006-10-11T00:00:00,Demography,I01.240
17035356,2006-10-11T00:00:00,Demography,N01.224
17035356,2006-10-11T00:00:00,Demography,N06.850.505.400
17035356,2006-10-11T00:00:00,Disasters,N06.230.100
17035356,2006-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17035356,2006-10-11T00:00:00,Mental Disorders,F03
17035356,2006-10-11T00:00:00,Middle Aged,M01.060.116.630
17035356,2006-10-11T00:00:00,Risk Factors,E05.318.740.600.800.725
17035356,2006-10-11T00:00:00,Risk Factors,N05.715.350.200.700
17035356,2006-10-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17035356,2006-10-11T00:00:00,Risk Factors,N06.850.490.625.750
17035356,2006-10-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17035536,2006-10-11T00:00:00,Animals,B01.050
17035536,2006-10-11T00:00:00,"Animals, Newborn",B01.050.050.282
17035536,2006-10-11T00:00:00,Cell Line,A11.251.210
17035536,2006-10-11T00:00:00,Cell Proliferation,G04.299.233.750
17035536,2006-10-11T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17035536,2006-10-11T00:00:00,Cystine,D01.248.497.158.874.390.369
17035536,2006-10-11T00:00:00,Cystine,D01.875.350.850.150.369
17035536,2006-10-11T00:00:00,Cystine,D02.886.030.230.369
17035536,2006-10-11T00:00:00,Cystine,D02.886.520.150.087
17035536,2006-10-11T00:00:00,Cystine,D12.125.095.369
17035536,2006-10-11T00:00:00,Cystine,D12.125.119.369
17035536,2006-10-11T00:00:00,Cystine,D12.125.166.230.369
17035536,2006-10-11T00:00:00,Glutamic Acid,D12.125.067.750
17035536,2006-10-11T00:00:00,Glutamic Acid,D12.125.119.450
17035536,2006-10-11T00:00:00,Glutamic Acid,D12.125.427.300
17035536,2006-10-11T00:00:00,Glutathione,D12.644.456.448
17035536,2006-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17035536,2006-10-11T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17035536,2006-10-11T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17035536,2006-10-11T00:00:00,Neurons,A08.663
17035536,2006-10-11T00:00:00,Neurons,A11.671
17035536,2006-10-11T00:00:00,Neuroprotective Agents,D27.505.696.706.548
17035536,2006-10-11T00:00:00,Neuroprotective Agents,D27.505.954.427.575
17035536,2006-10-11T00:00:00,Oxidative Stress,G03.495.710
17035536,2006-10-11T00:00:00,Oxidative Stress,G07.700.830.750
17035536,2006-10-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17157589,2006-10-11T00:00:00,Child,M01.060.406
17157589,2006-10-11T00:00:00,"Child, Preschool",M01.060.406.448
17157589,2006-10-11T00:00:00,Guideline Adherence,N04.761.337
17157589,2006-10-11T00:00:00,Guideline Adherence,N05.715.360.395
17157589,2006-10-11T00:00:00,Head,A01.456
17157589,2006-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17157589,2006-10-11T00:00:00,Infant,M01.060.703
17157589,2006-10-11T00:00:00,"Neoplasms, Radiation-Induced",C04.682
17157589,2006-10-11T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
17157589,2006-10-11T00:00:00,Orbit,A02.835.232.781.324.690
17157589,2006-10-11T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17157589,2006-10-11T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17157589,2006-10-11T00:00:00,Radiation Dosage,E05.799.513
17157589,2006-10-11T00:00:00,Radiation Dosage,G01.201.875.740
17157589,2006-10-11T00:00:00,Radiation Dosage,N06.850.810.250
17157589,2006-10-11T00:00:00,Risk Factors,E05.318.740.600.800.725
17157589,2006-10-11T00:00:00,Risk Factors,N05.715.350.200.700
17157589,2006-10-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17157589,2006-10-11T00:00:00,Risk Factors,N06.850.490.625.750
17157589,2006-10-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17157589,2006-10-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17157589,2006-10-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17157589,2006-10-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17157589,2006-10-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17157589,2006-10-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17157589,2006-10-11T00:00:00,United States,Z01.107.567.875
17020379,2006-10-12T00:00:00,Algorithms,G17.035
17020379,2006-10-12T00:00:00,Algorithms,L01.224.050
17020379,2006-10-12T00:00:00,Avidin,D12.776.034.614.300
17020379,2006-10-12T00:00:00,Avidin,D12.776.256.317.663.300
17020379,2006-10-12T00:00:00,Avidin,D12.776.290.663.100
17020379,2006-10-12T00:00:00,Avidin,D12.776.395.175
17020379,2006-10-12T00:00:00,Magnetics,H01.671.493
17020379,2006-10-12T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
17020379,2006-10-12T00:00:00,"Microscopy, Fluorescence",E05.595.458
17020379,2006-10-12T00:00:00,Nanoparticles,J01.637.512.600
17020379,2006-10-12T00:00:00,Nanotubes,J01.637.512.850
17020379,2006-10-12T00:00:00,Silicon Dioxide,D01.578.750
17020379,2006-10-12T00:00:00,Silicon Dioxide,D01.650.550.825
17020379,2006-10-12T00:00:00,Silicon Dioxide,D01.837.725
17041001,2006-10-13T00:00:00,Adolescent,M01.060.057
17041001,2006-10-13T00:00:00,Adult,M01.060.116
17041001,2006-10-13T00:00:00,Aged,M01.060.116.100
17041001,2006-10-13T00:00:00,Bone Density Conservation Agents,D27.505.696.242
17041001,2006-10-13T00:00:00,Glomerulonephritis,C12.777.419.570.363
17041001,2006-10-13T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
17041001,2006-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17041001,2006-10-13T00:00:00,Middle Aged,M01.060.116.630
17041006,2006-10-13T00:00:00,Alveolar Bone Loss,C05.116.264.150
17041006,2006-10-13T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
17041006,2006-10-13T00:00:00,Animals,B01.050
17041006,2006-10-13T00:00:00,Cytokines,D12.644.276.374
17041006,2006-10-13T00:00:00,Cytokines,D12.776.467.374
17041006,2006-10-13T00:00:00,Cytokines,D23.529.374
17041006,2006-10-13T00:00:00,Lipopolysaccharides,D09.400.500
17041006,2006-10-13T00:00:00,Lipopolysaccharides,D09.698.718.450
17041006,2006-10-13T00:00:00,Lipopolysaccharides,D10.494
17041006,2006-10-13T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17041006,2006-10-13T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17041006,2006-10-13T00:00:00,Osteoclasts,A11.329.372.700
17041006,2006-10-13T00:00:00,Osteoclasts,A11.627.482.700
17041006,2006-10-13T00:00:00,Periodontitis,C07.465.714.533
17041006,2006-10-13T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17041006,2006-10-13T00:00:00,RANK Ligand,D12.644.276.374.750.562
17041006,2006-10-13T00:00:00,RANK Ligand,D12.644.276.972.562
17041006,2006-10-13T00:00:00,RANK Ligand,D12.776.467.374.750.562
17041006,2006-10-13T00:00:00,RANK Ligand,D12.776.467.972.562
17041006,2006-10-13T00:00:00,RANK Ligand,D23.529.374.750.562
17041006,2006-10-13T00:00:00,RANK Ligand,D23.529.972.562
17041006,2006-10-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17041006,2006-10-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17041006,2006-10-13T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17041006,2006-10-13T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17041006,2006-10-13T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17041006,2006-10-13T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17097791,2006-10-13T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
17097791,2006-10-13T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
17097791,2006-10-13T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
17097791,2006-10-13T00:00:00,Apoptosis,G04.299.139.160
17097791,2006-10-13T00:00:00,Calpain,D08.811.277.656.262.500.120
17097791,2006-10-13T00:00:00,Calpain,D08.811.277.656.300.200.120
17097791,2006-10-13T00:00:00,Caspases,D08.811.277.656.262.500.126
17097791,2006-10-13T00:00:00,Caspases,D08.811.277.656.300.200.126
17097791,2006-10-13T00:00:00,Caspases,D12.644.360.075.405
17097791,2006-10-13T00:00:00,Caspases,D12.776.476.075.405
17097791,2006-10-13T00:00:00,Cathepsin B,D08.811.277.656.224.125
17097791,2006-10-13T00:00:00,Cathepsin B,D08.811.277.656.262.500.133
17097791,2006-10-13T00:00:00,Cathepsin B,D08.811.277.656.300.200.133
17097791,2006-10-13T00:00:00,Ceramides,D02.065.313
17097791,2006-10-13T00:00:00,Ceramides,D09.400.410.420.525.200
17097791,2006-10-13T00:00:00,Ceramides,D10.390.470.675.200
17097791,2006-10-13T00:00:00,Ceramides,D10.570.877.360.612.200
17097791,2006-10-13T00:00:00,Cisplatin,D01.210.375
17097791,2006-10-13T00:00:00,Cisplatin,D01.625.125
17097791,2006-10-13T00:00:00,Cisplatin,D01.710.100
17097791,2006-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17097791,2006-10-13T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17097791,2006-10-13T00:00:00,Kidney Neoplasms,C12.758.820.750
17097791,2006-10-13T00:00:00,Kidney Neoplasms,C12.777.419.473
17097791,2006-10-13T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17097791,2006-10-13T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17097791,2006-10-13T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
17126652,2006-10-13T00:00:00,Adult,M01.060.116
17126652,2006-10-13T00:00:00,Body Mass Index,E01.370.600.115.100.125
17126652,2006-10-13T00:00:00,Body Mass Index,E05.041.124.125
17126652,2006-10-13T00:00:00,Body Mass Index,G07.100.100.125
17126652,2006-10-13T00:00:00,Body Mass Index,N06.850.505.200.100.175
17126652,2006-10-13T00:00:00,C-Reactive Protein,D12.776.034.145
17126652,2006-10-13T00:00:00,C-Reactive Protein,D12.776.124.050.120
17126652,2006-10-13T00:00:00,C-Reactive Protein,D12.776.124.486.157
17126652,2006-10-13T00:00:00,Cardiovascular Diseases,C14
17126652,2006-10-13T00:00:00,Cholesterol,D04.808.247.222.284
17126652,2006-10-13T00:00:00,Cholesterol,D04.808.247.808.197
17126652,2006-10-13T00:00:00,Cholesterol,D10.570.938.208
17126652,2006-10-13T00:00:00,Cholesterol,D10.851.208
17126652,2006-10-13T00:00:00,Exercise Test,E01.370.370.380.250
17126652,2006-10-13T00:00:00,Exercise Test,E01.370.386.700.250
17126652,2006-10-13T00:00:00,Exercise Test,E05.333.250
17126652,2006-10-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17126652,2006-10-13T00:00:00,Insulin,D06.472.699.587.740.625
17126652,2006-10-13T00:00:00,Insulin,D12.644.548.586.740.625
17126652,2006-10-13T00:00:00,"Lipoproteins, HDL",D10.532.432
17126652,2006-10-13T00:00:00,"Lipoproteins, HDL",D12.776.521.479
17126652,2006-10-13T00:00:00,Middle Aged,M01.060.116.630
17126652,2006-10-13T00:00:00,Obesity,C18.654.726.500
17126652,2006-10-13T00:00:00,Obesity,C23.888.144.699.500
17126652,2006-10-13T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17126652,2006-10-13T00:00:00,Obesity,G07.100.100.160.120.699.500
17126652,2006-10-13T00:00:00,Oxygen Consumption,G03.730
17126652,2006-10-13T00:00:00,Physical Fitness,I03.621
17126652,2006-10-13T00:00:00,Physical Fitness,N01.400.545
17126652,2006-10-13T00:00:00,Risk Factors,E05.318.740.600.800.725
17126652,2006-10-13T00:00:00,Risk Factors,N05.715.350.200.700
17126652,2006-10-13T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17126652,2006-10-13T00:00:00,Risk Factors,N06.850.490.625.750
17126652,2006-10-13T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17038900,2006-10-15T00:00:00,African Continental Ancestry Group,M01.686.508.100
17038900,2006-10-15T00:00:00,Attitude to Health,F01.100.150
17038900,2006-10-15T00:00:00,Attitude to Health,N05.300.150
17038900,2006-10-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
17038900,2006-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17038900,2006-10-15T00:00:00,Kidney,A05.810.453
17038900,2006-10-15T00:00:00,Living Donors,M01.898.656
17038900,2006-10-15T00:00:00,North Carolina,Z01.107.567.875.075.475
17038900,2006-10-15T00:00:00,North Carolina,Z01.107.567.875.750.530
17149437,2006-10-15T00:00:00,"Education, Pharmacy",I02.358.525
17149437,2006-10-15T00:00:00,Educational Measurement,I02.399
17149437,2006-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17149437,2006-10-15T00:00:00,Teaching,I02.903
17049961,2006-10-16T00:00:00,Animals,B01.050
17049961,2006-10-16T00:00:00,Eye Proteins,D12.776.306
17049961,2006-10-16T00:00:00,Photic Stimulation,E05.723.729
17049961,2006-10-16T00:00:00,Rhodopsin,D12.776.543.750.100.955
17049961,2006-10-16T00:00:00,Rhodopsin,D23.767.930.750.500.500
17161267,2006-10-16T00:00:00,Age Factors,N05.715.350.075
17161267,2006-10-16T00:00:00,Age Factors,N06.850.490.250
17161267,2006-10-16T00:00:00,Aged,M01.060.116.100
17161267,2006-10-16T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
17161267,2006-10-16T00:00:00,Atrial Fibrillation,C14.280.067.198
17161267,2006-10-16T00:00:00,Atrial Fibrillation,C23.550.073.198
17161267,2006-10-16T00:00:00,Cardiovascular Diseases,C14
17161267,2006-10-16T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17161267,2006-10-16T00:00:00,Catheter Ablation,E02.148.110
17161267,2006-10-16T00:00:00,Catheter Ablation,E02.148.442.110
17161267,2006-10-16T00:00:00,Catheter Ablation,E02.154.402.110
17161267,2006-10-16T00:00:00,Catheter Ablation,E04.014.170.402.110
17161267,2006-10-16T00:00:00,Hospitalization,E02.760.400
17161267,2006-10-16T00:00:00,Hospitalization,N02.421.585.400
17161267,2006-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161267,2006-10-16T00:00:00,Hypertension,C14.907.489
17161267,2006-10-16T00:00:00,Medical Records,E05.318.308.940.968
17161267,2006-10-16T00:00:00,Medical Records,L01.280.900.968
17161267,2006-10-16T00:00:00,Medical Records,N04.452.859.564
17161267,2006-10-16T00:00:00,Medical Records,N05.715.360.300.715.500
17161267,2006-10-16T00:00:00,Medical Records,N06.850.520.308.940.968
17161267,2006-10-16T00:00:00,Middle Aged,M01.060.116.630
17161267,2006-10-16T00:00:00,Pulmonary Veins,A07.231.908.713
17161267,2006-10-16T00:00:00,Stroke Volume,E01.370.370.380.150.700
17161267,2006-10-16T00:00:00,Stroke Volume,G09.330.380.124.882
17047156,2006-10-17T00:00:00,Adenoviridae,B04.280.030
17047156,2006-10-17T00:00:00,Adenoviridae,B04.909.204.097
17047156,2006-10-17T00:00:00,Animals,B01.050
17047156,2006-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17047156,2006-10-17T00:00:00,Interferon Type I,D12.644.276.374.440.890
17047156,2006-10-17T00:00:00,Interferon Type I,D12.644.276.718.500
17047156,2006-10-17T00:00:00,Interferon Type I,D12.776.467.374.440.890
17047156,2006-10-17T00:00:00,Interferon Type I,D12.776.467.718.500
17047156,2006-10-17T00:00:00,Interferon Type I,D23.529.374.440.890
17047156,2006-10-17T00:00:00,Interferon Type I,D23.529.718.500
17047156,2006-10-17T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
17047156,2006-10-17T00:00:00,Interferon-alpha,D12.644.276.718.500.250
17047156,2006-10-17T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
17047156,2006-10-17T00:00:00,Interferon-alpha,D12.776.467.718.500.250
17047156,2006-10-17T00:00:00,Interferon-alpha,D23.529.374.440.890.250
17047156,2006-10-17T00:00:00,Interferon-alpha,D23.529.718.500.250
17047165,2006-10-17T00:00:00,Animals,B01.050
17047165,2006-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17047165,2006-10-17T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17047165,2006-10-17T00:00:00,Mitochondria,A11.284.835.626
17047165,2006-10-17T00:00:00,Oxidative Stress,G03.495.710
17047165,2006-10-17T00:00:00,Oxidative Stress,G07.700.830.750
17047165,2006-10-17T00:00:00,Rabbits,B01.050.150.900.649.521.700
17049595,2006-10-17T00:00:00,3T3 Cells,A11.251.210.700
17049595,2006-10-17T00:00:00,3T3 Cells,A11.329.228.900
17049595,2006-10-17T00:00:00,Adsorption,G02.149.047
17049595,2006-10-17T00:00:00,Adsorption,G02.149.767.029
17049595,2006-10-17T00:00:00,Adsorption,G02.842.750.029
17049595,2006-10-17T00:00:00,Animals,B01.050
17049595,2006-10-17T00:00:00,Biocompatible Materials,D25.130
17049595,2006-10-17T00:00:00,Biocompatible Materials,D27.720.102.130
17049595,2006-10-17T00:00:00,Biocompatible Materials,J01.637.051.130
17049595,2006-10-17T00:00:00,Cell Adhesion,G04.299.117
17049595,2006-10-17T00:00:00,"Coated Materials, Biocompatible",D25.130.420
17049595,2006-10-17T00:00:00,"Coated Materials, Biocompatible",J01.637.051.130.420
17049595,2006-10-17T00:00:00,Gold,D01.268.556.322
17049595,2006-10-17T00:00:00,Gold,D01.268.956.186
17049595,2006-10-17T00:00:00,Gold,D01.552.544.322
17049595,2006-10-17T00:00:00,Nanotechnology,H01.603
17049595,2006-10-17T00:00:00,Nanotechnology,J01.897.520.600
17049595,2006-10-17T00:00:00,Oligopeptides,D12.644.456
17049595,2006-10-17T00:00:00,Peptides,D12.644
17049595,2006-10-17T00:00:00,Polyethylene Glycols,D02.033.455.250.700
17049595,2006-10-17T00:00:00,Polyethylene Glycols,D05.750.741
17049595,2006-10-17T00:00:00,Polyethylene Glycols,D25.720.741
17049595,2006-10-17T00:00:00,Polyethylene Glycols,J01.637.051.720.741
17049595,2006-10-17T00:00:00,Polymers,D05.750
17049595,2006-10-17T00:00:00,Polymers,D25.720
17049595,2006-10-17T00:00:00,Polymers,J01.637.051.720
17049595,2006-10-17T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
17049595,2006-10-17T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
17049595,2006-10-17T00:00:00,Surface Properties,G02.842.850
17050618,2006-10-18T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
17050618,2006-10-18T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
17050618,2006-10-18T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
17050618,2006-10-18T00:00:00,Animals,B01.050
17050618,2006-10-18T00:00:00,"Animals, Newborn",B01.050.050.282
17050618,2006-10-18T00:00:00,Cell Survival,G04.299.316
17050618,2006-10-18T00:00:00,Cyanides,D01.248.497.158.291
17050618,2006-10-18T00:00:00,Cyanides,D01.625.400.100
17050618,2006-10-18T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.260.103.625.750
17050618,2006-10-18T00:00:00,"Hypoxia-Inducible Factor 1, alpha Subunit",D12.776.930.125.625.750
17050618,2006-10-18T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17050618,2006-10-18T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17050618,2006-10-18T00:00:00,"Myocytes, Cardiac",A11.620.500
17050618,2006-10-18T00:00:00,Oxygen,D01.268.185.550
17050618,2006-10-18T00:00:00,Oxygen,D01.362.670
17050618,2006-10-18T00:00:00,Oxygen Consumption,G03.730
17050618,2006-10-18T00:00:00,Procollagen-Proline Dioxygenase,D08.811.682.690.708.673
17050618,2006-10-18T00:00:00,Signal Transduction,G02.111.087.800
17050618,2006-10-18T00:00:00,Signal Transduction,G02.149.115.800
17050618,2006-10-18T00:00:00,Signal Transduction,G04.299.880
17050776,2006-10-18T00:00:00,Animals,B01.050
17050776,2006-10-18T00:00:00,Calcium,D01.268.552.100
17050776,2006-10-18T00:00:00,Calcium,D01.552.539.288
17050776,2006-10-18T00:00:00,Calcium,D23.119.100
17050776,2006-10-18T00:00:00,Calmodulin,D12.644.360.381.249
17050776,2006-10-18T00:00:00,Calmodulin,D12.776.157.125.412.249
17050776,2006-10-18T00:00:00,Calmodulin,D12.776.476.387.249
17050776,2006-10-18T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
17050776,2006-10-18T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
17050776,2006-10-18T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
17050776,2006-10-18T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
17050776,2006-10-18T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
17050776,2006-10-18T00:00:00,Janus Kinase 2,D08.811.913.696.620.682.725.124.200
17050776,2006-10-18T00:00:00,Janus Kinase 2,D12.776.476.393.200
17050776,2006-10-18T00:00:00,Janus Kinase 2,D12.776.624.664.700.117
17050776,2006-10-18T00:00:00,Protein Conformation,G02.111.570.790.709
17050776,2006-10-18T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.070.800.100.100
17050776,2006-10-18T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.100.800.100.100
17050776,2006-10-18T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.720.300.800.100.100
17050776,2006-10-18T00:00:00,Sodium-Hydrogen Antiporter,D12.776.157.530.450.162.775
17050776,2006-10-18T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.550.190.775
17050776,2006-10-18T00:00:00,Sodium-Hydrogen Antiporter,D12.776.543.585.450.162.775
17050776,2006-10-18T00:00:00,Tyrosine,D12.125.072.050.875
17054963,2006-10-18T00:00:00,Adult,M01.060.116
17054963,2006-10-18T00:00:00,Aged,M01.060.116.100
17054963,2006-10-18T00:00:00,Back,A01.176
17054963,2006-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17054963,2006-10-18T00:00:00,Middle Aged,M01.060.116.630
17054963,2006-10-18T00:00:00,Muscle Contraction,G11.427.590.540
17054963,2006-10-18T00:00:00,"Muscle, Skeletal",A02.633.567
17054963,2006-10-18T00:00:00,"Muscle, Skeletal",A10.690.552.500
17054963,2006-10-18T00:00:00,Orthotic Devices,E07.858.442.743
17054963,2006-10-18T00:00:00,Posture,G11.427.695
17054963,2006-10-18T00:00:00,Task Performance and Analysis,F02.784.412.846
17054963,2006-10-18T00:00:00,Task Performance and Analysis,F02.784.692.746
17054963,2006-10-18T00:00:00,Task Performance and Analysis,F02.808.600
17126054,2006-10-21T00:00:00,Cell Proliferation,G04.299.233.750
17126054,2006-10-21T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17126054,2006-10-21T00:00:00,Escherichia coli,B03.440.450.425.325.300
17126054,2006-10-21T00:00:00,Escherichia coli,B03.660.250.150.180.100
17126054,2006-10-21T00:00:00,Escherichia coli Proteins,D12.776.097.275
17126054,2006-10-21T00:00:00,Gene Deletion,G05.355.600.800.320
17126054,2006-10-21T00:00:00,Gene Deletion,G05.365.590.762.320
17126054,2006-10-21T00:00:00,Protein Engineering,E05.393.420.601
17126054,2006-10-21T00:00:00,Recombinant Proteins,D12.776.828
17060448,2006-10-23T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
17060448,2006-10-23T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
17060448,2006-10-23T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
17060448,2006-10-23T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
17060448,2006-10-23T00:00:00,Animals,B01.050
17060448,2006-10-23T00:00:00,"Behavior, Animal",F01.145.113
17060448,2006-10-23T00:00:00,Central Nervous System,A08.186
17060448,2006-10-23T00:00:00,Macrophages,A11.329.372
17060448,2006-10-23T00:00:00,Macrophages,A11.627.482
17060448,2006-10-23T00:00:00,Macrophages,A11.733.397
17060448,2006-10-23T00:00:00,Macrophages,A15.382.680.397
17060448,2006-10-23T00:00:00,Macrophages,A15.382.812.522
17060448,2006-10-23T00:00:00,Neurodegenerative Diseases,C10.574
17060448,2006-10-23T00:00:00,Phenotype,G05.695
17060448,2006-10-23T00:00:00,Psychomotor Agitation,C10.597.350.600
17060448,2006-10-23T00:00:00,Psychomotor Agitation,C10.597.606.881.700
17060448,2006-10-23T00:00:00,Psychomotor Agitation,C23.888.592.350.600
17060448,2006-10-23T00:00:00,Psychomotor Agitation,C23.888.592.604.882.700
17060448,2006-10-23T00:00:00,Psychomotor Agitation,F01.700.875.700
17060554,2006-10-24T00:00:00,African Americans,M01.686.508.100.100
17060554,2006-10-24T00:00:00,African Americans,M01.686.754.100
17060554,2006-10-24T00:00:00,Health Care Costs,N03.219.151.400
17060554,2006-10-24T00:00:00,Health Care Costs,N05.300.375
17060554,2006-10-24T00:00:00,Hispanic Americans,M01.686.754.441
17060554,2006-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17060554,2006-10-24T00:00:00,Stroke,C10.228.140.300.775
17060554,2006-10-24T00:00:00,Stroke,C14.907.253.855
17062604,2006-10-24T00:00:00,Apoptosis,G04.299.139.160
17062604,2006-10-24T00:00:00,Biological Markers,D23.101
17062604,2006-10-24T00:00:00,Cell Death,G04.299.139
17062604,2006-10-24T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
17062604,2006-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17062604,2006-10-24T00:00:00,Phenotype,G05.695
17062604,2006-10-24T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,E05.318.740.872
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,E05.318.780.800
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,G17.800
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17062604,2006-10-24T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.283.875
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.567.569.220.200
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.283.875
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.567.569.220.200
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.283.875
17062604,2006-10-24T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.567.569.220.200
17062604,2006-10-24T00:00:00,Viral Matrix Proteins,D12.776.964.970.880.940
17064901,2006-10-24T00:00:00,Adult,M01.060.116
17064901,2006-10-24T00:00:00,Bias (Epidemiology),N05.715.350.150
17064901,2006-10-24T00:00:00,Bias (Epidemiology),N06.850.490.500
17064901,2006-10-24T00:00:00,Clinical Nursing Research,H02.478.395.234
17064901,2006-10-24T00:00:00,Clinical Nursing Research,N04.590.233.508.613.234
17064901,2006-10-24T00:00:00,Color,G01.201.875.770.578.199
17064901,2006-10-24T00:00:00,Color,G01.590.540.199
17064901,2006-10-24T00:00:00,Continental Population Groups,M01.686.508
17064901,2006-10-24T00:00:00,Critical Care,E02.760.190
17064901,2006-10-24T00:00:00,Critical Care,N02.421.585.190
17064901,2006-10-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17064901,2006-10-24T00:00:00,Middle Aged,M01.060.116.630
17064901,2006-10-24T00:00:00,Oxygen,D01.268.185.550
17064901,2006-10-24T00:00:00,Oxygen,D01.362.670
17069800,2006-10-25T00:00:00,Animals,B01.050
17069800,2006-10-25T00:00:00,Apoptosis,G04.299.139.160
17069800,2006-10-25T00:00:00,B-Lymphocytes,A11.063.438
17069800,2006-10-25T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17069800,2006-10-25T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17069800,2006-10-25T00:00:00,B-Lymphocytes,A15.382.032.438
17069800,2006-10-25T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17069800,2006-10-25T00:00:00,Disease Progression,C23.550.291.656
17069800,2006-10-25T00:00:00,Gene Expression Profiling,E05.393.332
17069800,2006-10-25T00:00:00,Gene Expression Regulation,G05.355.315
17069800,2006-10-25T00:00:00,Retinal Degeneration,C11.768.585
17069800,2006-10-25T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
17069800,2006-10-25T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
17069800,2006-10-25T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
17116557,2006-10-25T00:00:00,Body Image,F02.463.593.112
17116557,2006-10-25T00:00:00,Body Mass Index,E01.370.600.115.100.125
17116557,2006-10-25T00:00:00,Body Mass Index,E05.041.124.125
17116557,2006-10-25T00:00:00,Body Mass Index,G07.100.100.125
17116557,2006-10-25T00:00:00,Body Mass Index,N06.850.505.200.100.175
17116557,2006-10-25T00:00:00,Body Weight,C23.888.144
17116557,2006-10-25T00:00:00,Body Weight,E01.370.600.115.100.160.120
17116557,2006-10-25T00:00:00,Body Weight,E05.041.124.160.750
17116557,2006-10-25T00:00:00,Body Weight,G07.100.100.160.120
17116557,2006-10-25T00:00:00,Body Weight,G07.700.320.249.314.120
17116557,2006-10-25T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17116557,2006-10-25T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17116557,2006-10-25T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17116557,2006-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17116557,2006-10-25T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
17116557,2006-10-25T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
17116557,2006-10-25T00:00:00,"Medical Staff, Hospital",N02.360.630.490
17116557,2006-10-25T00:00:00,"Medical Staff, Hospital",N02.360.740.422
17116557,2006-10-25T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
17116557,2006-10-25T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
17116557,2006-10-25T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
17116557,2006-10-25T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
17116557,2006-10-25T00:00:00,Obesity,C18.654.726.500
17116557,2006-10-25T00:00:00,Obesity,C23.888.144.699.500
17116557,2006-10-25T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17116557,2006-10-25T00:00:00,Obesity,G07.100.100.160.120.699.500
17068152,2006-10-26T00:00:00,Animals,B01.050
17068152,2006-10-26T00:00:00,Cell Adhesion,G04.299.117
17068152,2006-10-26T00:00:00,Cell Movement,G04.299.283
17068152,2006-10-26T00:00:00,Cell Movement,G07.700.560.500.180
17068152,2006-10-26T00:00:00,Endothelial Cells,A11.436.275
17068152,2006-10-26T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
17068152,2006-10-26T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
17068152,2006-10-26T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
17068152,2006-10-26T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
17068152,2006-10-26T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
17068152,2006-10-26T00:00:00,Leukocytes,A11.118.637
17068152,2006-10-26T00:00:00,Leukocytes,A15.145.229.637
17068152,2006-10-26T00:00:00,Leukocytes,A15.382.490
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17068152,2006-10-26T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17110912,2006-10-26T00:00:00,Amino Acid Sequence,G02.111.570.060
17110912,2006-10-26T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17110912,2006-10-26T00:00:00,Animals,B01.050
17110912,2006-10-26T00:00:00,Carrier Proteins,D12.776.157
17110912,2006-10-26T00:00:00,"Chromosomes, Human, Pair 3",A11.284.187.520.300.235.250
17110912,2006-10-26T00:00:00,"Chromosomes, Human, Pair 3",G05.360.162.520.300.235.250
17110912,2006-10-26T00:00:00,Chronic Disease,C23.550.291.500
17110912,2006-10-26T00:00:00,Down-Regulation,G02.111.087.225
17110912,2006-10-26T00:00:00,Down-Regulation,G02.149.115.225
17110912,2006-10-26T00:00:00,Down-Regulation,G05.355.315.200
17110912,2006-10-26T00:00:00,Down-Regulation,G07.690.812.230
17110912,2006-10-26T00:00:00,Down-Regulation,G07.700.680.230
17110912,2006-10-26T00:00:00,Genome,G05.360.340
17110912,2006-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17110912,2006-10-26T00:00:00,Ischemia,C23.550.513
17110912,2006-10-26T00:00:00,Molecular Sequence Data,L01.453.245.667
17110912,2006-10-26T00:00:00,"RNA, Messenger",D13.444.735.544
17110912,2006-10-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17110912,2006-10-26T00:00:00,Recombinant Proteins,D12.776.828
17110912,2006-10-26T00:00:00,Retinal Vessels,A07.231.611
17137568,2006-10-27T00:00:00,Adenoviridae,B04.280.030
17137568,2006-10-27T00:00:00,Adenoviridae,B04.909.204.097
17137568,2006-10-27T00:00:00,Animals,B01.050
17137568,2006-10-27T00:00:00,Cardiomegaly,C14.280.195
17137568,2006-10-27T00:00:00,Cardiomegaly,C23.300.775.250
17137568,2006-10-27T00:00:00,Gene Expression,G05.355.310
17137568,2006-10-27T00:00:00,Genetic Vectors,G05.360.337
17137568,2006-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17137568,2006-10-27T00:00:00,NF-kappa B,D12.776.260.600
17137568,2006-10-27T00:00:00,NF-kappa B,D12.776.660.600
17137568,2006-10-27T00:00:00,NF-kappa B,D12.776.930.600
17137568,2006-10-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17137568,2006-10-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
17137568,2006-10-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
17137568,2006-10-27T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
17137568,2006-10-27T00:00:00,Superoxides,D01.248.497.158.685.750.850
17137568,2006-10-27T00:00:00,Superoxides,D01.339.431.374.850
17137568,2006-10-27T00:00:00,Superoxides,D01.339.431.750
17137568,2006-10-27T00:00:00,Superoxides,D01.650.550.750.800
17137568,2006-10-27T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
17137568,2006-10-27T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
17137568,2006-10-27T00:00:00,Tissue Kallikreins,D23.101.840.870
17306721,2006-10-27T00:00:00,Adolescent,M01.060.057
17306721,2006-10-27T00:00:00,Attitude of Health Personnel,F01.100.050
17306721,2006-10-27T00:00:00,Attitude of Health Personnel,N05.300.100
17306721,2006-10-27T00:00:00,Behavior Therapy,F04.754.137
17306721,2006-10-27T00:00:00,Community Mental Health Services,F04.408.307
17306721,2006-10-27T00:00:00,Community Mental Health Services,N02.421.143.183
17306721,2006-10-27T00:00:00,Community Mental Health Services,N02.421.461.232
17306721,2006-10-27T00:00:00,Education,I02
17306721,2006-10-27T00:00:00,Evidence-Based Medicine,H02.249.750
17306721,2006-10-27T00:00:00,Evidence-Based Medicine,H02.403.200.400
17306721,2006-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17306721,2006-10-27T00:00:00,Leadership,F01.752.609
17306721,2006-10-27T00:00:00,Motivation,F01.658
17306721,2006-10-27T00:00:00,Motivation,F01.752.543.500.750
17306721,2006-10-27T00:00:00,South Carolina,Z01.107.567.875.075.662
17306721,2006-10-27T00:00:00,South Carolina,Z01.107.567.875.750.700
17306721,2006-10-27T00:00:00,Substance-Related Disorders,C21.739
17306721,2006-10-27T00:00:00,Substance-Related Disorders,F03.900
17071962,2006-10-28T00:00:00,Computer Graphics,L01.224.108
17071962,2006-10-28T00:00:00,Computer Graphics,L01.296.110
17071962,2006-10-28T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17071962,2006-10-28T00:00:00,Internet,L01.224.230.110.500
17071962,2006-10-28T00:00:00,"Models, Molecular",E05.599.595
17071962,2006-10-28T00:00:00,Multiprotein Complexes,D05.500
17071962,2006-10-28T00:00:00,User-Computer Interface,L01.224.900.910
17054360,2006-10-30T00:00:00,Alkynes,D02.455.326.397
17054360,2006-10-30T00:00:00,Copper,D01.268.556.195
17054360,2006-10-30T00:00:00,Copper,D01.268.956.170
17054360,2006-10-30T00:00:00,Copper,D01.552.544.195
17054360,2006-10-30T00:00:00,Ethers,D02.355
17054360,2006-10-30T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17054360,2006-10-30T00:00:00,Nitric Oxide,D01.339.387
17054360,2006-10-30T00:00:00,Nitric Oxide,D01.625.550.500
17054360,2006-10-30T00:00:00,Nitric Oxide,D01.625.700.500
17054360,2006-10-30T00:00:00,Nitric Oxide,D01.650.550.587.600
17054360,2006-10-30T00:00:00,Organometallic Compounds,D01.632
17054360,2006-10-30T00:00:00,Organometallic Compounds,D02.691
17054360,2006-10-30T00:00:00,"Spectrometry, Fluorescence",E05.196.712.516.600.676
17054360,2006-10-30T00:00:00,"Spectrometry, Fluorescence",E05.196.867.726
17081655,2006-10-31T00:00:00,Adult,M01.060.116
17081655,2006-10-31T00:00:00,Depression,F01.145.126.350
17081655,2006-10-31T00:00:00,Eating,G07.610.593.260
17081655,2006-10-31T00:00:00,Eating,G07.700.620.260
17081655,2006-10-31T00:00:00,Eating,G10.261.326.240
17081655,2006-10-31T00:00:00,Electric Stimulation Therapy,E02.342
17081655,2006-10-31T00:00:00,Electric Stimulation Therapy,E02.779.468
17081655,2006-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17081655,2006-10-31T00:00:00,Middle Aged,M01.060.116.630
17081655,2006-10-31T00:00:00,Obesity,C18.654.726.500
17081655,2006-10-31T00:00:00,Obesity,C23.888.144.699.500
17081655,2006-10-31T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17081655,2006-10-31T00:00:00,Obesity,G07.100.100.160.120.699.500
17083023,2006-10-31T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17083023,2006-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17083023,2006-10-31T00:00:00,Kidney Diseases,C12.777.419
17083023,2006-10-31T00:00:00,Kidney Diseases,C13.351.968.419
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,E05.318.740.872
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,E05.318.780.800
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,G17.800
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17083023,2006-10-31T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
16553465,2006-11-01T00:00:00,Animals,B01.050
16553465,2006-11-01T00:00:00,Carrier Proteins,D12.776.157
16553465,2006-11-01T00:00:00,Eye Proteins,D12.776.306
16553465,2006-11-01T00:00:00,Retina,A09.371.729
16553465,2006-11-01T00:00:00,Retinaldehyde,D02.047.850
16553465,2006-11-01T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
16553465,2006-11-01T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
16553465,2006-11-01T00:00:00,Retinaldehyde,D02.455.849.131.495.690
16553465,2006-11-01T00:00:00,Retinaldehyde,D23.767.261.700.690
16553465,2006-11-01T00:00:00,Rhodopsin,D12.776.543.750.100.955
16553465,2006-11-01T00:00:00,Rhodopsin,D23.767.930.750.500.500
16649170,2006-11-01T00:00:00,Animals,B01.050
16649170,2006-11-01T00:00:00,Bone Substitutes,D25.130.325
16649170,2006-11-01T00:00:00,Bone Substitutes,J01.637.051.130.325
16649170,2006-11-01T00:00:00,Collagen,D05.750.078.280
16649170,2006-11-01T00:00:00,Collagen,D12.776.860.300.250
16649170,2006-11-01T00:00:00,"Models, Animal",E05.598
16649170,2006-11-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
16883574,2006-11-01T00:00:00,Alleles,G05.360.340.024.340.030
16883574,2006-11-01T00:00:00,Alternative Splicing,G02.111.087.750.700.100
16883574,2006-11-01T00:00:00,Alternative Splicing,G02.149.115.750.700.100
16883574,2006-11-01T00:00:00,Alternative Splicing,G03.495.839.700.100
16883574,2006-11-01T00:00:00,Alternative Splicing,G05.355.315.700.700.100
16883574,2006-11-01T00:00:00,Breast Neoplasms,C04.588.180
16883574,2006-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
16883574,2006-11-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
16883574,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16883574,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
16883574,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
16883574,2006-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16883574,2006-11-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
16883574,2006-11-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
16883574,2006-11-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
16883574,2006-11-01T00:00:00,"Transcription, Genetic",G02.111.087.847
16883574,2006-11-01T00:00:00,"Transcription, Genetic",G02.149.115.847
16883574,2006-11-01T00:00:00,"Transcription, Genetic",G05.355.310.700
16906107,2006-11-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
16906107,2006-11-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
16906107,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16906107,2006-11-01T00:00:00,Patient Readmission,E02.760.400.620
16906107,2006-11-01T00:00:00,Patient Readmission,N02.421.585.400.620
16906107,2006-11-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
16906791,2006-11-01T00:00:00,Animals,B01.050
16906791,2006-11-01T00:00:00,"Models, Molecular",E05.599.595
16906791,2006-11-01T00:00:00,Mutation,G05.365.590
16906791,2006-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
16906791,2006-11-01T00:00:00,Recombinant Proteins,D12.776.828
16906791,2006-11-01T00:00:00,Rhodopsin,D12.776.543.750.100.955
16906791,2006-11-01T00:00:00,Rhodopsin,D23.767.930.750.500.500
16998933,2006-11-01T00:00:00,Adult,M01.060.116
16998933,2006-11-01T00:00:00,Aged,M01.060.116.100
16998933,2006-11-01T00:00:00,Biological Markers,D23.101
16998933,2006-11-01T00:00:00,Disease Progression,C23.550.291.656
16998933,2006-11-01T00:00:00,HIV Infections,C02.782.815.616.400
16998933,2006-11-01T00:00:00,HIV Infections,C02.800.801.400
16998933,2006-11-01T00:00:00,HIV Infections,C20.673.480
16998933,2006-11-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
16998933,2006-11-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
16998933,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16998933,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
16998933,2006-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
16998933,2006-11-01T00:00:00,Risk Factors,N05.715.350.200.700
16998933,2006-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
16998933,2006-11-01T00:00:00,Risk Factors,N06.850.490.625.750
16998933,2006-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17029231,2006-11-01T00:00:00,Adult,M01.060.116
17029231,2006-11-01T00:00:00,Algorithms,G17.035
17029231,2006-11-01T00:00:00,Algorithms,L01.224.050
17029231,2006-11-01T00:00:00,Brain,A08.186.211
17029231,2006-11-01T00:00:00,Contrast Media,D27.720.259
17029231,2006-11-01T00:00:00,Gadolinium DTPA,D01.632.400
17029231,2006-11-01T00:00:00,Gadolinium DTPA,D02.092.782.590.401
17029231,2006-11-01T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
17029231,2006-11-01T00:00:00,Gadolinium DTPA,D02.691.400
17029231,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17029231,2006-11-01T00:00:00,Image Enhancement,E01.370.350.600.350
17029231,2006-11-01T00:00:00,Image Enhancement,L01.224.308.380
17029231,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17029231,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17029231,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17029231,2006-11-01T00:00:00,Microcirculation,G09.330.190.163.645
17029231,2006-11-01T00:00:00,Multiple Sclerosis,C10.114.375.500
17029231,2006-11-01T00:00:00,Multiple Sclerosis,C10.314.350.500
17029231,2006-11-01T00:00:00,Multiple Sclerosis,C20.111.258.250.500
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,G17.800
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17029231,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17032838,2006-11-01T00:00:00,Aging,G07.700.320.124
17032838,2006-11-01T00:00:00,Animals,B01.050
17032838,2006-11-01T00:00:00,Calcium,D01.268.552.100
17032838,2006-11-01T00:00:00,Calcium,D01.552.539.288
17032838,2006-11-01T00:00:00,Calcium,D23.119.100
17032838,2006-11-01T00:00:00,Chickens,B01.050.150.900.248.350.150
17032838,2006-11-01T00:00:00,Chickens,B01.050.150.900.248.617.192
17032838,2006-11-01T00:00:00,Cholesterol,D04.808.247.222.284
17032838,2006-11-01T00:00:00,Cholesterol,D04.808.247.808.197
17032838,2006-11-01T00:00:00,Cholesterol,D10.570.938.208
17032838,2006-11-01T00:00:00,Cholesterol,D10.851.208
17032838,2006-11-01T00:00:00,Mycoplasma Infections,C01.252.400.610.610
17032838,2006-11-01T00:00:00,Mycoplasma gallisepticum,B03.440.560.580.553.553.345
17032838,2006-11-01T00:00:00,Poultry Diseases,C22.131.728
17035872,2006-11-01T00:00:00,Adult,M01.060.116
17035872,2006-11-01T00:00:00,Aged,M01.060.116.100
17035872,2006-11-01T00:00:00,Chronic Disease,C23.550.291.500
17035872,2006-11-01T00:00:00,Contrast Media,D27.720.259
17035872,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17035872,2006-11-01T00:00:00,Kidney Diseases,C12.777.419
17035872,2006-11-01T00:00:00,Kidney Diseases,C13.351.968.419
17035872,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17035872,2006-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17035872,2006-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17035872,2006-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17035872,2006-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17035872,2006-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17040625,2006-11-01T00:00:00,Counseling,F02.784.176
17040625,2006-11-01T00:00:00,Counseling,F04.408.413
17040625,2006-11-01T00:00:00,Counseling,N02.421.143.303
17040625,2006-11-01T00:00:00,Counseling,N02.421.461.363
17040625,2006-11-01T00:00:00,Health Personnel,M01.526.485
17040625,2006-11-01T00:00:00,Health Personnel,N02.360
17040625,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17040625,2006-11-01T00:00:00,Nicotine,D03.132.760.570
17040625,2006-11-01T00:00:00,Nicotine,D03.383.725.518
17040625,2006-11-01T00:00:00,Pharmaceutical Preparations,D26
17040625,2006-11-01T00:00:00,Smoking Cessation,F01.145.940.700
17040625,2006-11-01T00:00:00,Tobacco Use Disorder,C21.739.912
17040625,2006-11-01T00:00:00,Tobacco Use Disorder,F03.900.912
17043320,2006-11-01T00:00:00,Adolescent,M01.060.057
17043320,2006-11-01T00:00:00,Child,M01.060.406
17043320,2006-11-01T00:00:00,Child Abuse,I01.198.240.856.350.250
17043320,2006-11-01T00:00:00,Child Abuse,I01.880.735.900.350.250
17043320,2006-11-01T00:00:00,Child Abuse,I01.880.787.293.292
17043320,2006-11-01T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
17043320,2006-11-01T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
17043320,2006-11-01T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
17043320,2006-11-01T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
17043320,2006-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17043320,2006-11-01T00:00:00,Crime,I01.198.240
17043320,2006-11-01T00:00:00,Crime,I01.880.735.191
17043320,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17043320,2006-11-01T00:00:00,Mental Health Services,F04.408
17043320,2006-11-01T00:00:00,Mental Health Services,N02.421.461
17043320,2006-11-01T00:00:00,Referral and Consultation,N04.452.758.849
17043320,2006-11-01T00:00:00,Social Support,I01.880.656.600
17043320,2006-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17043320,2006-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17043320,2006-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17055881,2006-11-01T00:00:00,Animals,B01.050
17055881,2006-11-01T00:00:00,Appendectomy,E04.210.078
17055881,2006-11-01T00:00:00,Appendicitis,C06.405.205.099
17055881,2006-11-01T00:00:00,Appendicitis,C06.405.469.110.207
17055881,2006-11-01T00:00:00,"Endoscopy, Digestive System",E01.370.372.250
17055881,2006-11-01T00:00:00,"Endoscopy, Digestive System",E01.370.388.250.250
17055881,2006-11-01T00:00:00,"Endoscopy, Digestive System",E04.210.240
17055881,2006-11-01T00:00:00,"Endoscopy, Digestive System",E04.800.250.250
17055881,2006-11-01T00:00:00,Gastrostomy,E04.210.496
17055881,2006-11-01T00:00:00,Gastrostomy,E04.579.408
17055881,2006-11-01T00:00:00,Pilot Projects,E05.318.760.750
17055881,2006-11-01T00:00:00,Pilot Projects,E05.337.737
17055881,2006-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
17055881,2006-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
17055881,2006-11-01T00:00:00,Research Design,E05.581.500
17055881,2006-11-01T00:00:00,Research Design,H01.770.644.728
17055881,2006-11-01T00:00:00,Swine,B01.050.150.900.649.077.880
17055881,2006-11-01T00:00:00,Uterus,A05.360.319.679
17060765,2006-11-01T00:00:00,Animals,B01.050
17060765,2006-11-01T00:00:00,Chronic Disease,C23.550.291.500
17060765,2006-11-01T00:00:00,Esophagus,A03.556.875.500
17060765,2006-11-01T00:00:00,Gastroplasty,E02.065.062.750
17060765,2006-11-01T00:00:00,Gastroplasty,E04.062.750
17060765,2006-11-01T00:00:00,Gastroplasty,E04.210.485
17060765,2006-11-01T00:00:00,Laparoscopy,E01.370.388.250.520
17060765,2006-11-01T00:00:00,Laparoscopy,E04.800.250.520
17060765,2006-11-01T00:00:00,Manometry,E05.559
17060765,2006-11-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17060765,2006-11-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17060765,2006-11-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17060765,2006-11-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17060765,2006-11-01T00:00:00,Pressure,G01.374.715
17060765,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17060765,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17060765,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17062203,2006-11-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
17062203,2006-11-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
17062203,2006-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17062203,2006-11-01T00:00:00,Fontan Procedure,E04.035.410.295
17062203,2006-11-01T00:00:00,Fontan Procedure,E04.100.376.410.295
17062203,2006-11-01T00:00:00,Fontan Procedure,E04.928.220.370.295
17062203,2006-11-01T00:00:00,"Heart Defects, Congenital",C14.240.400
17062203,2006-11-01T00:00:00,"Heart Defects, Congenital",C14.280.400
17062203,2006-11-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
17062203,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17062203,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
17062203,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
17062203,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
17062203,2006-11-01T00:00:00,Myocardial Infarction,C14.280.647.500
17062203,2006-11-01T00:00:00,Myocardial Infarction,C14.907.585.500
17062203,2006-11-01T00:00:00,Secondary Prevention,N02.421.726.825
17062203,2006-11-01T00:00:00,Secondary Prevention,N06.850.780.750
17062203,2006-11-01T00:00:00,Thrombectomy,E04.100.814.842
17062203,2006-11-01T00:00:00,Thrombosis,C14.907.355.830
17062283,2006-11-01T00:00:00,Adult,M01.060.116
17062283,2006-11-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
17062283,2006-11-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
17062283,2006-11-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
17062283,2006-11-01T00:00:00,Heart Failure,C14.280.434
17062283,2006-11-01T00:00:00,Heart-Assist Devices,E04.050.430
17062283,2006-11-01T00:00:00,Heart-Assist Devices,E07.695.300.300
17062283,2006-11-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
17062283,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17063111,2006-11-01T00:00:00,Adult,M01.060.116
17063111,2006-11-01T00:00:00,Aged,M01.060.116.100
17063111,2006-11-01T00:00:00,Gastrointestinal Diseases,C06.405
17063111,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17063111,2006-11-01T00:00:00,Length of Stay,E02.760.400.480
17063111,2006-11-01T00:00:00,Length of Stay,N02.421.585.400.480
17063111,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17063111,2006-11-01T00:00:00,North Carolina,Z01.107.567.875.075.475
17063111,2006-11-01T00:00:00,North Carolina,Z01.107.567.875.750.530
17063111,2006-11-01T00:00:00,Patient Admission,E02.760.400.600
17063111,2006-11-01T00:00:00,Patient Admission,N02.421.585.400.600
17067209,2006-11-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17067209,2006-11-01T00:00:00,Animals,B01.050
17067209,2006-11-01T00:00:00,Environmental Exposure,N06.850.460.350
17067209,2006-11-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17067209,2006-11-01T00:00:00,Lung Neoplasms,C08.381.540
17067209,2006-11-01T00:00:00,Lung Neoplasms,C08.785.520
17067209,2006-11-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
17067209,2006-11-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
17067209,2006-11-01T00:00:00,Radiation Dosage,E05.799.513
17067209,2006-11-01T00:00:00,Radiation Dosage,G01.201.875.740
17067209,2006-11-01T00:00:00,Radiation Dosage,N06.850.810.250
17067352,2006-11-01T00:00:00,Adult,M01.060.116
17067352,2006-11-01T00:00:00,Alcoholism,C21.739.100.250
17067352,2006-11-01T00:00:00,Alcoholism,F03.900.100.350
17067352,2006-11-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
17067352,2006-11-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17067352,2006-11-01T00:00:00,Ethanol,D02.033.375
17067352,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17067352,2006-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17067352,2006-11-01T00:00:00,Transferrin,D12.776.124.050.800
17067352,2006-11-01T00:00:00,Transferrin,D12.776.124.790.223.839
17067352,2006-11-01T00:00:00,Transferrin,D12.776.157.427.500
17067352,2006-11-01T00:00:00,Transferrin,D12.776.377.715.182.839
17067352,2006-11-01T00:00:00,Transferrin,D12.776.556.579.500
17068180,2006-11-01T00:00:00,Diagnostic Errors,E01.354
17068180,2006-11-01T00:00:00,Diagnostic Errors,N02.421.450.280
17068180,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17068180,2006-11-01T00:00:00,Questionnaires,E05.318.308.750
17068180,2006-11-01T00:00:00,Questionnaires,L01.280.800
17068180,2006-11-01T00:00:00,Questionnaires,N05.715.360.300.695
17068180,2006-11-01T00:00:00,Questionnaires,N06.850.520.308.750
17068180,2006-11-01T00:00:00,Vitamin D,D04.808.812.768
17068314,2006-11-01T00:00:00,Affect,F01.470.047
17068314,2006-11-01T00:00:00,Aged,M01.060.116.100
17068314,2006-11-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17068314,2006-11-01T00:00:00,Alzheimer Disease,C10.574.945.249
17068314,2006-11-01T00:00:00,Alzheimer Disease,F03.087.400.100
17068314,2006-11-01T00:00:00,Caregivers,M01.085
17068314,2006-11-01T00:00:00,Caregivers,M01.526.485.200
17068314,2006-11-01T00:00:00,Caregivers,N02.360.200
17068314,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17068314,2006-11-01T00:00:00,Counseling,F02.784.176
17068314,2006-11-01T00:00:00,Counseling,F04.408.413
17068314,2006-11-01T00:00:00,Counseling,N02.421.143.303
17068314,2006-11-01T00:00:00,Counseling,N02.421.461.363
17068314,2006-11-01T00:00:00,Depressive Disorder,F03.600.300
17068314,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17068314,2006-11-01T00:00:00,Patient Dropouts,M01.643.673
17068314,2006-11-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
17068314,2006-11-01T00:00:00,"Quality Assurance, Health Care",N05.700
17068314,2006-11-01T00:00:00,Research Design,E05.581.500
17068314,2006-11-01T00:00:00,Research Design,H01.770.644.728
17068314,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
17068314,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
17068314,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
17068314,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
17068314,2006-11-01T00:00:00,Sertraline,D02.092.705.800
17068314,2006-11-01T00:00:00,Sertraline,D02.455.426.559.847.638.845.800
17068314,2006-11-01T00:00:00,Sertraline,D04.615.638.845.800
17068314,2006-11-01T00:00:00,Social Support,I01.880.656.600
17068314,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17068314,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17068314,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17069605,2006-11-01T00:00:00,Adolescent,M01.060.057
17069605,2006-11-01T00:00:00,Adult,M01.060.116
17069605,2006-11-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17069605,2006-11-01T00:00:00,Aortic Diseases,C14.907.109
17069605,2006-11-01T00:00:00,Child,M01.060.406
17069605,2006-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17069605,2006-11-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
17069605,2006-11-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
17069605,2006-11-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
17069605,2006-11-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
17069605,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
17069605,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
17069605,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
17069605,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17069605,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
17069605,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
17069605,2006-11-01T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
17069605,2006-11-01T00:00:00,Infant,M01.060.703
17069605,2006-11-01T00:00:00,"Infant, Newborn",M01.060.703.520
17069605,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17069605,2006-11-01T00:00:00,Research Design,E05.581.500
17069605,2006-11-01T00:00:00,Research Design,H01.770.644.728
17070449,2006-11-01T00:00:00,Breast Neoplasms,C04.588.180
17070449,2006-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
17070449,2006-11-01T00:00:00,Calcinosis,C18.452.174.130
17070449,2006-11-01T00:00:00,Clinical Competence,I02.399.630.210
17070449,2006-11-01T00:00:00,Clinical Competence,N04.761.210
17070449,2006-11-01T00:00:00,Computer Simulation,L01.224.160
17070449,2006-11-01T00:00:00,Data Display,F02.784.412.221
17070449,2006-11-01T00:00:00,Data Display,L01.296
17070449,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17070449,2006-11-01T00:00:00,Liquid Crystals,J01.637.506
17070449,2006-11-01T00:00:00,Mammography,E01.370.350.700.500
17070449,2006-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17070449,2006-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17070449,2006-11-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17070449,2006-11-01T00:00:00,Research Design,E05.581.500
17070449,2006-11-01T00:00:00,Research Design,H01.770.644.728
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,G17.800
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17070449,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17070449,2006-11-01T00:00:00,Task Performance and Analysis,F02.784.412.846
17070449,2006-11-01T00:00:00,Task Performance and Analysis,F02.784.692.746
17070449,2006-11-01T00:00:00,Task Performance and Analysis,F02.808.600
17070449,2006-11-01T00:00:00,User-Computer Interface,L01.224.900.910
17070452,2006-11-01T00:00:00,Adult,M01.060.116
17070452,2006-11-01T00:00:00,Artificial Intelligence,L01.224.065
17070452,2006-11-01T00:00:00,Breast Neoplasms,C04.588.180
17070452,2006-11-01T00:00:00,Breast Neoplasms,C17.800.090.500
17070452,2006-11-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.200.025.232.500
17070452,2006-11-01T00:00:00,"Carcinoma, Ductal, Breast",C04.557.470.615.132.500
17070452,2006-11-01T00:00:00,"Carcinoma, Ductal, Breast",C04.588.180.390
17070452,2006-11-01T00:00:00,"Carcinoma, Ductal, Breast",C17.800.090.500.390
17070452,2006-11-01T00:00:00,"Carcinoma, Lobular",C04.557.470.200.025.305
17070452,2006-11-01T00:00:00,"Carcinoma, Lobular",C04.557.470.615.305
17070452,2006-11-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17070452,2006-11-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17070452,2006-11-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17070452,2006-11-01T00:00:00,Contrast Media,D27.720.259
17070452,2006-11-01T00:00:00,Gadolinium DTPA,D01.632.400
17070452,2006-11-01T00:00:00,Gadolinium DTPA,D02.092.782.590.401
17070452,2006-11-01T00:00:00,Gadolinium DTPA,D02.241.081.038.694.400
17070452,2006-11-01T00:00:00,Gadolinium DTPA,D02.691.400
17070452,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17070452,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
17070452,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
17070452,2006-11-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
17070452,2006-11-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17070452,2006-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17070452,2006-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17070452,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,G17.800
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17070452,2006-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17071309,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17071309,2006-11-01T00:00:00,Hyperparathyroidism,C19.642.355
17071309,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17071309,2006-11-01T00:00:00,Parathyroidectomy,E04.270.694
17071309,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.600.850
17071309,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.519.625.850.900
17071309,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.600.850
17071309,2006-11-01T00:00:00,Serotonin Uptake Inhibitors,D27.505.696.577.850.900
17074576,2006-11-01T00:00:00,Adult,M01.060.116
17074576,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17074576,2006-11-01T00:00:00,Nasal Cavity,A04.531.449
17074576,2006-11-01T00:00:00,Orbital Diseases,C11.675
17074576,2006-11-01T00:00:00,Pressure,G01.374.715
17079214,2006-11-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17079214,2006-11-01T00:00:00,Catheter Ablation,E02.148.110
17079214,2006-11-01T00:00:00,Catheter Ablation,E02.148.442.110
17079214,2006-11-01T00:00:00,Catheter Ablation,E02.154.402.110
17079214,2006-11-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17079214,2006-11-01T00:00:00,Computer Simulation,L01.224.160
17079214,2006-11-01T00:00:00,Electrodes,E07.305.250
17079214,2006-11-01T00:00:00,Hot Temperature,G01.906.595.543
17079214,2006-11-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
17079214,2006-11-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
17079214,2006-11-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
17079214,2006-11-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
17079214,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17079214,2006-11-01T00:00:00,Liver Neoplasms,C04.588.274.623
17079214,2006-11-01T00:00:00,Liver Neoplasms,C06.301.623
17079214,2006-11-01T00:00:00,Liver Neoplasms,C06.552.697
17079214,2006-11-01T00:00:00,Temperature,G01.906.595
17079214,2006-11-01T00:00:00,Temperature,G16.500.275.063.725.710
17079214,2006-11-01T00:00:00,Temperature,G16.500.750.775.710
17079214,2006-11-01T00:00:00,Temperature,N06.230.150.450
17079214,2006-11-01T00:00:00,Temperature,N06.230.300.100.725.710
17080198,2006-11-01T00:00:00,Animals,B01.050
17080198,2006-11-01T00:00:00,Cell Movement,G04.299.283
17080198,2006-11-01T00:00:00,Cell Movement,G07.700.560.500.180
17080198,2006-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
17080198,2006-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
17080198,2006-11-01T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
17080198,2006-11-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17080198,2006-11-01T00:00:00,Hyaluronic Acid,D09.698.373.475
17080198,2006-11-01T00:00:00,"Muscle, Smooth",A02.633.570
17080198,2006-11-01T00:00:00,"Muscle, Smooth",A10.690.467
17080198,2006-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17080198,2006-11-01T00:00:00,Signal Transduction,G02.111.087.800
17080198,2006-11-01T00:00:00,Signal Transduction,G02.149.115.800
17080198,2006-11-01T00:00:00,Signal Transduction,G04.299.880
17080198,2006-11-01T00:00:00,"Transcription, Genetic",G02.111.087.847
17080198,2006-11-01T00:00:00,"Transcription, Genetic",G02.149.115.847
17080198,2006-11-01T00:00:00,"Transcription, Genetic",G05.355.310.700
17081209,2006-11-01T00:00:00,Atrial Fibrillation,C14.280.067.198
17081209,2006-11-01T00:00:00,Atrial Fibrillation,C23.550.073.198
17081209,2006-11-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17081209,2006-11-01T00:00:00,Catheter Ablation,E02.148.110
17081209,2006-11-01T00:00:00,Catheter Ablation,E02.148.442.110
17081209,2006-11-01T00:00:00,Catheter Ablation,E02.154.402.110
17081209,2006-11-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17081209,2006-11-01T00:00:00,Heart Atria,A07.541.358
17081209,2006-11-01T00:00:00,Heart Conduction System,A07.541.409
17081209,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17081209,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17081209,2006-11-01T00:00:00,Pulmonary Veins,A07.231.908.713
17081209,2006-11-01T00:00:00,Reoperation,E04.690
17081209,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17081209,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17081209,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17081504,2006-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17081504,2006-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17081504,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17081504,2006-11-01T00:00:00,Phenotype,G05.695
17081504,2006-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17081504,2006-11-01T00:00:00,Tobacco Use Disorder,C21.739.912
17081504,2006-11-01T00:00:00,Tobacco Use Disorder,F03.900.912
17082279,2006-11-01T00:00:00,"Diagnosis, Differential",E01.171
17082279,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C04.588.149.721.450.692
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C04.588.443.591.692
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C05.116.231.754.450.692
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C05.500.499.692
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C07.320.515.692
17082279,2006-11-01T00:00:00,Palatal Neoplasms,C07.465.565.692
17083697,2006-11-01T00:00:00,"Diagnosis, Differential",E01.171
17083697,2006-11-01T00:00:00,Fibrosis,C23.550.355
17083697,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17083697,2006-11-01T00:00:00,Kidney Diseases,C12.777.419
17083697,2006-11-01T00:00:00,Kidney Diseases,C13.351.968.419
17083697,2006-11-01T00:00:00,Skin,A17.815
17083697,2006-11-01T00:00:00,Skin Diseases,C17.800
17090215,2006-11-01T00:00:00,Animals,B01.050
17090215,2006-11-01T00:00:00,Body Weight,C23.888.144
17090215,2006-11-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
17090215,2006-11-01T00:00:00,Body Weight,E05.041.124.160.750
17090215,2006-11-01T00:00:00,Body Weight,G07.100.100.160.120
17090215,2006-11-01T00:00:00,Body Weight,G07.700.320.249.314.120
17090215,2006-11-01T00:00:00,Energy Metabolism,G03.495.335
17090215,2006-11-01T00:00:00,Gene Expression Regulation,G05.355.315
17090215,2006-11-01T00:00:00,Heart,A07.541
17090215,2006-11-01T00:00:00,Liver,A03.620
17090215,2006-11-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17090215,2006-11-01T00:00:00,Mitochondria,A11.284.835.626
17090215,2006-11-01T00:00:00,"Mitochondria, Heart",A11.284.430.214.190.875.564.627.603
17090215,2006-11-01T00:00:00,"Mitochondria, Heart",A11.284.835.626.627.603
17090215,2006-11-01T00:00:00,"Muscle, Skeletal",A02.633.567
17090215,2006-11-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17090215,2006-11-01T00:00:00,Norepinephrine,D02.033.100.291.502
17090215,2006-11-01T00:00:00,Norepinephrine,D02.092.063.480
17090215,2006-11-01T00:00:00,Norepinephrine,D02.092.211.215.311.560
17090215,2006-11-01T00:00:00,Norepinephrine,D02.092.311.461.484
17090215,2006-11-01T00:00:00,Trans-Activators,D12.776.260.755
17090215,2006-11-01T00:00:00,Trans-Activators,D12.776.930.900
17090215,2006-11-01T00:00:00,Trans-Activators,D12.776.964.925.984
17090215,2006-11-01T00:00:00,Transcription Factors,D12.776.930
17090819,2006-11-01T00:00:00,Blood Flow Velocity,E01.370.370.130
17090819,2006-11-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
17090819,2006-11-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17090819,2006-11-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17090819,2006-11-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17090819,2006-11-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
17090819,2006-11-01T00:00:00,Coronary Angiography,E01.370.370.050.200
17090819,2006-11-01T00:00:00,Coronary Angiography,E01.370.370.380.200
17090819,2006-11-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
17090819,2006-11-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
17090819,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17090819,2006-11-01T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17090819,2006-11-01T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17090819,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17090819,2006-11-01T00:00:00,Probability,E05.318.740.600
17090819,2006-11-01T00:00:00,Probability,G17.680
17090819,2006-11-01T00:00:00,Probability,N05.715.360.750.625
17090819,2006-11-01T00:00:00,Probability,N06.850.520.830.600
17090819,2006-11-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
17090819,2006-11-01T00:00:00,Stroke Volume,G09.330.380.124.882
17091147,2006-11-01T00:00:00,Adolescent,M01.060.057
17091147,2006-11-01T00:00:00,"Diagnosis, Differential",E01.171
17091147,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17101360,2006-11-01T00:00:00,Adolescent,M01.060.057
17101360,2006-11-01T00:00:00,Child,M01.060.406
17101360,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17101360,2006-11-01T00:00:00,Laparoscopy,E01.370.388.250.520
17101360,2006-11-01T00:00:00,Laparoscopy,E04.800.250.520
17102704,2006-11-01T00:00:00,Adult,M01.060.116
17102704,2006-11-01T00:00:00,Alcoholism,C21.739.100.250
17102704,2006-11-01T00:00:00,Alcoholism,F03.900.100.350
17102704,2006-11-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17102704,2006-11-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17102704,2006-11-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17102704,2006-11-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17102704,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17102704,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17102704,2006-11-01T00:00:00,"Models, Statistical",E05.318.740.500
17102704,2006-11-01T00:00:00,"Models, Statistical",E05.599.835
17102704,2006-11-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17102704,2006-11-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17102704,2006-11-01T00:00:00,Phenotype,G05.695
17102704,2006-11-01T00:00:00,Prevalence,E05.318.308.985.525.750
17102704,2006-11-01T00:00:00,Prevalence,L01.280.975.525.750
17102704,2006-11-01T00:00:00,Prevalence,N01.224.935.597.750
17102704,2006-11-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17102704,2006-11-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17102704,2006-11-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17102704,2006-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17102704,2006-11-01T00:00:00,Risk Factors,N05.715.350.200.700
17102704,2006-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17102704,2006-11-01T00:00:00,Risk Factors,N06.850.490.625.750
17102704,2006-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17102704,2006-11-01T00:00:00,Sex Factors,N05.715.350.675
17102704,2006-11-01T00:00:00,Sex Factors,N06.850.490.875
17106299,2006-11-01T00:00:00,Disaster Planning,N06.230.100.035
17106299,2006-11-01T00:00:00,Disasters,N06.230.100
17106299,2006-11-01T00:00:00,Emergency Medical Services,N02.421.297
17106299,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17107917,2006-11-01T00:00:00,Ascites,C23.550.081
17107917,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17107917,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17109581,2006-11-01T00:00:00,Adult,M01.060.116
17109581,2006-11-01T00:00:00,Complementary Therapies,E02.190
17109581,2006-11-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17109581,2006-11-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17109581,2006-11-01T00:00:00,Health Behavior,F01.145.488
17109581,2006-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17109581,2006-11-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17109581,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17109581,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17109581,2006-11-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17109581,2006-11-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
17109581,2006-11-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
17109581,2006-11-01T00:00:00,Patient Satisfaction,N05.715.360.600
17109581,2006-11-01T00:00:00,Questionnaires,E05.318.308.750
17109581,2006-11-01T00:00:00,Questionnaires,L01.280.800
17109581,2006-11-01T00:00:00,Questionnaires,N05.715.360.300.695
17109581,2006-11-01T00:00:00,Questionnaires,N06.850.520.308.750
17109581,2006-11-01T00:00:00,Self Care,E02.900
17109581,2006-11-01T00:00:00,Self Care,N02.421.784.680
17109581,2006-11-01T00:00:00,United States,Z01.107.567.875
17110664,2006-11-01T00:00:00,Adolescent,M01.060.057
17110664,2006-11-01T00:00:00,Adult,M01.060.116
17110664,2006-11-01T00:00:00,Aged,M01.060.116.100
17110664,2006-11-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17110664,2006-11-01T00:00:00,Brain Ischemia,C14.907.253.092
17110664,2006-11-01T00:00:00,Catheterization,E02.148
17110664,2006-11-01T00:00:00,Catheterization,E05.157
17110664,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17110664,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17110664,2006-11-01T00:00:00,Stroke,C10.228.140.300.775
17110664,2006-11-01T00:00:00,Stroke,C14.907.253.855
17112884,2006-11-01T00:00:00,Adult,M01.060.116
17112884,2006-11-01T00:00:00,Aged,M01.060.116.100
17112884,2006-11-01T00:00:00,Blood Pressure,E01.370.600.875.249
17112884,2006-11-01T00:00:00,Blood Pressure,G09.330.380.076
17112884,2006-11-01T00:00:00,Echocardiography,E01.370.350.850.220
17112884,2006-11-01T00:00:00,Echocardiography,E01.370.370.380.220
17112884,2006-11-01T00:00:00,Heart,A07.541
17112884,2006-11-01T00:00:00,Heart Failure,C14.280.434
17112884,2006-11-01T00:00:00,Heart Transplantation,E04.100.376.475
17112884,2006-11-01T00:00:00,Heart Transplantation,E04.928.220.390
17112884,2006-11-01T00:00:00,Heart Transplantation,E04.936.450.475
17112884,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17112884,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17112884,2006-11-01T00:00:00,Postoperative Complications,C23.550.767
17112884,2006-11-01T00:00:00,Pulmonary Artery,A07.231.114.715
17112884,2006-11-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
17119059,2006-11-01T00:00:00,Adult,M01.060.116
17119059,2006-11-01T00:00:00,Aged,M01.060.116.100
17119059,2006-11-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17119059,2006-11-01T00:00:00,Body Mass Index,E05.041.124.125
17119059,2006-11-01T00:00:00,Body Mass Index,G07.100.100.125
17119059,2006-11-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17119059,2006-11-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17119059,2006-11-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17119059,2006-11-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17119059,2006-11-01T00:00:00,Genetic Variation,G05.365
17119059,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17119059,2006-11-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
17119059,2006-11-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
17119059,2006-11-01T00:00:00,Interleukin-6,D23.529.374.465.506
17119059,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17119059,2006-11-01T00:00:00,Multiple Myeloma,C04.557.595.500
17119059,2006-11-01T00:00:00,Multiple Myeloma,C14.907.454.460
17119059,2006-11-01T00:00:00,Multiple Myeloma,C15.378.147.780.650
17119059,2006-11-01T00:00:00,Multiple Myeloma,C15.378.463.835.460
17119059,2006-11-01T00:00:00,Multiple Myeloma,C20.683.515.845
17119059,2006-11-01T00:00:00,Multiple Myeloma,C20.683.780.650
17119059,2006-11-01T00:00:00,Plasmacytoma,C04.557.595.600
17119059,2006-11-01T00:00:00,Plasmacytoma,C20.683.515.880
17119059,2006-11-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17122680,2006-11-01T00:00:00,Activities of Daily Living,E02.831.067
17122680,2006-11-01T00:00:00,Activities of Daily Living,I03.050
17122680,2006-11-01T00:00:00,Activities of Daily Living,N02.421.784.110
17122680,2006-11-01T00:00:00,Adolescent,M01.060.057
17122680,2006-11-01T00:00:00,Adult,M01.060.116
17122680,2006-11-01T00:00:00,Aged,M01.060.116.100
17122680,2006-11-01T00:00:00,Brain Injuries,C10.228.140.199
17122680,2006-11-01T00:00:00,Brain Injuries,C10.900.300.087
17122680,2006-11-01T00:00:00,Brain Injuries,C21.866.260.118
17122680,2006-11-01T00:00:00,Brain Injuries,C21.866.915.300.200
17122680,2006-11-01T00:00:00,Hospitalization,E02.760.400
17122680,2006-11-01T00:00:00,Hospitalization,N02.421.585.400
17122680,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17122680,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17122680,2006-11-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
17122680,2006-11-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
17122680,2006-11-01T00:00:00,Population Surveillance,E05.318.308.250.700
17122680,2006-11-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
17122680,2006-11-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
17122680,2006-11-01T00:00:00,Population Surveillance,N06.850.780.675
17122680,2006-11-01T00:00:00,Quality of Life,I01.800
17122680,2006-11-01T00:00:00,Quality of Life,K01.752.400.750
17122680,2006-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17122680,2006-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17122697,2006-11-01T00:00:00,Adolescent,M01.060.057
17122697,2006-11-01T00:00:00,Child,M01.060.406
17122697,2006-11-01T00:00:00,Crime Victims,M01.135
17122697,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17122697,2006-11-01T00:00:00,Interpersonal Relations,F01.829.401
17122697,2006-11-01T00:00:00,Juvenile Delinquency,I01.880.735.479
17122697,2006-11-01T00:00:00,Life Change Events,F01.829.458.410
17122697,2006-11-01T00:00:00,Mental Health Services,F04.408
17122697,2006-11-01T00:00:00,Mental Health Services,N02.421.461
17122697,2006-11-01T00:00:00,Psychotherapy,F04.754
17122697,2006-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17122697,2006-11-01T00:00:00,Risk Assessment,N04.452.871.715
17122697,2006-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17122697,2006-11-01T00:00:00,Risk Assessment,N06.850.505.715
17122697,2006-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17122697,2006-11-01T00:00:00,Risk-Taking,F01.145.722
17122697,2006-11-01T00:00:00,Self-Injurious Behavior,F01.145.126.980
17122697,2006-11-01T00:00:00,Sexual Behavior,F01.145.802
17122697,2006-11-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17122697,2006-11-01T00:00:00,Substance-Related Disorders,C21.739
17122697,2006-11-01T00:00:00,Substance-Related Disorders,F03.900
17122697,2006-11-01T00:00:00,Violence,I01.198.240.856
17122697,2006-11-01T00:00:00,Violence,I01.880.735.900
17128681,2006-11-01T00:00:00,African Americans,M01.686.508.100.100
17128681,2006-11-01T00:00:00,African Americans,M01.686.754.100
17128681,2006-11-01T00:00:00,Cholesterol,D04.808.247.222.284
17128681,2006-11-01T00:00:00,Cholesterol,D04.808.247.808.197
17128681,2006-11-01T00:00:00,Cholesterol,D10.570.938.208
17128681,2006-11-01T00:00:00,Cholesterol,D10.851.208
17128681,2006-11-01T00:00:00,"Cholesterol, HDL",D10.532.432.400
17128681,2006-11-01T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
17128681,2006-11-01T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
17128681,2006-11-01T00:00:00,"Cholesterol, LDL",D10.532.515.500
17128681,2006-11-01T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
17128681,2006-11-01T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
17128681,2006-11-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
17128681,2006-11-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
17128681,2006-11-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
17128681,2006-11-01T00:00:00,Coronary Disease,C14.280.647.250
17128681,2006-11-01T00:00:00,Coronary Disease,C14.907.585.250
17128681,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17128681,2006-11-01T00:00:00,Lipids,D10
17128681,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17128681,2006-11-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17128681,2006-11-01T00:00:00,Risk Assessment,N04.452.871.715
17128681,2006-11-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17128681,2006-11-01T00:00:00,Risk Assessment,N06.850.505.715
17128681,2006-11-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17132217,2006-11-01T00:00:00,Animals,B01.050
17132217,2006-11-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17132217,2006-11-01T00:00:00,Cyclosporine,D04.345.566.235.300
17132217,2006-11-01T00:00:00,Cyclosporine,D12.644.641.235.300
17132217,2006-11-01T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
17132217,2006-11-01T00:00:00,Glomerular Filtration Rate,G08.852.357
17132217,2006-11-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17132217,2006-11-01T00:00:00,Kidney,A05.810.453
17132217,2006-11-01T00:00:00,Kidney Diseases,C12.777.419
17132217,2006-11-01T00:00:00,Kidney Diseases,C13.351.968.419
17132217,2006-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17132217,2006-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17133146,2006-11-01T00:00:00,Adult,M01.060.116
17133146,2006-11-01T00:00:00,Conflict (Psychology),F01.658.209
17133146,2006-11-01T00:00:00,Conflict of Interest,K01.316.130
17133146,2006-11-01T00:00:00,Conflict of Interest,N05.350.225
17133146,2006-11-01T00:00:00,Health Services Accessibility,N04.590.374.350
17133146,2006-11-01T00:00:00,Health Services Accessibility,N05.300.430
17133146,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17133146,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17133146,2006-11-01T00:00:00,Nurse Practitioners,M01.526.485.650.640
17133146,2006-11-01T00:00:00,Nurse Practitioners,N02.360.650.640
17133146,2006-11-01T00:00:00,Physician Assistants,M01.526.485.067.740
17133146,2006-11-01T00:00:00,Physician Assistants,N02.360.067.740
17133146,2006-11-01T00:00:00,Professional-Patient Relations,F01.829.401.650
17133146,2006-11-01T00:00:00,Professional-Patient Relations,N05.300.660
17133146,2006-11-01T00:00:00,United States,Z01.107.567.875
17135604,2006-11-01T00:00:00,Adult,M01.060.116
17135604,2006-11-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17135604,2006-11-01T00:00:00,Diabetes Mellitus,C19.246
17135604,2006-11-01T00:00:00,Gene Expression Regulation,G05.355.315
17135604,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17135604,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17135604,2006-11-01T00:00:00,"Muscle, Skeletal",A02.633.567
17135604,2006-11-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17135604,2006-11-01T00:00:00,Obesity,C18.654.726.500
17135604,2006-11-01T00:00:00,Obesity,C23.888.144.699.500
17135604,2006-11-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17135604,2006-11-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17135604,2006-11-01T00:00:00,"RNA, Messenger",D13.444.735.544
17135604,2006-11-01T00:00:00,"Receptors, Cell Surface",D12.776.543.750
17135604,2006-11-01T00:00:00,"Receptors, Leptin",D12.776.543.750.065.500
17135604,2006-11-01T00:00:00,Weight Loss,C23.888.144.243.963
17135604,2006-11-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17135615,2006-11-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17135615,2006-11-01T00:00:00,Body Mass Index,E05.041.124.125
17135615,2006-11-01T00:00:00,Body Mass Index,G07.100.100.125
17135615,2006-11-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17135615,2006-11-01T00:00:00,Child,M01.060.406
17135615,2006-11-01T00:00:00,Child Behavior Disorders,F03.550.300
17135615,2006-11-01T00:00:00,Exercise,G11.427.590.237
17135615,2006-11-01T00:00:00,Exercise,I03.350
17135615,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17135615,2006-11-01T00:00:00,Obesity,C18.654.726.500
17135615,2006-11-01T00:00:00,Obesity,C23.888.144.699.500
17135615,2006-11-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
17135615,2006-11-01T00:00:00,Obesity,G07.100.100.160.120.699.500
17135615,2006-11-01T00:00:00,Prevalence,E05.318.308.985.525.750
17135615,2006-11-01T00:00:00,Prevalence,L01.280.975.525.750
17135615,2006-11-01T00:00:00,Prevalence,N01.224.935.597.750
17135615,2006-11-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17135615,2006-11-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17135615,2006-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17135615,2006-11-01T00:00:00,Risk Factors,N05.715.350.200.700
17135615,2006-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17135615,2006-11-01T00:00:00,Risk Factors,N06.850.490.625.750
17135615,2006-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17135615,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17135615,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17135615,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17143237,2006-11-01T00:00:00,Adult,M01.060.116
17143237,2006-11-01T00:00:00,Aged,M01.060.116.100
17143237,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17143237,2006-11-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17143237,2006-11-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17143237,2006-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17143237,2006-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17143237,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17143237,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17143237,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17143237,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17161155,2006-11-01T00:00:00,Adolescent,M01.060.057
17161155,2006-11-01T00:00:00,Adult,M01.060.116
17161155,2006-11-01T00:00:00,Aged,M01.060.116.100
17161155,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161155,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161155,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161155,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161155,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161155,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161155,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161155,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161155,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161155,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161155,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161155,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161155,2006-11-01T00:00:00,Uterine Neoplasms,C04.588.945.418.948
17161155,2006-11-01T00:00:00,Uterine Neoplasms,C13.351.500.852.762
17161155,2006-11-01T00:00:00,Uterine Neoplasms,C13.351.937.418.875
17161156,2006-11-01T00:00:00,Adolescent,M01.060.057
17161156,2006-11-01T00:00:00,Adult,M01.060.116
17161156,2006-11-01T00:00:00,Aged,M01.060.116.100
17161156,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161156,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161156,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161156,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161156,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161156,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161156,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161156,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161156,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161156,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161156,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161156,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161157,2006-11-01T00:00:00,Adolescent,M01.060.057
17161157,2006-11-01T00:00:00,Adult,M01.060.116
17161157,2006-11-01T00:00:00,Aged,M01.060.116.100
17161157,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161157,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161157,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161157,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161157,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161157,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161157,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161157,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161157,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161157,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161157,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161157,2006-11-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
17161157,2006-11-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
17161157,2006-11-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
17161157,2006-11-01T00:00:00,Ovarian Neoplasms,C19.344.410
17161157,2006-11-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
17161157,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161158,2006-11-01T00:00:00,Adolescent,M01.060.057
17161158,2006-11-01T00:00:00,Adult,M01.060.116
17161158,2006-11-01T00:00:00,Aged,M01.060.116.100
17161158,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161158,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161158,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161158,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161158,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161158,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161158,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161158,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161158,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161158,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161158,2006-11-01T00:00:00,Pregnancy,G08.686.785.760.769
17161158,2006-11-01T00:00:00,"Pregnancy Complications, Neoplastic",C04.850
17161158,2006-11-01T00:00:00,"Pregnancy Complications, Neoplastic",C13.703.720
17161158,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161165,2006-11-01T00:00:00,Adolescent,M01.060.057
17161165,2006-11-01T00:00:00,Adult,M01.060.116
17161165,2006-11-01T00:00:00,Aged,M01.060.116.100
17161165,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161165,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161165,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161165,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161165,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161165,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161165,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161165,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161165,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161165,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161165,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161165,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161167,2006-11-01T00:00:00,Adolescent,M01.060.057
17161167,2006-11-01T00:00:00,Adult,M01.060.116
17161167,2006-11-01T00:00:00,Aged,M01.060.116.100
17161167,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161167,2006-11-01T00:00:00,Cervical Intraepithelial Neoplasia,C04.557.470.200.240.250
17161167,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161167,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161167,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161167,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161167,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161167,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161167,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161167,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161167,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161167,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161167,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17161167,2006-11-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
17161167,2006-11-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
17161167,2006-11-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
17161167,2006-11-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
17161169,2006-11-01T00:00:00,Adolescent,M01.060.057
17161169,2006-11-01T00:00:00,Adult,M01.060.116
17161169,2006-11-01T00:00:00,Aged,M01.060.116.100
17161169,2006-11-01T00:00:00,Carcinoma,C04.557.470.200
17161169,2006-11-01T00:00:00,Combined Modality Therapy,E02.186
17161169,2006-11-01T00:00:00,Disease-Free Survival,E01.789.200
17161169,2006-11-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
17161169,2006-11-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
17161169,2006-11-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
17161169,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
17161169,2006-11-01T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
17161169,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17161169,2006-11-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17161169,2006-11-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17161169,2006-11-01T00:00:00,"Societies, Medical",N03.540.828.589
17164123,2006-11-01T00:00:00,Hepacivirus,B04.450.410
17164123,2006-11-01T00:00:00,Hepacivirus,B04.820.250.475
17164123,2006-11-01T00:00:00,Hepacivirus,B04.909.777.310.475
17164123,2006-11-01T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
17164123,2006-11-01T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
17164123,2006-11-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
17164123,2006-11-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
17164123,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.644.276.718.550
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D12.776.467.718.550
17164123,2006-11-01T00:00:00,Interferon-gamma,D23.529.374.440.893
17164123,2006-11-01T00:00:00,Interferon-gamma,D23.529.374.480.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
17164123,2006-11-01T00:00:00,Interferon-gamma,D23.529.718.550
17164123,2006-11-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
17164123,2006-11-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
17164123,2006-11-01T00:00:00,Interleukin-10,D23.529.374.465.510
17164123,2006-11-01T00:00:00,Liver Cirrhosis,C06.552.630
17182453,2006-11-01T00:00:00,Adult,M01.060.116
17182453,2006-11-01T00:00:00,Cerebellar Ataxia,C10.228.140.252.190
17182453,2006-11-01T00:00:00,Cerebellar Ataxia,C10.597.350.090.500
17182453,2006-11-01T00:00:00,Cerebellar Ataxia,C23.888.592.350.090.200
17182453,2006-11-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17182453,2006-11-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
17182453,2006-11-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
17182453,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17182453,2006-11-01T00:00:00,Neurologic Examination,E01.370.376.550
17182453,2006-11-01T00:00:00,Neurologic Examination,E01.370.600.550
17182453,2006-11-01T00:00:00,Psychomotor Disorders,C10.597.606.881
17182453,2006-11-01T00:00:00,Psychomotor Disorders,C23.888.592.604.882
17182453,2006-11-01T00:00:00,Psychomotor Disorders,F01.700.875
17182453,2006-11-01T00:00:00,Substance-Related Disorders,C21.739
17182453,2006-11-01T00:00:00,Substance-Related Disorders,F03.900
17195408,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17195408,2006-11-01T00:00:00,Hypertension,C14.907.489
17195408,2006-11-01T00:00:00,Prevalence,E05.318.308.985.525.750
17195408,2006-11-01T00:00:00,Prevalence,L01.280.975.525.750
17195408,2006-11-01T00:00:00,Prevalence,N01.224.935.597.750
17195408,2006-11-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17195408,2006-11-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17195408,2006-11-01T00:00:00,Rural Population,N01.600.725
17195408,2006-11-01T00:00:00,Urban Population,N01.600.900
17240823,2006-11-01T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
17240823,2006-11-01T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
17240823,2006-11-01T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
17240823,2006-11-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17240823,2006-11-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17240823,2006-11-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17240823,2006-11-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17240823,2006-11-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
17240823,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17240823,2006-11-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17240823,2006-11-01T00:00:00,Lung Neoplasms,C08.381.540
17240823,2006-11-01T00:00:00,Lung Neoplasms,C08.785.520
17240823,2006-11-01T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17240823,2006-11-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17240823,2006-11-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17240823,2006-11-01T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17266782,2006-11-01T00:00:00,Animals,B01.050
17266782,2006-11-01T00:00:00,Larva,B05.500.500
17266782,2006-11-01T00:00:00,Larva,G07.700.320.500.550.500.500
17266782,2006-11-01T00:00:00,Photic Stimulation,E05.723.729
17266782,2006-11-01T00:00:00,Retina,A09.371.729
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
17266782,2006-11-01T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.850.625.670.650
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.663.650.915.937.670.650
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A08.800.950.937.670.650
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A09.371.729.831.625.670.650
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.850.625.670.650
17266782,2006-11-01T00:00:00,Retinal Rod Photoreceptor Cells,A11.671.650.915.937.670.650
17266782,2006-11-01T00:00:00,Transducin,D08.811.277.040.330.300.200.800
17266782,2006-11-01T00:00:00,Transducin,D12.644.360.375.940
17266782,2006-11-01T00:00:00,Transducin,D12.776.157.325.332.940
17266782,2006-11-01T00:00:00,Transducin,D12.776.476.375.940
17266782,2006-11-01T00:00:00,Transducin,D12.776.543.325.800
17312856,2006-11-01T00:00:00,Blood Pressure,E01.370.600.875.249
17312856,2006-11-01T00:00:00,Blood Pressure,G09.330.380.076
17312856,2006-11-01T00:00:00,Brain,A08.186.211
17312856,2006-11-01T00:00:00,Carbon Dioxide,D01.200.200
17312856,2006-11-01T00:00:00,Carbon Dioxide,D01.362.150
17312856,2006-11-01T00:00:00,Carbon Dioxide,D01.650.550.200
17312856,2006-11-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
17312856,2006-11-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
17312856,2006-11-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
17312856,2006-11-01T00:00:00,Child,M01.060.406
17312856,2006-11-01T00:00:00,"Child, Preschool",M01.060.406.448
17312856,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17312856,2006-11-01T00:00:00,Infant,M01.060.703
17312856,2006-11-01T00:00:00,"Monitoring, Intraoperative",E01.370.520.510
17312856,2006-11-01T00:00:00,"Monitoring, Intraoperative",E04.510
17312856,2006-11-01T00:00:00,Oxygen,D01.268.185.550
17312856,2006-11-01T00:00:00,Oxygen,D01.362.670
17312856,2006-11-01T00:00:00,Pilot Projects,E05.318.760.750
17312856,2006-11-01T00:00:00,Pilot Projects,E05.337.737
17312856,2006-11-01T00:00:00,Pilot Projects,N05.715.360.775.625
17312856,2006-11-01T00:00:00,Pilot Projects,N06.850.520.450.720
17312856,2006-11-01T00:00:00,Regression Analysis,E05.318.740.750
17312856,2006-11-01T00:00:00,Regression Analysis,N05.715.360.750.695
17312856,2006-11-01T00:00:00,Regression Analysis,N06.850.520.830.750
17312856,2006-11-01T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
17312856,2006-11-01T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
17436176,2006-11-01T00:00:00,Adult,M01.060.116
17436176,2006-11-01T00:00:00,Age Factors,N05.715.350.075
17436176,2006-11-01T00:00:00,Age Factors,N06.850.490.250
17436176,2006-11-01T00:00:00,Aged,M01.060.116.100
17436176,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17436176,2006-11-01T00:00:00,Locomotion,G07.700.560.500
17436176,2006-11-01T00:00:00,Locomotion,G11.427.590.530.568
17436176,2006-11-01T00:00:00,Middle Aged,M01.060.116.630
17436176,2006-11-01T00:00:00,Physical Therapy Modalities,E02.779
17436176,2006-11-01T00:00:00,Postural Balance,G11.427.690
17436176,2006-11-01T00:00:00,Postural Balance,G11.561.600.810.541.595
17436176,2006-11-01T00:00:00,Quadriplegia,C10.597.622.760
17436176,2006-11-01T00:00:00,Quadriplegia,C23.888.592.636.786
17436176,2006-11-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17436176,2006-11-01T00:00:00,Risk Factors,N05.715.350.200.700
17436176,2006-11-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17436176,2006-11-01T00:00:00,Risk Factors,N06.850.490.625.750
17436176,2006-11-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17436176,2006-11-01T00:00:00,Sex Factors,N05.715.350.675
17436176,2006-11-01T00:00:00,Sex Factors,N06.850.490.875
17436176,2006-11-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
17436176,2006-11-01T00:00:00,Spinal Cord Injuries,C10.900.850
17436176,2006-11-01T00:00:00,Spinal Cord Injuries,C21.866.819
17436176,2006-11-01T00:00:00,Task Performance and Analysis,F02.784.412.846
17436176,2006-11-01T00:00:00,Task Performance and Analysis,F02.784.692.746
17436176,2006-11-01T00:00:00,Task Performance and Analysis,F02.808.600
17436176,2006-11-01T00:00:00,Treatment Outcome,E01.789.800
17436176,2006-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17436176,2006-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
18377499,2006-11-01T00:00:00,Adolescent,M01.060.057
18377499,2006-11-01T00:00:00,Adult,M01.060.116
18377499,2006-11-01T00:00:00,Child,M01.060.406
18377499,2006-11-01T00:00:00,"Child, Preschool",M01.060.406.448
18377499,2006-11-01T00:00:00,Clinical Competence,I02.399.630.210
18377499,2006-11-01T00:00:00,Clinical Competence,N04.761.210
18377499,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
18377499,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
18377499,2006-11-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
18377499,2006-11-01T00:00:00,"Heart Defects, Congenital",C14.240.400
18377499,2006-11-01T00:00:00,"Heart Defects, Congenital",C14.280.400
18377499,2006-11-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
18377499,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18377499,2006-11-01T00:00:00,Infant,M01.060.703
18377499,2006-11-01T00:00:00,Point-of-Care Systems,N04.452.442.452.680
18377499,2006-11-01T00:00:00,Point-of-Care Systems,N04.452.515.360.652
18377499,2006-11-01T00:00:00,Point-of-Care Systems,N04.590.874
18377499,2006-11-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
18377499,2006-11-01T00:00:00,Stroke Volume,G09.330.380.124.882
18377499,2006-11-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
18377503,2006-11-01T00:00:00,Adolescent,M01.060.057
18377503,2006-11-01T00:00:00,Angiography,E01.370.350.700.060
18377503,2006-11-01T00:00:00,Angiography,E01.370.370.050
18377503,2006-11-01T00:00:00,Anoxia,C23.888.852.079
18377503,2006-11-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
18377503,2006-11-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
18377503,2006-11-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
18377503,2006-11-01T00:00:00,Child,M01.060.406
18377503,2006-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18377503,2006-11-01T00:00:00,Pulmonary Artery,A07.231.114.715
18377503,2006-11-01T00:00:00,Pulmonary Veins,A07.231.908.713
17082323,2006-11-02T00:00:00,Adult,M01.060.116
17082323,2006-11-02T00:00:00,Aged,M01.060.116.100
17082323,2006-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17082323,2006-11-02T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
17082323,2006-11-02T00:00:00,Middle Aged,M01.060.116.630
17082323,2006-11-02T00:00:00,Quinolones,D03.438.810.835
17082323,2006-11-02T00:00:00,Remission Induction,E02.860
17082323,2006-11-02T00:00:00,Treatment Outcome,E01.789.800
17082323,2006-11-02T00:00:00,Treatment Outcome,N04.761.559.590.800
17082323,2006-11-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17085954,2006-11-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17085954,2006-11-02T00:00:00,Paranasal Sinuses,A04.531.621
17085954,2006-11-02T00:00:00,"RNA, Messenger",D13.444.735.544
17085484,2006-11-03T00:00:00,Adult,M01.060.116
17085484,2006-11-03T00:00:00,African Americans,M01.686.508.100.100
17085484,2006-11-03T00:00:00,African Americans,M01.686.754.100
17085484,2006-11-03T00:00:00,African Continental Ancestry Group,M01.686.508.100
17085484,2006-11-03T00:00:00,Alleles,G05.360.340.024.340.030
17085484,2006-11-03T00:00:00,Cocaine-Related Disorders,C21.739.300
17085484,2006-11-03T00:00:00,Cocaine-Related Disorders,F03.900.300
17085484,2006-11-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
17085484,2006-11-03T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17085484,2006-11-03T00:00:00,Genetic Predisposition to Disease,G05.380.355
17085484,2006-11-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17085484,2006-11-03T00:00:00,Linkage Disequilibrium,G05.540.500
17085484,2006-11-03T00:00:00,Middle Aged,M01.060.116.630
17085484,2006-11-03T00:00:00,Opioid-Related Disorders,C21.739.675
17085484,2006-11-03T00:00:00,Opioid-Related Disorders,F03.900.675
17085484,2006-11-03T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17085484,2006-11-03T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
17085484,2006-11-03T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
17085484,2006-11-03T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
17085484,2006-11-03T00:00:00,Tobacco Use Disorder,C21.739.912
17085484,2006-11-03T00:00:00,Tobacco Use Disorder,F03.900.912
17155588,2006-11-03T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
17155588,2006-11-03T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
17086392,2006-11-04T00:00:00,Animals,B01.050
17086392,2006-11-04T00:00:00,Cognition,F02.463.188
17086392,2006-11-04T00:00:00,Dopamine,D02.092.211.215.311.342
17086392,2006-11-04T00:00:00,Dopamine,D02.092.311.342
17086392,2006-11-04T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
17086392,2006-11-04T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
17086392,2006-11-04T00:00:00,Glutamic Acid,D12.125.067.750
17086392,2006-11-04T00:00:00,Glutamic Acid,D12.125.119.450
17086392,2006-11-04T00:00:00,Glutamic Acid,D12.125.427.300
17086392,2006-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17086392,2006-11-04T00:00:00,Learning,F02.463.425
17086392,2006-11-04T00:00:00,Learning,F02.784.629.529
17086392,2006-11-04T00:00:00,Neural Pathways,A08.612
17086392,2006-11-04T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17086392,2006-11-04T00:00:00,Synaptic Transmission,G02.111.087.800.850
17086392,2006-11-04T00:00:00,Synaptic Transmission,G02.149.115.800.850
17086392,2006-11-04T00:00:00,Synaptic Transmission,G04.299.880.850
17086392,2006-11-04T00:00:00,Synaptic Transmission,G07.265.337.900
17086392,2006-11-04T00:00:00,Synaptic Transmission,G07.700.240.900
17086392,2006-11-04T00:00:00,Synaptic Transmission,G11.561.600.835
17086392,2006-11-04T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
17086392,2006-11-04T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
17086392,2006-11-04T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17086392,2006-11-04T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17088268,2006-11-06T00:00:00,Amino Acid Sequence,G02.111.570.060
17088268,2006-11-06T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17088268,2006-11-06T00:00:00,Catalytic Domain,G02.111.570.120.704
17088268,2006-11-06T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
17088268,2006-11-06T00:00:00,DNA,D13.444.308
17088268,2006-11-06T00:00:00,DNA-Directed DNA Polymerase,D08.811.913.696.445.308.300
17088268,2006-11-06T00:00:00,Glutamic Acid,D12.125.067.750
17088268,2006-11-06T00:00:00,Glutamic Acid,D12.125.119.450
17088268,2006-11-06T00:00:00,Glutamic Acid,D12.125.427.300
17088268,2006-11-06T00:00:00,Glycine,D12.125.481
17088268,2006-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17088268,2006-11-06T00:00:00,Mitochondrial Diseases,C18.452.660
17088268,2006-11-06T00:00:00,"Models, Molecular",E05.599.595
17088268,2006-11-06T00:00:00,Molecular Sequence Data,L01.453.245.667
17088268,2006-11-06T00:00:00,Mutation,G05.365.590
17088268,2006-11-06T00:00:00,"Polymorphism, Genetic",G05.365.795
17088268,2006-11-06T00:00:00,Protein Conformation,G02.111.570.790.709
17088268,2006-11-06T00:00:00,Serine,D12.125.154.800
17088268,2006-11-06T00:00:00,Serine,D12.125.837
17073493,2006-11-07T00:00:00,Biosensing Techniques,E05.601.123
17073493,2006-11-07T00:00:00,Lysine,D12.125.068.555
17073493,2006-11-07T00:00:00,Lysine,D12.125.095.647
17073493,2006-11-07T00:00:00,Lysine,D12.125.142.497
17073493,2006-11-07T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
17073493,2006-11-07T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
17073493,2006-11-07T00:00:00,Surface Plasmon Resonance,E05.196.890
17073493,2006-11-07T00:00:00,Surface Plasmon Resonance,E05.601.123.700
17073493,2006-11-07T00:00:00,Water,D01.455.900
17073493,2006-11-07T00:00:00,Water,D01.650.550.925
17087992,2006-11-07T00:00:00,Animals,B01.050
17087992,2006-11-07T00:00:00,Calcium,D01.268.552.100
17087992,2006-11-07T00:00:00,Calcium,D01.552.539.288
17087992,2006-11-07T00:00:00,Calcium,D23.119.100
17087992,2006-11-07T00:00:00,Calcium Signaling,G02.111.087.800.800.100
17087992,2006-11-07T00:00:00,Calcium Signaling,G02.149.115.800.800.100
17087992,2006-11-07T00:00:00,Calcium Signaling,G03.495.166.500.100
17087992,2006-11-07T00:00:00,Calcium Signaling,G04.299.880.800.100
17087992,2006-11-07T00:00:00,Cell Membrane,A11.284.149
17087992,2006-11-07T00:00:00,Heart Atria,A07.541.358
17087992,2006-11-07T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17087992,2006-11-07T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17087992,2006-11-07T00:00:00,"Microscopy, Confocal",E05.595.395
17087992,2006-11-07T00:00:00,Pressure,G01.374.715
17087992,2006-11-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17089077,2006-11-07T00:00:00,Clinical Competence,I02.399.630.210
17089077,2006-11-07T00:00:00,Clinical Competence,N04.761.210
17089077,2006-11-07T00:00:00,Communication,F01.145.209
17089077,2006-11-07T00:00:00,Communication,L01.143
17089077,2006-11-07T00:00:00,Educational Measurement,I02.399
17089077,2006-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17089077,2006-11-07T00:00:00,School Admission Criteria,I02.399.750
17089077,2006-11-07T00:00:00,"Schools, Medical",I02.783.660.552
17089077,2006-11-07T00:00:00,"Schools, Medical",N02.278.020.578
17089077,2006-11-07T00:00:00,"Students, Medical",I02.851.686.602
17089077,2006-11-07T00:00:00,"Students, Medical",M01.848.769.602
17092542,2006-11-07T00:00:00,Environmental Monitoring,N06.850.460.350.080
17092542,2006-11-07T00:00:00,Environmental Monitoring,N06.850.780.375
17092542,2006-11-07T00:00:00,Geologic Sediments,G01.311.500
17092542,2006-11-07T00:00:00,Geologic Sediments,G16.500.320
17092542,2006-11-07T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
17092542,2006-11-07T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
17092542,2006-11-07T00:00:00,South Carolina,Z01.107.567.875.075.662
17092542,2006-11-07T00:00:00,South Carolina,Z01.107.567.875.750.700
17092542,2006-11-07T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17097606,2006-11-07T00:00:00,Animals,B01.050
17097606,2006-11-07T00:00:00,Anoxia,C23.888.852.079
17097606,2006-11-07T00:00:00,Hepatocytes,A11.436.348
17097606,2006-11-07T00:00:00,Ischemia,C23.550.513
17097606,2006-11-07T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17097606,2006-11-07T00:00:00,"Microscopy, Confocal",E05.595.395
17097606,2006-11-07T00:00:00,Morphine,D03.132.577.249.547
17097606,2006-11-07T00:00:00,Morphine,D03.549.686.575
17097606,2006-11-07T00:00:00,Morphine,D03.605.497.575
17097606,2006-11-07T00:00:00,Morphine,D04.615.723.795.547
17097606,2006-11-07T00:00:00,Nitric Oxide,D01.339.387
17097606,2006-11-07T00:00:00,Nitric Oxide,D01.625.550.500
17097606,2006-11-07T00:00:00,Nitric Oxide,D01.625.700.500
17097606,2006-11-07T00:00:00,Nitric Oxide,D01.650.550.587.600
17097606,2006-11-07T00:00:00,Oxygen,D01.268.185.550
17097606,2006-11-07T00:00:00,Oxygen,D01.362.670
17097606,2006-11-07T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17097606,2006-11-07T00:00:00,"Receptors, Opioid",D12.776.543.750.100.620
17097606,2006-11-07T00:00:00,"Receptors, Opioid",D12.776.543.750.720.600.610
17097606,2006-11-07T00:00:00,"Receptors, Opioid",D12.776.543.750.750.555.610
17092991,2006-11-08T00:00:00,Algorithms,G17.035
17092991,2006-11-08T00:00:00,Algorithms,L01.224.050
17092991,2006-11-08T00:00:00,Computer Simulation,L01.224.160
17092991,2006-11-08T00:00:00,"Models, Biological",E05.599.395
17092991,2006-11-08T00:00:00,Protein Interaction Mapping,E05.601.690
17092991,2006-11-08T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
17092991,2006-11-08T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
17092991,2006-11-08T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
17092991,2006-11-08T00:00:00,Signal Transduction,G02.111.087.800
17092991,2006-11-08T00:00:00,Signal Transduction,G02.149.115.800
17092991,2006-11-08T00:00:00,Signal Transduction,G04.299.880
17092991,2006-11-08T00:00:00,Software,L01.224.900
17095723,2006-11-09T00:00:00,Animals,B01.050
17095723,2006-11-09T00:00:00,Calcium,D01.268.552.100
17095723,2006-11-09T00:00:00,Calcium,D01.552.539.288
17095723,2006-11-09T00:00:00,Calcium,D23.119.100
17095723,2006-11-09T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
17095723,2006-11-09T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
17095723,2006-11-09T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
17095723,2006-11-09T00:00:00,Connexin 43,D12.776.543.585.250.200
17095723,2006-11-09T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
17095723,2006-11-09T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
17095723,2006-11-09T00:00:00,Fibrosis,C23.550.355
17095723,2006-11-09T00:00:00,Gap Junctions,A11.284.149.165.420.471
17095723,2006-11-09T00:00:00,Heart,A07.541
17095723,2006-11-09T00:00:00,Heart Failure,C14.280.434
17095723,2006-11-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17095723,2006-11-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17095723,2006-11-09T00:00:00,Myocardial Contraction,G09.330.190.541
17095723,2006-11-09T00:00:00,Myocardial Contraction,G11.427.590.540.570
17095723,2006-11-09T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17095723,2006-11-09T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17095723,2006-11-09T00:00:00,"Myocytes, Cardiac",A11.620.500
17095723,2006-11-09T00:00:00,Phenotype,G05.695
17096152,2006-11-10T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17096152,2006-11-10T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17096152,2006-11-10T00:00:00,Head and Neck Neoplasms,C04.588.443
17096152,2006-11-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17096152,2006-11-10T00:00:00,"Leukocytes, Mononuclear",A11.118.637.555
17096152,2006-11-10T00:00:00,"Leukocytes, Mononuclear",A15.145.229.637.555
17096152,2006-11-10T00:00:00,"Leukocytes, Mononuclear",A15.382.490.555
17096152,2006-11-10T00:00:00,Lymphocyte Activation,E01.450.495.482
17096152,2006-11-10T00:00:00,Lymphocyte Activation,E05.478.594.530
17096152,2006-11-10T00:00:00,Lymphocyte Activation,G12.425.747
17096152,2006-11-10T00:00:00,Lymphocyte Activation,G12.450.050.400.545
17096152,2006-11-10T00:00:00,Membrane Proteins,D12.776.543
17096152,2006-11-10T00:00:00,Mouth Diseases,C07.465
17098919,2006-11-10T00:00:00,Amino Acid Sequence,G02.111.570.060
17098919,2006-11-10T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17098919,2006-11-10T00:00:00,Bacterial Proteins,D12.776.097
17098919,2006-11-10T00:00:00,Molecular Sequence Data,L01.453.245.667
17098919,2006-11-10T00:00:00,Oxidoreductases,D08.811.682
17098919,2006-11-10T00:00:00,Peptides,D12.644
17098919,2006-11-10T00:00:00,Phylogeny,G05.697
17098919,2006-11-10T00:00:00,Phylogeny,G16.100.275.605
17098919,2006-11-10T00:00:00,Phylogeny,L01.100.697
17098919,2006-11-10T00:00:00,Proteomics,H01.158.201.843
17098919,2006-11-10T00:00:00,Proteomics,H01.158.273.180.350.700
17098919,2006-11-10T00:00:00,Proteomics,H01.158.273.343.350.700
17098919,2006-11-10T00:00:00,Proteomics,H01.181.122.738
17098919,2006-11-10T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
17141994,2006-11-10T00:00:00,Animals,B01.050
17141994,2006-11-10T00:00:00,Cell Line,A11.251.210
17141994,2006-11-10T00:00:00,Cell Survival,G04.299.316
17141994,2006-11-10T00:00:00,Plant Extracts,D20.215.784.500
17141994,2006-11-10T00:00:00,Plant Extracts,D26.667
17141994,2006-11-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17204862,2006-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17204862,2006-11-11T00:00:00,Neoplasms,C04
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
17204862,2006-11-11T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
17083235,2006-11-13T00:00:00,Copper,D01.268.556.195
17083235,2006-11-13T00:00:00,Copper,D01.268.956.170
17083235,2006-11-13T00:00:00,Copper,D01.552.544.195
17083235,2006-11-13T00:00:00,Molecular Structure,G02.111.570
17083235,2006-11-13T00:00:00,Molecular Structure,G02.575
17083235,2006-11-13T00:00:00,Molecular Structure,G02.842.575
17083235,2006-11-13T00:00:00,Nitric Oxide,D01.339.387
17083235,2006-11-13T00:00:00,Nitric Oxide,D01.625.550.500
17083235,2006-11-13T00:00:00,Nitric Oxide,D01.625.700.500
17083235,2006-11-13T00:00:00,Nitric Oxide,D01.650.550.587.600
17083235,2006-11-13T00:00:00,Polymers,D05.750
17083235,2006-11-13T00:00:00,Polymers,D25.720
17083235,2006-11-13T00:00:00,Polymers,J01.637.051.720
17097893,2006-11-13T00:00:00,Adult,M01.060.116
17097893,2006-11-13T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
17097893,2006-11-13T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
17097893,2006-11-13T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
17097893,2006-11-13T00:00:00,Electroencephalography,E01.370.376.300
17097893,2006-11-13T00:00:00,Electroencephalography,E01.370.405.245
17097893,2006-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17097893,2006-11-13T00:00:00,Video Recording,L01.240.960
17100961,2006-11-13T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
17100961,2006-11-13T00:00:00,Esophagus,A03.556.875.500
17100961,2006-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17100961,2006-11-13T00:00:00,Manometry,E05.559
17101739,2006-11-13T00:00:00,Adult,M01.060.116
17101739,2006-11-13T00:00:00,Aged,M01.060.116.100
17101739,2006-11-13T00:00:00,Attitude to Health,F01.100.150
17101739,2006-11-13T00:00:00,Attitude to Health,N05.300.150
17101739,2006-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17101739,2006-11-13T00:00:00,Lung Neoplasms,C04.588.894.797.520
17101739,2006-11-13T00:00:00,Lung Neoplasms,C08.381.540
17101739,2006-11-13T00:00:00,Lung Neoplasms,C08.785.520
17101739,2006-11-13T00:00:00,Mass Screening,E01.370.500
17101739,2006-11-13T00:00:00,Mass Screening,E05.318.308.250.580
17101739,2006-11-13T00:00:00,Mass Screening,N02.421.143.827.233.443
17101739,2006-11-13T00:00:00,Mass Screening,N02.421.726.233.443
17101739,2006-11-13T00:00:00,Mass Screening,N05.715.360.300.375.500
17101739,2006-11-13T00:00:00,Mass Screening,N06.850.520.308.250.580
17101739,2006-11-13T00:00:00,Mass Screening,N06.850.780.500
17101739,2006-11-13T00:00:00,Middle Aged,M01.060.116.630
17101739,2006-11-13T00:00:00,Smoking,F01.145.466.753
17101818,2006-11-13T00:00:00,Animals,B01.050
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.850.625.670.100
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A08.663.650.915.937.670.100
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A08.800.950.937.670.100
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A09.371.729.831.625.670.100
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.850.625.670.100
17101818,2006-11-13T00:00:00,Retinal Cone Photoreceptor Cells,A11.671.650.915.937.670.100
17101818,2006-11-13T00:00:00,Retinaldehyde,D02.047.850
17101818,2006-11-13T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
17101818,2006-11-13T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
17101818,2006-11-13T00:00:00,Retinaldehyde,D02.455.849.131.495.690
17101818,2006-11-13T00:00:00,Retinaldehyde,D23.767.261.700.690
17101818,2006-11-13T00:00:00,Rhodopsin,D12.776.543.750.100.955
17101818,2006-11-13T00:00:00,Rhodopsin,D23.767.930.750.500.500
17103272,2006-11-14T00:00:00,Animals,B01.050
17103272,2006-11-14T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17103272,2006-11-14T00:00:00,Manometry,E05.559
17103272,2006-11-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17103272,2006-11-14T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17107941,2006-11-14T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.250
17107941,2006-11-14T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.196.401.402.250
17107941,2006-11-14T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.230
17107941,2006-11-14T00:00:00,"Electrophoresis, Gel, Two-Dimensional",E05.301.300.319.450
17107941,2006-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17107941,2006-11-14T00:00:00,Kidney,A05.810.453
17107941,2006-11-14T00:00:00,Kidney Glomerulus,A05.810.453.324.359
17107941,2006-11-14T00:00:00,Kidney Glomerulus,A05.810.453.736.520
17107941,2006-11-14T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17107941,2006-11-14T00:00:00,Kidney Neoplasms,C12.758.820.750
17107941,2006-11-14T00:00:00,Kidney Neoplasms,C12.777.419.473
17107941,2006-11-14T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17107941,2006-11-14T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17107941,2006-11-14T00:00:00,"Kidney Tubules, Collecting",A05.810.453.736.560.510
17107941,2006-11-14T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
17107941,2006-11-14T00:00:00,Protein Biosynthesis,G02.111.087.675.871
17107941,2006-11-14T00:00:00,Protein Biosynthesis,G02.149.115.675.871
17107941,2006-11-14T00:00:00,Protein Biosynthesis,G03.495.770.871
17107941,2006-11-14T00:00:00,Protein Biosynthesis,G05.355.310.670
17107941,2006-11-14T00:00:00,Proteinuria,C12.777.934.734
17107941,2006-11-14T00:00:00,Proteinuria,C13.351.968.934.734
17107941,2006-11-14T00:00:00,Proteinuria,C23.888.942.750
17107941,2006-11-14T00:00:00,Proteomics,H01.158.201.843
17107941,2006-11-14T00:00:00,Proteomics,H01.158.273.180.350.700
17107941,2006-11-14T00:00:00,Proteomics,H01.158.273.343.350.700
17107941,2006-11-14T00:00:00,Proteomics,H01.181.122.738
17107941,2006-11-14T00:00:00,Renal Dialysis,E02.870.300
17107941,2006-11-14T00:00:00,Renal Dialysis,E02.912.800
17082645,2006-11-15T00:00:00,Animals,B01.050
17082645,2006-11-15T00:00:00,Apoptosis,G04.299.139.160
17082645,2006-11-15T00:00:00,Brain Ischemia,C10.228.140.300.150
17082645,2006-11-15T00:00:00,Brain Ischemia,C14.907.253.092
17082645,2006-11-15T00:00:00,Complement C3,D12.776.124.050.140
17082645,2006-11-15T00:00:00,Complement C3,D12.776.124.486.274.250
17082645,2006-11-15T00:00:00,Complement Inactivator Proteins,D12.776.124.486.274.920
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
17082645,2006-11-15T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
17082645,2006-11-15T00:00:00,Reperfusion Injury,C14.907.725
17082645,2006-11-15T00:00:00,Reperfusion Injury,C23.550.767.877
17082662,2006-11-15T00:00:00,Animals,B01.050
17082662,2006-11-15T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
17082662,2006-11-15T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
17082662,2006-11-15T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
17082662,2006-11-15T00:00:00,Autoantigens,D23.050.422
17082662,2006-11-15T00:00:00,Glomerulonephritis,C12.777.419.570.363
17082662,2006-11-15T00:00:00,Glomerulonephritis,C13.351.968.419.570.363
17082662,2006-11-15T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17082662,2006-11-15T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17082662,2006-11-15T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17082662,2006-11-15T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
17082662,2006-11-15T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
17082662,2006-11-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
17082662,2006-11-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
17082662,2006-11-15T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
17102774,2006-11-15T00:00:00,Animals,B01.050
17102774,2006-11-15T00:00:00,Graft Rejection,G12.425.901.545.328
17102774,2006-11-15T00:00:00,Liver,A03.620
17102774,2006-11-15T00:00:00,Liver Transplantation,E04.210.650
17102774,2006-11-15T00:00:00,Liver Transplantation,E04.936.450.490
17102774,2006-11-15T00:00:00,Liver Transplantation,E04.936.580.490
17102774,2006-11-15T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.073.750
17102774,2006-11-15T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.705.852.760.597
17102774,2006-11-15T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.050.301.264.035.908
17102774,2006-11-15T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.101.100.110.912
17105794,2006-11-15T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
17105794,2006-11-15T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
17105794,2006-11-15T00:00:00,Adult,M01.060.116
17105794,2006-11-15T00:00:00,Aged,M01.060.116.100
17105794,2006-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17105794,2006-11-15T00:00:00,Middle Aged,M01.060.116.630
17105794,2006-11-15T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
17105794,2006-11-15T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
17105794,2006-11-15T00:00:00,Prostatic Hyperplasia,C12.294.565.500
17105794,2006-11-15T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
17105794,2006-11-15T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
17105794,2006-11-15T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
17140723,2006-11-15T00:00:00,Aged,M01.060.116.100
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17140723,2006-11-15T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17140723,2006-11-15T00:00:00,Disease Progression,C23.550.291.656
17140723,2006-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17140723,2006-11-15T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17140723,2006-11-15T00:00:00,Kidney Neoplasms,C12.758.820.750
17140723,2006-11-15T00:00:00,Kidney Neoplasms,C12.777.419.473
17140723,2006-11-15T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17140723,2006-11-15T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17140723,2006-11-15T00:00:00,Middle Aged,M01.060.116.630
17140723,2006-11-15T00:00:00,Nephrectomy,E04.950.774.435
17140723,2006-11-15T00:00:00,Postoperative Complications,C23.550.767
17140723,2006-11-15T00:00:00,Treatment Outcome,E01.789.800
17140723,2006-11-15T00:00:00,Treatment Outcome,N04.761.559.590.800
17140723,2006-11-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17109126,2006-11-16T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17109126,2006-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17109126,2006-11-16T00:00:00,Middle Aged,M01.060.116.630
17109126,2006-11-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17109126,2006-11-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17109126,2006-11-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17109126,2006-11-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17109126,2006-11-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17109126,2006-11-16T00:00:00,"Wounds, Nonpenetrating",C21.866.974
17109752,2006-11-16T00:00:00,Algorithms,G17.035
17109752,2006-11-16T00:00:00,Algorithms,L01.224.050
17109752,2006-11-16T00:00:00,Computational Biology,H01.158.273.180
17109752,2006-11-16T00:00:00,Genetic Variation,G05.365
17109752,2006-11-16T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
17109752,2006-11-16T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
17109752,2006-11-16T00:00:00,Internet,L01.224.230.110.500
17109752,2006-11-16T00:00:00,"Models, Statistical",E05.318.740.500
17109752,2006-11-16T00:00:00,"Models, Statistical",E05.599.835
17109752,2006-11-16T00:00:00,"Models, Statistical",N05.715.360.750.530
17109752,2006-11-16T00:00:00,"Models, Statistical",N06.850.520.830.500
17109752,2006-11-16T00:00:00,Mutation,G05.365.590
17109752,2006-11-16T00:00:00,Proteins,D12.776
17113054,2006-11-17T00:00:00,Animals,B01.050
17113054,2006-11-17T00:00:00,Brain,A08.186.211
17113054,2006-11-17T00:00:00,Cocaine,D02.145.074.722.388
17113054,2006-11-17T00:00:00,Cocaine,D03.132.889.354
17113054,2006-11-17T00:00:00,Cocaine,D03.605.869.388
17113054,2006-11-17T00:00:00,Cocaine,D04.075.080.875.099.722.388
17113054,2006-11-17T00:00:00,Cocaine-Related Disorders,C21.739.300
17113054,2006-11-17T00:00:00,Cocaine-Related Disorders,F03.900.300
17113054,2006-11-17T00:00:00,Dopamine,D02.092.211.215.311.342
17113054,2006-11-17T00:00:00,Dopamine,D02.092.311.342
17113054,2006-11-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
17113054,2006-11-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
17113054,2006-11-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
17113054,2006-11-17T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
17113054,2006-11-17T00:00:00,Gene Expression Regulation,G05.355.315
17113054,2006-11-17T00:00:00,Glutamic Acid,D12.125.067.750
17113054,2006-11-17T00:00:00,Glutamic Acid,D12.125.119.450
17113054,2006-11-17T00:00:00,Glutamic Acid,D12.125.427.300
17113054,2006-11-17T00:00:00,Methamphetamine,D02.092.471.683.152.619
17113054,2006-11-17T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
17113054,2006-11-17T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
17113054,2006-11-17T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17113054,2006-11-17T00:00:00,Oxidative Stress,G03.495.710
17113054,2006-11-17T00:00:00,Oxidative Stress,G07.700.830.750
17113207,2006-11-17T00:00:00,Acetylcysteine,D02.886.030.230.259
17113207,2006-11-17T00:00:00,Acetylcysteine,D12.125.166.230.259
17113207,2006-11-17T00:00:00,Adolescent,M01.060.057
17113207,2006-11-17T00:00:00,Adult,M01.060.116
17113207,2006-11-17T00:00:00,Cocaine-Related Disorders,C21.739.300
17113207,2006-11-17T00:00:00,Cocaine-Related Disorders,F03.900.300
17113207,2006-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17113207,2006-11-17T00:00:00,Middle Aged,M01.060.116.630
17113207,2006-11-17T00:00:00,Pilot Projects,E05.318.760.750
17113207,2006-11-17T00:00:00,Pilot Projects,E05.337.737
17113207,2006-11-17T00:00:00,Pilot Projects,N05.715.360.775.625
17113207,2006-11-17T00:00:00,Pilot Projects,N06.850.520.450.720
17113207,2006-11-17T00:00:00,Treatment Outcome,E01.789.800
17113207,2006-11-17T00:00:00,Treatment Outcome,N04.761.559.590.800
17113207,2006-11-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17113208,2006-11-17T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
17113208,2006-11-17T00:00:00,Educational Measurement,I02.399
17113208,2006-11-17T00:00:00,Electric Countershock,E02.342.287
17113208,2006-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17113208,2006-11-17T00:00:00,Leadership,F01.752.609
17113208,2006-11-17T00:00:00,Nurses,M01.526.485.650
17113208,2006-11-17T00:00:00,Nurses,N02.360.650
17113208,2006-11-17T00:00:00,Teaching,I02.903
17161896,2006-11-18T00:00:00,Adolescent,M01.060.057
17161896,2006-11-18T00:00:00,Adult,M01.060.116
17161896,2006-11-18T00:00:00,Animals,B01.050
17161896,2006-11-18T00:00:00,Chloral Hydrate,D02.033.455.250.130
17161896,2006-11-18T00:00:00,Drug-Induced Liver Injury,C06.552.195
17161896,2006-11-18T00:00:00,Drug-Induced Liver Injury,C21.613.260
17161896,2006-11-18T00:00:00,Formates,D02.241.081.504.435
17161896,2006-11-18T00:00:00,Hepatocytes,A11.436.348
17161896,2006-11-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161896,2006-11-18T00:00:00,Kidney Diseases,C12.777.419
17161896,2006-11-18T00:00:00,Kidney Diseases,C13.351.968.419
17161896,2006-11-18T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
17161896,2006-11-18T00:00:00,Liver Diseases,C06.552
17161896,2006-11-18T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
17161896,2006-11-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17161896,2006-11-18T00:00:00,Trichloroacetic Acid,D02.241.081.038.866
17116659,2006-11-20T00:00:00,Animals,B01.050
17116659,2006-11-20T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
17116659,2006-11-20T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17116659,2006-11-20T00:00:00,Mitochondria,A11.284.835.626
17116659,2006-11-20T00:00:00,Oxidative Stress,G03.495.710
17116659,2006-11-20T00:00:00,Oxidative Stress,G07.700.830.750
17116659,2006-11-20T00:00:00,Quinazolines,D03.438.786
17116659,2006-11-20T00:00:00,Rabbits,B01.050.150.900.649.521.700
17116659,2006-11-20T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
17116659,2006-11-20T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
17116659,2006-11-20T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
17116659,2006-11-20T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
17116659,2006-11-20T00:00:00,Regeneration,G16.100.856
17116659,2006-11-20T00:00:00,Reperfusion Injury,C14.907.725
17116659,2006-11-20T00:00:00,Reperfusion Injury,C23.550.767.877
17116659,2006-11-20T00:00:00,Signal Transduction,G02.111.087.800
17116659,2006-11-20T00:00:00,Signal Transduction,G02.149.115.800
17116659,2006-11-20T00:00:00,Signal Transduction,G04.299.880
17116659,2006-11-20T00:00:00,Transcription Factors,D12.776.930
17116759,2006-11-20T00:00:00,Adolescent,M01.060.057
17116759,2006-11-20T00:00:00,Adult,M01.060.116
17116759,2006-11-20T00:00:00,African Continental Ancestry Group,M01.686.508.100
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.644.456.073.070
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.644.822.750.020
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.644.861.020
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.776.645.750.020
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.776.811.070
17116759,2006-11-20T00:00:00,Angiotensinogen,D12.776.872.020
17116759,2006-11-20T00:00:00,Blood Pressure,E01.370.600.875.249
17116759,2006-11-20T00:00:00,Blood Pressure,G09.330.380.076
17116759,2006-11-20T00:00:00,Child,M01.060.406
17116759,2006-11-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
17116759,2006-11-20T00:00:00,Genetic Variation,G05.365
17116759,2006-11-20T00:00:00,Glycine,D12.125.481
17116759,2006-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17116759,2006-11-20T00:00:00,Phenotype,G05.695
17116759,2006-11-20T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
17116759,2006-11-20T00:00:00,Renin-Angiotensin System,G03.495.805
17116759,2006-11-20T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
17116759,2006-11-20T00:00:00,"Stress, Psychological",F01.145.126.990
17116759,2006-11-20T00:00:00,"Stress, Psychological",F02.830.900
17116759,2006-11-20T00:00:00,Threonine,D12.125.142.815
17116759,2006-11-20T00:00:00,Threonine,D12.125.154.900
17116759,2006-11-20T00:00:00,Threonine,D12.125.901
17124167,2006-11-21T00:00:00,Amino Acid Sequence,G02.111.570.060
17124167,2006-11-21T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17124167,2006-11-21T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
17124167,2006-11-21T00:00:00,DNA,D13.444.308
17124167,2006-11-21T00:00:00,DNA Helicases,D08.811.277.040.025.159
17124167,2006-11-21T00:00:00,DNA Helicases,D08.811.399.340
17124167,2006-11-21T00:00:00,DNA Replication,G02.111.087.222
17124167,2006-11-21T00:00:00,DNA Replication,G02.149.115.222
17124167,2006-11-21T00:00:00,DNA Replication,G05.355.200
17124167,2006-11-21T00:00:00,DNA-Binding Proteins,D12.776.260
17124167,2006-11-21T00:00:00,Molecular Sequence Data,L01.453.245.667
17124167,2006-11-21T00:00:00,Plasmids,G05.360.600
17124167,2006-11-21T00:00:00,Trans-Activators,D12.776.260.755
17124167,2006-11-21T00:00:00,Trans-Activators,D12.776.930.900
17124167,2006-11-21T00:00:00,Trans-Activators,D12.776.964.925.984
17119929,2006-11-22T00:00:00,Animals,B01.050
17119929,2006-11-22T00:00:00,Dopamine,D02.092.211.215.311.342
17119929,2006-11-22T00:00:00,Dopamine,D02.092.311.342
17119929,2006-11-22T00:00:00,Goals,F01.658.500
17119929,2006-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17119929,2006-11-22T00:00:00,Limbic System,A08.186.211.464
17119929,2006-11-22T00:00:00,Motivation,F01.658
17119929,2006-11-22T00:00:00,Motivation,F01.752.543.500.750
17119929,2006-11-22T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17121773,2006-11-22T00:00:00,Algorithms,G17.035
17121773,2006-11-22T00:00:00,Algorithms,L01.224.050
17121773,2006-11-22T00:00:00,Computer Graphics,L01.224.108
17121773,2006-11-22T00:00:00,Computer Graphics,L01.296.110
17121773,2006-11-22T00:00:00,Database Management Systems,L01.224.900.280
17121773,2006-11-22T00:00:00,Database Management Systems,L01.700.508.300.680.110
17121773,2006-11-22T00:00:00,Database Management Systems,N04.452.515.110
17121773,2006-11-22T00:00:00,Proteins,D12.776
17121773,2006-11-22T00:00:00,Software,L01.224.900
17121773,2006-11-22T00:00:00,User-Computer Interface,L01.224.900.910
17122056,2006-11-22T00:00:00,Animals,B01.050
17122056,2006-11-22T00:00:00,"Behavior, Animal",F01.145.113
17122056,2006-11-22T00:00:00,Cocaine,D02.145.074.722.388
17122056,2006-11-22T00:00:00,Cocaine,D03.132.889.354
17122056,2006-11-22T00:00:00,Cocaine,D03.605.869.388
17122056,2006-11-22T00:00:00,Cocaine,D04.075.080.875.099.722.388
17122056,2006-11-22T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
17122056,2006-11-22T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
17122056,2006-11-22T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
17122056,2006-11-22T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
17122056,2006-11-22T00:00:00,Electric Stimulation,E05.723.402
17122056,2006-11-22T00:00:00,Motor Activity,F01.145.632
17122056,2006-11-22T00:00:00,Motor Activity,G11.427.590.530.698
17122056,2006-11-22T00:00:00,Neurons,A08.663
17122056,2006-11-22T00:00:00,Neurons,A11.671
17122056,2006-11-22T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
17122056,2006-11-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17122056,2006-11-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17122056,2006-11-22T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17122056,2006-11-22T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17122056,2006-11-22T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
17122056,2006-11-22T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
17122093,2006-11-22T00:00:00,Adipocytes,A11.329.114
17122093,2006-11-22T00:00:00,Animals,B01.050
17122093,2006-11-22T00:00:00,Glucose,D09.546.359.448
17122093,2006-11-22T00:00:00,Insulin,D06.472.699.587.740.625
17122093,2006-11-22T00:00:00,Insulin,D12.644.548.586.740.625
17122093,2006-11-22T00:00:00,Insulin Resistance,C18.452.394.968.500
17122093,2006-11-22T00:00:00,Insulin Resistance,G07.690.320.617
17123153,2006-11-22T00:00:00,Aged,M01.060.116.100
17123153,2006-11-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17123153,2006-11-22T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17123153,2006-11-22T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17123153,2006-11-22T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17123153,2006-11-22T00:00:00,Gastrostomy,E04.210.496
17123153,2006-11-22T00:00:00,Gastrostomy,E04.579.408
17123153,2006-11-22T00:00:00,"Hernia, Ventral",C23.300.707.374.937
17123153,2006-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17123776,2006-11-22T00:00:00,Adult,M01.060.116
17123776,2006-11-22T00:00:00,Affect,F01.470.047
17123776,2006-11-22T00:00:00,Aged,M01.060.116.100
17123776,2006-11-22T00:00:00,Attention,F02.830.104.214
17123776,2006-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17123776,2006-11-22T00:00:00,Intelligence,F01.752.543
17123776,2006-11-22T00:00:00,Mental Processes,F02.463
17123776,2006-11-22T00:00:00,Middle Aged,M01.060.116.630
17123776,2006-11-22T00:00:00,Neuropsychological Tests,F04.711.513
17123776,2006-11-22T00:00:00,Psychometrics,F04.711.780
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,E05.318.740.872
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,E05.318.780.800
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,G17.800
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17123776,2006-11-22T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C10.314.400.250
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
17125847,2006-11-27T00:00:00,Adrenoleukodystrophy,C19.053.500.270
17125847,2006-11-27T00:00:00,Complement System Proteins,D12.776.124.486.274
17125847,2006-11-27T00:00:00,Cytokines,D12.644.276.374
17125847,2006-11-27T00:00:00,Cytokines,D12.776.467.374
17125847,2006-11-27T00:00:00,Cytokines,D23.529.374
17125847,2006-11-27T00:00:00,Fatty Acids,D10.251
17125847,2006-11-27T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
17125847,2006-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17130310,2006-11-27T00:00:00,Adult,M01.060.116
17130310,2006-11-27T00:00:00,Anoxia,C23.888.852.079
17130310,2006-11-27T00:00:00,Blood Pressure,E01.370.600.875.249
17130310,2006-11-27T00:00:00,Blood Pressure,G09.330.380.076
17130310,2006-11-27T00:00:00,Body Weight,C23.888.144
17130310,2006-11-27T00:00:00,Body Weight,E01.370.600.115.100.160.120
17130310,2006-11-27T00:00:00,Body Weight,E05.041.124.160.750
17130310,2006-11-27T00:00:00,Body Weight,G07.100.100.160.120
17130310,2006-11-27T00:00:00,Body Weight,G07.700.320.249.314.120
17130310,2006-11-27T00:00:00,Circadian Rhythm,G07.180.562.190
17130310,2006-11-27T00:00:00,Echocardiography,E01.370.350.850.220
17130310,2006-11-27T00:00:00,Echocardiography,E01.370.370.380.220
17130310,2006-11-27T00:00:00,Heart,A07.541
17130310,2006-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17130310,2006-11-27T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
17130310,2006-11-27T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
17130310,2006-11-27T00:00:00,Middle Aged,M01.060.116.630
17130310,2006-11-27T00:00:00,"Obesity, Morbid",C18.654.726.500.700
17130310,2006-11-27T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
17130310,2006-11-27T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
17130310,2006-11-27T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
17130344,2006-11-27T00:00:00,Adolescent,M01.060.057
17130344,2006-11-27T00:00:00,Adult,M01.060.116
17130344,2006-11-27T00:00:00,African Continental Ancestry Group,M01.686.508.100
17130344,2006-11-27T00:00:00,Aging,G07.700.320.124
17130344,2006-11-27T00:00:00,Blood Pressure,E01.370.600.875.249
17130344,2006-11-27T00:00:00,Blood Pressure,G09.330.380.076
17130344,2006-11-27T00:00:00,Circadian Rhythm,G07.180.562.190
17130344,2006-11-27T00:00:00,Continental Population Groups,M01.686.508
17130344,2006-11-27T00:00:00,Ethnic Groups,M01.686.754
17130344,2006-11-27T00:00:00,Ethnic Groups,N01.224.317
17130344,2006-11-27T00:00:00,European Continental Ancestry Group,M01.686.508.400
17130344,2006-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17130344,2006-11-27T00:00:00,Sex Characteristics,G08.686.815
17129619,2006-11-28T00:00:00,Animals,B01.050
17129619,2006-11-28T00:00:00,"Behavior, Animal",F01.145.113
17129619,2006-11-28T00:00:00,Discrimination (Psychology),F02.463.593.257
17129619,2006-11-28T00:00:00,Nicotine,D03.132.760.570
17129619,2006-11-28T00:00:00,Nicotine,D03.383.725.518
17129619,2006-11-28T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
17129619,2006-11-28T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
17129619,2006-11-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17129619,2006-11-28T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17129619,2006-11-28T00:00:00,Sweetening Agents,D27.720.364.609
17129619,2006-11-28T00:00:00,Sweetening Agents,D27.720.888
17129619,2006-11-28T00:00:00,Sweetening Agents,J02.500.512.400.700
17240454,2006-11-28T00:00:00,GTP-Binding Protein beta Subunits,D12.644.360.375.520
17240454,2006-11-28T00:00:00,GTP-Binding Protein beta Subunits,D12.776.157.325.332.520
17240454,2006-11-28T00:00:00,GTP-Binding Protein beta Subunits,D12.776.476.375.520
17240454,2006-11-28T00:00:00,GTP-Binding Protein beta Subunits,D12.776.543.325.450
17240454,2006-11-28T00:00:00,GTP-Binding Protein gamma Subunits,D12.644.360.375.730
17240454,2006-11-28T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.157.325.332.730
17240454,2006-11-28T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.476.375.730
17240454,2006-11-28T00:00:00,GTP-Binding Protein gamma Subunits,D12.776.543.325.625
17240454,2006-11-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17240454,2006-11-28T00:00:00,"Models, Biological",E05.599.395
17240454,2006-11-28T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
17240454,2006-11-28T00:00:00,Signal Transduction,G02.111.087.800
17240454,2006-11-28T00:00:00,Signal Transduction,G02.149.115.800
17240454,2006-11-28T00:00:00,Signal Transduction,G04.299.880
17138611,2006-11-30T00:00:00,Acclimatization,G07.700.062.133
17138611,2006-11-30T00:00:00,Acclimatization,G16.100.057.500.133
17138611,2006-11-30T00:00:00,Adult,M01.060.116
17138611,2006-11-30T00:00:00,Anoxia,C23.888.852.079
17138611,2006-11-30T00:00:00,Autonomic Nervous System,A08.800.050
17138611,2006-11-30T00:00:00,Blood Pressure,E01.370.600.875.249
17138611,2006-11-30T00:00:00,Blood Pressure,G09.330.380.076
17138611,2006-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17138611,2006-11-30T00:00:00,Pulmonary Circulation,G09.330.190.163.770
17138611,2006-11-30T00:00:00,Pulmonary Circulation,G09.772.770.690
17138611,2006-11-30T00:00:00,Respiratory Mechanics,G09.772.770.755.700
17138614,2006-11-30T00:00:00,Adult,M01.060.116
17138614,2006-11-30T00:00:00,African Americans,M01.686.508.100.100
17138614,2006-11-30T00:00:00,African Americans,M01.686.754.100
17138614,2006-11-30T00:00:00,Aged,M01.060.116.100
17138614,2006-11-30T00:00:00,Cultural Competency,I01.880.143.364
17138614,2006-11-30T00:00:00,Environment Design,I01.283
17138614,2006-11-30T00:00:00,Environment Design,I01.880.709.359
17138614,2006-11-30T00:00:00,Environment Design,N06.230.200
17138614,2006-11-30T00:00:00,Health Behavior,F01.145.488
17138614,2006-11-30T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17138614,2006-11-30T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17138614,2006-11-30T00:00:00,Health Promotion,N02.370
17138614,2006-11-30T00:00:00,Health Promotion,N02.421.726.507
17138614,2006-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17138614,2006-11-30T00:00:00,Middle Aged,M01.060.116.630
17138614,2006-11-30T00:00:00,Motor Activity,F01.145.632
17138614,2006-11-30T00:00:00,Motor Activity,G11.427.590.530.698
17138614,2006-11-30T00:00:00,Qualitative Research,H01.770.644.241.850
17138614,2006-11-30T00:00:00,Religion and Psychology,F02.880
17138614,2006-11-30T00:00:00,Religion and Psychology,K01.844.664
17138614,2006-11-30T00:00:00,Social Support,I01.880.656.600
17138614,2006-11-30T00:00:00,South Carolina,Z01.107.567.875.075.662
17138614,2006-11-30T00:00:00,South Carolina,Z01.107.567.875.750.700
17208481,2006-11-30T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
17208481,2006-11-30T00:00:00,Animals,B01.050
17208481,2006-11-30T00:00:00,Gene Expression Profiling,E05.393.332
17208481,2006-11-30T00:00:00,Gene Expression Regulation,G05.355.315
17208481,2006-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17208481,2006-11-30T00:00:00,Molecular Sequence Data,L01.453.245.667
17208481,2006-11-30T00:00:00,Phylogeny,G05.697
17208481,2006-11-30T00:00:00,Phylogeny,G16.100.275.605
17208481,2006-11-30T00:00:00,Phylogeny,L01.100.697
17208481,2006-11-30T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
17208481,2006-11-30T00:00:00,"Sequence Homology, Amino Acid",G02.111.810.200
17208481,2006-11-30T00:00:00,"Sequence Homology, Amino Acid",G05.810.200
17208481,2006-11-30T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
16788424,2006-12-01T00:00:00,Action Potentials,G04.580.100
16788424,2006-12-01T00:00:00,Action Potentials,G07.265.750.100
16788424,2006-12-01T00:00:00,Action Potentials,G11.561.570.100
16788424,2006-12-01T00:00:00,Animals,B01.050
16788424,2006-12-01T00:00:00,Auditory Threshold,F02.463.593.071.173
16788424,2006-12-01T00:00:00,Auditory Threshold,F02.463.593.710.190
16788424,2006-12-01T00:00:00,Cochlea,A09.246.631.246
16788424,2006-12-01T00:00:00,Gerbillinae,B01.050.150.900.649.865.635.300
16988947,2006-12-01T00:00:00,Apoptosis,G04.299.139.160
16988947,2006-12-01T00:00:00,Calpain,D08.811.277.656.262.500.120
16988947,2006-12-01T00:00:00,Calpain,D08.811.277.656.300.200.120
16988947,2006-12-01T00:00:00,Caspases,D08.811.277.656.262.500.126
16988947,2006-12-01T00:00:00,Caspases,D08.811.277.656.300.200.126
16988947,2006-12-01T00:00:00,Caspases,D12.644.360.075.405
16988947,2006-12-01T00:00:00,Caspases,D12.776.476.075.405
16988947,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16988947,2006-12-01T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
16988947,2006-12-01T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
16988947,2006-12-01T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
17019723,2006-12-01T00:00:00,Computer Simulation,L01.224.160
17019723,2006-12-01T00:00:00,"Models, Chemical",E05.599.495
17019723,2006-12-01T00:00:00,"Models, Molecular",E05.599.595
17019723,2006-12-01T00:00:00,Proteins,D12.776
17019723,2006-12-01T00:00:00,Solvents,D27.720.844
17019723,2006-12-01T00:00:00,Surface Properties,G02.842.850
17019723,2006-12-01T00:00:00,Water,D01.455.900
17019723,2006-12-01T00:00:00,Water,D01.650.550.925
17051602,2006-12-01T00:00:00,Adolescent,M01.060.057
17051602,2006-12-01T00:00:00,Adult,M01.060.116
17051602,2006-12-01T00:00:00,Aged,M01.060.116.100
17051602,2006-12-01T00:00:00,Child,M01.060.406
17051602,2006-12-01T00:00:00,"Child, Preschool",M01.060.406.448
17051602,2006-12-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17051602,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17051602,2006-12-01T00:00:00,Infant,M01.060.703
17051602,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17051602,2006-12-01T00:00:00,Proton Pump Inhibitors,D27.505.519.389.848
17051602,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17051602,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17051602,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17064398,2006-12-01T00:00:00,Animals,B01.050
17064398,2006-12-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
17064398,2006-12-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
17064398,2006-12-01T00:00:00,Fibroblasts,A11.329.228
17064398,2006-12-01T00:00:00,Fibroblasts,A11.872.228
17064398,2006-12-01T00:00:00,Gene Expression,G05.355.310
17064398,2006-12-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
17064398,2006-12-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
17064398,2006-12-01T00:00:00,Interleukin-6,D23.529.374.465.506
17064398,2006-12-01T00:00:00,Lipopolysaccharides,D09.400.500
17064398,2006-12-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17064398,2006-12-01T00:00:00,Lipopolysaccharides,D10.494
17064398,2006-12-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17064398,2006-12-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17064398,2006-12-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17064398,2006-12-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17064398,2006-12-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17064398,2006-12-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17064398,2006-12-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17064398,2006-12-01T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17064398,2006-12-01T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17064398,2006-12-01T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17073812,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17073812,2006-12-01T00:00:00,"Monitoring, Physiologic",E01.370.520
17073812,2006-12-01T00:00:00,Pilot Projects,E05.318.760.750
17073812,2006-12-01T00:00:00,Pilot Projects,E05.337.737
17073812,2006-12-01T00:00:00,Pilot Projects,N05.715.360.775.625
17073812,2006-12-01T00:00:00,Pilot Projects,N06.850.520.450.720
17073812,2006-12-01T00:00:00,Research Design,E05.581.500
17073812,2006-12-01T00:00:00,Research Design,H01.770.644.728
17073812,2006-12-01T00:00:00,Serum Albumin,D12.776.034.841
17073812,2006-12-01T00:00:00,Serum Albumin,D12.776.124.050.700
17073812,2006-12-01T00:00:00,Serum Albumin,D12.776.124.727
17073812,2006-12-01T00:00:00,Stroke,C10.228.140.300.775
17073812,2006-12-01T00:00:00,Stroke,C14.907.253.855
17073812,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17073812,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17073812,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17075371,2006-12-01T00:00:00,Academic Medical Centers,N02.278.020
17075371,2006-12-01T00:00:00,Blood Glucose,D09.546.359.448.500
17075371,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17075371,2006-12-01T00:00:00,Hyperglycemia,C18.452.394.952
17075371,2006-12-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
17075371,2006-12-01T00:00:00,Insulin,D06.472.699.587.740.625
17075371,2006-12-01T00:00:00,Insulin,D12.644.548.586.740.625
17075371,2006-12-01T00:00:00,Intensive Care Units,N02.278.388.493
17075371,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17075371,2006-12-01T00:00:00,Sepsis,C01.539.757
17075371,2006-12-01T00:00:00,Sepsis,C23.550.470.790.500
17075371,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17075371,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17075371,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17081080,2006-12-01T00:00:00,Adenoviridae,B04.280.030
17081080,2006-12-01T00:00:00,Adenoviridae,B04.909.204.097
17081080,2006-12-01T00:00:00,Animals,B01.050
17081080,2006-12-01T00:00:00,Apoptosis,G04.299.139.160
17081080,2006-12-01T00:00:00,Carrier Proteins,D12.776.157
17081080,2006-12-01T00:00:00,Gene Expression,G05.355.310
17081080,2006-12-01T00:00:00,Genetic Vectors,G05.360.337
17081080,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17081080,2006-12-01T00:00:00,Inflammation,C23.550.470
17081080,2006-12-01T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
17081080,2006-12-01T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
17081080,2006-12-01T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
17081080,2006-12-01T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
17081080,2006-12-01T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
17081080,2006-12-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17081080,2006-12-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17081080,2006-12-01T00:00:00,"Myocytes, Cardiac",A11.620.500
17081080,2006-12-01T00:00:00,Nitric Oxide,D01.339.387
17081080,2006-12-01T00:00:00,Nitric Oxide,D01.625.550.500
17081080,2006-12-01T00:00:00,Nitric Oxide,D01.625.700.500
17081080,2006-12-01T00:00:00,Nitric Oxide,D01.650.550.587.600
17081080,2006-12-01T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
17081080,2006-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17081080,2006-12-01T00:00:00,Recombinant Proteins,D12.776.828
17081080,2006-12-01T00:00:00,Serpins,D12.644.822.750
17081080,2006-12-01T00:00:00,Serpins,D12.644.861
17081080,2006-12-01T00:00:00,Serpins,D12.776.645.750
17081080,2006-12-01T00:00:00,Serpins,D12.776.872
17086529,2006-12-01T00:00:00,Aged,M01.060.116.100
17086529,2006-12-01T00:00:00,Calcinosis,C18.452.174.130
17086529,2006-12-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17086529,2006-12-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17086529,2006-12-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
17086529,2006-12-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
17086529,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17086529,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17086529,2006-12-01T00:00:00,Stents,E07.695.750
17086529,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17086529,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17086529,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17092445,2006-12-01T00:00:00,Academic Medical Centers,N02.278.020
17092445,2006-12-01T00:00:00,"Faculty, Medical",I02.463.373
17092445,2006-12-01T00:00:00,"Faculty, Medical",M01.526.339.373
17092445,2006-12-01T00:00:00,"Faculty, Medical",M01.526.485.375
17092445,2006-12-01T00:00:00,"Faculty, Medical",N02.360.375
17092445,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17092445,2006-12-01T00:00:00,Rheumatology,H02.403.429.730
17092445,2006-12-01T00:00:00,Teaching,I02.903
17094924,2006-12-01T00:00:00,Bipolar Disorder,F03.600.150.150
17094924,2006-12-01T00:00:00,Chronic Disease,C23.550.291.500
17094924,2006-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17094924,2006-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
17094924,2006-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17094924,2006-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17094924,2006-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17094924,2006-12-01T00:00:00,Drug Resistance,G07.690.320
17094924,2006-12-01T00:00:00,Electric Stimulation Therapy,E02.342
17094924,2006-12-01T00:00:00,Electric Stimulation Therapy,E02.779.468
17094924,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17109472,2006-12-01T00:00:00,Apoptosis,G04.299.139.160
17109472,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17109472,2006-12-01T00:00:00,Lymphocyte Activation,E01.450.495.482
17109472,2006-12-01T00:00:00,Lymphocyte Activation,E05.478.594.530
17109472,2006-12-01T00:00:00,Lymphocyte Activation,G12.425.747
17109472,2006-12-01T00:00:00,Lymphocyte Activation,G12.450.050.400.545
17109472,2006-12-01T00:00:00,Melanoma,C04.557.465.625.650.510
17109472,2006-12-01T00:00:00,Melanoma,C04.557.580.625.650.510
17109472,2006-12-01T00:00:00,Melanoma,C04.557.665.510
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.283.875
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A11.118.637.555.567.569.220.200
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.283.875
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A15.145.229.637.555.567.569.220.200
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.283.875
17109472,2006-12-01T00:00:00,"T-Lymphocytes, Cytotoxic",A15.382.490.555.567.569.220.200
17114368,2006-12-01T00:00:00,Antineoplastic Agents,D27.505.954.248
17114368,2006-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
17114368,2006-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
17114368,2006-12-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
17114368,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17114368,2006-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17114368,2006-12-01T00:00:00,Lung Neoplasms,C08.381.540
17114368,2006-12-01T00:00:00,Lung Neoplasms,C08.785.520
17117967,2006-12-01T00:00:00,Alcohol Drinking,F01.145.317.269
17117967,2006-12-01T00:00:00,Alcoholism,C21.739.100.250
17117967,2006-12-01T00:00:00,Alcoholism,F03.900.100.350
17117967,2006-12-01T00:00:00,Animals,B01.050
17117967,2006-12-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17117967,2006-12-01T00:00:00,"Behavior, Animal",F01.145.113
17117967,2006-12-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
17117967,2006-12-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17117967,2006-12-01T00:00:00,Ethanol,D02.033.375
17117967,2006-12-01T00:00:00,Self Administration,E02.319.890
17117967,2006-12-01T00:00:00,Self Administration,E02.900.890
17117967,2006-12-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17117967,2006-12-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17122211,2006-12-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
17122211,2006-12-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
17122211,2006-12-01T00:00:00,Heart Atria,A07.541.358
17122211,2006-12-01T00:00:00,Heart Neoplasms,C04.588.894.309
17122211,2006-12-01T00:00:00,Heart Neoplasms,C14.280.459
17122211,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17122211,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17124708,2006-12-01T00:00:00,Electrophoresis,E05.196.401
17124708,2006-12-01T00:00:00,Electrophoresis,E05.301.300
17124708,2006-12-01T00:00:00,Electrophoresis,G02.149.767.570
17124708,2006-12-01T00:00:00,Electrophoresis,G02.842.750.570
17124708,2006-12-01T00:00:00,"Models, Chemical",E05.599.495
17124708,2006-12-01T00:00:00,Nanotechnology,H01.603
17124708,2006-12-01T00:00:00,Nanotechnology,J01.897.520.600
17130628,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17130628,2006-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17130628,2006-12-01T00:00:00,Risk Assessment,N04.452.871.715
17130628,2006-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17130628,2006-12-01T00:00:00,Risk Assessment,N06.850.505.715
17130628,2006-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17130628,2006-12-01T00:00:00,Smoking,F01.145.466.753
17130628,2006-12-01T00:00:00,Tobacco Industry,J01.576.919
17130628,2006-12-01T00:00:00,United States,Z01.107.567.875
17132179,2006-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17132179,2006-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
17132179,2006-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17132179,2006-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17132179,2006-12-01T00:00:00,Depressive Disorder,F03.600.300
17132179,2006-12-01T00:00:00,Drug Resistance,G07.690.320
17132179,2006-12-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
17132179,2006-12-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
17132179,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17132179,2006-12-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17132179,2006-12-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17132179,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17132179,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17132179,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17132521,2006-12-01T00:00:00,Attitude to Health,F01.100.150
17132521,2006-12-01T00:00:00,Attitude to Health,N05.300.150
17132521,2006-12-01T00:00:00,Coronary Disease,C14.280.647.250
17132521,2006-12-01T00:00:00,Coronary Disease,C14.907.585.250
17132521,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17132521,2006-12-01T00:00:00,Motivation,F01.658
17132521,2006-12-01T00:00:00,Motivation,F01.752.543.500.750
17132521,2006-12-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17132521,2006-12-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17132521,2006-12-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17132521,2006-12-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17132521,2006-12-01T00:00:00,Smoking,F01.145.466.753
17132521,2006-12-01T00:00:00,Smoking Cessation,F01.145.940.700
17133239,2006-12-01T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
17133239,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17133664,2006-12-01T00:00:00,Aortic Valve,A07.541.510.110
17133664,2006-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
17133664,2006-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
17133664,2006-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
17133664,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17133664,2006-12-01T00:00:00,Informed Consent,I01.880.604.473.650.718
17133664,2006-12-01T00:00:00,Informed Consent,I01.880.604.583.427
17133664,2006-12-01T00:00:00,Informed Consent,N03.706.437.650.312
17133664,2006-12-01T00:00:00,Informed Consent,N03.706.535.489
17133664,2006-12-01T00:00:00,Peer Review,F01.829.316.549
17133664,2006-12-01T00:00:00,Peer Review,I01.880.604.640
17133664,2006-12-01T00:00:00,Peer Review,N03.706.700
17133664,2006-12-01T00:00:00,Reoperation,E04.690
17138714,2006-12-01T00:00:00,Adult,M01.060.116
17138714,2006-12-01T00:00:00,Alcohol Drinking,F01.145.317.269
17138714,2006-12-01T00:00:00,Alcoholism,C21.739.100.250
17138714,2006-12-01T00:00:00,Alcoholism,F03.900.100.350
17138714,2006-12-01T00:00:00,Attitude of Health Personnel,F01.100.050
17138714,2006-12-01T00:00:00,Attitude of Health Personnel,N05.300.100
17138714,2006-12-01T00:00:00,Dentists,M01.526.485.330
17138714,2006-12-01T00:00:00,Dentists,N02.360.330
17138714,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17138714,2006-12-01T00:00:00,Mass Screening,E01.370.500
17138714,2006-12-01T00:00:00,Mass Screening,E05.318.308.250.580
17138714,2006-12-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17138714,2006-12-01T00:00:00,Mass Screening,N02.421.726.233.443
17138714,2006-12-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17138714,2006-12-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17138714,2006-12-01T00:00:00,Mass Screening,N06.850.780.500
17138714,2006-12-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
17138714,2006-12-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
17138714,2006-12-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
17138714,2006-12-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
17138714,2006-12-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17138714,2006-12-01T00:00:00,Prevalence,E05.318.308.985.525.750
17138714,2006-12-01T00:00:00,Prevalence,L01.280.975.525.750
17138714,2006-12-01T00:00:00,Prevalence,N01.224.935.597.750
17138714,2006-12-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17138714,2006-12-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17138714,2006-12-01T00:00:00,Questionnaires,E05.318.308.750
17138714,2006-12-01T00:00:00,Questionnaires,L01.280.800
17138714,2006-12-01T00:00:00,Questionnaires,N05.715.360.300.695
17138714,2006-12-01T00:00:00,Questionnaires,N06.850.520.308.750
17138714,2006-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17138714,2006-12-01T00:00:00,Risk Factors,N05.715.350.200.700
17138714,2006-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17138714,2006-12-01T00:00:00,Risk Factors,N06.850.490.625.750
17138714,2006-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17138714,2006-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17138714,2006-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17139484,2006-12-01T00:00:00,Dietary Supplements,J02.500.456
17139484,2006-12-01T00:00:00,Molecular Structure,G02.111.570
17139484,2006-12-01T00:00:00,Molecular Structure,G02.575
17139484,2006-12-01T00:00:00,Molecular Structure,G02.842.575
17139484,2006-12-01T00:00:00,Plant Extracts,D20.215.784.500
17139484,2006-12-01T00:00:00,Plant Extracts,D26.667
17139484,2006-12-01T00:00:00,Plant Leaves,A18.024.812
17141457,2006-12-01T00:00:00,Adult,M01.060.116
17141457,2006-12-01T00:00:00,Antifungal Agents,D27.505.954.122.136
17141457,2006-12-01T00:00:00,HIV Infections,C02.782.815.616.400
17141457,2006-12-01T00:00:00,HIV Infections,C02.800.801.400
17141457,2006-12-01T00:00:00,HIV Infections,C20.673.480
17141457,2006-12-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
17141457,2006-12-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
17141457,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17141457,2006-12-01T00:00:00,Intestinal Perforation,C06.405.469.557
17141457,2006-12-01T00:00:00,"Lymphohistiocytosis, Hemophagocytic",C15.604.250.410.575
17141457,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17141457,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17141457,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17143157,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17143157,2006-12-01T00:00:00,Pain,C10.597.617
17143157,2006-12-01T00:00:00,Pain,C23.888.592.612
17143157,2006-12-01T00:00:00,Pain,C23.888.646
17143157,2006-12-01T00:00:00,Pain,F02.830.816.444
17143157,2006-12-01T00:00:00,Pain,G11.561.600.810.444
17143157,2006-12-01T00:00:00,Pain Measurement,E01.370.376.550.600
17143157,2006-12-01T00:00:00,Pilot Projects,E05.318.760.750
17143157,2006-12-01T00:00:00,Pilot Projects,E05.337.737
17143157,2006-12-01T00:00:00,Pilot Projects,N05.715.360.775.625
17143157,2006-12-01T00:00:00,Pilot Projects,N06.850.520.450.720
17143157,2006-12-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17143157,2006-12-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17145436,2006-12-01T00:00:00,Animals,B01.050
17145436,2006-12-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
17145436,2006-12-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
17145436,2006-12-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
17145436,2006-12-01T00:00:00,Disease Progression,C23.550.291.656
17145436,2006-12-01T00:00:00,Fibroblasts,A11.329.228
17145436,2006-12-01T00:00:00,Fibroblasts,A11.872.228
17145436,2006-12-01T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
17145436,2006-12-01T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
17145436,2006-12-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17145436,2006-12-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17145436,2006-12-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
17145436,2006-12-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
17145436,2006-12-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
17145436,2006-12-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17145436,2006-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17145436,2006-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17145436,2006-12-01T00:00:00,"RNA, Messenger",D13.444.735.544
17145436,2006-12-01T00:00:00,"Transcription, Genetic",G02.111.087.847
17145436,2006-12-01T00:00:00,"Transcription, Genetic",G02.149.115.847
17145436,2006-12-01T00:00:00,"Transcription, Genetic",G05.355.310.700
17145436,2006-12-01T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
17146008,2006-12-01T00:00:00,Adolescent,M01.060.057
17146008,2006-12-01T00:00:00,Adult,M01.060.116
17146008,2006-12-01T00:00:00,Aged,M01.060.116.100
17146008,2006-12-01T00:00:00,Ambulatory Care,E02.760.106
17146008,2006-12-01T00:00:00,Ambulatory Care,N02.421.585.106
17146008,2006-12-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
17146008,2006-12-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
17146008,2006-12-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
17146008,2006-12-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
17146008,2006-12-01T00:00:00,Functional Laterality,F02.830.297.425
17146008,2006-12-01T00:00:00,Functional Laterality,G11.561.225.425
17146008,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17146008,2006-12-01T00:00:00,Lithium Carbonate,D01.045.125.500
17146008,2006-12-01T00:00:00,Lithium Carbonate,D01.200.275.150.550
17146008,2006-12-01T00:00:00,Lithium Carbonate,D01.510.475
17146008,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17146008,2006-12-01T00:00:00,Nortriptyline,D02.455.426.559.847.181.384.535
17146008,2006-12-01T00:00:00,Nortriptyline,D04.615.181.384.535
17146008,2006-12-01T00:00:00,Patient Dropouts,M01.643.673
17146008,2006-12-01T00:00:00,Research Design,E05.581.500
17146008,2006-12-01T00:00:00,Research Design,H01.770.644.728
17146008,2006-12-01T00:00:00,Secondary Prevention,N02.421.726.825
17146008,2006-12-01T00:00:00,Secondary Prevention,N06.850.780.750
17146008,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17146008,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17146008,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17146114,2006-12-01T00:00:00,"Education, Medical",I02.358.399
17146114,2006-12-01T00:00:00,Health Personnel,M01.526.485
17146114,2006-12-01T00:00:00,Health Personnel,N02.360
17146114,2006-12-01T00:00:00,Specialization,H02.811
17146114,2006-12-01T00:00:00,United States,Z01.107.567.875
17149006,2006-12-01T00:00:00,Adult,M01.060.116
17149006,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17149006,2006-12-01T00:00:00,Palliative Care,E02.760.666
17149006,2006-12-01T00:00:00,Palliative Care,N02.421.585.666
17149006,2006-12-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
17149006,2006-12-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
17149006,2006-12-01T00:00:00,Pancreatic Neoplasms,C06.301.761
17149006,2006-12-01T00:00:00,Pancreatic Neoplasms,C06.689.667
17149006,2006-12-01T00:00:00,Pancreatic Neoplasms,C19.344.421
17149006,2006-12-01T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
17149006,2006-12-01T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
17149006,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17149006,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17149006,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17149009,2006-12-01T00:00:00,Brachytherapy,E02.815.150
17149009,2006-12-01T00:00:00,Breast Neoplasms,C04.588.180
17149009,2006-12-01T00:00:00,Breast Neoplasms,C17.800.090.500
17149009,2006-12-01T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
17149009,2006-12-01T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
17149009,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17149009,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17149009,2006-12-01T00:00:00,Radiodermatitis,C17.800.174.826
17149009,2006-12-01T00:00:00,Radiodermatitis,C21.866.733.804
17157791,2006-12-01T00:00:00,Breast Neoplasms,C04.588.180
17157791,2006-12-01T00:00:00,Breast Neoplasms,C17.800.090.500
17157791,2006-12-01T00:00:00,Gene Expression Profiling,E05.393.332
17157791,2006-12-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17157791,2006-12-01T00:00:00,Genomics,H01.158.273.180.350
17157791,2006-12-01T00:00:00,Genomics,H01.158.273.343.350
17157791,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17157791,2006-12-01T00:00:00,Neoplasm Proteins,D12.776.624
17164633,2006-12-01T00:00:00,Adolescent,M01.060.057
17164633,2006-12-01T00:00:00,Adult,M01.060.116
17164633,2006-12-01T00:00:00,Aged,M01.060.116.100
17164633,2006-12-01T00:00:00,Combat Disorders,F03.080.931.249
17164633,2006-12-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
17164633,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17164633,2006-12-01T00:00:00,Life Change Events,F01.829.458.410
17164633,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17164633,2006-12-01T00:00:00,Personality Inventory,F04.711.647.513
17164633,2006-12-01T00:00:00,Psychiatric Status Rating Scales,F04.586
17164633,2006-12-01T00:00:00,Psychometrics,F04.711.780
17164633,2006-12-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17164633,2006-12-01T00:00:00,Students,I02.233.748
17164633,2006-12-01T00:00:00,Students,I02.851
17164633,2006-12-01T00:00:00,Students,M01.848
17164633,2006-12-01T00:00:00,Veterans,M01.930
17168646,2006-12-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
17168646,2006-12-01T00:00:00,Animals,B01.050
17168646,2006-12-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.074.500
17168646,2006-12-01T00:00:00,Aspartic Acid Endopeptidases,D08.811.277.656.300.048
17168646,2006-12-01T00:00:00,Cell Death,G04.299.139
17168646,2006-12-01T00:00:00,Gene Expression Regulation,G05.355.315
17168646,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17168646,2006-12-01T00:00:00,Nerve Tissue Proteins,D12.776.641
17168646,2006-12-01T00:00:00,Neurons,A08.663
17168646,2006-12-01T00:00:00,Neurons,A11.671
17168646,2006-12-01T00:00:00,Nuclear Proteins,D12.776.660
17168646,2006-12-01T00:00:00,Peptide Fragments,D12.644.541
17168646,2006-12-01T00:00:00,Transcription Factors,D12.776.930
17169726,2006-12-01T00:00:00,Adolescent,M01.060.057
17169726,2006-12-01T00:00:00,Alleles,G05.360.340.024.340.030
17169726,2006-12-01T00:00:00,Gingival Crevicular Fluid,A12.383.500
17169726,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17169726,2006-12-01T00:00:00,Interleukin-1,D12.644.276.374.465.501
17169726,2006-12-01T00:00:00,Interleukin-1,D12.644.276.374.500.400
17169726,2006-12-01T00:00:00,Interleukin-1,D12.776.467.374.465.501
17169726,2006-12-01T00:00:00,Interleukin-1,D12.776.467.374.500.400
17169726,2006-12-01T00:00:00,Interleukin-1,D23.529.374.465.501
17169726,2006-12-01T00:00:00,Interleukin-1,D23.529.374.500.400
17169726,2006-12-01T00:00:00,Maxilla,A02.835.232.781.324.502.645
17169726,2006-12-01T00:00:00,Maxilla,A14.521.645
17170611,2006-12-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.519.625.050.200.100
17170611,2006-12-01T00:00:00,Adrenergic alpha-Antagonists,D27.505.696.577.050.200.100
17170611,2006-12-01T00:00:00,Adult,M01.060.116
17170611,2006-12-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
17170611,2006-12-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
17170611,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17170611,2006-12-01T00:00:00,Hypertension,C14.907.489
17170611,2006-12-01T00:00:00,Medical Records,E05.318.308.940.968
17170611,2006-12-01T00:00:00,Medical Records,L01.280.900.968
17170611,2006-12-01T00:00:00,Medical Records,N04.452.859.564
17170611,2006-12-01T00:00:00,Medical Records,N05.715.360.300.715.500
17170611,2006-12-01T00:00:00,Medical Records,N06.850.520.308.940.968
17170611,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17170611,2006-12-01T00:00:00,Myocardial Infarction,C14.280.647.500
17170611,2006-12-01T00:00:00,Myocardial Infarction,C14.907.585.500
17170611,2006-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
17170611,2006-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
17170611,2006-12-01T00:00:00,United States,Z01.107.567.875
17170614,2006-12-01T00:00:00,Aged,M01.060.116.100
17170614,2006-12-01T00:00:00,Blood Pressure,E01.370.600.875.249
17170614,2006-12-01T00:00:00,Blood Pressure,G09.330.380.076
17170614,2006-12-01T00:00:00,Community Networks,I01.880.656.300
17170614,2006-12-01T00:00:00,Community Networks,L01.700.508.300.184
17170614,2006-12-01T00:00:00,Community Networks,N02.421.143.202
17170614,2006-12-01T00:00:00,Health Promotion,N02.370
17170614,2006-12-01T00:00:00,Health Promotion,N02.421.726.507
17170614,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17170614,2006-12-01T00:00:00,Hypertension,C14.907.489
17170614,2006-12-01T00:00:00,Interprofessional Relations,F01.829.401.205
17170614,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17170614,2006-12-01T00:00:00,North Carolina,Z01.107.567.875.075.475
17170614,2006-12-01T00:00:00,North Carolina,Z01.107.567.875.750.530
17170614,2006-12-01T00:00:00,"Societies, Medical",N03.540.828.589
17170614,2006-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17170614,2006-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17175270,2006-12-01T00:00:00,Animals,B01.050
17175270,2006-12-01T00:00:00,"Immunity, Innate",G12.450.575
17175270,2006-12-01T00:00:00,Liver Transplantation,E04.210.650
17175270,2006-12-01T00:00:00,Liver Transplantation,E04.936.450.490
17175270,2006-12-01T00:00:00,Liver Transplantation,E04.936.580.490
17175270,2006-12-01T00:00:00,Macrophages,A11.329.372
17175270,2006-12-01T00:00:00,Macrophages,A11.627.482
17175270,2006-12-01T00:00:00,Macrophages,A11.733.397
17175270,2006-12-01T00:00:00,Macrophages,A15.382.680.397
17175270,2006-12-01T00:00:00,Macrophages,A15.382.812.522
17175270,2006-12-01T00:00:00,Microcirculation,G09.330.190.163.645
17175270,2006-12-01T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
17175270,2006-12-01T00:00:00,Reperfusion Injury,C14.907.725
17175270,2006-12-01T00:00:00,Reperfusion Injury,C23.550.767.877
17176110,2006-12-01T00:00:00,Binding Sites,G02.111.570.120
17176110,2006-12-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
17176110,2006-12-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
17176110,2006-12-01T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
17176110,2006-12-01T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
17176110,2006-12-01T00:00:00,Penicillin-Binding Proteins,D08.811.710
17176110,2006-12-01T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
17176110,2006-12-01T00:00:00,Streptococcus pneumoniae,B03.510.400.800.872.550
17185689,2006-12-01T00:00:00,Aged,M01.060.116.100
17185689,2006-12-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
17185689,2006-12-01T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
17185689,2006-12-01T00:00:00,Blood Vessel Prosthesis,E07.695.110
17185689,2006-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
17185689,2006-12-01T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
17185689,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17185689,2006-12-01T00:00:00,Prosthesis Design,E05.320.550
17185689,2006-12-01T00:00:00,Prosthesis Design,E07.695.680
17185689,2006-12-01T00:00:00,Stents,E07.695.750
17185689,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17185689,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17185689,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17185689,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17185689,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17185689,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17185689,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17185689,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17200461,2006-12-01T00:00:00,Animals,B01.050
17200461,2006-12-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
17200461,2006-12-01T00:00:00,Brain,A08.186.211
17200461,2006-12-01T00:00:00,Cognition,F02.463.188
17200461,2006-12-01T00:00:00,"Extinction, Psychological",F02.463.425.770.232
17200461,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17200461,2006-12-01T00:00:00,Substance-Related Disorders,C21.739
17200461,2006-12-01T00:00:00,Substance-Related Disorders,F03.900
17201613,2006-12-01T00:00:00,Animals,B01.050
17201613,2006-12-01T00:00:00,Carrier Proteins,D12.776.157
17201613,2006-12-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17201613,2006-12-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17201613,2006-12-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
17201613,2006-12-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
17201613,2006-12-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
17201613,2006-12-01T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
17201613,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17201613,2006-12-01T00:00:00,Ion Channels,D12.776.157.530.400
17201613,2006-12-01T00:00:00,Ion Channels,D12.776.543.550.425
17201613,2006-12-01T00:00:00,Ion Channels,D12.776.543.585.400
17201613,2006-12-01T00:00:00,Methylphenidate,D02.241.223.601.600
17201613,2006-12-01T00:00:00,Methylphenidate,D03.383.621.460
17201613,2006-12-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.186
17201613,2006-12-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.750
17201613,2006-12-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.186
17201613,2006-12-01T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.750
17201613,2006-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17201613,2006-12-01T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.070.800.100.100
17201613,2006-12-01T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.100.800.100.100
17201613,2006-12-01T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.720.300.800.100.100
17201844,2006-12-01T00:00:00,Animals,B01.050
17201844,2006-12-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
17201844,2006-12-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
17201844,2006-12-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17201844,2006-12-01T00:00:00,Catheter Ablation,E02.148.110
17201844,2006-12-01T00:00:00,Catheter Ablation,E02.148.442.110
17201844,2006-12-01T00:00:00,Catheter Ablation,E02.154.402.110
17201844,2006-12-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17201844,2006-12-01T00:00:00,Equipment Failure Analysis,E05.325.192
17201844,2006-12-01T00:00:00,Myocardium,A02.633.580
17201844,2006-12-01T00:00:00,Myocardium,A07.541.704
17201844,2006-12-01T00:00:00,Myocardium,A10.690.552.750
17201844,2006-12-01T00:00:00,Swine,B01.050.150.900.649.077.880
17201844,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17201844,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17201844,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17216816,2006-12-01T00:00:00,Adolescent,M01.060.057
17216816,2006-12-01T00:00:00,Adult,M01.060.116
17216816,2006-12-01T00:00:00,Aged,M01.060.116.100
17216816,2006-12-01T00:00:00,Biocompatible Materials,D25.130
17216816,2006-12-01T00:00:00,Biocompatible Materials,D27.720.102.130
17216816,2006-12-01T00:00:00,Biocompatible Materials,J01.637.051.130
17216816,2006-12-01T00:00:00,Collagen,D05.750.078.280
17216816,2006-12-01T00:00:00,Collagen,D12.776.860.300.250
17216816,2006-12-01T00:00:00,Device Removal,E04.199
17216816,2006-12-01T00:00:00,"Hernia, Ventral",C23.300.707.374.937
17216816,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17216816,2006-12-01T00:00:00,Hypertension,C14.907.489
17216816,2006-12-01T00:00:00,Length of Stay,E02.760.400.480
17216816,2006-12-01T00:00:00,Length of Stay,N02.421.585.400.480
17216816,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17216816,2006-12-01T00:00:00,Multiple Organ Failure,C23.550.835.525
17216816,2006-12-01T00:00:00,Prosthesis-Related Infections,C01.539.685
17216816,2006-12-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
17216816,2006-12-01T00:00:00,Sepsis,C01.539.757
17216816,2006-12-01T00:00:00,Sepsis,C23.550.470.790.500
17216816,2006-12-01T00:00:00,Surgical Wound Infection,C01.539.947.692
17216816,2006-12-01T00:00:00,Surgical Wound Infection,C23.550.767.925
17216816,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17216816,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17216816,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17227516,2006-12-01T00:00:00,Aged,M01.060.116.100
17227516,2006-12-01T00:00:00,Conscious Sedation,E03.250
17227516,2006-12-01T00:00:00,Cross-Over Studies,E05.318.780.150
17227516,2006-12-01T00:00:00,Cross-Over Studies,N05.715.360.780.150
17227516,2006-12-01T00:00:00,Cross-Over Studies,N06.850.520.445.150
17227516,2006-12-01T00:00:00,Endoscopy,E01.370.388.250
17227516,2006-12-01T00:00:00,Endoscopy,E04.800.250
17227516,2006-12-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
17227516,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17227516,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17227516,2006-12-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
17227516,2006-12-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
17227516,2006-12-01T00:00:00,Patient Satisfaction,N05.715.360.600
17229020,2006-12-01T00:00:00,Animals,B01.050
17229020,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17229020,2006-12-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17229020,2006-12-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17229020,2006-12-01T00:00:00,Osteitis Deformans,C05.116.692
17229020,2006-12-01T00:00:00,Osteoclasts,A11.329.372.700
17229020,2006-12-01T00:00:00,Osteoclasts,A11.627.482.700
17229020,2006-12-01T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
17229020,2006-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
17229020,2006-12-01T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
17229098,2006-12-01T00:00:00,Actins,D05.750.078.730.250
17229098,2006-12-01T00:00:00,Actins,D12.776.210.500.100
17229098,2006-12-01T00:00:00,Actins,D12.776.220.525.255
17229098,2006-12-01T00:00:00,Animals,B01.050
17229098,2006-12-01T00:00:00,"Animals, Newborn",B01.050.050.282
17229098,2006-12-01T00:00:00,Cell Survival,G04.299.316
17229098,2006-12-01T00:00:00,Central Nervous System Depressants,D27.505.696.277
17229098,2006-12-01T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
17229098,2006-12-01T00:00:00,Drug Interactions,G07.690.812.240
17229098,2006-12-01T00:00:00,Drug Interactions,G07.700.680.240
17229098,2006-12-01T00:00:00,Ethanol,D02.033.375
17229098,2006-12-01T00:00:00,Gene Expression Regulation,G05.355.315
17229098,2006-12-01T00:00:00,Homeostasis,G07.700.360
17229098,2006-12-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
17229098,2006-12-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17229098,2006-12-01T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17229098,2006-12-01T00:00:00,Membrane Proteins,D12.776.543
17229098,2006-12-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
17229098,2006-12-01T00:00:00,"Microscopy, Confocal",E05.595.395
17229098,2006-12-01T00:00:00,Neurons,A08.663
17229098,2006-12-01T00:00:00,Neurons,A11.671
17229098,2006-12-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17233212,2006-12-01T00:00:00,"History, 19th Century",K01.400.504.937
17233212,2006-12-01T00:00:00,"History, 20th Century",K01.400.504.968
17233212,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17233212,2006-12-01T00:00:00,Hypertension,C14.907.489
17233212,2006-12-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
17233212,2006-12-01T00:00:00,"Societies, Medical",N03.540.828.589
17243258,2006-12-01T00:00:00,Bone Density Conservation Agents,D27.505.696.242
17243258,2006-12-01T00:00:00,Calcitonin,D06.472.699.150
17243258,2006-12-01T00:00:00,Calcitonin,D12.644.400.095
17243258,2006-12-01T00:00:00,Calcitonin,D12.644.548.150
17243258,2006-12-01T00:00:00,Calcitonin,D12.776.641.650.095
17243258,2006-12-01T00:00:00,Diphosphonates,D02.705.206
17243258,2006-12-01T00:00:00,Evidence-Based Medicine,H02.249.750
17243258,2006-12-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17243258,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17243258,2006-12-01T00:00:00,Osteoporosis,C05.116.198.579
17254438,2006-12-01T00:00:00,Adolescent,M01.060.057
17254438,2006-12-01T00:00:00,Adult,M01.060.116
17254438,2006-12-01T00:00:00,African Americans,M01.686.508.100.100
17254438,2006-12-01T00:00:00,African Americans,M01.686.754.100
17254438,2006-12-01T00:00:00,Cardiovascular Diseases,C14
17254438,2006-12-01T00:00:00,Child,M01.060.406
17254438,2006-12-01T00:00:00,Chronic Disease,C23.550.291.500
17254438,2006-12-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17254438,2006-12-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17254438,2006-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17254438,2006-12-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17254438,2006-12-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17254438,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17254438,2006-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17254438,2006-12-01T00:00:00,Risk Factors,N05.715.350.200.700
17254438,2006-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17254438,2006-12-01T00:00:00,Risk Factors,N06.850.490.625.750
17254438,2006-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17254438,2006-12-01T00:00:00,"Stress, Physiological",G07.700.830
17296467,2006-12-01T00:00:00,Aged,M01.060.116.100
17296467,2006-12-01T00:00:00,"Cholesterol, LDL",D10.532.515.500
17296467,2006-12-01T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
17296467,2006-12-01T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
17296467,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17296467,2006-12-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
17296467,2006-12-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
17296467,2006-12-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
17296467,2006-12-01T00:00:00,Medical Records,E05.318.308.940.968
17296467,2006-12-01T00:00:00,Medical Records,L01.280.900.968
17296467,2006-12-01T00:00:00,Medical Records,N04.452.859.564
17296467,2006-12-01T00:00:00,Medical Records,N05.715.360.300.715.500
17296467,2006-12-01T00:00:00,Medical Records,N06.850.520.308.940.968
17296467,2006-12-01T00:00:00,Middle Aged,M01.060.116.630
17296467,2006-12-01T00:00:00,Treatment Outcome,E01.789.800
17296467,2006-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17296467,2006-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17336832,2006-12-01T00:00:00,Animals,B01.050
17336832,2006-12-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17336832,2006-12-01T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
17336832,2006-12-01T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
17336832,2006-12-01T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
17336832,2006-12-01T00:00:00,Rabbits,B01.050.150.900.649.521.700
17336832,2006-12-01T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
17336832,2006-12-01T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
17709083,2006-12-01T00:00:00,Angiography,E01.370.350.700.060
17709083,2006-12-01T00:00:00,Angiography,E01.370.370.050
17709083,2006-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17709083,2006-12-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
17709083,2006-12-01T00:00:00,Myocardial Infarction,C14.280.647.500
17709083,2006-12-01T00:00:00,Myocardial Infarction,C14.907.585.500
17709083,2006-12-01T00:00:00,Pulmonary Artery,A07.231.114.715
17709083,2006-12-01T00:00:00,Pulmonary Embolism,C08.381.746
17709083,2006-12-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
17709083,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17709083,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17709083,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17709083,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17709083,2006-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17709083,2006-12-01T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
17141829,2006-12-04T00:00:00,Adult,M01.060.116
17141829,2006-12-04T00:00:00,Device Removal,E04.199
17141829,2006-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17141829,2006-12-04T00:00:00,Polypropylenes,D02.455.326.271.665.590
17141829,2006-12-04T00:00:00,Polypropylenes,D05.750.716.550
17141829,2006-12-04T00:00:00,Polypropylenes,D25.720.716.550
17141829,2006-12-04T00:00:00,Polypropylenes,J01.637.051.720.716.550
17141829,2006-12-04T00:00:00,Postoperative Complications,C23.550.767
17141829,2006-12-04T00:00:00,Prosthesis Implantation,E04.650
17141829,2006-12-04T00:00:00,Reoperation,E04.690
17141829,2006-12-04T00:00:00,Suburethral Slings,E07.695.752
17141829,2006-12-04T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
17141829,2006-12-04T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
17141829,2006-12-04T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
17106251,2006-12-05T00:00:00,Apoptosis,G04.299.139.160
17106251,2006-12-05T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17106251,2006-12-05T00:00:00,Doxorubicin,D04.615.562.050.200.175
17106251,2006-12-05T00:00:00,Doxorubicin,D09.408.051.059.200.175
17106251,2006-12-05T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
17106251,2006-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17106251,2006-12-05T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17106251,2006-12-05T00:00:00,Prostatic Neoplasms,C12.294.260.750
17106251,2006-12-05T00:00:00,Prostatic Neoplasms,C12.294.565.625
17106251,2006-12-05T00:00:00,Prostatic Neoplasms,C12.758.409.750
17106251,2006-12-05T00:00:00,RNA Interference,G05.355.315.203.374.790
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
17106251,2006-12-05T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
17150310,2006-12-05T00:00:00,Adult,M01.060.116
17150310,2006-12-05T00:00:00,Anxiety Disorders,F03.080
17150310,2006-12-05T00:00:00,Cocaine-Related Disorders,C21.739.300
17150310,2006-12-05T00:00:00,Cocaine-Related Disorders,F03.900.300
17150310,2006-12-05T00:00:00,Depression,F01.145.126.350
17150310,2006-12-05T00:00:00,Drug Therapy,E02.319
17150310,2006-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17150310,2006-12-05T00:00:00,Marijuana Abuse,C21.739.635
17150310,2006-12-05T00:00:00,Marijuana Abuse,F03.900.635
17173655,2006-12-06T00:00:00,Adolescent,M01.060.057
17173655,2006-12-06T00:00:00,Adult,M01.060.116
17173655,2006-12-06T00:00:00,Aged,M01.060.116.100
17173655,2006-12-06T00:00:00,Body Mass Index,E01.370.600.115.100.125
17173655,2006-12-06T00:00:00,Body Mass Index,E05.041.124.125
17173655,2006-12-06T00:00:00,Body Mass Index,G07.100.100.125
17173655,2006-12-06T00:00:00,Body Mass Index,N06.850.505.200.100.175
17173655,2006-12-06T00:00:00,Body Weight,C23.888.144
17173655,2006-12-06T00:00:00,Body Weight,E01.370.600.115.100.160.120
17173655,2006-12-06T00:00:00,Body Weight,E05.041.124.160.750
17173655,2006-12-06T00:00:00,Body Weight,G07.100.100.160.120
17173655,2006-12-06T00:00:00,Body Weight,G07.700.320.249.314.120
17173655,2006-12-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17173655,2006-12-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17173655,2006-12-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17173655,2006-12-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17173655,2006-12-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17173655,2006-12-06T00:00:00,Kidney Transplantation,E02.870.500
17173655,2006-12-06T00:00:00,Kidney Transplantation,E04.936.450.485
17173655,2006-12-06T00:00:00,Kidney Transplantation,E04.950.774.400
17173655,2006-12-06T00:00:00,Middle Aged,M01.060.116.630
17173655,2006-12-06T00:00:00,Treatment Outcome,E01.789.800
17173655,2006-12-06T00:00:00,Treatment Outcome,N04.761.559.590.800
17173655,2006-12-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17173655,2006-12-06T00:00:00,Waiting Lists,N04.452.095.738
17173655,2006-12-06T00:00:00,Weight Loss,C23.888.144.243.963
17173655,2006-12-06T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
17223134,2006-12-06T00:00:00,Hydrogen Bonding,G02.149.767.620
17223134,2006-12-06T00:00:00,Hydrogen Bonding,G02.842.750.620
17223134,2006-12-06T00:00:00,"Models, Molecular",E05.599.595
17223134,2006-12-06T00:00:00,Molecular Structure,G02.111.570
17223134,2006-12-06T00:00:00,Molecular Structure,G02.575
17223134,2006-12-06T00:00:00,Molecular Structure,G02.842.575
17223134,2006-12-06T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
17223134,2006-12-06T00:00:00,Nucleic Acid Conformation,G02.111.570.790.486
17223134,2006-12-06T00:00:00,Nucleic Acid Conformation,G05.360.580
17223134,2006-12-06T00:00:00,Poisson Distribution,E05.318.740.994.750
17223134,2006-12-06T00:00:00,Poisson Distribution,G17.820.750
17223134,2006-12-06T00:00:00,Poisson Distribution,N05.715.360.750.750.620
17223134,2006-12-06T00:00:00,Poisson Distribution,N06.850.520.830.994.750
17223134,2006-12-06T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
17223134,2006-12-06T00:00:00,Protons,D01.248.497.300.459.700
17223134,2006-12-06T00:00:00,Protons,D01.435.550
17223134,2006-12-06T00:00:00,Protons,G01.249.765
17223134,2006-12-06T00:00:00,RNA,D13.444.735
17223134,2006-12-06T00:00:00,"RNA, Viral",D13.444.735.828
17223134,2006-12-06T00:00:00,Static Electricity,G01.201.249.820
17156501,2006-12-07T00:00:00,Clostridium Infections,C01.252.410.222
17156501,2006-12-07T00:00:00,Clostridium difficile,B03.300.390.400.200.250
17156501,2006-12-07T00:00:00,Clostridium difficile,B03.510.415.400.200.250
17156501,2006-12-07T00:00:00,Cross Infection,C01.539.248
17156501,2006-12-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17156501,2006-12-07T00:00:00,Middle Aged,M01.060.116.630
17156501,2006-12-07T00:00:00,Population Surveillance,E05.318.308.250.700
17156501,2006-12-07T00:00:00,Population Surveillance,N05.715.360.300.375.625
17156501,2006-12-07T00:00:00,Population Surveillance,N06.850.520.308.250.700
17156501,2006-12-07T00:00:00,Population Surveillance,N06.850.780.675
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,E05.318.740.872
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,E05.318.780.800
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,G17.800
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17156501,2006-12-07T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17261405,2006-12-08T00:00:00,Aged,M01.060.116.100
17261405,2006-12-08T00:00:00,Cardiotonic Agents,D27.505.954.411.222
17261405,2006-12-08T00:00:00,Cardiotonic Agents,D27.720.799.080
17261405,2006-12-08T00:00:00,Diastole,G09.330.190.541.295
17261405,2006-12-08T00:00:00,Diastole,G11.427.590.540.554.250
17261405,2006-12-08T00:00:00,Diastole,G11.427.590.540.570.295
17261405,2006-12-08T00:00:00,Disease Progression,C23.550.291.656
17261405,2006-12-08T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
17261405,2006-12-08T00:00:00,Glomerular Filtration Rate,G08.852.357
17261405,2006-12-08T00:00:00,Heart Failure,C14.280.434
17261405,2006-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17261405,2006-12-08T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
17261405,2006-12-08T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
17261405,2006-12-08T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
17261405,2006-12-08T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
17261405,2006-12-08T00:00:00,Middle Aged,M01.060.116.630
17261405,2006-12-08T00:00:00,Myocardial Contraction,G09.330.190.541
17261405,2006-12-08T00:00:00,Myocardial Contraction,G11.427.590.540.570
17261405,2006-12-08T00:00:00,Risk Factors,E05.318.740.600.800.725
17261405,2006-12-08T00:00:00,Risk Factors,N05.715.350.200.700
17261405,2006-12-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17261405,2006-12-08T00:00:00,Risk Factors,N06.850.490.625.750
17261405,2006-12-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17158855,2006-12-11T00:00:00,Adult,M01.060.116
17158855,2006-12-11T00:00:00,Breast Neoplasms,C04.588.180
17158855,2006-12-11T00:00:00,Breast Neoplasms,C17.800.090.500
17158855,2006-12-11T00:00:00,Case-Control Studies,E05.318.760.500.500
17158855,2006-12-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17158855,2006-12-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17158855,2006-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17158855,2006-12-11T00:00:00,Middle Aged,M01.060.116.630
17158855,2006-12-11T00:00:00,New York,Z01.107.567.875.075.437
17158855,2006-12-11T00:00:00,New York,Z01.107.567.875.350.530
17158855,2006-12-11T00:00:00,New York,Z01.107.567.875.500.530
17158855,2006-12-11T00:00:00,Questionnaires,E05.318.308.750
17158855,2006-12-11T00:00:00,Questionnaires,L01.280.800
17158855,2006-12-11T00:00:00,Questionnaires,N05.715.360.300.695
17158855,2006-12-11T00:00:00,Questionnaires,N06.850.520.308.750
17158855,2006-12-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
17158855,2006-12-11T00:00:00,Risk Assessment,N04.452.871.715
17158855,2006-12-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17158855,2006-12-11T00:00:00,Risk Assessment,N06.850.505.715
17158855,2006-12-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17158855,2006-12-11T00:00:00,Risk Factors,E05.318.740.600.800.725
17158855,2006-12-11T00:00:00,Risk Factors,N05.715.350.200.700
17158855,2006-12-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17158855,2006-12-11T00:00:00,Risk Factors,N06.850.490.625.750
17158855,2006-12-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17161654,2006-12-11T00:00:00,Adolescent,M01.060.057
17161654,2006-12-11T00:00:00,Adult,M01.060.116
17161654,2006-12-11T00:00:00,Age Factors,N05.715.350.075
17161654,2006-12-11T00:00:00,Age Factors,N06.850.490.250
17161654,2006-12-11T00:00:00,Child,M01.060.406
17161654,2006-12-11T00:00:00,"Child, Preschool",M01.060.406.448
17161654,2006-12-11T00:00:00,Epilepsy,C10.228.140.490
17161654,2006-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17161654,2006-12-11T00:00:00,Mental Health Services,F04.408
17161654,2006-12-11T00:00:00,Mental Health Services,N02.421.461
17161654,2006-12-11T00:00:00,Pediatrics,H02.403.670
17161654,2006-12-11T00:00:00,Questionnaires,E05.318.308.750
17161654,2006-12-11T00:00:00,Questionnaires,L01.280.800
17161654,2006-12-11T00:00:00,Questionnaires,N05.715.360.300.695
17161654,2006-12-11T00:00:00,Questionnaires,N06.850.520.308.750
17161654,2006-12-11T00:00:00,Referral and Consultation,N04.452.758.849
17161654,2006-12-11T00:00:00,Sex Factors,N05.715.350.675
17161654,2006-12-11T00:00:00,Sex Factors,N06.850.490.875
17166921,2006-12-13T00:00:00,Animals,B01.050
17166921,2006-12-13T00:00:00,Carrier Proteins,D12.776.157
17166921,2006-12-13T00:00:00,Cilia,A11.284.180.165
17166921,2006-12-13T00:00:00,Flagella,A11.284.180.290
17166921,2006-12-13T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17166921,2006-12-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
17166921,2006-12-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
17166921,2006-12-13T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17166921,2006-12-13T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17166921,2006-12-13T00:00:00,Mutation,G05.365.590
17166921,2006-12-13T00:00:00,Phenotype,G05.695
17166921,2006-12-13T00:00:00,Pregnancy,G08.686.785.760.769
17166921,2006-12-13T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
17166941,2006-12-13T00:00:00,Cell Line,A11.251.210
17166941,2006-12-13T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
17166941,2006-12-13T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17166941,2006-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17166941,2006-12-13T00:00:00,Membrane Proteins,D12.776.543
17166941,2006-12-13T00:00:00,Mutation,G05.365.590
17166941,2006-12-13T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
17166941,2006-12-13T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
17166941,2006-12-13T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
17166941,2006-12-13T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
17166941,2006-12-13T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
17166941,2006-12-13T00:00:00,Signal Transduction,G02.111.087.800
17166941,2006-12-13T00:00:00,Signal Transduction,G02.149.115.800
17166941,2006-12-13T00:00:00,Signal Transduction,G04.299.880
17208318,2006-12-13T00:00:00,Animals,B01.050
17208318,2006-12-13T00:00:00,Apoptosis,G04.299.139.160
17208318,2006-12-13T00:00:00,Fibroblasts,A11.329.228
17208318,2006-12-13T00:00:00,Fibroblasts,A11.872.228
17208318,2006-12-13T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
17208318,2006-12-13T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
17208318,2006-12-13T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
17208318,2006-12-13T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
17208318,2006-12-13T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
17208318,2006-12-13T00:00:00,Gene Expression Regulation,G05.355.315
17208318,2006-12-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17208318,2006-12-13T00:00:00,Molecular Weight,G02.842.580
17208318,2006-12-13T00:00:00,Piperazines,D03.383.606
17208318,2006-12-13T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.070.800.100.100
17208318,2006-12-13T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.100.800.100.100
17208318,2006-12-13T00:00:00,"Receptor, Serotonin, 5-HT1A",D12.776.543.750.720.300.800.100.100
17208318,2006-12-13T00:00:00,rho GTP-Binding Proteins,D08.811.277.040.330.300.400.700
17208318,2006-12-13T00:00:00,rho GTP-Binding Proteins,D12.644.360.525.700
17208318,2006-12-13T00:00:00,rho GTP-Binding Proteins,D12.776.157.325.515.700
17208318,2006-12-13T00:00:00,rho GTP-Binding Proteins,D12.776.476.525.700
17170006,2006-12-14T00:00:00,Animals,B01.050
17170006,2006-12-14T00:00:00,Cell Cycle,G04.299.134
17170006,2006-12-14T00:00:00,Cell Proliferation,G04.299.233.750
17170006,2006-12-14T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17170006,2006-12-14T00:00:00,Chlorambucil,D02.455.526.728.650.156
17170006,2006-12-14T00:00:00,DNA,D13.444.308
17170006,2006-12-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17170006,2006-12-14T00:00:00,Nylons,D05.750.716.392
17170006,2006-12-14T00:00:00,Nylons,D25.720.716.392
17170006,2006-12-14T00:00:00,Nylons,J01.576.885.800.600
17170006,2006-12-14T00:00:00,Nylons,J01.637.051.720.716.392
17170006,2006-12-14T00:00:00,Nylons,J01.637.548
17170006,2006-12-14T00:00:00,Plasmids,G05.360.600
17171246,2006-12-14T00:00:00,Disasters,N06.230.100
17171246,2006-12-14T00:00:00,Rivers,G01.311.750
17171246,2006-12-14T00:00:00,Rivers,G16.500.275.280.500
17171246,2006-12-14T00:00:00,Rivers,N06.230.232.500
17171246,2006-12-14T00:00:00,Seasons,G01.910.645.661
17171246,2006-12-14T00:00:00,Seasons,G16.500.275.071.590
17171246,2006-12-14T00:00:00,Seasons,N06.230.300.100.250.525
17171246,2006-12-14T00:00:00,South Carolina,Z01.107.567.875.075.662
17171246,2006-12-14T00:00:00,South Carolina,Z01.107.567.875.750.700
17171246,2006-12-14T00:00:00,Water,D01.455.900
17171246,2006-12-14T00:00:00,Water,D01.650.550.925
17171246,2006-12-14T00:00:00,Water Movements,G16.500.240.960
17171246,2006-12-14T00:00:00,Water Movements,N06.230.850
17171246,2006-12-14T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17171448,2006-12-14T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17171448,2006-12-14T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17171448,2006-12-14T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17171448,2006-12-14T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17171448,2006-12-14T00:00:00,Enteral Nutrition,E02.421.360
17171448,2006-12-14T00:00:00,Enteral Nutrition,E02.642.500.360
17171448,2006-12-14T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
17171448,2006-12-14T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
17171448,2006-12-14T00:00:00,Gastrostomy,E04.210.496
17171448,2006-12-14T00:00:00,Gastrostomy,E04.579.408
17171448,2006-12-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17171448,2006-12-14T00:00:00,Liver,A03.620
17171448,2006-12-14T00:00:00,Middle Aged,M01.060.116.630
17171448,2006-12-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17171448,2006-12-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17171448,2006-12-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17171448,2006-12-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17171448,2006-12-14T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17165840,2006-12-15T00:00:00,Animals,B01.050
17165840,2006-12-15T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17165840,2006-12-15T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17165840,2006-12-15T00:00:00,Polypropylenes,D02.455.326.271.665.590
17165840,2006-12-15T00:00:00,Polypropylenes,D05.750.716.550
17165840,2006-12-15T00:00:00,Polypropylenes,D25.720.716.550
17165840,2006-12-15T00:00:00,Polypropylenes,J01.637.051.720.716.550
17165840,2006-12-15T00:00:00,Proteins,D12.776
17172258,2006-12-15T00:00:00,Adult,M01.060.116
17172258,2006-12-15T00:00:00,Aged,M01.060.116.100
17172258,2006-12-15T00:00:00,Alcoholism,C21.739.100.250
17172258,2006-12-15T00:00:00,Alcoholism,F03.900.100.350
17172258,2006-12-15T00:00:00,Attitude of Health Personnel,F01.100.050
17172258,2006-12-15T00:00:00,Attitude of Health Personnel,N05.300.100
17172258,2006-12-15T00:00:00,Combined Modality Therapy,E02.186
17172258,2006-12-15T00:00:00,Community Health Services,N02.421.143
17172258,2006-12-15T00:00:00,Counseling,F02.784.176
17172258,2006-12-15T00:00:00,Counseling,F04.408.413
17172258,2006-12-15T00:00:00,Counseling,N02.421.143.303
17172258,2006-12-15T00:00:00,Counseling,N02.421.461.363
17172258,2006-12-15T00:00:00,Data Collection,E05.318.308
17172258,2006-12-15T00:00:00,Data Collection,L01.280
17172258,2006-12-15T00:00:00,Data Collection,N05.715.360.300
17172258,2006-12-15T00:00:00,Data Collection,N06.850.520.308
17172258,2006-12-15T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17172258,2006-12-15T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17172258,2006-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17172258,2006-12-15T00:00:00,Inservice Training,I02.574
17172258,2006-12-15T00:00:00,Middle Aged,M01.060.116.630
17172258,2006-12-15T00:00:00,Naltrexone,D03.132.577.249.706.550
17172258,2006-12-15T00:00:00,Naltrexone,D03.549.686.750.550
17172258,2006-12-15T00:00:00,Naltrexone,D03.605.497.750.550
17172258,2006-12-15T00:00:00,Naltrexone,D04.615.723.795.706.550
17172258,2006-12-15T00:00:00,South Carolina,Z01.107.567.875.075.662
17172258,2006-12-15T00:00:00,South Carolina,Z01.107.567.875.750.700
17172258,2006-12-15T00:00:00,Substance Abuse Treatment Centers,N02.278.035.128.800
17172258,2006-12-15T00:00:00,Substance Abuse Treatment Centers,N02.278.808.930
17172331,2006-12-15T00:00:00,Animals,B01.050
17172331,2006-12-15T00:00:00,Bacterial Adhesion,G06.099.112.100
17172331,2006-12-15T00:00:00,Bacterial Adhesion,G06.590.110.100
17172331,2006-12-15T00:00:00,Bacterial Proteins,D12.776.097
17172331,2006-12-15T00:00:00,Chickens,B01.050.150.900.248.350.150
17172331,2006-12-15T00:00:00,Chickens,B01.050.150.900.248.617.192
17172331,2006-12-15T00:00:00,Epithelial Cells,A11.436
17172331,2006-12-15T00:00:00,Heat-Shock Proteins,D12.776.580.216
17172331,2006-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17178857,2006-12-15T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17178857,2006-12-15T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17178857,2006-12-15T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17178857,2006-12-15T00:00:00,Breast Neoplasms,C04.588.180
17178857,2006-12-15T00:00:00,Breast Neoplasms,C17.800.090.500
17178857,2006-12-15T00:00:00,Cell Division,G04.299.134.220
17178857,2006-12-15T00:00:00,Cell Division,G04.299.233.750.500
17178857,2006-12-15T00:00:00,Cell Division,G05.355.105
17178857,2006-12-15T00:00:00,Cell Division,G07.700.320.249.410.750.500
17178857,2006-12-15T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
17178857,2006-12-15T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
17178857,2006-12-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17178857,2006-12-15T00:00:00,Lentivirus,B04.820.650.589
17178857,2006-12-15T00:00:00,Lentivirus,B04.909.777.731.589
17178857,2006-12-15T00:00:00,Neoplasm Proteins,D12.776.624
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17178857,2006-12-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17178857,2006-12-15T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
17178857,2006-12-15T00:00:00,RNA-Binding Proteins,D12.776.157.725
17178857,2006-12-15T00:00:00,RNA-Binding Proteins,D12.776.664.962
17240461,2006-12-17T00:00:00,Animals,B01.050
17240461,2006-12-17T00:00:00,"Embryo, Nonmammalian",A13.350
17240461,2006-12-17T00:00:00,"Embryo, Nonmammalian",A16.331
17240461,2006-12-17T00:00:00,Environmental Exposure,N06.850.460.350
17240461,2006-12-17T00:00:00,Estradiol,D04.808.365.415.248
17240461,2006-12-17T00:00:00,Estradiol,D06.472.334.851.437.500
17240461,2006-12-17T00:00:00,Gene Expression,G05.355.310
17240461,2006-12-17T00:00:00,Liver,A03.620
17240461,2006-12-17T00:00:00,Pesticides,D27.720.031.700
17240461,2006-12-17T00:00:00,Pesticides,D27.720.723
17240461,2006-12-17T00:00:00,Pesticides,D27.888.723
17240461,2006-12-17T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
17240461,2006-12-17T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
17240461,2006-12-17T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
17240461,2006-12-17T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17182181,2006-12-19T00:00:00,Aging,G07.700.320.124
17182181,2006-12-19T00:00:00,Animals,B01.050
17182181,2006-12-19T00:00:00,Down-Regulation,G02.111.087.225
17182181,2006-12-19T00:00:00,Down-Regulation,G02.149.115.225
17182181,2006-12-19T00:00:00,Down-Regulation,G05.355.315.200
17182181,2006-12-19T00:00:00,Down-Regulation,G07.690.812.230
17182181,2006-12-19T00:00:00,Down-Regulation,G07.700.680.230
17182181,2006-12-19T00:00:00,Hippocampus,A08.186.211.464.405
17182181,2006-12-19T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
17182181,2006-12-19T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17182181,2006-12-19T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17182181,2006-12-19T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17182181,2006-12-19T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17182181,2006-12-19T00:00:00,Memory Disorders,C10.597.606.525
17182181,2006-12-19T00:00:00,Memory Disorders,C23.888.592.604.529
17182181,2006-12-19T00:00:00,Memory Disorders,F01.700.625
17182181,2006-12-19T00:00:00,Nerve Growth Factor,D12.644.276.860.437
17182181,2006-12-19T00:00:00,Nerve Growth Factor,D12.776.467.860.437
17182181,2006-12-19T00:00:00,Nerve Growth Factor,D12.776.641.600.437
17182181,2006-12-19T00:00:00,Nerve Growth Factor,D23.529.850.437
17182181,2006-12-19T00:00:00,Neural Pathways,A08.612
17182181,2006-12-19T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
17182181,2006-12-19T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
17182181,2006-12-19T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
17182181,2006-12-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17184739,2006-12-19T00:00:00,Animals,B01.050
17184739,2006-12-19T00:00:00,Astrocytes,A08.637.200
17184739,2006-12-19T00:00:00,Astrocytes,A11.650.200
17184739,2006-12-19T00:00:00,Cell Movement,G04.299.283
17184739,2006-12-19T00:00:00,Cell Movement,G07.700.560.500.180
17184739,2006-12-19T00:00:00,Cell Survival,G04.299.316
17184739,2006-12-19T00:00:00,Dopamine,D02.092.211.215.311.342
17184739,2006-12-19T00:00:00,Dopamine,D02.092.311.342
17184739,2006-12-19T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
17184739,2006-12-19T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
17184739,2006-12-19T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
17184739,2006-12-19T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
17184739,2006-12-19T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
17184739,2006-12-19T00:00:00,Substantia Nigra,A08.186.211.653.822.731
17184739,2006-12-19T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
17184739,2006-12-19T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
17184925,2006-12-19T00:00:00,Animals,B01.050
17184925,2006-12-19T00:00:00,Cholinesterase Inhibitors,D27.505.519.389.275
17184925,2006-12-19T00:00:00,Cholinesterase Inhibitors,D27.505.519.625.120.300
17184925,2006-12-19T00:00:00,Cholinesterase Inhibitors,D27.505.696.577.120.300
17184925,2006-12-19T00:00:00,Cues,F02.463.425.234
17184925,2006-12-19T00:00:00,Learning,F02.463.425
17184925,2006-12-19T00:00:00,Learning,F02.784.629.529
17184925,2006-12-19T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
17184925,2006-12-19T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
17184925,2006-12-19T00:00:00,Narcotics,D27.505.696.277.600
17184925,2006-12-19T00:00:00,Narcotics,D27.505.696.663.850.014.760
17184925,2006-12-19T00:00:00,Narcotics,D27.505.954.427.040.550
17184925,2006-12-19T00:00:00,Narcotics,D27.505.954.427.210.600
17184925,2006-12-19T00:00:00,Neural Pathways,A08.612
17184925,2006-12-19T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17184925,2006-12-19T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17184925,2006-12-19T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17184925,2006-12-19T00:00:00,Reinforcement (Psychology),F02.463.425.770
17184925,2006-12-19T00:00:00,Self Administration,E02.319.890
17184925,2006-12-19T00:00:00,Self Administration,E02.900.890
17184925,2006-12-19T00:00:00,Synaptic Transmission,G02.111.087.800.850
17184925,2006-12-19T00:00:00,Synaptic Transmission,G02.149.115.800.850
17184925,2006-12-19T00:00:00,Synaptic Transmission,G04.299.880.850
17184925,2006-12-19T00:00:00,Synaptic Transmission,G07.265.337.900
17184925,2006-12-19T00:00:00,Synaptic Transmission,G07.700.240.900
17184925,2006-12-19T00:00:00,Synaptic Transmission,G11.561.600.835
17184925,2006-12-19T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
17184925,2006-12-19T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
17179460,2006-12-20T00:00:00,Adolescent,M01.060.057
17179460,2006-12-20T00:00:00,Adult,M01.060.116
17179460,2006-12-20T00:00:00,African Continental Ancestry Group,M01.686.508.100
17179460,2006-12-20T00:00:00,Case-Control Studies,E05.318.760.500.500
17179460,2006-12-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17179460,2006-12-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17179460,2006-12-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
17179460,2006-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17179460,2006-12-20T00:00:00,Middle Aged,M01.060.116.630
17179460,2006-12-20T00:00:00,Multiple Sclerosis,C10.114.375.500
17179460,2006-12-20T00:00:00,Multiple Sclerosis,C10.314.350.500
17179460,2006-12-20T00:00:00,Multiple Sclerosis,C20.111.258.250.500
17179460,2006-12-20T00:00:00,Vitamin D,D04.808.812.768
17182976,2006-12-20T00:00:00,Aged,M01.060.116.100
17182976,2006-12-20T00:00:00,Blood Glucose,D09.546.359.448.500
17182976,2006-12-20T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
17182976,2006-12-20T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
17182976,2006-12-20T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
17182976,2006-12-20T00:00:00,Cholesterol,D04.808.247.222.284
17182976,2006-12-20T00:00:00,Cholesterol,D04.808.247.808.197
17182976,2006-12-20T00:00:00,Cholesterol,D10.570.938.208
17182976,2006-12-20T00:00:00,Cholesterol,D10.851.208
17182976,2006-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17182976,2006-12-20T00:00:00,Middle Aged,M01.060.116.630
17182976,2006-12-20T00:00:00,Risk Factors,E05.318.740.600.800.725
17182976,2006-12-20T00:00:00,Risk Factors,N05.715.350.200.700
17182976,2006-12-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17182976,2006-12-20T00:00:00,Risk Factors,N06.850.490.625.750
17182976,2006-12-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17182976,2006-12-20T00:00:00,Sex Factors,N05.715.350.675
17182976,2006-12-20T00:00:00,Sex Factors,N06.850.490.875
17182976,2006-12-20T00:00:00,Smoking,F01.145.466.753
17182976,2006-12-20T00:00:00,Stroke,C10.228.140.300.775
17182976,2006-12-20T00:00:00,Stroke,C14.907.253.855
17182976,2006-12-20T00:00:00,Thrombolytic Therapy,E02.319.913
17187080,2006-12-21T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
17187080,2006-12-21T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
17187080,2006-12-21T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
17187080,2006-12-21T00:00:00,Cell Division,G04.299.134.220
17187080,2006-12-21T00:00:00,Cell Division,G04.299.233.750.500
17187080,2006-12-21T00:00:00,Cell Division,G05.355.105
17187080,2006-12-21T00:00:00,Cell Division,G07.700.320.249.410.750.500
17187080,2006-12-21T00:00:00,Gene Transfer Techniques,E05.393.350
17187080,2006-12-21T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17187080,2006-12-21T00:00:00,Genetic Predisposition to Disease,G05.380.355
17187080,2006-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17187080,2006-12-21T00:00:00,Mutation,G05.365.590
17187080,2006-12-21T00:00:00,Osteitis Deformans,C05.116.692
17187080,2006-12-21T00:00:00,Osteoclasts,A11.329.372.700
17187080,2006-12-21T00:00:00,Osteoclasts,A11.627.482.700
17187080,2006-12-21T00:00:00,Proteins,D12.776
17187080,2006-12-21T00:00:00,RANK Ligand,D12.644.276.374.750.562
17187080,2006-12-21T00:00:00,RANK Ligand,D12.644.276.972.562
17187080,2006-12-21T00:00:00,RANK Ligand,D12.776.467.374.750.562
17187080,2006-12-21T00:00:00,RANK Ligand,D12.776.467.972.562
17187080,2006-12-21T00:00:00,RANK Ligand,D23.529.374.750.562
17187080,2006-12-21T00:00:00,RANK Ligand,D23.529.972.562
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17187080,2006-12-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17187776,2006-12-21T00:00:00,Adult,M01.060.116
17187776,2006-12-21T00:00:00,Age Factors,N05.715.350.075
17187776,2006-12-21T00:00:00,Age Factors,N06.850.490.250
17187776,2006-12-21T00:00:00,Body Mass Index,E01.370.600.115.100.125
17187776,2006-12-21T00:00:00,Body Mass Index,E05.041.124.125
17187776,2006-12-21T00:00:00,Body Mass Index,G07.100.100.125
17187776,2006-12-21T00:00:00,Body Mass Index,N06.850.505.200.100.175
17187776,2006-12-21T00:00:00,Diabetes Mellitus,C18.452.394.750
17187776,2006-12-21T00:00:00,Diabetes Mellitus,C19.246
17187776,2006-12-21T00:00:00,Environmental Exposure,N06.850.460.350
17187776,2006-12-21T00:00:00,Environmental Pollutants,D27.888.284
17187776,2006-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17187776,2006-12-21T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
17187776,2006-12-21T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
17187776,2006-12-21T00:00:00,United States,Z01.107.567.875
17189282,2006-12-21T00:00:00,Albumins,D12.776.034
17189282,2006-12-21T00:00:00,Albuminuria,C12.777.934.734.269
17189282,2006-12-21T00:00:00,Albuminuria,C13.351.968.934.734.269
17189282,2006-12-21T00:00:00,Albuminuria,C23.888.942.750.269
17189282,2006-12-21T00:00:00,Creatinine,D03.383.129.308.207
17189282,2006-12-21T00:00:00,Disease Progression,C23.550.291.656
17189282,2006-12-21T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17189282,2006-12-21T00:00:00,Genetic Predisposition to Disease,G05.380.355
17189282,2006-12-21T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
17189282,2006-12-21T00:00:00,Glomerular Filtration Rate,G08.852.357
17189282,2006-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17189282,2006-12-21T00:00:00,Middle Aged,M01.060.116.630
17189282,2006-12-21T00:00:00,Phenotype,G05.695
17293184,2006-12-21T00:00:00,Aged,M01.060.116.100
17293184,2006-12-21T00:00:00,Diastole,G09.330.190.541.295
17293184,2006-12-21T00:00:00,Diastole,G11.427.590.540.554.250
17293184,2006-12-21T00:00:00,Diastole,G11.427.590.540.570.295
17293184,2006-12-21T00:00:00,Heart Failure,C14.280.434
17293184,2006-12-21T00:00:00,Hospitalization,E02.760.400
17293184,2006-12-21T00:00:00,Hospitalization,N02.421.585.400
17293184,2006-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17293184,2006-12-21T00:00:00,Incidence,E05.318.308.985.525.375
17293184,2006-12-21T00:00:00,Incidence,L01.280.975.525.375
17293184,2006-12-21T00:00:00,Incidence,N01.224.935.597.500
17293184,2006-12-21T00:00:00,Incidence,N06.850.505.400.975.525.375
17293184,2006-12-21T00:00:00,Incidence,N06.850.520.308.985.525.375
17293184,2006-12-21T00:00:00,Middle Aged,M01.060.116.630
17186014,2006-12-22T00:00:00,Adenoviridae,B04.280.030
17186014,2006-12-22T00:00:00,Adenoviridae,B04.909.204.097
17186014,2006-12-22T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
17186014,2006-12-22T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
17186014,2006-12-22T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
17186014,2006-12-22T00:00:00,Antineoplastic Agents,D27.505.954.248
17186014,2006-12-22T00:00:00,Apoptosis,G04.299.139.160
17186014,2006-12-22T00:00:00,Caspases,D08.811.277.656.262.500.126
17186014,2006-12-22T00:00:00,Caspases,D08.811.277.656.300.200.126
17186014,2006-12-22T00:00:00,Caspases,D12.644.360.075.405
17186014,2006-12-22T00:00:00,Caspases,D12.776.476.075.405
17186014,2006-12-22T00:00:00,Cisplatin,D01.210.375
17186014,2006-12-22T00:00:00,Cisplatin,D01.625.125
17186014,2006-12-22T00:00:00,Cisplatin,D01.710.100
17186014,2006-12-22T00:00:00,Combined Modality Therapy,E02.186
17186014,2006-12-22T00:00:00,Deoxycytidine,D03.383.742.680.245.500
17186014,2006-12-22T00:00:00,Deoxycytidine,D13.570.230.329
17186014,2006-12-22T00:00:00,Deoxycytidine,D13.570.685.245.500
17186014,2006-12-22T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
17186014,2006-12-22T00:00:00,Doxorubicin,D04.615.562.050.200.175
17186014,2006-12-22T00:00:00,Doxorubicin,D09.408.051.059.200.175
17186014,2006-12-22T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
17186014,2006-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17186014,2006-12-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17186014,2006-12-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
17186014,2006-12-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
17186014,2006-12-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
17186014,2006-12-22T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
17188302,2006-12-22T00:00:00,Curriculum,I02.158
17188302,2006-12-22T00:00:00,"Education, Medical, Graduate",I02.358.337.350
17188302,2006-12-22T00:00:00,"Education, Medical, Graduate",I02.358.399.350
17188302,2006-12-22T00:00:00,"Faculty, Medical",I02.463.373
17188302,2006-12-22T00:00:00,"Faculty, Medical",M01.526.339.373
17188302,2006-12-22T00:00:00,"Faculty, Medical",M01.526.485.375
17188302,2006-12-22T00:00:00,"Faculty, Medical",N02.360.375
17188302,2006-12-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17188302,2006-12-22T00:00:00,"Models, Educational",E05.599.545
17188302,2006-12-22T00:00:00,"Models, Educational",I02.903.302
17188302,2006-12-22T00:00:00,Program Development,N04.452.760
17250822,2006-12-23T00:00:00,Animals,B01.050
17250822,2006-12-23T00:00:00,Cell Differentiation,G04.299.151
17250822,2006-12-23T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17250822,2006-12-23T00:00:00,Green Fluorescent Proteins,D12.776.532.265
17250822,2006-12-23T00:00:00,Heart Conduction System,A07.541.409
17250822,2006-12-23T00:00:00,Homeodomain Proteins,D12.776.260.400
17250822,2006-12-23T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17250822,2006-12-23T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17250822,2006-12-23T00:00:00,"Models, Cardiovascular",E05.599.395.161
17250822,2006-12-23T00:00:00,Recombinant Proteins,D12.776.828
17250822,2006-12-23T00:00:00,Transcription Factors,D12.776.930
17190860,2006-12-26T00:00:00,Animals,B01.050
17190860,2006-12-26T00:00:00,Embryonic Development,G07.700.320.500.325.180
17190860,2006-12-26T00:00:00,Embryonic Development,G08.686.785.760.170.104
17190860,2006-12-26T00:00:00,Heart Conduction System,A07.541.409
17190860,2006-12-26T00:00:00,Morphogenesis,G07.700.320.500
17191136,2006-12-27T00:00:00,Animals,B01.050
17191136,2006-12-27T00:00:00,Central Nervous System,A08.186
17191136,2006-12-27T00:00:00,Down-Regulation,G02.111.087.225
17191136,2006-12-27T00:00:00,Down-Regulation,G02.149.115.225
17191136,2006-12-27T00:00:00,Down-Regulation,G05.355.315.200
17191136,2006-12-27T00:00:00,Down-Regulation,G07.690.812.230
17191136,2006-12-27T00:00:00,Down-Regulation,G07.700.680.230
17191136,2006-12-27T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
17191136,2006-12-27T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17191136,2006-12-27T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17191136,2006-12-27T00:00:00,Nerve Tissue Proteins,D12.776.641
17191136,2006-12-27T00:00:00,Oligodendroglia,A08.637.600
17191136,2006-12-27T00:00:00,Oligodendroglia,A11.650.600
17191136,2006-12-27T00:00:00,Schwann Cells,A08.637.800
17191136,2006-12-27T00:00:00,Schwann Cells,A08.800.800.690
17191136,2006-12-27T00:00:00,Schwann Cells,A11.650.800
17191136,2006-12-27T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
17196272,2006-12-28T00:00:00,Animals,B01.050
17196272,2006-12-28T00:00:00,Apoptosis,G04.299.139.160
17196272,2006-12-28T00:00:00,Bradykinin,D12.644.276.812.169
17196272,2006-12-28T00:00:00,Bradykinin,D12.644.400.090
17196272,2006-12-28T00:00:00,Bradykinin,D12.644.456.193
17196272,2006-12-28T00:00:00,Bradykinin,D12.776.467.812.169
17196272,2006-12-28T00:00:00,Bradykinin,D12.776.641.650.090
17196272,2006-12-28T00:00:00,Bradykinin,D23.469.050.375.110
17196272,2006-12-28T00:00:00,Bradykinin,D23.529.812.169
17196272,2006-12-28T00:00:00,Gene Expression Regulation,G05.355.315
17196272,2006-12-28T00:00:00,Inflammation,C23.550.470
17196272,2006-12-28T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
17196272,2006-12-28T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
17196272,2006-12-28T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
17196272,2006-12-28T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
17196272,2006-12-28T00:00:00,Myocardial Infarction,C14.280.647.500
17196272,2006-12-28T00:00:00,Myocardial Infarction,C14.907.585.500
17196272,2006-12-28T00:00:00,"Myocytes, Cardiac",A07.541.704.570
17196272,2006-12-28T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
17196272,2006-12-28T00:00:00,"Myocytes, Cardiac",A11.620.500
17196272,2006-12-28T00:00:00,NF-kappa B,D12.776.260.600
17196272,2006-12-28T00:00:00,NF-kappa B,D12.776.660.600
17196272,2006-12-28T00:00:00,NF-kappa B,D12.776.930.600
17196272,2006-12-28T00:00:00,Oxidative Stress,G03.495.710
17196272,2006-12-28T00:00:00,Oxidative Stress,G07.700.830.750
17196272,2006-12-28T00:00:00,Polymerase Chain Reaction,E05.393.620.500
17196272,2006-12-28T00:00:00,Protein Transport,G03.495.166.700
17196272,2006-12-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17196272,2006-12-28T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
17196272,2006-12-28T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
17196272,2006-12-28T00:00:00,Tissue Kallikreins,D23.101.840.870
17196272,2006-12-28T00:00:00,Ventricular Remodeling,C23.300.985
17196272,2006-12-28T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17196831,2006-12-28T00:00:00,Adult,M01.060.116
17196831,2006-12-28T00:00:00,Brain Mapping,E01.370.350.086
17196831,2006-12-28T00:00:00,Brain Mapping,E01.370.376.149
17196831,2006-12-28T00:00:00,Brain Mapping,E05.132
17196831,2006-12-28T00:00:00,Cues,F02.463.425.234
17196831,2006-12-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17196831,2006-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17196831,2006-12-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17196831,2006-12-28T00:00:00,"Models, Statistical",E05.318.740.500
17196831,2006-12-28T00:00:00,"Models, Statistical",E05.599.835
17196831,2006-12-28T00:00:00,"Models, Statistical",N05.715.360.750.530
17196831,2006-12-28T00:00:00,"Models, Statistical",N06.850.520.830.500
17196831,2006-12-28T00:00:00,Respiration,G09.772.770.755
17258706,2006-12-28T00:00:00,Age Factors,N05.715.350.075
17258706,2006-12-28T00:00:00,Age Factors,N06.850.490.250
17258706,2006-12-28T00:00:00,Animals,B01.050
17258706,2006-12-28T00:00:00,Apoptosis,G04.299.139.160
17258706,2006-12-28T00:00:00,Cell Proliferation,G04.299.233.750
17258706,2006-12-28T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17258706,2006-12-28T00:00:00,Fatty Acids,D10.251
17258706,2006-12-28T00:00:00,Glutathione Transferase,D08.811.913.225.500
17258706,2006-12-28T00:00:00,Hepatocytes,A11.436.348
17258706,2006-12-28T00:00:00,Liver,A03.620
17258706,2006-12-28T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
17258706,2006-12-28T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
17258706,2006-12-28T00:00:00,Oxidative Stress,G03.495.710
17258706,2006-12-28T00:00:00,Oxidative Stress,G07.700.830.750
17258706,2006-12-28T00:00:00,Phospholipids,D10.570.755
17258706,2006-12-28T00:00:00,Phospholipids,D10.695
17258706,2006-12-28T00:00:00,Reactive Oxygen Species,D01.339.431
17258706,2006-12-28T00:00:00,Reactive Oxygen Species,D01.650.775
17275791,2006-12-29T00:00:00,Alcohol Drinking,F01.145.317.269
17275791,2006-12-29T00:00:00,Animals,B01.050
17275791,2006-12-29T00:00:00,Ethanol,D02.033.375
17275791,2006-12-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
17275791,2006-12-29T00:00:00,Self Administration,E02.319.890
17275791,2006-12-29T00:00:00,Self Administration,E02.900.890
17289363,2006-12-29T00:00:00,Actins,D05.750.078.730.250
17289363,2006-12-29T00:00:00,Actins,D12.776.210.500.100
17289363,2006-12-29T00:00:00,Actins,D12.776.220.525.255
17289363,2006-12-29T00:00:00,Animals,B01.050
17289363,2006-12-29T00:00:00,"Cartilage, Articular",A02.165.407.150
17289363,2006-12-29T00:00:00,"Cartilage, Articular",A02.835.583.192
17289363,2006-12-29T00:00:00,Cell Proliferation,G04.299.233.750
17289363,2006-12-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
17289363,2006-12-29T00:00:00,Chondrocytes,A11.329.171
17289363,2006-12-29T00:00:00,Cilia,A11.284.180.165
17289363,2006-12-29T00:00:00,Extracellular Matrix,A11.284.295.310
17289363,2006-12-29T00:00:00,Gene Expression Regulation,G05.355.315
17289363,2006-12-29T00:00:00,Growth Plate,A02.835.232.251.352
17289363,2006-12-29T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17289363,2006-12-29T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17289363,2006-12-29T00:00:00,Tubulin,D05.750.078.734.800
17289363,2006-12-29T00:00:00,Tubulin,D12.776.220.600.800
17289363,2006-12-29T00:00:00,Tubulin,D12.776.641.920
17289363,2006-12-29T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
16892418,2007-01-01T00:00:00,Activities of Daily Living,E02.831.067
16892418,2007-01-01T00:00:00,Activities of Daily Living,I03.050
16892418,2007-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
16892418,2007-01-01T00:00:00,Adult,M01.060.116
16892418,2007-01-01T00:00:00,Bipolar Disorder,F03.600.150.150
16892418,2007-01-01T00:00:00,Community Mental Health Services,F04.408.307
16892418,2007-01-01T00:00:00,Community Mental Health Services,N02.421.143.183
16892418,2007-01-01T00:00:00,Community Mental Health Services,N02.421.461.232
16892418,2007-01-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
16892418,2007-01-01T00:00:00,"Diagnosis, Differential",E01.171
16892418,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
16892418,2007-01-01T00:00:00,Mass Screening,E01.370.500
16892418,2007-01-01T00:00:00,Mass Screening,E05.318.308.250.580
16892418,2007-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
16892418,2007-01-01T00:00:00,Mass Screening,N02.421.726.233.443
16892418,2007-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
16892418,2007-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
16892418,2007-01-01T00:00:00,Mass Screening,N06.850.780.500
16892418,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
16892418,2007-01-01T00:00:00,Personality Inventory,F04.711.647.513
16892418,2007-01-01T00:00:00,Psychometrics,F04.711.780
16892418,2007-01-01T00:00:00,Psychotic Disorders,F03.700.675
16892418,2007-01-01T00:00:00,Referral and Consultation,N04.452.758.849
16892418,2007-01-01T00:00:00,"Rehabilitation, Vocational",E02.831.782
16892418,2007-01-01T00:00:00,"Rehabilitation, Vocational",N02.421.784.644
16892418,2007-01-01T00:00:00,Schizophrenia,F03.700.750
16892418,2007-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17019693,2007-01-01T00:00:00,Animals,B01.050
17019693,2007-01-01T00:00:00,Blood-Brain Barrier,A07.035
17019693,2007-01-01T00:00:00,Blood-Brain Barrier,A08.186.211.035
17019693,2007-01-01T00:00:00,Cell Adhesion,G04.299.117
17019693,2007-01-01T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
17019693,2007-01-01T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
17019693,2007-01-01T00:00:00,Cell Adhesion Molecules,D23.050.301.350
17019693,2007-01-01T00:00:00,Cell Line,A11.251.210
17019693,2007-01-01T00:00:00,Central Nervous System,A08.186
17019693,2007-01-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
17019693,2007-01-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
17019693,2007-01-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
17019693,2007-01-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
17019693,2007-01-01T00:00:00,Endothelial Cells,A11.436.275
17019693,2007-01-01T00:00:00,Monocytes,A11.118.637.555.652
17019693,2007-01-01T00:00:00,Monocytes,A11.148.580
17019693,2007-01-01T00:00:00,Monocytes,A11.627.624
17019693,2007-01-01T00:00:00,Monocytes,A11.733.547
17019693,2007-01-01T00:00:00,Monocytes,A15.145.229.637.555.652
17019693,2007-01-01T00:00:00,Monocytes,A15.378.316.580
17019693,2007-01-01T00:00:00,Monocytes,A15.382.490.555.652
17019693,2007-01-01T00:00:00,Monocytes,A15.382.680.547
17019693,2007-01-01T00:00:00,Monocytes,A15.382.812.547
17019693,2007-01-01T00:00:00,NF-kappa B,D12.776.260.600
17019693,2007-01-01T00:00:00,NF-kappa B,D12.776.660.600
17019693,2007-01-01T00:00:00,NF-kappa B,D12.776.930.600
17019693,2007-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17019693,2007-01-01T00:00:00,S-Nitrosoglutathione,D02.654.846.500.249
17019693,2007-01-01T00:00:00,S-Nitrosoglutathione,D02.886.489.650.750
17019693,2007-01-01T00:00:00,S-Nitrosoglutathione,D12.644.456.448.750
17019693,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17019693,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17019693,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17019693,2007-01-01T00:00:00,Transcription Factor RelA,D12.776.260.600.249
17019693,2007-01-01T00:00:00,Transcription Factor RelA,D12.776.660.600.249
17019693,2007-01-01T00:00:00,Transcription Factor RelA,D12.776.930.600.249
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17019693,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17022087,2007-01-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
17022087,2007-01-01T00:00:00,Aged,M01.060.116.100
17022087,2007-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17022087,2007-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17022087,2007-01-01T00:00:00,Deglutition Disorders,C06.405.117.119
17022087,2007-01-01T00:00:00,Deglutition Disorders,C09.775.174
17022087,2007-01-01T00:00:00,Dilatation,E05.284
17022087,2007-01-01T00:00:00,Esophageal Stenosis,C06.405.117.544
17022087,2007-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17022087,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17022087,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17022087,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17022087,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17022087,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17041913,2007-01-01T00:00:00,Animals,B01.050
17041913,2007-01-01T00:00:00,Biocompatible Materials,D25.130
17041913,2007-01-01T00:00:00,Biocompatible Materials,D27.720.102.130
17041913,2007-01-01T00:00:00,Biocompatible Materials,J01.637.051.130
17041913,2007-01-01T00:00:00,Bioprosthesis,E07.695.100
17041913,2007-01-01T00:00:00,Cattle,B01.050.150.900.649.077.380.271
17041913,2007-01-01T00:00:00,Heart Valve Prosthesis,E07.695.310
17041913,2007-01-01T00:00:00,Materials Testing,E05.570
17041913,2007-01-01T00:00:00,Pericardium,A07.541.795
17041913,2007-01-01T00:00:00,Pericardium,A10.615.789.470
17041913,2007-01-01T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
17041913,2007-01-01T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
17127261,2007-01-01T00:00:00,Animals,B01.050
17127261,2007-01-01T00:00:00,Atherosclerosis,C14.907.137.126.307
17127261,2007-01-01T00:00:00,Factor XIII,D12.776.124.125.475
17127261,2007-01-01T00:00:00,Factor XIII,D23.119.475
17127261,2007-01-01T00:00:00,Heart Diseases,C14.280
17127261,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17127261,2007-01-01T00:00:00,Inflammation,C23.550.470
17127261,2007-01-01T00:00:00,Myocardium,A02.633.580
17127261,2007-01-01T00:00:00,Myocardium,A07.541.704
17127261,2007-01-01T00:00:00,Myocardium,A10.690.552.750
17127261,2007-01-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
17127261,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17127261,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17127261,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17127261,2007-01-01T00:00:00,Transglutaminases,D08.811.913.050.200.800
17135060,2007-01-01T00:00:00,Adolescent,M01.060.057
17135060,2007-01-01T00:00:00,Adult,M01.060.116
17135060,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17135060,2007-01-01T00:00:00,Personality Inventory,F04.711.647.513
17135060,2007-01-01T00:00:00,Psychometrics,F04.711.780
17135060,2007-01-01T00:00:00,Sex Factors,N05.715.350.675
17135060,2007-01-01T00:00:00,Sex Factors,N06.850.490.875
17135060,2007-01-01T00:00:00,Somatoform Disorders,F03.875
17135060,2007-01-01T00:00:00,Students,I02.233.748
17135060,2007-01-01T00:00:00,Students,I02.851
17135060,2007-01-01T00:00:00,Students,M01.848
17169868,2007-01-01T00:00:00,Brain Injuries,C10.228.140.199
17169868,2007-01-01T00:00:00,Brain Injuries,C10.900.300.087
17169868,2007-01-01T00:00:00,Brain Injuries,C21.866.260.118
17169868,2007-01-01T00:00:00,Brain Injuries,C21.866.915.300.200
17169868,2007-01-01T00:00:00,Emergency Medical Services,N02.421.297
17169868,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17169868,2007-01-01T00:00:00,United States,Z01.107.567.875
17174169,2007-01-01T00:00:00,Adult,M01.060.116
17174169,2007-01-01T00:00:00,Anti-Infective Agents,D27.505.954.122
17174169,2007-01-01T00:00:00,"Diagnosis, Differential",E01.171
17174169,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17174169,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17174169,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17174169,2007-01-01T00:00:00,Nocardia Infections,C01.252.410.040.692
17174169,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17174169,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17174169,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17174169,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17174169,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17174170,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17174170,2007-01-01T00:00:00,Intensive Care Units,N02.278.388.493
17174170,2007-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17174170,2007-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17174170,2007-01-01T00:00:00,"Radiography, Interventional",E01.370.350.700.725
17174170,2007-01-01T00:00:00,"Radiography, Interventional",E02.148.694
17174170,2007-01-01T00:00:00,"Radiography, Interventional",E04.800.780
17174170,2007-01-01T00:00:00,Sepsis,C01.539.757
17174170,2007-01-01T00:00:00,Sepsis,C23.550.470.790.500
17174170,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17174170,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17174170,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17174170,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17174170,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17174171,2007-01-01T00:00:00,Anti-Infective Agents,D27.505.954.122
17174171,2007-01-01T00:00:00,Diagnostic Imaging,E01.370.350
17174171,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17174171,2007-01-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17174171,2007-01-01T00:00:00,Organ Transplantation,E04.936.450
17174171,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17174171,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17174171,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17174171,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17174171,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17174627,2007-01-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
17174627,2007-01-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
17174627,2007-01-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
17174627,2007-01-01T00:00:00,"Defibrillators, Implantable",E07.695.175
17174627,2007-01-01T00:00:00,Exercise Tolerance,G11.427.680.270
17174627,2007-01-01T00:00:00,Heart Failure,C14.280.434
17174627,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17174627,2007-01-01T00:00:00,Quality of Life,I01.800
17174627,2007-01-01T00:00:00,Quality of Life,K01.752.400.750
17174627,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17174627,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17174627,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17174627,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17174627,2007-01-01T00:00:00,Research Design,E05.581.500
17174627,2007-01-01T00:00:00,Research Design,H01.770.644.728
17175389,2007-01-01T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
17175389,2007-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
17175389,2007-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
17175389,2007-01-01T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
17175389,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17175389,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17175389,2007-01-01T00:00:00,"Translocation, Genetic",C23.550.210.870
17175389,2007-01-01T00:00:00,"Translocation, Genetic",G05.355.600.860
17175389,2007-01-01T00:00:00,"Translocation, Genetic",G05.365.590.175.870
17177581,2007-01-01T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
17177581,2007-01-01T00:00:00,Coronary Disease,C14.280.647.250
17177581,2007-01-01T00:00:00,Coronary Disease,C14.907.585.250
17177581,2007-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
17177581,2007-01-01T00:00:00,HIV Infections,C02.782.815.616.400
17177581,2007-01-01T00:00:00,HIV Infections,C02.800.801.400
17177581,2007-01-01T00:00:00,HIV Infections,C20.673.480
17177581,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
17177581,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
17177581,2007-01-01T00:00:00,HIV-1,B04.820.650.589.650.350.400
17177581,2007-01-01T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
17177581,2007-01-01T00:00:00,Health Care Costs,N03.219.151.400
17177581,2007-01-01T00:00:00,Health Care Costs,N05.300.375
17177581,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17177581,2007-01-01T00:00:00,Markov Chains,E05.318.740.600.500
17177581,2007-01-01T00:00:00,Markov Chains,E05.318.740.996.500
17177581,2007-01-01T00:00:00,Markov Chains,G17.830.500
17177581,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
17177581,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
17177581,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
17177581,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
17177581,2007-01-01T00:00:00,"Models, Statistical",E05.318.740.500
17177581,2007-01-01T00:00:00,"Models, Statistical",E05.599.835
17177581,2007-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17177581,2007-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17177581,2007-01-01T00:00:00,Oligopeptides,D12.644.456
17177581,2007-01-01T00:00:00,Ritonavir,D02.886.675.653
17177581,2007-01-01T00:00:00,Ritonavir,D03.383.129.708.653
17178362,2007-01-01T00:00:00,"Abdomen, Acute",C23.888.646.100.200
17178362,2007-01-01T00:00:00,"Abdomen, Acute",C23.888.821.030.249
17178362,2007-01-01T00:00:00,Adolescent,M01.060.057
17178362,2007-01-01T00:00:00,Adult,M01.060.116
17178362,2007-01-01T00:00:00,Aged,M01.060.116.100
17178362,2007-01-01T00:00:00,Child,M01.060.406
17178362,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17178362,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,G17.800
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17178362,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17178362,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17178362,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17178362,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17178362,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17178362,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17179264,2007-01-01T00:00:00,Adolescent,M01.060.057
17179264,2007-01-01T00:00:00,"Anesthesia, Obstetrical",E03.155.364
17179264,2007-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
17179264,2007-01-01T00:00:00,Blood Pressure,G09.330.380.076
17179264,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17179264,2007-01-01T00:00:00,Hypertension,C14.907.489
17179264,2007-01-01T00:00:00,"Monitoring, Physiologic",E01.370.520
17179264,2007-01-01T00:00:00,Posture,G11.427.695
17179264,2007-01-01T00:00:00,Pregnancy,G08.686.785.760.769
17186443,2007-01-01T00:00:00,Curriculum,I02.158
17186443,2007-01-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
17186443,2007-01-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
17186443,2007-01-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
17186443,2007-01-01T00:00:00,Family Practice,H02.403.280
17186443,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17186443,2007-01-01T00:00:00,Interprofessional Relations,F01.829.401.205
17186443,2007-01-01T00:00:00,Program Development,N04.452.760
17186444,2007-01-01T00:00:00,Clinical Competence,I02.399.630.210
17186444,2007-01-01T00:00:00,Clinical Competence,N04.761.210
17186444,2007-01-01T00:00:00,Curriculum,I02.158
17186444,2007-01-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
17186444,2007-01-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
17186444,2007-01-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
17186444,2007-01-01T00:00:00,Family Practice,H02.403.280
17186444,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17186444,2007-01-01T00:00:00,Interprofessional Relations,F01.829.401.205
17186444,2007-01-01T00:00:00,"Schools, Medical",I02.783.660.552
17186444,2007-01-01T00:00:00,"Schools, Medical",N02.278.020.578
17186444,2007-01-01T00:00:00,"Societies, Medical",N03.540.828.589
17186446,2007-01-01T00:00:00,Clinical Clerkship,I02.358.399.450.110
17186446,2007-01-01T00:00:00,Clinical Competence,I02.399.630.210
17186446,2007-01-01T00:00:00,Clinical Competence,N04.761.210
17186446,2007-01-01T00:00:00,Curriculum,I02.158
17186446,2007-01-01T00:00:00,"Faculty, Medical",I02.463.373
17186446,2007-01-01T00:00:00,"Faculty, Medical",M01.526.339.373
17186446,2007-01-01T00:00:00,"Faculty, Medical",M01.526.485.375
17186446,2007-01-01T00:00:00,"Faculty, Medical",N02.360.375
17186446,2007-01-01T00:00:00,Family Practice,H02.403.280
17186446,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17186446,2007-01-01T00:00:00,"Schools, Medical",I02.783.660.552
17186446,2007-01-01T00:00:00,"Schools, Medical",N02.278.020.578
17186449,2007-01-01T00:00:00,Curriculum,I02.158
17186449,2007-01-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
17186449,2007-01-01T00:00:00,Family Practice,H02.403.280
17186449,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17186449,2007-01-01T00:00:00,Problem-Based Learning,F02.463.425.720
17186449,2007-01-01T00:00:00,Problem-Based Learning,I02.158.660
17186449,2007-01-01T00:00:00,Problem-Based Learning,I02.903.565
17186449,2007-01-01T00:00:00,Program Development,N04.452.760
17187439,2007-01-01T00:00:00,Animals,B01.050
17187439,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17187439,2007-01-01T00:00:00,Liver Cirrhosis,C06.552.630
17187439,2007-01-01T00:00:00,United States,Z01.107.567.875
17187484,2007-01-01T00:00:00,Breast Neoplasms,C04.588.180
17187484,2007-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
17187484,2007-01-01T00:00:00,Cell Division,G04.299.134.220
17187484,2007-01-01T00:00:00,Cell Division,G04.299.233.750.500
17187484,2007-01-01T00:00:00,Cell Division,G05.355.105
17187484,2007-01-01T00:00:00,Cell Division,G07.700.320.249.410.750.500
17187484,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17187484,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
17187484,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
17187484,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
17187484,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
17187484,2007-01-01T00:00:00,Neoplasm Invasiveness,C04.697.645
17187484,2007-01-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
17187484,2007-01-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
17187484,2007-01-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
17187484,2007-01-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
17187484,2007-01-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
17187484,2007-01-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
17187498,2007-01-01T00:00:00,Cognition Disorders,F03.087.250
17187498,2007-01-01T00:00:00,Depression,F01.145.126.350
17187498,2007-01-01T00:00:00,Electric Stimulation Therapy,E02.342
17187498,2007-01-01T00:00:00,Electric Stimulation Therapy,E02.779.468
17187498,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17187498,2007-01-01T00:00:00,Neuropsychology,F04.096.795.600
17187498,2007-01-01T00:00:00,Neuropsychology,H01.158.782.795.110
17188098,2007-01-01T00:00:00,Adult,M01.060.116
17188098,2007-01-01T00:00:00,Critical Care,E02.760.190
17188098,2007-01-01T00:00:00,Critical Care,N02.421.585.190
17188098,2007-01-01T00:00:00,Emergency Medicine,H02.403.250
17188098,2007-01-01T00:00:00,General Surgery,H02.403.810.300
17188098,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17188098,2007-01-01T00:00:00,Internship and Residency,I02.358.399.644
17188098,2007-01-01T00:00:00,"Models, Organizational",E05.599.670
17188098,2007-01-01T00:00:00,"Models, Organizational",N04.452.534
17188098,2007-01-01T00:00:00,Patient Simulation,I02.903.525
17188098,2007-01-01T00:00:00,Program Evaluation,E05.337.820
17188098,2007-01-01T00:00:00,Program Evaluation,N04.761.685
17188098,2007-01-01T00:00:00,Program Evaluation,N05.715.360.650
17188098,2007-01-01T00:00:00,Task Performance and Analysis,F02.784.412.846
17188098,2007-01-01T00:00:00,Task Performance and Analysis,F02.784.692.746
17188098,2007-01-01T00:00:00,Task Performance and Analysis,F02.808.600
17188098,2007-01-01T00:00:00,United States,Z01.107.567.875
17190529,2007-01-01T00:00:00,Bipolar Disorder,F03.600.150.150
17190529,2007-01-01T00:00:00,Carbamazepine,D03.494.240.127
17190529,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17190529,2007-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17190529,2007-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17192325,2007-01-01T00:00:00,Adult,M01.060.116
17192325,2007-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
17192325,2007-01-01T00:00:00,Blood Pressure,G09.330.380.076
17192325,2007-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
17192325,2007-01-01T00:00:00,Body Mass Index,E05.041.124.125
17192325,2007-01-01T00:00:00,Body Mass Index,G07.100.100.125
17192325,2007-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
17192325,2007-01-01T00:00:00,Cardiovascular Diseases,C14
17192325,2007-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17192325,2007-01-01T00:00:00,Diabetes Mellitus,C19.246
17192325,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17192325,2007-01-01T00:00:00,Incidence,E05.318.308.985.525.375
17192325,2007-01-01T00:00:00,Incidence,L01.280.975.525.375
17192325,2007-01-01T00:00:00,Incidence,N01.224.935.597.500
17192325,2007-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17192325,2007-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17192325,2007-01-01T00:00:00,Lipids,D10
17192325,2007-01-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
17192325,2007-01-01T00:00:00,Metabolic Syndrome X,C18.452.625
17192325,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17192325,2007-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
17192325,2007-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17192325,2007-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17192325,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
17192325,2007-01-01T00:00:00,Questionnaires,L01.280.800
17192325,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
17192325,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
17192325,2007-01-01T00:00:00,"Societies, Medical",N03.540.828.589
17192475,2007-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
17192475,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17192475,2007-01-01T00:00:00,Insulin,D06.472.699.587.740.625
17192475,2007-01-01T00:00:00,Insulin,D12.644.548.586.740.625
17192475,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17192475,2007-01-01T00:00:00,Phenotype,G05.695
17192475,2007-01-01T00:00:00,Sex Characteristics,G08.686.815
17192475,2007-01-01T00:00:00,Smoking,F01.145.466.753
17197479,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17197479,2007-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17197479,2007-01-01T00:00:00,Lung Neoplasms,C08.381.540
17197479,2007-01-01T00:00:00,Lung Neoplasms,C08.785.520
17197479,2007-01-01T00:00:00,Mass Screening,E01.370.500
17197479,2007-01-01T00:00:00,Mass Screening,E05.318.308.250.580
17197479,2007-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
17197479,2007-01-01T00:00:00,Mass Screening,N02.421.726.233.443
17197479,2007-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
17197479,2007-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
17197479,2007-01-01T00:00:00,Mass Screening,N06.850.780.500
17197479,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17197479,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17197479,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17197479,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17197479,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17197479,2007-01-01T00:00:00,Smoking,F01.145.466.753
17198082,2007-01-01T00:00:00,Animals,B01.050
17198082,2007-01-01T00:00:00,Apoptosis,G04.299.139.160
17198082,2007-01-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
17198082,2007-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
17198082,2007-01-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
17198082,2007-01-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
17198082,2007-01-01T00:00:00,Cyclophosphamide,D02.705.670.243
17198082,2007-01-01T00:00:00,Dendritic Cells,A11.066.270
17198082,2007-01-01T00:00:00,Dendritic Cells,A11.436.270
17198082,2007-01-01T00:00:00,Dendritic Cells,A15.382.066.270
17198082,2007-01-01T00:00:00,Dendritic Cells,A15.382.812.260
17198082,2007-01-01T00:00:00,"Epitopes, T-Lymphocyte",D23.050.550.402
17198082,2007-01-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
17198082,2007-01-01T00:00:00,"Immunotherapy, Adoptive",E02.095.465.425.400.330.050.400
17198082,2007-01-01T00:00:00,"Immunotherapy, Adoptive",E05.478.550.520.050.400
17198082,2007-01-01T00:00:00,Interferon Type I,D12.644.276.374.440.890
17198082,2007-01-01T00:00:00,Interferon Type I,D12.644.276.718.500
17198082,2007-01-01T00:00:00,Interferon Type I,D12.776.467.374.440.890
17198082,2007-01-01T00:00:00,Interferon Type I,D12.776.467.718.500
17198082,2007-01-01T00:00:00,Interferon Type I,D23.529.374.440.890
17198082,2007-01-01T00:00:00,Interferon Type I,D23.529.718.500
17198082,2007-01-01T00:00:00,Interleukin-6,D12.644.276.374.465.506
17198082,2007-01-01T00:00:00,Interleukin-6,D12.776.467.374.465.506
17198082,2007-01-01T00:00:00,Interleukin-6,D23.529.374.465.506
17198082,2007-01-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
17198082,2007-01-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
17198082,2007-01-01T00:00:00,Myeloid Cells,A11.627
17198082,2007-01-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
17198082,2007-01-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
17198082,2007-01-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
17198092,2007-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
17198092,2007-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
17198092,2007-01-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
17198092,2007-01-01T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
17198092,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17198092,2007-01-01T00:00:00,Interleukin-2,D12.644.276.374.465.502
17198092,2007-01-01T00:00:00,Interleukin-2,D12.644.276.374.480.372
17198092,2007-01-01T00:00:00,Interleukin-2,D12.776.467.374.465.502
17198092,2007-01-01T00:00:00,Interleukin-2,D12.776.467.374.480.372
17198092,2007-01-01T00:00:00,Interleukin-2,D23.529.374.465.502
17198092,2007-01-01T00:00:00,Interleukin-2,D23.529.374.480.372
17198092,2007-01-01T00:00:00,Intestinal Perforation,C06.405.469.557
17198092,2007-01-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
17198092,2007-01-01T00:00:00,Kidney Neoplasms,C12.758.820.750
17198092,2007-01-01T00:00:00,Kidney Neoplasms,C12.777.419.473
17198092,2007-01-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
17198092,2007-01-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
17198092,2007-01-01T00:00:00,Melanoma,C04.557.465.625.650.510
17198092,2007-01-01T00:00:00,Melanoma,C04.557.580.625.650.510
17198092,2007-01-01T00:00:00,Melanoma,C04.557.665.510
17207674,2007-01-01T00:00:00,"Adaptation, Physiological",G07.700.062
17207674,2007-01-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
17207674,2007-01-01T00:00:00,Aged,M01.060.116.100
17207674,2007-01-01T00:00:00,Body Weight,C23.888.144
17207674,2007-01-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
17207674,2007-01-01T00:00:00,Body Weight,E05.041.124.160.750
17207674,2007-01-01T00:00:00,Body Weight,G07.100.100.160.120
17207674,2007-01-01T00:00:00,Body Weight,G07.700.320.249.314.120
17207674,2007-01-01T00:00:00,Canes,E07.858.442.250
17207674,2007-01-01T00:00:00,Chronic Disease,C23.550.291.500
17207674,2007-01-01T00:00:00,Exercise Test,E01.370.370.380.250
17207674,2007-01-01T00:00:00,Exercise Test,E01.370.386.700.250
17207674,2007-01-01T00:00:00,Exercise Test,E05.333.250
17207674,2007-01-01T00:00:00,Gait,E01.370.600.250
17207674,2007-01-01T00:00:00,Gait,G11.427.590.530.389
17207674,2007-01-01T00:00:00,Hemiplegia,C10.597.622.295
17207674,2007-01-01T00:00:00,Hemiplegia,C23.888.592.636.312
17207674,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17207674,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17207674,2007-01-01T00:00:00,Recovery of Function,G16.757
17207674,2007-01-01T00:00:00,Walking,G11.427.590.530.568.900
17207674,2007-01-01T00:00:00,Walking,G11.427.590.530.698.940
17207674,2007-01-01T00:00:00,Walking,I03.450.642.845.940
17209113,2007-01-01T00:00:00,Adult,M01.060.116
17209113,2007-01-01T00:00:00,Aged,M01.060.116.100
17209113,2007-01-01T00:00:00,Culture,I01.076.201.450
17209113,2007-01-01T00:00:00,Culture,I01.880.143
17209113,2007-01-01T00:00:00,Decision Making,F02.463.785.373
17209113,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17209113,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17209113,2007-01-01T00:00:00,Physicians,M01.526.485.810
17209113,2007-01-01T00:00:00,Physicians,N02.360.810
17209113,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
17209113,2007-01-01T00:00:00,Questionnaires,L01.280.800
17209113,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
17209113,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
17209207,2007-01-01T00:00:00,Chronic Disease,C23.550.291.500
17209207,2007-01-01T00:00:00,Dietary Supplements,J02.500.456
17209207,2007-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
17209207,2007-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17209207,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17209207,2007-01-01T00:00:00,Minerals,D01.578
17209207,2007-01-01T00:00:00,Primary Prevention,N02.421.726.758
17209207,2007-01-01T00:00:00,Primary Prevention,N06.850.780.680
17209207,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17209207,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17209207,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17209207,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17209207,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17209207,2007-01-01T00:00:00,United States,Z01.107.567.875
17212848,2007-01-01T00:00:00,Adult,M01.060.116
17212848,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
17212848,2007-01-01T00:00:00,African Americans,M01.686.754.100
17212848,2007-01-01T00:00:00,Aged,M01.060.116.100
17212848,2007-01-01T00:00:00,Diet,E05.272
17212848,2007-01-01T00:00:00,Diet,G07.610.240
17212848,2007-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17212848,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17212848,2007-01-01T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
17212848,2007-01-01T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
17212848,2007-01-01T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
17212848,2007-01-01T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
17212848,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17212848,2007-01-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
17212848,2007-01-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
17212848,2007-01-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
17212848,2007-01-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
17212848,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
17212848,2007-01-01T00:00:00,Questionnaires,L01.280.800
17212848,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
17212848,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
17212993,2007-01-01T00:00:00,Adult,M01.060.116
17212993,2007-01-01T00:00:00,Color Vision Defects,C10.597.751.941.256
17212993,2007-01-01T00:00:00,Color Vision Defects,C11.966.256
17212993,2007-01-01T00:00:00,Color Vision Defects,C23.888.592.763.941.256
17212993,2007-01-01T00:00:00,"Diagnosis, Differential",E01.171
17212993,2007-01-01T00:00:00,Endoscopy,E01.370.388.250
17212993,2007-01-01T00:00:00,Endoscopy,E04.800.250
17212993,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17212993,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17212993,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17212993,2007-01-01T00:00:00,Mucocele,C04.182.511
17212993,2007-01-01T00:00:00,Ophthalmologic Surgical Procedures,E04.540
17212993,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17212993,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17212993,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17212993,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17212993,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17214672,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
17214672,2007-01-01T00:00:00,African Americans,M01.686.754.100
17214672,2007-01-01T00:00:00,Aged,M01.060.116.100
17214672,2007-01-01T00:00:00,Foot Diseases,C05.360
17214672,2007-01-01T00:00:00,Foot Diseases,C17.800.321
17214672,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17214672,2007-01-01T00:00:00,Melanoma,C04.557.465.625.650.510
17214672,2007-01-01T00:00:00,Melanoma,C04.557.580.625.650.510
17214672,2007-01-01T00:00:00,Melanoma,C04.557.665.510
17214672,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17214672,2007-01-01T00:00:00,Mohs Surgery,E04.494.575
17214672,2007-01-01T00:00:00,Skin Neoplasms,C04.588.805
17214672,2007-01-01T00:00:00,Skin Neoplasms,C17.800.882
17214672,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17214672,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17214672,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17214727,2007-01-01T00:00:00,Adult,M01.060.116
17214727,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17214846,2007-01-01T00:00:00,Animals,B01.050
17214846,2007-01-01T00:00:00,Bone Density Conservation Agents,D27.505.696.242
17214846,2007-01-01T00:00:00,Cytokines,D12.644.276.374
17214846,2007-01-01T00:00:00,Cytokines,D12.776.467.374
17214846,2007-01-01T00:00:00,Cytokines,D23.529.374
17214846,2007-01-01T00:00:00,Diphosphonates,D02.705.206
17214846,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17214846,2007-01-01T00:00:00,NF-kappa B,D12.776.260.600
17214846,2007-01-01T00:00:00,NF-kappa B,D12.776.660.600
17214846,2007-01-01T00:00:00,NF-kappa B,D12.776.930.600
17214846,2007-01-01T00:00:00,Periodontitis,C07.465.714.533
17214846,2007-01-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
17214846,2007-01-01T00:00:00,RANK Ligand,D12.644.276.972.562
17214846,2007-01-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
17214846,2007-01-01T00:00:00,RANK Ligand,D12.776.467.972.562
17214846,2007-01-01T00:00:00,RANK Ligand,D23.529.374.750.562
17214846,2007-01-01T00:00:00,RANK Ligand,D23.529.972.562
17214846,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17214846,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17214846,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
17214846,2007-01-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
17218204,2007-01-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
17218204,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
17218204,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
17218204,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
17218204,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
17218204,2007-01-01T00:00:00,Forecasting,I01.320
17218204,2007-01-01T00:00:00,Heart Failure,C14.280.434
17218204,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17218204,2007-01-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
17218204,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17218204,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17218204,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17218204,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,G17.800
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17218204,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17218204,2007-01-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
17218204,2007-01-01T00:00:00,Stroke Volume,G09.330.380.124.882
17218204,2007-01-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17218205,2007-01-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
17218205,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
17218205,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
17218205,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
17218205,2007-01-01T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
17218205,2007-01-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
17218205,2007-01-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
17218205,2007-01-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
17218205,2007-01-01T00:00:00,Forecasting,I01.320
17218205,2007-01-01T00:00:00,Heart Failure,C14.280.434
17218205,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17218205,2007-01-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
17218205,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
17218205,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
17218205,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
17218205,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
17218205,2007-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
17218205,2007-01-01T00:00:00,Risk Assessment,N04.452.871.715
17218205,2007-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
17218205,2007-01-01T00:00:00,Risk Assessment,N06.850.505.715
17218205,2007-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,G17.800
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17218205,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17218205,2007-01-01T00:00:00,Stroke Volume,E01.370.370.380.150.700
17218205,2007-01-01T00:00:00,Stroke Volume,G09.330.380.124.882
17218205,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17218205,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17218205,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17218205,2007-01-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
17218205,2007-01-01T00:00:00,Ventricular Remodeling,C23.300.985
17218205,2007-01-01T00:00:00,Ventricular Remodeling,G09.330.190.962.975
17218212,2007-01-01T00:00:00,Animals,B01.050
17218212,2007-01-01T00:00:00,Bone Marrow Cells,A11.148
17218212,2007-01-01T00:00:00,Bone Marrow Cells,A15.378.316
17218212,2007-01-01T00:00:00,Calcinosis,C18.452.174.130
17218212,2007-01-01T00:00:00,Cholecalciferol,D04.808.247.222.159
17218212,2007-01-01T00:00:00,Cholecalciferol,D04.808.247.808.146
17218212,2007-01-01T00:00:00,Cholecalciferol,D04.808.812.768.196
17218212,2007-01-01T00:00:00,Cholecalciferol,D10.570.938.146
17218212,2007-01-01T00:00:00,Elastin,D05.750.078.421
17218212,2007-01-01T00:00:00,Elastin,D12.776.860.300.350
17218212,2007-01-01T00:00:00,Gene Expression,G05.355.310
17218212,2007-01-01T00:00:00,Osteoclasts,A11.329.372.700
17218212,2007-01-01T00:00:00,Osteoclasts,A11.627.482.700
17218212,2007-01-01T00:00:00,"RNA, Messenger",D13.444.735.544
17218212,2007-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17218212,2007-01-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
17218577,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17218577,2007-01-01T00:00:00,Lung Diseases,C08.381
17218577,2007-01-01T00:00:00,Manometry,E05.559
17218577,2007-01-01T00:00:00,Paracentesis,E01.450.865.632.600
17218577,2007-01-01T00:00:00,Paracentesis,E02.800.550
17218577,2007-01-01T00:00:00,Paracentesis,E04.581
17218577,2007-01-01T00:00:00,Pleural Effusion,C08.528.652
17218577,2007-01-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
17218577,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17218577,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17218577,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17218577,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17218577,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17224518,2007-01-01T00:00:00,Adult,M01.060.116
17224518,2007-01-01T00:00:00,Aged,M01.060.116.100
17224518,2007-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
17224518,2007-01-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
17224518,2007-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
17224518,2007-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
17224518,2007-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
17224518,2007-01-01T00:00:00,Head and Neck Neoplasms,C04.588.443
17224518,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17224518,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17224518,2007-01-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
17224518,2007-01-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
17224520,2007-01-01T00:00:00,Adolescent,M01.060.057
17224520,2007-01-01T00:00:00,Adult,M01.060.116
17224520,2007-01-01T00:00:00,Aged,M01.060.116.100
17224520,2007-01-01T00:00:00,Bronchoscopy,E01.370.386.105
17224520,2007-01-01T00:00:00,Bronchoscopy,E01.370.388.250.100
17224520,2007-01-01T00:00:00,Bronchoscopy,E04.800.250.100
17224520,2007-01-01T00:00:00,Bronchoscopy,E04.928.600.080
17224520,2007-01-01T00:00:00,Device Removal,E04.199
17224520,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17224520,2007-01-01T00:00:00,Stents,E07.695.750
17224520,2007-01-01T00:00:00,Tracheal Stenosis,C08.907.663
17227876,2007-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17227876,2007-01-01T00:00:00,Diabetes Mellitus,C19.246
17227876,2007-01-01T00:00:00,Family Practice,H02.403.280
17227876,2007-01-01T00:00:00,Guideline Adherence,N04.761.337
17227876,2007-01-01T00:00:00,Guideline Adherence,N05.715.360.395
17227876,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17227876,2007-01-01T00:00:00,"Models, Organizational",E05.599.670
17227876,2007-01-01T00:00:00,"Models, Organizational",N04.452.534
17227876,2007-01-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
17227876,2007-01-01T00:00:00,"Quality Assurance, Health Care",N05.700
17227876,2007-01-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
17227876,2007-01-01T00:00:00,United States,Z01.107.567.875
17228206,2007-01-01T00:00:00,Adult,M01.060.116
17228206,2007-01-01T00:00:00,Aged,M01.060.116.100
17228206,2007-01-01T00:00:00,Arterial Occlusive Diseases,C14.907.137
17228206,2007-01-01T00:00:00,Bias (Epidemiology),N05.715.350.150
17228206,2007-01-01T00:00:00,Bias (Epidemiology),N06.850.490.500
17228206,2007-01-01T00:00:00,Brachial Artery,A07.231.114.139
17228206,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17228206,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17228206,2007-01-01T00:00:00,Point-of-Care Systems,N04.452.442.452.680
17228206,2007-01-01T00:00:00,Point-of-Care Systems,N04.452.515.360.652
17228206,2007-01-01T00:00:00,Point-of-Care Systems,N04.590.874
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,G17.800
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
17228206,2007-01-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
17235226,2007-01-01T00:00:00,Activities of Daily Living,E02.831.067
17235226,2007-01-01T00:00:00,Activities of Daily Living,I03.050
17235226,2007-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
17235226,2007-01-01T00:00:00,Adolescent,M01.060.057
17235226,2007-01-01T00:00:00,Adult,M01.060.116
17235226,2007-01-01T00:00:00,Aged,M01.060.116.100
17235226,2007-01-01T00:00:00,Brain Injuries,C10.228.140.199
17235226,2007-01-01T00:00:00,Brain Injuries,C10.900.300.087
17235226,2007-01-01T00:00:00,Brain Injuries,C21.866.260.118
17235226,2007-01-01T00:00:00,Brain Injuries,C21.866.915.300.200
17235226,2007-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
17235226,2007-01-01T00:00:00,Health Services Accessibility,N05.300.430
17235226,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17235226,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17235226,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17235226,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17235226,2007-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
17235226,2007-01-01T00:00:00,"Stress, Psychological",F02.830.900
17241144,2007-01-01T00:00:00,Adult,M01.060.116
17241144,2007-01-01T00:00:00,Electromyography,E01.370.405.255
17241144,2007-01-01T00:00:00,Electromyography,E01.370.530.255
17241144,2007-01-01T00:00:00,Emotions,F01.470
17241144,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17241144,2007-01-01T00:00:00,Motivation,F01.658
17241144,2007-01-01T00:00:00,Motivation,F01.752.543.500.750
17241144,2007-01-01T00:00:00,Motor Cortex,A08.186.211.730.885.287.500.270.548
17241144,2007-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
17241144,2007-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
17241144,2007-01-01T00:00:00,Photic Stimulation,E05.723.729
17241144,2007-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
17241144,2007-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
17241144,2007-01-01T00:00:00,Visual Perception,F02.463.593.932
17261870,2007-01-01T00:00:00,Family Practice,H02.403.280
17261870,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17261870,2007-01-01T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
17261870,2007-01-01T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
17261870,2007-01-01T00:00:00,"Societies, Medical",N03.540.828.589
17261870,2007-01-01T00:00:00,United States,Z01.107.567.875
17261873,2007-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
17261873,2007-01-01T00:00:00,"Drug Resistance, Microbial",G06.225
17261873,2007-01-01T00:00:00,"Drug Resistance, Microbial",G07.690.320.269
17261873,2007-01-01T00:00:00,Health Services Research,N03.349.380
17261873,2007-01-01T00:00:00,Health Services Research,N05.425
17261873,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17261873,2007-01-01T00:00:00,Physician's Practice Patterns,N04.590.748
17261873,2007-01-01T00:00:00,Physician's Practice Patterns,N05.300.625
17261873,2007-01-01T00:00:00,Primary Health Care,N04.590.233.727
17266523,2007-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
17266523,2007-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
17266523,2007-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
17266523,2007-01-01T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
17266523,2007-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
17266523,2007-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
17266523,2007-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
17266523,2007-01-01T00:00:00,Amino Acid Sequence,G02.111.570.060
17266523,2007-01-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
17266523,2007-01-01T00:00:00,"Cholesterol, LDL",D10.532.515.500
17266523,2007-01-01T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
17266523,2007-01-01T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
17266523,2007-01-01T00:00:00,Molecular Sequence Data,L01.453.245.667
17266523,2007-01-01T00:00:00,Mutation,G05.365.590
17266523,2007-01-01T00:00:00,Neoplasms,C04
17266523,2007-01-01T00:00:00,Protein Transport,G03.495.166.700
17272800,2007-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
17272800,2007-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
17272800,2007-01-01T00:00:00,Health Behavior,F01.145.488
17272800,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17272800,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17272800,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17272800,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17272800,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17274152,2007-01-01T00:00:00,"Child, Preschool",M01.060.406.448
17274152,2007-01-01T00:00:00,"Diagnosis, Differential",E01.171
17274152,2007-01-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
17274152,2007-01-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
17274152,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17274152,2007-01-01T00:00:00,Lead Poisoning,C21.613.589
17274216,2007-01-01T00:00:00,Adult,M01.060.116
17274216,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
17274216,2007-01-01T00:00:00,African Americans,M01.686.754.100
17274216,2007-01-01T00:00:00,Culture,I01.076.201.450
17274216,2007-01-01T00:00:00,Culture,I01.880.143
17274216,2007-01-01T00:00:00,Environment,G16.500.275
17274216,2007-01-01T00:00:00,Environment,N06.230
17274216,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
17274216,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
17274216,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17274216,2007-01-01T00:00:00,Smoking,F01.145.466.753
17274216,2007-01-01T00:00:00,Smoking Cessation,F01.145.940.700
17274264,2007-01-01T00:00:00,Adolescent,M01.060.057
17274264,2007-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
17274264,2007-01-01T00:00:00,Blood Pressure,G09.330.380.076
17274264,2007-01-01T00:00:00,Health Surveys,E05.318.308.250
17274264,2007-01-01T00:00:00,Health Surveys,N05.715.360.300.375
17274264,2007-01-01T00:00:00,Health Surveys,N06.850.520.308.250
17274264,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17274264,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
17274264,2007-01-01T00:00:00,Questionnaires,L01.280.800
17274264,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
17274264,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
17274264,2007-01-01T00:00:00,"Stress, Psychological",F01.145.126.990
17274264,2007-01-01T00:00:00,"Stress, Psychological",F02.830.900
17274264,2007-01-01T00:00:00,United States,Z01.107.567.875
17283573,2007-01-01T00:00:00,Biological Markers,D23.101
17283573,2007-01-01T00:00:00,Chronic Disease,C23.550.291.500
17283573,2007-01-01T00:00:00,Dendritic Cells,A11.066.270
17283573,2007-01-01T00:00:00,Dendritic Cells,A11.436.270
17283573,2007-01-01T00:00:00,Dendritic Cells,A15.382.066.270
17283573,2007-01-01T00:00:00,Dendritic Cells,A15.382.812.260
17283573,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17283573,2007-01-01T00:00:00,Rhinitis,C08.460.799
17283573,2007-01-01T00:00:00,Rhinitis,C08.730.674
17283573,2007-01-01T00:00:00,Rhinitis,C09.603.799
17283573,2007-01-01T00:00:00,Sinusitis,C08.460.692.752
17283573,2007-01-01T00:00:00,Sinusitis,C08.730.749
17283573,2007-01-01T00:00:00,Sinusitis,C09.603.692.752
17283574,2007-01-01T00:00:00,Adolescent,M01.060.057
17283574,2007-01-01T00:00:00,Adult,M01.060.116
17283574,2007-01-01T00:00:00,Cystic Fibrosis,C06.689.202
17283574,2007-01-01T00:00:00,Cystic Fibrosis,C08.381.187
17283574,2007-01-01T00:00:00,Cystic Fibrosis,C16.320.190
17283574,2007-01-01T00:00:00,Cystic Fibrosis,C16.614.213
17283574,2007-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.157.530.400.175.125
17283574,2007-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.550.425.175.125
17283574,2007-01-01T00:00:00,Cystic Fibrosis Transmembrane Conductance Regulator,D12.776.543.585.400.175.125
17283574,2007-01-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
17283574,2007-01-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
17283574,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17283574,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17283574,2007-01-01T00:00:00,Mutation,G05.365.590
17283574,2007-01-01T00:00:00,Paranasal Sinuses,A04.531.621
17283574,2007-01-01T00:00:00,Phenotype,G05.695
17283574,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17283574,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17283574,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17283574,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17283574,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17296700,2007-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
17296700,2007-01-01T00:00:00,Catheter Ablation,E02.148.110
17296700,2007-01-01T00:00:00,Catheter Ablation,E02.148.442.110
17296700,2007-01-01T00:00:00,Catheter Ablation,E02.154.402.110
17296700,2007-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
17296700,2007-01-01T00:00:00,Finite Element Analysis,E05.355
17296700,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17296700,2007-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
17296700,2007-01-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
17296700,2007-01-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
17296700,2007-01-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
17296700,2007-01-01T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
17296700,2007-01-01T00:00:00,Software,L01.224.900
17296700,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17296700,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17296700,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17296700,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17296700,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17304570,2007-01-01T00:00:00,Atherosclerosis,C14.907.137.126.307
17304570,2007-01-01T00:00:00,Diabetes Complications,C19.246.099
17304570,2007-01-01T00:00:00,Evidence-Based Medicine,H02.249.750
17304570,2007-01-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
17304570,2007-01-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
17304570,2007-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
17304570,2007-01-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
17304570,2007-01-01T00:00:00,Hospitalists,M01.526.485.630.490.400
17304570,2007-01-01T00:00:00,Hospitalists,M01.526.485.740.422.400
17304570,2007-01-01T00:00:00,Hospitalists,M01.526.485.810.580
17304570,2007-01-01T00:00:00,Hospitalists,N02.360.630.490.400
17304570,2007-01-01T00:00:00,Hospitalists,N02.360.740.422.400
17304570,2007-01-01T00:00:00,Hospitalists,N02.360.810.580
17304570,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17304570,2007-01-01T00:00:00,Hypertension,C14.907.489
17304570,2007-01-01T00:00:00,Patient Discharge,E02.760.400.610
17304570,2007-01-01T00:00:00,Patient Discharge,N02.421.585.400.610
17304570,2007-01-01T00:00:00,Patient Education as Topic,I02.233.332.500
17304570,2007-01-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
17304570,2007-01-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
17304570,2007-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
17304570,2007-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
17304570,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17304570,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17304570,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17304570,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17304570,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17304570,2007-01-01T00:00:00,Secondary Prevention,N02.421.726.825
17304570,2007-01-01T00:00:00,Secondary Prevention,N06.850.780.750
17304570,2007-01-01T00:00:00,Stroke,C10.228.140.300.775
17304570,2007-01-01T00:00:00,Stroke,C14.907.253.855
17315835,2007-01-01T00:00:00,Adult,M01.060.116
17315835,2007-01-01T00:00:00,Aged,M01.060.116.100
17315835,2007-01-01T00:00:00,Cysts,C04.182
17315835,2007-01-01T00:00:00,Cysts,C23.300.306
17315835,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17315835,2007-01-01T00:00:00,Incidence,E05.318.308.985.525.375
17315835,2007-01-01T00:00:00,Incidence,L01.280.975.525.375
17315835,2007-01-01T00:00:00,Incidence,N01.224.935.597.500
17315835,2007-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17315835,2007-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17315835,2007-01-01T00:00:00,Incidental Findings,E01.410
17315835,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17315835,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17315835,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17315835,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
17315835,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
17315835,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
17315835,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
17315835,2007-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
17320806,2007-01-01T00:00:00,Fatty Liver,C06.552.241
17320806,2007-01-01T00:00:00,Hepatitis C,C02.440.440
17320806,2007-01-01T00:00:00,Hepatitis C,C02.782.350.350
17320806,2007-01-01T00:00:00,Hepatitis C,C06.552.380.705.440
17320806,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17320806,2007-01-01T00:00:00,Liver Transplantation,E04.210.650
17320806,2007-01-01T00:00:00,Liver Transplantation,E04.936.450.490
17320806,2007-01-01T00:00:00,Liver Transplantation,E04.936.580.490
17320806,2007-01-01T00:00:00,Tissue Donors,M01.898
17320806,2007-01-01T00:00:00,Tissue and Organ Procurement,N02.421.911
17338182,2007-01-01T00:00:00,B-Lymphocytes,A11.063.438
17338182,2007-01-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
17338182,2007-01-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
17338182,2007-01-01T00:00:00,B-Lymphocytes,A15.382.032.438
17338182,2007-01-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
17338182,2007-01-01T00:00:00,Gene Expression Profiling,E05.393.332
17338182,2007-01-01T00:00:00,Histocompatibility Antigens Class II,D23.050.301.500.410
17338182,2007-01-01T00:00:00,Histocompatibility Antigens Class II,D23.050.705.552.410
17338182,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17338182,2007-01-01T00:00:00,Interleukin-4,D12.644.276.374.465.504
17338182,2007-01-01T00:00:00,Interleukin-4,D12.776.467.374.465.504
17338182,2007-01-01T00:00:00,Interleukin-4,D23.529.374.465.504
17338182,2007-01-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
17338182,2007-01-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
17338182,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17338182,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17338182,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17351850,2007-01-01T00:00:00,Adolescent,M01.060.057
17351850,2007-01-01T00:00:00,Adult,M01.060.116
17351850,2007-01-01T00:00:00,Aged,M01.060.116.100
17351850,2007-01-01T00:00:00,Continental Population Groups,M01.686.508
17351850,2007-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
17351850,2007-01-01T00:00:00,Diabetes Mellitus,C19.246
17351850,2007-01-01T00:00:00,Diet,E05.272
17351850,2007-01-01T00:00:00,Diet,G07.610.240
17351850,2007-01-01T00:00:00,Exercise,G11.427.590.237
17351850,2007-01-01T00:00:00,Exercise,I03.350
17351850,2007-01-01T00:00:00,Fruit,A18.024.500
17351850,2007-01-01T00:00:00,Fruit,J02.500.562
17351850,2007-01-01T00:00:00,Health Behavior,F01.145.488
17351850,2007-01-01T00:00:00,Health Education,I02.233.332
17351850,2007-01-01T00:00:00,Health Education,N02.421.143.827.407
17351850,2007-01-01T00:00:00,Health Education,N02.421.726.407
17351850,2007-01-01T00:00:00,Health Surveys,E05.318.308.250
17351850,2007-01-01T00:00:00,Health Surveys,N05.715.360.300.375
17351850,2007-01-01T00:00:00,Health Surveys,N06.850.520.308.250
17351850,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17351850,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17351850,2007-01-01T00:00:00,Self Care,E02.900
17351850,2007-01-01T00:00:00,Self Care,N02.421.784.680
17351850,2007-01-01T00:00:00,Self-Examination,E01.370.600.750
17351850,2007-01-01T00:00:00,Self-Examination,F01.145.488.700
17351850,2007-01-01T00:00:00,United States,Z01.107.567.875
17365738,2007-01-01T00:00:00,Adult,M01.060.116
17365738,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
17365738,2007-01-01T00:00:00,African Americans,M01.686.754.100
17365738,2007-01-01T00:00:00,Algorithms,G17.035
17365738,2007-01-01T00:00:00,Algorithms,L01.224.050
17365738,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17365738,2007-01-01T00:00:00,Nicotine,D03.132.760.570
17365738,2007-01-01T00:00:00,Nicotine,D03.383.725.518
17365738,2007-01-01T00:00:00,Pilot Projects,E05.318.760.750
17365738,2007-01-01T00:00:00,Pilot Projects,E05.337.737
17365738,2007-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
17365738,2007-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
17365738,2007-01-01T00:00:00,Smoking,F01.145.466.753
17365738,2007-01-01T00:00:00,Smoking Cessation,F01.145.940.700
17365738,2007-01-01T00:00:00,Substance Withdrawal Syndrome,C21.739.835
17365738,2007-01-01T00:00:00,Substance Withdrawal Syndrome,F03.900.825
17365738,2007-01-01T00:00:00,Tobacco Use Disorder,C21.739.912
17365738,2007-01-01T00:00:00,Tobacco Use Disorder,F03.900.912
17366253,2007-01-01T00:00:00,Adult,M01.060.116
17366253,2007-01-01T00:00:00,Ambulatory Care,E02.760.106
17366253,2007-01-01T00:00:00,Ambulatory Care,N02.421.585.106
17366253,2007-01-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
17366253,2007-01-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
17366253,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17366253,2007-01-01T00:00:00,Mental Disorders,F03
17366253,2007-01-01T00:00:00,Motivation,F01.658
17366253,2007-01-01T00:00:00,Motivation,F01.752.543.500.750
17366253,2007-01-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17366253,2007-01-01T00:00:00,Prevalence,E05.318.308.985.525.750
17366253,2007-01-01T00:00:00,Prevalence,L01.280.975.525.750
17366253,2007-01-01T00:00:00,Prevalence,N01.224.935.597.750
17366253,2007-01-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
17366253,2007-01-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
17366253,2007-01-01T00:00:00,Retention (Psychology),F02.463.425.540.772
17366253,2007-01-01T00:00:00,Substance-Related Disorders,C21.739
17366253,2007-01-01T00:00:00,Substance-Related Disorders,F03.900
17390187,2007-01-01T00:00:00,Adult,M01.060.116
17390187,2007-01-01T00:00:00,Aged,M01.060.116.100
17390187,2007-01-01T00:00:00,Autoimmune Diseases,C20.111
17390187,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17390187,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17390187,2007-01-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
17390187,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17390187,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17390187,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17397785,2007-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
17397785,2007-01-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
17397785,2007-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
17397785,2007-01-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
17397785,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17397785,2007-01-01T00:00:00,United States,Z01.107.567.875
17433986,2007-01-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
17433986,2007-01-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
17433986,2007-01-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
17433986,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17433986,2007-01-01T00:00:00,Infant,M01.060.703
17433986,2007-01-01T00:00:00,Mitral Valve Insufficiency,C14.280.484.461
17433986,2007-01-01T00:00:00,"Pacemaker, Artificial",E07.858.082.748
17433986,2007-01-01T00:00:00,Postoperative Complications,C23.550.767
17433986,2007-01-01T00:00:00,Reoperation,E04.690
17433986,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17433986,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17433986,2007-01-01T00:00:00,Suture Techniques,E04.901
17433986,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17433986,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17433986,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17439340,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17439340,2007-01-01T00:00:00,Transferrin,D12.776.124.050.800
17439340,2007-01-01T00:00:00,Transferrin,D12.776.124.790.223.839
17439340,2007-01-01T00:00:00,Transferrin,D12.776.157.427.500
17439340,2007-01-01T00:00:00,Transferrin,D12.776.377.715.182.839
17439340,2007-01-01T00:00:00,Transferrin,D12.776.556.579.500
17445700,2007-01-01T00:00:00,Animals,B01.050
17445700,2007-01-01T00:00:00,Cations,D01.248.497.300
17445700,2007-01-01T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
17445700,2007-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
17445700,2007-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
17445700,2007-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
17445700,2007-01-01T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
17445700,2007-01-01T00:00:00,Fluorescent Dyes,D27.720.233.348
17445700,2007-01-01T00:00:00,Fluorescent Dyes,D27.720.470.330.348
17445700,2007-01-01T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
17445700,2007-01-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
17445700,2007-01-01T00:00:00,Mitochondria,A11.284.430.214.190.875.564
17445700,2007-01-01T00:00:00,Mitochondria,A11.284.835.626
17486853,2007-01-01T00:00:00,Conservation of Natural Resources,J01.256
17486853,2007-01-01T00:00:00,Conservation of Natural Resources,N06.230.080
17486853,2007-01-01T00:00:00,Paper,J01.576.154.600
17486853,2007-01-01T00:00:00,Paper,J01.637.650
17486853,2007-01-01T00:00:00,"Waste Disposal, Fluid",N06.850.780.200.800.800.890
17486853,2007-01-01T00:00:00,"Waste Disposal, Fluid",N06.850.860.510.900.600.900
17486853,2007-01-01T00:00:00,"Waste Disposal, Fluid",N06.850.860.510.900.800
17486854,2007-01-01T00:00:00,Biological Assay,E05.091
17486854,2007-01-01T00:00:00,Endocrine Disruptors,D27.505.696.353
17486854,2007-01-01T00:00:00,Endocrine Disruptors,D27.888.284.295
17486854,2007-01-01T00:00:00,Industrial Waste,D20.944.420
17486854,2007-01-01T00:00:00,Industrial Waste,D27.888.284.404
17486854,2007-01-01T00:00:00,Industrial Waste,N06.850.460.710.420
17486854,2007-01-01T00:00:00,Paper,J01.576.154.600
17486854,2007-01-01T00:00:00,Paper,J01.637.650
17486854,2007-01-01T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
17486854,2007-01-01T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
17486854,2007-01-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
17499120,2007-01-01T00:00:00,Animals,B01.050
17499120,2007-01-01T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
17499120,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17499120,2007-01-01T00:00:00,Neural Pathways,A08.612
17499120,2007-01-01T00:00:00,Neurons,A08.663
17499120,2007-01-01T00:00:00,Neurons,A11.671
17499120,2007-01-01T00:00:00,Neuropeptides,D12.644.400
17499120,2007-01-01T00:00:00,Neuropeptides,D12.776.641.650
17499120,2007-01-01T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.720.600
17499120,2007-01-01T00:00:00,"Receptors, Neuropeptide",D12.776.543.750.750.555
17499120,2007-01-01T00:00:00,Synaptic Transmission,G02.111.087.800.850
17499120,2007-01-01T00:00:00,Synaptic Transmission,G02.149.115.800.850
17499120,2007-01-01T00:00:00,Synaptic Transmission,G04.299.880.850
17499120,2007-01-01T00:00:00,Synaptic Transmission,G07.265.337.900
17499120,2007-01-01T00:00:00,Synaptic Transmission,G07.700.240.900
17499120,2007-01-01T00:00:00,Synaptic Transmission,G11.561.600.835
17499120,2007-01-01T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
17499120,2007-01-01T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
17518847,2007-01-01T00:00:00,Animals,B01.050
17518847,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17518847,2007-01-01T00:00:00,Organ Transplantation,E04.936.450
17518852,2007-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
17518852,2007-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
17518852,2007-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
17518852,2007-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
17518852,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17518852,2007-01-01T00:00:00,Patient Dropouts,M01.643.673
17518852,2007-01-01T00:00:00,United States,Z01.107.567.875
17519056,2007-01-01T00:00:00,Cognitive Therapy,F04.754.137.428
17519056,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17519056,2007-01-01T00:00:00,Life Change Events,F01.829.458.410
17519056,2007-01-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
17519056,2007-01-01T00:00:00,Telemedicine,H02.403.840
17519056,2007-01-01T00:00:00,Telemedicine,L01.178.847.652
17519056,2007-01-01T00:00:00,Telemedicine,N04.590.374.800
17519056,2007-01-01T00:00:00,Veterans,M01.930
17522798,2007-01-01T00:00:00,Aged,M01.060.116.100
17522798,2007-01-01T00:00:00,Artifacts,E05.047
17522798,2007-01-01T00:00:00,Brain,A08.186.211
17522798,2007-01-01T00:00:00,Contrast Media,D27.720.259
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C10.228.140.300.535.450.400
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C10.900.300.837.600
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C14.907.253.573.400.450
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C21.866.260.616.600
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C21.866.915.300.490.450
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C23.550.414.838.700
17522798,2007-01-01T00:00:00,"Hematoma, Subdural",C23.550.414.913.700
17522798,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17563124,2007-01-01T00:00:00,Adult,M01.060.116
17563124,2007-01-01T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
17563124,2007-01-01T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
17563124,2007-01-01T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
17563124,2007-01-01T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
17563124,2007-01-01T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
17563124,2007-01-01T00:00:00,Coronary Disease,C14.280.647.250
17563124,2007-01-01T00:00:00,Coronary Disease,C14.907.585.250
17563124,2007-01-01T00:00:00,Data Collection,E05.318.308
17563124,2007-01-01T00:00:00,Data Collection,L01.280
17563124,2007-01-01T00:00:00,Data Collection,N05.715.360.300
17563124,2007-01-01T00:00:00,Data Collection,N06.850.520.308
17563124,2007-01-01T00:00:00,HIV Infections,C02.782.815.616.400
17563124,2007-01-01T00:00:00,HIV Infections,C02.800.801.400
17563124,2007-01-01T00:00:00,HIV Infections,C20.673.480
17563124,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
17563124,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
17563124,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17563124,2007-01-01T00:00:00,Markov Chains,E05.318.740.600.500
17563124,2007-01-01T00:00:00,Markov Chains,E05.318.740.996.500
17563124,2007-01-01T00:00:00,Markov Chains,G17.830.500
17563124,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
17563124,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
17563124,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
17563124,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
17563124,2007-01-01T00:00:00,"Models, Statistical",E05.318.740.500
17563124,2007-01-01T00:00:00,"Models, Statistical",E05.599.835
17563124,2007-01-01T00:00:00,"Models, Statistical",N05.715.360.750.530
17563124,2007-01-01T00:00:00,"Models, Statistical",N06.850.520.830.500
17563124,2007-01-01T00:00:00,Quality of Life,I01.800
17563124,2007-01-01T00:00:00,Quality of Life,K01.752.400.750
17563124,2007-01-01T00:00:00,Ritonavir,D02.886.675.653
17563124,2007-01-01T00:00:00,Ritonavir,D03.383.129.708.653
17563124,2007-01-01T00:00:00,United States,Z01.107.567.875
17565527,2007-01-01T00:00:00,Adolescent,M01.060.057
17565527,2007-01-01T00:00:00,Adult,M01.060.116
17565527,2007-01-01T00:00:00,Aged,M01.060.116.100
17565527,2007-01-01T00:00:00,Child,M01.060.406
17565527,2007-01-01T00:00:00,"Child, Preschool",M01.060.406.448
17565527,2007-01-01T00:00:00,Demography,I01.240
17565527,2007-01-01T00:00:00,Demography,N01.224
17565527,2007-01-01T00:00:00,Demography,N06.850.505.400
17565527,2007-01-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17565527,2007-01-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17565527,2007-01-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17565527,2007-01-01T00:00:00,Hospital Costs,N03.219.151.400.687
17565527,2007-01-01T00:00:00,Hospital Costs,N03.219.262.500
17565527,2007-01-01T00:00:00,Hospital Costs,N05.300.375.500
17565527,2007-01-01T00:00:00,"Hospitals, Rural",N02.278.421.518
17565527,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17565527,2007-01-01T00:00:00,Infant,M01.060.703
17565527,2007-01-01T00:00:00,"Infant, Newborn",M01.060.703.520
17565527,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17565527,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17565527,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17565527,2007-01-01T00:00:00,United States,Z01.107.567.875
17565527,2007-01-01T00:00:00,Urban Population,N01.600.900
17570028,2007-01-01T00:00:00,Animals,B01.050
17570028,2007-01-01T00:00:00,Cell Culture Techniques,E05.200.249.249
17570028,2007-01-01T00:00:00,Cell Differentiation,G04.299.151
17570028,2007-01-01T00:00:00,Chick Embryo,A13.350.150
17570028,2007-01-01T00:00:00,Chick Embryo,A16.331.200
17570028,2007-01-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
17570028,2007-01-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
17570028,2007-01-01T00:00:00,Coronary Vessels,A07.231.114.269
17570028,2007-01-01T00:00:00,Coronary Vessels,A07.231.908.194
17570028,2007-01-01T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
17570028,2007-01-01T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
17570028,2007-01-01T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
17570028,2007-01-01T00:00:00,Pericardium,A07.541.795
17570028,2007-01-01T00:00:00,Pericardium,A10.615.789.470
17570028,2007-01-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
17572859,2007-01-01T00:00:00,Adult,M01.060.116
17572859,2007-01-01T00:00:00,Aged,M01.060.116.100
17572859,2007-01-01T00:00:00,Brain,A08.186.211
17572859,2007-01-01T00:00:00,"Decompression, Surgical",E04.188
17572859,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.150.477.200.450
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.510.200.387
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C10.228.140.300.775.200.200.450
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.092.477.200.450
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.560.200.387
17572859,2007-01-01T00:00:00,"Infarction, Middle Cerebral Artery",C14.907.253.855.200.200.450
17572859,2007-01-01T00:00:00,Intracranial Pressure,G11.561.170.505
17572859,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17572859,2007-01-01T00:00:00,Oxygen,D01.268.185.550
17572859,2007-01-01T00:00:00,Oxygen,D01.362.670
17572859,2007-01-01T00:00:00,Oxygen Consumption,G03.730
17572859,2007-01-01T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
17572859,2007-01-01T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
17572859,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17572859,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17572859,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17594215,2007-01-01T00:00:00,Adult,M01.060.116
17594215,2007-01-01T00:00:00,Educational Measurement,I02.399
17594215,2007-01-01T00:00:00,"Faculty, Medical",I02.463.373
17594215,2007-01-01T00:00:00,"Faculty, Medical",M01.526.339.373
17594215,2007-01-01T00:00:00,"Faculty, Medical",M01.526.485.375
17594215,2007-01-01T00:00:00,"Faculty, Medical",N02.360.375
17594215,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17594215,2007-01-01T00:00:00,Peer Group,F01.829.316.483
17594215,2007-01-01T00:00:00,"Schools, Medical",I02.783.660.552
17594215,2007-01-01T00:00:00,"Schools, Medical",N02.278.020.578
17594215,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17594215,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17594215,2007-01-01T00:00:00,Teaching,I02.903
17598313,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
17598313,2007-01-01T00:00:00,African Americans,M01.686.754.100
17598313,2007-01-01T00:00:00,Communication,F01.145.209
17598313,2007-01-01T00:00:00,Communication,L01.143
17598313,2007-01-01T00:00:00,Community Networks,I01.880.656.300
17598313,2007-01-01T00:00:00,Community Networks,L01.700.508.300.184
17598313,2007-01-01T00:00:00,Community Networks,N02.421.143.202
17598313,2007-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
17598313,2007-01-01T00:00:00,Health Education,I02.233.332
17598313,2007-01-01T00:00:00,Health Education,N02.421.143.827.407
17598313,2007-01-01T00:00:00,Health Education,N02.421.726.407
17598313,2007-01-01T00:00:00,Health Promotion,N02.370
17598313,2007-01-01T00:00:00,Health Promotion,N02.421.726.507
17598313,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17598313,2007-01-01T00:00:00,Interinstitutional Relations,N04.452.822.400
17598313,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
17598313,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
17598313,2007-01-01T00:00:00,Universities,I02.783.850
17598315,2007-01-01T00:00:00,Academic Medical Centers,N02.278.020
17598315,2007-01-01T00:00:00,Aged,M01.060.116.100
17598315,2007-01-01T00:00:00,Aging,G07.700.320.124
17598315,2007-01-01T00:00:00,Community Networks,I01.880.656.300
17598315,2007-01-01T00:00:00,Community Networks,L01.700.508.300.184
17598315,2007-01-01T00:00:00,Community Networks,N02.421.143.202
17598315,2007-01-01T00:00:00,Consumer Participation,N02.421.143.262
17598315,2007-01-01T00:00:00,Consumer Participation,N03.540.245.360
17598315,2007-01-01T00:00:00,Cooperative Behavior,F01.145.813.115
17598315,2007-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
17598315,2007-01-01T00:00:00,Health Services Accessibility,N05.300.430
17598315,2007-01-01T00:00:00,Health Services Research,N03.349.380
17598315,2007-01-01T00:00:00,Health Services Research,N05.425
17598315,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17598315,2007-01-01T00:00:00,Minority Groups,I01.880.371
17598315,2007-01-01T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
17598315,2007-01-01T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
17598315,2007-01-01T00:00:00,United States,Z01.107.567.875
17607952,2007-01-01T00:00:00,Animals,B01.050
17607952,2007-01-01T00:00:00,"Antigens, CD",D23.050.301.264.035
17607952,2007-01-01T00:00:00,"Antigens, CD",D23.101.100.110
17607952,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17607952,2007-01-01T00:00:00,Nerve Tissue Proteins,D12.776.641
17607952,2007-01-01T00:00:00,"Receptors, Cell Surface",D12.776.543.750
17607952,2007-01-01T00:00:00,Semaphorins,D12.644.276.923
17607952,2007-01-01T00:00:00,Semaphorins,D12.776.467.923
17607952,2007-01-01T00:00:00,Semaphorins,D23.529.923
17607952,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17607952,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17607952,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17621549,2007-01-01T00:00:00,Animals,B01.050
17621549,2007-01-01T00:00:00,Cell Line,A11.251.210
17621549,2007-01-01T00:00:00,Lipopolysaccharides,D09.400.500
17621549,2007-01-01T00:00:00,Lipopolysaccharides,D09.698.718.450
17621549,2007-01-01T00:00:00,Lipopolysaccharides,D10.494
17621549,2007-01-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
17621549,2007-01-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
17621549,2007-01-01T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
17621549,2007-01-01T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
17621549,2007-01-01T00:00:00,MAP Kinase Signaling System,G03.495.553.560
17621549,2007-01-01T00:00:00,MAP Kinase Signaling System,G04.299.880.560
17621549,2007-01-01T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
17621549,2007-01-01T00:00:00,"Microscopy, Fluorescence",E05.595.458
17621549,2007-01-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
17621549,2007-01-01T00:00:00,Transcriptional Activation,G05.355.315.800
17621549,2007-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
17621549,2007-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
17621549,2007-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
17621549,2007-01-01T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
17622217,2007-01-01T00:00:00,Animals,B01.050
17622217,2007-01-01T00:00:00,Fishes,B01.050.150.900.493
17622217,2007-01-01T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
17622217,2007-01-01T00:00:00,Hydrocortisone,D04.808.745.745.654.600
17622217,2007-01-01T00:00:00,Hydrocortisone,D06.472.040.585.353.476
17622217,2007-01-01T00:00:00,Hydrocortisone,D06.472.040.585.478.392
17622217,2007-01-01T00:00:00,"Stress, Physiological",G07.700.830
17622492,2007-01-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
17622492,2007-01-01T00:00:00,Aged,M01.060.116.100
17622492,2007-01-01T00:00:00,Brain Ischemia,C10.228.140.300.150
17622492,2007-01-01T00:00:00,Brain Ischemia,C14.907.253.092
17622492,2007-01-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
17622492,2007-01-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
17622492,2007-01-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
17622492,2007-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
17622492,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17622492,2007-01-01T00:00:00,Medical Records,E05.318.308.940.968
17622492,2007-01-01T00:00:00,Medical Records,L01.280.900.968
17622492,2007-01-01T00:00:00,Medical Records,N04.452.859.564
17622492,2007-01-01T00:00:00,Medical Records,N05.715.360.300.715.500
17622492,2007-01-01T00:00:00,Medical Records,N06.850.520.308.940.968
17622492,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17622492,2007-01-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
17622492,2007-01-01T00:00:00,Stroke,C10.228.140.300.775
17622492,2007-01-01T00:00:00,Stroke,C14.907.253.855
17622492,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17622492,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17622492,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17654566,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17654566,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
17654566,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
17654566,2007-01-01T00:00:00,Urethra,A05.360.444.492.726
17654566,2007-01-01T00:00:00,Urethra,A05.810.876
17654566,2007-01-01T00:00:00,Urethral Diseases,C12.777.767
17654566,2007-01-01T00:00:00,Urethral Diseases,C13.351.968.767
17654566,2007-01-01T00:00:00,Urinary Incontinence,C12.777.934.852
17654566,2007-01-01T00:00:00,Urinary Incontinence,C13.351.968.934.814
17654566,2007-01-01T00:00:00,Urinary Incontinence,C23.888.942.800
17673856,2007-01-01T00:00:00,Coronary Restenosis,C14.280.647.250.285.200
17673856,2007-01-01T00:00:00,Coronary Restenosis,C14.907.585.250.285.200
17673856,2007-01-01T00:00:00,Drug Delivery Systems,E02.319.300
17673856,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17673856,2007-01-01T00:00:00,Myocardial Infarction,C14.280.647.500
17673856,2007-01-01T00:00:00,Myocardial Infarction,C14.907.585.500
17673856,2007-01-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
17673856,2007-01-01T00:00:00,Stents,E07.695.750
17673856,2007-01-01T00:00:00,Thrombosis,C14.907.355.830
17673856,2007-01-01T00:00:00,United States,Z01.107.567.875
17684890,2007-01-01T00:00:00,Accidental Falls,N06.850.135.122
17684890,2007-01-01T00:00:00,Adult,M01.060.116
17684890,2007-01-01T00:00:00,Aged,M01.060.116.100
17684890,2007-01-01T00:00:00,Exercise,G11.427.590.237
17684890,2007-01-01T00:00:00,Exercise,I03.350
17684890,2007-01-01T00:00:00,Health Status,I01.240.425
17684890,2007-01-01T00:00:00,Health Status,N01.224.425
17684890,2007-01-01T00:00:00,Health Status,N06.850.505.400.425
17684890,2007-01-01T00:00:00,Health Surveys,E05.318.308.250
17684890,2007-01-01T00:00:00,Health Surveys,N05.715.360.300.375
17684890,2007-01-01T00:00:00,Health Surveys,N06.850.520.308.250
17684890,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17684890,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17684890,2007-01-01T00:00:00,Motor Activity,F01.145.632
17684890,2007-01-01T00:00:00,Motor Activity,G11.427.590.530.698
17684890,2007-01-01T00:00:00,Pilot Projects,E05.318.760.750
17684890,2007-01-01T00:00:00,Pilot Projects,E05.337.737
17684890,2007-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
17684890,2007-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
17684890,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17684890,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17684890,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17684890,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17684890,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17684890,2007-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
17684890,2007-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
17684890,2007-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
17709692,2007-01-01T00:00:00,"Diagnosis, Differential",E01.171
17709692,2007-01-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
17709692,2007-01-01T00:00:00,Flow Cytometry,E05.200.500.386.350
17709692,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17709692,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
17709692,2007-01-01T00:00:00,"Tumor Markers, Biological",D23.101.840
17762163,2007-01-01T00:00:00,Cell Membrane,A11.284.149
17762163,2007-01-01T00:00:00,Ceramides,D02.065.313
17762163,2007-01-01T00:00:00,Ceramides,D09.400.410.420.525.200
17762163,2007-01-01T00:00:00,Ceramides,D10.390.470.675.200
17762163,2007-01-01T00:00:00,Ceramides,D10.570.877.360.612.200
17762163,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17762163,2007-01-01T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
17762163,2007-01-01T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
17762163,2007-01-01T00:00:00,"Receptors, IgG",D23.101.100.110.695
17762163,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
17762163,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
17762163,2007-01-01T00:00:00,Signal Transduction,G04.299.880
17762163,2007-01-01T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
17891658,2007-01-01T00:00:00,Adult,M01.060.116
17891658,2007-01-01T00:00:00,Hospitalization,E02.760.400
17891658,2007-01-01T00:00:00,Hospitalization,N02.421.585.400
17891658,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17891658,2007-01-01T00:00:00,Incidence,E05.318.308.985.525.375
17891658,2007-01-01T00:00:00,Incidence,L01.280.975.525.375
17891658,2007-01-01T00:00:00,Incidence,N01.224.935.597.500
17891658,2007-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
17891658,2007-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
17891658,2007-01-01T00:00:00,Medical Record Linkage,E05.318.308.940.968.500
17891658,2007-01-01T00:00:00,Medical Record Linkage,L01.280.900.968.500
17891658,2007-01-01T00:00:00,Medical Record Linkage,N04.452.859.564.550
17891658,2007-01-01T00:00:00,Medical Record Linkage,N05.715.360.300.715.500.500
17891658,2007-01-01T00:00:00,Medical Record Linkage,N06.850.520.308.940.968.500
17891658,2007-01-01T00:00:00,Mental Disorders,F03
17891658,2007-01-01T00:00:00,Naltrexone,D03.132.577.249.706.550
17891658,2007-01-01T00:00:00,Naltrexone,D03.549.686.750.550
17891658,2007-01-01T00:00:00,Naltrexone,D03.605.497.750.550
17891658,2007-01-01T00:00:00,Naltrexone,D04.615.723.795.706.550
17891658,2007-01-01T00:00:00,Narcotic Antagonists,D27.505.696.543
17891658,2007-01-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
17891658,2007-01-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
17891658,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
17891658,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
17891658,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
17891658,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
17891658,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
17891658,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
17891658,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
17891658,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
17911916,2007-01-01T00:00:00,Artificial Intelligence,L01.224.065
17911916,2007-01-01T00:00:00,Computational Biology,H01.158.273.180
17911916,2007-01-01T00:00:00,Gene Expression,G05.355.310
17911916,2007-01-01T00:00:00,Gene Expression Profiling,E05.393.332
17911916,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
17911916,2007-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
17911916,2007-01-01T00:00:00,Lung Neoplasms,C08.381.540
17911916,2007-01-01T00:00:00,Lung Neoplasms,C08.785.520
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
17911916,2007-01-01T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
17954250,2007-01-01T00:00:00,Animals,B01.050
17954250,2007-01-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
17954250,2007-01-01T00:00:00,Fatty Acids,D10.251
17954250,2007-01-01T00:00:00,Oxidoreductases,D08.811.682
17954250,2007-01-01T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
17954250,2007-01-01T00:00:00,Sphingolipids,D10.570.877
17954250,2007-01-01T00:00:00,Sphingolipids,D10.808
18000368,2007-01-01T00:00:00,Chromosome Aberrations,C23.550.210
18000368,2007-01-01T00:00:00,Chromosome Aberrations,G05.365.590.175
18000368,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18000368,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
18000368,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
18000368,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
18000368,2007-01-01T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
18000368,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18000368,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18000368,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18000368,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18000368,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18002251,2007-01-01T00:00:00,Animals,B01.050
18002251,2007-01-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
18002251,2007-01-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
18002251,2007-01-01T00:00:00,Catheter Ablation,E01.370.370.380.410.200
18002251,2007-01-01T00:00:00,Catheter Ablation,E02.148.110
18002251,2007-01-01T00:00:00,Catheter Ablation,E02.148.442.110
18002251,2007-01-01T00:00:00,Catheter Ablation,E02.154.402.110
18002251,2007-01-01T00:00:00,Catheter Ablation,E04.014.170.402.110
18002251,2007-01-01T00:00:00,Cryosurgery,E04.014.180
18002251,2007-01-01T00:00:00,Heart,A07.541
18002251,2007-01-01T00:00:00,Swine,B01.050.150.900.649.077.880
18018813,2007-01-01T00:00:00,Adult,M01.060.116
18018813,2007-01-01T00:00:00,Attitude to Health,F01.100.150
18018813,2007-01-01T00:00:00,Attitude to Health,N05.300.150
18018813,2007-01-01T00:00:00,Awareness,F02.463.188.150
18018813,2007-01-01T00:00:00,Culture,I01.076.201.450
18018813,2007-01-01T00:00:00,Culture,I01.880.143
18018813,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18018813,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
18018813,2007-01-01T00:00:00,Questionnaires,L01.280.800
18018813,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
18018813,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
18018813,2007-01-01T00:00:00,"Schools, Medical",I02.783.660.552
18018813,2007-01-01T00:00:00,"Schools, Medical",N02.278.020.578
18018813,2007-01-01T00:00:00,Smoking Cessation,F01.145.940.700
18018813,2007-01-01T00:00:00,Tobacco Use Disorder,C21.739.912
18018813,2007-01-01T00:00:00,Tobacco Use Disorder,F03.900.912
18018813,2007-01-01T00:00:00,United States,Z01.107.567.875
18020538,2007-01-01T00:00:00,Adult,M01.060.116
18020538,2007-01-01T00:00:00,Coronary Disease,C14.280.647.250
18020538,2007-01-01T00:00:00,Coronary Disease,C14.907.585.250
18020538,2007-01-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
18020538,2007-01-01T00:00:00,HIV Infections,C02.782.815.616.400
18020538,2007-01-01T00:00:00,HIV Infections,C02.800.801.400
18020538,2007-01-01T00:00:00,HIV Infections,C20.673.480
18020538,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
18020538,2007-01-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
18020538,2007-01-01T00:00:00,Health Care Costs,N03.219.151.400
18020538,2007-01-01T00:00:00,Health Care Costs,N05.300.375
18020538,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18020538,2007-01-01T00:00:00,Markov Chains,E05.318.740.600.500
18020538,2007-01-01T00:00:00,Markov Chains,E05.318.740.996.500
18020538,2007-01-01T00:00:00,Markov Chains,G17.830.500
18020538,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.625.500
18020538,2007-01-01T00:00:00,Markov Chains,N05.715.360.750.770.500
18020538,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.600.500
18020538,2007-01-01T00:00:00,Markov Chains,N06.850.520.830.996.500
18020538,2007-01-01T00:00:00,Oligopeptides,D12.644.456
18020538,2007-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
18020538,2007-01-01T00:00:00,Risk Factors,N05.715.350.200.700
18020538,2007-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
18020538,2007-01-01T00:00:00,Risk Factors,N06.850.490.625.750
18020538,2007-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
18020538,2007-01-01T00:00:00,Ritonavir,D02.886.675.653
18020538,2007-01-01T00:00:00,Ritonavir,D03.383.129.708.653
18030287,2007-01-01T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
18030287,2007-01-01T00:00:00,Animals,B01.050
18030287,2007-01-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
18030287,2007-01-01T00:00:00,Environmental Monitoring,N06.850.780.375
18030287,2007-01-01T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
18030287,2007-01-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
18058331,2007-01-01T00:00:00,Carrier Proteins,D12.776.157
18058331,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18058331,2007-01-01T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
18058331,2007-01-01T00:00:00,Mental Disorders,F03
18058331,2007-01-01T00:00:00,Pregnancy,G08.686.785.760.769
18058331,2007-01-01T00:00:00,Pregnancy Complications,C13.703
18067438,2007-01-01T00:00:00,Clinical Competence,I02.399.630.210
18067438,2007-01-01T00:00:00,Clinical Competence,N04.761.210
18067438,2007-01-01T00:00:00,Curriculum,I02.158
18067438,2007-01-01T00:00:00,"Education, Dental",I02.358.274
18067438,2007-01-01T00:00:00,Educational Measurement,I02.399
18067438,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
18067438,2007-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
18067438,2007-01-01T00:00:00,Health Personnel,M01.526.485
18067438,2007-01-01T00:00:00,Health Personnel,N02.360
18067438,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18067438,2007-01-01T00:00:00,"Models, Educational",E05.599.545
18067438,2007-01-01T00:00:00,"Models, Educational",I02.903.302
18067438,2007-01-01T00:00:00,Mouth Neoplasms,C04.588.443.591
18067438,2007-01-01T00:00:00,Mouth Neoplasms,C07.465.565
18067438,2007-01-01T00:00:00,Problem-Based Learning,F02.463.425.720
18067438,2007-01-01T00:00:00,Problem-Based Learning,I02.158.660
18067438,2007-01-01T00:00:00,Problem-Based Learning,I02.903.565
18067438,2007-01-01T00:00:00,"Students, Dental",I02.851.686.519
18067438,2007-01-01T00:00:00,"Students, Dental",M01.848.769.519
18072369,2007-01-01T00:00:00,Adolescent,M01.060.057
18072369,2007-01-01T00:00:00,Adult,M01.060.116
18072369,2007-01-01T00:00:00,African Americans,M01.686.508.100.100
18072369,2007-01-01T00:00:00,African Americans,M01.686.754.100
18072369,2007-01-01T00:00:00,Body Image,F02.463.593.112
18072369,2007-01-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
18072369,2007-01-01T00:00:00,Body Mass Index,E05.041.124.125
18072369,2007-01-01T00:00:00,Body Mass Index,G07.100.100.125
18072369,2007-01-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
18072369,2007-01-01T00:00:00,Body Weight,C23.888.144
18072369,2007-01-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
18072369,2007-01-01T00:00:00,Body Weight,E05.041.124.160.750
18072369,2007-01-01T00:00:00,Body Weight,G07.100.100.160.120
18072369,2007-01-01T00:00:00,Body Weight,G07.700.320.249.314.120
18072369,2007-01-01T00:00:00,Health Surveys,E05.318.308.250
18072369,2007-01-01T00:00:00,Health Surveys,N05.715.360.300.375
18072369,2007-01-01T00:00:00,Health Surveys,N06.850.520.308.250
18072369,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18072369,2007-01-01T00:00:00,Obesity,C18.654.726.500
18072369,2007-01-01T00:00:00,Obesity,C23.888.144.699.500
18072369,2007-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
18072369,2007-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
18072369,2007-01-01T00:00:00,Students,I02.233.748
18072369,2007-01-01T00:00:00,Students,I02.851
18072369,2007-01-01T00:00:00,Students,M01.848
18080048,2007-01-01T00:00:00,Adult,M01.060.116
18080048,2007-01-01T00:00:00,Analgesia,E03.091
18080048,2007-01-01T00:00:00,Functional Laterality,F02.830.297.425
18080048,2007-01-01T00:00:00,Functional Laterality,G11.561.225.425
18080048,2007-01-01T00:00:00,Hot Temperature,G01.906.595.543
18080048,2007-01-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
18080048,2007-01-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
18080048,2007-01-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
18080048,2007-01-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
18080048,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18080048,2007-01-01T00:00:00,Neural Inhibition,G07.265.337.615
18080048,2007-01-01T00:00:00,Neural Inhibition,G07.700.240.615
18080048,2007-01-01T00:00:00,Neural Inhibition,G11.561.600.625
18080048,2007-01-01T00:00:00,Pain,C10.597.617
18080048,2007-01-01T00:00:00,Pain,C23.888.592.612
18080048,2007-01-01T00:00:00,Pain,C23.888.646
18080048,2007-01-01T00:00:00,Pain,F02.830.816.444
18080048,2007-01-01T00:00:00,Pain,G11.561.600.810.444
18080048,2007-01-01T00:00:00,Pain Threshold,F02.463.593.710.560
18080048,2007-01-01T00:00:00,Pain Threshold,F02.830.816.444.700
18080048,2007-01-01T00:00:00,Pain Threshold,G11.561.600.810.444.700
18080048,2007-01-01T00:00:00,Pilot Projects,E05.318.760.750
18080048,2007-01-01T00:00:00,Pilot Projects,E05.337.737
18080048,2007-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
18080048,2007-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
18080048,2007-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
18080048,2007-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
18080048,2007-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
18084901,2007-01-01T00:00:00,Animals,B01.050
18084901,2007-01-01T00:00:00,Epithelial Cells,A11.436
18084901,2007-01-01T00:00:00,Glutathione Transferase,D08.811.913.225.500
18084901,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18084901,2007-01-01T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
18084901,2007-01-01T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
18084901,2007-01-01T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
18084901,2007-01-01T00:00:00,Lung,A04.411
18084901,2007-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
18084901,2007-01-01T00:00:00,Lung Neoplasms,C08.381.540
18084901,2007-01-01T00:00:00,Lung Neoplasms,C08.785.520
18084901,2007-01-01T00:00:00,Mesothelioma,C04.557.470.035.510
18084901,2007-01-01T00:00:00,Mesothelioma,C04.557.470.660.510
18084901,2007-01-01T00:00:00,"Models, Biological",E05.599.395
18084901,2007-01-01T00:00:00,Oxidative Stress,G03.495.710
18084901,2007-01-01T00:00:00,Oxidative Stress,G07.700.830.750
18084901,2007-01-01T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.300.500
18084901,2007-01-01T00:00:00,Peroxiredoxin VI,D08.811.277.352.100.680.750.937.625.624
18084901,2007-01-01T00:00:00,Peroxiredoxin VI,D08.811.682.732.850.500
18084901,2007-01-01T00:00:00,Phospholipids,D10.570.755
18084901,2007-01-01T00:00:00,Phospholipids,D10.695
18084901,2007-01-01T00:00:00,Protein Folding,G01.154.100.640
18084901,2007-01-01T00:00:00,Protein Folding,G01.595.100.640
18084901,2007-01-01T00:00:00,Protein Folding,G02.111.087.690
18084901,2007-01-01T00:00:00,Protein Folding,G02.149.115.690
18084901,2007-01-01T00:00:00,Pulmonary Surfactants,D27.505.954.796.600
18084901,2007-01-01T00:00:00,"Sarcoidosis, Pulmonary",C08.381.483.725
18084901,2007-01-01T00:00:00,"Sarcoidosis, Pulmonary",C15.604.515.827.725
18084901,2007-01-01T00:00:00,Thioredoxins,D12.776.915
18161478,2007-01-01T00:00:00,Animals,B01.050
18161478,2007-01-01T00:00:00,Gene Deletion,G05.355.600.800.320
18161478,2007-01-01T00:00:00,Gene Deletion,G05.365.590.762.320
18161478,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18161478,2007-01-01T00:00:00,Insulin,D06.472.699.587.740.625
18161478,2007-01-01T00:00:00,Insulin,D12.644.548.586.740.625
18161478,2007-01-01T00:00:00,Pregnancy,G08.686.785.760.769
18161478,2007-01-01T00:00:00,Proteins,D12.776
18161478,2007-01-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
18161478,2007-01-01T00:00:00,"Receptors, Peptide",D12.776.543.750.750
18161478,2007-01-01T00:00:00,Relaxin,D06.472.334.734.769
18161478,2007-01-01T00:00:00,Relaxin,D06.472.699.715
18161478,2007-01-01T00:00:00,Relaxin,D12.644.548.762
18161478,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
18161478,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
18161478,2007-01-01T00:00:00,Signal Transduction,G04.299.880
18171646,2007-01-01T00:00:00,Adult,M01.060.116
18171646,2007-01-01T00:00:00,Aged,M01.060.116.100
18171646,2007-01-01T00:00:00,Case-Control Studies,E05.318.760.500.500
18171646,2007-01-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
18171646,2007-01-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
18171646,2007-01-01T00:00:00,Disinfectants,D27.505.954.122.425
18171646,2007-01-01T00:00:00,Disinfectants,D27.720.274
18171646,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18171646,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
18171646,2007-01-01T00:00:00,New York,Z01.107.567.875.075.437
18171646,2007-01-01T00:00:00,New York,Z01.107.567.875.350.530
18171646,2007-01-01T00:00:00,New York,Z01.107.567.875.500.530
18171646,2007-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
18171646,2007-01-01T00:00:00,Risk Assessment,N04.452.871.715
18171646,2007-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
18171646,2007-01-01T00:00:00,Risk Assessment,N06.850.505.715
18171646,2007-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
18171646,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
18171646,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
18171646,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
18171646,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
18171646,2007-01-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
18200803,2007-01-01T00:00:00,Antioxidants,D27.505.519.217
18200803,2007-01-01T00:00:00,Antioxidants,D27.505.696.706.125
18200803,2007-01-01T00:00:00,Antioxidants,D27.720.799.047
18200803,2007-01-01T00:00:00,Diabetes Complications,C19.246.099
18200803,2007-01-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
18200803,2007-01-01T00:00:00,"Glycosylation End Products, Advanced",D02.415
18200803,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18200803,2007-01-01T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
18200803,2007-01-01T00:00:00,Reactive Oxygen Species,D01.339.431
18200803,2007-01-01T00:00:00,Reactive Oxygen Species,D01.650.775
18247232,2007-01-01T00:00:00,Adult,M01.060.116
18247232,2007-01-01T00:00:00,Cervical Vertebrae,A02.835.232.834.151
18247232,2007-01-01T00:00:00,Exercise Test,E01.370.370.380.250
18247232,2007-01-01T00:00:00,Exercise Test,E01.370.386.700.250
18247232,2007-01-01T00:00:00,Exercise Test,E05.333.250
18247232,2007-01-01T00:00:00,"Gait Disorders, Neurologic",C10.597.404
18247232,2007-01-01T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
18247232,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18247232,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
18247232,2007-01-01T00:00:00,"Monitoring, Physiologic",E01.370.520
18247232,2007-01-01T00:00:00,Recovery of Function,G16.757
18247232,2007-01-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
18247232,2007-01-01T00:00:00,Spinal Cord Injuries,C10.900.850
18247232,2007-01-01T00:00:00,Spinal Cord Injuries,C21.866.819
18247232,2007-01-01T00:00:00,Walking,G11.427.590.530.568.900
18247232,2007-01-01T00:00:00,Walking,G11.427.590.530.698.940
18247232,2007-01-01T00:00:00,Walking,I03.450.642.845.940
18247232,2007-01-01T00:00:00,Young Adult,M01.060.116.815
18247243,2007-01-01T00:00:00,Activities of Daily Living,E02.831.067
18247243,2007-01-01T00:00:00,Activities of Daily Living,I03.050
18247243,2007-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
18247243,2007-01-01T00:00:00,Adult,M01.060.116
18247243,2007-01-01T00:00:00,Aged,M01.060.116.100
18247243,2007-01-01T00:00:00,Disability Evaluation,E01.370.400
18247243,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18247243,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
18247243,2007-01-01T00:00:00,Psychometrics,F04.711.780
18247243,2007-01-01T00:00:00,Recovery of Function,G16.757
18247243,2007-01-01T00:00:00,Walking,G11.427.590.530.568.900
18247243,2007-01-01T00:00:00,Walking,G11.427.590.530.698.940
18247243,2007-01-01T00:00:00,Walking,I03.450.642.845.940
18253469,2007-01-01T00:00:00,Antifungal Agents,D27.505.954.122.136
18253469,2007-01-01T00:00:00,"Candidiasis, Vulvovaginal",C01.703.160.190
18253469,2007-01-01T00:00:00,"Candidiasis, Vulvovaginal",C13.351.500.894.906.820.500
18253469,2007-01-01T00:00:00,"Candidiasis, Vulvovaginal",C13.351.500.944.902.737.500
18253469,2007-01-01T00:00:00,Health Services Accessibility,N04.590.374.350
18253469,2007-01-01T00:00:00,Health Services Accessibility,N05.300.430
18253469,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18253469,2007-01-01T00:00:00,Pharmaceutical Services,N02.421.668
18253469,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
18253469,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
18253469,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
18253469,2007-01-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
18253469,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18253469,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18286799,2007-01-01T00:00:00,Amphetamine,D02.092.471.683.152.110
18286799,2007-01-01T00:00:00,Animals,B01.050
18286799,2007-01-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
18286799,2007-01-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
18286799,2007-01-01T00:00:00,Cocaine,D02.145.074.722.388
18286799,2007-01-01T00:00:00,Cocaine,D03.132.889.354
18286799,2007-01-01T00:00:00,Cocaine,D03.605.869.388
18286799,2007-01-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
18286799,2007-01-01T00:00:00,Glutamic Acid,D12.125.067.750
18286799,2007-01-01T00:00:00,Glutamic Acid,D12.125.119.450
18286799,2007-01-01T00:00:00,Glutamic Acid,D12.125.427.300
18286799,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18286799,2007-01-01T00:00:00,Neuronal Plasticity,G11.561.600.635
18300414,2007-01-01T00:00:00,Animals,B01.050
18300414,2007-01-01T00:00:00,Blood Vessels,A07.231
18300414,2007-01-01T00:00:00,Cell Lineage,G04.172
18300414,2007-01-01T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
18300414,2007-01-01T00:00:00,Cell Lineage,G08.686.155
18300414,2007-01-01T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
18300414,2007-01-01T00:00:00,Cell Movement,G04.299.283
18300414,2007-01-01T00:00:00,Cell Movement,G07.700.560.500.180
18300414,2007-01-01T00:00:00,Cell Proliferation,G04.299.233.750
18300414,2007-01-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
18300414,2007-01-01T00:00:00,Cell Survival,G04.299.316
18300414,2007-01-01T00:00:00,Endothelial Cells,A11.436.275
18300414,2007-01-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
18300414,2007-01-01T00:00:00,Signal Transduction,G02.111.087.800
18300414,2007-01-01T00:00:00,Signal Transduction,G02.149.115.800
18300414,2007-01-01T00:00:00,Signal Transduction,G04.299.880
18300414,2007-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
18300414,2007-01-01T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
18300414,2007-01-01T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
18430982,2007-01-01T00:00:00,Adult,M01.060.116
18430982,2007-01-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
18430982,2007-01-01T00:00:00,Functional Laterality,F02.830.297.425
18430982,2007-01-01T00:00:00,Functional Laterality,G11.561.225.425
18430982,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18430982,2007-01-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
18430982,2007-01-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
18430982,2007-01-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
18430982,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
18430982,2007-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
18430982,2007-01-01T00:00:00,Stroke,C10.228.140.300.775
18430982,2007-01-01T00:00:00,Stroke,C14.907.253.855
18430982,2007-01-01T00:00:00,Temporal Lobe,A08.186.211.730.885.287.500.863
18476502,2007-01-01T00:00:00,"Education, Graduate",I02.358.337
18476502,2007-01-01T00:00:00,Health Facility Administrators,M01.526.070.490
18476502,2007-01-01T00:00:00,Health Facility Administrators,M01.526.485.430
18476502,2007-01-01T00:00:00,Health Facility Administrators,N02.360.430
18476502,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
18476502,2007-01-01T00:00:00,Leadership,F01.752.609
18476502,2007-01-01T00:00:00,"Schools, Medical",I02.783.660.552
18476502,2007-01-01T00:00:00,"Schools, Medical",N02.278.020.578
18476502,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
18476502,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
18654192,2007-01-01T00:00:00,Biomimetics,H01.158.550.100
18654192,2007-01-01T00:00:00,Biomimetics,J01.897.120.100
18654192,2007-01-01T00:00:00,Drug Carriers,D26.255.260
18654192,2007-01-01T00:00:00,Drug Carriers,D27.720.280.260
18654192,2007-01-01T00:00:00,Drug Carriers,E02.319.300.380
18654192,2007-01-01T00:00:00,Nanostructures,J01.637.512
18654192,2007-01-01T00:00:00,Nanotechnology,H01.603
18654192,2007-01-01T00:00:00,Nanotechnology,J01.897.520.600
19649164,2007-01-01T00:00:00,Asthma,C08.127.108
19649164,2007-01-01T00:00:00,Asthma,C08.381.495.108
19649164,2007-01-01T00:00:00,Asthma,C08.674.095
19649164,2007-01-01T00:00:00,Asthma,C20.543.480.680.095
19649164,2007-01-01T00:00:00,Community-Based Participatory Research,N05.425.104
19649164,2007-01-01T00:00:00,Community-Institutional Relations,N04.452.822.210
19649164,2007-01-01T00:00:00,Health Education,I02.233.332
19649164,2007-01-01T00:00:00,Health Education,N02.421.143.827.407
19649164,2007-01-01T00:00:00,Health Education,N02.421.726.407
19649164,2007-01-01T00:00:00,Health Surveys,E05.318.308.250
19649164,2007-01-01T00:00:00,Health Surveys,N05.715.360.300.375
19649164,2007-01-01T00:00:00,Health Surveys,N06.850.520.308.250
19649164,2007-01-01T00:00:00,Hispanic Americans,M01.686.754.441
19649164,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19649164,2007-01-01T00:00:00,Program Evaluation,E05.337.820
19649164,2007-01-01T00:00:00,Program Evaluation,N04.761.685
19649164,2007-01-01T00:00:00,Program Evaluation,N05.715.360.650
19759994,2007-01-01T00:00:00,Allied Health Occupations,H02.010
19759994,2007-01-01T00:00:00,Allied Health Personnel,M01.526.485.067
19759994,2007-01-01T00:00:00,Allied Health Personnel,N02.360.067
19759994,2007-01-01T00:00:00,Career Choice,F02.463.785.373.346.400
19759994,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19759994,2007-01-01T00:00:00,Occupational Therapy,E02.831.489
19759994,2007-01-01T00:00:00,Occupational Therapy,H02.010.500
19759994,2007-01-01T00:00:00,Questionnaires,E05.318.308.750
19759994,2007-01-01T00:00:00,Questionnaires,L01.280.800
19759994,2007-01-01T00:00:00,Questionnaires,N05.715.360.300.695
19759994,2007-01-01T00:00:00,Questionnaires,N06.850.520.308.750
19759994,2007-01-01T00:00:00,School Admission Criteria,I02.399.750
19759994,2007-01-01T00:00:00,"Students, Health Occupations",I02.851.686
19759994,2007-01-01T00:00:00,"Students, Health Occupations",M01.848.769
19759994,2007-01-01T00:00:00,United States,Z01.107.567.875
19759996,2007-01-01T00:00:00,Adult,M01.060.116
19759996,2007-01-01T00:00:00,Aged,M01.060.116.100
19759996,2007-01-01T00:00:00,Breast Neoplasms,C04.588.180
19759996,2007-01-01T00:00:00,Breast Neoplasms,C17.800.090.500
19759996,2007-01-01T00:00:00,Exercise,G11.427.590.237
19759996,2007-01-01T00:00:00,Exercise,I03.350
19759996,2007-01-01T00:00:00,Fatigue,C23.888.369
19759996,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19759996,2007-01-01T00:00:00,Middle Aged,M01.060.116.630
19759996,2007-01-01T00:00:00,Pilot Projects,E05.318.760.750
19759996,2007-01-01T00:00:00,Pilot Projects,E05.337.737
19759996,2007-01-01T00:00:00,Pilot Projects,N05.715.360.775.625
19759996,2007-01-01T00:00:00,Pilot Projects,N06.850.520.450.720
19759996,2007-01-01T00:00:00,Self Care,E02.900
19759996,2007-01-01T00:00:00,Self Care,N02.421.784.680
19759996,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19759996,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19759996,2007-01-01T00:00:00,Treatment Outcome,E01.789.800
19759996,2007-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
19759996,2007-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
19759996,2007-01-01T00:00:00,Walking,G11.427.590.530.568.900
19759996,2007-01-01T00:00:00,Walking,G11.427.590.530.698.940
19759996,2007-01-01T00:00:00,Walking,I03.450.642.845.940
19759997,2007-01-01T00:00:00,Academic Medical Centers,N02.278.020
19759997,2007-01-01T00:00:00,Adult,M01.060.116
19759997,2007-01-01T00:00:00,"Education, Graduate",I02.358.337
19759997,2007-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
19759997,2007-01-01T00:00:00,Information Dissemination,F01.145.209.364
19759997,2007-01-01T00:00:00,Information Dissemination,L01.143.443
19759997,2007-01-01T00:00:00,Learning,F02.463.425
19759997,2007-01-01T00:00:00,Learning,F02.784.629.529
19759997,2007-01-01T00:00:00,Research,H01.770.644
19759997,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
19759997,2007-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
19759997,2007-01-01T00:00:00,"Students, Health Occupations",I02.851.686
19759997,2007-01-01T00:00:00,"Students, Health Occupations",M01.848.769
19759997,2007-01-01T00:00:00,Teaching,I02.903
19759997,2007-01-01T00:00:00,Young Adult,M01.060.116.815
